
<!doctype html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>QBank: NEET PG</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <script type="text/javascript" async src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.7/latest.js?config=TeX-MML-AM_CHTML"></script>
    <script type="text/x-mathjax-config">
        MathJax.Hub.Config({
            "HTML-CSS": { preferredFont: "TeX", linebreaks: { automatic: true } },
            CommonHTML: { linebreaks: { automatic: true } },
            SVG: { linebreaks: { automatic: true } }
        });
    </script>
    <style>
        /* --- Global Styles & Variables --- */
        :root {
            --bg-color: #f4f7fa;
            --surface-color: #ffffff;
            --on-surface-color: #1c1b1f;
            --primary-color: #006494;
            --primary-variant: #004c75;
            --secondary-color: #025e73;
            --correct-color: #146c2e;
            --incorrect-color: #ba1a1a;
            --correct-bg: #c8e6c9;
            --incorrect-bg: #f8d7da;
            --border-color: #c1c7cd;
            --shadow-1: 0px 2px 4px rgba(0,0,0,0.1);
            --shadow-2: 0px 4px 12px rgba(0,0,0,0.12);
            --font-family: 'Inter', -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, sans-serif;
            --sidebar-width: 320px;
            --category-bg: #e3f2fd;
            --subject-bg: #e8f5e9;
            --module-bg: #fff3e0;
        }

        /* --- Dark Theme Variables --- */
        body.dark-mode {
            --bg-color: #121212;
            --surface-color: #1e1e1e;
            --on-surface-color: #e0e0e0;
            --primary-color: #4fc3f7;
            --primary-variant: #29b6f6;
            --secondary-color: #4dd0e1;
            --border-color: #333;
            --correct-bg: #1b5e20;
            --incorrect-bg: #b71c1c;
            --category-bg: #1a237e;
            --subject-bg: #1b5e20;
            --module-bg: #e65100;
        }

        html, body {
            margin: 0;
            padding: 0;
            width: 100%;
            height: 100%;
            background-color: var(--bg-color);
            color: var(--on-surface-color);
            font-family: var(--font-family);
            font-size: 16px;
            line-height: 1.6;
            -webkit-font-smoothing: antialiased;
            -moz-osx-font-smoothing: grayscale;
            transition: background-color 0.3s ease, color 0.3s ease;
        }

        /* --- Layout --- */
        .app-container {
            display: flex;
            min-height: 100vh;
            height: 100dvh;
            overflow: hidden;
        }
        .sidebar {
            width: var(--sidebar-width);
            flex-shrink: 0;
            background-color: var(--surface-color);
            border-right: 1px solid var(--border-color);
            display: flex;
            flex-direction: column;
            overflow-y: auto;
            transition: transform 0.3s ease;
            box-shadow: var(--shadow-1);
        }
        .main-content {
            flex-grow: 1;
            display: flex;
            flex-direction: column;
            overflow: hidden;
            min-height: 0;
        }
        .content-area {
            flex-grow: 1;
            padding: 24px;
            overflow-y: auto;
            min-height: 0;
            padding-bottom: 120px;
        }

        /* --- Header --- */
        .header {
            background-color: var(--surface-color);
            padding: 16px 24px;
            border-bottom: 1px solid var(--border-color);
            box-shadow: var(--shadow-1);
            z-index: 10;
            display: flex;
            justify-content: space-between;
            align-items: center;
            flex-wrap: wrap;
            gap: 16px;
        }
        .header h1 {
            margin: 0;
            font-size: 1.5em;
            font-weight: 700;
            color: var(--primary-color);
        }
        .header .subtitle {
            margin: 4px 0 0 0;
            font-size: 0.9em;
            color: #5f6368;
        }
        body.dark-mode .header .subtitle { color: #aaa; }
        
        .header-controls {
            display: flex;
            align-items: center;
            gap: 16px;
        }
        .theme-toggle {
            background: none;
            border: none;
            font-size: 1.2em;
            cursor: pointer;
            color: var(--on-surface-color);
            padding: 8px;
            border-radius: 50%;
            transition: background-color 0.3s ease;
        }
        .theme-toggle:hover {
            background-color: var(--bg-color);
        }

        /* --- Sidebar Navigation --- */
        .sidebar-header {
            padding: 16px;
            font-weight: 600;
            font-size: 1.1em;
            color: var(--primary-color);
            border-bottom: 1px solid var(--border-color);
            text-align: center;
            background-color: var(--primary-color);
            color: white;
        }
        .nav-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }
        .nav-item {
            border-bottom: 1px solid var(--border-color);
        }
        .nav-link {
            display: flex;
            align-items: center;
            padding: 12px 16px;
            cursor: pointer;
            transition: background-color 0.2s ease;
            position: relative;
        }
        .nav-link:hover {
            background-color: var(--bg-color);
        }
        .nav-link.active {
            background-color: var(--primary-color);
            color: white;
        }
        .nav-link.active .nav-icon {
            color: white;
        }
        .nav-icon {
            margin-right: 12px;
            width: 20px;
            text-align: center;
            color: var(--primary-color);
        }
        .nav-text {
            flex-grow: 1;
            font-weight: 500;
        }
        .nav-count {
            background-color: var(--primary-color);
            color: white;
            border-radius: 12px;
            padding: 2px 8px;
            font-size: 0.8em;
            font-weight: 600;
        }
        .nav-link.active .nav-count {
            background-color: white;
            color: var(--primary-color);
        }
        .expand-icon {
            margin-left: 8px;
            transition: transform 0.2s ease;
        }
        .nav-item.expanded > .nav-link .expand-icon {
            transform: rotate(90deg);
        }
        .sub-nav {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.3s ease;
            background-color: var(--bg-color);
        }
        .nav-item.expanded > .sub-nav {
            max-height: 2000px;
        }
        .sub-nav .nav-link {
            padding-left: 48px;
            font-size: 0.95em;
        }
        .sub-nav .sub-nav .nav-link {
            padding-left: 72px;
            font-size: 0.9em;
        }
        .category-item .nav-link {
            background-color: var(--category-bg);
            font-weight: 600;
        }
        .subject-item .nav-link {
            background-color: var(--subject-bg);
        }
        .module-item .nav-link {
            background-color: var(--module-bg);
        }
        body.dark-mode .category-item .nav-link {
            background-color: var(--category-bg);
        }
        body.dark-mode .subject-item .nav-link {
            background-color: var(--subject-bg);
        }
        body.dark-mode .module-item .nav-link {
            background-color: var(--module-bg);
        }

        /* --- Breadcrumb --- */
        .breadcrumb {
            padding: 12px 24px;
            background-color: var(--surface-color);
            border-bottom: 1px solid var(--border-color);
            font-size: 0.9em;
        }
        .breadcrumb-item {
            display: inline-block;
        }
        .breadcrumb-item:not(:last-child)::after {
            content: " > ";
            margin: 0 8px;
            color: var(--primary-color);
        }

        /* --- Question Card --- */
        .card {
            background-color: var(--surface-color);
            border-radius: 12px;
            padding: 24px;
            margin-bottom: 24px;
            box-shadow: var(--shadow-1);
            transition: box-shadow 0.3s ease, transform 0.3s ease;
            border: 1px solid var(--border-color);
        }
        .card:hover {
            box-shadow: var(--shadow-2);
            transform: translateY(-2px);
        }
        .question-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 16px;
        }
        .question-number {
            font-weight: 700;
            font-size: 1.1em;
            color: var(--secondary-color);
        }
        .mark-review-btn {
            background: none;
            border: 1px solid var(--border-color);
            padding: 6px 12px;
            border-radius: 16px;
            cursor: pointer;
            font-size: 0.9em;
            color: var(--on-surface-color);
            transition: all 0.2s ease;
        }
        .mark-review-btn:hover {
            background-color: var(--bg-color);
        }
        .mark-review-btn.marked {
            background-color: var(--primary-color);
            color: white;
            border-color: var(--primary-color);
        }
        .question-text {
            font-size: 1.05em;
            margin-bottom: 20px;
        }
        .options-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }
        .options-list li {
            border: 1px solid var(--border-color);
            border-radius: 8px;
            padding: 16px;
            margin-bottom: 12px;
            cursor: pointer;
            transition: all 0.2s ease;
            display: flex;
            align-items: flex-start;
        }
        .options-list li:hover:not(.locked) {
            border-color: var(--primary-color);
            background-color: var(--bg-color);
        }
        .options-list li .option-label {
            font-weight: 600;
            color: var(--primary-color);
            margin-right: 12px;
            min-width: 24px;
        }
        .options-list li.user-correct {
            border-color: var(--correct-color);
            background-color: var(--correct-bg);
            color: white;
        }
        .options-list li.user-incorrect {
            border-color: var(--incorrect-color);
            background-color: var(--incorrect-bg);
            color: white;
        }
        .options-list li.correct-reveal {
            border-color: var(--correct-color);
            background-color: var(--correct-bg);
            color: white;
            font-weight: 600;
            box-shadow: 0 0 8px rgba(20, 108, 46, 0.4);
        }
        .options-list li.locked {
            cursor: not-allowed;
        }
        .explanation-container {
            margin-top: 20px;
        }
        .show-explanation-btn {
            background-color: var(--primary-color);
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 20px;
            font-weight: 600;
            cursor: pointer;
            transition: background-color 0.2s ease;
        }
        .show-explanation-btn:hover {
            background-color: var(--primary-variant);
        }
        .explanation {
            margin-top: 16px;
            padding: 16px;
            background-color: var(--bg-color);
            border-left: 5px solid var(--primary-color);
            border-radius: 4px;
            display: none;
        }
        .explanation p:first-child { margin-top: 0; }
        .explanation p:last-child { margin-bottom: 0; }
        .correct-answer-label {
            font-weight: 700;
            color: var(--correct-color);
        }
        body.dark-mode .correct-answer-label { color: #81c784; }
        
        /* --- Progress Bar --- */
        .progress-container {
            width: 100%;
            height: 6px;
            background-color: var(--border-color);
            border-radius: 3px;
            overflow: hidden;
            margin-top: 8px;
        }
        .progress-bar {
            height: 100%;
            background-color: var(--primary-color);
            width: 0%;
            transition: width 0.4s ease;
        }
        
        /* --- Media & Math --- */
        .question-text img, .explanation img {
            max-width: 100%;
            height: auto;
            display: block;
            margin: 16px auto;
            border-radius: 8px;
            box-shadow: var(--shadow-1);
        }
        .MathJax_Display, .MathJax {
            overflow-x: auto;
            overflow-y: hidden;
        }

        /* --- Mobile Responsiveness --- */
        @media (max-width: 768px) {
            .header {
                padding: 12px 16px;
            }
            .header h1 { font-size: 1.2em; }
            .header-controls {
                width: 100%;
                justify-content: space-between;
            }
            .app-container {
                flex-direction: column;
            }
            .sidebar {
                width: 100%;
                height: auto;
                border-right: none;
                border-bottom: 1px solid var(--border-color);
                position: fixed;
                top: 0;
                left: 0;
                z-index: 20;
                transform: translateY(-100%);
            }
            .sidebar.open {
                transform: translateY(0);
            }
            .sidebar-header {
                text-align: center;
            }
            .nav-list {
                display: block;
                padding: 0;
                overflow-x: visible;
                overflow-y: auto;
            }
            .nav-list li {
                padding: 0;
                margin-right: 0;
                border-radius: 0;
                border: 0;
                font-size: 0.9em;
                white-space: normal;
            }
            .nav-list li.active {
                border-color: initial;
                background-color: initial;
                color: inherit;
            }
            .content-area {
                padding: 16px;
                margin-top: 60px; /* Space for mobile header */
            }
            .card {
                padding: 16px;
            }
        }
    </style>
</head>
<body>

    <div class="app-container">
        <div class="sidebar" id="sidebar">
            <div class="sidebar-header">Course Navigation</div>
            <ul class="nav-list" id="nav-list">
                <!-- Navigation will be injected here by JS -->
            </ul>
        </div>
        <div class="main-content">
            <div class="header">
                <div>
                    <h1>QBank: NEET PG</h1>
                    <p class="subtitle">NEET PG | Total Questions: <span id="total-q-count">0</span></p>
                    <div class="progress-container"><div class="progress-bar" id="progress-bar"></div></div>
                </div>
                <div class="header-controls">
                    <button class="theme-toggle" id="theme-toggle"><i class="fas fa-moon"></i></button>
                </div>
            </div>
            <div class="breadcrumb" id="breadcrumb">
                <span class="breadcrumb-item">Home</span>
            </div>
            <div class="content-area" id="questions-container">
                <p>Please select a category, subject, or module to begin.</p>
            </div>
        </div>
    </div>

<script>
    // DATA IS INJECTED HERE BY PYTHON
    const COURSE_DATA = {"courseId": 1, "courseName": "NEET PG", "total_questions": 22635, "categories": [{"categoryId": "main", "name": "Main", "subjects": {"subjectId": 1000186, "name": "Biochemistry", "modules": [{"moduleId": 1008713, "name": "Classification And General Properties Of Sugars", "questions": [{"id": "1173068", "html_qtxt": "Which of the following is not an aldose?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Aldoses are monosaccharides that contain an aldehyde group (-CHO) as their functional group.</li>\n<li>Ketoses are monosaccharides that contain a ketone group (C=O), usually at the second carbon.</li>\n</ul>\n<p>Common aldoses and ketoses are:</p><br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508145bd3a458-a5de-4767-98cb-038c1c03260e.png\">", "options": ["Glucose", "Mannose", "Fructose", "Galactose"], "html_options": ["Glucose", "Mannose", "Fructose", "Galactose"], "corr_idx": 2}, {"id": "1173072", "html_qtxt": "Sugar exhibits various forms of isomerism. Which of the following is not true about glucose sugar?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>In aqueous solution, glucose predominantly exists in its cyclic pyranose form (a six-membered ring). After dissolving, mutarotation occurs-an interconversion between the alpha (&alpha;) and beta (&beta;) anomers at the anomeric carbon (C1).</p>\n<ul>\n<li>&alpha;-D-glucopyranose: the -OH group on C1 is axial (down)</li>\n<li>&beta;-D-glucopyranose: the -OH group on C1 is equatorial (up) &rarr; more stable</li>\n</ul>\n<p>Because the &beta;-anomer is sterically more stable, it is present in higher proportion.</p>\n<p><strong>Actual distribution in solution</strong>:</p>\n<ul>\n<li>~62% &beta;-D-glucopyranose</li>\n<li>~38% &alpha;-D-glucopyranose</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>D or L form of a sugar is determined by the -OH/-H orientation on the carbon before the terminal alcohol (Option A): </strong>The D or L configuration of glucose depends on the orientation of the -OH group on the chiral carbon farthest from the carbonyl group (carbon 5 in glucose).</p>\n<p><strong>In solution, glucose is dextrorotatory, so glucose is called dextrose (Option B)</strong>: Glucose rotates plane-polarised light to the right and is therefore dextrorotatory-commonly known as dextrose in clinical settings.</p>\n<p><strong>Crystalline Glucose is alpha-D-glucopyranose (Option C)</strong>: In the crystalline form, glucose predominantly exists as &alpha;-D-glucopyranose, a six-membered ring (pyranose).</p>", "options": ["D or L form of a sugar is determined by the -OH/-H orientation on the carbon before the terminal alcohol.", "In solution, glucose is dextrorotatory, so glucose is called dextrose", "Crystalline Glucose is alpha-D-glucopyranose", "In a solution, it gives a mixture of alpha-glucopyranose (62%) and beta-glucopyranose(38%)"], "html_options": ["D or L form of a sugar is determined by the -OH/-H orientation on the carbon before the terminal alcohol.", "In solution, glucose is dextrorotatory, so glucose is called dextrose", "Crystalline Glucose is alpha-D-glucopyranose", "In a solution, it gives a mixture of alpha-glucopyranose (62%) and beta-glucopyranose(38%)"], "corr_idx": 3}, {"id": "1173076", "html_qtxt": "Starch is an important dietary constituent of food. Which of the following sentences is not correct about starch?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The statement that \"Amylose is a soluble branched structure and amylopectin is an insoluble branched structure\" is incorrect.</p>\n<p>Starch is a homopolysaccharide composed entirely of glucose units linked by &alpha;-glucosidic bonds; hence, it is also called a glucan (or glucosan). It is a major dietary carbohydrate found in cereals, potatoes, legumes, and vegetables.</p>\n<p>Starch consists mainly of two components:</p>\n<ul>\n<li>Amylose (13-20%): A soluble, unbranched helical polymer with &alpha;-1,4 glycosidic bonds.</li>\n<li>Amylopectin (80-87%): An insoluble, branched polymer with &alpha;-1,4 bonds in linear chains and &alpha;-1,6 bonds at branch points.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814733d74fb-c4b3-4e05-b217-7f9b09bf8ed0.png\"></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Homopolysaccharides made up only of glucose (Option A): </strong>Starch is a homopolysaccharide, meaning it is composed of only one type of monomer: glucose.</p>\n<p><strong>Mixture of Amylose 15-20% and Amylopectin 80-85% (Option B): </strong></p>\n<ul>\n<li>Starch is made up of two components:\n<ul>\n<li>Amylose: linear, makes up about 15-20%</li>\n<li>Amylopectin: branched, makes up about 80-85%</li>\n</ul>\n</li>\n<li>These percentages can vary slightly by source (e.g., rice, corn, potatoes), but the range is accurate.</li>\n</ul>\n<p><strong>Also called glucan or glucosan (Option D): </strong>The term glucan refers to a polysaccharide composed entirely of glucose units, which applies to starch. Glucosan is a less common term, but it also refers to glucose polymers.</p>", "options": ["Homopolysaccharides are made up of only glucose", "Mixture of Amylose 15-20% and Amylopectin 80-85%", "Amylose is a soluble branched and amylopectin is an insoluble branched structure", "Also called glucan or glucose"], "html_options": ["Homopolysaccharides are made up of only glucose", "Mixture of Amylose 15-20% and Amylopectin 80-85%", "Amylose is a soluble branched and amylopectin is an insoluble branched structure", "Also called glucan or glucose"], "corr_idx": 2}, {"id": "1173081", "html_qtxt": "All of the following sugars give a Benedict's test positive except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Sucrose Does not give a positive Benedict's test</p>\n<ul>\n<li>Disaccharide of glucose + fructose</li>\n<li>No free anomeric carbon &rarr; both involved in glycosidic bond (&alpha;1&rarr;&beta;2 linkage)</li>\n<li>Non-reducing sugar</li>\n</ul>\n<p>Benedict's test is used to detect reducing sugars, which have a free aldehyde or keto group.<br /> </p>\n<p>In alkaline solution, these groups can reduce Cu&#178;&#8314; to Cu&#8314;, forming a brick-red precipitate of copper(I) oxide (CuH&#8322;O).</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814517bf105-9b47-4a15-a7bc-2dd4aa8a3737.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lactose (Option B): </strong>A reducing disaccharide (&beta;1&rarr;4 linkage); the glucose unit has a free anomeric carbon, allowing it to reduce Cu&#178;&#8314;;</p>\n<p><strong>Glucose (Option C): </strong>A monosaccharide with a free aldehyde group (in open-chain form); gives a positive Benedict's test.</p>\n<p><strong>Fructose (Option D): </strong>A ketose, but under alkaline conditions, it isomerizes to glucose/mannose (aldoses) and gives a positive Benedict's test.</p>", "options": ["Sucrose", "Lactose", "Glucose", "Fructose"], "html_options": ["Sucrose", "Lactose", "Glucose", "Fructose"], "corr_idx": 0}, {"id": "1173086", "html_qtxt": "Which of the following are enantiomers:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Enantiomers are non-superimposable mirror images of each other.</li>\n<li>They have opposite configurations at all chiral centres.</li>\n<li>In sugars, D- and L-forms are enantiomers, differing in the configuration around the penultimate carbon (second-last carbon in the chain).</li>\n<li>The D/L system is based on the configuration of the chiral carbon furthest from the carbonyl group.</li>\n<li>Examples of Enantiomers\n<ul>\n<li>D Glucose and L Glucose</li>\n<li>D Fructose and L Fructose</li>\n<li>D Mannose and L Mannose</li>\n<li>D-Glyceraldehyde and L-Glyceraldehyde</li>\n</ul>\n</li>\n</ul>", "options": ["D-Galactose and L-Glucose", "D- Galactose and I-Glucose", "D-Mannose and L-Mannose", "D-Mannose and I-Mannose"], "html_options": ["D-Galactose and L-Glucose", "D- Galactose and I-Glucose", "D-Mannose and L-Mannose", "D-Mannose and I-Mannose"], "corr_idx": 2}, {"id": "1173095", "html_qtxt": "Epimer combination(s) is/are:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>D-Galactose is an epimer of D-glucose at the 4th carbon.</p>\n<ul>\n<li>Epimers are diastereomers that differ in configuration at only one specific chiral carbon (excluding the anomeric and penultimate carbons).</li>\n<li>For aldohexoses like glucose, the common chiral centres are C-2, C-3, C-4, and C-5.</li>\n<li>So, if two sugars differ only at one of these positions, they are epimers.</li>\n<li>Epimers of Glucose:\n<ul>\n<li>2nd Epimer of Glucose - Mannose</li>\n<li>3rd Epimer of Glucose - Allose</li>\n<li>4th Epimer of Glucose - Galactose.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508145ca62fc5-111e-4668-970b-30e31cffdfab.png\"></li>\n</ul>\n</li>\n</ul>", "options": ["D-Glucose and D-Fructose", "D-Mannose and D-Talose", "D-Galactose and D-Mannose", "D-Galactose and D-Glucose"], "html_options": ["D-Glucose and D-Fructose", "D-Mannose and D-Talose", "D-Galactose and D-Mannose", "D-Galactose and D-Glucose"], "corr_idx": 3}, {"id": "1173113", "html_qtxt": "D galactose and D mannose are?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Diastereomers are stereoisomers that are not mirror images.</li>\n<li>They differ at one or more (but not all) chiral centres.</li>\n<li>D-Galactose and D-Mannose differ at two chiral centres (C-2 and C-4) &rarr; They are diastereomers of each other.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814802f26c5-9617-4c8d-b775-4f362c5bf2d9.png\"></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Enantiomers (Option A):</strong></p>\n<ul>\n<li>These are non-superimposable mirror images.</li>\n<li>Enantiomers differ at all chiral centres.</li>\n<li>Example: D-Glucose vs L-Glucose</li>\n<li>D-Galactose and D-Mannose are not mirror images of each other &rarr; Not enantiomers.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508143d07f13c-c941-49de-8fd2-8530e607f6a7.png\"></li>\n</ul>\n<p><strong>Anomers (Option C):</strong></p>\n<ul>\n<li>Anomers differ in configuration only at the anomeric carbon (C-1 in aldoses)</li>\n<li>Example: &alpha;-D-Glucose vs &beta;-D-Glucose<br /> &rarr; D-Galactose and D-Mannose differ at multiple carbons and not at the anomeric carbon alone.<br /> &rarr; Not anomers.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081473d2e4fe-34cb-4b51-87b5-44e3111c2124.png\"></li>\n</ul>\n<p><strong>Epimers (Option D):</strong></p>\n<ul>\n<li>Epimers differ at only one chiral centre.</li>\n<li>Example: D-Glucose vs D-Mannose (C-2 epimers), D-Glucose vs D-Galactose (C-4 epimers)</li>\n</ul>\n<p>D-Galactose and D-Mannose differ at two carbons (C-2 and C-4) &rarr; not epimers</p>", "options": ["Enantiomers of each other", "Diastereomers of each other", "Anomers of each other", "Epimers of each other"], "html_options": ["Enantiomers of each other", "Diastereomers of each other", "Anomers of each other", "Epimers of each other"], "corr_idx": 1}, {"id": "1173114", "html_qtxt": "Enzyme that hydrolyzes sucrose is", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Sucrose is a disaccharide made up of glucose + fructose, linked via a glycosidic bond (&alpha;1&rarr;&beta;2).</li>\n<li>The enzyme that hydrolyses sucrose into glucose and fructose is called:\n<ul>\n<li><strong>Invertase</strong> (commonly used name)</li>\n<li>Also known as <strong>Sucrase</strong> (especially in human intestinal enzymes)</li>\n</ul>\n</li>\n<li>The hydrolysis of sucrose changes the optical rotation of the solution:\n<ul>\n<li>Sucrose: +66.5&deg; (dextrorotatory)</li>\n<li>Glucose: +52.5&deg;</li>\n<li>Fructose: &minus;92&deg; (levorotatory)</li>\n</ul>\n</li>\n<li>The resulting mixture (glucose + fructose) has a net negative rotation, so the plane of polarised light is inverted; hence, \"invert sugar.\"</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Amylase (Option B)</strong>: Breaks down starch (amylose/amylopectin<strong>)</strong> into maltose and dextrins-not active on sucrose.</p>\n<p><strong>Sucrose phosphorylase (Option C)</strong>: Catalyzes phosphorolysis (not hydrolysis) of sucrose - more relevant in some bacterial systems.</p>\n<p><strong>Saccharase (Option D)</strong>: Outdated or alternate term sometimes used interchangeably, but <strong>Invertase</strong> is the classical and more widely accepted name.</p>", "options": ["Invertase", "Amylase", "Sucrose phosphorylase", "Saccharase"], "html_options": ["Invertase", "Amylase", "Sucrose phosphorylase", "Saccharase"], "corr_idx": 0}, {"id": "1173119", "html_qtxt": "Which of the following compound is a fructosan?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>A fructosan is a homopolysaccharide made up only of fructose units.</li>\n<li>The fructose monomers are typically linked by &beta;(2&rarr;1) glycosidic bonds.</li>\n<li>Inulin (Fructosan)\n<ul>\n<li>Homopolysaccharide of Fructose in &beta; 2 &rarr; 1 linkage</li>\n<li>Found in the roots of dahlias, chicory, onion, garlic, and dandelions</li>\n<li>Belongs to a class of fibres</li>\n<li>Readily soluble in water</li>\n<li>Used in the clearance test to determine GFR</li>\n<li>Not hydrolysed by human digestive enzymes.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Fructose (Option A): </strong>It is a monosaccharide and hence not a fructan</p>\n<p><strong>Chitin (Option B): </strong>Homopolymer of N-acetylglucosamine, not fructose</p>\n<p><strong>Cellulose (Option C)</strong>: Homopolymer of glucose, with &beta;(1&rarr;4) linkages</p>", "options": ["Fructose", "Chitin", "Inulin", "Cellulose"], "html_options": ["Fructose", "Chitin", "Inulin", "Cellulose"], "corr_idx": 2}, {"id": "1173125", "html_qtxt": "All of the following statements about optical isomers of carbohydrates are true except", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Sucrose itself is dextrorotatory (+66.5&deg;)</li>\n<li>On hydrolysis, it yields:\n<ul>\n<li>D-Glucose (+52.5&deg;)</li>\n<li>D-Fructose (&minus;92&deg;)</li>\n</ul>\n</li>\n<li>The strong levorotation of fructose dominates, so the final mixture is levorotatory</li>\n<li>This change in optical rotation from positive to negative is why it's called invert sugar &rarr; Hence, after hydrolysis, sucrose is not dextrorotatory- it becomes levorotatory</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>D-Glucose is dextrorotatory, but D-Fructose is levorotatory (Option A): </strong>D-Glucose rotates plane-polarised light to the right (+52.5&deg;) &rarr; hence called Dextrose. D-Fructose, despite being a D-isomer, rotates light to the left (&minus;92&deg;)</p>\n<p><strong>Monosaccharide with no asymmetric carbon atom -Dihydroxyacetone (Option B): </strong>Dihydroxyacetone is the simplest ketose. Structure: CH₂OH-CO-CH₂OH. No chiral (asymmetric) carbon atoms, so no optical activity</p>\n<p><strong>An equimolar mixture of optical isomers that has no net rotation of plane-polarised light is called a racemic mixture (Option C): </strong>A racemic mixture contains equal amounts of dextrorotatory (+) and levorotatory (&minus;) enantiomers. Their optical activities cancel out, giving no net rotation</p>", "options": ["D Glucose is dextrorotatory but D Fructose is levorotatory", "Monosaccharide with no Asymmetric Carbon atom-Dihydroxy-acetone", "An equimolar mixture of optical isomers that has no net rotation of plane-polarised light is called a racemic mixture", "On hydrolysis, Sucrose is dextrorotatory"], "html_options": ["D Glucose is dextrorotatory but D Fructose is levorotatory", "Monosaccharide with no Asymmetric Carbon atom-Dihydroxy-acetone", "An equimolar mixture of optical isomers that has no net rotation of plane-polarised light is called a racemic mixture", "On hydrolysis, Sucrose is dextrorotatory"], "corr_idx": 3}, {"id": "1173127", "html_qtxt": "Osazone is formed by all of the following compounds except", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>An osazone is a crystalline derivative formed when a reducing sugar reacts with excess phenylhydrazine under heating.</li>\n<li>Reaction occurs mainly at C-1 and C-2 of the sugar molecule.</li>\n<li>Oxazones are insoluble and have distinct crystal shapes under the microscope.</li>\n<li>Only reducing sugars can form osazones. These include:\n<ul>\n<li>Glucose (aldohexose) <strong>(Option A ruled out)</strong></li>\n<li>Fructose (ketohexose-becomes enediol under reaction conditions) <strong>(Option B ruled out)</strong></li>\n<li>Mannose (aldohexose) <strong>(Option C ruled out)</strong></li>\n<li>Lactose, maltose, etc.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Sucrose is a non-reducing sugar.\n<ul>\n<li>Its anomeric carbons (C-1 of glucose and C-2 of fructose) are involved in the glycosidic bond.</li>\n<li>This prevents the formation of the free aldehyde or keto group needed for osazone formation.</li>\n</ul>\n</li>\n</ul>", "options": ["Glucose", "Fructose", "Mannose", "Sucrose"], "html_options": ["Glucose", "Fructose", "Mannose", "Sucrose"], "corr_idx": 3}, {"id": "1173129", "html_qtxt": "Hedgehog shapes of osazone is found in", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Osazones are crystalline derivatives formed when reducing sugars react with excess phenylhydrazine.</li>\n<li>The shape of the crystals varies by sugar and can be used to identify sugars microscopically.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508140cb03438-91cf-4ce3-ab0e-3e54864d816e.png\"></li>\n</ul>", "options": ["Sucrose", "Fructose", "Mannose", "Lactose"], "html_options": ["Sucrose", "Fructose", "Mannose", "Lactose"], "corr_idx": 3}, {"id": "1173149", "html_qtxt": "Heparin is all except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Heparin is NOT a Proteoglycan:</p>\n<ul>\n<li>Proteoglycans = Core protein + One or more GAG chains (like heparan sulfate).</li>\n<li>Heparin does not contain a protein core, so it's not a proteoglycan.</li>\n</ul>\n<p>Instead, it is a free-standing glycosaminoglycan.</p>\n<p>Heparin is the following:</p>\n<ul>\n<li>Glycosaminoglycan (GAG) <strong>(Option A ruled out)</strong>:\n<ul>\n<li>Heparin is a sulfated GAG.</li>\n<li>Composed of repeating disaccharide units: glucosamine and iduronic acid.</li>\n<li>Functions mainly as a natural anticoagulant.</li>\n</ul>\n</li>\n<li>Polysaccharide <strong>(Option B ruled out)</strong>:\n<ul>\n<li>GAGs like heparin are heteropolysaccharides (i.e., made from more than one type of sugar).</li>\n<li>They are long chains of sugar units &rarr; hence polysaccharides.</li>\n</ul>\n</li>\n<li>Carbohydrate <strong>(Option D ruled out)</strong>:\n<ul>\n<li>Polysaccharides are complex carbohydrates.</li>\n<li>So, by definition, heparin is a carbohydrate.</li>\n</ul>\n</li>\n</ul>", "options": ["Glycosaminoglycan", "Polysaccharide", "Proteoglycan", "Carbohydrate"], "html_options": ["Glycosaminoglycan", "Polysaccharide", "Proteoglycan", "Carbohydrate"], "corr_idx": 2}, {"id": "1173151", "html_qtxt": "Glycogenin is a:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glycogenin is a protein</li>\n<li>37K Da protein</li>\n</ul>\n<p><strong>Key Functions of Glycogenin:</strong></p>\n<ul>\n<li>Acts as a primer for glycogen synthesis.</li>\n<li>Catalyzes the attachment of 7 glucose residues from UDP-glucose to its own tyrosine residue.</li>\n<li>The glucose units are linked by &alpha;-1,4-glycosidic bonds.</li>\n<li>Once this initial chain is formed, glycogen synthase can take over and elongate the glycogen molecule.</li>\n<li>Glycogenin remains embedded in the center of the growing glycogen granule<strong>.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Polysaccharide (Option B): </strong>Glycogen itself is a branched polysaccharide of glucose; glycogenin is the protein nucleus on which that polysaccharide is built.</p>\n<p><strong>Lipid (Option C): </strong>Glycogenin does not have a structural or metabolic role involving lipids; it is entirely protein-based.</p>\n<p><strong>Glycosaminoglycan (Option D): </strong>GAGs are extracellular, unbranched sugar chains (e.g., hyaluronan); glycogenin is an intracellular protein primer, unrelated in structure or function.</p>", "options": ["Polypeptide", "Polysaccharide", "Lipid", "Glycosaminoglycan"], "html_options": ["Polypeptide", "Polysaccharide", "Lipid", "Glycosaminoglycan"], "corr_idx": 0}, {"id": "1173153", "html_qtxt": "Complex polysaccharides are converted to glucose and absorbed by the help of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Polysaccharides like starch are first partially digested by salivary and pancreatic amylase &rarr; breaking them into smaller oligosaccharides and disaccharides.</li>\n<li>Final digestion to monosaccharides (like glucose) occurs in the small intestine via disaccharidases on the brush border.</li>\n</ul>\n<ul>\n<li><strong> Role of Sucrase:</strong></li>\n</ul>\n<li>Sucrase-isomaltase complex is a brush border enzyme.</li>\n<li>It hydrolyses sucrose &rarr; glucose + fructose.</li>\n<li>Also involved in the final step of carbohydrate digestion, assisting in converting disaccharides into absorbable monosaccharides.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508141ebd8150-05d7-41de-80a9-e6da70c7bc13.png\"></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Na&#x207A;/K&#x207A; ATPase (Option A):</strong> Active transport of ions; not involved in digestion.</p>\n<p><strong>Enterokinase (Option C): </strong>Activates trypsinogen (protein digestion).</p>\n<p><strong>Carboxypeptidase (Option D): </strong>A pancreatic enzyme that removes amino acids from the carboxyl end of peptides (also involved in protein digestion).</p>", "options": ["Na+ K+ ATPase", "Sucrase", "Enterokinase", "Carboxypeptidase"], "html_options": ["Na+ K+ ATPase", "Sucrase", "Enterokinase", "Carboxypeptidase"], "corr_idx": 1}, {"id": "1173160", "html_qtxt": "Which of the following biologically important glycosaminoglycans are present in the umbilical cord?", "html_expl": "<p><strong>Explanation:</strong></p>\n<h4><strong>Hyaluronic Acid (HA):</strong></h4>\n<ul>\n<li>A non-sulfated glycosaminoglycan (GAG).</li>\n<li>Composed of repeating disaccharide units of:\n<ul>\n<li>Glucuronic acid (GlcUA)</li>\n<li>N-acetylglucosamine (GlcNAc)</li>\n</ul>\n</li>\n<li>Form very large, highly hydrated polymers.</li>\n</ul>\n<p><strong>Functions and Locations:</strong></p>\n<ul>\n<li>Found widely in the extracellular matrix (ECM) of connective tissues.</li>\n<li>Highly concentrated in:\n<ul>\n<li>Umbilical cord</li>\n<li>Synovial fluid (joints)</li>\n<li>Vitreous humour (eye)</li>\n<li>Skin</li>\n<li>Cartilage and embryonic tissues</li>\n</ul>\n</li>\n</ul>\n<p><strong>Biological Roles:</strong></p>\n<ul>\n<li>Hydration and resilience of tissues.</li>\n<li>Facilitates cell migration, especially during:\n<ul>\n<li>Morphogenesis (embryonic development)</li>\n<li>Wound healing</li>\n</ul>\n</li>\n<li>Helps loosen the ECM by attracting water &rarr; promoting cell movement.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Heparan Sulfate (Option A): </strong>Found in basement membranes, cell surfaces</p>\n<p><strong>Heparin (Option B): </strong>Found in mast cell granules (anticoagulant)</p>\n<p><strong>Keratan Sulfate (Option D): </strong>Found in cornea, cartilage</p>", "options": ["Heparan Sulphate", "Heparin", "Hyaluronic Acid", "Keratan Sulphate"], "html_options": ["Heparan Sulphate", "Heparin", "Hyaluronic Acid", "Keratan Sulphate"], "corr_idx": 2}, {"id": "1173162", "html_qtxt": "Which of the following biologically important glycosaminoglycans are present in the Cornea?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Keratan sulfates consist of repeating Gal-GlcNAc disaccharide units containing sulfate attached to the 6 position of GlcNAc or occasionally of Gal.</p>\n<ul>\n<li>Keratan sulfate I was originally isolated from the cornea, while keratan sulfate II came from cartilage.</li>\n<li>In the eye, they lie between collagen fibrils and play a critical role in corneal transparency. Changes in proteoglycan composition found in corneal scars disappear when the cornea heals.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Heparan Sulphate (Option A): </strong>Found in cell surfaces, basement membranes, and extracellular matrix (ECM). Involved in cell signalling and filtration</p>\n<p><strong>Keratan Sulphate II (Option B): </strong>Found in cartilage, intervertebral discs, and loose connective tissues. Structurally similar to KS I but not located in the cornea</p>\n<p><strong>Hyaluronic Acid (Option C): </strong>Found in the vitreous humour of the eye, synovial fluid, skin, and umbilical cord</p>", "options": ["Heparan Sulphate", "Keratan Sulphate II", "Hyaluronic Acid", "Keratan Sulphate I"], "html_options": ["Heparan Sulphate", "Keratan Sulphate II", "Hyaluronic Acid", "Keratan Sulphate I"], "corr_idx": 3}, {"id": "1173163", "html_qtxt": "Which of the following glycosaminoglycans plays an important role in charge selectiveness of glomerular filtration?", "html_expl": "<p><strong>Explanation:</strong></p>\n<h4>Heparan Sulphate:</h4>\n<ul>\n<li>A glycosaminoglycan (GAG) found on cell surfaces and in basement membranes.</li>\n<li>Structurally similar to heparin, but with:\n<ul>\n<li>Fewer N-sulfates</li>\n<li>Predominant uronic acid: glucuronic acid (GlcUA)</li>\n</ul>\n</li>\n<li>Present in proteoglycan form, often attached to core proteins that span the plasma membrane.</li>\n</ul>\n<p><strong>Role in Kidney (Glomerulus):</strong></p>\n<ul>\n<li>Located in the glomerular basement membrane (GBM) of the kidney.</li>\n<li>The GBM contains:\n<ul>\n<li>Heparan sulfate</li>\n<li>Type IV collagen</li>\n<li>Laminin</li>\n</ul>\n</li>\n<li>Heparan sulfate contributes to the negative charge of the GBM.</li>\n<li>This charge barrier prevents filtration of negatively charged proteins, such as albumin.</li>\n<li>Thus, it plays a crucial role in the charge selectivity of the glomerular filtration barrier.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Keratan Sulfate (Option B): </strong>Found in cartilage and cornea; not involved in glomerular filtration.</p>\n<p><strong>Hyaluronic Acid (Option C): </strong>A non-sulfated GAG; found in synovial fluid and vitreous humor; lacks charge barrier role in the kidney.</p>\n<p><strong>Chondroitin Sulfate (Option D): </strong>Found in cartilage and connective tissue; does not contribute significantly to glomerular charge selectivity.</p>", "options": ["Heparan Sulphate", "Keratan Sulphate", "Hyaluronic Acid", "Chondroitin Sulphate"], "html_options": ["Heparan Sulphate", "Keratan Sulphate", "Hyaluronic Acid", "Chondroitin Sulphate"], "corr_idx": 0}, {"id": "1176903", "html_qtxt": "Which of the following confirmatory test is used for detection of ketose sugar?", "html_expl": "<p><strong>Explanation:</strong></p>\n<h4><strong>Seliwanoff's Test:</strong></h4>\n<ul>\n<li>A specific test used to differentiate ketoses from aldoses.</li>\n<li>Based on dehydration of sugars by concentrated HCl &rarr; forms furfural derivatives.</li>\n<li>In the presence of resorcinol, ketoses produce a deep red colour rapidly.</li>\n<li>Aldoses may react slowly and produce a light pink colour (if at all).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Barfoed's Test (Option A): </strong>Purpose: Distinguishes monosaccharides from disaccharides. Principle: Monosaccharides reduce copper ions in an acidic medium faster.</p>\n<p><strong>Molisch Test (Option C): </strong>Purpose: General test for all carbohydrates. Principle: Carbohydrates form purple/violet rings with &alpha;-naphthol and sulfuric acid.</p>\n<p><strong>Fehling's Test (Option D): </strong>Purpose: Detects reducing sugars (e.g., glucose). Principle: Reduction of Cu&sup2;⁺ &rarr; Cu⁺ with formation of red precipitate.</p>", "options": ["Barfoed's Test", "Seliwanoff's Test", "Molisch test", "Fehling's Test"], "html_options": ["Barfoed's Test", "Seliwanoff's Test", "Molisch test", "Fehling's Test"], "corr_idx": 1}]}, {"moduleId": 1008714, "name": "Glucose, Glycolysis, Gluconeogenesis", "questions": [{"id": "1173183", "html_qtxt": "Which of the following sentences is best suitable for Glucose?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glucose and Galactose are both aldohexoses (6-carbon sugars with an aldehyde group).</li>\n<li>They differ only in the configuration around carbon 4 (C-4).</li>\n<li>This makes glucose a C-4 epimer of galactose.</li>\n<li>Enzymes called epimerases can interconvert these sugars.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It is ketose and usually exists as a furanose ring in a solution (Option A):</strong> Incorrect because glucose is an aldose, not a ketose. It typically exists as a pyranose ring (6-membered), not a furanose. Fructose is a ketose and forms a furanose ring.</p>\n<p><strong>It is produced from dietary starch by the action of alpha-amylase (Option C): </strong>&alpha;-amylase breaks down starch into maltose and dextrins, not free glucose. Final glucose is released by further digestion with maltase, isomaltase, etc. So, &alpha;-amylase alone does not produce glucose directly.</p>\n<p><strong>It is utilised in biological systems only in L-isomeric form. (Option D): </strong>Biologically active glucose is in the D-isomeric form. Carbohydrates (like glucose) are used in the D-form. L-Glucose exists but is not metabolised in humans.</p>", "options": ["It is a ketose and usually exists as a furanose ring in a solution", "A C-4 epimer of galactose", "It is produced from dietary starch by the action of alpha-amylase", "It is utilised in biological systems only in the L-isomeric form"], "html_options": ["It is a ketose and usually exists as a furanose ring in a solution", "A C-4 epimer of galactose", "It is produced from dietary starch by the action of alpha-amylase", "It is utilised in biological systems only in the L-isomeric form"], "corr_idx": 1}, {"id": "1173190", "html_qtxt": "Which deposition results in cataract?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Sugar Alcohols</strong></p>\n<ul>\n<li>Also known as polyols.</li>\n<li>Formed by the reduction of sugars (e.g., glucose, galactose).</li>\n<li>Examples:\n<ul>\n<li>Sorbitol (from glucose)</li>\n<li>Dulcitol/Galactitol (from galactose)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Role in Cataract Formation:</strong></p>\n<p>In Diabetes Mellitus:</p>\n<ul>\n<li>High glucose levels &rarr; Glucose enters the lens of the eye.</li>\n<li>Enzyme Aldose Reductase converts glucose to Sorbitol.</li>\n<li>Sorbitol accumulates because it's not easily diffused out.</li>\n<li>Leads to osmotic stress, swelling of lens fibres &rarr; Cataract.</li>\n</ul>\n<p>In Galactosemia:</p>\n<ul>\n<li>Galactose is converted to Dulcitol (Galactitol) in the lens.</li>\n<li>Accumulation causes similar osmotic damage, resulting in early-onset cataracts.</li>\n</ul>", "options": ["Glucose", "Galactose", "Sugar amines", "Sugar alcohols"], "html_options": ["Glucose", "Galactose", "Sugar amines", "Sugar alcohols"], "corr_idx": 3}, {"id": "1173194", "html_qtxt": "An 8-year-old boy has a problem of increased thirst and an increased appetite along with cataracts in his eyes. On laboratory examination, his fasting blood sugar level is 205 mg/dl. Which of the following sugar alcohols is responsible for the development of cataract?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>This child is showing classic signs of Type 1 Diabetes Mellitus:</p>\n<ul>\n<li>Increased thirst (polydipsia)</li>\n<li>Increased hunger (polyphagia)</li>\n<li>High fasting glucose (205 mg/dL)</li>\n<li>Cataracts at a young age</li>\n</ul>\n<p>These symptoms point toward sorbitol accumulation in the lens of the eye, a known cause of diabetic cataract.</p>\n<p><strong>Biochemical Pathway (Polyol Pathway):</strong></p>\n<ol>\n<li>Glucose is reduced to Sorbitol\n<ul>\n<li>Enzyme: Aldose reductase</li>\n<li>Cofactor: NADPH</li>\n</ul>\n</li>\n<li>Sorbitol is slowly oxidised to Fructose\n<ul>\n<li>Enzyme: Sorbitol dehydrogenase (absent/low in the lens)</li>\n</ul>\n</li>\n<li>Sorbitol accumulates in the lens &rarr; creates osmotic stress &rarr; leads to lens opacity (cataract).</li>\n</ol>\n<p><strong>Key Points About Sorbitol:</strong></p>\n<ul>\n<li>Accumulates in non-insulin-sensitive tissues: Lens, retina, peripheral nerves, kidneys</li>\n<li>Osmotically active &rarr; draws water into cells</li>\n<li>Causes swelling and damage &rarr; especially in the lens (cataracts) and nerves (neuropathy)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Galactitol (Option A): </strong>Found in galactosemia, not diabetes</p>\n<p><strong>Dulcitol (Option B):</strong> Another name for galactitol</p>\n<p><strong>Xylitol (Option D): </strong>A sugar alcohol used as a sweetener; not involved in cataractogenesis</p>", "options": ["Galactitol", "Dulcitol", "Sorbitol", "Xylitol"], "html_options": ["Galactitol", "Dulcitol", "Sorbitol", "Xylitol"], "corr_idx": 2}, {"id": "1173195", "html_qtxt": "Inulin-like fructosans are used as prebiotics as they are non-digestible. Resistance to digestion in the upper GI tract results from:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Inulin (Fructosan):</strong></p>\n<ul>\n<li>A homopolysaccharide made of D-fructose units linked by &beta;(2&rarr;1) glycosidic bonds.</li>\n<li>Naturally found in tubers and bulbs of chicory, dahlia, dandelion, onion, and garlic.</li>\n<li>Beta configuration of the anomeric carbon (C2) makes it resistant to digestion by human enzymes &rarr; reaches the colon undigested &rarr; acts as a prebiotic, promoting beneficial gut bacteria like <em>Bifidobacteria</em>.</li>\n</ul>\n<p><strong>Clinical Use:<br /> </strong>Inulin is the gold standard for measuring GFR due to its ideal properties:</p>\n<ul>\n<li>Not absorbed in the intestine</li>\n<li>Not metabolized by the body</li>\n<li>Freely filtered at the glomerulus</li>\n<li>Not reabsorbed or secreted by renal tubules</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Presence of &beta;(1&rarr;4) glycosidic linkages (Option A):</strong> Inulin contains &beta;(2&rarr;1) linkages, not &beta;(1&rarr;4) (which are found in cellulose).</p>\n<p><strong>Low pH of the stomach (Option C): </strong>Acid does not break glycosidic bonds in polysaccharides - enzymes do.</p>\n<p><strong>Presence of &alpha;-Glycosidic linkage (Option D):</strong> Inulin has &beta;-linkages, not &alpha;. &alpha;-linkages (like in starch) are digestible by human enzymes.</p>", "options": ["Presence of &beta;(1&rarr;4) glycosidic linkages", "Beta configuration of anomeric C2", "Low pH of the stomach", "Presence of &alpha;-Glycosidic linkage"], "html_options": ["Presence of &beta;(1&rarr;4) glycosidic linkages", "Beta configuration of anomeric C2", "Low pH of the stomach", "Presence of &alpha;-Glycosidic linkage"], "corr_idx": 1}, {"id": "1173202", "html_qtxt": "Irreversible steps of Glycolysis are catalysed by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Only three steps in glycolysis are physiologically irreversible, and they serve as key regulatory points.</p>\n<p>Irreversible Steps & Their Enzymes:</p>\n<ul>\n<li>Hexokinase (or Glucokinase in the liver):\n<ul>\n<li>Converts Glucose &rarr; Glucose-6-phosphate</li>\n<li>ATP-dependent phosphorylation (irreversible)</li>\n</ul>\n</li>\n<li>Phosphofructokinase-1 (PFK-1):\n<ul>\n<li>Converts Fructose-6-phosphate &rarr; Fructose-1,6-bisphosphate</li>\n<li>The major rate-limiting enzyme of glycolysis</li>\n<li>Highly regulated (by ATP, AMP, citrate)</li>\n</ul>\n</li>\n<li>Pyruvate Kinase:\n<ul>\n<li>Converts Phosphoenolpyruvate (PEP) &rarr; Pyruvate</li>\n<li>Final ATP-yielding step in glycolysis</li>\n<li>Irreversible under cellular conditions</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options</strong></p>\n<p><strong>Glucokinase, Pyruvate Kinase, Glyceraldehyde 3 Phosphate Dehydrogenase (Option A): </strong>Glyceraldehyde-3-phosphate dehydrogenase is a reversible enzyme.</p>\n<p><strong>Hexokinase, Phospho Glycerate Kinase, Pyruvate Kinase(Option C): </strong>Phosphoglycerate kinase catalyzes a reversible step.</p>\n<p><strong>Pyruvate Kinase, Fructose 1, 6 Bisphosphatase, Phosphofructokinase (Option D):</strong> Fructose-1,6-bisphosphatase is a gluconeogenic enzyme, not part of glycolysis.</p>", "options": ["Hexokinase, Phosphofructokinase, Pyruvate Kinase", "Glucokinase, Pyruvate Kinase, Glyceraldehyde 3 Phosphate Dehydrogenase", "Hexokinase, Phospho Glycerate Kinase, Pyruvate Kinase", "Pyruvate Kinase, Fructose 1, 6 Bisphosphatase, Phosphofructokinase"], "html_options": ["Hexokinase, Phosphofructokinase, Pyruvate Kinase", "Glucokinase, Pyruvate Kinase, Glyceraldehyde 3 Phosphate Dehydrogenase", "Hexokinase, Phospho Glycerate Kinase, Pyruvate Kinase", "Pyruvate Kinase, Fructose 1, 6 Bisphosphatase, Phosphofructokinase"], "corr_idx": 0}, {"id": "1173204", "html_qtxt": "Glycolysis occurs in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glycolysis is the first step in glucose metabolism and takes place in the cytosol (cytoplasm) of all cells.</li>\n<li>It is a universal pathway, present in prokaryotes and eukaryotes.</li>\n<li>It can proceed under both:\n<ul>\n<li>Aerobic conditions &rarr; Ends with pyruvate entering mitochondria for the TCA cycle.</li>\n<li>Anaerobic conditions &rarr; Ends with lactate (e.g., in red blood cells or exercising muscle<strong>).</strong></li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081460114d23-a981-41b6-acb9-369bead0d318.png\">\n<p><strong>Explanation of other options:</strong><strong> </strong></p>\n<p><strong>Mitochondria (Option B): </strong>Site of aerobic processes like the TCA cycle and oxidative phosphorylation, not glycolysis.</p>\n<p><strong>Nucleus (Option C): </strong>Responsible for DNA/RNA processes-not involved in metabolism.</p>\n<p><strong>Lysosome (Option D): Involved in the degradation of macromolecules, not energy metabolism.</strong></p>", "options": ["Cytosol", "Mitochondria", "Nucleus", "Lysosome"], "html_options": ["Cytosol", "Mitochondria", "Nucleus", "Lysosome"], "corr_idx": 0}, {"id": "1173206", "html_qtxt": "A person has been doing regular exercise in the gym. He has been taking a high-carbohydrate diet, but while doing the exercise, he is not able to perform his best. He feels his exercise capacity is reduced. Deficiency of which glycolytic enzyme in skeletal muscles can be responsible for fatigue in this patient?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This condition describes Glycogen Storage Disease type VII (GSD VII), also known as Tarui disease, which is caused by a deficiency of Phosphofructokinase (PFK) in skeletal muscles.</li>\n<li>PFK is a key regulatory enzyme in glycolysis, converting:<br /> Fructose-6-phosphate &rarr; Fructose-1,6-bisphosphate</li>\n<li>In muscle PFK deficiency:\n<ul>\n<li>Glycolysis is impaired.</li>\n<li>The muscle cannot efficiently utilise glucose for energy.</li>\n<li>This leads to exercise intolerance, muscle cramps, and early fatigue.</li>\n<li>A high-carbohydrate diet worsens symptoms because glucose cannot be metabolised properly.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pyruvate Kinase (Option A):</strong> A deficiency affects the last step of glycolysis, but it is more associated with hemolytic anemia than exercise intolerance.</p>\n<p><strong>Glyceraldehyde 3-phosphate dehydrogenase (Option C):</strong> This enzyme plays a role in the middle of glycolysis, but its deficiency is not commonly linked to a clinical syndrome with exercise intolerance.</p>\n<p><strong>Phosphoglycerate kinase (Option D):</strong> A rare enzyme deficiency that can affect muscle, but PFK deficiency is more classically associated with this type of clinical presentation.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508147465ec20-24c7-4569-b1ff-80e7311ed3d5.png\">", "options": ["Pyruvate Kinase", "Phosphofructokinase", "Glyceraldehyde 3 phosphate dehydrogenase", "Phosphoglycerate kinase"], "html_options": ["Pyruvate Kinase", "Phosphofructokinase", "Glyceraldehyde 3 phosphate dehydrogenase", "Phosphoglycerate kinase"], "corr_idx": 1}, {"id": "1173210", "html_qtxt": "Which of the following ions is required for the normal functioning of glycolysis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Magnesium (Mg&#178;&#8314;) is essential for glycolysis, as it acts as a cofactor for multiple key enzymes in the pathway.</li>\n<li>It stabilizes the negatively charged phosphate groups in ATP and other phosphate intermediates, allowing proper substrate binding and enzyme activity.</li>\n<li>Enzymes in Glycolysis that Require Mg&#178;&#8314;\n<ul>\n<li>Hexokinase / Glucokinase</li>\n<li>Phosphofructokinase-1 (PFK-1)</li>\n<li>3-Phosphoglycerate Kinase</li>\n<li>Pyruvate Kinase</li>\n<li>Enolase (requires Mg&#178;&#8314; or Mn&#178;&#8314;)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Calcium (Option A):</strong>  Not directly involved in glycolytic enzyme function; plays a larger role in signalling and muscle contraction.</p>\n<p><strong>Phosphorus (Option C): </strong> While phosphate groups are part of glycolytic intermediates, phosphorus itself (as a free ion) is not a direct enzyme cofactor.</p>\n<p><strong>Iron (Option D):</strong> Important in electron transport and cytochromes, not in glycolysis.</p>", "options": ["Calcium", "Magnesium", "Phosphorus", "Iron"], "html_options": ["Calcium", "Magnesium", "Phosphorus", "Iron"], "corr_idx": 1}, {"id": "1173212", "html_qtxt": "A 43-year-old man presented with symptoms of weakness, fatigue, shortness of breath, and dizziness. His haemoglobin levels were between 5 to 7 g/dl. Red blood cells isolated from the patient showed abnormally low levels of lactate production. A deficiency of which one of the following enzymes would be the most likely cause of this patient's anaemia?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>RBCs lack mitochondria, so they rely entirely on anaerobic glycolysis for ATP production.</li>\n<li>Pyruvate kinase (PK) catalyses the final step of glycolysis:<br /> Phosphoenolpyruvate (PEP) &rarr; Pyruvate + ATP</li>\n</ul>\n<p> In <strong>Pyruvate Kinase Deficiency</strong>:</p>\n<ul>\n<li>&darr; ATP production &rarr; affects Na&#x207A;/K&#x207A; pumps &rarr; membrane instability</li>\n<li>RBCs become rigid and get destroyed prematurely &rarr; hemolytic anemia</li>\n<li>&darr; Lactate production (since pyruvate is not formed effectively)</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li>Chronic hemolytic anemia</li>\n<li>Fatigue, pallor, jaundice</li>\n<li>Splenomegaly</li>\n<li>Normal to elevated reticulocyte count</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphoglucose Isomerase (PGI) (Option A): </strong>Converts glucose-6-phosphate &harr; fructose-6-phosphate. Deficiency is rare (&asymp;4% of glycolytic enzyme defects). Can cause mild to moderate hemolytic anemia, but is not typically associated with very low lactate levels</p>\n<p><strong>Phosphofructokinase (PFK) (Option B): </strong>Key regulatory enzyme of glycolysis. Deficiency (Tarui disease) affects muscles > RBCs. Causes exercise intolerance, not significant anemia. RBC glycolysis is partially spared due to alternative regulation</p>\n<p><strong>Hexokinase (Option D): </strong>Catalyzes the first step: glucose &rarr; glucose-6-phosphate. Deficiency is extremely rare, often fatal, early in life. Causes severe hemolytic anemia, but is much less common than pyruvate kinase deficiency</p>", "options": ["Phosphoglucose isomerase", "Phosphofructokinase", "Pyruvate Kinase", "Hexokinase"], "html_options": ["Phosphoglucose isomerase", "Phosphofructokinase", "Pyruvate Kinase", "Hexokinase"], "corr_idx": 2}, {"id": "1173218", "html_qtxt": "Which one of the following statements concerning glycolysis is correct?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Irreversible Steps in Glycolysis:</p>\n<p>Glycolysis consists of 10 enzymatic steps, three of which are irreversible due to their large negative Gibbs free energy changes. These steps are catalysed by:</p>\n<ul>\n<li>Hexokinase: Converts glucose to glucose-6-phosphate.</li>\n<li>Phosphofructokinase-1 (PFK-1): Converts fructose-6-phosphate to fructose-1,6-bisphosphate.</li>\n<li>Pyruvate Kinase: Converts phosphoenolpyruvate to pyruvate.</li>\n</ul>\n<p>These irreversible steps are also the rate-limiting steps of glycolysis, meaning they regulate the overall flux of the pathway and are key points for metabolic control.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814f801516f-da3c-4c48-97ee-ff820ea77350.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>The conversion of glucose to lactate requires the presence of oxygen (Option A): </strong>False. The conversion of glucose to lactate occurs during anaerobic glycolysis, which does not require oxygen. This process allows cells to generate ATP in the absence of oxygen, such as during intense exercise.</p>\n<p><strong>Hexokinase is important in hepatic glucose metabolism only in the absorptive period following consumption of a carbohydrate-containing meal (Option B):</strong> False. While glucokinase (not hexokinase) is the enzyme primarily responsible for glucose phosphorylation in the liver during the absorptive period, hexokinase is present in various tissues and is involved in glucose metabolism under different conditions.</p>\n<p><strong><strong>Fructose 2,6-bisphosphate is a potent inhibitor of phosphofructokinase (Option C):</strong> </strong>False. Fructose 2,6-bisphosphate is actually a potent activator of phosphofructokinase-1 (PFK-1), the rate-limiting enzyme in glycolysis. It enhances PFK-1 activity, promoting glycolysis, especially in response to high glucose levels.</p>", "options": ["The conversion of glucose to lactate requires the presence of oxygen.", "Hexokinase is important in hepatic glucose metabolism only in the absorptive period following consumption of a carbohydrate-containing meal", "Fructose 2, 6-bisphosphate is a potent inhibitor of phosphofructokinase", "The rate-limiting reactions are also the irreversible reactions."], "html_options": ["The conversion of glucose to lactate requires the presence of oxygen.", "Hexokinase is important in hepatic glucose metabolism only in the absorptive period following consumption of a carbohydrate-containing meal", "Fructose 2, 6-bisphosphate is a potent inhibitor of phosphofructokinase", "The rate-limiting reactions are also the irreversible reactions."], "corr_idx": 3}, {"id": "1173220", "html_qtxt": "The reaction catalysed by phosphofructokinase:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Phosphofructokinase-1 (PFK-1) catalyzes the conversion of fructose 6-phosphate to fructose 1,6-bisphosphate, using ATP.</p>\n<p>This is:</p>\n<ul>\n<li>One of the key regulatory and rate-limiting steps in glycolysis.</li>\n<li>Highly regulated, based on the energy needs of the cell.</li>\n<li>Irreversible under physiological conditions (far from equilibrium).</li>\n<li>Allosterically controlled by various effectors (e.g., inhibited by ATP and citrate, activated by AMP and fructose 2,6-bisphosphate).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Is activated by high concentrations of ATP and citrate (Option A):</strong> Incorrect. PFK-1 is inhibited, not activated, by high ATP and citrate levels. This reflects the cell having high energy, reducing the need for more glycolysis.</p>\n<p><strong>Uses fructose 1-phosphate as substrate (Option B): </strong>Incorrect. PFK-1 uses fructose 6-phosphate as its substrate. Fructose 1-phosphate is part of the fructose metabolism pathway, not glycolysis.</p>\n<p><strong>Is near equilibrium in most tissues (Option D):</strong> Incorrect. The PFK-1 reaction is far from equilibrium and irreversible, making it a control point in glycolysis.</p>", "options": ["Is activated by high concentrations of ATP and citrate.", "Uses fructose 1-phosphate as substrate.", "Is the regulated reaction of the glycolytic pathway.", "Is near equilibrium in most tissues."], "html_options": ["Is activated by high concentrations of ATP and citrate.", "Uses fructose 1-phosphate as substrate.", "Is the regulated reaction of the glycolytic pathway.", "Is near equilibrium in most tissues."], "corr_idx": 2}, {"id": "1173257", "html_qtxt": "A true statement about glycolysis is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycolysis involves the conversion of glucose (a 6-carbon molecule) into two molecules of pyruvate (each 3-carbon). Therefore, the statement \"Conversion of glucose to 3C units\" is correct.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Occurs in mitochondria (Option A):</strong> Incorrect. Glycolysis takes place in the cytosol, not the mitochondria. The mitochondria are involved later in aerobic metabolism (pyruvate oxidation, TCA cycle, and oxidative phosphorylation).</p>\n<p><strong>Complete breakdown of glucose (Option B): </strong>Incorrect. Glycolysis only partially breaks down glucose into pyruvate. Complete breakdown to CO<sub>2</sub> and H<sub>2</sub>O requires pyruvate dehydrogenase reaction, TCA (Krebs) cycle, and electron transport chain (oxidative phosphorylation)</p>\n<p><strong>3 ATPs are used in the anaerobic pathway (Option D): </strong>Incorrect. In glycolysis, 2 ATPs are used in the energy investment phase, and 4 ATPs are produced in the energy payoff phase. Thus, the net gain is 2 ATP, even under anaerobic conditions. There is no stage where 3 ATPs are used.</p>", "options": ["Occurs in mitochondria", "Complete breakdown of glucose", "Conversion of glucose to 3C units", "3 ATPs are used in the anaerobic pathway"], "html_options": ["Occurs in mitochondria", "Complete breakdown of glucose", "Conversion of glucose to 3C units", "3 ATPs are used in the anaerobic pathway"], "corr_idx": 2}, {"id": "1173261", "html_qtxt": "Which of the following pathways provides nutrition to cancer cells?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Cancer cells primarily rely on glycolysis for energy and nutrient production, even when oxygen is available - a phenomenon known as the Warburg effect.</p>\n<ul>\n<li>It describes how cancer cells consume large amounts of glucose and convert it to lactic acid, even in the presence of sufficient oxygen,&nbsp;through a process known as aerobic glycolysis.</li>\n<li>Warburg's hypothesis:\n<ul>\n<li>The elevated glycolysis-to-respiration ratio in cancer cells is likely due to defects in the mitochondrial respiratory chain.</li>\n<li>Enhanced glycolysis enables cancer cells to proliferate in low-oxygen (hypoxic) environments, which are common in tumors.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Oxidative phosphorylation (Option B): </strong>This is the primary energy pathway in most healthy cells, but cancer cells often suppress it in favor of glycolysis, even when oxygen is present. While some cancer types still use this pathway, it is not the dominant source of nutrition for most tumors.</p>\n<p><strong>Pentose phosphate pathway (Option C): </strong>While this pathway supports nucleotide and NADPH production (important for proliferation), it is not the primary energy source or main nutritional pathway in most cancers.</p>\n<p><strong>Fatty acid oxidation (Option D):</strong> Some cancer types may utilize fatty acids for energy under certain conditions, but it is not the main metabolic pathway.</p>", "options": ["Glycolysis", "Oxidative phosphorylation", "Pentose phosphate pathway", "Fatty acid oxidation"], "html_options": ["Glycolysis", "Oxidative phosphorylation", "Pentose phosphate pathway", "Fatty acid oxidation"], "corr_idx": 0}, {"id": "1173264", "html_qtxt": "Which of the following does not contribute to glucose production via gluconeogenesis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Acetyl-CoA cannot serve as a substrate for gluconeogenesis because its carbon atoms are lost as CO&#x2082; in the citric acid cycle. As a result, it does not contribute to net glucose synthesis.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lactate (Option A): </strong>Produced by anaerobic glycolysis (e.g., in red blood cells and exercising muscle), it is converted to pyruvate, which enters gluconeogenesis. This process is part of the Cori cycle.</p>\n<p><strong>Pyruvate (Option C): </strong>A direct precursor for gluconeogenesis. It is converted to oxaloacetate, then to phosphoenolpyruvate (PEP)via PEP carboxykinase (PEPCK), continuing through the gluconeogenic pathway.</p>\n<p><strong>Oxaloacetate (Option D): </strong>A critical intermediate in gluconeogenesis. It is directly converted into PEP and helps generate glucose, particularly during fasting or prolonged exercise.</p>", "options": ["Lactate", "Acetyl CoA", "Pyruvate", "Oxaloacetate"], "html_options": ["Lactate", "Acetyl CoA", "Pyruvate", "Oxaloacetate"], "corr_idx": 1}, {"id": "1173265", "html_qtxt": "True about gluconeogenesis is all except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Gluconeogenesis occurs primarily in the liver and kidneys, not in muscle.</li>\n<li>Muscle lacks the enzyme glucose-6-phosphatase, which is essential for the final step of gluconeogenesis (conversion of glucose-6-phosphate to free glucose).</li>\n<li>Therefore, while muscle can generate intermediates like pyruvate and lactate, it cannot complete gluconeogenesis or release glucose into the blood.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Prevents hypoglycemia during prolonged fasting (Option A): </strong>True. Gluconeogenesis maintains blood glucose levels during fasting or starvation when glycogen stores are depleted.</p>\n<p><strong>Excess acetyl-CoA stimulates gluconeogenesis(Option C):</strong> True. High levels of acetyl-CoA activate pyruvate carboxylase, the enzyme that converts pyruvate to oxaloacetate - an early step in gluconeogenesis.</p>\n<p><strong>Carbon skeletons of amino acids contribute to gluconeogenesis (Option D):</strong> True. Glucogenic amino acids are deaminated to provide carbon skeletons that can enter the gluconeogenic pathway.</p>", "options": ["Prevent hypoglycemia during prolonged fasting", "Occurs both in the muscle and the liver", "Excess acetyl-CoA causes stimulation", "The carbon skeleton of amino acids is involved in gluconeogenesis"], "html_options": ["Prevent hypoglycemia during prolonged fasting", "Occurs both in the muscle and the liver", "Excess acetyl-CoA causes stimulation", "The carbon skeleton of amino acids is involved in gluconeogenesis"], "corr_idx": 1}, {"id": "1173266", "html_qtxt": "In the fasting state, gluconeogenesis is promoted by which enzyme?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>During fasting, fatty acid oxidation increases, producing high levels of acetyl-CoA. This acetyl-CoA allosterically activates pyruvate carboxylase, the enzyme that catalyses the conversion of pyruvate to oxaloacetate, a key step in gluconeogenesis.</li>\n<li>This shift ensures that pyruvate is directed away from energy production via the TCA cycle (by inhibiting pyruvate dehydrogenase) and instead enters the gluconeogenic pathway.</li>\n<li>This mechanism helps maintain blood glucose during fasting.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Citrate-induced stimulation of Acetyl CoA Carboxylase (Option B):</strong> Citrate activates acetyl CoA carboxylase, a key enzyme in fatty acid synthesis, not gluconeogenesis - and this pathway is downregulated during fasting.</p>\n<p><strong>Fructose 2,6-bisphosphate-induced stimulation of Phosphofructokinase-1 (Option C): </strong>Fructose 2,6-bisphosphate activates glycolysis (via PFK-1) and inhibits gluconeogenesis. Its levels fall during fasting to favor glucose production, not breakdown.</p>\n<p><strong>Stimulation of Pyruvate Kinase by Fructose 1,6-bisphosphate (Option D):</strong> This promotes glycolysis, not gluconeogenesis. In fasting, pyruvate kinase is inhibited to conserve pyruvate for glucose synthesis.</p>", "options": ["Acetyl-CoA induced stimulation of Pyruvate Carboxylase", "Citrate-induced stimulation of Acetyl-CoA Decarboxylase", "Fructose 2, 6 bisphosphate induced stimulation of Phosphofructokinase-1", "Stimulation of Pyruvate Kinase by Fructose 1, 6 1,6-Bisphosphate"], "html_options": ["Acetyl-CoA induced stimulation of Pyruvate Carboxylase", "Citrate-induced stimulation of Acetyl-CoA Decarboxylase", "Fructose 2, 6 bisphosphate induced stimulation of Phosphofructokinase-1", "Stimulation of Pyruvate Kinase by Fructose 1, 6 1,6-Bisphosphate"], "corr_idx": 0}, {"id": "1173267", "html_qtxt": "Which of the following reactions takes place in two compartments?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Gluconeogenesis takes place in both the mitochondria and the cytosol, making it a compartmentalised pathway:</p>\n<ul>\n<li>The initial step - conversion of pyruvate to oxaloacetate - is catalysed by pyruvate carboxylase and occurs in the mitochondria.</li>\n<li>Oxaloacetate is then converted to malate or aspartate, transported to the cytosol, and reconverted to oxaloacetate before continuing through the gluconeogenic pathway to form glucose.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycolysis (Option B): </strong>Occurs entirely in the cytosol<strong>.</strong></p>\n<p><strong>Glycogenesis (Option C): </strong>Also a cytosolic process involving the synthesis of glycogen from glucose.</p>\n<p><strong>Glycogenolysis (Option D):</strong> Takes place entirely in the cytosol, where glycogen is broken down into glucose-1-phosphate.</p>", "options": ["Gluconeogenesis", "Glycolysis", "Glycogenesis", "Glycogenolysis"], "html_options": ["Gluconeogenesis", "Glycolysis", "Glycogenesis", "Glycogenolysis"], "corr_idx": 0}, {"id": "1173268", "html_qtxt": "Why is Glucose 6-phosphate in the cytoplasm of a hepatocyte not acted upon by Glucose 6-phosphatase as soon as it is formed?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In hepatocytes, glucose-6-phosphatase is localised to the lumen of the smooth endoplasmic reticulum (SER), not freely in the cytoplasm. Therefore, glucose-6-phosphate must first be transported into the SER by a specific transporter protein (glucose-6-phosphate translocase) before it can be dephosphorylated to free glucose.</li>\n<li>This spatial separation helps regulate glucose release into the blood and prevents uncontrolled hydrolysis of glucose-6-phosphate in the cytoplasm.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thermodynamically possible only when gluconeogenesis occurs (Option A): </strong>The reaction is thermodynamically favourable and can occur during both gluconeogenesis and glycogenolysis - this is not the limiting factor.</p>\n<p><strong>Needs protein kinase for its activation (Option B): </strong>Glucose-6-phosphatase does not require phosphorylation for activation.</p>\n<p><strong>Stearic inhibition of the phosphatase by albumin (Option D): </strong>There's no physiological or biochemical evidence supporting this. Albumin does not regulate glucose-6-phosphatase activity.</p>", "options": ["Thermodynamically possible only when gluconeogenesis occurs", "Needs Protein Kinase for its activation", "Enzyme is present in the Smooth endoplasmic reticulum. Glucose 6-phosphate needs to be transported into the SER", "Stearic inhibition of Phosphatase by albumin"], "html_options": ["Thermodynamically possible only when gluconeogenesis occurs", "Needs Protein Kinase for its activation", "Enzyme is present in the Smooth endoplasmic reticulum. Glucose 6-phosphate needs to be transported into the SER", "Stearic inhibition of Phosphatase by albumin"], "corr_idx": 2}, {"id": "1173269", "html_qtxt": "Lactic acidosis in thiamine deficiency is due to dysfunction of which of the following enzymes?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Thiamine (vitamin B1) is an essential coenzyme in the pyruvate dehydrogenase (PDH) complex, particularly for the E1 subunit (pyruvate dehydrogenase), where it functions as thiamine pyrophosphate (TPP).</p>\n<p>In <strong>thiamine deficiency</strong>:</p>\n<ul>\n<li>PDH activity is impaired, leading to the accumulation of pyruvate, which is then diverted to lactate production by lactate dehydrogenase.</li>\n<li>This results in lactic acidosis, a key feature in conditions like Wernicke's encephalopathy and beriberi, commonly seen in chronic alcoholics.</li>\n</ul>\n<p><strong>PDH Complex Components</strong>:</p>\n<ul>\n<li>Enzymes:\n<ul>\n<li>E1: Pyruvate dehydrogenase (TPP-dependent)</li>\n<li>E2: Dihydrolipoyl transacetylase</li>\n<li>E3: Dihydrolipoyl dehydrogenase</li>\n</ul>\n</li>\n<li>Coenzymes:\n<ul>\n<li>TPP (Vitamin B1)</li>\n<li>FAD (Vitamin B2)</li>\n<li>NAD<sup>+</sup> (Vitamin B3)</li>\n<li>CoA (Vitamin B5)</li>\n<li>Lipoic acid</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphoenolpyruvate carboxykinase (Option A):</strong> Involved in gluconeogenesis, not directly linked to lactic acidosis or thiamine metabolism.</p>\n<p><strong>Aldolase (Option C): </strong>A glycolytic enzyme; not dependent on thiamine and not involved in lactate accumulation.</p>\n<p><strong>Steric inhibition of phosphatase by albumin (Option D):</strong> This is not a real or physiologically relevant mechanism</p>", "options": ["Phosphoenol Pyruvate Carboxykinase", "Pyruvate Dehydrogenase", "Aldolase", "Steric inhibition of Phosphatase by albumin"], "html_options": ["Phosphoenol Pyruvate Carboxykinase", "Pyruvate Dehydrogenase", "Aldolase", "Steric inhibition of Phosphatase by albumin"], "corr_idx": 1}, {"id": "1173270", "html_qtxt": "Which coenzyme-cosubstrate is used by dehydrogenases in both glycolysis and the tricarboxylic acid cycle?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>NAD<sup>+</sup> (Nicotinamide Adenine Dinucleotide) is the key coenzyme used by several dehydrogenases in both glycolysis and the TCA cycle. It functions as an electron acceptor, getting reduced to NADH, which then donates electrons to the electron transport chain for ATP production.</p>\n<p>Examples:</p>\n<ul>\n<li>In glycolysis:\n<ul>\n<li>Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)</li>\n</ul>\n</li>\n<li>In the TCA cycle:\n<ul>\n<li>Isocitrate dehydrogenase</li>\n<li>&alpha;-Ketoglutarate dehydrogenase</li>\n<li>Malate dehydrogenase</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>TPP (Option B):</strong> Thiamine Pyrophosphate is used by pyruvate dehydrogenase and &alpha;-ketoglutarate dehydrogenase, but not broadly by dehydrogenases in glycolysis or throughout the TCA cycle.</p>\n<p><strong>Biotin (Option C):</strong> A coenzyme for carboxylation reactions (e.g., pyruvate carboxylase), not dehydrogenases.</p>\n<p><strong>FMN (Option D):</strong> Flavin Mononucleotide functions in complex I of the electron transport chain and in some redox enzymes, but is not a major coenzyme for the dehydrogenases in glycolysis or most of the TCA cycle.</p>", "options": ["NAD+", "TPP", "Biotin", "FMN"], "html_options": ["NAD+", "TPP", "Biotin", "FMN"], "corr_idx": 0}, {"id": "1173271", "html_qtxt": "Which one of the following statements concerning gluconeogenesis is correct?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Gluconeogenesis is important in maintaining blood glucose during a 2-day fast.</p>\n<ul>\n<li>During a 2-day fast, hepatic glycogen stores are nearly depleted.</li>\n<li>The body shifts to gluconeogenesis as the primary source of blood glucose.</li>\n<li>This is vital for glucose-dependent tissues like the brain, RBCs, and renal medulla.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Rise in the insulin/glucagon ratio stimulates gluconeogenesis (Option A): </strong>Incorrect - Insulin inhibits gluconeogenesis, while glucagon stimulates it. A low insulin/glucagon ratio favors gluconeogenesis.</p>\n<p><strong>It is not an energy-requiring process (Option C): </strong>Incorrect - Gluconeogenesis is energy-intensive. It consumes 4 ATP, 2 GTP, and 2 NADH per glucose molecule synthesized.</p>\n<p><strong>It uses carbon skeletons provided by fatty acid degradation (Option D): </strong>Incorrect - Even-chain fatty acids yield acetyl-CoA, which cannot be converted to glucose (due to the irreversible PDH step and no net gain of carbon in the TCA cycle).<br /> Only odd-chain fatty acids (via propionyl-CoA &rarr; succinyl-CoA) and glycerol from triglycerides can contribute</p>", "options": ["A rise in the insulin/glucagon ratio stimulates gluconeogenesis.", "It is important in maintaining blood glucose during a 2-day fast.", "It is not an energy-requiring (endergonic) process.", "It uses carbon skeletons provided by fatty acid degradation."], "html_options": ["A rise in the insulin/glucagon ratio stimulates gluconeogenesis.", "It is important in maintaining blood glucose during a 2-day fast.", "It is not an energy-requiring (endergonic) process.", "It uses carbon skeletons provided by fatty acid degradation."], "corr_idx": 1}, {"id": "1173272", "html_qtxt": "Which of the following are required for the oxidative decarboxylation function of the Pyruvate dehydrogenase complex?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The Pyruvate Dehydrogenase Complex (PDC) catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, linking glycolysis to the TCA cycle.</p>\n<p>It consists of three enzymatic components:</p>\n<ul>\n<li>E1: Pyruvate dehydrogenase</li>\n<li>E2: Dihydrolipoyl transacetylase</li>\n<li>E3: Dihydrolipoyl dehydrogenase</li>\n</ul>\n<p>Five essential coenzymes are required: </p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814ade3be7d-8061-4238-a506-60e2b3570a08.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>CoA-SH and Lipoic acid (Option A):</strong> Only 2 of the 5 required components</p>\n<p><strong>NAD&#x207A; and FAD (Option B):</strong> Cofactors of E3 only</p>\n<p><strong>CoA-SH and TPP (Option C):</strong> Needed for E1 and E2, but incomplete</p>", "options": ["CoA-SH and Lipoic acid", "NAD+ and FAD", "CoA-SH and TPP", "CoA-SH, TPP, NAD+, FAD, Lipoate"], "html_options": ["CoA-SH and Lipoic acid", "NAD+ and FAD", "CoA-SH and TPP", "CoA-SH, TPP, NAD+, FAD, Lipoate"], "corr_idx": 3}, {"id": "1173273", "html_qtxt": "In which of the conditions is the oxidation of acetyl coenzyme A by the citric acid cycle reduced?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The TCA (Krebs) cycle depends heavily on the availability of oxidized NAD&#x207A; for several key NAD&#x207A;-dependent dehydrogenase reactions, including:</p>\n<ul>\n<li>Isocitrate dehydrogenase</li>\n<li>&alpha;-Ketoglutarate dehydrogenase</li>\n<li>Malate dehydrogenase</li>\n</ul>\n<p>When the NAD&#x207A;/NADH ratio is low (i.e., NADH is high), these reactions are inhibited due to product feedback inhibition. As a result, oxidation of acetyl-CoA is reduced.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>A high availability of calcium (Option A): </strong>Activates isocitrate and &alpha;-ketoglutarate dehydrogenase, enhancing TCA activity.</p>\n<p><strong>A high acetyl-CoA/CoA ratio (Option B):</strong>  Ensures substrate availability but does not inhibit the cycle.</p>\n<p><strong>Low ATP/ADP ratio (Option C): </strong> Signals high energy demand &rarr; activates the TCA cycle to generate more ATP.</p>", "options": ["A high availability of calcium", "A high acetyl CoA/CoA ratio", "A low ATP/ADP ratio", "A low NAD+/NADH ratio"], "html_options": ["A high availability of calcium", "A high acetyl CoA/CoA ratio", "A low ATP/ADP ratio", "A low NAD+/NADH ratio"], "corr_idx": 3}, {"id": "1173274", "html_qtxt": "In the TCA Cycle, the conversion of pyruvate to acetyl coenzyme A and carbon dioxide:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The pyruvate dehydrogenase complex (PDHC) catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA and CO<sub>2</sub>, serving as the link between glycolysis and the TCA cycle.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814d736d020-5257-4689-8409-928dfc0c2b2b.png\">\n<p>Key Coenzymes Involved: </p>\n<p>Lipoic acid is covalently bound to E2 and acts as a \"swinging arm\", transferring the acetyl group and reducing equivalents between enzyme subunits.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Activated when PDH is phosphorylated by PDH kinase (Option B):</strong> Incorrect &rarr; Phosphorylation inactivates PDH. Dephosphorylation by PDH phosphatase reactivates it.</p>\n<p><strong>Occurs in the cytosol (Option C): </strong>Incorrect &rarr; PDHC is located in the mitochondrial matrix, not the cytosol.</p>\n<p><strong>Requires biotin (Option D): </strong>Incorrect &rarr; Biotin is a coenzyme for carboxylation reactions (e.g., pyruvate carboxylase), not decarboxylation.</p>", "options": ["Involves the participation of lipoic acid.", "Is activated when pyruvate decarboxylase of the pyruvate dehydrogenase complex (PDHC) is phosphorylated by PDH kinase in the presence of ATP.", "Occurs in the cytosol.", "Requires the coenzyme biotin."], "html_options": ["Involves the participation of lipoic acid.", "Is activated when pyruvate decarboxylase of the pyruvate dehydrogenase complex (PDHC) is phosphorylated by PDH kinase in the presence of ATP.", "Occurs in the cytosol.", "Requires the coenzyme biotin."], "corr_idx": 0}, {"id": "1173275", "html_qtxt": "A 2-month-old infant presents with poor feeding, lethargy, and developmental delay. Labs show elevated lactic acid. PDH complex activity in fibroblasts is 5% at low thiamine pyrophosphate (TPP) levels but increases to 80% with high TPP. Which of the following is the most likely explanation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The child has a partial deficiency of PDHC, likely due to a mutation in the E1 (pyruvate decarboxylase) subunit that results in a high Km for TPP (i.e., the enzyme has reduced affinity for TPP at normal concentrations).</li>\n<li>At high TPP concentrations, enzyme activity improves drastically, indicating the defect can be partially bypassed by TPP supplementation.</li>\n<li>Thiamine (Vitamin B1) is the precursor of TPP. Administering thiamine increases intracellular TPP levels, improving enzyme function and reducing lactate accumulation, thereby improving symptoms.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081461dcaee5-65a4-4544-935f-4a2a7e6a8d37.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Dextrose administration (Option A)</strong>: Worsens the condition: Increases glycolytic flux, producing more pyruvate, which cannot enter the TCA cycle &rarr; worsens lactic acidosis.</p>\n<p><strong>Citrate production increased (Option C):</strong> False. PDHC deficiency decreases acetyl-CoA production &rarr; less citrate synthesis from OAA + acetyl-CoA.</p>\n<p><strong>(Option D) PDH kinase is expected to be active:</strong> Incorrect. High pyruvate levels inhibit PDH kinase, keeping PDHC in its active dephosphorylated state, though the enzyme is still functionally limited due to low TPP affinity.</p>", "options": ["Intravenous dextrose administration is helpful.", "Thiamine administration is expected to reduce his serum lactate level and improve his clinical symptoms.", "Aerobic glycolysis, producing citrate, is expected to be increased.", "PDH kinase, a regulatory enzyme of the PDHC, is expected to be active."], "html_options": ["Intravenous dextrose administration is helpful.", "Thiamine administration is expected to reduce his serum lactate level and improve his clinical symptoms.", "Aerobic glycolysis, producing citrate, is expected to be increased.", "PDH kinase, a regulatory enzyme of the PDHC, is expected to be active."], "corr_idx": 1}, {"id": "1173276", "html_qtxt": "Which of the following reactions occurs only in gluconeogenesis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The reaction Oxaloacetate &rarr; Phosphoenolpyruvate is catalyzed by the enzyme Phosphoenolpyruvate Carboxykinase (PEPCK), and is a unique step in gluconeogenesis. It is one of the key bypass reactions that circumvent the irreversible step of glycolysis catalyzed by pyruvate kinase.</p>\n<p>This reaction is necessary because:</p>\n<ul>\n<li>In glycolysis: Phosphoenolpyruvate (PEP) &rarr; Pyruvate (irreversible, by pyruvate kinase)</li>\n<li>In gluconeogenesis, this must be bypassed using two steps:\n<ol>\n<li>Pyruvate &rarr; Oxaloacetate (by pyruvate carboxylase; requires ATP + biotin)</li>\n<li>Oxaloacetate &rarr; PEP (by PEPCK; uses GTP)</li>\n</ol>\n</li>\n</ul>\n<p>This two-step bypass allows glucose to be synthesized from non-carbohydrate sources during fasting or starvation.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>1,3-Bisphosphoglycerate &rarr; 3-Phosphoglycerate (Option A):</strong> This reaction occurs in both glycolysis and gluconeogenesis. In glycolysis, it is catalyzed by phosphoglycerate kinase, producing ATP. In gluconeogenesis, the same enzyme operates in reverse to generate 1,3-bisphosphoglycerate from 3-phosphoglycerate using ATP. Thus, it is a reversible reaction, not exclusive to gluconeogenesis.</p>\n<p><strong>Lactate &rarr; Pyruvate (Option B): </strong>This is a reversible reaction catalyzed by lactate dehydrogenase (LDH). It occurs in both directions depending on the metabolic state:</p>\n<ul>\n<li>During anaerobic glycolysis, pyruvate is converted to lactate.</li>\n<li>During gluconeogenesis or aerobic conditions, lactate is converted back to pyruvate.</li>\n</ul>\n<p>Since it occurs in both directions and pathways, it is not unique to gluconeogenesis</p>\n<p><strong>Phosphoenolpyruvate &rarr; Pyruvate (Option D):</strong> This is an irreversible reaction that occurs in glycolysis, not gluconeogenesis. It is catalyzed by pyruvate kinase.<br /> In gluconeogenesis, this step must be bypassed because the reaction cannot proceed in reverse. Instead, gluconeogenesis uses two separate enzymes-pyruvate carboxylase and PEPCK-to go from pyruvate to phosphoenolpyruvate.</p>", "options": ["1,3-Bisphosphoglycerate &rarr; 3-phosphoglycerate", "Lactate &rarr; pyruvate", "Oxaloacetate &rarr; phosphoenolpyruvate", "Phosphoenolpyruvate &rarr; pyruvate"], "html_options": ["1,3-Bisphosphoglycerate &rarr; 3-phosphoglycerate", "Lactate &rarr; pyruvate", "Oxaloacetate &rarr; phosphoenolpyruvate", "Phosphoenolpyruvate &rarr; pyruvate"], "corr_idx": 2}, {"id": "1173277", "html_qtxt": "In the normal resting state of humans, most of the blood glucose used as fuel is consumed by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>In the resting, post-absorptive state (i.e., between meals), the brain is the largest consumer of blood glucose. Although it comprises only ~2% of total body weight, it uses about 60-70% of circulating glucose to meet its constant energy demands.</p>\n<ul>\n<li>The brain relies almost exclusively on glucose as its energy source under normal conditions.</li>\n<li>It cannot store glucose and is entirely dependent on a continuous blood supply.</li>\n<li>It lacks significant stores of glycogen and has a limited ability to use fatty acids (due to the blood-brain barrier).</li>\n<li>During prolonged fasting, the brain adapts to use ketone bodies, but not fatty acids.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Liver (Option A): </strong>Does not consume large amounts of glucose for energy; instead, it produces glucose through glycogenolysis and gluconeogenesis to maintain blood glucose levels.</p>\n<p><strong>Adipose tissue (Option C): </strong>Uses glucose for lipogenesis and triglyceride synthesis, but its resting glucose consumption is relatively low.</p>\n<p><strong>Muscles (Option D):</strong> Do use glucose, especially during exercise, but at rest, fatty acids are the predominant fuel. Muscles also store glycogen for their use and do not contribute it to the blood glucose pool.</p>", "options": ["Liver", "Brain", "Adipose tissue", "Muscles"], "html_options": ["Liver", "Brain", "Adipose tissue", "Muscles"], "corr_idx": 1}, {"id": "1173278", "html_qtxt": "Glycolysis in erythrocytes always terminates in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Erythrocytes (red blood cells) do not have mitochondria, so they cannot perform aerobic metabolism</li>\n<li>This means that pyruvate, the end product of glycolysis, cannot enter the citric acid cycle (which requires mitochondria).</li>\n<li>Instead, pyruvate is reduced to lactate by the enzyme lactate dehydrogenase (LDH) to regenerate NAD&#x207A;, which is essential for glycolysis to continue.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pyruvate (Option A): </strong>It's produced initially, but always converted to lactate in RBCs.</p>\n<p><strong>ATP (Option B): </strong>Produced during glycolysis, but it's not the final product.</p>\n<p><strong>CO&#x2082; + H&#x2082;O (Option D):  </strong>These are products of aerobic metabolism, which RBCs cannot perform.</p>\n<p><strong>Key takeaway:</strong></p>\n<ul>\n<li>Glycolysis: Glucose &rarr; Pyruvate</li>\n<li>In cells with mitochondria: Pyruvate &rarr; CO&#x2082; + H&#x2082;o (via TCA cycle and oxidative phosphorylation)</li>\n<li>In erythrocytes: Pyruvate &rarr; Lactate (due to lack of mitochondria)</li>\n</ul>", "options": ["Pyruvate", "ATP", "Lactate", "CO&#x2082;+H&#x2082;O"], "html_options": ["Pyruvate", "ATP", "Lactate", "CO&#x2082;+H&#x2082;O"], "corr_idx": 2}, {"id": "1192092", "html_qtxt": "Abnormality of which of the following can lead to glycosuria despite a normal plasma glucose level?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Under normal conditions, glucose filtered in the kidney is completely reabsorbed in the proximal convoluted tubule by Sodium-Glucose Cotransporter 2 (SGLT2).</p>\n<ul>\n<li>If there is a mutation or dysfunction of SGLT2, glucose cannot be reabsorbed efficiently.</li>\n<li>As a result, glucose appears in the urine despite normal blood glucose levels.</li>\n<li>This condition is called renal glycosuria, and it is typically benign.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>SGLT 1 (Option A):</strong> Found in the small intestine, not primarily responsible for renal glucose reabsorption.</p>\n<p><strong>GLUT 4 (Option C):</strong> Insulin-dependent glucose transporter in muscle and fat cells, not involved in renal glucose reabsorption.</p>\n<p><strong>GLUT 5 (Option D): </strong>Transports fructose, not glucose, mainly in the small intestine.</p>", "options": ["SGLT 1", "SGLT 2", "GLUT 4", "GLUT 5"], "html_options": ["SGLT 1", "SGLT 2", "GLUT 4", "GLUT 5"], "corr_idx": 1}]}, {"moduleId": 1008715, "name": "Galactose Metabolism, Fructose Metabolism, HMP Shunt", "questions": [{"id": "1173437", "html_qtxt": "A newborn develops refusal to feed by day 2, vomiting with breastfeeding, and diarrhoea by day 3. By day 5, he develops jaundice, hepatomegaly, and bilateral cataracts. Urine tests positive for reducing sugars, and blood glucose is very low. On eye examination, oil-drop cataracts are noted. Which of the following sugar alcohols is responsible for the cataract formation in this newborn?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The clinical picture is suggestive of classic galactosemia, most often caused by a deficiency of galactose-1-phosphate uridyl transferase (GALT).</p>\n<ul>\n<li>Galactose, unable to be properly metabolised, accumulates.</li>\n<li>It is reduced by aldose reductase to galactitol (also called dulcitol).</li>\n<li>Dulcitol accumulates in the lens, drawing in water and leading to osmotic cataract formation, especially the classic oil-drop cataract seen in galactosemia.</li>\n</ul>\n<p>Other associated findings:</p>\n<ul>\n<li>Hepatomegaly, jaundice, due to the toxic buildup of galactose-1-phosphate in the liver.</li>\n<li>Hypoglycemia, due to liver dysfunction.</li>\n<li>Positive urinary reducing sugars, due to galactose in the urine.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Ribitol (Option A): </strong>A sugar alcohol derived from ribose; not implicated in galactosemia.</p>\n<p><strong>Sorbitol (Option C):</strong> Formed from glucose in diabetes; involved in diabetic cataracts, not in galactosemia.</p>\n<p><strong>Xylitol (Option D):</strong> A sugar alcohol used as a sweetener; not produced in galactose metabolism.</p>", "options": ["Ribitol", "Dulcitol", "Sorbitol", "Xylitol"], "html_options": ["Ribitol", "Dulcitol", "Sorbitol", "Xylitol"], "corr_idx": 1}, {"id": "1173438", "html_qtxt": "Active transport is not required for the absorption of which of the following molecules?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Fructose is absorbed in the small intestine by facilitated diffusion, not active transport.</li>\n<li>It uses a Na<sup>+</sup>-independent transporter called GLUT5, which allows fructose to move down its concentration gradient into enterocytes without the use of ATP or sodium gradients.</li>\n<li>After entering the enterocyte, GLUT2 helps transport fructose into the bloodstream.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glucose (Option A): </strong>Glucose absorption occurs via SGLT1, a sodium-dependent secondary active transporter. It couples glucose uptake with Na<sup>+</sup> ions using the Na<sup>+</sup>/K<sup>+</sup> ATPase pump to maintain the gradient. Requires active transport.</p>\n<p><strong>Galactose (Option B):</strong> Like glucose, galactose is absorbed through SGLT1, which is also Na<sup>+</sup>-dependent. It uses secondary active transport to enter enterocytes against its concentration gradient. Requires active transport.</p>\n<p><strong>Sucrose (Option D): </strong>Sucrose is a disaccharide and cannot be absorbed directly. It must first be broken down by sucrase into glucose and fructose. Thus, sucrose itself is not absorbed, and its breakdown products do use transporters, some of which involve active mechanisms.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814ebe826f6-96d3-4033-b91e-4c3700a7ea69.png\">", "options": ["Glucose", "Galactose", "Fructose", "Sucrose"], "html_options": ["Glucose", "Galactose", "Fructose", "Sucrose"], "corr_idx": 2}, {"id": "1173440", "html_qtxt": "In which of the following steps is ATP released?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The conversion of Phosphoenol pyruvate to pyruvate is catalysed by the enzyme pyruvate kinase in glycolysis.</li>\n<li>It is an example of substrate-level phosphorylation, where a high-energy phosphate bond from phosphoenolpyruvate (PEP) is transferred to ADP, forming ATP and pyruvate.</li>\n<li>This reaction is irreversible and a key regulatory step in glycolysis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate (Option B): </strong>This step is catalyzed by glyceraldehyde-3-phosphate dehydrogenase. It requires NAD<sup>+</sup> and inorganic phosphate (Pi) but does not generate ATP at this point. It's an energy-requiring step that stores energy for a subsequent ATP-generating step.</p>\n<p><strong>Fructose-6-phosphate to fructose-1,6-bisphosphate (Option C): </strong>This is a rate-limiting and committed step of glycolysis catalysed by phosphofructokinase-1 (PFK-1). It actually uses ATP to phosphorylate F6P. No ATP is produced; ATP is consumed.</p>\n<p><strong>Glucose to glucose-6-phosphate (Option D): </strong>Catalysed by hexokinase (or glucokinase in the liver). This step also consumes ATP to phosphorylate glucose. Again, no ATP is produced; it is used.</p>", "options": ["Phosphoenol pyruvate to pyruvate", "Glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate", "Fructose-6-phosphate to fructose-1,6-bisphosphate", "Glucose to Glucose-6-phosphate"], "html_options": ["Phosphoenol pyruvate to pyruvate", "Glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate", "Fructose-6-phosphate to fructose-1,6-bisphosphate", "Glucose to Glucose-6-phosphate"], "corr_idx": 0}, {"id": "1173442", "html_qtxt": "An advertisement promotes energy bars containing fructose as an ideal food to take on extreme mountain-climbing expeditions. Which of the following statements concerning fructose absorption is true?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Fructose is absorbed passively via facilitated diffusion using the GLUT5 transporter on the apical membrane of enterocytes.</li>\n<li>It does not require ATP or a sodium gradient, unlike glucose and galactose, which use SGLT1 (sodium-dependent).</li>\n<li>Fructose then exits the enterocyte into the blood via GLUT2 on the basolateral membrane.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Metabolism of fructose generates more energy than glucose (Option B): </strong>Incorrect. Fructose and glucose both yield similar amounts of ATP when metabolised. Fructose bypasses phosphofructokinase (PFK-1), leading to less regulation but not more energy.</p>\n<p><strong>Some fructose is absorbed in the mouth; hence, it is the fastest way to give energy (Option C): </strong>Incorrect. Unlike glucose, fructose is not absorbed in the oral cavity. It must be digested and absorbed in the small intestine.</p>\n<p><strong>The presence of fructose inhibits the reabsorption of glucose, which is then more readily available for muscle activity (Option D): </strong>Incorrect and biochemically inaccurate. Fructose does not inhibit glucose absorption or reabsorption. Both can be absorbed simultaneously through independent transporters.</p>", "options": ["Absorption of fructose into intestinal epithelial cells is by facilitated transport and thus does not require energy", "Metabolism of fructose generates more energy than glucose", "Some fructose is absorbed in the mouth, hence it is the fastest way to give energy", "The presence of fructose inhibits the reabsorption of glucose, which is then more readily available for muscle activity"], "html_options": ["Absorption of fructose into intestinal epithelial cells is by facilitated transport and thus does not require energy", "Metabolism of fructose generates more energy than glucose", "Some fructose is absorbed in the mouth, hence it is the fastest way to give energy", "The presence of fructose inhibits the reabsorption of glucose, which is then more readily available for muscle activity"], "corr_idx": 0}, {"id": "1173445", "html_qtxt": "All of the following occur during the resting state except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>During fasting, the blood glucose level drops, which leads to:</p>\n<ul>\n<li>&uarr; Glucagon secretion (from pancreatic alpha cells)</li>\n<li>Glucagon &rarr; Activates adenylate cyclase &rarr; &uarr; cAMP &rarr; Activates Protein Kinase A (PKA)</li>\n<li>PKA phosphorylates the bifunctional enzyme (PFK-2/FBPase-2), resulting in:\n<ul>\n<li>&darr; PFK-2 activity (which normally produces Fructose 2,6-bisphosphate)</li>\n<li>&uarr; FBPase-2 activity (which breaks down Fructose 2,6-bisphosphate)</li>\n</ul>\n</li>\n</ul>\n<p>Net result: &darr; Fructose 2,6-bisphosphate</p>\n<p>This decrease:</p>\n<ul>\n<li>Inhibits glycolysis (less activation of PFK-1)</li>\n<li>Stimulates gluconeogenesis (less inhibition of fructose-1,6-bisphosphatase)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Inhibition of PFK-II (Option A):</strong> Correct: Glucagon &rarr; PKA phosphorylates PFK-2 &rarr; Inhibited.</p>\n<p><strong>Activation of Fructose 2,6-Bisphosphatase (Option B):</strong> Correct: The same phosphorylation activates the FBPase-2 part of the bifunctional enzyme.</p>\n<p><strong>Increase in glucagon (Option C):</strong> Correct: Glucagon increases in response to hypoglycemia during fasting.</p>\n<p><strong>Key takeaways:</strong></p>\n<p>Fructose 2,6-bisphosphate increases only in the fed state, promoting glycolysis.</p>\n<p>During fasting, its levels decrease, shifting metabolism toward gluconeogenesis.</p>", "options": ["Inhibition of PFK-II", "Activation of Fructose 2, 6 Bisphosphatase", "Increase in glucagon", "Increase in Fructose 2, 6 Bisphosphate"], "html_options": ["Inhibition of PFK-II", "Activation of Fructose 2, 6 Bisphosphatase", "Increase in glucagon", "Increase in Fructose 2, 6 Bisphosphate"], "corr_idx": 3}, {"id": "1173448", "html_qtxt": "The enzyme responsible for the complete oxidation of glucose to CO2 and water is located in the:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The complete oxidation of glucose involves multiple steps:</p>\n<ol>\n<li>Glycolysis occurs in the cytosol, producing pyruvate.</li>\n<li>Pyruvate oxidation to acetyl-CoA occurs in the mitochondrial matrix.</li>\n<li>Citric Acid Cycle (Krebs Cycle) - also in the mitochondrial matrix, fully oxidises acetyl-CoA to COH&#8322;O.</li>\n<li>Electron Transport Chain and Oxidative Phosphorylation - located on the inner mitochondrial membrane, converts NADH/FADHH&#8322;O into ATP and forms HH&#8322;OO by reducing OH&#8322;O.</li>\n</ol>\n<p>Thus, mitochondria are the key site for the complete oxidation of glucose to COH&#8322;O and water.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cytosol (Option A):</strong> Site of glycolysis only, not full oxidation. Pyruvate remains incompletely oxidized here.</p>\n<p><strong>Lysosomes (Option C):</strong> Involved in the degradation of macromolecules, not glucose metabolism.</p>\n<p><strong>Endoplasmic reticulum (Option D):</strong> Involved in protein and lipid synthesis, not glucose oxidation.</p>", "options": ["Cytosol", "Mitochondria", "Lysosomes", "Endoplasmic reticulum"], "html_options": ["Cytosol", "Mitochondria", "Lysosomes", "Endoplasmic reticulum"], "corr_idx": 1}, {"id": "1173453", "html_qtxt": "Substrate-level phosphorylation is by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Pyruvate kinase catalyzes the final step of glycolysis, where the high-energy phosphate from phosphoenolpyruvate (PEP) is directly transferred to ADP to form ATP and pyruvate. This is a classic example of substrate-level phosphorylation, because ATP is generated directly from a phosphorylated metabolic intermediate without involvement of the electron-transport chain.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphofructokinase (Option B):</strong></p>\n<ul>\n<li>Catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate.</li>\n<li>Consumes ATP (adding a phosphate), rather than producing it.</li>\n</ul>\n<p><strong>Hexokinase (Option C):</strong></p>\n<ul>\n<li>Catalyzes the first step of glycolysis: glucose &rarr; glucose-6-phosphate.</li>\n<li>Also uses ATP to phosphorylate glucose; does not generate ATP.</li>\n</ul>\n<p><strong>ATP Synthase (Option D): </strong></p>\n<ul>\n<li>Generates ATP by oxidative phosphorylation in the mitochondria, using the proton-motive force across the inner membrane.</li>\n<li>This is not substrate-level phosphorylation, but rather chemiosmotic phosphorylation via the electron-transport chain.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Substrate-level phosphorylation occurs when a phosphorylated intermediate directly donates its phosphate to ADP (e.g., via pyruvate kinase or phosphoglycerate kinase).</li>\n<li>Oxidative phosphorylation (via ATP synthase) relies on the electron-transport chain and a proton gradient.</li>\n</ul>", "options": ["Pyruvate kinase", "Phosphofructokinase", "Hexokinase", "ATP Synthase"], "html_options": ["Pyruvate kinase", "Phosphofructokinase", "Hexokinase", "ATP Synthase"], "corr_idx": 0}, {"id": "1173457", "html_qtxt": "Acetyl-CoA can be converted into all of the following except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Acetyl-CoA cannot be converted back into glucose in humans because:</p>\n<ul>\n<li>The pyruvate dehydrogenase complex (PDH) reaction (which converts pyruvate &rarr; acetyl-CoA) is irreversible.</li>\n<li>Once carbons enter the TCA cycle as Acetyl-CoA, they are lost as COH&#8322;O, not available for gluconeogenesis.</li>\n<li>Net gain of glucose from Acetyl CoA is not possible, unlike from certain amino acids or lactate.</li>\n</ul>\n<p>Thus, while Acetyl CoA is a central metabolic intermediate, it is not glucogenic.</p>\n<p><strong>Explanation of other options: </strong></p>\n<p><strong>Fatty acids (Option B):</strong> Acetyl-CoA is a precursor for fatty acid synthesis via malonyl-CoA.</p>\n<p><strong>Cholesterol (Option C):</strong> Cholesterol is synthesised from multiple acetyl-CoA units via the mevalonate pathway.</p>\n<p><strong>Ketone bodies(Option D)</strong>: In liver mitochondria, Acetyl CoA is converted to acetoacetate, &beta;-hydroxybutyrate, and acetone, especially during fasting/starvation.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508145ada78ac-276f-4f02-82b9-b020197c2446.png\">", "options": ["Glucose", "Fatty acids", "Cholesterol", "Ketone bodies"], "html_options": ["Glucose", "Fatty acids", "Cholesterol", "Ketone bodies"], "corr_idx": 0}, {"id": "1173464", "html_qtxt": "A breastfed infant comes with frequent vomiting and loss of weight. After several days, he developed jaundice, hepatomegaly, and bilateral cataracts. What is the possible diagnosis of this child?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The clinical picture points towards galactosemia:</p>\n<ul>\n<li>The infant is breastfed, which means they are consuming lactose (broken down into glucose and galactose).</li>\n<li>In classic galactosemia (due to GALT deficiency), the body cannot metabolize galactose properly.</li>\n<li>This leads to the accumulation of galactose-1-phosphate and galactitol.</li>\n<li>Galactitol accumulates in the lens, causing bilateral cataracts (a hallmark sign).</li>\n<li>Additional findings like vomiting, jaundice, hepatomegaly, and failure to thrive are typical.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Juvenile Diabetes Mellitus (Type 1 DM) (Option A):</strong></p>\n<ul>\n<li>Typically presents after infancy (usually after age 5).</li>\n<li>Features polyuria, polydipsia, weight loss, but not cataracts, hepatomegaly, or jaundice in this context.</li>\n</ul>\n<p><strong>Gaucher's Disease (Option B):</strong></p>\n<ul>\n<li>A lysosomal storage disorder causing hepatosplenomegaly, bone crises, and anemia.</li>\n<li>No association with cataracts or acute symptoms triggered by milk.</li>\n</ul>\n<p><strong>Hereditary Fructose Intolerance (HFI) (Option C):</strong></p>\n<ul>\n<li>Caused by aldolase B deficiency.</li>\n<li>Symptoms are triggered by fructose intake, not lactose.</li>\n<li>Presents after weaning (when fructose is introduced).</li>\n<li>No cataracts are seen in HFI.</li>\n</ul>", "options": ["Juvenile DM", "Gaucher's disease", "HFI", "Galactosemia"], "html_options": ["Juvenile DM", "Gaucher's disease", "HFI", "Galactosemia"], "corr_idx": 3}, {"id": "1173468", "html_qtxt": "All of the following metabolites are seen in the HMP Shunt except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycerol-3-phosphate is not part of the HMP shunt.</p>\n<p>It is involved in lipid metabolism and glycerol phosphate shuttle, not in the pentose phosphate pathway.</p>\n<p>Metabolites in HMP Shunt Pathway:</p>\n<ul>\n<li>Glucose-6-phosphate</li>\n<li>6-Phosphogluconate</li>\n<li>Ribulose-5-Phosphate</li>\n<li>Xylulose-5-Phosphate <strong>(Option D ruled out)</strong></li>\n<li>Ribose-5-Phosphate</li>\n<li>Glyceraldehyde-3-Phosphate <strong>(Option C ruled out)</strong></li>\n<li>Sedoheptulose-7-Phosphate <strong>(Option B ruled out)</strong></li>\n<li>Fructose-6-phosphate</li>\n<li>Erythrose 4 Phosphate</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814a79f3ed5-89e1-4aac-a47b-47c410523926.png\">", "options": ["Glycerol-3-phosphate", "Sedoheptulose-7-phosphate", "Glyceraldehyde-3-phosphate", "Xylulose-5-phosphate"], "html_options": ["Glycerol-3-phosphate", "Sedoheptulose-7-phosphate", "Glyceraldehyde-3-phosphate", "Xylulose-5-phosphate"], "corr_idx": 0}]}, {"moduleId": 1008716, "name": "Glycogen Metabolism And Storage Disorders", "questions": [{"id": "1173164", "html_qtxt": "All of the following statements about glycogen are true except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycogen has a main chain formed by &alpha;(1&rarr;4) glycosidic bonds with branch points occurring at every 8-12 residues, formed by &alpha;(1&rarr;6) glycosidic bonds.</p>\n<p>Chains between these branches typically contain 12-15 glucose units.</p>\n<p><strong>Explanation of incorrect options:</strong></p>\n<p><strong>Glycogen is the storage polysaccharide in animals and is sometimes called animal starch (Option A):</strong>True</p>\n<p><strong>It is a more highly branched structure than amylopectin (Option B):</strong> Amylopectin (from plants) has branch points every 24-30 glucose units, while glycogen has branches every 8-12 glucose units.</p>\n<p><strong>It is an example of a homoglycan (Option D):</strong> It is a polysaccharide made from only one type of monosaccharide, ie, &alpha;-D-glucose units.</p>", "options": ["Glycogen is the storage polysaccharide in animals and is sometimes called animal starch", "It is a more highly branched structure than amylopectin", "It consists of 12 to 15 &alpha;-D-glucopyranose residues (in &alpha;1 &rarr; 6 glucosidic linkage) with branching by means of &alpha;1 &rarr; 4 glucosidic bond", "It is an example of a homoglycan."], "html_options": ["Glycogen is the storage polysaccharide in animals and is sometimes called animal starch", "It is a more highly branched structure than amylopectin", "It consists of 12 to 15 &alpha;-D-glucopyranose residues (in &alpha;1 &rarr; 6 glucosidic linkage) with branching by means of &alpha;1 &rarr; 4 glucosidic bond", "It is an example of a homoglycan."], "corr_idx": 2}, {"id": "1173165", "html_qtxt": "Which of the following molecules is the link between gluconeogenesis, glycogenesis and glycogenolysis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glucose 6-phosphate is a key intermediate that connects all three pathways:</p>\n<ul>\n<li>Glycogenesis: Glucose &rarr; <strong>Glucose 6-phosphate</strong> &rarr; Glucose 1-phosphate &rarr; UDP-glucose &rarr; Glycogen.</li>\n<li>Glycogenolysis: Glycogen &rarr; Glucose 1-phosphate &rarr; <strong>Glucose 6-phosphate</strong> &rarr; (Used in glycolysis or converted to glucose by G6Pase in liver).</li>\n<li>Gluconeogenesis: Non-carbohydrate precursors are converted to intermediates like phosphoenolpyruvate &rarr; &rarr; <strong>Glucose 6-phosphate</strong> &rarr; Glucose.</li>\n</ul>\n<p>It also plays a role in glycolysis and the pentose phosphate pathway, making it one of the most central metabolites in glucose metabolism.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glucose 1-phosphate (Option A):</strong> Involved only in glycogen metabolism, It is converted to glucose 6-phosphate by phosphoglucomutase to enter other pathways.</p>\n<p><strong>Glucose 1,6-bisphosphate (Option B):</strong> A transient regulatory intermediate, not a major pathway metabolite. Plays a role in enzyme regulation (e.g., activates phosphoglucomutase).</p>\n<p><strong>Fructose 6-phosphate (Option C):</strong> Present in glycolysis and gluconeogenesis. Not involved in glycogenesis or glycogenolysis.</p>", "options": ["Glucose 1-Phosphate", "Glucose 1-6 biphosphate", "Fructose 6 Phosphate", "Glucose 6-phosphate"], "html_options": ["Glucose 1-Phosphate", "Glucose 1-6 biphosphate", "Fructose 6 Phosphate", "Glucose 6-phosphate"], "corr_idx": 3}, {"id": "1173189", "html_qtxt": "A child presents with recurrent fasting hypoglycemia. Laboratory testing shows normal liver glycogen content but an inability to raise blood glucose levels after glucagon administration. Which of the following enzymes is most likely deficient?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glucose-6-phosphatase is the key enzyme responsible for the final step of both glycogenolysis and gluconeogenesis, converting glucose-6-phosphate to free glucose in the liver and kidneys, allowing its release into the bloodstream.</p>\n<ul>\n<li>In its absence (as in von Gierke disease, GSD type I), glucose cannot be produced from glycogen or gluconeogenic precursors.</li>\n<li>This leads to hypoglycemia during fasting, despite normal or increased glycogen stores in the liver.</li>\n<li>Glucagon has no effect because the liver cannot release free glucose without this enzyme.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Fructokinase (Option A):</strong> Involved in fructose metabolism. Deficiency causes essential fructosuria, a benign condition with no hypoglycemia or glycogen abnormalities.</p>\n<p><strong>Glucokinase (Option B):</strong> Catalyses the phosphorylation of glucose to glucose-6-phosphate in the liver and pancreas. Deficiency impairs glucose sensing in pancreatic &beta;-cells, leading to mild fasting hyperglycemia, not hypoglycemia. It is not involved in glycogen breakdown or gluconeogenesis.</p>\n<p><strong>Transketolase (Option D):</strong> An enzyme of the pentose phosphate pathway (HMP shunt). Important for nucleotide synthesis and NADPH production, especially in RBCs. Deficiency (seen in thiamine deficiency) does not cause hypoglycemia or affect glycogenolysis/gluconeogenesis.</p>\n<p><strong>Glycogen Storage Diseases</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508149b6ee9c4-e850-4d83-8624-80c8f3174d48.png\">", "options": ["Fructokinase", "Glucokinase", "Glucose 6-Phosphatase", "Transketolase"], "html_options": ["Fructokinase", "Glucokinase", "Glucose 6-Phosphatase", "Transketolase"], "corr_idx": 2}, {"id": "1173198", "html_qtxt": "A genetic disorder renders fructose 1, 6-bisphosphatase in the liver less sensitive to regulation by fructose 2, 6-bisphosphate. Which of the following metabolic changes is most likely observed in this disorder?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Fructose 1,6-bisphosphatase is a key gluconeogenic enzyme that converts fructose 1,6-bisphosphate &rarr; fructose 6-phosphate.</p>\n<ul>\n<li>Fructose 2,6-bisphosphate is a potent inhibitor of this enzyme and activator of glycolysis (by stimulating PFK-1).</li>\n<li>In this genetic disorder, fructose 1,6-bisphosphatase becomes less sensitive to inhibition, so it remains more active than usual.</li>\n<li>Result: Enhanced gluconeogenesis &rarr; fructose 1,6-bisphosphate is more rapidly converted to fructose 6-phosphate &rarr; its level decreases.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>The level of fructose 1,6-bisphosphate is higher than normal (Option A):</strong> Incorrect. Since fructose 1,6-bisphosphatase is more active, it breaks down fructose 1,6-bisphosphate faster than normal &rarr; level drops, not increases.</p>\n<p><strong>Less pyruvate is formed (Option C):</strong> Not directly related. Pyruvate is produced from glycolysis, primarily regulated by PFK-1 and pyruvate kinase, not fructose 1,6-bisphosphatase. While enhanced gluconeogenesis could reduce glycolytic flux slightly, it does not directly reduce pyruvate production to a significant extent in this context.</p>\n<p><strong>Less ATP is generated (Option D):</strong> Also incorrect. ATP production is primarily tied to glycolysis, oxidative phosphorylation, and the TCA cycle. While there may be shifts in metabolic flux, this mutation doesn't significantly affect ATP generation under typical physiological conditions.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250814c2f112c6-a554-4d51-97fb-d8e75e9df1c3.png\">", "options": ["The level of fructose 1,6-bisphosphate is higher than normal", "The level of fructose 1,6-bisphosphate is lower than normal", "Less pyruvate is formed", "Less ATP is generated"], "html_options": ["The level of fructose 1,6-bisphosphate is higher than normal", "The level of fructose 1,6-bisphosphate is lower than normal", "Less pyruvate is formed", "Less ATP is generated"], "corr_idx": 1}, {"id": "1173207", "html_qtxt": "Acetone is increased in the serum of a patient with Von Gierke's disease. Which of the following is not a reason for ketosis in this disease?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Von Gierke's disease (Glycogen Storage Disease Type I) is caused by glucose-6-phosphatase deficiency. This results in:</p>\n<ul>\n<li>Severe fasting hypoglycemia (glucose can't be released into the bloodstream)</li>\n<li>Accumulation of glucose-6-phosphate &rarr; shunted into other pathways like lactic acid, uric acid, lipogenesis</li>\n<li>Gluconeogenesis is impaired (because the final step is blocked), leading to:\n<ul>\n<li>Accumulation of pyruvate and lactate</li>\n<li>Increased fatty acid mobilisation due to hypoglycemia and low insulin</li>\n<li>Excess acetyl-CoA &rarr; ketone body formation (acetoacetate, &beta;-hydroxybutyrate, acetone)</li>\n</ul>\n</li>\n</ul>\n<p>So, fatty acid mobilization is high, not low, making Option D incorrect and hence the correct answer for the question.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hypoglycemia (Option A):</strong> True. Because of defective gluconeogenesis and glycogenolysis, blood glucose levels fall, triggering lipolysis and ketogenesis.</p>\n<p><strong>Oxaloacetate is necessary for gluconeogenesis (Option B):</strong> True. In fasting, oxaloacetate is diverted to gluconeogenesis. If gluconeogenesis is blocked, acetyl-CoA accumulates, &rarr; ketone production increases.</p>\n<p><strong>Low blood glucose less than 40 mg% (Option C):</strong> True. Severe hypoglycemia (<40 mg%) stimulates the release of glucagon and epinephrine, which enhances lipolysis and leads to ketosis.</p>", "options": ["Hypoglycemia", "Oxaloacetate is necessary for gluconeogenesis", "Low blood glucose, less than 40 mg%", "Fatty acid mobilisation is low"], "html_options": ["Hypoglycemia", "Oxaloacetate is necessary for gluconeogenesis", "Low blood glucose, less than 40 mg%", "Fatty acid mobilisation is low"], "corr_idx": 3}, {"id": "1173211", "html_qtxt": "Glycogen is released from the muscle because of increased cAMP due to:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Epinephrine stimulates glycogenolysis in skeletal muscle via &beta;-adrenergic receptors, which activate adenylate cyclase &rarr; &uarr; cAMP &rarr; activation of protein kinase A (PKA) &rarr; phosphorylation of phosphorylase kinase &rarr; activation of glycogen phosphorylase, which breaks down glycogen to glucose-1-phosphate.</p>\n<ul>\n<li>In muscle, glycogen is used for internal energy needs, not for blood glucose maintenance.</li>\n<li>Unlike liver, muscle lacks glucose-6-phosphatase, so glucose cannot be released into the bloodstream.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thyroxine (Option B):</strong> Incorrect. Thyroxine (T4) increases basal metabolic rate and enhances overall metabolism but does not directly activate cAMP-mediated glycogenolysis in muscle.</p>\n<p><strong>Glucagon (Option C):</strong> Incorrect. Glucagon acts only on the liver, not muscle. It increases cAMP in hepatocytes to stimulate hepatic glycogenolysis and gluconeogenesis. Skeletal muscle cells lack glucagon receptors.</p>\n<p><strong>Growth hormone (Option D):</strong> Incorrect. Growth hormone has long-term effects on metabolism by promoting protein synthesis and lipolysis. It does not directly increase cAMP or promote glycogenolysis in muscle.</p>", "options": ["Epinephrine", "Thyroxine", "Glucagon", "Growth hormone"], "html_options": ["Epinephrine", "Thyroxine", "Glucagon", "Growth hormone"], "corr_idx": 0}, {"id": "1173214", "html_qtxt": "A 5-year-old boy is brought to the pediatric clinic with complaints of lethargy, irritability, and poor weight gain. His mother reports that he becomes drowsy and sweaty between meals and feels better after eating. On examination, the child has a protuberant abdomen and enlarged liver. Urine tests reveal ketones, and markedly low blood glucose during fasting. There is no family history of diabetes. Which of the following is the most likely diagnosis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycogen storage disorders, especially Type I (von Gierke's disease), are caused by enzyme deficiencies in glycogen metabolism.</p>\n<ul>\n<li>In Von Gierke's disease, deficiency of glucose-6-phosphatase prevents release of free glucose from the liver &rarr; fasting hypoglycemia.</li>\n<li>Glycogen accumulates in the liver, leading to hepatomegaly.</li>\n<li>Due to impaired glucose availability, the body shifts to lipolysis and ketogenesis, causing ketosis.</li>\n<li>Common features include:\n<ul>\n<li>Lethargy and hypoglycemia between meals</li>\n<li>Hepatomegaly</li>\n<li>Ketosis</li>\n<li>Doll-like facies, short stature, lactic acidosis, hyperuricemia, and hyperlipidemia in some cases</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Mucopolysaccharidosis (MPS) (Option A):</strong> A group of lysosomal storage disorders involving defects in the degradation of glycosaminoglycans (GAGs). Features include coarse facial features, corneal clouding, joint stiffness, developmental delay, and sometimes organomegaly, but hypoglycemia and ketosis are not typical. Does not present with fasting symptoms or ketotic hypoglycemia.</p>\n<p><strong>Lipopolysaccharidosis (Option C)</strong>(e.g., Gaucher, Niemann-Pick): Involves accumulation of lipids in organs like the liver, spleen, and CNS due to enzyme deficiencies. Presents with hepatosplenomegaly, neurological symptoms, or bone pain, depending on the subtype. Hypoglycemia and ketosis are not typical features.</p>\n<p><strong>Type 1 Diabetes Mellitus (Option D):</strong> More common in older children or adolescents. Presents with polyuria, polydipsia, weight loss, and high blood sugar, not hypoglycemia. Ketosis occurs with hyperglycemia, unlike the fasting hypoglycemia with ketosis seen in GSD. Hepatomegaly is not a feature.</p>", "options": ["Mucopolysaccharidosis", "Glycogen storage disorder", "Lipopolysaccharidosis", "Diabetes mellitus"], "html_options": ["Mucopolysaccharidosis", "Glycogen storage disorder", "Lipopolysaccharidosis", "Diabetes mellitus"], "corr_idx": 1}, {"id": "1173222", "html_qtxt": "Glycogen phosphorylase can be regulated by all the following except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glycogenin is a primer protein required for the <em>initiation</em> of glycogen synthesis, not involved in the regulation of glycogen phosphorylase, which is the enzyme responsible for glycogen breakdown (glycogenolysis).</li>\n<li>It provides the initial tyrosine residue on which glucose units are added to begin forming the glycogen chain.</li>\n<li>Hence, glycogenin has no role in regulating glycogen phosphorylase</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>cAMP (Option A):</strong> cAMP (cyclic AMP) is produced in response to glucagon or epinephrine. It activates Protein Kinase A (PKA), which in turn activates phosphorylase kinase, ultimately activating glycogen phosphorylase via phosphorylation.</p>\n<p><strong>Calmodulin (Option B):</strong> In muscle, contraction increases intracellular Ca2+, which binds to calmodulin. Calmodulin then activates phosphorylase kinase even without cAMP, leading to activation of glycogen phosphorylase.</p>\n<p><strong>Protein Kinase A (PKA) (Option C):</strong> Activated by cAMP. It phosphorylates phosphorylase kinase, which then phosphorylates and activates glycogen phosphorylase. PKA also inhibits glycogen synthase, ensuring reciprocal regulation of synthesis and breakdown.</p>", "options": ["cAMP", "Calmodulin", "Protein Kinase A", "Glycogenin"], "html_options": ["cAMP", "Calmodulin", "Protein Kinase A", "Glycogenin"], "corr_idx": 3}, {"id": "1173228", "html_qtxt": "Cofactor for Glycogen Phosphorylase:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glycogen phosphorylase is the key enzyme in glycogenolysis, catalysing the release of glucose-1-phosphate from glycogen via phosphorolysis.</li>\n<li>It requires pyridoxal phosphate (PLP), the active form of vitamin B6, as a coenzyme.</li>\n<li>In this enzyme, the phosphate group of PLP is catalytically active (unlike in transamination reactions, where the aldehyde group is reactive).</li>\n<li>This makes PLP essential for the enzyme's function in breaking &alpha;-1,4-glycosidic bonds.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thiamine Pyrophosphate (TPP) (Option A):</strong> TPP is the coenzyme for enzymes involved in decarboxylation reactions (e.g., pyruvate dehydrogenase, &alpha;-ketoglutarate dehydrogenase, transketolase). It has no role in glycogen metabolism.</p>\n<p><strong>Citrate (Option C):</strong> Citrate is an intermediate in the TCA cycle, and an allosteric regulator of some enzymes (e.g., inhibits PFK-1 in glycolysis), but it is not a cofactor or coenzyme. It plays no direct role in glycogen phosphorylase activity.</p>\n<p><strong>FAD (Flavin Adenine Dinucleotide) (Option D):</strong> FAD is a redox coenzyme involved in oxidation-reduction reactions (e.g., in succinate dehydrogenase, acyl-CoA dehydrogenase). It is not required by glycogen phosphorylase.</p>", "options": ["Thiamine Pyrophosphate", "Pyridoxal Phosphate", "Citrate", "FAD"], "html_options": ["Thiamine Pyrophosphate", "Pyridoxal Phosphate", "Citrate", "FAD"], "corr_idx": 1}, {"id": "1173251", "html_qtxt": "In the fed state, the major fate of glucose-6-phosphate in the liver is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glucose-6-phosphate is formed in hepatocytes when glucose enters the liver and is phosphorylated by glucokinase.</p>\n<p>In the fed state, glucose is abundant, and insulin is high.</p>\n<p>The liver does not need all the glucose for immediate energy, so:</p>\n<ul>\n<li>Excess glucose is stored as glycogen.</li>\n<li>Insulin stimulates glycogen synthase and inhibits glycogen phosphorylase &rarr; promotes glycogen storage.</li>\n<li>The liver stores glucose-6-phosphate in the form of glycogen as a major post-prandial (fed-state) fate.</li>\n</ul>", "options": ["Storage as fructose", "Storage as glyceraldehyde-3-phosphate", "Enters HMP shunt via ribulose-5-phosphate", "Storage as glycogen"], "html_options": ["Storage as fructose", "Storage as glyceraldehyde-3-phosphate", "Enters HMP shunt via ribulose-5-phosphate", "Storage as glycogen"], "corr_idx": 3}, {"id": "1173255", "html_qtxt": "The cause of hyperuricemia and gout in Glucose-6-phosphatase deficiency is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In Glucose-6-phosphatase deficiency (as seen in von Gierke's disease), glucose-6-phosphate cannot be converted to free glucose.</li>\n<li>This leads to the accumulation of glucose-6-phosphate in hepatocytes.</li>\n<li>Excess glucose-6-phosphate is diverted into the Pentose Phosphate Pathway (HMP Shunt) &rarr; producing ribose-5-phosphate.</li>\n<li>Ribose-5-phosphate is a precursor for PRPP (phosphoribosyl pyrophosphate) &rarr; key substrate for purine nucleotide synthesis.</li>\n<li>Excess purines are eventually degraded to uric acid &rarr; causing hyperuricemia and gout.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Decreased availability of glucose to tissues (Option B):</strong> While hypoglycemia does occur in von Gierke's, this is not the mechanism of hyperuricemia. It contributes to symptoms like irritability, seizures, etc., but not urate accumulation.</p>\n<p><strong>Increased accumulation of sorbitol (Option C):</strong> Sorbitol is linked to diabetic complications, not to von Gierke's disease. This pathway involves aldose reductase, and its accumulation affects eyes (cataract), nerves, and kidneys, not uric acid levels.</p>\n<p><strong>Impaired degradation of free radicals (Option D):</strong> This refers more to oxidative stress and antioxidant mechanisms. It is not related to the cause of hyperuricemia in G6Pase deficiency.</p>", "options": ["More formation of pentose", "Decreased availability of glucose to tissues", "Increased accumulation of sorbitol", "Impaired degradation of free radicals"], "html_options": ["More formation of pentose", "Decreased availability of glucose to tissues", "Increased accumulation of sorbitol", "Impaired degradation of free radicals"], "corr_idx": 0}, {"id": "1173258", "html_qtxt": "Which of the following will provide the main fuel for muscle contraction during short-term maximum exertion?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>During short-term, high-intensity exercise (e.g., sprinting, weight lifting), the immediate energy source must be rapidly mobilised.</li>\n<li>Muscle glycogen is stored locally and is broken down via anaerobic glycolysis, providing glucose-6-phosphate for ATP production quickly.</li>\n<li>This results in lactate formation, which is tolerable for a short duration.</li>\n<li>Since oxygen delivery may not match demand during peak exertion, aerobic oxidation of fatty acids is too slow, making glycogen the preferred source.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Muscle reserves of fatty acids (Option A):</strong> While muscles can use fatty acids for energy, fatty acid oxidation is slow and requires oxygen, making it unsuitable for maximum short-term exertion.</p>\n<p><strong>Plasma Glucose (Option C):</strong> Plasma glucose is used during prolonged or moderate-intensity activity. But it's less significant than intramuscular glycogen for rapid energy during short-term bursts.</p>\n<p><strong>Muscle reserve of triglyceride (Option D):</strong> Muscle triglycerides are a source of fatty acids, which are oxidized aerobically. Not efficient for short-term maximal efforts due to slower mobilization and the requirement for oxygen.</p>", "options": ["Muscle reserves of fatty acids", "Muscle Glycogen", "Plasma Glucose", "Muscle reserve of triglyceride"], "html_options": ["Muscle reserves of fatty acids", "Muscle Glycogen", "Plasma Glucose", "Muscle reserve of triglyceride"], "corr_idx": 1}, {"id": "1173259", "html_qtxt": "Glucose is stored as glycogen and not as glucose itself because of", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Free glucose is highly osmotically active, meaning it draws water into cells, which can lead to cellular swelling and even lysis. Storing glucose in its free form would therefore be dangerous.</li>\n<li>Instead, glucose is polymerized into glycogen-a large, branched polysaccharide-which allows the storage of thousands of glucose units in a compact form with minimal osmotic effect.</li>\n<li>Thus, polysaccharides like glycogen are used for energy storage rather than monosaccharides like glucose.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>High molecular weight of glucose (Option A):</strong> Glucose is a low molecular weight monosaccharide. This is not a reason for it not being stored directly.</p>\n<p><strong>Lack of enzyme (Option C):</strong> Enzymes for glucose metabolism and glycogen synthesis are present; lack of enzymes is not the issue.</p>\n<p><strong>Chemical structure of glucose (Option D):</strong> The structure allows it to be metabolised and polymerized, so this is not a limiting factor for storage.</p>", "options": ["High molecular weight of Glucose", "Glucose is osmotically active", "Lack of enzyme", "Chemical structure of Glucose"], "html_options": ["High molecular weight of Glucose", "Glucose is osmotically active", "Lack of enzyme", "Chemical structure of Glucose"], "corr_idx": 1}]}, {"moduleId": 1008717, "name": "Miscellaneous", "questions": [{"id": "1173296", "html_qtxt": "Which of the following monosaccharides are absorbed from the small intestine by sodium-dependent glucose transporter-1?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glucose and galactose are absorbed in the small intestine via a sodium-dependent active transport mechanism, specifically through the SGLT-1 (Sodium-Glucose Linked Transporter 1).</li>\n<li>Both sugars share the same transporter and compete with each other for absorption.</li>\n</ul>\n<p><strong>Fructose:</strong></p>\n<ul>\n<li>Fructose is absorbed via facilitated diffusion by GLUT-5, which is sodium-independent.</li>\n<li>Because fructose absorption is passive, it depends on the concentration gradient. Excess intake can exceed its absorptive capacity, leading to osmotic diarrhea.</li>\n</ul>\n<p>Therefore, fructose is not absorbed via SGLT-1 <strong>(Options A, C, and D ruled out)</strong>.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082076bc9d8b-9c07-4527-8e7d-c91438e3b2e2.png\">", "options": ["Glucose and Fructose", "Glucose and Galactose", "Fructose and Galactose", "All of the above"], "html_options": ["Glucose and Fructose", "Glucose and Galactose", "Fructose and Galactose", "All of the above"], "corr_idx": 1}, {"id": "1173298", "html_qtxt": "After overnight fasting, levels of glucose transporters are reduced in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glucose uptake into muscle and adipose tissue is primarily mediated by GLUT-4 transporters, which are insulin-dependent.</li>\n<li>In the fasting state, insulin levels are low, causing GLUT-4 transporters to remain sequestered within intracellular vesicles.</li>\n<li>As a result, the number of glucose transporters on the surface of adipocytes is significantly reduced, thereby limiting glucose uptake.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Brain cells (Option A):</strong> Utilize GLUT-1 and GLUT-3, which are insulin-independent and always present on the membrane.</p>\n<p><strong>RBCs (Option B):</strong> Use GLUT-1, also insulin-independent.</p>\n<p><strong>Hepatocytes (Option C):</strong> Express GLUT-2, which functions bidirectionally and is not regulated by insulin.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508201dffd487-9bb1-4589-80e1-18ea199a268e.png\">", "options": ["Brain cells", "RBCs", "Adipocyte", "Hepatocyte"], "html_options": ["Brain cells", "RBCs", "Adipocyte", "Hepatocyte"], "corr_idx": 2}, {"id": "1173301", "html_qtxt": "The glucose transporter in myocytes stimulated by insulin is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>GLUT-4 is the insulin-responsive glucose transporter found in skeletal muscle (myocytes), cardiac muscle, and adipose tissue. In the basal (fasting) state, GLUT-4 transporters are stored in intracellular vesicles. Upon stimulation by insulin, these vesicles translocate to the plasma membrane, allowing increased glucose uptake into the cell.</p>\n<p>Other GLUT transporters are not insulin-dependent:</p>\n<ul>\n<li>GLUT-1: Found in RBCs and brain; insulin-independent. (Option A ruled out)</li>\n<li>GLUT-2: Found in liver, pancreas, and kidney; insulin-independent and bidirectional. (Option B ruled out)</li>\n<li>GLUT-3: Found in neurons; high affinity, insulin-independent. (Option C ruled out)</li>\n</ul>\n<p>Additional insulin-responsive transporters include:</p>\n<ul>\n<li>GLUT-8: Testis, blastocyst.</li>\n<li>GLUT-12: Heart, prostate, mammary gland, and white adipose tissue.</li>\n</ul>\n<p>However, GLUT-4 remains the primary insulin-sensitive transporter in myocytes.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820f5ac5475-d56c-43ca-a77e-f130745fa106.png\">", "options": ["GLUT-1", "GLUT-2", "GLUT-3", "GLUT-4"], "html_options": ["GLUT-1", "GLUT-2", "GLUT-3", "GLUT-4"], "corr_idx": 3}, {"id": "1173313", "html_qtxt": "Facilitated transport of glucose that is insulin-insensitive (non-dependent) takes place in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The <strong>liver</strong> uses <strong>GLUT-2,</strong> a facilitated diffusion transporter that is <strong>insulin-independent</strong>. GLUT-2 has a high Km (low affinity), allowing the liver to uptake glucose efficiently only when blood glucose levels are high, such as after a meal. It also facilitates bidirectional glucose transport, playing a key role in both glucose uptake (after eating) and glucose release (during fasting).</p>\n<p>In contrast:</p>\n<ul>\n<li>Skeletal muscle, adipose tissue, and heart primarily use GLUT-4, which is insulin-dependent. GLUT-4 transporters are stored intracellularly and move to the plasma membrane in response to insulin, allowing glucose uptake in the fed state. <strong>(Option A, C and D ruled out)</strong></li>\n</ul>\n<p>Insulin-responsive glucose transporters:</p>\n<ul>\n<li>GLUT-4: Heart, skeletal muscle, adipose tissue</li>\n<li>GLUT-8: Testis, blastocyst, brain, adipose tissue</li>\n<li>GLUT-12: Heart, prostate, white adipose tissue, mammary gland</li>\n</ul>\n<p>Thus, among the options, only the liver relies on insulin-insensitive (non-dependent) facilitated transport via GLUT-2.</p>", "options": ["Skeletal muscle", "Liver", "Adipose tissue", "Heart"], "html_options": ["Skeletal muscle", "Liver", "Adipose tissue", "Heart"], "corr_idx": 1}, {"id": "1173339", "html_qtxt": "Cellulose is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Cellulose is a non-starch polysaccharide composed of &beta;-D-glucose units linked by &beta;-1,4-glycosidic bonds. It is the main structural component of plant cell walls.</p>\n<ul>\n<li>Unlike starch (which has &alpha;-glycosidic bonds), humans lack the enzyme cellulase needed to break &beta;-1,4 linkages.</li>\n<li>As a result, cellulose is not digested in the human gut and passes through the intestine, contributing to dietary fibre.</li>\n<li>Dietary fibre, especially from cellulose, aids in bowel movement and promotes gut health.</li>\n</ul>\n<p>Other examples of non-starch polysaccharides:</p>\n<ul>\n<li>Inulin (from onions, garlic, chicory) - a polymer of fructose</li>\n<li>Pectin, hemicellulose, and gums - found in fruits and vegetables</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Complex Lipoprotein (Option A):</strong> Lipoproteins are made of lipids and proteins, not carbohydrates.</p>\n<p><strong>Starch Polysaccharide (Option B):</strong> Starch is a different polysaccharide (composed of &alpha;-glucose) and is digestible by humans.</p>\n<p><strong>Complex Glycoprotein (Option D):</strong> Glycoproteins are proteins with attached oligosaccharides, not purely carbohydrate polymers like cellulose.</p>", "options": ["Complex Lipoprotein", "Starch Polysaccharide", "Non-starch Polysaccharide", "Complex Glycoprotein"], "html_options": ["Complex Lipoprotein", "Starch Polysaccharide", "Non-starch Polysaccharide", "Complex Glycoprotein"], "corr_idx": 2}, {"id": "1173344", "html_qtxt": "Which of the following mucopolysaccharides does not contain a uronic acid residue?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Keratan sulfate is the only GAG that does not contain a uronic acid (like glucuronic or iduronic acid).</p>\n<p>Instead, it contains galactose as its acidic sugar component.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820cebc80fb-be99-4c55-b779-56cbeeba0f32.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Heparan Sulfate (Option A):</strong> Contains glucuronic and/or iduronic acid</p>\n<p><strong>Heparin (Option B):</strong> Contains iduronic acid</p>\n<p><strong>Chondroitin Sulfate (Option C):</strong> Contains glucuronic acid</p>", "options": ["Heparan Sulfate", "Heparin", "Chondroitin Sulfate", "Keratan Sulfate"], "html_options": ["Heparan Sulfate", "Heparin", "Chondroitin Sulfate", "Keratan Sulfate"], "corr_idx": 3}, {"id": "1173355", "html_qtxt": "This is a diagram of proteoglycans. All of the following statements are true about them except-<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508202208b3af-1aac-420f-bbe8-044d4598c9b2.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Hyaluronic acid (HA) is unique among glycosaminoglycans (GAGs).</p>\n<ul>\n<li>It is a non-sulfated, high molecular weight polysaccharide composed of repeating disaccharide units of glucuronic acid and N-acetylglucosamine.</li>\n<li>HA exists freely in the ECM and does not form a covalent bond with a core protein, unlike other GAGs.</li>\n<li>Instead, HA acts as a scaffold, to which multiple proteoglycans (e.g., aggrecan) attach non-covalently via link proteins.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820780571c8-d8b6-4e34-b463-2344d285ecad.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>The proteins bound covalently to glycosaminoglycans are called \"core proteins\" (Option A): </strong>True. GAG chains are covalently attached to a central core protein to form a proteoglycan.</p>\n<p><strong>Proteoglycans contain much more carbohydrate than glycoproteins-up to 95% of their weight (Option B):</strong> True. Proteoglycans can be up to 95% carbohydrate, much more than glycoproteins.</p>\n<p><strong>Proteoglycans are found in every tissue of the body, mainly in the ECM (Option C):</strong> True. Proteoglycans are widely distributed in all tissues, especially in the extracellular matrix, providing structural and biochemical support.</p>", "options": ["The proteins bound covalently to glycosaminoglycans are called \"core proteins\".", "Proteoglycans contain much more carbohydrate than glycoproteins-up to 95% of their weight.", "Proteoglycans are found in every tissue of the body, mainly in the ECM", "Hyaluronic acid is a polysaccharide in the ECM, with covalent attachment to protein."], "html_options": ["The proteins bound covalently to glycosaminoglycans are called \"core proteins\".", "Proteoglycans contain much more carbohydrate than glycoproteins-up to 95% of their weight.", "Proteoglycans are found in every tissue of the body, mainly in the ECM", "Hyaluronic acid is a polysaccharide in the ECM, with covalent attachment to protein."], "corr_idx": 3}, {"id": "1173357", "html_qtxt": "Which of the following glycosaminoglycans plays an important role in cell migration?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Hyaluronic acid (HA) plays a key role in facilitating cell migration, particularly during:</p>\n<ul>\n<li>Embryonic development (morphogenesis)</li>\n<li>Wound healing</li>\n<li>Inflammation and tissue repair</li>\n</ul>\n<p>HA achieves this through:</p>\n<ul>\n<li>The ability to bind large volumes of water, creating a hydrated, gel-like ECM.</li>\n<li>This loosens the extracellular matrix, providing a permissive environment for cell movement.</li>\n<li>It also interacts with cell surface receptors (like CD44) to promote cell detachment, adhesion, and motility.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Heparan Sulfate (Option A):</strong> Primarily involved in cell signalling, growth factor binding, and regulation of angiogenesis, but not a major contributor to cell migration.</p>\n<p><strong>Heparin (Option B):</strong> Found mainly in mast cells, with anticoagulant properties; it is not involved in structural ECM functions or migration.</p>\n<p><strong>Keratan Sulfate (Option D):</strong> Found in cornea, cartilage, and intervertebral discs; contributes to tissue hydration and mechanical resilience, not directly to cell migration.</p>", "options": ["Heparan Sulphate", "Heparin", "Hyaluronic Acid", "Keratan Sulphate"], "html_options": ["Heparan Sulphate", "Heparin", "Hyaluronic Acid", "Keratan Sulphate"], "corr_idx": 2}, {"id": "1173361", "html_qtxt": "Glycosaminoglycans that play a role in corneal transparency are?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Corneal transparency is essential for clear vision and is maintained by a highly organised extracellular matrix in the corneal stroma.</p>\n<p>Two glycosaminoglycans are particularly important for this:</p>\n<ul>\n<li>Keratan Sulfate I (KS-I):\n<ul>\n<li>Found abundantly in the corneal stroma, KS-I contributes to maintaining hydration and uniform collagen fibril spacing, which is essential for transparency.</li>\n</ul>\n</li>\n<li>Dermatan Sulfate:\n<ul>\n<li>Also present in the corneal stroma, it complements KS-I by regulating collagen fibril organisation and maintaining tissue viscoelasticity.</li>\n</ul>\n</li>\n</ul>\n<p>The precise spacing of collagen fibrils and the controlled water content facilitated by these GAGs prevent light scattering, thus preserving optical clarity.</p>\n<p><strong>Explanation of Incorrect Options:</strong></p>\n<p><strong>Keratan Sulfate II and Heparan Sulfate (Option A):</strong> KS-II is mainly found in skeletal tissues. Heparan sulfate is more involved in cell signalling and basement membranes, not directly in corneal transparency.</p>\n<p><strong>Keratan Sulfate I and Chondroitin Sulfate (Option C):</strong> Chondroitin sulfate is important in cartilage and connective tissues, not specifically in the cornea.</p>\n<p><strong>Keratan Sulfate I and Hyaluronic Acid (Option D):</strong> Hyaluronic acid is abundant in the vitreous humor and ECM, not specifically contributing to the tightly regulated structure of the <strong>corneal stroma</strong>.</p>\n<p><strong>Key takeaways:</strong></p>\n<p>Some Functions of Glycosaminoglycans and Proteoglycans</p>\n<ul>\n<li>Act as structural components of the extracellular matrix (ECM).</li>\n<li>Interact with collagen, elastin, fibronectin, laminin, and other proteins like growth factors.</li>\n<li>Act as polyanions, binding polycations and cations.</li>\n<li>Contribute to the characteristic turgor (swelling pressure) of various tissues.</li>\n<li>Function as molecular sieves in the ECM.</li>\n<li>Facilitate cell migration (e.g., Hyaluronic Acid - HA).</li>\n<li>Aid compressibility of cartilage in weight-bearing areas (e.g., HA, Chondroitin Sulfate - CS).</li>\n<li>Maintain corneal transparency (e.g., Keratan Sulfate I and Dermatan Sulfate - DS).</li>\n<li>Provide structural support to the sclera (e.g., DS).</li>\n<li>Serve as anticoagulants (e.g., Heparin).</li>\n<li>Act as plasma membrane components, participating in receptor signaling, cell adhesion, and interactions (e.g., Heparan Sulfate - HS).</li>\n<li>Help determine charge selectivity in the renal glomerulus (e.g., HS).</li>\n<li>They are part of synaptic and other vesicular systems (e.g., HS).</li>\n</ul>", "options": ["Keratan Sulfate II and Heparan Sulfate", "Keratan Sulfate I and Dermatan Sulfate", "Keratan Sulfate I and Chondroitin Sulfate", "Keratan Sulfate I and Hyaluronic Acid"], "html_options": ["Keratan Sulfate II and Heparan Sulfate", "Keratan Sulfate I and Dermatan Sulfate", "Keratan Sulfate I and Chondroitin Sulfate", "Keratan Sulfate I and Hyaluronic Acid"], "corr_idx": 1}, {"id": "1173367", "html_qtxt": "A 33-year-old female presents with frequent urination and burning micturition. She reports that these symptoms have occurred repeatedly in the past. Urine analysis reveals glycosuria, but fasting blood glucose and HbA1c are within normal limits. What is the most likely underlying defect in this patient?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The presence of glycosuria with normal fasting glucose and HbA1c strongly suggests renal glycosuria, a rare benign condition.</p>\n<ul>\n<li>In this condition, glucose is filtered normally by the glomerulus, but a defect in the SGLT2 (sodium-glucose co-transporter 2) in the proximal renal tubule impairs reabsorption.</li>\n<li>As a result, glucose is excreted in the urine despite normal plasma glucose levels.</li>\n<li>The glycosuria predisposes the patient to urinary tract infections (UTIs), explaining her recurrent symptoms.</li>\n<li>A urine culture should be performed to confirm the presence of a current UTI.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Defect in SGLT 1 in renal tubule (Option A):</strong> SGLT1 is primarily found in the intestine and the late proximal tubule, but SGLT2 is the main transporter responsible for glucose reabsorption in the early proximal tubule.</p>\n<p><strong>Increased excretion of glucose due to bacterial infection (Option B):</strong> Bacterial infections do not cause primary glycosuria; they may result from it, but are not the cause.</p>\n<p><strong>Increased absorption of glucose in the intestine leading to increased secretion in urine (Option D):</strong> There's no physiological mechanism where increased intestinal glucose absorption directly causes glycosuria unless blood glucose levels are elevated, which is not the case here.</p>", "options": ["Defect in SGLT 1 in the renal tubule", "Increased excretion of excess glucose in urine due to bacterial infection.", "Decreased ability of glucose to be reabsorbed due to a defect in SGLT 2 in the renal tubule", "Increased absorption of glucose in the intestine leads to an increase in secretion in urine."], "html_options": ["Defect in SGLT 1 in the renal tubule", "Increased excretion of excess glucose in urine due to bacterial infection.", "Decreased ability of glucose to be reabsorbed due to a defect in SGLT 2 in the renal tubule", "Increased absorption of glucose in the intestine leads to an increase in secretion in urine."], "corr_idx": 2}, {"id": "1173372", "html_qtxt": "Compared to with resting state, vigorously contracting skeletal muscle shows:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>During vigorous muscle contraction, the oxygen supply is often insufficient to meet the energy demands of the working muscle. As a result:</p>\n<ul>\n<li>Anaerobic glycolysis becomes the dominant pathway.</li>\n<li>Pyruvate formed from glycolysis is converted to lactate by lactate dehydrogenase to regenerate NAD&#x207A;, which is essential for glycolysis to continue.</li>\n<li>This leads to an increase in lactate production-a hallmark of anaerobic metabolism in active skeletal muscle.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Decreased AMP/ATP ratio (Option A):</strong> Incorrect - ATP is rapidly consumed during muscle contraction, increasing AMP levels. Therefore, the AMP/ATP ratio increases, not decreases, which activates AMP-activated protein kinase (AMPK) to promote energy-generating pathways.</p>\n<p><strong>Decreased level of fructose 2,6-bisphosphate (Option B):</strong> Incorrect - Fructose 2,6-bisphosphate is an important activator of glycolysis via stimulation of phosphofructokinase-1 (PFK-1). Its levels generally increase during muscle activity to enhance glycolytic flux.</p>\n<p><strong>Increased activity of pyruvate dehydrogenase (Option D):</strong> Incorrect - Under anaerobic conditions, pyruvate dehydrogenase (PDH) is less active because pyruvate is preferentially converted to lactate instead of entering the mitochondria for aerobic metabolism.</p>", "options": ["Decreased AMP/ATP ratio", "Decreased level of fructose-2,6-bisphosphate", "Increased reduction of pyruvate to lactate", "Increased activity of pyruvate dehydrogenase"], "html_options": ["Decreased AMP/ATP ratio", "Decreased level of fructose-2,6-bisphosphate", "Increased reduction of pyruvate to lactate", "Increased activity of pyruvate dehydrogenase"], "corr_idx": 2}, {"id": "1173375", "html_qtxt": "Glucokinase is important in regulating blood glucose after a meal. All of the following statements are true about glucokinase except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glucokinase is <em>not</em> inhibited by glucose-6-phosphate.</li>\n<li>This is in contrast to hexokinase, which is inhibited by glucose-6-phosphate (product inhibition).</li>\n<li>Because glucokinase avoids feedback inhibition, it allows the liver and pancreatic &beta;-cells to continue phosphorylating glucose even when intracellular glucose-6-phosphate levels are high, ensuring effective glucose storage or metabolism after meals.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Km value is higher than normal blood sugar (Option A):</strong> True. Glucokinase has a high Km (~10 mM) compared to hexokinase. This means it has low affinity for glucose and becomes active only when blood glucose levels are high, such as after meals.</p>\n<p><strong>Found in liver (Option B):</strong> True. Glucokinase is primarily found in liver cells and pancreatic &beta;-cells. In the liver, it facilitates glycogen synthesis. In &beta;-cells, it acts as a glucose sensor to help regulate insulin release.</p>\n<p><strong>Glucose enters cells through GLUT-2 (Option D):</strong> True. GLUT-2 is a low-affinity, high-capacity glucose transporter. It facilitates glucose uptake into the liver and pancreatic &beta;-cells, especially when blood glucose is high (after meals).</p>", "options": ["Km value is higher than normal blood sugar", "Found in liver", "Glucose-6-phosphate inhibits it", "Glucose enters cells through GLUT-2"], "html_options": ["Km value is higher than normal blood sugar", "Found in liver", "Glucose-6-phosphate inhibits it", "Glucose enters cells through GLUT-2"], "corr_idx": 2}, {"id": "1173377", "html_qtxt": "Which of the following enzymes is not involved in substrate-level phosphorylation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Phosphofructokinase (PFK-1) catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate using ATP in the glycolytic pathway.</li>\n<li>This is a regulatory, ATP-consuming step, not a substrate-level phosphorylation reaction.</li>\n<li>Hence, it is not involved in the generation of ATP via substrate-level phosphorylation.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pyruvate kinase (Option A):</strong> Involved in substrate-level phosphorylation. Catalyzes the transfer of a phosphate from phosphoenolpyruvate (PEP) to ADP, producing pyruvate and ATP. This is a classic example of substrate-level phosphorylation in glycolysis.</p>\n<p><strong>Succinate thiokinase (Succinyl-CoA synthetase) (Option C):</strong> Involved in substrate-level phosphorylation. Catalyzes the conversion of succinyl-CoA to succinate in the TCA cycle, generating GTP (or ATP) directly. This is the only substrate-level phosphorylation step in the TCA cycle.</p>\n<p><strong>Phosphoglycerate kinase (Option D):</strong> Involved in substrate-level phosphorylation. Transfers a phosphate group from 1,3-bisphosphoglycerate to ADP, producing 3-phosphoglycerate and ATP. This step also occurs in glycolysis.</p>", "options": ["Pyruvate kinase", "Phosphofructokinase", "Succinate thiokinase", "Phosphoglycerate kinase"], "html_options": ["Pyruvate kinase", "Phosphofructokinase", "Succinate thiokinase", "Phosphoglycerate kinase"], "corr_idx": 1}, {"id": "1173384", "html_qtxt": "A male infant presents with failure to thrive, hepatosplenomegaly, coarse facial features, and developmental delay. Urinalysis reveals the presence of dermatan sulfate and heparan sulfate. Which of the following enzyme deficiencies is most likely responsible for this condition?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>This infant's presentation - failure to thrive, coarse facial features, hepatosplenomegaly, developmental delay, and excretion of dermatan and heparan sulfate - is classic for a mucopolysaccharidosis (MPS), specifically Hurler syndrome (MPS I)</p>\n<ul>\n<li>Hurler syndrome results from a deficiency of &alpha;-L-iduronidase, a lysosomal enzyme required to degrade dermatan sulfate and heparan sulfate (types of glycosaminoglycans/GAGs).</li>\n<li>Accumulation of these GAGs in lysosomes causes multisystem involvement: skeletal abnormalities, organomegaly, coarse facial features, and cognitive impairment.</li>\n<li>It's inherited in an autosomal recessive manner.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>&beta;-Glucuronidase (Option A):</strong> Deficient in Sly syndrome (MPS VII) - also involves dermatan/heparan sulfate accumulation, but is much rarer and usually presents similarly. Not the best match for this case.</p>\n<p><strong>&beta;-Galactosidase (Option B):</strong> Deficiency causes GM1 gangliosidosis, not an MPS. Presents with neurologic symptoms but not GAGs in urine.</p>\n<p><strong>&alpha;-N-Acetylglucosaminidase (Option D):</strong> Deficiency seen in Sanfilippo syndrome (MPS III) - also involves heparan sulfate accumulation but without dermatan sulfate. Features are more neurologically dominant, with less organomegaly.</p>", "options": ["&beta;-Glucuronidase", "&beta;-Galactosidase", "&alpha;-L-Iduronidase", "&alpha;-N-Acetylglucosaminidase"], "html_options": ["&beta;-Glucuronidase", "&beta;-Galactosidase", "&alpha;-L-Iduronidase", "&alpha;-N-Acetylglucosaminidase"], "corr_idx": 2}, {"id": "1173387", "html_qtxt": "A 4-year-old child is brought to the clinic due to concerns about short stature. On physical examination, the child has disproportionately short limbs, a relatively normal-sized trunk, macrocephaly with frontal bossing, and lumbar lordosis. Developmental milestones are age-appropriate, and there is no evidence of cognitive delay. Which of the following investigations would be most appropriate to confirm the diagnosis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>This child presents with classic features of achondroplasia, the most common cause of short-limbed dwarfism.</p>\n<ul>\n<li>It is caused by gain-of-function mutations in the FGFR3 gene, which encodes a receptor tyrosine kinase involved in cartilage growth.</li>\n<li>The mutation at nucleotide 1138 (G1138A) results in arginine substitution for glycine at position 380 (Gly380Arg) in the transmembrane domain of the FGFR3 protein.</li>\n<li>This abnormal FGFR3 inhibits chondrocyte proliferation, leading to impaired endochondral ossification and resulting in the typical skeletal features of achondroplasia.</li>\n<li>Genetic testing for FGFR3 mutations is the gold standard for confirming the diagnosis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Measurement of growth hormone (Option A):</strong> While growth hormone deficiency causes short stature, it typically leads to proportionate dwarfism, not the disproportionate features seen in achondroplasia. GH levels are usually normal in achondroplasia.</p>\n<p><strong>Assays for enzymes involved in the metabolism of GAGs (Option B):</strong> These are relevant for mucopolysaccharidoses, not skeletal dysplasias like achondroplasia.</p>\n<p><strong>Tests for urinary mucopolysaccharides (Option C):</strong> Used to diagnose lysosomal storage diseases such as Hurler or Hunter syndrome, where patients have coarse facial features, organomegaly, and cognitive decline, not the skeletal profile of achondroplasia.</p>", "options": ["Measurement of growth hormone", "Assays for enzymes involved in the metabolism of GAGs", "Tests for urinary mucopolysaccharides", "Gene tests for abnormalities of the fibroblast growth factor receptor 3 (FGFR3)"], "html_options": ["Measurement of growth hormone", "Assays for enzymes involved in the metabolism of GAGs", "Tests for urinary mucopolysaccharides", "Gene tests for abnormalities of the fibroblast growth factor receptor 3 (FGFR3)"], "corr_idx": 3}, {"id": "1173392", "html_qtxt": "All of the following statements are true about mucopolysaccharides except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The statement is false because not all GAGs are sulfated.</p>\n<ul>\n<li>Hyaluronic acid is a major exception.</li>\n<li>It is:\n<ul>\n<li>A high-molecular-weight GAG</li>\n<li>Non-sulfated</li>\n<li>Not covalently linked to a core protein</li>\n<li>Found freely in the extracellular matrix, where it facilitates cell migration and tissue hydration</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Most but not all GAGs contain an amino sugar and a uronic acid (Option A):</strong> True. GAGs are composed of repeating disaccharide units. One component is always an amino sugar (e.g., glucosamine or galactosamine), and the other is typically a uronic acid (e.g., glucuronic or iduronic acid). Exception: Keratan sulfate contains galactose instead of a uronic acid.</p>\n<p><strong>GAGs are built up by the actions of glycosyltransferases using sugars donated by nucleotide-sugars (Option C):</strong> True. GAG chains are synthesized in the Golgi by glycosyltransferases. These enzymes use activated sugars (like UDP-glucuronic acid, UDP-N-acetylglucosamine) as donors.</p>\n<p><strong>Glucuronic acid can be converted to iduronic acid by an epimerase (Option D):</strong> True. This C-5 epimerization occurs after GAG chain synthesis and is important in forming heparin and dermatan sulfate. It allows the molecule to adopt conformations needed for specific biological functions.</p>\n<p><strong>Key takeaways:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082054257db4-c84d-43b7-b260-bee965cb4e4f.png\">", "options": ["Most but not all GAGs contain an amino sugar and a uronic acid.", "All GAGs are sulfated.", "GAGs are built up by the actions of glycosyltransferases using sugars donated by nucleotide sugars.", "Glucuronic acid can be converted to iduronic acid by an epimerase."], "html_options": ["Most but not all GAGs contain an amino sugar and a uronic acid.", "All GAGs are sulfated.", "GAGs are built up by the actions of glycosyltransferases using sugars donated by nucleotide sugars.", "Glucuronic acid can be converted to iduronic acid by an epimerase."], "corr_idx": 1}, {"id": "1173395", "html_qtxt": "The following metabolic abnormalities occur in Diabetes mellitus, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>In diabetes mellitus, particularly in uncontrolled type 1 diabetes, gluconeogenesis is increased, not decreased. This is due to:</p>\n<ul>\n<li>Insulin deficiency or insulin resistance, both of which fail to suppress hepatic glucose production.</li>\n<li>Unopposed glucagon action, which stimulates gluconeogenesis using substrates like amino acids and lactate.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Increased plasma FFA (Option A):</strong> True. Insulin normally inhibits lipolysis. In diabetes, insulin deficiency leads to enhanced lipolysis, raising plasma FFA levels. FFAs are then used for ketogenesis and energy production.</p>\n<p><strong>Increased pyruvate carboxylase activity (Option B):</strong> True. Pyruvate carboxylase is a key enzyme in gluconeogenesis. Its activity increases in response to elevated glucagon and cortisol in diabetes. It converts pyruvate to oxaloacetate, a precursor for glucose synthesis.</p>\n<p><strong>Decreased lipogenesis (Option C):</strong> True. Insulin stimulates lipogenesis in the liver and adipose tissue. In diabetes, lack of insulin reduces this process. Thus, fat synthesis (lipogenesis) is decreased.</p>", "options": ["Increase plasma FFA", "Increased pyruvate carboxylase activity", "Decrease lipogenesis", "Decrease gluconeogenesis"], "html_options": ["Increase plasma FFA", "Increased pyruvate carboxylase activity", "Decrease lipogenesis", "Decrease gluconeogenesis"], "corr_idx": 3}, {"id": "1173400", "html_qtxt": "Which of the following hormones is not involved in carbohydrate metabolism?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Vasopressin (also known as antidiuretic hormone, ADH) is primarily involved in water and electrolyte balance.</li>\n<li>It acts on the kidneys to promote water reabsorption by increasing the permeability of the collecting ducts via V2 receptors.</li>\n<li>Though it may have minor vasoconstrictive effects via V1 receptors, it plays no direct role in regulating carbohydrate metabolism.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cortisol (Option A):</strong> A glucocorticoid that increases blood glucose by stimulating gluconeogenesis and reducing glucose uptake in peripheral tissues.</p>\n<p><strong>ACTH (Adrenocorticotropic hormone) (Option B):</strong> Stimulates the adrenal cortex to release cortisol, thereby indirectly influencing carbohydrate metabolism.</p>\n<p><strong>Glucagon (Option C):</strong> A key hormone that raises blood glucose by promoting glycogenolysis and gluconeogenesis in the liver.</p>", "options": ["Cortisol", "ACTH", "Glucagon", "Vasopressin"], "html_options": ["Cortisol", "ACTH", "Glucagon", "Vasopressin"], "corr_idx": 3}, {"id": "1173405", "html_qtxt": "Which of the following statements is true for insulin but not for glucagon?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Catecholamines (epinephrine and norepinephrine) inhibit insulin secretion from pancreatic &beta;-cells.</li>\n<li>In contrast, glucagon secretion from &alpha;-cells is stimulated by catecholamines.</li>\n<li>This is part of the body's \"fight or flight\" response, where glucose needs to be elevated, achieved by suppressing insulin and promoting glucagon.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It is a peptide hormone secreted by pancreatic cells (Option A):</strong> This is true for both insulin (from &beta;-cells) and glucagon (from &alpha;-cells).</p>\n<p><strong>Its actions are mediated by binding to a receptor found on the cell membrane of liver cells (Option B):</strong> Both insulin and glucagon act via receptors on hepatocyte membranes. Insulin uses a tyrosine kinase receptor. Glucagon uses a G-protein-coupled receptor (GPCR) that signals via cAMP.</p>\n<p><strong>Its synthesis involves a nonfunctional precursor that gets cleaved to yield a functional molecule (Option D):</strong> This applies to both hormones: Insulin is made from preproinsulin &rarr; proinsulin &rarr; insulin + C-peptide. Glucagon is also derived from a larger preproglucagon that is cleaved enzymatically.</p>", "options": ["It is a peptide hormone secreted by pancreatic cells.", "Its actions are mediated by binding to a receptor found on the cell membrane of liver cells.", "Its secretion is decreased by the catecholamines.", "Its synthesis involves a nonfunctional precursor that gets cleaved to yield a functional molecule."], "html_options": ["It is a peptide hormone secreted by pancreatic cells.", "Its actions are mediated by binding to a receptor found on the cell membrane of liver cells.", "Its secretion is decreased by the catecholamines.", "Its synthesis involves a nonfunctional precursor that gets cleaved to yield a functional molecule."], "corr_idx": 2}, {"id": "1173410", "html_qtxt": "A 45-year-old woman is brought to the emergency department complaining of weakness and dizziness. She reports skipping breakfast and having only coffee for lunch. In the evening, she met with friends and consumed several alcoholic beverages, but did not eat. Later that night, she became symptomatic and was found to have a blood glucose level of 45 mg/dL. She felt significantly better after consuming orange juice. What is the most likely biochemical alteration responsible for her symptoms?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>This patient is experiencing alcohol-induced hypoglycemia. After a prolonged period of fasting (skipping meals) and consuming alcohol without food, her liver is unable to maintain adequate glucose levels. This is a well-known biochemical effect of alcohol in the fasting state.</p>\n<p>When alcohol is metabolised in the liver, it proceeds through two main steps:</p>\n<ol>\n<li>Ethanol &rarr; Acetaldehyde (via <em>alcohol dehydrogenase</em>)</li>\n<li>Acetaldehyde &rarr; Acetate (via <em>aldehyde dehydrogenase</em>)</li>\n</ol>\n<p>Both reactions generate NADH, leading to a significantly increased NADH/NAD&#x207A; ratio in hepatocytes.</p>\n<p>This altered redox state disrupts several key gluconeogenic reactions:</p>\n<ul>\n<li>Pyruvate &rarr; Lactate: Pyruvate is diverted to lactate due to excess NADH.</li>\n<li>Oxaloacetate &rarr; Malate: Oxaloacetate is reduced to malate, making it unavailable for gluconeogenesis.</li>\n</ul>\n<p>These changes result in a block in gluconeogenesis, which is the body's primary means of maintaining blood glucose during fasting. Since glycogen stores are already depleted, hypoglycemia ensues.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Fatty acid oxidation increases (Option A):</strong> No. NAD&#x207A; is required for &beta;-oxidation. In alcohol metabolism, NAD+ is depleted, so fatty acid oxidation is impaired, not increased.</p>\n<p><strong>Oxaloacetate and pyruvate levels increase (Option C):</strong> No. Both are diverted away from gluconeogenesis:</p>\n<ul>\n<li>Pyruvate &rarr; Lactate</li>\n<li>Oxaloacetate &rarr; Malate</li>\n</ul>\n<p>This decreases their levels as gluconeogenic substrates.</p>\n<p><strong>Use of acetyl-CoA in fatty acid synthesis increases (Option D):</strong> While acetyl-CoA may accumulate, fatty acid synthesis requires NADPH, not NADH. Also, this is not the main mechanism behind the hypoglycemia.</p>\n<p><strong>Key takeaway:</strong></p>\n<p>In alcohol-induced hypoglycemia, the elevated NADH/NAD&#x207A; ratio is the central metabolic disturbance. It blocks gluconeogenesis at multiple points, especially dangerous in the fasting state, leading to symptomatic hypoglycemia.</p>", "options": ["Fatty acid oxidation.", "The ratio of the reduced and oxidised forms of nicotinamide adenine dinucleotide.", "Oxaloacetate and pyruvate.", "Use of acetyl coenzyme A in fatty acid synthesis."], "html_options": ["Fatty acid oxidation.", "The ratio of the reduced and oxidised forms of nicotinamide adenine dinucleotide.", "Oxaloacetate and pyruvate.", "Use of acetyl coenzyme A in fatty acid synthesis."], "corr_idx": 1}, {"id": "1173418", "html_qtxt": "Which of the following reactions occur in the liver in the case of relative or absolute deficiency of insulin?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>In the absence or deficiency of insulin (as seen in type 1 diabetes or poorly controlled type 2 diabetes):</p>\n<ul>\n<li>Lipolysis is increased due to activation of hormone-sensitive lipase (HSL) in adipose tissue.</li>\n<li>This leads to a flood of free fatty acids (FFAs) reaching the liver, where they undergo &beta;-oxidation, generating acetyl-CoA.</li>\n<li>Since oxaloacetate is diverted to gluconeogenesis, acetyl-CoA cannot enter the TCA cycle and is instead used to form ketone bodies:\n<ul>\n<li>Acetoacetate</li>\n<li>3-hydroxybutyrate (formed from acetoacetate by 3-hydroxybutyrate dehydrogenase)</li>\n</ul>\n</li>\n</ul>\n<p>Thus, increased formation of 3-hydroxybutyrate is a hallmark of insulin deficiency and can lead to diabetic ketoacidosis (DKA) in severe cases.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Decreased glycogenolysis (Option A):</strong> Incorrect. Insulin deficiency causes increased glycogenolysis, not decreased, due to the unopposed action of glucagon and catecholamines.</p>\n<p><strong>Decreased activity of hormone-sensitive lipase (Option B):</strong> Incorrect. Insulin inhibits HSL. In its absence, HSL becomes more active, promoting lipolysis.</p>\n<p><strong>Decreased gluconeogenesis from lactate (Option C):</strong> Incorrect. Insulin normally inhibits gluconeogenesis. Without it, gluconeogenesis increases, especially from substrates like lactate, alanine, and glycerol.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820426ac941-b95d-4f12-bb9e-18ffa16c2368.png\">", "options": ["Decreased glycogenolysis", "Decreased activity of hormone-sensitive lipase", "Decreased gluconeogenesis from lactate", "Increased formation of 3-hydroxybutyrate"], "html_options": ["Decreased glycogenolysis", "Decreased activity of hormone-sensitive lipase", "Decreased gluconeogenesis from lactate", "Increased formation of 3-hydroxybutyrate"], "corr_idx": 3}, {"id": "1173424", "html_qtxt": "A 36-year-old male weighing 98 kg with a BMI of 32 presents with a Fasting Blood Sugar (FBS) of 169 mg/dL, Postprandial Blood Sugar (PPBS) of 354 mg/dL, HbA1c of 8.2% and elevated insulin levels. Which of the following statements is typically correct about his condition?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>This is a classic case of type 2 diabetes mellitus (T2DM) in an obese adult with insulin resistance.</p>\n<ul>\n<li>Obesity is a major risk factor for insulin resistance and T2DM.</li>\n<li>Insulin levels are high because pancreatic &beta;-cells compensate early on by producing more insulin to overcome resistance.</li>\n<li>Weight loss reduces insulin resistance and improves glucose uptake by peripheral tissues, improving glucose tolerance and potentially delaying the progression of diabetes.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>He benefits from receiving insulin about 6 hours after a meal (Option A):</strong> Giving insulin 6 hours post-meal is not physiologically timed and would be ineffective or risky.</p>\n<p><strong>He has a lower plasma level of glucagon than a normal individual (Option B):</strong> Incorrect. In T2DM, glucagon levels are often inappropriately elevated, contributing to hepatic glucose production. Suppression of glucagon secretion is impaired in insulin resistance.</p>\n<p><strong>He shows a sudden onset of symptoms (Option C):</strong> Incorrect. Type 2 diabetes typically has a gradual onset, often detected during routine screenings. Sudden onset with marked symptoms (e.g., weight loss, polydipsia, polyuria) is more characteristic of type 1 diabetes.</p>", "options": ["He benefits from receiving insulin about 6 hours after a meal.", "He has a lower plasma level of glucagon than a normal individual does", "He shows a sudden onset of symptoms.", "He shows improvement in glucose tolerance if his body weight is reduced."], "html_options": ["He benefits from receiving insulin about 6 hours after a meal.", "He has a lower plasma level of glucagon than a normal individual does", "He shows a sudden onset of symptoms.", "He shows improvement in glucose tolerance if his body weight is reduced."], "corr_idx": 3}, {"id": "1173425", "html_qtxt": "All of the following substances stimulate insulin release from pancreatic &beta;-cells except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Esterified fatty acids do not directly stimulate insulin secretion. Instead, non-esterified (free) fatty acids can stimulate insulin release to a limited extent.</p>\n<p>Insulin secretion is primarily stimulated by increased blood glucose levels, but other substances can also potentiate insulin release, including:</p>\n<ul>\n<li>Amino acids: Especially arginine and leucine. <strong>(Option A ruled out)</strong></li>\n<li>Ketone bodies: Indirectly stimulate insulin release by acting as energy sources during fasting. <strong>(Option C ruled out)</strong></li>\n<li>Glucagon: Stimulates insulin secretion via paracrine signaling within the pancreas to balance its hyperglycemic effect. <strong>(Option D ruled out)</strong></li>\n</ul>", "options": ["Amino Acid", "Esterified fatty acid", "Ketone bodies", "Glucagon"], "html_options": ["Amino Acid", "Esterified fatty acid", "Ketone bodies", "Glucagon"], "corr_idx": 1}, {"id": "1173427", "html_qtxt": "Glycosylation & sorting of proteins occur in", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The Golgi apparatus plays two critical roles in the post-translational processing of proteins:</p>\n<ul>\n<li>Glycosylation:\n<ul>\n<li>It modifies N-linked oligosaccharides that were added in the rough endoplasmic reticulum (RER) and is also the main site for O-linked glycosylation of proteins.</li>\n</ul>\n</li>\n<li>Protein Sorting and Trafficking:\n<ul>\n<li>The trans-Golgi network (TGN) is responsible for sorting proteins and packaging them into vesicles for delivery to their final destinations, such as the plasma membrane, lysosomes, or secretory vesicles.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Nucleus (Option A):</strong> The nucleus is the site of DNA replication and transcription, not protein glycosylation or sorting.</p>\n<p><strong>Mitochondria (Option C):</strong> Mitochondria are responsible for energy production (ATP via oxidative phosphorylation). They synthesise a few of their own proteins but do not glycosylate or sort proteins.</p>\n<p><strong>Endoplasmic Reticulum (ER) (Option D):</strong> The rough ER is involved in the initial synthesis and folding of proteins, including the initiation of N-linked glycosylation. However, it does not complete glycosylation or perform final sorting-these occur in the Golgi apparatus.</p>", "options": ["Nucleus", "Golgi apparatus", "Mitochondria", "Endoplasmic Reticulum"], "html_options": ["Nucleus", "Golgi apparatus", "Mitochondria", "Endoplasmic Reticulum"], "corr_idx": 1}, {"id": "1173429", "html_qtxt": "Glucose regulation is primarily mediated by insulin. Which of the following statements about the mechanism of insulin release is not true?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Insulin secretion is stimulated by an <em>increase</em>, not a decrease, in Ca&#x00B2;&#x207A; influx.</li>\n<li>Glucose enters &beta;-cells via GLUT-2 &rarr; metabolised to ATP &rarr; ATP inhibits K&#x207A; channels &rarr; cell depolarises &rarr; opens voltage-gated Ca&#x00B2;&#x207A;channels &rarr; increased Ca&#x00B2;&#x207A; triggers insulin release.</li>\n<li>So, decreased Ca&#x00B2;&#x207A; influx would inhibit, not stimulate, insulin secretion.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Insulin is produced by &beta;-cells of the islets of Langerhans in the pancreas in response to hyperglycemia (Option A):</strong> True: Insulin is secreted from &beta;-cells in response to rising blood glucose. The pancreas plays a key role in maintaining euglycemia.</p>\n<p><strong>The increase in [ATP] inhibits ATP-sensitive K&#x207A; channels, causing depolarization of the cell membrane (Option B):</strong> True: Increased ATP (from glucose metabolism) inhibits ATP-sensitive K&#x207A; channels, which leads to cell membrane depolarization, a critical step in insulin release.</p>\n<p><strong>Sulfonylurea drugs stimulate insulin secretion in type 2 diabetes mellitus via ATP-sensitive K&#x207A; channels (Option D):</strong> True: Sulfonylurea drugs (like tolbutamide and glyburide) stimulate insulin release by closing ATP-sensitive K&#x207A; channels, mimicking the intracellular effects of glucose metabolism.</p>", "options": ["Insulin is produced by cells of the islets of Langerhans in the pancreas in response to hyperglycemia.", "The increase in [ATP] inhibits ATP-sensitive K+ channels, causing depolarisation of the cell membrane.", "Decrease Ca&#x00B2;&#x207A; influx via voltage-sensitive Ca&#x00B2;&#x207A; channels, stimulating exocytosis of insulin", "Sulfonylurea drugs are used to stimulate insulin secretion in type 2 diabetes mellitus via the ATP-sensitive K&#x207A; channels."], "html_options": ["Insulin is produced by cells of the islets of Langerhans in the pancreas in response to hyperglycemia.", "The increase in [ATP] inhibits ATP-sensitive K+ channels, causing depolarisation of the cell membrane.", "Decrease Ca&#x00B2;&#x207A; influx via voltage-sensitive Ca&#x00B2;&#x207A; channels, stimulating exocytosis of insulin", "Sulfonylurea drugs are used to stimulate insulin secretion in type 2 diabetes mellitus via the ATP-sensitive K&#x207A; channels."], "corr_idx": 2}, {"id": "1192028", "html_qtxt": "All of the following molecules are present in the inner mitochondrial membrane, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Creatine kinase is located in the intermembrane space, not the inner membrane.</li>\n<li>It plays a role in buffering and transferring high-energy phosphate groups, particularly in tissues with high energy demands (e.g., muscle and brain).</li>\n</ul>\n<p>The mitochondrion is divided into specific compartments, each with distinct components and functions:</p>\n<p><strong>Molecules present in the inner mitochondrial membrane:</strong></p>\n<ul>\n<li>Cardiolipin: <strong>(Option A ruled out)</strong>\n<ul>\n<li>A unique phospholipid found almost exclusively in the inner mitochondrial membrane.</li>\n<li>It maintains the integrity and function of the electron transport chain (ETC) complexes.</li>\n</ul>\n</li>\n<li>ATP synthase: <strong>(Option B ruled out)</strong>\n<ul>\n<li>A key enzyme in oxidative phosphorylation, located in the inner membrane, where it uses the proton gradient to synthesize ATP.</li>\n</ul>\n</li>\n<li>Respiratory chain proteins (Complexes I-IV): <strong>(Option C ruled out)</strong>\n<ul>\n<li>These are embedded in the inner membrane, forming the electron transport chain responsible for generating the proton gradient.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820b3076f37-b359-47be-96da-e4036f2d6c65.png\">", "options": ["Cardiolipin", "ATP synthase", "Respiratory chain proteins", "Creatine Kinase"], "html_options": ["Cardiolipin", "ATP synthase", "Respiratory chain proteins", "Creatine Kinase"], "corr_idx": 3}, {"id": "1192031", "html_qtxt": "Most of the energy liberated during the oxidation of carbohydrates, fatty acids, and amino acids is made available within mitochondria as reducing equivalents (either hydrogen or electrons). Which of the following processes converts the liberated free energy into high-energy phosphate?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>During the metabolism of carbohydrates, fatty acids, and amino acids:</p>\n<ul>\n<li>Reducing equivalents (NADH and FADHH&#8322;) are generated by:\n<ul>\n<li>Glycolysis &rarr; NADH</li>\n<li>Citric acid cycle &rarr; NADH and FADHH&#8322;/li>\n<li>Beta-oxidation &rarr; NADH and FADHH&#8322;</li>\n</ul>\n</li>\n</ul>\n<p>These reducing equivalents are then transferred to the electron transport chain (ETC) in the inner mitochondrial membrane, where:</p>\n<ul>\n<li>Electrons are passed through ETC complexes, ultimately reducing oxygen to water.</li>\n<li>This electron flow is coupled to proton pumping across the inner membrane, creating a proton gradient.</li>\n<li>Oxidative phosphorylation (via ATP synthase) uses this proton gradient to synthesize ATP from ADP and Pi, converting free energy into high-energy phosphate bonds.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Citric acid cycle (Option A):</strong> Produces reducing equivalents (NADH, FADHH&#8322;O) and GTP, but does not primarily convert free energy into high-energy phosphate.</p>\n<p><strong>Glycolysis (Option B)</strong> is not the main mechanism for converting reducing equivalent energy into ATP.</p>\n<p><strong>Beta-oxidation of fatty acids (Option D):</strong> Breaks down fatty acids to acetyl-CoA and generates NADH and FADHH&#8322;, but does not directly form ATP.</p>", "options": ["Citric acid cycle", "Glycolysis", "Oxidative phosphorylation", "Beta oxidation of fatty acids"], "html_options": ["Citric acid cycle", "Glycolysis", "Oxidative phosphorylation", "Beta oxidation of fatty acids"], "corr_idx": 2}, {"id": "1192033", "html_qtxt": "Which of the following soluble proteins involved in the electron transport chain (ETC) acts as an electron carrier?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Cytochrome c is a soluble, heme-containing protein located in the intermembrane space of mitochondria.</li>\n<li>It transfers electrons from Complex III (cytochrome bc1 complex) to Complex IV (cytochrome c oxidase) in the electron transport chain.</li>\n<li>It is water-soluble, unlike most ETC components, and acts as a mobile electron shuttle, playing a key role in oxidative phosphorylation.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082000105aa8-69f5-485a-8c04-9f5ab08bc1f3.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Coenzyme Q (Option A)</strong> (ubiquinone): It is lipid-soluble, not a protein. Located within the inner mitochondrial membrane, it transports electrons from Complex I and II to Complex III.</p>\n<p><strong>Cytochrome oxidase (Option B)</strong> (Complex IV): It is an integral membrane protein complex, not a soluble protein. It accepts electrons from cytochrome c and reduces molecular oxygen to water.</p>\n<p><strong>Complex II (Option D)</strong> (Succinate dehydrogenase): A membrane-bound enzyme complex that feeds electrons from FADHH&#x2082; into the ETC. It is not soluble and not primarily an electron shuttle between complexes.</p>", "options": ["Coenzyme Q", "Cytochrome oxidase", "Cytochrome c", "Complex II of ETC"], "html_options": ["Coenzyme Q", "Cytochrome oxidase", "Cytochrome c", "Complex II of ETC"], "corr_idx": 2}, {"id": "1192035", "html_qtxt": "Iron-sulfur proteins are found in all of the following complexes of the electron transport chain, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Complex IV (Cytochrome c oxidase) does not contain Fe-S proteins. Instead, it uses heme groups (cytochromes a and aH&#8323;O) and copper centres (Cu_A and Cu_B) to carry out the final reduction of oxygen to water.</p>\n<p>Iron-sulfur (Fe-S) proteins are essential components of the electron transport chain and participate in one-electron transfers by cycling between Fe&#178;&#8314; and Fe&#x00B3;&#x207A; oxidation states.</p>\n<p>These proteins are found in:</p>\n<ul>\n<li>Complex I (NADH: ubiquinone oxidoreductase) <strong>(Option A ruled out)</strong></li>\n<li>Complex II (Succinate dehydrogenase) <strong>(Option B ruled out)</strong></li>\n<li>Complex III (Cytochrome bc&#x2081; complex) <strong>(Option C ruled out)</strong></li>\n</ul>", "options": ["Complex I", "Complex II", "Complex III", "Complex IV"], "html_options": ["Complex I", "Complex II", "Complex III", "Complex IV"], "corr_idx": 3}, {"id": "1192037", "html_qtxt": "Which of the following complexes in the electron transport chain does not act as a proton pump?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Complex II (Succinate dehydrogenase) transfers electrons from succinate to ubiquinone (CoQ).</p>\n<ul>\n<li>It does not pump protons, and thus does not contribute directly to the proton gradient.</li>\n<li>In the electron transport chain (ETC), Complexes I, III, and IV function as proton pumps, actively transporting H&#8314; ions from the mitochondrial matrix to the intermembrane space. <strong>(Options A, C, and D ruled out)</strong></li>\n<li>This builds up a proton gradient (proton motive force) used by ATP synthase (Complex V) to generate ATP.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820befe661c-e70c-4d8b-bd1e-6bbb3b33a13e.png\">", "options": ["Complex I", "Complex II", "Complex III", "Complex IV"], "html_options": ["Complex I", "Complex II", "Complex III", "Complex IV"], "corr_idx": 1}, {"id": "1192039", "html_qtxt": "Malonate is a competitive inhibitor of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Malonate is a structural analogue of succinate and acts as a competitive inhibitor of succinate dehydrogenase, which is Complex II of the electron transport chain (ETC) and also a component of the TCA cycle.</p>\n<p>It binds to the active site of succinate dehydrogenase, preventing succinate from binding, thus blocking the transfer of electrons from FADH2 to Coenzyme Q.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820070e02e1-a7b9-4370-ae65-63443467e2aa.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508203c7cb4c4-b726-45d0-8ecd-d4e2236f1da2.png\">", "options": ["Complex I", "Complex II", "Complex III", "Complex IV"], "html_options": ["Complex I", "Complex II", "Complex III", "Complex IV"], "corr_idx": 1}, {"id": "1192043", "html_qtxt": "Barbiturates at very high doses are fatal because they inhibit the electron transport chain. What is their mechanism of action?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Barbiturates like amobarbital are inhibitors of Complex I of the electron transport chain (ETC).</li>\n<li>Specifically, they block the transfer of electrons from iron-sulfur (Fe-S) centres to Coenzyme Q (ubiquinone).</li>\n<li>This halts the entire downstream flow of electrons, stopping ATP synthesis and eventually leading to cell death at high doses.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Inhibit cytochrome oxidase (Option B):</strong> Cytochrome oxidase is Complex IV, and its inhibitors include cyanide, carbon monoxide, and hydrogen sulfide (H&#8322;S) - not barbiturates.</p>\n<p><strong>Uncouple oxidative phosphorylation (Option C):</strong> Uncouplers (e.g., 2,4-Dinitrophenol, thermogenin) allow electron transport to continue, but dissociate ATP synthesis from proton gradient, producing heat instead of ATP. Barbiturates are not uncouplers.</p>\n<p><strong>Inhibit ADP/ATP translocase (Option D):</strong> This refers to attractyloside, which blocks the adenine nucleotide transporter (ANT), preventing ADP entry into and ATP exit from the mitochondrion.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820a19bb8de-392e-48cb-8423-7df27d1d9ead.png\">", "options": ["Inhibit electron transport via Complex I by blocking the transfer from Fe-S to Q", "Inhibit cytochrome oxidase", "Uncoupling of oxidative phosphorylation", "Inhibit oxidative phosphorylation by inhibiting the transporter of ADP into and ATP out of the mitochondrion"], "html_options": ["Inhibit electron transport via Complex I by blocking the transfer from Fe-S to Q", "Inhibit cytochrome oxidase", "Uncoupling of oxidative phosphorylation", "Inhibit oxidative phosphorylation by inhibiting the transporter of ADP into and ATP out of the mitochondrion"], "corr_idx": 0}, {"id": "1192045", "html_qtxt": "Which of the following is a chemical uncoupler of oxidative phosphorylation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>2,4-Dinitrophenol (DNP) is a synthetic chemical uncoupler of oxidative phosphorylation.</p>\n<ul>\n<li>It disrupts the proton gradient across the inner mitochondrial membrane by allowing protons to leak back into the matrix without passing through ATP synthase.</li>\n<li>This dissociates electron transport from ATP production, resulting in:\n<ul>\n<li>Uncontrolled electron transport (continued respiration)</li>\n<li>Heat generation instead of ATP synthesis</li>\n<li>Increased oxygen consumption</li>\n</ul>\n</li>\n<li>Because ATP is not formed, ADP no longer regulates the electron transport chain, causing it to run unchecked.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thermogenin (UCP1) (Option B):</strong> A physiological uncoupler found in brown adipose tissue, especially in newborns and hibernating animals. It promotes heat generation (non-shivering thermogenesis).</p>\n<p><strong>Bilirubin (Option C):</strong> While it can act as an uncoupler at high concentrations, it is considered a physiological uncoupler and does not function in normal physiological conditions as a significant uncoupler.</p>\n<p><strong>Free fatty acids (Option D):</strong> These can mildly uncouple oxidative phosphorylation at high concentrations but are also physiological, not synthetic/chemical uncouplers.</p>", "options": ["2,4-dinitrophenol", "Thermogenin", "Bilirubin", "Free fatty acids"], "html_options": ["2,4-dinitrophenol", "Thermogenin", "Bilirubin", "Free fatty acids"], "corr_idx": 0}, {"id": "1192048", "html_qtxt": "In a resting condition in a cell, the rate of respiration of mitochondria can be controlled by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The availability of ADP is the rate-limiting factor in mitochondrial respiration under resting conditions.</p>\n<p>In mitochondria, oxidation (ETC) and phosphorylation (ATP synthesis) are tightly coupled, meaning electron flow through the respiratory chain occurs only when ADP is available to be phosphorylated to ATP.</p>\n<p>This mechanism is known as \"respiratory control\".</p>\n<ul>\n<li>In resting cells (State 4 respiration), ADP levels are low, so oxygen consumption is minimal.</li>\n<li>When cellular energy demand increases, ATP is hydrolysed, raising ADP levels, which stimulates oxidative phosphorylation (State 3 respiration).</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508201ade3e86-45b4-4fcd-a39d-4f13f0cd7c41.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Availability of ATP (Option A):</strong> Incorrect. High ATP levels actually inhibit respiration by indicating low energy demand.</p>\n<p><strong>Availability of AMP (Option C):</strong> Incorrect. AMP is more relevant in cytoplasmic metabolic regulation (e.g., activating PFK-1 in glycolysis) but does not directly control mitochondrial respiration.</p>\n<p><strong>Physiological Uncouplers (Option D):</strong> Incorrect. Uncouplers (like thermogenin) increase respiration independently of ADP levels, by collapsing the proton gradient - this is not the physiological control mechanism under resting conditions.</p>", "options": ["Availability of ATP", "Availability of ADP", "Availability of AMP", "Physiological Uncouplers"], "html_options": ["Availability of ATP", "Availability of ADP", "Availability of AMP", "Physiological Uncouplers"], "corr_idx": 1}, {"id": "1192050", "html_qtxt": "Which of the following components catalyses electron transport between NADH and Coenzyme Q?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The electron transport from NADH to Coenzyme Q (ubiquinone) is carried out by Complex I (NADH-CoQ oxidoreductase) in the electron transport chain.</p>\n<ul>\n<li>Flavoprotein refers to the FMN (Flavin Mononucleotide)-containing enzyme within Complex I.</li>\n<li>Electrons from NADH are first transferred to FMN, forming FMNH&#8322;.</li>\n<li>These are then passed through a series of Fe-S (iron-sulfur) centers to Coenzyme Q, reducing it to QH&#8322;.</li>\n<li>This process also pumps 4 protons (H+) across the inner mitochondrial membrane, contributing to the proton gradient.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082009e2d385-5746-474d-99d4-6534166be94c.png\">\n<p><strong>Explanation of other Options:</strong></p>\n<p><strong>Cytochrome c (Option A):</strong> Transfers electrons from Complex III to Complex IV. Not involved between NADH and CoQ.</p>\n<p><strong>Cytochrome oxidase (Complex IV) (Option B):</strong> Transfers electrons from cytochrome c to O&#8322;, reducing it to H&#8322;O. Occurs much later in the chain.</p>\n<p><strong>Cytochrome b (Option C):</strong> Part of Complex III, involved in electron transfer from QH&#8322; to cytochrome c via the Q-cycle. Not part of NADH. CoQ step.</p>", "options": ["Cytochrome c", "Cytochrome oxidase", "Cytochrome b", "Flavoprotein"], "html_options": ["Cytochrome c", "Cytochrome oxidase", "Cytochrome b", "Flavoprotein"], "corr_idx": 3}, {"id": "1192052", "html_qtxt": "Which of the following statements regarding cytochrome oxidase is true?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Cytochrome oxidase (Complex IV) is the final complex in the electron transport chain (ETC). It:</p>\n<ul>\n<li>Accepts four electrons, one at a time, from cytochrome c</li>\n<li>Transfers these electrons to molecular oxygen (O&#8322;)</li>\n<li>Reduces O&#8322; to two molecules of H&#8322;O</li>\n<li>This reaction also pumps protons across the inner mitochondrial membrane, contributing to the proton gradient needed for ATP synthesis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It is inhibited by copper (Option A):</strong> Incorrect. Cytochrome oxidase requires copper (CuA and CuB centers) for its function. It is not inhibited by copper; rather, it's inhibited by cyanide, CO, and H&#8322;S.</p>\n<p><strong>It transfers electrons from CoQ to cytochrome c (Option B):</strong> Incorrect. That step is done by Complex III (cytochrome bc1 complex), not Complex IV.</p>\n<p><strong>It contains a single cytochrome protein (Option D):</strong> Incorrect. Cytochrome oxidase is a multi-subunit complex and contains multiple cytochromes-notably cytochrome a and cytochrome a3-along with copper centers.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082042578ba3-5a50-41d5-bf04-178988411193.png\">", "options": ["It is inhibited by copper", "It transfers electrons from CoQ to cytochrome c", "It transfers four electrons to form the H2O molecule", "It contains a single cytochrome protein"], "html_options": ["It is inhibited by copper", "It transfers electrons from CoQ to cytochrome c", "It transfers four electrons to form the H2O molecule", "It contains a single cytochrome protein"], "corr_idx": 2}, {"id": "1192214", "html_qtxt": "Which of the following processes occurs during Phase I metabolism of xenobiotics?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Phase I reactions involve functionalization, where the goal is to introduce or expose functional groups (e.g., -OH, -NH2, -COOH) on xenobiotic molecules. These new groups make the compound more polar and prepare it for Phase II (conjugation).</p>\n<ul>\n<li>Most Phase I reactions are oxidation reactions catalyzed by cytochrome P450 monooxygenases.</li>\n<li>These reactions may result in activation (e.g., conversion of prodrugs to active drugs) or sometimes more toxic intermediates.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Involves the process of conjugation (Option A):</strong> Incorrect. Conjugation reactions occur in Phase II, not Phase I. Phase II attaches hydrophilic groups like glucuronic acid, sulfate, or glutathione.</p>\n<p><strong>Catalyzed by dioxygenase enzymes (Option B):</strong> Incorrect. Phase I reactions are primarily catalyzed by monooxygenases, especially the cytochrome P450 family. Dioxygenases are more involved in specific metabolic pathways, like tryptophan or arachidonic acid metabolism.</p>\n<p><strong>Always make compounds nonreactive (Option D):</strong> Incorrect. Phase I reactions often make compounds more reactive (e.g., epoxides), but not always safer. Some become toxic or carcinogenic unless further detoxified in Phase II.</p>", "options": ["Involves the process of conjugation", "Catalysed by dioxygenase enzymes", "Introducing new groups that can be conjugated", "Always make compounds nonreactive"], "html_options": ["Involves the process of conjugation", "Catalysed by dioxygenase enzymes", "Introducing new groups that can be conjugated", "Always make compounds nonreactive"], "corr_idx": 2}, {"id": "1192221", "html_qtxt": "Which of the following Cytochrome enzyme inhibition will provide a novel way to help smoking cessation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>CYP2A6 is the primary enzyme responsible for the metabolism of nicotine into cotinine.</li>\n<li>Individuals with inactive variants (null alleles) of CYP2A6 metabolize nicotine more slowly, leading to higher and prolonged nicotine levels in the brain.</li>\n<li>As a result, they are less likely to develop nicotine addiction and often smoke fewer cigarettes.</li>\n<li>Therefore, inhibition of CYP2A6 is a promising strategy for smoking cessation, as it could mimic this naturally protective effect.</li>\n</ul>\n<p><strong>Explanation of Incorrect Options:</strong></p>\n<p><strong>CYP2C9 (Option A):</strong> Metabolizes drugs like warfarin, not nicotine. Inhibition or induction of CYP2C9 affects drug metabolism, but has no role in smoking cessation.</p>\n<p><strong>CYP2E1 (Option B):</strong> Metabolizes ethanol and tobacco-related procarcinogens, but not nicotine. Inhibition may reduce toxicity, but it doesn't impact nicotine addiction directly.</p>\n<p><strong>CYP1A2 (Option D):</strong> Involved in the metabolism of caffeine, steroid hormones, and some drugs. Though induced by smoking, its inhibition doesn't assist in quitting smoking.</p>", "options": ["CYP2C9", "CYP2E1", "CYP2A6", "CYP1A2"], "html_options": ["CYP2C9", "CYP2E1", "CYP2A6", "CYP1A2"], "corr_idx": 2}, {"id": "1192223", "html_qtxt": "Which of the following is the most common Phase II conjugation reaction involved in drug metabolism?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Phase II metabolism of xenobiotics (foreign substances like drugs or toxins) involves conjugation reactions, where polar groups are added to increase water solubility and enhance excretion.</li>\n<li>Among these, glucuronidation (conjugation with glucuronic acid) is the most common and frequent reaction.</li>\n<li>The enzyme UDP-glucuronosyltransferase uses UDP-glucuronic acid as a donor, attaching glucuronic acid to drugs, hormones, bilirubin, and various toxins. These glucuronides are easily excreted in urine or bile.</li>\n</ul>\n<p><strong>Explanation of Incorrect Options:</strong></p>\n<p><strong>Glutathione (Option A):</strong> Important in detoxifying electrophilic xenobiotics, especially reactive oxygen species and carcinogens. Less frequent than glucuronidation.</p>\n<p><strong>Sulfate (Option C):</strong> Used in sulfation reactions, especially for phenols, alcohols, and steroids. Uses PAPS (phosphoadenosine phosphosulfate) as a sulfate donor. Still less common than glucuronidation.</p>\n<p><strong>Hydroxyl group (Option D):</strong> Not a conjugation group but a product of hydroxylation, a Phase I reaction. It introduces a reactive site for Phase II conjugation but isn't itself a conjugating molecule.</p>", "options": ["Glutathione", "Glucuronic acid", "Sulfate", "Hydroxyl group"], "html_options": ["Glutathione", "Glucuronic acid", "Sulfate", "Hydroxyl group"], "corr_idx": 1}, {"id": "1192227", "html_qtxt": "The metabolism of the following compounds will involve the enzyme cytochrome P450, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Vitamin E does not primarily involve CYP450.</p>\n<ul>\n<li>Unlike vitamin D, which is activated by CYP450-mediated hydroxylation, vitamin E metabolism involves different enzymatic pathways and does not rely significantly on cytochrome P450 enzymes.</li>\n<li>Cytochrome P450 enzymes (CYPs) are a superfamily of enzymes primarily involved in Phase I detoxification, especially hydroxylation reactions.</li>\n<li>They are located mostly in the endoplasmic reticulum of liver cells and are key players in the metabolism of endogenous (e.g., steroid hormones) and exogenous (e.g., drugs and pollutants) substances.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Acetaminophen (Option A):</strong> A commonly used drug that undergoes Phase I metabolism via CYP2E1, forming a toxic intermediate (NAPQI), which is then detoxified by glutathione.</p>\n<p><strong>Steroid hormones(Option B):</strong> The biosynthesis and metabolism of steroids like cortisol, testosterone, and estrogen depend on various CYP450 isoenzymes (e.g., CYP11A1, CYP17).</p>\n<p><strong>Pollutants (Option C):</strong> Involve CYP450. Environmental toxins, polycyclic aromatic hydrocarbons (PAHs), and other pollutants are metabolised by inducible CYP enzymes (e.g., CYP1A1).</p>", "options": ["Acetaminophen", "Steroid hormones", "Pollutants", "Vitamin E"], "html_options": ["Acetaminophen", "Steroid hormones", "Pollutants", "Vitamin E"], "corr_idx": 3}, {"id": "1192230", "html_qtxt": "All of the following are conjugating agents, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glucose is not a conjugating agent in Phase II metabolism.</li>\n<li>Although it's an important metabolic fuel and precursor for biosynthetic processes, it does not participate directly in conjugation reactions meant for detoxification or excretion of xenobiotics or drugs.</li>\n</ul>\n<p><strong>Explanation of the Other Options:</strong></p>\n<p><strong>Glucuronate (Option A)</strong> is a conjugating agent.</p>\n<ul>\n<li>Derived from UDP-glucuronic acid.</li>\n<li>Conjugates with various substances (e.g., bilirubin, drugs, steroids) to form glucuronides, making them water-soluble for excretion.</li>\n<li>The most frequent conjugation reaction in the body.</li>\n</ul>\n<p><strong>Glutathione (Option B)</strong> is a conjugating agent.</p>\n<ul>\n<li>A tripeptide (&gamma;-glutamyl-cysteinyl-glycine).</li>\n<li>Conjugates with electrophilic toxins and reactive intermediates.</li>\n<li>Helps detoxify harmful compounds, particularly in the liver, forming glutathione-S-conjugates.</li>\n</ul>\n<p><strong>Glycine (Option D)</strong> is a conjugating agent.</p>\n<ul>\n<li>An amino acid used in conjugation with carboxylic acid-containing compounds.</li>\n<li>Example: Benzoic acid is conjugated with glycine to form hippuric acid, which is excreted in urine.</li>\n</ul>", "options": ["Glucuronate", "Glutathione", "Glucose", "Glycine"], "html_options": ["Glucuronate", "Glutathione", "Glucose", "Glycine"], "corr_idx": 2}, {"id": "1192232", "html_qtxt": "Which one of the following molecules serves as a donor of sulfates in the phase II detoxification reaction by conjugation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>PAPS is the universal sulfate donor used in sulfation reactions during Phase II detoxification.</li>\n<li>It donates sulfate groups to compounds like phenols, alcohols, and aromatic amines, making them more water-soluble for excretion.</li>\n<li>It is also used in the sulfation of hormones, glycosaminoglycans, and other biomolecules.</li>\n</ul>\n<p><strong>Explanation of the other option:</strong></p>\n<p><strong>SAM (S-Adenosyl Methionine) (Option A):</strong></p>\n<ul>\n<li>Donor of methyl groups, not sulfate.</li>\n<li>Involved in methylation reactions, such as methylation of catecholamines, DNA, and some drugs during Phase II detoxification.</li>\n</ul>\n<p><strong>SAH (S-Adenosyl Homocysteine) (Option B):</strong></p>\n<ul>\n<li>A byproduct is formed after SAM donates its methyl group.</li>\n<li>Not a donor of sulfate, nor directly involved in conjugation.</li>\n</ul>\n<p><strong>GSH (Glutathione) (Option D):</strong></p>\n<ul>\n<li>A tripeptide (&gamma;-glutamyl-cysteinyl-glycine).</li>\n<li>Conjugates with electrophilic compounds during Phase II detoxification (e.g., reactive oxygen species, some drugs).</li>\n<li>Does not donate sulfate, but acts as a nucleophile.</li>\n</ul>", "options": ["SAM (S-Adenosyl Methionine)", "SAH (S-Adenosyl Homocysteine)", "PAPS (Adenosine 3'-phosphate-5'-phosphosulfate)", "GSH (Glutathione)"], "html_options": ["SAM (S-Adenosyl Methionine)", "SAH (S-Adenosyl Homocysteine)", "PAPS (Adenosine 3'-phosphate-5'-phosphosulfate)", "GSH (Glutathione)"], "corr_idx": 2}]}, {"moduleId": 1008720, "name": "Classification And Properties", "questions": [{"id": "1169859", "html_qtxt": "Which of the following is a simple lipid?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Beeswax</strong> is classified as a <strong>simple lipid</strong>.</li>\n<li>A <strong>Simple lipid</strong>includes fats and waxes, which are esters of fatty acids with various alcohols:\n<ul>\n<li><strong>Fats:</strong>Esters of fatty acids with glycerol, and oils are their liquid form</li>\n<li><strong>Waxes:</strong>Esters of fatty acids with higher molecular weight.</li>\n</ul>\n</li>\n<li><strong>Complex lipids</strong> include <strong>phospholipids</strong>, <strong>glycolipids</strong>, and <strong>lipoproteins</strong>. They contain additional functional groups, such as <strong>phosphate</strong>, <strong>carbohydrate</strong>, or <strong>protein</strong> components, along with fatty acids and alcohols, and are crucial for maintaining <strong>membrane integrity and performing signalling functions</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycolipids (Option A)</strong> are complex lipids composed of a fatty acid, sphingosine, and a carbohydrate group.</p>\n<p><strong>Lipoproteins (Option B)</strong> are complex lipid-protein assemblies involved in lipid transport, not simple lipids.</p>\n<p><strong>Vitamin E (Option C) </strong>is a derived lipid; it is not structurally a simple lipid.</p>", "options": ["Glycolipid", "Lipoproteins", "Vitamin E", "Beeswax"], "html_options": ["Glycolipid", "Lipoproteins", "Vitamin E", "Beeswax"], "corr_idx": 3}, {"id": "1169861", "html_qtxt": "Which among the following statements is true regarding medium-chain fatty acids?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Short-chain and <strong>medium-chain fatty acids do not require</strong> the aid of a carrier molecule such as <strong>carnitine</strong> and can cross directly.<strong> (Option A)</strong></li>\n<li>They are also not carrier dependent on<strong> CPT 1(Carnitine Palmitoyltransferase I)</strong> and thus not regulated by<strong> Malonyl CoA.</strong></li>\n<li>They have<strong> no role in atherosclerosis. (Option B)</strong></li>\n<li><strong>Only long-chain fatty acids are accumulated in cerebro-hepato-renal syndrome,</strong> and medium chains are not. <strong>(Option D)</strong></li>\n<li>Medium-chain fatty acids are found in <strong>coconut oil</strong> and <strong>palm kernel oil</strong>, rich in capric and caprylic acids.</li>\n<li>Medium-chain fatty acids are commonly used in <strong>medical formulas and parenteral nutrition</strong> due to their easy digestibility.</li>\n<li>Medium-chain fatty acids are useful in patients with <strong>fat malabsorption, pancreatic insufficiency</strong>, and <strong>inborn errors of long-chain fatty acid metabolism</strong> (e.g., CPT deficiencies).</li>\n<li>Medium-chain fatty acids <strong>do not require bile salts</strong> for emulsification during digestion.</li>\n</ul>", "options": ["Do not need a carrier for transport across the mitochondrial membrane", "No effect on atherosclerosis", "Role of carnitine in metabolism", "Not accumulated in cerebro-hepato-renal syndrome"], "html_options": ["Do not need a carrier for transport across the mitochondrial membrane", "No effect on atherosclerosis", "Role of carnitine in metabolism", "Not accumulated in cerebro-hepato-renal syndrome"], "corr_idx": 2}, {"id": "1169864", "html_qtxt": "Respiratory quotient of fats is?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The <strong>respiratory quotient of fats is 0.7</strong></li>\n<li>The <strong>Respiratory Quotient or RQ</strong> value is a measure of the <strong>ratio of carbon dioxide</strong><strong> produced and oxygen consumed by an organism per unit time</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904dd8c1652-89a7-4eee-9cf1-0aaf84b4d8d1.png\"></li>\n<li>RQ of <strong>carbohydrates is 1.0 (Option C)</strong></li>\n<li>RQ of <strong>proteins is 0.81 (Option B)</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081655e0af42-3f23-47b4-8e4b-d42367f80d5f.png\"></li>\n</ul>", "options": ["0.71", "0.81", "1.0", "0.66"], "html_options": ["0.71", "0.81", "1.0", "0.66"], "corr_idx": 0}, {"id": "1169866", "html_qtxt": "Aspirin blocks an enzyme irreversibly to produce its antithrombotic and anti-inflammatory effects. Which lipid product is utilised by enzymes to produce its effects?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Aspirin</strong> blocks the <strong>enzyme COX,</strong> which blocks the conversion of <strong>Arachidonic acid</strong> into proinflammatory prostaglandins.</li>\n<li><strong>Arachidonic acid is a 20-carbon, 4-double-bonds containing &omega;-6 fatty acid.</strong></li>\n<li>Arachidonic acid is a semi-essential fatty acid, as it is made from linolenic acid but becomes essential in its absence.</li>\n</ul>\n<p><strong>Explanation of other options</strong>:</p>\n<p><strong>3 double bonds containing &omega;-3 fatty acid (Option A): </strong>This refers to <strong>&alpha;-linolenic acid (C18:3, &omega;-3)</strong>, an <strong>essential fatty acid</strong> and precursor of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).</p>\n<p><strong>1 double bond containing &omega;-9 fatty acid</strong> <strong>(Option C): </strong>This refers to <strong>oleic acid</strong>, which has <strong>cardioprotective properties</strong> by improving HDL and reducing LDL.</p>\n<p><strong>5 double bonds containing &omega;-3 fatty acid (Option D):</strong> This refers to <strong>eicosapentaenoic acid (EPA, &omega;-3)</strong>. It competes with arachidonic acid for COX and LOX enzymes, producing <strong>less inflammatory eicosanoids</strong>. Used therapeutically in <strong>hypertriglyceridemia and cardiovascular risk reduction</strong>.</p>", "options": ["3 double bonds containing &omega;-3 fatty acid.", "4 double bonds containing &omega;-6 fatty acid.", "1 double bond containing &omega;-9 fatty acid.", "5 double bonds containing &omega;-3 fatty acid."], "html_options": ["3 double bonds containing &omega;-3 fatty acid.", "4 double bonds containing &omega;-6 fatty acid.", "1 double bond containing &omega;-9 fatty acid.", "5 double bonds containing &omega;-3 fatty acid."], "corr_idx": 1}, {"id": "1169867", "html_qtxt": "The Highest concentration of fatty acids is present in?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Coconut oil</strong> contains the <strong>highest concentration of saturated fatty acids</strong> among common edible oils.</li>\n<li>Coconut oil is composed predominantly of <strong>medium-chain triglycerides (MCTs)</strong>, particularly <strong>lauric acid (C12:0)</strong>, which accounts for nearly <strong>50% of its fatty acid content</strong>.</li>\n<li><strong>Ghee</strong> contains a high amount of saturated fat, but not as high as coconut oil in fatty acid concentration. <strong>(Option A ruled out)</strong></li>\n<li><strong>Cottonseed oil is </strong>rich in polyunsaturated fatty acids but has a lower total fatty acid concentration. <strong>(Option B ruled out)</strong></li>\n<li><strong>Palm kernel oil</strong> has high saturated fat, but less than coconut oil. <strong>(Option C ruled out)</strong></li>\n</ul>", "options": ["Ghee", "Cottonseed oil", "Palm kernel oil", "Coconut oil"], "html_options": ["Ghee", "Cottonseed oil", "Palm kernel oil", "Coconut oil"], "corr_idx": 3}, {"id": "1169868", "html_qtxt": "The benefits of &omega;-3 fatty acids are protective effects against all the following except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Omega-3 fatty acids (&omega;-3 FAs)</strong>, particularly <strong>eicosapentaenoic acid (EPA)</strong> and <strong>docosahexaenoic acid (DHA)</strong>, have been shown to have multiple health benefits:\n<ul>\n<li>CVD</li>\n<li>Rheumatoid Arthritis (RA) <strong>(Option B)</strong></li>\n<li>Cancer <strong>(Option A)</strong></li>\n<li>Alzheimer's disease <strong>(Option D)</strong></li>\n</ul>\n</li>\n<li>But <strong>not in mania.</strong></li>\n</ul>", "options": ["Cancers", "RA", "Mania", "Alzheimer's"], "html_options": ["Cancers", "RA", "Mania", "Alzheimer's"], "corr_idx": 2}, {"id": "1169869", "html_qtxt": "All are true about Cervonic acid except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Cervonic acid</strong> is formed from<strong> &alpha;-Linolenic acid</strong>, <strong>not linoleic acid.</strong></li>\n<li>Cervonic acid, also known as <strong>DHA (docosahexaenoic acid)</strong>, is an <strong>&omega;-3 fatty acid</strong> found in <strong>breast milk</strong>, fish oils and algal oil. <strong>(Option D)</strong></li>\n<li>Highest concentrations are in the <strong>retina</strong>, <strong>cerebral cortex</strong> and <strong> (Option A)</strong></li>\n<li>Deficiency of DHA has been implicated in <strong>retinal dysfunction,</strong> including <strong>retinitis pigmentosa,</strong> as well as cognitive and neurodevelopmental disorders. <strong>(Option C)</strong></li>\n</ul>", "options": ["Found in the cerebral cortex and sperm", "Is synthesised from linoleic acid", "Deficiency causes Retinitis pigmentosa", "Breast milk is a source"], "html_options": ["Found in the cerebral cortex and sperm", "Is synthesised from linoleic acid", "Deficiency causes Retinitis pigmentosa", "Breast milk is a source"], "corr_idx": 1}, {"id": "1169871", "html_qtxt": "A preterm infant admitted to the NICU shows reticulo-granular opacities on X-ray with a white out appearance. The child had chest retractions, tachypnea, and nasal flaring. Which of the following can be used as a test for the diagnosis of this condition?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The given clinical scenario is highly suggestive of <strong>Hyaline membrane disease or Respiratory distress syndrome,</strong> which is due to defective production of surfactant.</li>\n<li>The active component of surfactant is <strong>phosphatidylcholine (lecithin)</strong></li>\n<li>Chemically, <strong>phosphatidylcholine</strong> is composed of:<br /> <strong>Glycerol + 2 fatty acids + phosphate group (PO<sub>2</sub>) + choline</strong>.</li>\n<li>Measurement of the <strong>Lecithin: Sphingomyelin (L: S) ratio</strong> in amniotic fluid is the classic test used to <strong>assess fetal lung maturity</strong>. An <strong>L:S ratio >2</strong> indicates <strong>adequate surfactant production.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycerol + 2 fatty acids + PO4 + ethanolamine</strong> <strong>(Option A): Ethanolamine </strong>forms<strong> phosphatidylethanolamine (PE). </strong>It is involved in membrane structure and blood coagulation.</p>\n<p><strong>Glycerol + 2 fatty acids + PO4 + serine (Option C): Serine </strong>forms<strong> phosphatidylserine (PS), </strong>which plays an important role in<strong> apoptosis and cell signalling.</strong></p>\n<p><strong>Glycerol + 2 fatty acids + PO4 + inositol (Option D): Inositol </strong>forms<strong> phosphatidylinositol (PI), </strong>which plays an important role in<strong> signal transduction as a secondary messenger.</strong></p>", "options": ["Glycerol + 2 fatty acids + po4 + ethanolamine", "Glycerol + 2 fatty acids + po4 + choline", "Glycerol + 2 fatty acids + po4 + serine", "Glycerol + 2 fatty acids + po4 + inositol"], "html_options": ["Glycerol + 2 fatty acids + po4 + ethanolamine", "Glycerol + 2 fatty acids + po4 + choline", "Glycerol + 2 fatty acids + po4 + serine", "Glycerol + 2 fatty acids + po4 + inositol"], "corr_idx": 1}, {"id": "1169873", "html_qtxt": "Which of the following statements about glycolipids is incorrect?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Glycolipids</strong> are found in the <strong>outer</strong> <strong>leaflet</strong> of the <strong>plasma membrane</strong>.</li>\n<li>All glycolipids are formed from the <strong>alcohol</strong> <strong> (Option A)</strong></li>\n<li>They are widely distributed in the body, most commonly found in neurons. <strong>(Option B)</strong></li>\n<li><strong>Phosphatidyl serine</strong> is generally always present on the <strong>inner leaflet</strong> of the plasma membrane (except during apoptosis)</li>\n<li>The glycosphingolipids differ from sphingomyelin in that they<strong> do not contain phosphate. (Option D)</strong></li>\n</ul>", "options": ["Alcohol in them is always Sphingosine", "Widely distributed", "Found on the inner leaflet of the plasma membrane", "Complex lipids that do not contain phosphoric acid"], "html_options": ["Alcohol in them is always Sphingosine", "Widely distributed", "Found on the inner leaflet of the plasma membrane", "Complex lipids that do not contain phosphoric acid"], "corr_idx": 2}, {"id": "1169876", "html_qtxt": "The receptor for the cholera toxin on the cell membrane is:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Cholera toxin</strong>, produced by Vibrio cholerae, exerts its pathogenic effects by binding specifically to the <strong>GM1 ganglioside</strong> present on the <strong>outer leaflet of the plasma membrane</strong> of intestinal epithelial cells.</li>\n<li><strong>GM1</strong> is a <strong>glycosphingolipid</strong> that serves as a receptor facilitating toxin entry into the cell.</li>\n<li>Once internalised, cholera toxin activates <strong>adenylyl cyclase</strong>, leading to increased <strong>cAMP levels</strong>, causing chloride ion secretion and resulting in <strong>secretory diarrhoea</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816eccc13a9-353e-4f96-b2ba-0190e68eed30.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>GM2 (Option B) </strong>is involved in <strong>Tay-Sachs disease</strong>.</p>\n<p><strong>GM3 (Option C): </strong>Plays a role in <strong>cancer development and progression</strong>.</p>\n<p><strong>GM4 (Option D): </strong>Contributes to maintaining <strong>neural membranes</strong> and <strong>synaptic function</strong>.</p>", "options": ["GM1", "GM2", "GM3", "GM4"], "html_options": ["GM1", "GM2", "GM3", "GM4"], "corr_idx": 0}, {"id": "1169878", "html_qtxt": "Hormones that cause an increase in free fatty acid levels in the blood are all of the above except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Insulin</strong> <strong>inhibits lipolysis by inhibiting hormone-sensitive lipase (HSL) </strong>and causes a <strong>decrease in free fatty acid levels in the blood.</strong></li>\n</ul>\n<p>Hormones that increase lipolysis are:</p>\n<ul>\n<li>Epinephrine</li>\n<li>Norepinephrine</li>\n<li>Glucagon</li>\n<li>ACTH</li>\n<li><strong>TSH (Option B)</strong></li>\n<li>MSH (melanocyte-stimulating hormone) <strong>(Option A)</strong></li>\n<li>GH</li>\n<li><strong>Vasopressin (Option C)</strong></li>\n</ul>", "options": ["Beta melanocyte-stimulating hormone", "TSH", "Vasopressin", "Insulin"], "html_options": ["Beta melanocyte-stimulating hormone", "TSH", "Vasopressin", "Insulin"], "corr_idx": 3}, {"id": "1169881", "html_qtxt": "Which among the following is the most active plasma lipid?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Although <strong>cholesterol esters</strong> are quantitatively the most abundant plasma lipids, the <strong>most metabolically active</strong> are the <strong>unesterified long-chain fatty acids</strong>, i.e., <strong>Free Fatty Acids (FFAs)</strong>.</li>\n<li>Plasma lipids consist of:\n<ul>\n<li>Triacylglycerol (16%)</li>\n<li>Phospholipids (30%)</li>\n<li>Cholesterol (14%)</li>\n<li>Cholesterol esters(36%)</li>\n<li>Un-esterified long chain fatty acids(4%), also known as NEFA (Non-Esterified Fatty Acids) or FFA (Free Fatty Acids)</li>\n</ul>\n</li>\n<li>FFAs play a dynamic role in <strong>energy metabolism</strong>, being rapidly mobilised and utilised by tissues as an energy source.</li>\n<li>They circulate in plasma bound to <strong>albumin</strong> and are key in fasting and stress conditions.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Chylomicron (Option B): </strong>Large lipoproteins for dietary fat transport; not highly metabolically active in plasma.</p>\n<p><strong>Phospholipid (Option C): </strong>Structural components, not primary active plasma lipid<strong>.</strong></p>\n<p><strong>Cholesterol (Option D): </strong>Important for membranes and hormones but not metabolically active in plasma.</p>", "options": ["FFA", "Chylomicron", "Phospholipid", "Cholesterol"], "html_options": ["FFA", "Chylomicron", "Phospholipid", "Cholesterol"], "corr_idx": 0}, {"id": "1169892", "html_qtxt": "Maximum content of triglycerides is present in?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Four major groups of lipoproteins are present, which are:</p>\r\n<ul>\r\n<li><strong>Chylomicrons</strong>: contain the <strong>largest amount of lipids (98-99%),</strong> made up of <strong>triglycerides</strong> and other lipids</li>\r\n<li><strong>Very low-density lipoproteins (VLDL)</strong>: derived from the liver for the transport of triacylglycerol. <strong>(Option C ruled out)</strong></li>\r\n<li><strong>Low-density lipoproteins (LDL):</strong> These represent the final stage of catabolism of VLDL. <strong>(Option B ruled out)</strong></li>\r\n<li><strong>High-density lipoproteins (HDL):</strong> involved in cholesterol transport and VLDL and Chylomicron metabolism. <strong>(Option A ruled out)</strong></li>\r\n</ul>\r\n<p><strong>Triacylglycerol glycerol</strong> is the predominant lipid in Chylomicrons and VLDL, and Cholesterol and phospholipid are the contents of LDL and HDL, respectively</p>\r\n<p>Lipoproteins are also classified according to their electrophoretic properties as:</p>\r\n<ul>\r\n<li>Alpha band: HDL</li>\r\n<li>Beta band: LDL</li>\r\n<li>Pre-Beta band: VLDL<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2024031923c4b1b3-79ec-487a-ba36-81871ab64f46.png\"></li>\r\n</ul>", "options": ["HDL", "LDL", "VLDL", "Chylomicrons"], "html_options": ["HDL", "LDL", "VLDL", "Chylomicrons"], "corr_idx": 3}, {"id": "1169895", "html_qtxt": "Which of the following statements about lipoproteins is false?<br>a. Polar groups face outwards<br>b. Non-polar group faces outwards<br>c. The protein part is called apoprotein<br>d. Polar groups form the core of the lipoprotein.", "html_expl": "<p><strong>Explanation</strong>:</p>\r\n<ul>\r\n<li>Lipoproteins consist of a Nonpolar core and a single layer of Amphipathic lipid.</li>\r\n<li>The <strong>non-polar components</strong> form the core. <strong>(Statement d is false)</strong></li>\r\n<li>The non-polar core consists of TGs and Cholesterol ester, and the orientation is such that the <strong>polar groups face outward to the aqueous medium.</strong><br /><strong>(Statement a is true and Statement b is false)</strong></li>\r\n<li>The <strong>protein part</strong> of the lipoprotein is called <strong>Apolipoprotein or Apoprotein (Statement c is true)</strong></li>\r\n</ul>\r\n<p>Statements <strong>b </strong>and <strong>d </strong> are false.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20240311890b1f39-47dc-43e2-9eab-d3a9f9e206a2.png\">", "options": ["a, b, c, d", "b, d", "b, c, d", "Only d"], "html_options": ["a, b, c, d", "b, d", "b, c, d", "Only d"], "corr_idx": 1}, {"id": "1180395", "html_qtxt": "The following statements are true about Trans fatty acids except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>Trans fatty acids</strong></p>\n<ul>\n<li><strong>Trans fatty acids exacerbate essential fatty acids deficiency</strong> by competing for essential fatty acids, <strong>so increased trans fatty acids in the diet lead to decreased essential fatty acids in the human body.</strong></li>\n<li>Present in <strong>dairy products</strong>and partially <strong>hydrogenated edible oils. (Option C)</strong></li>\n<li>They are used in the food industry to improve the shelf life.</li>\n<li>Trans fatty acids are present in high amounts in <strong>processed foods</strong>, fast foods and bakery items. <strong>(Option B)</strong></li>\n<li>Consumption of trans fatty acids for the long term may raise the risk factor for cardiovascular diseases like <strong>Atherosclerosis</strong>,<strong> coronary Artery disease</strong>, and <strong>Diabetes mellitus </strong>since they increase <strong>LDL. (Option D)</strong></li>\n</ul>", "options": ["Increased TFA in the diet leads to increased essential fatty acids in the body.", "Fried rice has a high content of Trans Fatty acids", "Partial Hydrogenation increases Trans Fatty Acid", "Increases LDL"], "html_options": ["Increased TFA in the diet leads to increased essential fatty acids in the body.", "Fried rice has a high content of Trans Fatty acids", "Partial Hydrogenation increases Trans Fatty Acid", "Increases LDL"], "corr_idx": 0}, {"id": "1180400", "html_qtxt": "Which of the following are the active compounds of the eicosanoids?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Eicosanoids</strong> are <strong>physiologically</strong> and <strong>pharmacologically</strong> active compounds.</li>\n<li>Active compounds of the eicosanoids include:\n<ul>\n<li><strong>Prostaglandins (PG)</strong></li>\n<li><strong>Thromboxane (TX) </strong></li>\n<li>Leukotrienes (LT)</li>\n<li><strong>Lipoxins (LX).</strong></li>\n</ul>\n</li>\n<li>Physiologically, they are considered to act as local hormones functioning through G-protein-linked receptors to elicit their biochemical effects.</li>\n<li><strong>Arachidonate</strong> and some other<strong> C20 polyunsaturated fatty acids </strong>give rise to Eicosanoids.</li>\n<li>Three groups of eicosanoids are synthesised from C20 Arachidonic acids derived from the essential fatty acids linoleate and linolenate, or directly from dietary Arachidonate and Eicosapentanoate.</li>\n<li>Upon stimulation, <strong>phospholipase A2</strong> releases arachidonic acid, which is then metabolised by:\n<ul>\n<li><strong>Cyclooxygenase (COX)</strong>: Prostaglandins and Thromboxanes.</li>\n<li><strong>Lipoxygenase (LOX)</strong>: Leukotrienes and Lipoxins.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508166ca910b2-67a5-499b-97cf-aa351d7f5ae3.png\"></li>\n</ul>\n</li>\n</ul>", "options": ["Prostaglandins", "Thromboxane", "Lipoxins", "All of the above"], "html_options": ["Prostaglandins", "Thromboxane", "Lipoxins", "All of the above"], "corr_idx": 3}, {"id": "1180403", "html_qtxt": "Wrong statement about fatty acid?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Most of the naturally occurring <strong>unsaturated fatty acids</strong> exist in the <strong>cis-form</strong>.</li>\n<li>PUFA is essential for <strong>membrane structure</strong>.<strong> (Option A)</strong></li>\n<li>Biologically, <strong>arachidonic acid</strong> is crucial to life. <strong>(Option B)</strong></li>\n<li><strong>Hydrogenated vegetable oils</strong> contain <strong>trans fatty acids</strong>. <strong>(Option C) </strong></li>\n<li>Trans fatty acids are present in certain foods, arising as a <strong>by-product of the saturation of fatty acids</strong> during hydrogenation, or \"hardening\", of natural oils in the manufacture of margarine.</li>\n</ul>", "options": ["PUFA is essential for membrane structure", "Biologically, arachidonic acid is essential to life", "Hydrogenated vegetable oils contain Trans fatty acids", "Most of the naturally occurring unsaturated FAs exist as trans-isomers"], "html_options": ["PUFA is essential for membrane structure", "Biologically, arachidonic acid is essential to life", "Hydrogenated vegetable oils contain Trans fatty acids", "Most of the naturally occurring unsaturated FAs exist as trans-isomers"], "corr_idx": 3}, {"id": "1180405", "html_qtxt": "The highest PUFA content is seen in?", "html_expl": "<p><strong>Explanation</strong>:</p>\r\n<ul>\r\n<li><strong>Polyunsaturated fatty acids (PUFAs)</strong> are essential components of the diet and play important roles in <strong>cell membrane structure and function</strong>, <strong>eicosanoid synthesis</strong>, and <strong>cardiovascular health</strong>.</li>\r\n<li>Among commonly used oils, the <strong>PUFA content</strong> is highest in:\r\n<ul>\r\n<li><strong>Safflower oil:</strong> ~75% PUFA</li>\r\n<li><strong>Sunflower oil:</strong> ~65% PUFA <strong>(Option D)</strong></li>\r\n<li><strong>Corn oil:</strong> ~60% PUFA <strong>(Option C)</strong></li>\r\n<li><strong>Groundnut oil (Peanut oil):</strong> Lower PUFA (~30-35%) <strong>(Option A)</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>Thus, <strong>safflower oil</strong> has the <strong>highest PUFA content</strong> among the given options.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20240311571489d4-cfcc-4ad6-bd95-3ada0048a9af.png\">", "options": ["Groundnut oil", "Safflower oil", "Corn oil", "Sunflower oil"], "html_options": ["Groundnut oil", "Safflower oil", "Corn oil", "Sunflower oil"], "corr_idx": 1}, {"id": "1180408", "html_qtxt": "Which among the following is a cardio-protective fatty acid?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>Significance of &omega;3 Fatty Acid</strong></p>\n<ul>\n<li><strong>Decreases the risk of Cardiovascular Disease</strong></li>\n<li>Appear to <strong>replace arachidonic acid</strong> in platelet membranes</li>\n<li><strong>Lower the production of thromboxane and the tendency of platelet aggregation</strong></li>\n<li><strong>Decrease</strong> <strong>Serum Triglycerides</strong></li>\n<li>Important for Infant Development</li>\n<li>Lowers the risk of various mental illnesses (Depression, ADHD)</li>\n<li>Lowers the risk of chronic degenerative diseases such as Cancer, Rheumatoid Arthritis, and <strong>Alzheimer's Disease</strong>.</li>\n</ul>\n<p><strong>Explanation of other options</strong>:</p>\n<p><strong>Palmitic acid (Option A):</strong> A saturated fatty acid associated with increased cardiovascular risk.</p>\n<p><strong>Stearic acid (Option B): </strong>A Saturated fatty acid; neutral or slightly negative cardiovascular impact.</p>\n<p><strong>Oleic acid (Option C): </strong>Monounsaturated; mildly beneficial but not strongly cardio-protective.</p>", "options": ["Palmitic acid", "Stearic acid", "Oleic acid", "Omega-3 fatty acid"], "html_options": ["Palmitic acid", "Stearic acid", "Oleic acid", "Omega-3 fatty acid"], "corr_idx": 3}, {"id": "1180411", "html_qtxt": "Which of the following is not an omega-6 fatty acid?", "html_expl": "<p><strong>Explanation</strong>:</p>\r\n<ul>\r\n<li><strong>Alpha-linolenic acid (ALA)</strong>, on the other hand, is an <strong>omega-3 (&omega;-3) fatty acid</strong> (18:3, &omega;-3) and does <strong>not belong to the omega-6 family</strong>.</li>\r\n<li><strong>Omega-6 (&omega;-6) fatty acids</strong> are unsaturated fatty acids where the first double bond is located at the <strong>6th carbon</strong> from the methyl (omega) end.</li>\r\n</ul>\r\n<p>Examples of <strong>omega-6 fatty acids</strong> include:</p>\r\n<ul>\r\n<li><strong>Linoleic acid (LA; 18:2, &omega;-6) (Option B)</strong></li>\r\n<li><strong>Gamma-linolenic acid (GLA; 18:3, &omega;-6) (Option D)</strong></li>\r\n<li><strong>Arachidonic acid (AA; 20:4, &omega;-6) (Option A)</strong><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202403111e8c2c29-0585-4153-aa9e-dd3cb323f777.png\"></li>\r\n</ul>", "options": ["Arachidonic Acid", "Linoleic Acid", "Alpha-linolenic acid", "Gamma linolenic acid ."], "html_options": ["Arachidonic Acid", "Linoleic Acid", "Alpha-linolenic acid", "Gamma linolenic acid ."], "corr_idx": 2}, {"id": "1180415", "html_qtxt": "A 40-year-old male wants to reduce his weight, so he tries to stay away from fatty food for several weeks. Which of the following lipid products is most deficient in him?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Prostaglandins</strong> are <strong>eicosanoids</strong> derived from <strong>arachidonic acid</strong>, which is a polyunsaturated fatty acid present in membrane phospholipids.</li>\n<li>Arachidonic acid itself comes from <strong>dietary essential fatty acids</strong> (like linoleic acid).</li>\n<li>When a person <strong>avoids fatty food</strong>, they are likely to have <strong>reduced intake of essential fatty acids</strong>.</li>\n<li>Over time, this can lead to <strong>a decrease in the synthesis of arachidonic acid</strong>, thereby reducing the availability of substrates for prostaglandin synthesis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sphingolipids (Option A): </strong>Found in neural tissues (myelin sheath). Mostly structural lipids, not significantly affected by short-term dietary fat restriction.</p>\n<p><strong>Glycolipids (Option B): </strong>Composed of a lipid and carbohydrate, also primarily structural. Their levels are more genetically and metabolically regulated, not significantly diet-dependent.</p>\n<p><strong>Phospholipids (Option D): </strong>A major component of cell membranes. The body maintains its levels even during fat restriction due to de novo synthesis from carbohydrates and proteins.</p>", "options": ["Sphingolipids", "Glycolipids", "Prostaglandins", "Phospholipids"], "html_options": ["Sphingolipids", "Glycolipids", "Prostaglandins", "Phospholipids"], "corr_idx": 2}, {"id": "1180418", "html_qtxt": "The Maximum number of saturated fatty acids is seen in:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Coconut oil</strong> contains the <strong>highest percentage of saturated fatty acids</strong> among commonly used oils.</li>\n<li>It is also the <strong>richest source of medium-chain fatty acids (MCFAs)</strong>.</li>\n<li>Saturated fatty acids in coconut oil are primarily <strong>lauric acid, myristic acid, and palmitic acid</strong>.</li>\n<li>In contrast, oils such as <strong>safflower oil, corn oil, and sunflower oil</strong> are rich in <strong>polyunsaturated fatty acids (PUFAs)</strong>. <strong>(Options B, C and D ruled out)</strong></li>\n<li><strong>Safflower oil</strong> has one of the <strong>highest PUFA contents</strong>, while <strong>coconut oil has the least PUFA content</strong>.</li>\n</ul>", "options": ["Coconut oil", "Safflower oil", "Corn oil", "Sunflower oil"], "html_options": ["Coconut oil", "Safflower oil", "Corn oil", "Sunflower oil"], "corr_idx": 0}, {"id": "1180422", "html_qtxt": "All sentences are true about essential fatty acids except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Arachidonic acid</strong> is considered a semi-essential fatty acid as it can be synthesised from <strong>linoleic acid.</strong></li>\n<li>Some polyunsaturated fatty acids cannot be synthesised by mammals and are <strong>nutritionally essential</strong>. <strong>(Option A)</strong></li>\n<li>Linoleic and &alpha;-linolenic acids are the only fatty acids known to be essential for the complete nutrition of many species of animals, including humans, and are termed the nutritionally essential fatty acids.</li>\n<li>In most mammals, arachidonic acid can be formed from linoleic acid. Double bonds can be introduced at the &delta;4, &delta;5, &delta;6, and &delta;9 positions in most animals, <strong>but never beyond the &delta;9 position. (Option B)</strong></li>\n<li>In contrast, plants can synthesise the nutritionally essential fatty acids by introducing double bonds at the &delta;12 and &delta;15 positions.</li>\n<li><strong>Linoleic acid is the most essential fatty acid. (Option D)</strong></li>\n</ul>\n<p><strong>Functions of essential fatty acids</strong></p>\n<ul>\n<li>They are crucial components of <strong>phospholipids</strong> in cellular and organelle membranes, maintaining <strong>fluidity</strong> and <strong>integrity.</strong></li>\n<li>Eicosanoids are synthesised from Arachidonic acid.</li>\n<li>Lower the risk of Cardiovascular disease.</li>\n</ul>", "options": ["Fatty acids that are required by humans, but are not synthesised in the body, hence need to be supplied in the diet", "Humans lack the enzymes that can introduce a double bond beyond the 9th Carbon.", "Arachidonic acid is considered a semi-essential fatty acid as it can be synthesised from oleic Acid.", "Linoleic Acid is the most essential Fatty Acid"], "html_options": ["Fatty acids that are required by humans, but are not synthesised in the body, hence need to be supplied in the diet", "Humans lack the enzymes that can introduce a double bond beyond the 9th Carbon.", "Arachidonic acid is considered a semi-essential fatty acid as it can be synthesised from oleic Acid.", "Linoleic Acid is the most essential Fatty Acid"], "corr_idx": 2}, {"id": "1180425", "html_qtxt": "Which of the following fatty acids is present in high concentration in human milk?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Docosahexaenoic acid (DHA),</strong> also known as <strong>Cervonic Acid (22:6, &omega;3),</strong> is present in high concentrations in <strong>human milk, retina, cerebral cortex, testis, and sperm</strong>.</li>\n<li>It is synthesised in the human body to a limited extent from <strong>&alpha;-linolenic acid</strong> or obtained directly from <strong>fish oils</strong>.</li>\n<li><strong>DHA</strong> is essential for <strong>brain development</strong>, <strong>visual function</strong>, and is particularly supplied via the <strong>placenta and breast milk</strong>.</li>\n<li>Deficiency of DHA is linked with conditions such as <strong>retinitis pigmentosa,</strong> where reduced levels are observed.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Eicosapentaenoic Acid - EPA (Option B):</strong> An &omega;3 fatty acid important for cardiovascular protection but less abundant in human milk.</p>\n<p><strong>Arachidonic Acid - AA (Option C):</strong> An &omega;6 fatty acid, important for inflammatory mediators but not the major fatty acid in human milk.</p>\n<p><strong>&alpha;-Linolenic Acid - ALA (Option D):</strong> A plant-based &omega;3 fatty acid, precursor to DHA, but itself not the main fatty acid present in milk.<br /> </p>", "options": ["Cervonic Acid", "Eicosapentaenoic Acid", "Arachidonic Acid", "&alpha;-Linolenic Acid"], "html_options": ["Cervonic Acid", "Eicosapentaenoic Acid", "Arachidonic Acid", "&alpha;-Linolenic Acid"], "corr_idx": 0}, {"id": "1180437", "html_qtxt": "Which of the following is a glycolipid?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Glycolipids are <strong>lipids with a carbohydrate moiety </strong>attached.</li>\n<li>Glycolipids or Glycosphingolipids:\n<ul>\n<li><strong>Cerebroside</strong></li>\n<li>Sulfatide</li>\n<li>Globoside</li>\n<li>Ganglioside</li>\n</ul>\n</li>\n<li>They are important components of <strong>cell membranes</strong>, especially in the brain and nervous tissue, playing roles in <strong>cell recognition</strong> and <strong>signal transduction</strong>.</li>\n<li><strong>Cerebroside is a</strong> <strong>glycolipid</strong> consisting of <strong>Ceramide</strong> (sphingosine + fatty acid) and <strong>a single sugar</strong> (glucose or galactose). It is found in the <strong>myelin sheath of neurons.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Plasmalogen (Option B): </strong>A type of <strong>ether phospholipid</strong>, not a glycolipid. It is found in the <strong>heart and nervous tissue.</strong></p>\n<p><strong>Sphingomyelin (Option C): </strong>A <strong>sphingolipid</strong> with a <strong>phosphate group</strong>, not a sugar. Hence, it's a <strong>phospholipid</strong>, not a glycolipid.</p>\n<p><strong>Lecithin</strong> (aka Phosphatidylcholine) <strong>(Option D):</strong> A <strong>phospholipid</strong>, important in lung surfactant. It contains <strong>glycerol, phosphate, and choline</strong>, not sugar.</p>", "options": ["Cerebroside", "Plasmalogen", "Sphingomyelin", "Lecithin"], "html_options": ["Cerebroside", "Plasmalogen", "Sphingomyelin", "Lecithin"], "corr_idx": 0}, {"id": "1180440", "html_qtxt": "Many hormones act through second messengers. Second messenger is produced from:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Many hormones (like <strong>ADH, angiotensin II,</strong> and others) act through <strong>G-protein coupled receptors (GPCRs)</strong> that activate <strong>second messengers</strong> such as:\n<ul>\n<li><strong>cAMP</strong></li>\n<li><strong>IP<sub>3</sub>(Inositol triphosphate)</strong></li>\n<li><strong>DAG (Diacylglycerol)</strong></li>\n<li><strong>Ca<sup>2+</sup></strong></li>\n</ul>\n</li>\n<li>Among these, <strong>IP<sub>3</sub>and DAG</strong> are derived from <strong>phosphatidylinositol bisphosphate (PIP<sub>2</sub>)</strong>, a <strong>membrane phospholipid.</strong></li>\n</ul>\n<p><strong>Mechanism:</strong></p>\n<ul>\n<li><strong>Phosphatidylinositol &rarr; PIP<sub>2</sub></strong></li>\n<li>The inositol is present as its <strong>stereoisomer</strong>.</li>\n<li>Play an important role in <strong>cell signalling and membrane trafficking.</strong></li>\n<li>When acted upon by <strong>phospholipase C (PLC)</strong>, PIP<sub>2</sub> is cleaved into:\n<ul>\n<li><strong>IP<sub>3</sub></strong> &rarr; Mobilises <strong>Ca<sup>2+</sup></strong> from the endoplasmic reticulum</li>\n<li><strong>DAG</strong> &rarr; Activates <strong>protein kinase C (PKC)<br /> </strong></li>\n</ul>\n</li>\n</ul>\n<p>This is a classic <strong>second messenger system</strong> used by hormones like:</p>\n<ul>\n<li><strong>ADH (V1 receptor)</strong></li>\n<li><strong>Angiotensin II</strong></li>\n<li><strong>Oxytocin</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphatidylserine (Option B): </strong>Structural membrane phospholipid, <strong>not involved in second messenger synthesis.</strong></p>\n<p><strong>Phosphatidylcholine (Option C): </strong>Also structural; involved in lecithin formation, <strong>not directly forming second messengers.</strong></p>", "options": ["Phosphatidylinositol", "Phosphatidylserine", "Phosphatidylcholine", "None of these"], "html_options": ["Phosphatidylinositol", "Phosphatidylserine", "Phosphatidylcholine", "None of these"], "corr_idx": 0}, {"id": "1180442", "html_qtxt": "Which of the following molecules is present in Gangliosides?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Gangliosides</strong> are <strong>complex glycosphingolipids</strong> derived from <strong>glucosylceramide </strong>that contain one or more molecules of a <strong>sialic acid</strong>.</li>\n<li><strong>Neuraminic acid</strong> is the principal sialic acid found in human tissues.</li>\n<li>Gangliosides are present in <strong>nervous tissues</strong> in high concentration.</li>\n<li>They function in <strong>cell-cell recognition</strong> and <strong>communication as a receptor for a hormone.</strong></li>\n<li><strong>Ganglioside: Sphingosine + Fatty acid + Oligosaccharide, that contains one, two, three or four molecules of sialic acid.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphate (Option A):</strong> Found in phospholipids but not in gangliosides.</p>\n<p><strong>Sulfate (Option B):</strong> Present in sulfatides, not gangliosides.</p>\n<p><strong>Serine (Option C):</strong> Found in sphingolipids (as sphingosine precursor) but not as a characteristic component of gangliosides.</p>", "options": ["Phosphate", "Sulfate", "Serine", "Sialic Acid"], "html_options": ["Phosphate", "Sulfate", "Serine", "Sialic Acid"], "corr_idx": 3}, {"id": "1180445", "html_qtxt": "GM3 Gangliosides contain which of the following molecules?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The simplest ganglioside found in tissues is <strong>GM3</strong>, which contains <strong>ceramide</strong>, one molecule of glucose, one molecule of <strong>galactose</strong>, and one molecule of <strong>Neuraminic acid.</strong></li>\n<li>In the shorthand nomenclature used, <strong>G </strong>represents <strong>ganglioside</strong>; <strong>M </strong>is a <strong>monosialo</strong>-containing species; and the subscript <strong>3 </strong>is a number assigned based on <strong>chromatographic migration</strong>.</li>\n<li>GM1 is a more complex ganglioside derived from GM3, and is of considerable biologic interest, as it is known to be the receptor in human intestine for cholera toxin.</li>\n</ul>\n<p><strong>Note:</strong></p>\n<p><strong>Glycolipids: </strong>(Glycosphingolipids)</p>\n<ul>\n<li>The most important components in nerves and tissues & the cell membrane.</li>\n<li>Glycolipids are lipids with an attached carbohydrate or carbohydrate chain.</li>\n<li>They are widely distributed in every tissue of the body, particularly in nervous tissue such as the brain.</li>\n<li>They occur particularly in the outer leaflet of the plasma membrane, where they contribute to cell surface carbohydrates, which form the glycocalyx.</li>\n<li>Neuraminic acid is the principal sialic acid found in human tissues.</li>\n<li>Gangliosides are also present in nervous tissues in high concentration.</li>\n<li>They function in cell-cell recognition and communication and as receptors for hormones and bacterial toxins such as<strong> cholera toxin.</strong></li>\n</ul>", "options": ["Glucosyl ceramide", "Galactose", "Neuraminic acid", "All of the above"], "html_options": ["Glucosyl ceramide", "Galactose", "Neuraminic acid", "All of the above"], "corr_idx": 3}, {"id": "1180448", "html_qtxt": "Which of the following is the wrong statement regarding Polyunsaturated Fatty Acids (PUFA) and Essential Fatty Acids (EFA)?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>Clinical significance of PUFA and EFA</strong></p>\n<ul>\n<li>People with a normal diet will not have any deficiency, but those who are on parenteral nutrition for long periods will have a deficiency.</li>\n<li>PUFAs are used for esterification and the excretion of cholesterol. <strong>PUFA will reduce serum cholesterol levels. (Option B is incorrect)</strong></li>\n<li>Deficiency of EFA causes <strong>acanthocytosis</strong>, <strong>hyperkeratosis</strong>, <strong>acrodermatitis </strong>and <strong>hypercholesterolemia</strong>.<strong> (Option A)</strong></li>\n<li>EFA deficiency is connected with <strong>acrodermatitis enteropathica,</strong> <strong>hepatorenal syndrome</strong> and <strong>CNS manifestations.</strong></li>\n<li>Elevated PUFA levels are seen in <strong>Zellweger's syndrome. (Option C)</strong></li>\n<li><strong>DHA levels in blood are low in patients with retinitis pigmentosa</strong>. <strong>(Option D)</strong></li>\n<li>Trans fatty acids will compete with EFAs, and may increase the EFA deficiency and decrease the fluidity of membranes.</li>\n<li>Trans fatty acids decrease HDL-cholesterol and may cause <strong>atherosclerosis.</strong></li>\n</ul>", "options": ["Deficiency of EFA causes acanthocytosis", "Excessive consumption of PUFA will increase the serum cholesterol level.", "Elevated PUFA levels are seen in Zellweger's syndrome.", "DHA levels in blood are low in patients with retinitis pigmentosa"], "html_options": ["Deficiency of EFA causes acanthocytosis", "Excessive consumption of PUFA will increase the serum cholesterol level.", "Elevated PUFA levels are seen in Zellweger's syndrome.", "DHA levels in blood are low in patients with retinitis pigmentosa"], "corr_idx": 1}]}, {"moduleId": 1008721, "name": "Fatty Acid Synthesis And Metabolism", "questions": [{"id": "1180796", "html_qtxt": "Glycosphingolipid is made up of except:", "html_expl": "<p><strong>Explanation for answer</strong>:</p>\n<ul>\n<li><strong>Glycolipids (Glycosphingolipids) </strong>are lipids containing:\n<ul>\n<li><strong>Fatty acid (Option D)</strong></li>\n<li><strong>Alcohol</strong>: <strong>Sphingosine (Option C)</strong></li>\n<li><strong>Carbohydrate</strong> (instead of phosphate) <strong>(Option A)</strong></li>\n</ul>\n</li>\n<li><strong>No glycerol, no phosphate</strong>\n<ul>\n<li>Examples: <strong>Cerebroside</strong> - contains a single sugar (e.g., glucose or galactose)</li>\n<li><strong>Ganglioside</strong> - contains oligosaccharides with <strong>sialic acid (NANA)</strong></li>\n</ul>\n</li>\n<li>Glycosphingolipids contain sphingosine, not glycerol.</li>\n<li><strong>Phospholipids</strong></li>\n<li>Lipids that contain:\n<ul>\n<li><strong>Fatty acid</strong></li>\n<li><strong>Alcohol</strong> (either <strong>glycerol</strong> or <strong>sphingosine</strong>)</li>\n<li><strong>Phosphoric acid</strong></li>\n<li><strong>Nitrogenous base</strong> (e.g., choline, ethanolamine)</li>\n</ul>\n</li>\n</ul>\n<p>General formula: Fatty Acid + Alcohol + Phosphate + Nitrogenous Base</p>\n<p><strong>Glycerophospholipids:</strong></p>\n<ul>\n<li><strong>Alcohol</strong>: <strong>Glycerol</strong></li>\n<li>Examples:\n<ul>\n<li><strong>Lecithin (Phosphatidylcholine)</strong></li>\n<li><strong>Cephalin (Phosphatidylethanolamine)</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Sphingophospholipids:</strong></p>\n<ul>\n<li><strong>Alcohol</strong>: <strong>Sphingosine</strong></li>\n<li>Example: <strong>Sphingomyelin</strong> (The only phospholipid in the brain that uses sphingosine instead of glycerol)</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508262f12db17-43db-417a-a1cc-b6cadd16fa31.png\">", "options": ["Glucose", "Glycerol", "Sphingosine", "Fatty acids"], "html_options": ["Glucose", "Glycerol", "Sphingosine", "Fatty acids"], "corr_idx": 1}, {"id": "1180797", "html_qtxt": "Which of the following lipid compounds contains an alcoholic group?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Ceramide</strong> = Sphingosine (Amino alcohol) + Fatty acid</li>\n<li>Ganglioside = Ceramide + Oligosaccharide that contains N-Acetyl Neuraminic acid</li>\n<li><strong>Cerebroside</strong> = Ceramide +Monosaccharide</li>\n<li><strong>Sphingomyelin</strong> = Glycerol + 2 Fatty acid + PO<sub>4</sub> + Choline.</li>\n</ul>", "options": ["Ceramide", "Sphingomyelin", "Cerebroside", "All of the above"], "html_options": ["Ceramide", "Sphingomyelin", "Cerebroside", "All of the above"], "corr_idx": 3}, {"id": "1180798", "html_qtxt": "Which of the following is a glycolipid, according to Bloor's classification of lipids?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Cerebroside</strong></p>\n<ul>\n<li>A <strong>glycosphingolipid (Complex lipid)</strong></li>\n<li>Contains: <strong>Ceramide (sphingosine + fatty acid)</strong> + <strong>1 sugar (glucose or galactose).</strong></li>\n<li>Found abundantly in the <strong>myelin sheath of neurons.<br /> </strong></li>\n</ul>\n<p><strong>Bloor's Classification of Lipids:</strong></p>\n<p>Bloor classified lipids into three main types:</p>\n<ol>\n<li><strong>Simple lipids:</strong> e.g., fats (triglycerides), waxes</li>\n<li><strong>Compound/Complex lipids</strong>: Contain other groups like phosphate, carbohydrate</li>\n<li><strong>Derived lipids</strong>: e.g., fatty acids, steroids</li>\n</ol>\n<p><strong>Glycolipids</strong> are part of <strong>complex lipids</strong>, specifically <strong>glycosphingolipids</strong> - lipids with a carbohydrate attached to a sphingosine backbone.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508264d75d39c-4776-4a57-9547-1e954ddee9bf.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Plasmalogen (Option B)</strong>: An <strong>ether phospholipid</strong>, <strong>not</strong> a glycolipid. It is present in the heart and brain tissue. Contains glycerol + phosphate + ethanolamine or choline.</p>\n<p><strong>Sphingomyelin (Option C): </strong>A <strong>sphingophospholipid</strong>, not a glycolipid.Contains <strong>sphingosine</strong>, <strong>fatty acid</strong>, <strong>phosphate</strong>, and <strong>choline.<br /> </strong></p>\n<p><strong>Lecithin (Option D):</strong> Common name for <strong>phosphatidylcholine.</strong></p>", "options": ["Cerebroside", "Plasmalogen", "Sphingomyelin", "Lecithin"], "html_options": ["Cerebroside", "Plasmalogen", "Sphingomyelin", "Lecithin"], "corr_idx": 0}, {"id": "1180800", "html_qtxt": "Which of the following is a non-phosphorylated lipid?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Glycosphingolipids</strong> are <strong>non-phosphorylated lipids</strong>.</li>\n<li>They consist of <strong>sphingosine</strong>, <strong>fatty acid</strong>, and <strong>carbohydrate</strong> but <strong>lack phosphate</strong>.</li>\n<li>Glycolipids (glycosphingolipids) are important in nerve tissues and in the cell membrane.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cephalin (Option A)</strong>: Also known as <strong>phosphatidylethanolamine</strong>, contains <strong>phosphate</strong>.</p>\n<p><strong>Lecithin (Option B)</strong>: Also known as <strong>phosphatidylcholine</strong>, it contains <strong>phosphate</strong>.</p>\n<p><strong>Cardiolipin (Option D)</strong>: A <strong>diphosphatidylglycerol</strong>, also contains <strong>phosphate</strong>.</p>", "options": ["Cephalin", "Lecithin", "Glycosphingolipids", "Cardiolipin"], "html_options": ["Cephalin", "Lecithin", "Glycosphingolipids", "Cardiolipin"], "corr_idx": 2}, {"id": "1180801", "html_qtxt": "All sphingolipids are synthesised from which of the following molecules?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>All <strong>sphingolipids</strong> are formed from <strong>ceramide</strong>.</li>\n<li>Ceramide is synthesised in the <strong>endoplasmic reticulum</strong> from the amino acid</li>\n<li>Ceramide is an important signalling molecule (second messenger) regulating pathways, including <strong>programmed cell death.</strong></li>\n<li>Sphingomyelins are phospholipids and are formed when <strong>ceramide reacts with phosphatidylcholine</strong> to form sphingomyelin plus diacylglycerol.</li>\n<li>This occurs mainly in the <strong>Golgi apparatus</strong> and to a lesser extent in the plasma membrane.</li>\n<li><strong>Glycosphingolipids</strong> are a combination of ceramide with one or more sugar residues.</li>\n<li>The simplest glycosphingolipids (cerebrosides) are galactosylceramide (GalCer) and glucosylceramide (GlcCer).</li>\n<li><strong>GalCer</strong> is formed in a reaction between ceramide and UDP-Gal.</li>\n<li>Sulfogalactosylceramide and other sulfolipids, such as the sulfo(galacto)-glycerolipids and the steroid sulfates, are formed after further reactions involving 3'-phosphoadenosine-5'-phosphosulfate (PAPS; \"active sulfate\").</li>\n<li><strong>Gangliosides</strong> are synthesised from ceramide by the stepwise addition of activated sugars (eg, UDPGlc and UDPGal) and a sialic acid, usually N-acetylneuraminic acid.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphatidylcholine (Option A): </strong>It is a glycerophospholipid, not a sphingolipid. It consists of glycerol, two fatty acids, phosphate, and choline. It is not involved in the synthesis of sphingolipids but can donate its phosphocholine group to ceramide to form sphingomyelin.</p>\n<p><strong>Active Sulfate (Option C): </strong>Also known as PAPS (3'-phosphoadenosine-5'-phosphosulfate), it is a sulfate donor in various sulfation reactions, including the synthesis of sulfatides (sulfated glycolipids), but it is not the precursor for sphingolipid synthesis.</p>\n<p><strong>UDP-Galactose (Option D):</strong> It is an activated sugar nucleotide used for glycosylation reactions, including the formation of cerebrosides, but it requires ceramide as the base molecule. UDP-Galactose cannot independently form sphingolipids without ceramide.</p>", "options": ["Phosphatidylcholine", "Ceramide", "Active Sulfate", "UDPGalactose"], "html_options": ["Phosphatidylcholine", "Ceramide", "Active Sulfate", "UDPGalactose"], "corr_idx": 1}, {"id": "1180802", "html_qtxt": "Ceramide is synthesised from which of the following amino acids?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Ceramide</strong> is synthesised in the <strong>endoplasmic reticulum</strong> from the amino acid <strong>serine</strong>.</li>\n<li>Serine combines with palmitoyl-CoA to form <strong>3-ketosphinganine</strong>, which is the first committed step in ceramide and sphingolipid synthesis.</li>\n<li>Ceramide serves as the <strong>central molecule in the formation of all sphingolipids,</strong> including sphingomyelins and glycosphingolipids.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826a5cc68ea-0648-4298-a629-7c6c21c55bf0.png\"></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Histidine (Option A): </strong> Histidine is an essential amino acid primarily involved in the synthesis of histamine through decarboxylation. It does not participate in ceramide synthesis.</p>\n<p><strong>Glutamine (Option C): </strong>Glutamine is a key amino acid in nitrogen metabolism and purine/pyrimidine synthesis, but has no direct role in sphingolipid or ceramide biosynthesis.</p>\n<p><strong>Arginine (Option D):</strong> Arginine is involved in the urea cycle and nitric oxide synthesis. It does not contribute to the synthesis of ceramide or sphingolipids.</p>", "options": ["Histidine", "Serine", "Glutamine", "Arginine"], "html_options": ["Histidine", "Serine", "Glutamine", "Arginine"], "corr_idx": 1}, {"id": "1180804", "html_qtxt": "Action of Phospholipase C on PiP2(Phosphatidylinositol 4,5-bisphosphate) produces which of the following molecules:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Action of Phospholipase C on Phosphatidylinositol 4, 5 Bisphosphate (PiP2)</li>\n</ul>\n<p><strong>Diacyl Glycerol</strong> and <strong>Inositol Trisphosphate</strong> (IP3) are formed, and both act as <strong>second messengers.</strong></p>\n<p><strong>Mechanism:</strong></p>\n<ul>\n<li><strong>PIP2</strong> is cleaved by <strong>Phospholipase C</strong> into <strong>DAG</strong> and <strong>IP3</strong>.</li>\n<li><strong>DAG</strong> remains embedded in the plasma membrane where it activates <strong>Protein Kinase C (PKC)</strong>.</li>\n<li><strong>IP3</strong> diffuses through the cytoplasm to bind to <strong>IP3 receptors</strong> on the <strong>endoplasmic reticulum</strong>, triggering <strong>calcium release</strong> into the cytosol.</li>\n</ul>\n<p>Both <strong>DAG</strong> and <strong>IP3</strong> are key components in various <strong>signal transduction pathways</strong> that regulate numerous physiological processes.</p>", "options": ["Diacylgycerol", "Inositol triphosphate", "Both", "None of above"], "html_options": ["Diacylgycerol", "Inositol triphosphate", "Both", "None of above"], "corr_idx": 2}, {"id": "1180805", "html_qtxt": "Glycerophospholipid containing choline is very important for the human body. All of the following statements are correct about it except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Lecithin is the most abundant phospholipid of the cell membrane, not the mitochondrial membrane.</li>\n</ul>\n<p><strong>Lecithin (Phosphatidylcholine):</strong></p>\n<ul>\n<li><strong>Glycerophospholipid</strong> with <strong>Choline</strong> as nitrogenous base, i.e. Phosphatidic Acid + Choline. <strong>(Option A)</strong></li>\n<li>Most abundant phospholipid of the <strong>cell membrane, not mitochondria.</strong>.</li>\n<li>The largest body store of choline.<strong> (Option C)</strong></li>\n<li>Importance of choline\n<ul>\n<li>Acetylcholine in nerve transmission <strong>(Option D)</strong></li>\n<li>Transmethylation</li>\n</ul>\n</li>\n<li>Dipalmitoyl Lecithin (Di Palmitoyl Phosphatidyl Choline) is a major constituent of lung surfactant.</li>\n</ul>", "options": ["Glycerophospholipid containing choline is called as Lecithin", "Most abundant phospholipid in mitochondrial membrane.", "It represent a large proportion of body's storage of choline.", "Important in nervous transmission."], "html_options": ["Glycerophospholipid containing choline is called as Lecithin", "Most abundant phospholipid in mitochondrial membrane.", "It represent a large proportion of body's storage of choline.", "Important in nervous transmission."], "corr_idx": 1}, {"id": "1180806", "html_qtxt": "A short-stature male presented with enlarged and weak heart muscle, weakness of skeletal muscle, recurrent infection and was diagnosed with Barth syndrome. Which of the following lipid components is decreased in this disorder?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Cardiolipin</strong> is the <strong>major lipid of mitochondrial membranes</strong>. It is not found in other membranes of the cell. Cardiolipin is essential for proper mitochondrial function and energy metabolism.</li>\n<li>Decreased cardiolipin levels or alterations in its structure or metabolism cause <strong>mitochondrial dysfunction</strong> in <strong>ageing</strong> and pathological conditions, including <strong>heart failure, hypothyroidism</strong>, and <strong>Barth syndrome (cardioskeletal myopathy).</strong></li>\n<li>Cardiolipin is synthesised from <strong>phosphatidylglycerol</strong> and <strong>phosphatidic acid</strong> in the <strong>inner mitochondrial membrane</strong>.</li>\n<li>It plays a crucial role in maintaining <strong>mitochondrial structure</strong> and function, especially in the <strong>electron transport chain</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lecithin (Option A): </strong>Also known as Phosphatidylcholine, it is the most abundant phospholipid of the plasma (cell) membrane, not mitochondria.</p>\n<p><strong>Ceramide (Option B): </strong>Ceramide is not a phospholipid but a sphingolipid precursor involved in membrane structure and signalling pathways.</p>\n<p><strong>Phosphatidylserine (Option D): </strong>This phospholipid is found mainly in the inner leaflet of the plasma membrane and plays a role in cell signalling and apoptosis, but is not mitochondrial-specific.</p>", "options": ["Lecithin", "Ceramide", "Cardiolipin", "Phosphatidyl serine"], "html_options": ["Lecithin", "Ceramide", "Cardiolipin", "Phosphatidyl serine"], "corr_idx": 2}, {"id": "1180807", "html_qtxt": "A short-stature male presented with enlarged and weak heart muscle, weakness of skeletal muscle, recurrent infection and was diagnosed with Barth syndrome. Which of the following lipid components is decreased in this disorder?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Cardiolipin</strong> is a unique phospholipid found almost exclusively in the <strong>inner mitochondrial membrane</strong>.</li>\n<li>It plays a crucial role in <strong>mitochondrial bioenergetics</strong>, including the function of enzymes in <strong>oxidative phosphorylation</strong>.</li>\n<li>In <strong>Barth syndrome</strong>, a genetic defect in the enzyme <strong>tafazzin</strong> leads to defective remodelling of cardiolipin, resulting in its <strong>reduced levels or abnormal composition</strong>.</li>\n<li>This causes <strong>mitochondrial dysfunction</strong>, which manifests clinically as <strong>cardiomyopathy</strong>, <strong>skeletal muscle weakness</strong>, <strong>growth delay</strong>, and <strong>neutropenia</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lecithin (Option A):</strong> Major component of cell membranes, especially in the liver and CNS; not implicated in Barth syndrome.</p>\n<p><strong>Ceramide (Option B):</strong> A sphingolipid involved in cell signalling and apoptosis; not specific to mitochondrial membranes.</p>\n<p><strong>Phosphatidylserine (Option D):</strong> Important in apoptosis and membrane curvature; not associated with Barth syndrome pathogenesis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Barth syndrome</strong> is an <strong>X-linked recessive</strong> disorder of phospholipid metabolism.</li>\n<li><strong>Decreased or abnormal cardiolipin</strong> impairs mitochondrial function and energy production.</li>\n<li>Diagnosis is confirmed by clinical presentation + reduced cardiolipin levels or mutation in the <strong>TAZ gene</strong>.</li>\n</ul>", "options": ["Lecithin", "Ceramide", "Cardiolipin", "Phosphatidyl serine"], "html_options": ["Lecithin", "Ceramide", "Cardiolipin", "Phosphatidyl serine"], "corr_idx": 2}, {"id": "1180808", "html_qtxt": "A 10-year-old child is complaining of abdominal pain and weakness. On examination, hepatosplenomegaly was noted. In the blood investigation, pancytopenia was found. Bone marrow biopsy is shown below. Accumulation of which molecule is responsible for this condition?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826baf8fea4-6730-4902-b217-b1f31b27cd82.png\">", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The clinical vignette of a 10-year-old child with abdominal pain, weakness, hepatosplenomegaly, pancytopenia, and bone marrow biopsy showing a crumpled tissue paper appearance suggests <strong>Gaucher's disease</strong>.</li>\n</ul>\n<p><strong>Gaucher's Disease:</strong></p>\n<ul>\n<li>Most common Lysosomal Storage Disorder</li>\n<li>Enzyme Defect: <strong>Glucocerebrosidase</strong></li>\n<li>Lysosomes are filled with Glucocerebroside</li>\n<li>No cherry red spot in the macula</li>\n<li><strong>Haematological features</strong>: Pancytopenia, bleeding manifestation</li>\n<li><strong>Hepatosplenomegaly</strong></li>\n<li>Bone Pain and Pathological Fractures of long Bones</li>\n<li>X-ray Femur: <strong>Erlenmeyer Flask Deformity</strong> (flask-like appearance of distal femur and proximal tibia).<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826d556c277-69f4-41f3-969c-df847f14b955.png\"></li>\n<li>Bone Marrow Biopsy: <strong>Gaucher cell with Wrinkled paper appearance/crumbled tissue paper appearance.</strong></li>\n<li>Elevated serum levels of chitotriosidase, ACE & TRAP, also CCL-18/PARC</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sphingomyelin (Option B):</strong> Accumulates in <strong>Niemann-Pick disease</strong>, not Gaucher's disease. Characterised by hepatosplenomegaly, neurodegeneration, and foamy cells.</p>\n<p><strong>Ganglioside (Option C):</strong> Accumulates in <strong>Tay-Sachs disease</strong>, presenting with neurodegeneration, cherry-red spot on macula, but no hepatosplenomegaly.</p>\n<p><strong>Galactocerebroside (Option D):</strong> Accumulates in <strong>Krabbe disease</strong>, which presents with peripheral neuropathy, developmental delay, and optic atrophy.</p>", "options": ["Glucocerebroside", "Sphingomyelin", "Ganglioside", "Galactocerebroside"], "html_options": ["Glucocerebroside", "Sphingomyelin", "Ganglioside", "Galactocerebroside"], "corr_idx": 0}, {"id": "1180809", "html_qtxt": "All are sphingolipidosis diseases except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Sphingolipidoses</strong> are a group of inherited metabolic disorders caused by the accumulation of <strong>sphingolipids</strong> due to specific <strong>enzyme deficiencies</strong>.</li>\n<li>Each disorder is associated with a characteristic enzyme defect and accumulated substrate.</li>\n<li><strong>Wolman's disease </strong>is not a sphingolipidosis. It is a <strong>lysosomal acid lipase deficiency</strong> leading to the accumulation of <strong>cholesterol esters and triglycerides</strong> (not sphingolipids).</li>\n<li><strong>Tay-Sachs disease (Option A)</strong> is a sphingolipidosis caused by a deficiency of <strong>Hexosaminidase A</strong>, leading to the accumulation of <strong>GM2 ganglioside</strong>.</li>\n<li><strong>Fabry's disease (Option B) is a </strong>sphingolipidosis caused by a deficiency of <strong>&alpha;-galactosidase A</strong>, leading to accumulation of <strong>globotriaosylceramide (Gb3)</strong>.</li>\n<li><strong>Krabbe's disease (Option C)</strong> is a sphingolipidosis caused by a deficiency of <strong>galactocerebrosidase</strong>, leading to the accumulation of <strong>psychosine and galactocerebroside</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826e7c9b32f-1cb2-4846-8447-b5a1797b8577.png\">", "options": ["Tay-Sachs disease", "Fabry's disease", "Krabbe's disease", "Wolman's disease"], "html_options": ["Tay-Sachs disease", "Fabry's disease", "Krabbe's disease", "Wolman's disease"], "corr_idx": 3}, {"id": "1180812", "html_qtxt": "Deficiency of phosphorylating enzymes for the formation of which of the following recognition markers leads to I-cell disease?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>I-cell disease (Inclusion Cell disease)</strong> results from a defect in <strong>phosphorylating enzymes</strong> responsible for the addition of <strong>mannose 6-phosphate</strong> to lysosomal enzymes.</li>\n<li><strong>Mannose 6-phosphate</strong> acts as a recognition marker that directs enzymes to the <strong>lysosomes</strong>.</li>\n<li>In the absence of this marker, lysosomal enzymes fail to reach the lysosomes and instead get secreted outside the cell, leading to the accumulation of undigested substrates and the formation of <strong>inclusion bodies</strong>.</li>\n<li>Clinical features include <strong>severe psychomotor retardation, skeletal abnormalities, coarse facial features, and early death, often in the first decade of life</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>GM2 ganglioside (Option A):</strong> Involved in <strong>Tay-Sachs disease</strong> due to <strong>Hexosaminidase A deficiency</strong>.</p>\n<p><strong>Galactose (Option C):</strong> Accumulates in <strong>Galactosemia</strong> but is unrelated to lysosomal targeting.</p>\n<p><strong>Globoside (Option D):</strong> Accumulates in <strong>Fabry's disease</strong> but is not involved in I-cell disease.</p>", "options": ["GM2 ganglioside", "Mannose 6-phosphate", "Galactose", "Globoside"], "html_options": ["GM2 ganglioside", "Mannose 6-phosphate", "Galactose", "Globoside"], "corr_idx": 1}, {"id": "1180815", "html_qtxt": "Tay-Sachs disease is due to accumulation of:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Tay-Sachs disease</strong> is caused by a deficiency of the <strong>Hexosaminidase A</strong></li>\n<li>This leads to the accumulation of <strong>GM2 ganglioside</strong> in neuronal cells.</li>\n<li>Clinical features include <strong>mental retardation, blindness, and muscular weakness</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>GM1 ganglioside (Option B):</strong> Accumulates in <strong>GM1 gangliosidosis</strong>, not Tay-Sachs disease.</p>\n<p><strong>Glucocerebroside (Option C):</strong> Accumulates in <strong>Gaucher's disease</strong> due to <strong>beta-glucocerebrosidase deficiency</strong>.</p>\n<p><strong>Galactocerebroside (Option D):</strong> Accumulates in <strong>Krabbe's disease</strong> due to <strong>galactocerebrosidase deficiency</strong>.</p>", "options": ["GM2 ganglioside", "GM1 ganglioside", "Glucocerebroside", "Galactocerebroside"], "html_options": ["GM2 ganglioside", "GM1 ganglioside", "Glucocerebroside", "Galactocerebroside"], "corr_idx": 0}, {"id": "1180817", "html_qtxt": "Which of the following is a major phospholipid by mass in the membranes of human cells?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Phosphatidylcholine</strong> is generally the major phosphoglyceride by mass in the membranes of human cells.</li>\n<li>The major lipids in mammalian <strong>membranes</strong> are <strong>Phospholipids</strong>, <strong>Glycosphingolipids,</strong> & <strong>Cholesterol</strong></li>\n</ul>\n<p><strong>Phospholipids</strong>:</p>\n<ul>\n<li>Of the two major phospholipid classes present in membranes, <strong>phosphoglycerides</strong> are the more common</li>\n<li>In most phosphoglycerides present in membranes, the 3-phosphate is esterified to an alcohol such as <strong>choline</strong>, <strong>ethanolamine, glycerol, inositol or serine</strong>.</li>\n</ul>\n<p><strong>Explanation of other options</strong><strong>:</strong></p>\n<p><strong>Phosphatidyl inositol (Option A):</strong> It is a minor phospholipid involved in cell signalling pathways and not the major one by mass.</p>\n<p><strong>Phosphatidyl serine (Option C):</strong> It is primarily located in the inner leaflet of the plasma membrane and plays roles in apoptosis.</p>\n<p><strong>Phosphatidyl ethanolamine (Option D):</strong> Though abundant, it is less by mass compared to phosphatidylcholine.</p>", "options": ["Phosphotidyl inositol", "Phosphotidyl choline", "Phosphatidyl serine", "Phosphatidyl ethanolamine"], "html_options": ["Phosphotidyl inositol", "Phosphotidyl choline", "Phosphatidyl serine", "Phosphatidyl ethanolamine"], "corr_idx": 1}, {"id": "1180818", "html_qtxt": "The following are true statements about biomembrane, except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Membrane lipids are <strong> (Option A)</strong></li>\n<li>As the number of <strong>double bonds within the lipid side chains increases</strong>, the number of kinks in the tails increases. As a consequence, the <strong>membrane lipids become less tightly packed</strong> and the membrane becomes more fluid.</li>\n<li>All major lipids in membranes contain both hydrophobic and hydrophilic regions and are therefore termed amphipathic.</li>\n<li>If the <strong>hydrophobic region were separated from the rest of the molecule</strong>, it would be insoluble in water but soluble in organic solvents.</li>\n<li>Conversely, <strong>if the hydrophilic region were separated from the rest of the molecule, it would be insoluble in organic solvents but soluble in water. (Option D)</strong></li>\n<li><strong>Saturated fatty acids</strong> form relatively <strong>straight tails</strong>, whereas <strong>unsaturated fatty acids</strong>, which generally exist in the cis form in membranes, form <strong>\"kinked\" tails. (Option B)</strong></li>\n</ul>", "options": ["All major lipids are amphipathic.", "Saturated fatty acids form relatively straight tails, whereas unsaturated fatty acids, which form 'kinked' tails", "As the number of double bonds within the lipid side chains increases, the number of lipids becomes more tightly packed.", "If the hydrophilic region were separated from the rest of the molecule, it would be insoluble in organic solvents but soluble in water."], "html_options": ["All major lipids are amphipathic.", "Saturated fatty acids form relatively straight tails, whereas unsaturated fatty acids, which form 'kinked' tails", "As the number of double bonds within the lipid side chains increases, the number of lipids becomes more tightly packed.", "If the hydrophilic region were separated from the rest of the molecule, it would be insoluble in organic solvents but soluble in water."], "corr_idx": 2}]}, {"moduleId": 1008722, "name": "Ketone Bodies And Cholesterol", "questions": [{"id": "1169929", "html_qtxt": "All the following about ketone bodies are true except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Although the liver is the primary site for the synthesis of ketone bodies (ketogenesis), it cannot utilize them for energy. </li>\n<li>This is because the liver lacks the specific enzyme <strong>succinyl-CoA: acetoacetate CoA transferase (thiophorase)</strong>. </li>\n<li>Thiophorase is required to activate acetoacetate into acetoacetyl-CoA, allowing it to enter the metabolic pathway for energy generation. </li>\n<li>As a result, ketone bodies produced by the liver are exported into the bloodstream to be utilized by extrahepatic tissues such as the brain, heart, and skeletal muscles. </li>\n</ul>\n<p><strong>Explanation of Other Options:</strong> </p>\n<ul>\n<li>They are formed exclusively in the hepatic mitochondria (Option A): \n<ul>\n<li>This statement is true. Ketogenesis occurs primarily in the mitochondria of hepatocytes (liver cells) where acetyl-CoA derived from fatty acid oxidation is converted into ketone bodies. </li>\n</ul>\n</li>\n<li>Ketone bodies are formed under conditions causing a high rate of fatty acid oxidation (Option B):\n<ul>\n<li>This statement is true. Conditions such as fasting, starvation, prolonged exercise, or uncontrolled diabetes lead to increased lipolysis and beta-oxidation. This produces excess acetyl-CoA which saturates the Krebs cycle and is diverted to ketone body synthesis. </li>\n</ul>\n</li>\n<li>Acetone is excreted via the lungs (Option C): \n<ul>\n<li>This statement is true. Acetone is a volatile, minor ketone body formed by the non-enzymatic decarboxylation of acetoacetate. It is not metabolized significantly and is excreted via the breath (responsible for the \"fruity\" odor in ketoacidosis). </li>\n</ul>\n</li>\n</ul>", "options": ["They are formed exclusively in the hepatic mitochondria", "Ketone bodies are formed under conditions causing a high rate of fatty acid oxidation", "Acetone is excreted via the lungs", "Ketones are abundantly utilised in the liver"], "html_options": ["They are formed exclusively in the hepatic mitochondria", "Ketone bodies are formed under conditions causing a high rate of fatty acid oxidation", "Acetone is excreted via the lungs", "Ketones are abundantly utilised in the liver"], "corr_idx": 3}, {"id": "1169933", "html_qtxt": "HMG CoA is utilised in all of the following reactions except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>HMG-CoA is <strong>not involved in arginine metabolism</strong>.</li>\n</ul>\n<p><strong>HMG-CoA (3-hydroxy-3-methylglutaryl-CoA)</strong> is an important intermediate in several metabolic pathways:</p>\n<ul>\n<li><strong>Ketogenesis:</strong> Formation of HMG-CoA from three molecules of <strong>acetyl-CoA</strong> by the enzyme <strong>HMG-CoA synthase</strong>, which is the <strong>rate-limiting step of ketone body synthesis</strong>. <strong>(Option A ruled out)</strong></li>\n<li><strong>Cholesterol synthesis:</strong> HMG-CoA is converted to <strong>mevalonate</strong> by <strong>HMG-CoA reductase</strong>, which is the <strong>rate-limiting step of cholesterol synthesis</strong>.<strong> (Option B ruled out)</strong></li>\n<li><strong>Leucine metabolism:</strong> HMG-CoA acts as an intermediate in <strong>leucine catabolism</strong>. <strong>(Option C ruled out)</strong></li>\n</ul>", "options": ["Ketogenesis", "Cholesterol synthesis", "Leucine metabolism", "Arginine metabolism"], "html_options": ["Ketogenesis", "Cholesterol synthesis", "Leucine metabolism", "Arginine metabolism"], "corr_idx": 3}, {"id": "1169934", "html_qtxt": "Ketone bodies are utilised in all except?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Ketone bodies are not utilised in the <strong>liver and the RBCs</strong>.</li>\n<li>This is because the RBCs <strong>lack mitochondria</strong> and therefore cannot utilise ketone bodies and</li>\n<li>The liver lacks the enzyme <strong>thiophorase</strong> (succinyl CoA acetoacetate CoA transferase) and therefore cannot utilise ketone bodies.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Kidney and brain (Option B)</strong> can utilise ketone bodies, especially during <strong>prolonged fasting</strong> or <strong>starvation</strong>.</p>\n<p><strong>Kidney and heart</strong> <strong>(Option C) </strong>actively utilise ketone bodies as an energy source.</p>\n<p><strong>Muscle and brain (Option D)</strong> can both use ketone bodies, particularly when <strong>glucose availability is low</strong>.</p>", "options": ["Liver and RBC", "Kidney and brain", "Kidney and heart", "Muscle and brain"], "html_options": ["Liver and RBC", "Kidney and brain", "Kidney and heart", "Muscle and brain"], "corr_idx": 0}, {"id": "1169937", "html_qtxt": "All are true about ketosis and its tests except?<br>A. Rothera's test is answered by acetoacetate and acetone<br>B. Beta-hydroxybutyrate is the major ketone body in ketosis<br>C. Gerhardt's test is answered by Acetoacetate<br>D. In normal people, the ratio of BHB to Acetoacetate is 1:1", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>A: Rothera's test:</strong> Saturate 5 ml of urine with solid ammonium sulfate. Add 3 drops of freshly prepared sodium nitroprusside, followed by 2 ml of liquor ammonia, along the sides of the test tube. Development of a <strong>purple ring</strong> at the junction of the two liquids indicates the presence of <strong>acetone</strong> or <strong>acetoacetic</strong> acid in urine. It is <strong>not answered by beta-hydroxybutyrate.</strong> Strip tests based on the same principle are also available.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508268b5e7a95-18f6-46d3-a04e-6cf9255729e6.png\"><br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826ae5b217a-767f-4ab7-94de-fe7c99eb189d.png\">\n<p><strong>B: Beta-hydroxybutyrate</strong> is produced from acetoacetate, which is the <strong>major ketone body in ketoacidosis.</strong></p>\n<p><strong>C: Gerhardt's test for acetoacetic acid:</strong> To 5 ml of urine, add dilute ferric chloride solution drop by drop, till a maximum precipitate of ferric phosphate is obtained. This is to eliminate the phosphates, which may obscure the colour in the test. Filter. To the filtrate, add excess ferric chloride. A red colour indicates the presence of acetoacetic acid.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826719dc437-4e02-42bf-ba15-887a31839141.png\">\n<p><strong>D:</strong> In normal individuals, the <strong>BHB to Acetoacetate</strong> ratio is approximately <strong>1:1</strong>, but in ketosis, particularly <strong>diabetic ketoacidosis</strong>, this ratio shifts significantly, with <strong>beta-hydroxybutyrate predominating</strong>.</p>\n<p>So, all statements are correct.</p>", "options": ["A, B, C, D", "A, B", "A, D", "None of the above"], "html_options": ["A, B, C, D", "A, B", "A, D", "None of the above"], "corr_idx": 3}, {"id": "1169939", "html_qtxt": "The rate-limiting step of ketogenesis is the formation of:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p>The formation of <strong>HMG CoA</strong> from <strong>acetoacetate</strong> and<strong> acetyl-CoA</strong> by the enzyme <strong>HMG CoA synthase</strong> is the rate-limiting step of <strong>ketogenesis</strong>.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thiolase (Option A):</strong> Thiolase catalyses a <strong>reversible reaction</strong> involved in the initial step of ketogenesis, but it is not rate-limiting.</p>\n<p><strong>HMG CoA reductase (Option C):</strong> HMG CoA reductase is <strong>not involved in ketone body synthesis</strong>. It plays a role in <strong>cholesterol synthesis</strong> in the <strong>cytoplasm</strong>, not the mitochondria.</p>\n<p><strong>Thiophorase (Option D):</strong> Thiophorase is involved in <strong>ketone body utilisation</strong> (breakdown) in extra-hepatic tissues and not in ketone body synthesis.</p>", "options": ["Thiolase", "HMG CoA synthase", "HMG CoA reductase", "Thiophorase"], "html_options": ["Thiolase", "HMG CoA synthase", "HMG CoA reductase", "Thiophorase"], "corr_idx": 1}, {"id": "1169941", "html_qtxt": "Which of the following does not stimulate ketogenesis?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>An increase in the Insulin/Glucagon ratio</strong> will <strong>decrease ketogenesis</strong> by both decreasing the availability of FFA (by inhibition of hormone-sensitive lipase) and by inhibiting HMG CoA synthase in mitochondria.</li>\n</ul>\n<p>The stimulation of ketogenesis takes place in three crucial ways. They include:</p>\n<ul>\n<li><strong>Increase in free fatty acid availability (Option A)</strong></li>\n<li><strong>CPT-1 Gateway (Option B)</strong></li>\n<li><strong>Decrease in insulin/glucagon ratio (Option D)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826c6a43fd2-908b-4d35-9d48-4dd62f1197c1.png\">", "options": ["Increase in FFA availability", "CPT-1", "Increase in Insulin/Glucagon ratio", "Decrease in Insulin/Glucagon ratio"], "html_options": ["Increase in FFA availability", "CPT-1", "Increase in Insulin/Glucagon ratio", "Decrease in Insulin/Glucagon ratio"], "corr_idx": 2}, {"id": "1169945", "html_qtxt": "A child in Jamaica presented with symptoms of fasting hypoglycemia, more severe at night, acute vomiting, which occurred 6 hours after ingestion of a fruit, and the child rapidly developed coma and died shortly after. Which is a possible step inhibited in the patient?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Jamaican vomiting sickness</strong> is caused by eating the <strong>unripe fruit of the ackee tree,</strong> which contains the toxin</li>\n<li>This <strong>inactivates medium and short-chain acyl-CoA dehydrogenase,</strong> inhibiting oxidation and causing hypoglycemia.</li>\n<li>Dicarboxylic aciduria is due to the excretion of C6-C10 dicarboxylic acid with nonketotic hypoglycemia due to the lack of medium and short-chain fatty acid dehydrogenase.</li>\n<li>Recently, Jamaican vomiting sickness-like illness has been reported after consumption of <strong>large amounts of litchi</strong> by children from <strong>India,</strong> also, possibly by the same mechanism.</li>\n</ul>\n<p><strong>Explanation of other options</strong>:</p>\n<p><strong>Long-chain fatty acyl dehydrogenase (Option A):</strong> This enzyme is involved in long-chain fatty acid oxidation. In Jamaican vomiting sickness, it is specifically the <strong>medium and short-chain</strong> dehydrogenases that are inhibited.</p>\n<p><strong>HMG CoA synthase (Option C):</strong> HMG CoA synthase catalyses the rate-limiting step in <strong>ketogenesis</strong>, not directly related to the fatty acid oxidation block seen in this illness.</p>\n<p><strong>HMG CoA reductase (Option D):</strong> This enzyme is the <strong>rate-limiting enzyme in cholesterol biosynthesis</strong> and is not related to fatty acid oxidation or ketogenesis in mitochondria.</p>", "options": ["Long-chain fatty acyl dehydrogenase", "Medium and short-chain fatty acid dehydrogenase", "HMG CoA synthase", "HMG CoA reductase"], "html_options": ["Long-chain fatty acyl dehydrogenase", "Medium and short-chain fatty acid dehydrogenase", "HMG CoA synthase", "HMG CoA reductase"], "corr_idx": 1}, {"id": "1169951", "html_qtxt": "True regarding peroxisomal disorders:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Zellweger syndrome</strong>, also known as <strong>cerebrohepatorenal syndrome</strong>, is a <strong>peroxisomal biogenesis disorder</strong> caused by an <strong>inherited absence of peroxisomes</strong> in <strong>all tissues</strong>, not just the brain.</li>\n<li>There is an accumulation of <strong>very long chain fatty acids (VLCFA)</strong> in the <strong>brain tissue</strong> along with a <strong>generalised loss of peroxisomal function</strong> throughout the body.</li>\n<li>The disease manifests with severe <strong>neurologic deficits</strong> and <strong>hepatic dysfunction</strong>, and most affected infants die within the <strong>first year of life</strong>.</li>\n<li>Lorenzo's oil is used as a <strong>treatment</strong> for <strong>X-linked adrenoleukodystrophy (ALD)</strong>, not neonatal ALD. It is not related to Zellweger syndrome <strong>(Option A).</strong></li>\n<li>Refsum's disease is a <strong>rare</strong> peroxisomal disorder caused by a deficiency of the enzyme <strong>phytanoyl-CoA hydroxylase</strong>, leading to <strong>phytanic acid accumulation</strong>. It is not considered a <strong>common</strong> <strong>(Option C)</strong></li>\n<li>The absence of peroxisomes in <strong>Zellweger syndrome</strong> is <strong>systemic</strong>, affecting <strong>all tissues</strong>, not limited to the brain. <strong>(Option D)</strong></li>\n</ul>", "options": ["Lorenzo's oil causes neonatal adrenoleukodystrophy", "Zellweger syndrome is also called cerebrohepatorenal syndrome", "Refsum's disease is a common disorder caused by phytanic acid accumulation", "Zellweger syndrome is characterised by the absence of peroxisomes in the brain only"], "html_options": ["Lorenzo's oil causes neonatal adrenoleukodystrophy", "Zellweger syndrome is also called cerebrohepatorenal syndrome", "Refsum's disease is a common disorder caused by phytanic acid accumulation", "Zellweger syndrome is characterised by the absence of peroxisomes in the brain only"], "corr_idx": 1}, {"id": "1180406", "html_qtxt": "In which of the following pathways is the mitochondria not involved?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>De Novo Fatty Acid Synthesis (Lipogenesis)</strong> occurs in the <strong>cytosol</strong>, not in mitochondria.</li>\n<li>The pathway was elucidated by <strong>Feodor Lynen</strong>, hence also referred to as <strong>Lynen's Spiral</strong>.</li>\n<li>Major sites include: <strong>Liver, kidney, brain, lung, lactating mammary gland, and adipose tissue</strong>.</li>\n<li>Mitochondria provide <strong>acetyl-CoA</strong> (as citrate), but the actual fatty acid synthesis takes place in the <strong>cytosol</strong>.</li>\n<li><strong>Cofactors required:</strong>\n<ul>\n<li>NADPH</li>\n<li>ATP</li>\n  <li>Mn<sup>2</sup><sub>+</sub></li>\n<li>Biotin</li>\n<li>HCO<sub>3</sub><sup>-</sup> (as a source of CO2)</li>\n</ul>\n</li>\n<li><strong>Mitochondria are involved in:</strong>\n<ul>\n<li><strong>DNA Synthesis</strong> (mitochondrial DNA replication) <strong>(Option B)</strong></li>\n<li><strong>Fatty Acid Oxidation</strong> (beta-oxidation within mitochondria) <strong>(Option C)</strong></li>\n<li><strong>Protein Synthesis</strong> (via mitochondrial ribosomes) <strong>(Option D)</strong></li>\n</ul>\n</li>\n</ul>", "options": ["Fatty Acid Synthesis", "DNA Synthesis", "Fatty Acid Oxidation", "Protein Synthesis"], "html_options": ["Fatty Acid Synthesis", "DNA Synthesis", "Fatty Acid Oxidation", "Protein Synthesis"], "corr_idx": 0}, {"id": "1180413", "html_qtxt": "Triacylglycerol is a storage form of energy. The storage triacylglycerols are hydrolysed by:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Triacylglycerol undergoes hydrolysis by <strong>hormone-sensitive lipase (HSL)</strong> in adipose tissue to form <strong>free fatty acids (FFA)</strong> and <strong>glycerol</strong>.</li>\n<li>This process provides energy during fasting and stress by mobilising fat stores.</li>\n<li><strong>Hormone-sensitive lipase</strong> is regulated by hormones like epinephrine, norepinephrine, glucagon (activators), and insulin (inhibitor).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pancreatic Lipase (Option A):</strong> This enzyme hydrolyses <strong>dietary triacylglycerols</strong> in the small intestine, not stored fat.</p>\n<p><strong>Lipoprotein Lipase (Option B):</strong> This enzyme hydrolyses <strong>triacylglycerols in circulating lipoproteins (chylomicrons, VLDL)</strong> to facilitate fat storage in tissues.</p>\n<p><strong>Lysosomal Lipase (Option C):</strong> This enzyme is involved in the <strong>hydrolysis of intracellular lipids</strong> within lysosomes, not in the mobilisation of stored triacylglycerol for energy.</p>", "options": ["Pancreatic Lipase", "Lipoprotein Lipase", "Lysosomal Lipase", "Hormone-sensitive Lipase"], "html_options": ["Pancreatic Lipase", "Lipoprotein Lipase", "Lysosomal Lipase", "Hormone-sensitive Lipase"], "corr_idx": 3}, {"id": "1180417", "html_qtxt": "Which of the following is not a part of the Fatty Acid Synthase Complex?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Acetyl-CoA carboxylase</strong> is not a part <strong>FAS Complex</strong>.</li>\n</ul>\n<p>Fatty Acid Synthase (FAS) <strong>Multienzyme Complex</strong></p>\n<ul>\n<li>The complex is a homodimer of two identical polypeptide monomers, in which <strong>six enzyme activities</strong> and the <strong>acyl carrier protein (ACP).</strong></li>\n<li>Six enzyme activities of the Fatty Acid Synthase Complex are\n<ul>\n<li><strong>Ketoacyl Synthase (Option D)</strong></li>\n<li>Malonyl-Acetyl Transacylase</li>\n<li>Dehydratase</li>\n<li><strong>Enoyl Reductase (Option B)</strong></li>\n<li><strong>Ketoacyl Reductase (Option A)</strong></li>\n<li>Thioesterase (Deacylase).</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826314e0af0-5c3d-48ba-ab0d-9f2289e2db0e.png\">", "options": ["Ketoacyl Reductase", "Enoyl Reductase", "Acetyl-CoA Carboxylase", "Keto Acyl Synthase"], "html_options": ["Ketoacyl Reductase", "Enoyl Reductase", "Acetyl-CoA Carboxylase", "Keto Acyl Synthase"], "corr_idx": 2}, {"id": "1180421", "html_qtxt": "True about acetyl-CoA:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>Fates of Acetyl-CoA:</strong></p>\n<ul>\n<li>Synthesis of <strong>Cholesterol and other steroids</strong>. <strong>(Option A)</strong></li>\n<li>Synthesis of <strong>Fatty Acid</strong>. <strong>(Option C)</strong></li>\n<li>Synthesis of <strong>Ketone Bodies</strong>. <strong>(Option B)</strong></li>\n<li>Enter into the TCA Cycle</li>\n</ul>", "options": ["Precursor for the synthesis of cholesterol and other steroids", "Form Ketone bodies", "Starting material for the synthesis of fatty acid", "All of the above"], "html_options": ["Precursor for the synthesis of cholesterol and other steroids", "Form Ketone bodies", "Starting material for the synthesis of fatty acid", "All of the above"], "corr_idx": 3}, {"id": "1180430", "html_qtxt": "NADPH is required for:", "html_expl": "<p><strong>Explanation</strong>:</p>\r\n<p>Fatty acid synthesis is a <strong>reductive biosynthetic pathway</strong> that requires the following cofactors and conditions:</p>\r\n<p><strong>NADPH:</strong></p>\r\n<ul>\r\n<li><strong>NADPH</strong> is the principal reducing equivalent required for the synthesis of fatty acids.</li>\r\n<li>The biosynthesis of fatty acids requires NADPH as a reducing agent and occurs primarily in the cytosol of the liver and adipose tissue.</li>\r\n<li><strong>Sources</strong>:\r\n<ul>\r\n<li><strong>Pentose phosphate pathway (PPP)</strong> (main source)</li>\r\n<li><strong>Malic enzyme</strong> converts malate to pyruvate while generating NADPH.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Other essential cofactors and substrates:</strong></p>\r\n<ul>\r\n<li><strong>Acetyl-CoA</strong>: The two-carbon donor and fundamental building block.</li>\r\n<li><strong>ATP</strong>: Required for the activation of acetyl-CoA to malonyl-CoA.</li>\r\n<li><strong>Biotin</strong>: Coenzyme for <strong>acetyl-CoA carboxylase</strong>, which catalyses the formation of malonyl-CoA.</li>\r\n<li><strong>HCO<sub>3</sub><sup>-</sup> (Bicarbonate)</strong>: Provides the carboxyl group for carboxylation of acetyl-CoA.</li>\r\n<li><strong>Mn<sup>2</sup><sub>+</sub></strong>: Serves as a cofactor for various enzymes in fatty acid synthesis, especially acetyl-CoA carboxylase.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Gluconeogenesis</strong> <strong>(Option A):</strong> Uses <strong>NADH</strong>, not NADPH.</p>\r\n<p><strong>Glycolysis</strong> <strong>(Option B): </strong>Utilises <strong>NAD<sup>+</sup></strong> as a coenzyme in the glyceraldehyde-3-phosphate dehydrogenase step.</p>\r\n<p><strong>Glycogenolysis (Option D):</strong> Mainly involves <strong>glycogen phosphorylase</strong> and <strong>does not require NADPH</strong>.</p>", "options": ["Gluconeogenesis", "Glycolysis", "Fatty acid synthesis", "Glycogenolysis"], "html_options": ["Gluconeogenesis", "Glycolysis", "Fatty acid synthesis", "Glycogenolysis"], "corr_idx": 2}, {"id": "1180433", "html_qtxt": "The first step in fatty acid synthesis involves:", "html_expl": "<p><strong>Explanation</strong>:</p>\r\n<p><strong>Acetyl-CoA Carboxylase (ACC):</strong></p>\r\n<ul>\r\n<li><strong>Catalyses the first and rate-limiting step</strong> of <strong>fatty acid synthesis</strong>.</li>\r\n<li><strong>Reaction:</strong></li>\r\n</ul>\r\n<p>Acetyl-CoA (2C) + CO<sub>2</sub> + ATP &rarr; <strong>Malonyl-CoA (3C)</strong> + ADP + Pi</p>\r\n<ul>\r\n<li>Requires:\r\n<ul>\r\n<li><strong>ATP</strong></li>\r\n<li><strong>Biotin</strong> (Vitamin B7) as a prosthetic group (covalently bound coenzyme)</li>\r\n<li><strong>HCO<sub>3</sub><sup>-</sup> (as the CO<sub>2</sub> source)</strong></li>\r\n</ul>\r\n</li>\r\n<li>ACC is a <strong>multifunctional enzyme</strong>, but it is <strong>not</strong> part of the fatty acid synthase (FAS) complex.</li>\r\n</ul>\r\n<p><strong>Fatty Acid Synthase (FAS):</strong></p>\r\n<ul>\r\n<li>A multienzyme protein complex that carries out the subsequent steps of fatty acid chain elongation.</li>\r\n<li>Uses <strong>malonyl-CoA</strong> (from ACC) and <strong>NADPH</strong> for chain elongation.</li>\r\n</ul>\r\n<p><strong>Explanation of other options: </strong></p>\r\n<p><strong>&beta;-Hydroxyacyl CoA dehydrogenase (Option B):</strong> Involved in <strong>fatty acid &beta;-oxidation</strong>, not synthesis.</p>\r\n<p><strong>Acetyl dehydrogenase</strong> <strong>(Option C):</strong> No such enzyme</p>\r\n<p><strong>Pyruvate kinase (Option D):</strong> Involved in <strong>glycolysis</strong>, converting phosphoenolpyruvate (PEP) to pyruvate.</p>", "options": ["Acetyl-CoA carboxylase", "B - Hydroxyl CoA dehydrogenase", "Acetyl dehydrogenase", "Pyruvate kinase"], "html_options": ["Acetyl-CoA carboxylase", "B - Hydroxyl CoA dehydrogenase", "Acetyl dehydrogenase", "Pyruvate kinase"], "corr_idx": 0}, {"id": "1180439", "html_qtxt": "Carbon atoms added in fatty acid synthesis:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>First Cycle</strong> of Fatty Acid Synthase Complex: <strong>2 C from Acetyl CoA</strong> condense with 3 Carbon atoms of Malonyl CoA, followed by liberating <strong>1 CO<sub>2</sub></strong>. Hence,<strong> 4 Carbon atoms </strong>are added.</li>\n<li>In the <strong>second cycle,</strong> to the existing 4-carbon fatty acyl residue,<strong> 2 Carbon atoms are added</strong> by condensation with <strong>3 Carbon atoms of Malonyl CoA</strong>, followed by <strong>liberating 1 CO<sub>2</sub>.</strong></li>\n</ul>", "options": ["2 in Ist cycle and 4 in the 2nd cycle", "4 in Ist cycle and 2 in 2nd cycle", "2 in Ist cycle and 2 in the 2nd cycle", "4 in Ist cycle and 4 in the 2nd cycle"], "html_options": ["2 in Ist cycle and 4 in the 2nd cycle", "4 in Ist cycle and 2 in 2nd cycle", "2 in Ist cycle and 2 in the 2nd cycle", "4 in Ist cycle and 4 in the 2nd cycle"], "corr_idx": 1}, {"id": "1180446", "html_qtxt": "In which organelle(s) of the hepatocyte, the elongation of long-chain fatty acids take place?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Elongation of long-chain fatty acids (typically &ge; C10) primarily occurs in the <strong>endoplasmic reticulum (ER)</strong> of hepatocytes through the <strong>microsomal fatty acid elongation system</strong>.</li>\n<li>This system adds <strong>two carbon units</strong> at a time to existing fatty acyl-CoA chains.</li>\n<li>The elongation reaction uses <strong>malonyl-CoA</strong> as the carbon donor and <strong>NADPH</strong> as the reducing agent.</li>\n<li>Both <strong>saturated and unsaturated</strong> fatty acids can be elongated in the endoplasmic reticulum (ER).</li>\n<li>This process is fundamental in tissues like the <strong>brain</strong>, where longer-chain fatty acids (C22-C24) are needed for <strong>sphingolipid synthesis</strong> during <strong>myelination</strong>.</li>\n</ul>\n<p><strong>Explanation of other Options</strong><strong>:</strong></p>\n<p><strong>Golgi body (Option B):</strong> The Golgi apparatus is mainly involved in protein processing and glycosylation, not fatty acid elongation.</p>\n<p><strong>Lysosomes (Option C):</strong> Lysosomes are involved in the degradation of cellular waste, not biosynthetic processes like fatty acid elongation.</p>\n<p><strong>Ribosome (Option D):</strong> Ribosomes are responsible for protein synthesis, not lipid metabolism.</p>", "options": ["Endoplasmic reticulum", "Golgi body", "Lysosomes", "Ribosome"], "html_options": ["Endoplasmic reticulum", "Golgi body", "Lysosomes", "Ribosome"], "corr_idx": 0}, {"id": "1180447", "html_qtxt": "Acetyl-CoA acts as a substrate for all the enzymes except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p>Acetyl-CoA serves as a substrate for many enzymes involved in biosynthetic pathways, but <strong>not</strong> for <strong>malic enzyme</strong>.</p>\n<ul>\n<li><strong>Malic enzyme</strong> catalyses the oxidative decarboxylation of <strong>malate to pyruvate</strong>, producing <strong>NADPH</strong> and <strong>CO<sub>2</sub></strong>.</li>\n<li>It <strong>does not utilise Acetyl-CoA</strong> as a substrate.</li>\n</ul>\n<p><strong>In contrast:</strong></p>\n<ul>\n<li><strong>HMG-CoA synthase</strong> uses <strong>Acetyl-CoA</strong> to form HMG-CoA (key step in ketogenesis and cholesterol synthesis).<strong> (Option A)</strong></li>\n<li><strong>Malonyl-CoA synthetase</strong> activates <strong>Acetyl-CoA</strong> to form <strong>Malonyl-CoA</strong> (used in fatty acid synthesis). <strong>(Option C)</strong></li>\n<li><strong>Fatty acid synthase (FAS)</strong> utilises <strong>acetyl-CoA and malonyl-CoA</strong> as building blocks for fatty acid chain elongation. <strong>(Option D)</strong></li>\n</ul>", "options": ["HMG-CoA synthase", "Malic enzyme", "Malonyl-CoA synthetase", "Fatty acid synthetase"], "html_options": ["HMG-CoA synthase", "Malic enzyme", "Malonyl-CoA synthetase", "Fatty acid synthetase"], "corr_idx": 1}, {"id": "1180449", "html_qtxt": "Acetyl-CoA Carboxylase is activated by:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Acetyl-CoA carboxylase is an <strong>allosteric enzyme</strong> and is <strong>activated by citrate</strong>, which:\n<ul>\n<li>Increases in concentration in the <strong>well-fed state</strong></li>\n<li>It is an indicator of a <strong>plentiful supply of acetyl-CoA</strong></li>\n<li>Promotes conversion of the enzyme from an <strong>inactive dimer</strong> to an <strong>active polymeric form</strong> (molecular mass: several million)</li>\n</ul>\n</li>\n<li>Acetyl-CoA Carboxylase is the most important enzyme in the <strong>regulation of lipogenesis.</strong></li>\n</ul>\n<p><strong>Inactivation is promoted by:</strong></p>\n<ul>\n<li><strong>Phosphorylation</strong> of the enzyme</li>\n<li><strong>Long-chain acyl-CoA molecules</strong> (e.g., <strong>Palmitoyl CoA</strong>): negative feedback inhibition by a product of the reaction</li>\n<li><strong>Acyl-CoA</strong> also inhibits the <strong>mitochondrial tricarboxylate transporter</strong>, preventing citrate egress and enzyme activation.</li>\n</ul>\n<p><strong>Hormonal regulation:</strong></p>\n<ul>\n<li><strong>Glucagon, epinephrine</strong>: inhibit via <strong>phosphorylation</strong></li>\n<li><strong>Insulin</strong>: activates via <strong>dephosphorylation</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Malonyl-CoA (Option A):</strong> <strong>Malonyl-CoA</strong> is the product of the reaction catalysed by ACC, not its activator.</p>\n<p><strong>Palmitoyl-CoA (Option C):</strong> <strong>Palmitoyl-CoA</strong> is a <strong>long-chain fatty acyl-CoA</strong> that <strong>inhibits ACC</strong> by negative feedback.</p>\n<p><strong>Acetoacetate (Option D):</strong> <strong>Acetoacetate</strong> is a <strong>ketone body</strong> and does not play a role in the regulation of ACC.</p>", "options": ["Malonyl CoA", "Citrate", "Palmitoyl CoA", "Acetoacetate"], "html_options": ["Malonyl CoA", "Citrate", "Palmitoyl CoA", "Acetoacetate"], "corr_idx": 1}, {"id": "1180451", "html_qtxt": "The subcellular site of the breakdown of long-chain fatty acids to acetyl-CoA via beta-oxidation is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The <strong>subcellular site</strong> of &beta;-oxidation of long-chain fatty acids to acetyl-CoA is the <strong>mitochondrial matrix</strong>.</p>\n<ul>\n<li><strong>Carnitine-acyl carnitine translocase</strong> binds <strong>acyl carnitine</strong> and transports it across the inner mitochondrial membrane <strong>in exchange for carnitine</strong>.</li>\n<li>The <strong>acyl group</strong> is then transferred to <strong>CoA</strong> to reform <strong>acyl-CoA</strong>, and <strong>carnitine is liberated</strong>.</li>\n<li>This reaction is catalysed by <strong>carnitine palmitoyl transferase-II (CPT-II)</strong>, which is located <strong>on the inner side of the inner mitochondrial membrane</strong>.</li>\n</ul>\n<p>Thus, the &beta;-oxidation spiral proceeds inside the <strong>mitochondrial matrix</strong>, where acyl-CoA is sequentially cleaved to form <strong>acetyl-CoA</strong> units.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cytosol (Option A) </strong>is the site of fatty acid synthesis, not &beta;-oxidation.</p>\n<p><strong>Endoplasmic reticulum (Option C) </strong>is involved in fatty acid elongation and desaturation.</p>\n<p><strong>Mitochondrial intermembrane space (Option D) </strong>is involved in electron transport chain processes.</p>", "options": ["The cytosol", "The matrix of the mitochondria", "The endoplasmic reticulum", "The mitochondrial intermembrane space"], "html_options": ["The cytosol", "The matrix of the mitochondria", "The endoplasmic reticulum", "The mitochondrial intermembrane space"], "corr_idx": 1}, {"id": "1180452", "html_qtxt": "The breakdown of one molecule of a C16 fully saturated fatty acid (palmitic acid) by &beta;-oxidation leads to the formation of:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The breakdown of palmitic acid (C16) requires 7 cycles of &beta;-oxidation, each producing 1 FADH2 and 1 NADH molecule and results in the formation of eight 2C acetyl-CoA molecules.</li>\n<li>Oxidation of Fatty Acids Produces a Large Quantity of ATP.</li>\n<li>Transport of electrons from FADH2 and NADH via the respiratory chain leads to the synthesis of 4 high-energy phosphates for each of the seven cycles needed for the breakdown of the C16 fatty acid, palmitate, to acetyl-CoA (7 &times; 4 = 28).</li>\n<li>A total of 8 mol of acetyl-CoA is formed, and each gives rise to 10 mol of ATP on oxidation in the citric acid cycle, making 8 &times; 10 = 80 mol. Two must be subtracted for the initial activation of the fatty acid, yielding a <strong>net gain of 106 mol of ATP </strong>per mole of palmitate.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829bf5bf-3984-450c-85e3-0105fe961e87.png\">", "options": ["8 FADH2, 8 NADH and 8 acetyl-CoA molecules", "8 FADH2, 8 NADH and 7 acetyl-CoA molecules", "7 FADH2, 8 NADH and 8 acetyl-CoA molecules", "7 FADH2, 7 NADH and 8 acetyl-CoA molecules"], "html_options": ["8 FADH2, 8 NADH and 8 acetyl-CoA molecules", "8 FADH2, 8 NADH and 7 acetyl-CoA molecules", "7 FADH2, 8 NADH and 8 acetyl-CoA molecules", "7 FADH2, 7 NADH and 8 acetyl-CoA molecules"], "corr_idx": 3}, {"id": "1180454", "html_qtxt": "Number of ATP formed by oxidation of one molecule of palmitic acid (16 C):", "html_expl": "<p><strong>Explanation</strong>:</p>\r\n<ul>\r\n<li>The <strong>oxidation of palmitic acid (C16)</strong> involves multiple cycles of <strong>&beta;-oxidation</strong>, each producing <strong>FADH2, NADH,</strong> and <strong>acetyl-CoA</strong>, ultimately leading to ATP production.</li>\r\n<li>The number of &beta;-oxidation cycles = <strong>(n/2) - 1,</strong> where <strong>n = number of carbon atoms</strong>.</li>\r\n<li>For <strong>palmitic acid (16C)</strong>: <strong>(16/2) - 1 = 7 cycles</strong>.</li>\r\n</ul>\r\n<p>Each cycle produces:</p>\r\n<ul>\r\n<li><strong>1 FADH2</strong> (7 total)</li>\r\n<li><strong>1 NADH</strong> (7 total)</li>\r\n<li>Each cycle cleaves <strong>2C units</strong> as acetyl-CoA.</li>\r\n<li>Total <strong>acetyl-CoA molecules = 8</strong> (from 16 carbons).</li>\r\n</ul>\r\n<p><strong>ATP Yield:</strong></p>\r\n<ul>\r\n<li>From <strong>7 FADH2</strong> &rarr; 7 &times; 1.5 ATP = <strong>5 ATP</strong></li>\r\n<li>From <strong>7 NADH</strong> &rarr; 7 &times; 2.5 ATP = <strong>5 ATP</strong></li>\r\n<li>From <strong>8 acetyl-CoA</strong> (TCA cycle) &rarr; 8 &times; 10 ATP = <strong>80 ATP</strong></li>\r\n</ul>\r\n<p>Total ATP before activation = 10.5 + 17.5 + 80 = <strong>108 ATP</strong></p>\r\n<ul>\r\n<li>Subtract <strong>2 ATP</strong> for activation of palmitate &rarr; <strong>Net ATP = 106 ATP</strong></li>\r\n</ul>", "options": ["146", "106", "135", "34"], "html_options": ["146", "106", "135", "34"], "corr_idx": 1}, {"id": "1180456", "html_qtxt": "Beta Oxidation in the Peroxisome generates:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Peroxisomes oxidise <strong>very long-chain fatty acids</strong> (e.g., C20, C22) through a <strong>modified form of &beta;-oxidation</strong>.</li>\n<li>This process results in the formation of <strong>acetyl-CoA</strong> and <strong>H<sub>2</sub>O<sub>2</sub></strong> (produced in the <strong>flavoprotein-linked dehydrogenase step</strong>), which is subsequently broken down by <strong>catalase</strong>.</li>\n<li>Unlike mitochondrial &beta;-oxidation, <strong>peroxisomal dehydrogenation is not linked to ATP generation via oxidative phosphorylation</strong>. Instead, this system prepares fatty acids for further oxidation in mitochondria by <strong>shortening them</strong>, typically ending at <strong>octanoyl-CoA</strong>.</li>\n<li>Other functions of peroxisomes include:\n<ul>\n<li><strong>Shortening of the cholesterol side chain</strong> in <strong>bile acid formation</strong></li>\n<li><strong>Synthesis</strong> of <strong>ether glycerolipids</strong>, <strong>cholesterol</strong>, and <strong>dolichol</strong></li>\n<li>Peroxisomal &beta;-oxidation enzymes are <strong>induced by high-fat diets</strong> and, in some species, by <strong>hypolipidemic drugs</strong> such as <strong>clofibrate</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>NADPH (Option A)</strong> is not produced in peroxisomal &beta;-oxidation.</p>\n<p><strong>Long-chain fatty acids (Option C)</strong> are the <strong>substrates</strong>, not products, of peroxisomal oxidation.</p>\n<p><strong>FADH<sub>2</sub> (Option D):</strong> Unlike mitochondrial &beta;-oxidation, peroxisomal dehydrogenation does not yield FADH<sub>2</sub>.</p>", "options": ["NADPH", "H2O2", "Long-chain fatty acid", "FADH<sub>2</sub>"], "html_options": ["NADPH", "H2O2", "Long-chain fatty acid", "FADH<sub>2</sub>"], "corr_idx": 1}, {"id": "1180459", "html_qtxt": "Malonyl CoA, the first intermediate in fatty acid synthesis, is an important regulator of fatty acid metabolism because:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Malonyl CoA</strong>, the first intermediate in fatty acid synthesis, plays a crucial regulatory role in fatty acid metabolism.</li>\n<li>Its formation from <strong>acetyl-CoA and bicarbonate</strong> by the enzyme <strong>acetyl-CoA carboxylase</strong> represents the <strong>rate-limiting step in lipogenesis</strong>.</li>\n<li>Importantly, <strong>malonyl-CoA inhibits carnitine palmitoyl transferase-I (CPT-I)</strong>, the enzyme responsible for transporting <strong>fatty acyl-CoA into the mitochondrial matrix</strong>.</li>\n<li>When <strong>CPT-I is inhibited</strong>, fatty acyl groups <strong>cannot enter the mitochondria</strong>, and thus, <strong>&beta;-oxidation is blocked</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Its formation from acetyl-CoA and bicarbonate by the enzyme acetyl-CoA carboxylase is the main rate-limiting step in fatty acid synthesis</strong> <strong>(Option A): </strong>Although the formation of malonyl-CoA is indeed the <strong>rate-limiting step of fatty acid synthesis</strong>, this option does not explain the <strong>regulatory effect on fatty acid oxidation</strong>.</p>\n<p><strong>It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitine palmitoyl transferase-II</strong> <strong>(Option C):</strong> Malonyl-CoA specifically inhibits <strong>CPT-I</strong>, not <strong>CPT-II</strong>, which operates inside the mitochondria after the initial transport.</p>\n<p><strong>It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitineacylcarnitine translocase</strong> <strong>(Option D):</strong> Malonyl-CoA does not inhibit <strong>carnitine acylcarnitine translocase</strong>; the key regulatory target is <strong>CPT-I</strong>.</p>\n<p><strong>Note:</strong></p>\n<ul>\n<li>The regulation of fatty acid oxidation by malonyl-CoA plays an important role in conditions such as fasting, diabetes, and metabolic syndrome, where energy substrate switching between carbohydrates and fats is crucial.</li>\n<li>Dysregulation of this pathway can contribute to insulin resistance and other metabolic complications.</li>\n</ul>", "options": ["Its formation from acetyl-CoA and bicarbonate by the enzyme acetyl-CoA carboxylase is the main rate-limiting step in fatty acid synthesis.", "It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitine palmitoyl transferase-I.", "It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitine palmitoyl transferase-II.", "It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitineacylcarnitine translocase."], "html_options": ["Its formation from acetyl-CoA and bicarbonate by the enzyme acetyl-CoA carboxylase is the main rate-limiting step in fatty acid synthesis.", "It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitine palmitoyl transferase-I.", "It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitine palmitoyl transferase-II.", "It prevents entry of fatty acyl groups into the matrix of the mitochondria because it is a potent inhibitor of carnitineacylcarnitine translocase."], "corr_idx": 1}]}, {"moduleId": 1008723, "name": "Lipoproteins And Lipid Storage Disorders", "questions": [{"id": "1169862", "html_qtxt": "Lipoproteins consist of:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Lipoproteins consist of <strong>non-polar lipids and amphipathic lipids</strong>. Since <strong>lipids are insoluble in water</strong>, their transport in the blood is facilitated by the formation of <strong>lipoproteins</strong>, which are water-miscible.</li>\n<li>The <strong>non-polar lipids</strong>, such as <strong>triacylglycerol and cholesterol esters</strong>, are sequestered in the core of the lipoprotein.</li>\n<li>These are surrounded by <strong>amphipathic lipids</strong>, including <strong>phospholipids and cholesterol</strong>, which form a surface monolayer that makes the complex <strong>soluble in the aqueous environment</strong> of plasma.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Polar lipids and amphipathic lipids (Option A):</strong> Polar lipids are not the primary core content of lipoproteins; the core is made up of <strong>non-polar lipids</strong>.</p>\n<p><strong>Polar lipids and amphipathic lipids</strong> <strong>(Option C):</strong> The term <strong>amphiphobic lipids</strong> is not biochemically accurate; the correct term is <strong>amphipathic lipids</strong>.</p>\n<p><strong>Non-polar lipids and amphipathic lipids (Option D):</strong> Though non-polar lipids are correct, the term <strong>amphiphobic</strong> is incorrect.</p>", "options": ["Polar lipids and amphipathic lipids", "Non-polar lipids and amphipathic lipids", "Polar lipids and amphipathic lipids", "Non-polar lipids and amphipathic lipids"], "html_options": ["Polar lipids and amphipathic lipids", "Non-polar lipids and amphipathic lipids", "Polar lipids and amphipathic lipids", "Non-polar lipids and amphipathic lipids"], "corr_idx": 1}, {"id": "1169865", "html_qtxt": "Lipoproteins mediate the transport of lipids from the intestine and liver to tissues by?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Chylomicrons</strong> transport <strong>dietary lipids</strong> (mainly triacylglycerols) absorbed from the <strong>intestine</strong> to peripheral tissues.</li>\n<li><strong>VLDL (Very Low-Density Lipoprotein)</strong> transports <strong>endogenously synthesised lipids</strong>, mainly triacylglycerols, from the <strong>liver</strong> to peripheral tissues.</li>\n<li>These lipoproteins contain a core of <strong>non-polar lipids</strong> (triacylglycerol and cholesteryl esters) surrounded by a monolayer of <strong>amphipathic lipids</strong> (phospholipids and cholesterol) and <strong>apolipoproteins</strong>, enabling their <strong>aqueous solubility</strong> in plasma.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Chylomicrons and LDL (Option A):</strong> LDL primarily transports <strong>cholesterol</strong> to peripheral tissues, not triacylglycerols.</p>\n<p><strong>Chylomicrons and HDL (Option B):</strong> HDL mediates <strong>reverse cholesterol transport</strong> from peripheral tissues to the liver.</p>\n<p><strong>Chylomicrons and IDL (Option D):</strong> IDL is a transient product formed during VLDL degradation and is not a major transporter.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Defects in chylomicron metabolism (e.g., <strong>Type I hyperlipoproteinemia</strong>) or VLDL metabolism (e.g., <strong>Type IIb</strong>) lead to <strong>hyperlipidemias</strong>.</li>\n<li>Measurement of lipoproteins is essential in assessing <strong>cardiovascular risk</strong>.</li>\n</ul>", "options": ["Chylomicrons and LDL", "Chylomicrons and HDL", "Chylomicrons and VLDL", "Chylomicrons and IDL"], "html_options": ["Chylomicrons and LDL", "Chylomicrons and HDL", "Chylomicrons and VLDL", "Chylomicrons and IDL"], "corr_idx": 2}, {"id": "1169882", "html_qtxt": "The apoprotein responsible for the transport of the lipoprotein from the plasma into the liver is?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The apoprotein responsible for <strong>remnant uptake</strong> by the <strong>liver</strong> is <strong>Apo-E</strong>.</li>\n<li>It facilitates the <strong>transport of lipoproteins from the plasma into the liver</strong>.</li>\n<li>Apo-E is <strong>stored in HDL</strong> and is <strong>transferred into lipoproteins</strong> (such as chylomicron remnants and IDL) when needed.</li>\n<li>Notably, <strong>Apo-E is present on all lipoproteins except LDL</strong>.</li>\n<li><strong>Deficiency or mutations</strong> in Apo-E (e.g., <strong>ApoE2 homozygosity</strong>) can lead to <strong>familial dysbetalipoproteinemia</strong>, characterised by remnant accumulation and premature atherosclerosis.</li>\n<li>Apo-E polymorphisms (E2, E3, E4) have implications in both <strong>lipid metabolism</strong> and <strong>neurological diseases</strong> (e.g., ApoE4 in Alzheimer's).</li>\n</ul>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509013319a1ce-ffdd-40af-95ab-695f3e19a010.png\">", "options": ["Apo-E", "Apo-C", "Apo-A", "Apo-B"], "html_options": ["Apo-E", "Apo-C", "Apo-A", "Apo-B"], "corr_idx": 0}, {"id": "1169888", "html_qtxt": "False regarding the different lipases involved in lipid metabolism?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Lipoprotein lipase degrades TGs in circulating Chylomicrons and VLDLs in the Hepatic endothelium is <strong>false</strong> because <strong>lipoprotein lipase (LPL)</strong> is located in the <strong>vascular endothelium</strong> of <strong>extrahepatic tissues</strong> such as <strong>muscle</strong> and <strong>adipose tissue</strong>, <strong>not the hepatic endothelium</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509010a180bd7-4d36-44ba-89aa-a7b901c7b96e.png\">\n<p><strong>Key takeaways:</strong></p>\n<ul>\n<li><strong>Defects in lipoprotein lipase</strong> can cause <strong>Type I hyperlipoproteinemia</strong>, leading to elevated chylomicrons and severe hypertriglyceridemia.</li>\n<li><strong>Hepatic lipase deficiency</strong> can impair the conversion of IDL to LDL and affect cholesterol transport.</li>\n<li>Pancreatic lipase insufficiency (e.g., in chronic pancreatitis) causes <strong>fat malabsorption</strong> and <strong>steatorrhea</strong>.</li>\n</ul>", "options": ["Hepatic lipase degrades TGs in IDL", "Hormone-sensitive lipase degrades TGs in adipocytes", "Lipoprotein lipase degrades TGs in circulating Chylomicrons and VLDLs in the Hepatic endothelium", "Pancreatic lipase degrades TGs in the small intestine"], "html_options": ["Hepatic lipase degrades TGs in IDL", "Hormone-sensitive lipase degrades TGs in adipocytes", "Lipoprotein lipase degrades TGs in circulating Chylomicrons and VLDLs in the Hepatic endothelium", "Pancreatic lipase degrades TGs in the small intestine"], "corr_idx": 2}, {"id": "1169900", "html_qtxt": "Which of the following statements regarding HDL is true?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>HDL</strong> expresses <strong>Class B Scavenger Receptor B1 (SR-B1)</strong>.</li>\n<li>It has a <strong>dual function</strong> in HDL metabolism:\n<ol>\n<li><strong>Cholesterol Uptake</strong>: In the <strong>liver</strong> and <strong>steroidogenic tissues</strong>, SR-B1 binds HDL via <strong>Apo-A1</strong>, facilitating the delivery of cholesterol to these tissues.</li>\n<li><strong>Reverse Cholesterol Transport</strong>: SR-B1 also mediates the uptake of <strong>effluxed cholesterol</strong> from peripheral tissues into HDL, which is then transported to the liver and <strong>excreted in bile</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509019c34954c-7776-4834-90dd-a7ee430197b6.png\"></li>\n</ol>\n</li>\n</ul>\n<h3><strong>Reverse Cholesterol Transport Components:</strong></h3>\n<ul>\n<li><strong>ABCA1</strong>: Facilitates cholesterol efflux to lipid-poor Apo-A1</li>\n<li><strong>ABCG1</strong>: Transfers cholesterol to mature HDL</li>\n<li><strong>LCAT</strong>: Converts cholesterol to cholesteryl ester</li>\n<li><strong>CE</strong>: Cholesterol ester</li>\n<li><strong>PL</strong>: Phospholipid</li>\n<li><strong>Apo-A1</strong>: Key HDL apolipoprotein.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>HDL is synthesised in the liver only (Option A):</strong> HDL is synthesised <strong>in both the liver and the intestine</strong>, not the liver alone.</p>\n<p><strong>Apo-C and Apo-E are synthesised in the liver and intestine (Option B):</strong> <strong>Apo-E and Apo-C</strong> are synthesised <strong>only in the liver</strong>, not both liver and intestine.</p>\n<p><strong>HDL is required for the metabolism of Chylomicrons only (Option C):</strong> HDL is required for the metabolism of <strong>both chylomicrons and VLDL</strong>, not just chylomicrons.</p>", "options": ["HDL is synthesised in the liver only", "Apo-C and Apo-E are synthesised in the liver and the intestine", "HDL is required for the metabolism of Chylomicrons only", "Scavenger receptors are present on HDL"], "html_options": ["HDL is synthesised in the liver only", "Apo-C and Apo-E are synthesised in the liver and the intestine", "HDL is required for the metabolism of Chylomicrons only", "Scavenger receptors are present on HDL"], "corr_idx": 3}, {"id": "1169936", "html_qtxt": "All are true regarding lipoprotein (a) except?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Structurally</strong>,<strong> Lp(a)</strong> is <strong>nearly identical to LDL</strong>. <strong>(Option C)</strong>\n<ul>\n<li>Its distinguishing feature is the <strong>presence of an additional apolipoprotein molecule, apo(a)</strong>.</li>\n<li>This <strong>apo(a)</strong> is <strong>covalently linked</strong> at a <strong>single site</strong> to <strong>apo B-100</strong>, <strong>not Apo B-48</strong>.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Lipoprotein (a) [Lp(a)]</strong> is a <strong>lipoprotein particle</strong> that, when present in large amounts in the plasma, is associated with an <strong>increased risk of coronary heart disease (CHD)</strong>. <strong>(Option A)</strong></li>\n<li><strong>Genetics</strong> primarily determines circulating Lp(a) levels. However, dietary factors can have some influence:\n<ul>\n<li><strong>&uarr; Lp(a):</strong> Trans fatty acids</li>\n<li><strong>&darr; Lp(a):</strong> Omega-3 fatty acids</li>\n</ul>\n</li>\n<li><strong>Apo(a)</strong> is <strong>structurally homologous to plasminogen</strong>, the <strong>precursor of plasmin</strong>, which breaks down fibrin in clots.</li>\n<li>Therefore, elevated Lp(a) <strong>competes with plasminogen</strong>, possibly <strong>slowing fibrin breakdown</strong>, contributing to atherothrombosis.</li>\n<li><strong>The exact physiological role of Lp(a)</strong> remains <strong>unknown</strong>.</li>\n<li><strong>Niacin</strong> (vitamin B3):\n<ul>\n<li><strong>&darr; Lp(a) (Option D)</strong></li>\n<li><strong>&darr; LDL-cholesterol & TAGs</strong></li>\n<li><strong>&uarr; HDL</strong></li>\n</ul>\n</li>\n</ul>", "options": ["When present in large quantities can cause coronary heart disease", "Has an extra apo(a) molecule attached to Apo B-48", "Lp(a) is structurally related to LDL", "Niacin reduces Lp(a)"], "html_options": ["When present in large quantities can cause coronary heart disease", "Has an extra apo(a) molecule attached to Apo B-48", "Lp(a) is structurally related to LDL", "Niacin reduces Lp(a)"], "corr_idx": 1}, {"id": "1169938", "html_qtxt": "The lipoprotein that moves the fastest towards the anode is?", "html_expl": "<p><strong>Explanation for answer </strong>:</p>\n<ul>\n<li>The placement of the lipoproteins in electrophoresis depends on the <strong>charge</strong> and <strong>mass</strong> of the lipoproteins. The <strong>higher the protein content,</strong> the <strong>faster the lipoprotein moves.</strong></li>\n<li>In this aspect, <strong>HDL</strong> travels the <strong>fastest</strong> and <strong>towards</strong> <strong>the anode,</strong> and Chylomicrons remain at the origin.</li>\n<li>Lipoprotein electrophoresis is useful in evaluating <strong>dyslipidemias</strong> and <strong>lipoprotein disorders</strong>.</li>\n</ul>\n<p>The sequence in electrophoresis is as follows:</p>\n<ul>\n<li>Chylomicrons are the <strong>largest and least dense</strong> lipoproteins with <strong>minimal protein content</strong>; thus, they migrate the <strong>slowest</strong>. <strong>(Option A ruled out)</strong></li>\n<li>VLDL has <strong>intermediate protein content</strong>, migrates more slowly than HDL but faster than chylomicrons. <strong>(Option B ruled out)</strong></li>\n<li>LDL has <strong>less protein than HDL</strong> and therefore migrates <strong>more slowly</strong>. <strong>(Option D ruled out)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901cf5f27ed-b8ec-4f7a-8443-56e720cf6bfc.png\">", "options": ["Chylomicron", "VLDL", "HDL", "LDL"], "html_options": ["Chylomicron", "VLDL", "HDL", "LDL"], "corr_idx": 2}, {"id": "1169940", "html_qtxt": "The process of formation of Apo-B48 from Apo-B is by?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The process of formation of <strong>Apo B-48</strong> from <strong>Apo B</strong> occurs through <strong>RNA editing</strong>.</li>\n<li>This is a <strong>post-transcriptional modification</strong> where a <strong>cytidine (C)</strong> is <strong>deaminated to uridine (U)</strong> in the <strong>mRNA</strong> of the <strong>apo B gene</strong> in <strong>intestinal cells</strong>.</li>\n<li>As a result, a <strong>premature stop codon</strong> is introduced, leading to the production of a <strong>shorter protein</strong>, <strong>Apo B-48</strong>, instead of the full-length <strong>Apo B-100</strong> (which is produced in the liver).</li>\n<li>ApoB-48 is synthesised in the <strong>intestine</strong>, whereas ApoB-100 is produced in the</li>\n<li><strong>ApoB-48 is a structural component of chylomicrons, while ApoB-100 is found in VLDL, IDL, and LDL.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>RNA splicing (Option A): </strong>RNA splicing removes introns from pre-mRNA but does <strong>not</strong> result in the formation of ApoB-48.</p>\n<p><strong>RNA silencing</strong> <strong>(Option C): </strong>RNA silencing refers to gene expression inhibition via mechanisms such as siRNA or miRNA; not relevant to ApoB processing.</p>\n<p><strong>RNA pre-translational modification</strong> <strong>(Option D): </strong>This is a vague and non-standard term; the correct mechanism is <strong>RNA editing</strong>.</p>", "options": ["RNA splicing", "RNA editing", "RNA silencing", "RNA pre-translational modification"], "html_options": ["RNA splicing", "RNA editing", "RNA silencing", "RNA pre-translational modification"], "corr_idx": 1}, {"id": "1169943", "html_qtxt": "Which among the following is the largest lipoprotein?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Among the lipoproteins, <strong>chylomicrons are the largest</strong>, and <strong>HDL is the smallest</strong>.</li>\n<li>Lipoproteins differ in size, density, and protein/lipid composition.</li>\n<li>The <strong>relative size order</strong> from largest to smallest is:<br /> <strong>Chylomicron > Chylomicron remnant > VLDL > LDL > HDL</strong></li>\n<li>The large size of chylomicrons correlates with their function of transporting <strong>dietary triglycerides</strong> from the intestine to peripheral tissues.</li>\n</ul>", "options": ["Chylomicron", "Chylomicron remnant", "VLDL", "LDL"], "html_options": ["Chylomicron", "Chylomicron remnant", "VLDL", "LDL"], "corr_idx": 0}, {"id": "1169949", "html_qtxt": "Characteristics of Familial hyperlipoproteinemia?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Type IIa Hyperlipoproteinemia</strong> (Familial Hypercholesterolemia) is also known as <strong>Autosomal Dominant Hypercholesterolemia</strong>.</li>\n<li>It is an <strong>autosomal dominant disorder</strong> caused by <strong>mutations in the LDL receptor gene</strong>, leading to defective or absent LDL receptors.</li>\n<li>As a result, <strong>LDL clearance is impaired</strong>, causing the <strong>accumulation of LDL in plasma</strong>.</li>\n<li><strong>Homozygotes</strong> have <strong>2 defective alleles</strong>, resulting in <strong>extremely elevated LDL and total cholesterol levels</strong>, ranging from <strong>500-1,200 mg/dL</strong>.</li>\n<li><strong>Triglyceride levels</strong>: Normal to mildly elevated</li>\n<li><strong>HDL levels</strong>: May be slightly decreased.</li>\n</ul>\n<p><strong>Genes implicated in Type IIa Familial Hypercholesterolemia:</strong></p>\n<ul>\n<li><strong>LDLR gene</strong> mutation (the most common cause)</li>\n</ul>\n<p>Other less common causes:</p>\n<ul>\n<li><strong>APOB gene</strong> <strong>(ApoB-100)</strong> mutation - affects binding to LDL receptor</li>\n<li><strong>PCSK9 gain-of-function</strong> mutation - enhances LDL receptor degradation</li>\n</ul>\n<h3><strong>Clinical Features:</strong></h3>\n<ul>\n<li><strong>Receptor-negative patients</strong>: <2% normal LDL receptor activity</li>\n<li><strong>Receptor-defective patients</strong>: Up to 25% normal activity &rarr; Better prognosis</li>\n<li><strong>Presentation</strong>:\n<ul>\n<li><strong>Premature coronary artery disease (CAD)</strong></li>\n<li><strong>Corneal arcus</strong></li>\n<li><strong>Tendon xanthomas</strong> - Especially at the <strong>Achilles tendon</strong>, <strong>hands</strong>, <strong>elbows</strong>, <strong>knees</strong>, and <strong>buttocks</strong></li>\n<li><strong>Strong family history</strong> of <strong>premature CAD</strong> and <strong>sudden cardiac death.</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Complications:</strong></p>\n<ul>\n<li><strong>Premature coronary artery disease (CAD)</strong></li>\n<li><strong>Tendon xanthomas (Achilles tendon, elbows, knees)</strong></li>\n<li><strong>Corneal arcus</strong></li>\n</ul>\n<p><strong>Genetic pattern:</strong></p>\n<ul>\n<li><strong>Receptor-negative FH: <2% receptor activity &rarr; severe disease</strong></li>\n<li><strong>Receptor-defective FH: 2-25% receptor activity &rarr; better prognosis<br /> </strong></li>\n</ul>", "options": ["Low LDL and low cholesterol", "High LDL and low cholesterol", "High  LDL and high cholesterol", "Low LDL and High cholesterol"], "html_options": ["Low LDL and low cholesterol", "High LDL and low cholesterol", "High  LDL and high cholesterol", "Low LDL and High cholesterol"], "corr_idx": 2}, {"id": "1169952", "html_qtxt": "Which of the following is false about type 3 hyperlipoproteinemia?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Type III Hyperlipoproteinemia</strong> is also called <strong>familial dysbetalipoproteinemia</strong>, <strong>remnant removal disease</strong>, or <strong>broad beta disease</strong>.<strong> (Option A)</strong></li>\n<li>It is caused by a <strong>mutation in the Apo-E gene</strong>, which is essential for hepatic uptake of chylomicron remnants and IDL. <strong>(Option B)</strong></li>\n<li>The mutation impairs remnant clearance, leading to the <strong>accumulation of chylomicron remnants and VLDL</strong>, resulting in <strong>mixed hyperlipidemia</strong>. <strong>(Option C)</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901239f669c-99de-44e0-b5b4-c143b4fae29d.png\">", "options": ["A/K/A familial dysbetalipoproteinemia/Familial broad beta disease", "Mutation of the Apo-E gene", "Chylomicron remnant and VLDL are elevated", "None of the above"], "html_options": ["A/K/A familial dysbetalipoproteinemia/Familial broad beta disease", "Mutation of the Apo-E gene", "Chylomicron remnant and VLDL are elevated", "None of the above"], "corr_idx": 3}, {"id": "1169953", "html_qtxt": "A young child presents with diarrhoea, pigmentary retinopathy and bleeding manifestations. On closer examination, there is failure to thrive, blood reports show acanthocytosis and decreased LDL, VLDL and Chylomicron levels. Defect of which gene is the probable cause?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical presentation described (failure to thrive, diarrhea, pigmentary retinopathy, acanthocytosis, and reduced LDL/VLDL/chylomicrons) is classic for <strong>abetalipoproteinemia</strong>, which is due to a mutation in the <strong>microsomal triglyceride transfer protein (MTP)</strong> gene, which is necessary for the <strong>transfer of lipids to nascent chylomicrons in the small intestine and VLDL in the liver</strong>.</li>\n<li>This defect leads to the <strong>absence of chylomicrons, VLDL, LDL, and ApoB</strong>, and results in <strong>very low plasma cholesterol and triglyceride levels</strong>.</li>\n</ul>\n<p><strong>Clinical features</strong> include:</p>\n<ul>\n<li><strong>Fat malabsorption</strong>, chronic <strong>diarrhoea</strong>, and <strong>failure to thrive</strong> in early childhood</li>\n<li><strong>Acanthocytosis</strong> is seen on the peripheral smear</li>\n<li><strong>Pigmentary retinopathy</strong> causes progressive <strong>night and colour blindness</strong>, potentially leading to <strong>complete blindness</strong></li>\n<li><strong>Neurological manifestations</strong> (spinocerebellar degeneration) due to <strong>vitamin E deficiency</strong>, including <strong>loss of deep tendon reflexes</strong>, <strong>ataxia</strong>, and <strong>lower limb spasticity</strong> developing over time</li>\n</ul>\n<ul>\n<li>The <strong>neurologic symptoms and retinopathy</strong> may mimic <strong>Friedreich's ataxia</strong>, but the <strong>presence of fat malabsorption and acanthocytosis</strong> helps differentiate it.</li>\n<li>These clinical manifestations primarily result from <strong>malabsorption of fat-soluble vitamins</strong>, especially <strong>vitamins E, A, and K</strong>.</li>\n<li>Early and continuous <strong>vitamin E supplementation</strong> may <strong>significantly slow neurologic deterioration</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>MTP - Tangier's disease (Option A): </strong>MTP mutations cause <strong>abetalipoproteinemia</strong>, not Tangier&rsquo;s disease.</p>\n<p><strong>ABCA1 - Tangier's disease (Option B):</strong> ABCA1 mutation causes <strong>Tangier&rsquo;s disease</strong>, characterised by absent HDL but <strong>not</strong> low chylomicrons or VLDL.</p>\n<p><strong>ABCA1 - Abetalipoproteinemia (Option D):</strong> ABCA1 is not involved in chylomicron or VLDL metabolism; hence, this does not cause abetalipoproteinemia.</p>", "options": ["MTP-Tangier's disease", "ABCA1 - Tangier's disease", "MTP- abetalipoproteinemia", "ABCA1- abetalipoproteinemia"], "html_options": ["MTP-Tangier's disease", "ABCA1 - Tangier's disease", "MTP- abetalipoproteinemia", "ABCA1- abetalipoproteinemia"], "corr_idx": 2}, {"id": "1169954", "html_qtxt": "Match the apoprotein with the lipoprotein:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090180bb361b-10ba-4c76-95d4-1ce232ab7288.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The apoproteins present in the lipoproteins are as follows:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901f8d1fc1e-adc6-4b0f-8b21-58b19b230028.png\">\n<ul>\n<li><strong>Apo B-48</strong> - specific to <strong>chylomicrons</strong></li>\n<li><strong>Apo B-100</strong> - found in <strong>VLDL</strong> and <strong>LDL</strong></li>\n<li><strong>Apo A and Apo E</strong> are prominent in <strong>HDL</strong></li>\n</ul>", "options": ["a-1,b-2,c-3,d-4", "a-4,b-3,c-1,d-2", "a-4,b-3,c-2,d-1", "a-1,b-3,c-2,d-4"], "html_options": ["a-1,b-2,c-3,d-4", "a-4,b-3,c-1,d-2", "a-4,b-3,c-2,d-1", "a-1,b-3,c-2,d-4"], "corr_idx": 2}, {"id": "1169999", "html_qtxt": "Which among the following is not a saturated fatty acid?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Saturated fatty acids</strong> are those that do not have a double bond.</li>\n<li>They include <strong>palmitate</strong>, <strong>stearic</strong>, <strong>butyric</strong>, acetic, caproic, and valeric acids, etc.</li>\n</ul>\n<p><strong>(Options A, B and C ruled out)</strong></p>\n<ul>\n<li><strong>Unsaturated</strong> fatty acids are those with the presence of <strong>double bonds</strong>. They can be divided into:\n<ul>\n<li><strong>Monounsaturated fats:</strong> contain one double bond. eg, <strong>oleic acid</strong></li>\n<li><strong>Polyunsaturated fats:</strong> those with more than one double bond. E.g., linoleic acid, arachidonic acid</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509014a6a5f59-f463-452f-a3a1-ed1af80f1cef.png\">", "options": ["Butyrate acid", "Palmitic acid", "Stearic acid", "Oleic acid"], "html_options": ["Butyrate acid", "Palmitic acid", "Stearic acid", "Oleic acid"], "corr_idx": 3}, {"id": "1170006", "html_qtxt": "Match the apolipoproteins with their respective function:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090159e3aa5a-0883-49b2-872e-fce9e6c19821.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The correct matching is based on well-established roles of the apolipoproteins:</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901681d5007-8a6e-4a13-9692-36cfcba480f2.png\">", "options": ["1-A, 2-B, 3-C, 4-D, 5-E, 6-F", "1-D, 2-E, 3-C, 4-F, 5-B, 6-A", "1-F, 2-E, 3-C, 4-D, 5-A, 6-B", "1-E, 2-D, 3-F, 4-C, 5-A, 6-B"], "html_options": ["1-A, 2-B, 3-C, 4-D, 5-E, 6-F", "1-D, 2-E, 3-C, 4-F, 5-B, 6-A", "1-F, 2-E, 3-C, 4-D, 5-A, 6-B", "1-E, 2-D, 3-F, 4-C, 5-A, 6-B"], "corr_idx": 1}, {"id": "1191013", "html_qtxt": "The following are the features of Refsum's disease except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Refsum's Disease</strong></p>\n<ul>\n<li><strong>Rare autosomal recessive disorder due to a defect in Alpha oxidation of Phytanic Acid</strong>(Phytanic Acid Oxidase) <strong>(phytanoyl CoA hydroxylase) </strong>in the Peroxisome. This leads to the <strong>accumulation of phytanic acid</strong>. <strong>(Option B)</strong></li>\n<li>The manifestation of classic Refsum's Disease includes impaired vision from <strong>retinitis pigmentosa, ichthyosis, peripheral neuropathy, ataxia, and, occasionally, cardiac</strong> <strong>arrhythmias</strong>. <strong>(Option C)</strong></li>\n<li>Classic Refsum disease often does not manifest until young adulthood, but <strong>visual disturbances such as night blindness, ichthyosis, and peripheral neuropathy may already be present in childhood and adolescence</strong>.</li>\n<li>Management involves <strong>dietary restriction of phytanic acid (</strong>dietary dairy products and Green Leafy Vegetables) <strong>(Option D)</strong></li>\n</ul>", "options": ["Defect of beta oxidation", "Accumulation of Phytanic acid", "Peripheral neuropathy", "Treated by removing Phytanic acid precursors from the diet"], "html_options": ["Defect of beta oxidation", "Accumulation of Phytanic acid", "Peripheral neuropathy", "Treated by removing Phytanic acid precursors from the diet"], "corr_idx": 0}, {"id": "1191018", "html_qtxt": "Fatty acid-oxidation (&beta;-oxidation) in peroxisomes is differentiated from that occurring in mitochondria by:", "html_expl": "<p><strong>Explanation for answer:</strong></p>\r\n<ul>\r\n<li><strong>Peroxisomes oxidise very long-chain fatty acids (VLCFAs)</strong> using a <strong>modified &beta;-oxidation pathway</strong>, which results in the formation of <strong>acetyl-CoA</strong> and <strong>hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)</strong>.</li>\r\n<li>The <strong>flavoprotein-linked dehydrogenase</strong> step in peroxisomal &beta;-oxidation produces <strong>H<sub>2</sub>O<sub>2</sub></strong>, which is then broken down by <strong>catalase</strong>.</li>\r\n<li>Unlike in mitochondria, <strong>peroxisomal oxidation is not coupled to ATP generation</strong>, as it is <strong>not linked to oxidative phosphorylation</strong>.</li>\r\n<li>This system is especially suited for <strong>very long chain fatty acids (e.g., C20, C22)</strong>.</li>\r\n<li><strong>&beta;-oxidation in peroxisomes</strong> ends at <strong>octanoyl-CoA</strong>, which, along with <strong>acetyl-CoA</strong>, is further oxidised in <strong>mitochondria</strong>.</li>\r\n<li>The enzymes involved are induced by <strong>high-fat diets</strong> and in some species by <strong>hypolipidemic drugs</strong> (e.g., <strong>clofibrate</strong>).</li>\r\n<li>Peroxisomes also function in <strong>bile acid formation</strong> (by shortening the side chain of cholesterol) and in <strong>ether glycerolipid synthesis</strong>.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Acetyl-CoA (Option A) </strong>is formed in both peroxisomal and mitochondrial &beta;-oxidation.</p>\r\n<p><strong>Different enzymes are found in different sites (Option C): </strong>While true in general, this is not the specific distinguishing biochemical feature.</p>\r\n<p><strong>NADH is required (Option D): </strong>Peroxisomal &beta;-oxidation does not couple with NADH or ATP production; instead, it forms H<sub>2</sub>O<sub>2</sub><strong>.</strong></p>", "options": ["Acetyl-CoA", "H2O2 formed", "Different enzymes are found in different sites", "NADH is required"], "html_options": ["Acetyl-CoA", "H2O2 formed", "Different enzymes are found in different sites", "NADH is required"], "corr_idx": 1}, {"id": "1191025", "html_qtxt": "Which of the following is obtained as the end product in the &beta;-oxidation of odd-chain fatty acids?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Oxidation of Odd-Chain Fatty Acids:</strong></p>\r\n<ul>\r\n<li>Takes place in the <strong>mitochondria</strong>.</li>\r\n<li>During &beta;-oxidation, <strong>fatty acids with an odd number of carbon atoms</strong> are broken down to yield:\r\n<ul>\r\n<li><strong>Multiple molecules of Acetyl-CoA</strong>, and</li>\r\n<li><strong>One molecule of Propionyl-CoA</strong> at the end. <strong>(Option C ruled out)</strong></li>\r\n</ul>\r\n</li>\r\n<li>The final three-carbon fragment is released as <strong>Propionyl-CoA</strong>.</li>\r\n<li>This <strong>Propionyl-CoA</strong> is metabolised to <strong>Succinyl-CoA</strong>, which enters the <strong>TCA cycle</strong>.</li>\r\n<li>Hence, <strong>Propionyl-CoA</strong> is <strong>glucogenic</strong>, making it the <strong>only glucogenic portion</strong> of a fatty acid.</li>\r\n<li>Even-chain fatty acids yield only <strong>Acetyl-CoA</strong>, which is <strong>ketogenic</strong>. <strong>(Options A and D ruled out)</strong></li>\r\n<li><strong>Odd-chain fatty acids</strong> are unique in providing a <strong>glucogenic</strong> component (Propionyl CoA).</li>\r\n</ul>\r\n<p>Propionyl CoA &rarr; Methylmalonyl CoA &rarr; Succinyl CoA (via vitamin B12-dependent enzyme)</p>", "options": ["Acetyl-CoA + Acetyl-CoA", "Acetyl-CoA + Propionyl CoA", "Propionyl CoA + Propionyl CoA", "Acetyl-CoA alone"], "html_options": ["Acetyl-CoA + Acetyl-CoA", "Acetyl-CoA + Propionyl CoA", "Propionyl CoA + Propionyl CoA", "Acetyl-CoA alone"], "corr_idx": 1}, {"id": "1191033", "html_qtxt": "Which of the following is the common enzyme shared between cholesterol synthesis and ketone body synthesis?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Thiolase</strong> is an enzyme involved in <strong>ketone body synthesis</strong>. Thiolase converts <strong>acetoacetyl-CoA to acetyl-CoA.</strong></li>\n<li>In <strong>Cholesterol synthesis</strong>, two molecules of <strong>acetyl-CoA condense to form acetoacetyl-CoA by Thiolase.</strong></li>\n<li>Site of synthesis differs: <strong>mitochondria</strong> for ketone bodies, <strong>cytoplasm</strong> for cholesterol.</li>\n<li><strong>Cytoplasmic HMG CoA</strong> Synthase is for Cholesterol synthesis.</li>\n<li><strong>Mitochondrial HMG CoA</strong> Synthase is for ketone body synthesis. <strong>(Option C ruled out)</strong></li>\n<li><strong>HMG CoA reductase</strong>: specific to cholesterol synthesis, not common. <strong>(Option A ruled out)</strong></li>\n<li><strong>HMG CoA lyase</strong>: specific to ketone body synthesis. <strong>(Option B ruled out)</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509011d3b8b66-5f2f-46d6-8676-7b605aae814f.png\">", "options": ["HMG CoA reductase", "HMG CoA lyase", "Mitochondrial HMG CoA synthase", "Thiolase"], "html_options": ["HMG CoA reductase", "HMG CoA lyase", "Mitochondrial HMG CoA synthase", "Thiolase"], "corr_idx": 3}, {"id": "1191036", "html_qtxt": "All are derived from cholesterol except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Bile pigment</strong> is <strong>not</strong> derived from cholesterol, unlike vitamin D, bile salts, and steroids. Bile pigments like <strong>bilirubin</strong> originate from the <strong>breakdown of heme</strong> (from haemoglobin), not from cholesterol metabolism.</li>\n<li>Cholesterol acts as the <strong>precursor</strong> for several important biomolecules, such as:\n<ul>\n<li><strong>Bile acids/salts (Option B)</strong></li>\n<li><strong>Steroid hormones</strong> (e.g., cortisol, testosterone, estrogen) <strong>(Option D)</strong></li>\n<li><strong>Vitamin D (Option A)</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Bile pigments are products of <strong>heme catabolism</strong>, not cholesterol metabolism.</li>\n<li>Cholesterol serves as a vital precursor for multiple hormone and vitamin pathways.</li>\n</ul>", "options": ["Vitamin D", "Bile salt", "Bile pigment", "Steroid"], "html_options": ["Vitamin D", "Bile salt", "Bile pigment", "Steroid"], "corr_idx": 2}, {"id": "1191037", "html_qtxt": "Which coenzyme acts as a reducing agent in the anabolic reaction of cholesterol?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>NADPH</strong> specifically serves as the reducing agent in anabolic reactions like <strong>cholesterol synthesis</strong>, <strong>fatty acid synthesis</strong>, and <strong>steroid hormone biosynthesis</strong>, whereas other coenzymes listed do not participate in these reductive biosynthetic pathways.</li>\r\n<li>NADPH donates <strong>high-energy electrons (hydride ions)</strong> in <strong>biosynthetic (anabolic)</strong></li>\r\n</ul>\r\n<p><strong>Functions of NADPH include:</strong></p>\r\n<ol>\r\n<li><strong>Synthesis of fatty acids</strong></li>\r\n<li><strong>Synthesis of cholesterol and steroids</strong></li>\r\n<li><strong>Synthesis of glutamate</strong> from &alpha;-ketoglutarate</li>\r\n<li><strong>Synthesis of tyrosine</strong> from phenylalanine</li>\r\n<li><strong>Uronic acid pathway</strong> (synthesis of glucuronic acid)</li>\r\n<li><strong>Folate metabolism</strong> (tetrahydrofolate regeneration)</li>\r\n<li><strong>Antioxidant defence</strong> - by reducing oxidised glutathione to its active reduced form</li>\r\n</ol>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>FADH<sub>2</sub></strong> <strong>(Option A):</strong> Acts in <strong>oxidative</strong> pathways like the electron transport chain; not a reducing agent in biosynthesis.</p>\r\n<p><strong>FMNH<sub>2</sub></strong> <strong>(Option B): </strong>Functions as a prosthetic group in <strong>flavoproteins</strong> in electron transport, not in anabolic processes.</p>\r\n<p><strong>NADH (Option D):</strong> Used in <strong>catabolic</strong> processes and energy generation, not in reductive biosynthesis.</p>\r\n<h3><strong>Key Takeaways:</strong></h3>\r\n<ul>\r\n<li><strong>NADPH = Reductive biosynthesis</strong></li>\r\n<li><strong>NADH/FADH<sub>2</sub> = Energy production (oxidation)</strong></li>\r\n<li>Anabolism = NADPH dependent</li>\r\n<li>Catabolism = NADH/FADH<sub>2</sub> dependent</li>\r\n</ul>", "options": ["FADH2", "FMNH2", "NADPH", "NADH"], "html_options": ["FADH2", "FMNH2", "NADPH", "NADH"], "corr_idx": 2}, {"id": "1191041", "html_qtxt": "Which of the following compounds is the source of all carbon atoms in cholesterol synthesis?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Acetyl-CoA is the <strong>exclusive source of all 27 carbon atoms</strong> in the cholesterol molecule, unlike malonyl-CoA, acetoacetate, or NADPH, which do not contribute carbon atoms to the cholesterol skeleton.</li>\n<li>Cholesterol is synthesised in a <strong>multi-step anabolic pathway</strong> beginning with <strong>acetyl-CoA</strong>.</li>\n<li>The pathway involves:\n<ul>\n<li><strong>Synthesis of mevalonate</strong> from acetyl-CoA</li>\n<li><strong>Formation of isoprenoid units</strong> via loss of CO<sub>2</sub></li>\n<li><strong>Condensation of 6 isoprenoid units</strong> to form <strong>squalene</strong></li>\n<li><strong>Cyclisation of squalene</strong> into <strong>lanosterol</strong></li>\n<li><strong>Conversion of lanosterol</strong> to <strong>cholesterol</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Malonyl CoA (Option B): </strong>Used in fatty acid synthesis, not cholesterol biosynthesis.</p>\n<p><strong>Acetoacetate (Option C): </strong>A ketone body derived from acetyl-CoA, but not a direct carbon donor in cholesterol synthesis.</p>\n<p><strong>NADPH (Option D): </strong>NADPH is used as a reducing agent, not a carbon donor, in the process.</p>", "options": ["Acetyl-CoA", "Malonyl CoA", "Aceto acetate", "NADPH"], "html_options": ["Acetyl-CoA", "Malonyl CoA", "Aceto acetate", "NADPH"], "corr_idx": 0}, {"id": "1191049", "html_qtxt": "All of the following are primary bile acids except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Deoxycholic acid</strong> is a <strong>secondary bile acid</strong> formed in the intestine by bacterial dehydroxylation of primary bile acids.</li>\n<li>In contrast, cholic acid and chenodeoxycholic acid are synthesised in the liver and are true primary bile acids. Glycocholic acid is a conjugate of cholic acid with glycine and thus also considered primary.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509019704331f-3c64-4d09-bad8-ff5d98ea2a2a.png\">", "options": ["Glycocholic acid", "Cholic acid", "Chenodeoxycholic acid", "Deoxycholic acid"], "html_options": ["Glycocholic acid", "Cholic acid", "Chenodeoxycholic acid", "Deoxycholic acid"], "corr_idx": 3}, {"id": "1191052", "html_qtxt": "Cholesterol synthesis is controlled by the regulation of the HMG CoA reductase enzyme. All of the following factors inhibit the activity of HMG CoA reductase, except:", "html_expl": "<p><strong>Explanation for answer</strong>:</p>\n<ul>\n<li><strong>Thyroid hormone</strong> <strong>stimulates</strong> the activity of HMG CoA reductase and therefore increases cholesterol synthesis, unlike the other options, which inhibit the enzyme.</li>\n<li><strong>HMG-CoA reductase</strong> is the <strong>rate-limiting enzyme</strong> in cholesterol biosynthesis.</li>\n<li>Regulation of this enzyme occurs via <strong>hormonal, feedback, and phosphorylation/dephosphorylation mechanisms.</strong></li>\n</ul>\n<h3><strong>Explanation of other options</strong><strong>:</strong></h3>\n<p><strong>Cholesterol</strong> <strong>(Option A):</strong> Acts as a feedback inhibitor of HMG-CoA reductase. When intracellular cholesterol levels are high, enzyme activity is suppressed.</p>\n<p><strong>Glucagon</strong> <strong>(Option C):</strong> Inhibits HMG-CoA reductase by promoting its <strong>phosphorylation</strong>, thereby reducing cholesterol synthesis during fasting or low-energy states.</p>\n<p><strong>Glucocorticoids</strong> <strong>(Option D):</strong> These inhibit the transcription of genes involved in cholesterol biosynthesis, including HMG-CoA reductase.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Stimulators</strong> of HMG CoA reductase: Insulin, Thyroid hormone</li>\n<li><strong>Inhibitors</strong>: Glucagon, Cholesterol, Mevalonate, Glucocorticoids</li>\n</ul>\n<p>Regulation occurs at both <strong>transcriptional</strong> and <strong>post-translational</strong> levels</p>", "options": ["Cholesterol", "Thyroid hormone", "Glucagon", "Glucocorticoids."], "html_options": ["Cholesterol", "Thyroid hormone", "Glucagon", "Glucocorticoids."], "corr_idx": 1}, {"id": "1191053", "html_qtxt": "Which is the ligand for the receptors present in the liver for the uptake of LDL?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Apo B100 is the specific ligand that binds the LDL receptor for the hepatic uptake of LDL particles.</strong></li>\n<li><strong>Apo E</strong> mediates the uptake of remnant lipoproteins (e.g., chylomicron remnants and VLDL remnants). <strong>(Option A ruled out)</strong></li>\n<li>The <strong>LDL receptor</strong> has binding sites for both <strong>apo B100</strong> and <strong>apo E</strong>.</li>\n<li><strong>Ligand Specificity:</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090189c8694b-1839-441f-aedc-7cea8b0a41a6.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Apo A and apo E (Option B): Apo A</strong> is associated with HDL and plays no role in LDL receptor binding; apo E is for remnants only.</p>\n<p><strong>Apo E and apo B100 (Option C): </strong>While both bind LDL receptors, only <strong>apo B100</strong> is involved in LDL uptake, making this option inaccurate for this specific context.</p>", "options": ["apo E", "apo A and apo E", "apo E and apo B100", "apo B100"], "html_options": ["apo E", "apo A and apo E", "apo E and apo B100", "apo B100"], "corr_idx": 3}, {"id": "1191057", "html_qtxt": "Increased level of lipoprotein (a) predisposes to:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Lipoprotein (a) </strong>is structurally similar to<strong> LDL </strong>and is strongly associated with<strong> atherosclerosis and myocardial infarction </strong>due to its<strong> interference with fibrinolysis.</strong></li>\n<li>Lipoprotein (a) consists of an LDL-like particle linked to <strong>apo B100</strong> by a disulfide bond and is rich in cholesterol.</li>\n<li>It has <strong>structural similarity to plasminogen</strong>, which allows it to compete with plasminogen for binding sites but <strong>does not promote fibrinolysis</strong>.</li>\n<li>This competition <strong>inhibits the conversion of plasminogen to plasmin</strong>, thereby <strong>preventing fibrin clot lysis</strong>, contributing to a <strong>prothrombotic state</strong>.</li>\n<li>Elevated levels are an independent risk factor for <strong>atherosclerotic cardiovascular diseases (ASCVD)</strong> and <strong>coronary artery disease</strong>.</li>\n</ul>\n<p><strong>Lipoprotein x:</strong></p>\n<ul>\n<li>Cholesterol is excreted as bile acids in the bile.</li>\n<li>In cholestasis, cholesterol combines with Phospholipid and forms <strong>Lipoprotein X.</strong></li>\n<li>Hence, it is an <strong>index of cholestasis.</strong></li>\n</ul>\n<p><strong>Explanation of other options</strong>:</p>\n<p><strong>Liver cirrhosis (Option A):</strong> Not associated with Lp(a). Liver diseases may affect various lipoproteins, but Lp(a) elevation is not a marker or cause.</p>\n<p><strong>Nephritic syndrome (Option C):</strong> While nephrotic syndrome causes lipid abnormalities, <strong>Lp(a)</strong> is not typically implicated in <strong>nephritic</strong> syndrome.</p>\n<p><strong>Pancreatitis (Option D):</strong> Pancreatitis is commonly associated with elevated <strong>triglycerides</strong>, especially chylomicrons and VLDL, not Lp(a).</p>", "options": ["Liver cirrhosis", "Atherosclerosis", "Nephritic syndrome", "Pancreatitis"], "html_options": ["Liver cirrhosis", "Atherosclerosis", "Nephritic syndrome", "Pancreatitis"], "corr_idx": 1}, {"id": "1191060", "html_qtxt": "In which of the lipoprotein compounds is, triglyceride component maximum?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Chylomicrons</strong> are the largest and least dense lipoproteins.</li>\n<li>They are synthesised in the <strong>intestinal mucosa</strong> and are responsible for transporting <strong>dietary triglycerides</strong> from the intestine to peripheral tissues.</li>\n<li>Their composition is <strong>90-98% lipid</strong>, of which <strong>80-90% is triglyceride</strong>, making them the lipoprotein with the <strong>highest triglyceride content</strong>.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090149b3fa76-5c91-45bd-b5f5-78eef41c6542.png\">", "options": ["Chylomicrons", "VLDL", "LDL", "HDL"], "html_options": ["Chylomicrons", "VLDL", "LDL", "HDL"], "corr_idx": 0}, {"id": "1191070", "html_qtxt": "Cholesterol from dietary sources is transported to the peripheral tissue by:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>Transport of cholesterol</strong> between tissues</p>\n<ul>\n<li>Dietary cholesterol is <strong>incorporated into chylomicrons.</strong></li>\n<li>95% of chylomicron cholesterol is delivered to the liver in the <strong>Chylomicron remnant</strong>.</li>\n<li>The <strong>cholesterol is secreted from the liver in VLDL.</strong></li>\n<li>Most of the cholesterol secreted in VLDL is retained in IDL and <strong>ultimately LDL.</strong></li>\n<li><strong>LDL cholesterol is taken up by the liver and extrahepatic tissues (peripheral tissues).</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Chylomicron (Option A): </strong>Transports <strong>dietary triglycerides</strong> from the intestine to peripheral tissues. The majority of chylomicron cholesterol is returned to the liver, not to peripheral tissues.</p>\n<p><strong>VLDL (Option B): </strong>Transports <strong>endogenously synthesised triglycerides</strong> from the liver to peripheral tissues. Its cholesterol is mostly retained and delivered through LDL after sequential processing.</p>\n<p><strong>HDL (Option D): </strong>Functions primarily in <strong>reverse cholesterol transport</strong> (from peripheral tissues to liver). Not responsible for delivering dietary cholesterol to peripheral tissues.</p>", "options": ["Chylomicron", "VLDL", "LDL", "HDL"], "html_options": ["Chylomicron", "VLDL", "LDL", "HDL"], "corr_idx": 2}, {"id": "1191072", "html_qtxt": "Which among the following is the action of lipoprotein lipase?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Lipoprotein lipase (LPL)</strong> is an extracellular enzyme anchored to capillary endothelium, especially in <strong>adipose tissue, skeletal muscle, and heart</strong>.</li>\n<li>It hydrolyses <strong>triacylglycerols (TAGs)</strong> from circulating <strong>chylomicrons and VLDL</strong> into <strong>free fatty acids</strong> and <strong>glycerol</strong>.</li>\n<li>It forms <strong>remnant particles,</strong> which are cleared by the liver.</li>\n<li>This enzymatic action removes <strong>70&ndash;90% of the TAG content</strong>, converting:\n<ul>\n<li><strong>Chylomicrons &rarr; Chylomicron remnants</strong></li>\n<li><strong>VLDL &rarr; VLDL remnants (IDL)</strong></li>\n</ul>\n</li>\n<li><strong>Apo C</strong> is transferred to HDL during this reaction, while <strong>Apo E</strong> is retained on remnant particles to aid in hepatic clearance.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Promote lipolysis in adipose tissue (Option B): </strong>Lipolysis in adipose tissue is carried out by <strong>hormone-sensitive lipase</strong>, not lipoprotein lipase.</p>\n<p><strong>To form mature chylomicron (Option C): </strong>Maturation of chylomicrons occurs in plasma by acquiring <strong>apolipoproteins C-II and E</strong> from HDL; LPL is not involved.</p>\n<p><strong>To form HDL (Option C): </strong>HDL formation involves secretion by the <strong>liver and intestine</strong>, and subsequent lipid acquisition, not mediated by LPL.</p>", "options": ["To form remnant lipoprotein", "Promote Lipolysis in Adipose Tissue", "To form mature Chylomicron", "To form HDL"], "html_options": ["To form remnant lipoprotein", "Promote Lipolysis in Adipose Tissue", "To form mature Chylomicron", "To form HDL"], "corr_idx": 0}, {"id": "1191079", "html_qtxt": "Which of the following statements is true regarding cholesterol present in LDL?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>LDL</strong> transports <strong>cholesterol esters</strong> derived from VLDL metabolism to <strong>peripheral tissues</strong>. <strong>(Option A ruled out)</strong></li>\n<li>LDL binds to the <strong>LDL receptor</strong> via its <strong>apo B-100</strong></li>\n<li>The complex is internalised by <strong>receptor-mediated endocytosis</strong> via <strong>clathrin-coated pits</strong>. <strong>(Option B ruled out)</strong></li>\n<li>In the <strong>lysosome</strong>, LDL is degraded, and <strong>free cholesterol</strong> is released into the cell.</li>\n</ul>\n<h4><strong>Cellular Effects of Increased Intracellular Cholesterol:</strong></h4>\n<ul>\n<li><strong>Decreases de novo cholesterol synthesis</strong> (inhibits <strong>HMG-CoA reductase</strong> via SREBP pathway)</li>\n<li><strong>Decreases LDL receptor synthesis (prevents further uptake of LDL)</strong></li>\n<li><strong>Increases activity of ACAT</strong> (acyl-CoA cholesterol acyltransferase), which esterifies free cholesterol for storage. <strong>(Option D ruled out)</strong></li>\n</ul>", "options": ["Represents primarily cholesterol that is being removed from peripheral cells.", "Binds to a receptor, and cholesterol diffuses across the cell membrane.", "Accumulation in the cell inhibits replenishment of LDL receptors.", "When it enters a cell, it suppresses the activity of acyl-CoA: cholesterol acyltransferase ACAT"], "html_options": ["Represents primarily cholesterol that is being removed from peripheral cells.", "Binds to a receptor, and cholesterol diffuses across the cell membrane.", "Accumulation in the cell inhibits replenishment of LDL receptors.", "When it enters a cell, it suppresses the activity of acyl-CoA: cholesterol acyltransferase ACAT"], "corr_idx": 2}, {"id": "1191082", "html_qtxt": "A patient was diagnosed with an isolated increase in LDL. His father and brother had the same disease with increased cholesterol. What is the likely diagnosis?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Familial hypercholesterolemia</strong> is caused by a <strong>mutation in the LDL receptor gene</strong>, leading to <strong>defective or absent LDL receptors</strong>.</li>\n<li>This results in <strong>impaired clearance of LDL particles</strong>, causing an <strong>isolated increase in LDL cholesterol</strong> in plasma.</li>\n<li>The condition shows <strong>autosomal dominant inheritance</strong>, often with a family history (as seen in the father and brother).</li>\n<li>Patients are at high risk of <strong>premature atherosclerosis and coronary artery disease</strong>.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901458a1368-7e6f-4a99-96f2-9f7f76d67342.png\">", "options": ["Familial type III hyperlipoproteinemia", "Abetalipoproteinemia", "Familial LPL deficiency (type1)", "LDL receptor mutation"], "html_options": ["Familial type III hyperlipoproteinemia", "Abetalipoproteinemia", "Familial LPL deficiency (type1)", "LDL receptor mutation"], "corr_idx": 3}, {"id": "1191085", "html_qtxt": "Familial hypercholesterolemia is:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p>Disease: Familial hypercholesterolemia (type IIa)</p>\n<p>Defect: Defective LDL receptors or a mutation in the ligand region of apo B-100.</p>\n<p>Remarks: Elevated LDL levels and hypercholesterolemia, resulting in atherosclerosis and coronary disease.</p>", "options": ["Deficient LDL receptors", "Deficient HDL receptors", "HMG CoA reductase deficiency", "Deficient VLDL receptors"], "html_options": ["Deficient LDL receptors", "Deficient HDL receptors", "HMG CoA reductase deficiency", "Deficient VLDL receptors"], "corr_idx": 0}, {"id": "1191090", "html_qtxt": "Absence of this apo lipoprotein is responsible for the genetic disorder, familial type III hyperlipoproteinemia:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Familial type III hyperlipoproteinemia</strong> (also known as broad beta disease, remnant removal disease, or familial dysbetalipoproteinemia) is caused by an abnormality in <strong>Apolipoprotein E (Apo E)</strong>.</li>\n<li>The defect lies in the <strong>remnant clearance</strong> by the liver. Normally, Apo E binds to <strong>hepatic receptors</strong> and mediates the uptake of <strong>chylomicron remnants and VLDL remnants</strong>.</li>\n<li>In affected individuals, both <strong>Apo E3 and Apo E4 isoforms are absent</strong>, and only <strong>Apo E2</strong> is present, which <strong>does not bind effectively</strong> to hepatic Apo E receptors.</li>\n<li>This leads to the <strong>accumulation of remnant lipoproteins</strong>, especially &beta;-VLDL (density <1.019), and results in <strong>hypercholesterolemia</strong>, <strong>xanthomas</strong>, and <strong>increased atherosclerotic risk.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Apo B100 (Option A): </strong>This is a structural protein found in <strong>VLDL, IDL, and LDL</strong> and is responsible for binding to <strong>LDL receptors</strong>. It is not involved in remnant clearance and is not the cause of type III hyperlipoproteinemia.</p>\n<p><strong>Apo B48 (Option B): </strong>Found in <strong>chylomicrons and chylomicron remnants</strong>. Involved in intestinal lipid transport, but does not mediate remnant clearance via the liver.</p>\n<p><strong>Apo CII (Option D): </strong>Activates <strong>lipoprotein lipase (LPL)</strong>, which hydrolyses triglycerides in chylomicrons and VLDL. Its deficiency causes <strong>type I hyperlipoproteinemia</strong>, not type III.</p>", "options": ["Apo B100", "Apo B48", "Apo E", "Apo CII"], "html_options": ["Apo B100", "Apo B48", "Apo E", "Apo CII"], "corr_idx": 2}, {"id": "1191098", "html_qtxt": "The recently discovered protein, proprotein convertase subtilisin/kexin type 9 (PCSK9), has been identified as a potential target for antiatherogenic drugs because:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)</strong> plays a regulatory role in cholesterol homeostasis by targeting <strong>LDL receptors (LDLR)</strong> for degradation.</li>\n<li>After <strong>LDL receptor-mediated endocytosis</strong>, LDL receptors are typically recycled back to the hepatocyte surface to continue LDL clearance.</li>\n<li>However, <strong>PCSK9 binds to LDL receptors and targets them for lysosomal degradation</strong>, thus <strong>reducing the number of receptors available at the cell surface</strong>.</li>\n<li>This leads to <strong>decreased LDL clearance from the plasma</strong>, causing an <strong>increase in blood LDL cholesterol levels</strong>.</li>\n<li>Therefore, <strong>inhibition of PCSK9</strong> (by monoclonal antibodies or siRNA-based drugs) is a <strong>therapeutic strategy to increase LDL receptor expression</strong>, thereby lowering LDL-C levels.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It inhibits the binding of apoB to the LDL receptor, thus blocking uptake of the lipoprotein and raising blood cholesterol levels (Option B):</strong> PCSK9 does not inhibit ApoB binding to the LDL receptor. LDL particles are internalised through ApoB100 interaction with LDLR.</p>\n<p><strong>It prevents the breakdown of cholesterol to bile acids in the liver (Option C): </strong>Bile acid synthesis is regulated by enzymes like <strong>CYP7A1</strong>, not PCSK9. PCSK9 has no direct role in cholesterol catabolism to bile acids.</p>\n<p><strong>It increases the synthesis and secretion of VLDL in the liver, leading to increased LDL formation in the blood (Option D):</strong> VLDL synthesis is governed by lipid availability and transcription factors like <strong>SREBP-1c</strong>, not PCSK9.</p>", "options": ["It decreases the number of LDL receptors exposed at the cell surface, thus LDL uptake is lowered, and blood cholesterol levels rise.", "It inhibits the binding of apoB to the LDL receptor, thus blocking uptake of the lipoprotein and raising blood cholesterol levels.", "It prevents the breakdown of cholesterol to bile acids in the liver.", "It increases the synthesis and secretion of VLDL in the liver, leading to increased LDL formation in the blood."], "html_options": ["It decreases the number of LDL receptors exposed at the cell surface, thus LDL uptake is lowered, and blood cholesterol levels rise.", "It inhibits the binding of apoB to the LDL receptor, thus blocking uptake of the lipoprotein and raising blood cholesterol levels.", "It prevents the breakdown of cholesterol to bile acids in the liver.", "It increases the synthesis and secretion of VLDL in the liver, leading to increased LDL formation in the blood."], "corr_idx": 0}, {"id": "1192285", "html_qtxt": "Which of the following sentences is true regarding chemical modification of LDL (low-density lipoprotein) by free radicals?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Free radical&ndash;induced modification of LDL leads to <strong>oxidised LDL (oxLDL)</strong>, which is <strong>not recognised by LDL receptors on hepatocytes</strong> and is <strong>not cleared via the regular LDL pathway</strong>. <strong>(Option A and B ruled out)</strong></li>\n<li>Instead, it is taken up by <strong>macrophage scavenger receptors</strong>, particularly SR-A, which are not downregulated. <strong>(Option D ruled out)</strong></li>\n<li>This results in unregulated uptake of oxLDL, forming <strong>foam cells</strong>, which accumulate in the intima of blood vessels and initiate <strong>atherosclerotic plaque formation</strong>.</li>\n<li>Therefore, oxidised LDL is <strong>highly atherogenic</strong>, directly linking to cardiovascular disease risk.</li>\n</ul>", "options": ["Easily recognised by the liver LDL receptor", "Easily cleared by the liver", "Increases risk of atherosclerosis", "Not taken up by macrophage scavenger receptors"], "html_options": ["Easily recognised by the liver LDL receptor", "Easily cleared by the liver", "Increases risk of atherosclerosis", "Not taken up by macrophage scavenger receptors"], "corr_idx": 2}]}, {"moduleId": 1009596, "name": "Phospholipids, Shingolipids,Glycolipids, Lipid Storage Disorders ", "questions": [{"id": "1188770", "html_qtxt": "Ketone bodies can be utilized by all, except:", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<ul>\n<li><strong>Ketone bodies</strong> serve as an important fuel for most <strong>extrahepatic tissues</strong> during prolonged fasting or starvation.</li>\n<li>However, <strong>RBCs (Red Blood Cells)</strong> cannot utilise ketone bodies because they <strong>lack mitochondria</strong>, which are essential for ketolysis.</li>\n<li>Similarly, the <strong>liver</strong>, though the site of ketone body synthesis, <strong>cannot utilise them</strong> due to the absence of the enzyme <strong>thiophorase (succinyl-CoA: acetoacetate CoA transferase)</strong>.</li>\n<li>Thus, both <strong>RBCs</strong> and the <strong>liver</strong> are <strong>non-utilizers</strong> of ketone bodies, but the question asks for the <strong>only exception</strong>, making <strong>RBC</strong> the correct choice.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Brain (Option B):</strong> The brain switches to ketone bodies as a major fuel source during prolonged fasting (>3 days).</p>\n<p><strong>Skeletal Muscle (Option C):</strong> Utilises ketone bodies early during fasting before switching to fatty acid oxidation.</p>\n<p><strong>Renal Cortex (Option D):</strong> Actively uses ketone bodies during fasting/starvation.</p>", "options": ["RBC", "Brain", "Skeletal Muscle", "Renal Cortex"], "html_options": ["RBC", "Brain", "Skeletal Muscle", "Renal Cortex"], "corr_idx": 0}, {"id": "1188772", "html_qtxt": "Rothera's test is used for the detection of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Rothera's test (Nitroprusside test)</strong> is a <strong>qualitative test</strong> used to detect <strong>ketone bodies</strong> (specifically <strong>acetone</strong> and <strong>acetoacetate</strong>) in urine.</li>\n<li>The test is based on the <strong>reaction of ketone groups</strong> with <strong>sodium nitroprusside</strong> in an alkaline medium to produce a <strong>purple-colored complex</strong>.</li>\n<li><strong>Beta-hydroxybutyrate</strong>, however, is <strong>not detected</strong> as it lacks a free keto group.</li>\n<li>Other confirmatory tests include <strong>Gerhardt's test</strong> (ferric chloride reaction for acetoacetate).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Proteins (Option A):</strong> Detected by <strong>sulfosalicylic acid test</strong> or <strong>heat coagulation test</strong>.</p>\n<p><strong>Glucose (Option B):</strong> Detected by <strong>Benedict's test</strong> or <strong>glucose oxidase method</strong>.</p>\n<p><strong>Fatty Acid (Option C):</strong> Detected using chemical extraction and chromatography.</p>", "options": ["Proteins", "Glucose", "Fatty Acid", "Ketone Bodies"], "html_options": ["Proteins", "Glucose", "Fatty Acid", "Ketone Bodies"], "corr_idx": 3}, {"id": "1188774", "html_qtxt": "All of the following statements are true about Ketone bodies except:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>Ketogenesis occurs when there is a <strong>high rate of fatty acid oxidation in the liver (Option A)</strong></li>\n<li>Under metabolic conditions associated with a high rate of fatty acid oxidation, the liver produces considerable quantities of <strong>acetoacetate and &beta;-hydroxybutyrate </strong>but does not utilise them due to the absence of <strong>thiophorase</strong>.<strong> (Option D)</strong></li>\n<li><strong>Acetoacetate</strong> continually undergoes <strong>spontaneous decarboxylation</strong> to yield acetone, <strong>not oxidation.</strong></li>\n<li>These three substances are collectively known as the <strong>ketone bodies</strong>.</li>\n<li>Acetoacetate and 3-hydroxybutyrate are <strong>interconverted by the mitochondrial enzyme 3-hydroxybutyrate dehydrogenase</strong>; the equilibrium is controlled by the <strong>mitochondrial [NAD+]/[NADH] ratio</strong>, that is, the redox state.</li>\n<li>The concentration of total ketone bodies in the blood of well-fed mammals does not normally exceed <strong>2 mmol/L</strong> except in ruminants.</li>\n<li>In vivo, the liver appears to be the only organ in non-ruminants to add significant quantities of ketone bodies to the blood.</li>\n<li>Extrahepatic tissues utilise acetoacetate and &beta;-hydroxybutyrate as <strong>respiratory substrates. </strong></li>\n<li>Acetone is a waste product which, as it is volatile, can be <strong>excreted via the lungs</strong> <strong>(Option C)</strong></li>\n<li>Because there is active synthesis but little utilisation of ketone bodies in the liver, while they are used but not produced in extrahepatic tissues, there is a net flow of the compounds to the extrahepatic tissues.</li>\n</ul>", "options": ["Ketogenesis occurs when there is a high rate of fatty acid oxidation", "Acetoacetate continually undergoes spontaneous oxidation to yield acetone", "Acetone is a waste product which, as it is volatile, can be excreted via the lungs.", "The liver produces considerable quantities of acetoacetate and β-hydroxybutyrate"], "html_options": ["Ketogenesis occurs when there is a high rate of fatty acid oxidation", "Acetoacetate continually undergoes spontaneous oxidation to yield acetone", "Acetone is a waste product which, as it is volatile, can be excreted via the lungs.", "The liver produces considerable quantities of acetoacetate and β-hydroxybutyrate"], "corr_idx": 1}, {"id": "1188776", "html_qtxt": "The immediate precursor in the formation of acetoacetate from acetyl-CoA in the liver is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>HMG-CoA (3-hydroxy-3-methylglutaryl-CoA)</strong> is the immediate precursor of <strong>acetoacetate</strong> in the <strong>ketogenesis pathway</strong>.</li>\n<li>Initially, <strong>two acetyl-CoA</strong> molecules condense to form <strong>acetoacetyl-CoA</strong>.<strong> (Option C)</strong></li>\n<li>Acetoacetyl-CoA then reacts with a <strong>third acetyl-CoA</strong> to form <strong>HMG-CoA</strong>, catalysed by <strong>HMG-CoA synthase</strong>.</li>\n<li>Finally, <strong>HMG-CoA lyase</strong> cleaves HMG-CoA into <strong>acetoacetate</strong> and acetyl-CoA.</li>\n<li>Acetoacetate may be reduced to <strong>&beta;-hydroxybutyrate</strong> or decarboxylated to <strong>acetone</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Mevalonate (Option A):</strong> Intermediate in the cholesterol synthesis pathway, not involved in ketogenesis.</p>\n<p><strong>5-Hydroxybutyryl-CoA (Option D):</strong> Not involved in the classical ketone body formation pathway.</p>", "options": ["Mevalonate", "HMG CoA", "Aceto-acetyl CoA", "5-Hydroxy butyryl CoA"], "html_options": ["Mevalonate", "HMG CoA", "Aceto-acetyl CoA", "5-Hydroxy butyryl CoA"], "corr_idx": 1}, {"id": "1188779", "html_qtxt": "In a well-fed state, acetyl-CoA obtained from the diet is least used in the synthesis of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In the <strong>well-fed state</strong>, excess acetyl-CoA is mainly utilised for <strong>fatty acid synthesis</strong> (Palmitoyl CoA) and <strong>TCA cycle activity</strong> (Citrate, Oxalosuccinate are intermediates).</li>\n<li>However, <strong>Acetoacetate</strong> is a <strong>ketone body</strong>, which is <strong>not synthesised in the well-fed state</strong>. Instead, it is produced <strong>during prolonged fasting or starvation</strong>, when fatty acids are oxidised for energy.</li>\n<li>Hence, in the well-fed state, <strong>acetyl-CoA is least used for acetoacetate synthesis</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Palmitoyl CoA (Option A)</strong>: Acetyl-CoA serves as the starting substrate for <strong>fatty acid synthesis</strong> in the well-fed state.</p>\n<p><strong>Citrate (Option B)</strong>: Formed from acetyl-CoA and oxaloacetate in the TCA cycle; also used for cytosolic acetyl-CoA transport for lipogenesis.</p>\n<p><strong>Oxalosuccinate (Option D)</strong>: An intermediate in the <strong>TCA cycle</strong>, derived from isocitrate by <strong>isocitrate dehydrogenase</strong>.</p>", "options": ["Palmitoyl CoA", "Citrate", "Acetoacetate", "Oxalosuccinate"], "html_options": ["Palmitoyl CoA", "Citrate", "Acetoacetate", "Oxalosuccinate"], "corr_idx": 2}, {"id": "1188780", "html_qtxt": "All of the following statements about lipoprotein lipase are true, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Unlike the other listed statements, <strong>Lipoprotein lipase (LPL)</strong> does require <strong>Apolipoprotein C-II (Apo C-II)</strong> as a cofactor for activation.</li>\n<li>Its deficiency leads to <strong>Type I hyperlipoproteinemia</strong>, marked by <strong>hypertriglyceridemia</strong>.<strong> (Option C)</strong>.</li>\n<li>Lipoprotein lipase is located on the <strong>walls of blood capillaries</strong>, anchored to the endothelium by <strong>negatively charged proteoglycan chains of heparan sulfate</strong>.</li>\n<li>It has been found in the <strong>heart, adipose tissue,</strong> spleen, lung, renal medulla, aorta, diaphragm, and lactating mammary gland, although it is not active in adult liver. <strong>(Option A and B)</strong></li>\n<li>It is not normally found in blood; however, following injection of heparin, lipoprotein lipase is released from its heparan sulfate binding sites into the circulation.</li>\n</ul>", "options": ["Found in adipose tissue", "Found in myocytes", "Deficiency leads to hypertriacylglycerydemia.", "Does not require CII as cofactor"], "html_options": ["Found in adipose tissue", "Found in myocytes", "Deficiency leads to hypertriacylglycerydemia.", "Does not require CII as cofactor"], "corr_idx": 3}, {"id": "1188781", "html_qtxt": "All of the following statements about apoproteins are true except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Apoprotein A-II and apo C-III </strong>inhibit<strong> lipoprotein lipase</strong></li>\n<li><strong>Apoprotein C-II activates lipoprotein lipase (Option D)</strong></li>\n</ul>\n<p><strong>Apolipoproteins carry out several roles:</strong></p>\n<ul>\n<li>They can form part of the <strong>structure of the lipoprotein</strong>, for example, <strong>apo B.</strong></li>\n<li>They are:\n<ul>\n<li><strong>Enzyme cofactors</strong>, for example, <strong>C-II for lipoprotein lipase, A-I for lecithin: cholesterol acyltransferase (LCAT) (Option A).</strong></li>\n<li><strong>Enzyme inhibitors</strong>, for example, <strong>apo A-II and apo C-III for lipoprotein lipase, apo C-I for cholesteryl ester transfer protein (CETP) (Option B)</strong>.</li>\n<li>They act as <strong>ligands</strong> for <strong>interaction with lipoprotein receptors in tissues</strong>, for example, <strong>apo B-100 and apo E for the LDL receptor, apo E for the LDL-receptor-related protein-1 (LRP-1),</strong> which has been identified as the remnant receptor, and <strong>apo A-I for the HDL receptor</strong>.</li>\n</ul>\n</li>\n<li>The functions of apo A-IV and apo D, however, are not yet clearly defined, although <strong>apo D is believed to be an important factor in human neurodegenerative disorders.</strong></li>\n</ul>", "options": ["Apoprotein A-I activates LCAT", "Apoprotein C-I inhibits CETP", "Apoprotein C-II inhibits lipoprotein lipase", "Apoprotein C-II activates lipoprotein lipase"], "html_options": ["Apoprotein A-I activates LCAT", "Apoprotein C-I inhibits CETP", "Apoprotein C-II inhibits lipoprotein lipase", "Apoprotein C-II activates lipoprotein lipase"], "corr_idx": 2}, {"id": "1188782", "html_qtxt": "Which of the following types of Hypertriglyceridemia is associated with an increase in chylomicron and VLDL remnants?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Type III hyperlipoproteinemia</strong> (also known as <strong>familial dysbetalipoproteinemia</strong> or <strong>broad beta disease</strong>) is due to a defect in the <strong>clearance of chylomicron and VLDL remnants from plasma. </strong></li>\n<li>This is caused by a mutation in <strong>Apolipoprotein E</strong>, where patients possess only <strong>apo E2 isoforms</strong>, which have reduced binding to the hepatic apo-E receptor.</li>\n<li>This results in the accumulation of remnant lipoproteins rich in cholesterol and triglycerides.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082691ffdec3-5dc1-4579-b93d-3363885218.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Type I (Option A):</strong> Caused by <strong>lipoprotein lipase</strong> or <strong>apo C-II deficiency</strong>; characterised by <strong>elevated chylomicrons</strong>.</p>\n<p><strong>Type IIa (Option B):</strong> Characterised by <strong>elevated LDL levels due to LDL receptor deficiency,</strong> no increase in remnants.</p>\n<p><strong>Type IV (Option D): </strong>Involves <strong>increased VLDL levels</strong>, but <strong>remnant accumulation is not a feature</strong>.</p>", "options": ["Type I", "Type IIa", "Type III", "Type IV"], "html_options": ["Type I", "Type IIa", "Type III", "Type IV"], "corr_idx": 2}, {"id": "1188783", "html_qtxt": "Increase Lipoprotein x is found in which type of disorder?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Lipoprotein X</strong> is an abnormal lipoprotein that appears in the plasma primarily in <strong>cholestasis</strong>.</li>\n<li>In cholestasis, <strong>cholesterol</strong> is retained and combines with phospholipids and albumin to form <strong>Lipoprotein X (Lp-X)</strong>.</li>\n<li>Lp-X consists of free cholesterol, phospholipids, and minimal triglycerides, and lacks apolipoprotein B-100.</li>\n<li>It is not normally found in plasma but appears in <strong>obstructive liver diseases</strong>.</li>\n<li>This abnormal lipoprotein can deposit in skin folds, causing <strong>xanthomas</strong>, particularly <strong>xanthomata striata palmaris</strong> and <strong>plantar xanthomas</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Atherosclerosis (Option A):</strong> Associated with <strong>increased LDL and VLDL</strong>.</p>\n<p><strong>Hepatitis (Option C):</strong> Can <strong>alter liver enzymes and lipid metabolism,</strong> but does not typically result in Lp-X formation.</p>\n<p><strong>Myocardial Infarction (Option D):</strong> May show <strong>elevated LDL or lipoprotein(a),</strong> but not Lp-X.</p>", "options": ["Atherosclerosis", "Cholestasis", "Hepatitis", "Myocardial Infarction"], "html_options": ["Atherosclerosis", "Cholestasis", "Hepatitis", "Myocardial Infarction"], "corr_idx": 1}, {"id": "1188786", "html_qtxt": "A person on a fat-free, carbohydrate-rich diet continues to grow obese. Which of the following lipoproteins is likely to be elevated in his blood?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>In a <strong>fat-free but carbohydrate-rich diet</strong>, <strong>de novo lipogenesis</strong> becomes active in the <strong>liver</strong>.</li>\n<li>Excess carbohydrates are converted to <strong>fatty acids</strong> via <strong>acetyl-CoA</strong>, which are then esterified to form <strong>triacylglycerol (TAG)</strong>.</li>\n<li>The liver packages this newly synthesised TAG into <strong>VLDL (Very Low-Density Lipoproteins)</strong> and secretes them into the blood.</li>\n<li>Hence, <strong>VLDL levels rise</strong> despite the diet being fat-free.</li>\n<li>VLDL carries endogenously synthesised triglycerides from the liver to peripheral tissues.</li>\n<li>Factors that enhance both the <strong>synthesis of triacylglycerol and the secretion of VLDL</strong> by the liver include\n<ul>\n<li>The <strong>fed state</strong> rather than the starved state;</li>\n<li>The <strong>feeding of diets high in carbohydrate</strong> (particularly if they contain sucrose or fructose), leading to high rates of lipogenesis and esterification of fatty acids;</li>\n<li><strong>High levels of circulating FFA</strong>.</li>\n<li>Ingestion of <strong>ethanol</strong>.</li>\n<li>The presence of high concentrations of insulin and low concentrations of glucagon enhances fatty acid synthesis and esterification and inhibits their oxidation.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Chylomicrons (Option A):</strong> Transport dietary triglycerides and cholesterol from the intestine; would not be elevated in a fat-free diet.</p>\n<p><strong>LDL (Option C):</strong> Derived from VLDL catabolism; its elevation is secondary and not the primary marker here.</p>\n<p><strong>HDL (Option D):</strong> Involved in reverse cholesterol transport; its levels are not typically elevated in this metabolic context.</p>", "options": ["Chylomicrons", "VLDL", "LDL", "HDL"], "html_options": ["Chylomicrons", "VLDL", "LDL", "HDL"], "corr_idx": 1}, {"id": "1188788", "html_qtxt": "Lipoprotein a (Lp(a)) resembles:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Lipoprotein(a)</strong> is structurally similar to <strong>LDL</strong>, but with an additional <strong>apolipoprotein(a)</strong></li>\n<li><strong>Apo(a)</strong> has significant structural homology with <strong>plasminogen</strong>, a key protein involved in fibrinolysis.</li>\n<li>Apo(a) interferes with the conversion of <strong>plasminogen to plasmin</strong>, thereby inhibiting fibrinolysis.</li>\n<li>This promotes <strong>clot stability</strong> and increases the risk of <strong>atherosclerosis</strong> and <strong>myocardial infarction</strong>.</li>\n<li>Lp(a) is cleared mainly by the <strong>liver</strong> and is linked to <strong>intravascular thrombosis</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Plasmin (Option B):</strong> Active form of plasminogen; no structural similarity to Lp(a).</p>\n<p><strong>Thrombin (Option C):</strong> Involved in coagulation (not fibrinolysis); no relation to Lp(a).</p>\n<p><strong>Prothrombin (Option D):</strong> Precursor to thrombin; unrelated to lipoprotein(a) structure.</p>", "options": ["Plasminogen", "Plasmin", "Thrombin", "Prothrombin"], "html_options": ["Plasminogen", "Plasmin", "Thrombin", "Prothrombin"], "corr_idx": 0}, {"id": "1188790", "html_qtxt": "Both Triglycerides and HDL are increased in which of the following conditions:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Alcohol intake</strong> raises both <strong>serum triglycerides and HDL.</strong></li>\n<li><strong>Alcoholic fatty liver is the first stage in alcoholic liver disease (ALD),</strong> which is caused by chronic alcohol intake and can <strong>progress to cirrhosis</strong>.</li>\n<li>Ethanol metabolism <strong>increases NADH production</strong> via alcohol dehydrogenase and aldehyde dehydrogenase.</li>\n<li>The <strong>increased [NADH]/[NAD⁺] ratio inhibits &beta;-oxidation of fatty</strong> <strong>acids</strong> and promotes <strong>lipogenesis</strong>.</li>\n<li>This results in <strong>triglyceride accumulation in the liver and increases VLDL secretion</strong>.</li>\n<li>Chronic alcohol consumption is also associated with <strong>elevated HDL levels</strong> due to <strong>increased hepatic production of apolipoproteins</strong> involved in HDL metabolism.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Smoking (Option A):</strong> Smoking is associated with reduced HDL and increased oxidative stress but does not cause triglyceride elevation.</p>\n<p><strong>Athletes (Option B):</strong> Regular exercise in athletes raises HDL but usually reduces triglycerides due to enhanced lipid utilisation.</p>\n<p><strong>Statins (Option C:</strong> Statins reduce LDL and triglycerides and slightly increase HDL. They do not increase both HDL and triglycerides simultaneously.</p>", "options": ["Smoking", "Athletes", "Statin", "Alcoholism"], "html_options": ["Smoking", "Athletes", "Statin", "Alcoholism"], "corr_idx": 3}, {"id": "1188793", "html_qtxt": "In prolonged fasting, Glycerol is formed from triglycerides. Which of the following statements is true regarding Glycerol:", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>During fasting, <strong>hormone-sensitive lipase</strong> is activated by decreased insulin and increased catecholamines, which promotes <strong>lipolysis</strong> in adipose tissue.</li>\n<li>This enzyme catalyses the breakdown of stored triglycerides into <strong>free fatty acids (FFA)</strong> and <strong>glycerol</strong>.</li>\n<li>The glycerol thus formed enters the liver, where it can be converted to <strong>glycerol-3-phosphate</strong> via <strong>glycerol kinase</strong>, and subsequently used for gluconeogenesis or triglyceride resynthesis.</li>\n<li>Adipose tissue lacks glycerol kinase, so glycerol cannot be reused locally and must be transported to the liver.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Used in the synthesis of chylomicrons (Option A):</strong> Chylomicrons are synthesised in the intestinal mucosa using dietary fat. Glycerol from adipose lipolysis is not involved in their synthesis.</p>\n<p><strong>It is directly used by tissues for energy needs (Option B):</strong> Tissues do not directly oxidise glycerol for energy. Instead, it is transported to the liver for gluconeogenesis or triglyceride synthesis.</p>\n<p><strong>It is formed by the increased activity of Lipoprotein Lipase (Option D):</strong> Lipoprotein lipase acts on circulating lipoproteins like chylomicrons and VLDL, not on intracellular triglycerides. It is not responsible for glycerol release during fasting.</p>", "options": ["Used in the synthesis of chylomicron", "It is directly used by tissues for energy needs", "It is formed due to the increased activity of hormone-sensitive lipase", "It is formed by the increased activity of Lipoprotein Lipase"], "html_options": ["Used in the synthesis of chylomicron", "It is directly used by tissues for energy needs", "It is formed due to the increased activity of hormone-sensitive lipase", "It is formed by the increased activity of Lipoprotein Lipase"], "corr_idx": 2}, {"id": "1188794", "html_qtxt": "All of the following hormones promote lipolysis except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Lipolysis</strong> is stimulated by a variety of hormones that act via cAMP or other second messengers to activate <strong>hormone-sensitive lipase</strong>, which breaks down stored triglycerides.</li>\n<li>These include <strong>norepinephrine</strong>, <strong>ACTH</strong>, <strong>glucagon</strong>, <strong>MSH</strong>, <strong>TSH</strong>, <strong>GH</strong>, and <strong>vasopressin</strong>. <strong>(Options A, B and C)</strong></li>\n<li>These hormones act by increasing intracellular cAMP or Ca&sup2;<sup>+</sup>, activating <strong>protein kinase A</strong>, which phosphorylates and activates hormone-sensitive lipase.</li>\n<li><strong>Insulin</strong>, in contrast, <strong>inhibits lipolysis</strong> by activating <strong>phosphodiesterase</strong>, which degrades cAMP, thereby inactivating hormone-sensitive lipase. It also promotes triglyceride synthesis and fat storage.</li>\n</ul>", "options": ["Norepinephrine", "ACTH", "MSH", "Insulin"], "html_options": ["Norepinephrine", "ACTH", "MSH", "Insulin"], "corr_idx": 3}]}, {"moduleId": 1008729, "name": "Nucleotide Synthesis And Catabolism And Related Diseases", "questions": [{"id": "1182307", "html_qtxt": "Nucleosides are derivatives of purines and pyrimidines that have a sugar linked to a ring nitrogen of a purine or pyrimidine. A bond between sugar and a nitrogen base is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>N Base (purine or pyrimidine) is attached to a pentose sugar (ribose or deoxyribose) by the <strong>glycosidic bond</strong>.</p>\n<ul>\n<li>C1 of sugar is linked to N1 of pyrimidine or N9 of purine. Because the bond involves a nitrogen atom on the base, it is termed an <strong>N-glycosidic</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904eb4e7f04-13df-4fc0-9007-ce65def22753.png\">\n</li>\n</ul>\n<p>If the <strong>carbon</strong> of sugar forms a bond with the<strong> oxygen</strong> atom in the hydroxyl group, the bond formed is an <strong>O-glycosidic bond (Option B)</strong>. It is not found in nucleosides.</p>\n<p>Phosphodiester bond <strong>(Option C)</strong> joins the 3' hydroxyl group of deoxyribose of one nucleotide to the 5' hydroxyl group of another nucleotide through a phosphate group. All deoxyribonucleotides are linked together by 3'- 5' phosphodiester bonds in the DNA strand.</p>\n<p>The Nitrogen bases of one strand are paired with complementary Nitrogen bases of the second strand during the formation of double-stranded DNA. Such base pairs are held together by Hydrogen bonds. <strong>(Option D) </strong></p>", "options": ["N-glycosidic bond", "O-glycosidic bond", "Phosphodiester bond", "Hydrogen bond"], "html_options": ["N-glycosidic bond", "O-glycosidic bond", "Phosphodiester bond", "Hydrogen bond"], "corr_idx": 0}, {"id": "1182310", "html_qtxt": "Which of the following is true about pseudouridine?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Pseudouridine is excreted unchanged in the urine since there is no human enzyme that can hydrolyze or break it.</p>\n<ul>\n<li>Pseudouridine is a <strong>nucleoside</strong>, not a nucleotide. <strong>(Option A)</strong></li>\n<li>The nucleotide form, pseudouridylic acid (&psi;), is formed by rearrangement of uridine monophosphate (UMP) in preformed tRNA.</li>\n<li>Pseudouridine is present in transfer RNA.</li>\n<li>There is no human enzyme that can hydrolyze or break pseudouridine. As a result, it is excreted <strong>unchanged in the urine</strong> during tRNA degradation.</li>\n<li>In pseudouridine, the sugar (D-ribose) attaches to the <strong>C-5 position of uracil</strong>. <strong>(Option C)</strong></li>\n<li>This forms a <strong>carbon-carbon bond</strong>, not the usual nitrogen-carbon bond.</li>\n<li>Most nucleosides have a <strong>&beta;-N-glycosidic bond</strong> linking the sugar to N-1 of pyrimidines or N-9 of purines.</li>\n<li>In pseudouridine, the bond is <strong>not a &beta;-N-glycosidic bond</strong> but a carbon-carbon bond. <strong>(Option D)</strong></li>\n<li>The end product of pyrimidine catabolism (like uracil) is <strong>&beta;-alanine</strong> or <strong>&beta;-aminoisobutyrate</strong>. <strong>&beta;-aminoisobutyrate</strong> is excreted in the urine.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904b1bd2f24-485e-4e8b-8839-b97155053a2f.png\">\n</li>\n</ul>", "options": ["It is a nucleotide", "Excreted unchanged in urine during degradation of transfer RNA", "Ribose attach to N1 of uracil", "Bond between sugar and N base is beta N glycosidic bond"], "html_options": ["It is a nucleotide", "Excreted unchanged in urine during degradation of transfer RNA", "Ribose attach to N1 of uracil", "Bond between sugar and N base is beta N glycosidic bond"], "corr_idx": 1}, {"id": "1182319", "html_qtxt": "Which of the following statements regarding nucleotides is correct?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Many Coenzymes and related compounds are derivatives of Adenosine Monophosphate, for example:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509041fd9e1ae-ddda-4c8d-b2cb-2d628789adc3.png\">\n<p>Purines and pyrimidines are nitrogen-containing heterocycles, cyclic structures that contain, in addition to carbon, other (hetero) atoms such as nitrogen. Their six-atom rings in <strong>purines are numbered in an anticlockwise direction</strong>, whereas in <strong>pyrimidine rings are numbered in a clockwise direction. (Option A & B ruled out)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904f709d876-a47b-4162-9dc6-7a8438027d19.png\">\n<p>The primary and secondary phosphoryl groups of nucleosides have pKa values of about 1.0 and 6.2, respectively. Nucleotides, therefore, bear a significant <strong>negative</strong> charge at physiologic pH. <strong>(Option D ruled out)</strong></p>", "options": ["The six atom ring of purine is numbered clockwise", "The atoms of the pyrimidine ring are numbered anticlockwise", "Many coenzymes are derivatives of adenine nucleotides", "Nucleotides are positively charged at physiological pH"], "html_options": ["The six atom ring of purine is numbered clockwise", "The atoms of the pyrimidine ring are numbered anticlockwise", "Many coenzymes are derivatives of adenine nucleotides", "Nucleotides are positively charged at physiological pH"], "corr_idx": 2}, {"id": "1182324", "html_qtxt": "The major process that produces purine nucleotide for the synthesis of DNA during cell division is:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>During de novo synthesis in tissue, purine or pyrimidine nucleotides are produced from various amphibolic intermediates.</li>\r\n<li>De novo synthesis is a major pathway that provides nucleotides to tissues to meet their physiological demands.</li>\r\n<li>The three processes that contribute to purine nucleotide biosynthesis are, in order of decreasing importance:\r\n<ul>\r\n<li>Synthesis from amphibolic intermediates (synthesis de novo)</li>\r\n<li>Phosphoribosylation of purines</li>\r\n<li>Phosphorylation of purine nucleosides</li>\r\n</ul>\r\n</li>\r\n<li>All dietary nucleic acids and nucleotides are nonessential; they will not be incorporated into tissue nucleic acids.</li>\r\n<li>Following ingestion of nucleotide or nucleic acid in the diet, their degradation results in mononucleotides, which may be absorbed or converted to purine and pyrimidine bases.</li>\r\n<li>The purine bases are then oxidised to uric acid, which may be absorbed and excreted in the urine.</li>\r\n<li>Pyrimidine bases are degraded into CO<sub>2</sub>, NH<sub>3</sub>, beta-alanine, and beta-aminoisobutyrate.<strong> (Option A Ruled out) </strong></li>\r\n<li>During phosphorylation of purines, there is an addition of ribose phosphate to preformed purine or pyrimidine bases. <strong>(Option C Ruled out) </strong></li>\r\n<li>During phosphorylation of purine nucleosides, there is an addition of phosphate to the nucleoside. <strong>(Option D Ruled out) </strong></li>\r\n<li>Both phosphorylation of purines and phosphorylation of purine nucleosides occur during the salvage pathway. Such purine or pyrimidine bases or purine nucleosides are derived from the damaged DNA of broken-down cells (recycled).</li>\r\n</ul>", "options": ["Dietary intake", "De novo Synthesis", "Phosphorylation of purines", "Phosphorylation of purine nucleosides"], "html_options": ["Dietary intake", "De novo Synthesis", "Phosphorylation of purines", "Phosphorylation of purine nucleosides"], "corr_idx": 1}, {"id": "1182327", "html_qtxt": "During de novo synthesis, purine N base is produced from various amphibolic intermediates. Which will be the source of C6 of the purine ring (as shown in the image below) during de novo synthesis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509042d52fe1a-a3dc-441d-8f27-2c7d1b57ede7.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In the de novo pathway, respiratory CO2 contributes the carbon at position 6 of the purine ring.</li>\n<li>De novo synthesis is a major pathway that provides nucleotides to tissues to meet their physiological demands. During de novo synthesis in tissue, purine or pyrimidine nucleotides are produced from various amphibolic intermediates.</li>\n</ul>\n<p>Sources of the nitrogen and carbon atoms of the purine ring:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090441b8e693-a21b-41dc-bed2-d7a6cb00d0d1.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p>Glycine <strong>(Option B)</strong> provides C4, C5, and N7 of purine rings.</p>\n<p>Folic acid (Tetrahydrofolate) <strong>(Option C) </strong>provides C2 & C8 of purine rings.</p>\n<p>Glutamine <strong>(Option D) </strong>provides N3 and N9 of purine rings.</p>", "options": ["CO<sub>2</sub>", "Glycine", "Folic acid", "Glutamine"], "html_options": ["CO<sub>2</sub>", "Glycine", "Folic acid", "Glutamine"], "corr_idx": 0}, {"id": "1182330", "html_qtxt": "Mycophenolic acid inhibits which of the following enzymes of purine biosynthesis?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Mycophenolic acid is a selective, noncompetitive inhibitor of<strong> IMP (inosine monophosphate) dehydrogenase</strong>, the rate-limiting enzyme that converts IMP to XMP (Xanthosine Monophosphate) in the guanine nucleotide synthesis pathway.</li>\r\n<li>Mycophenolic acid is a drug used to prevent organ rejection in adult patients who have received kidney transplants.</li>\r\n<li>Many antifolate drugs & glutamine analogues block purine nucleotide biosynthesis by inhibiting a particular enzyme in the de novo biosynthesis pathway.</li>\r\n<li>Antifolate drugs like methotrexate inhibit the enzyme dihydrofolate reductase, reducing the synthesis of tetrahydrofolate. So, antifolate drugs stop reactions in which the carbons are contributed by derivatives of tetrahydrofolate. Such compounds that inhibit the formation of tetrahydrofolate and therefore block purine synthesis have been used in cancer chemotherapy.</li>\r\n</ul>\r\n<p><strong>Other inhibitory compounds that inhibit various enzymes and reactions of purine biosynthesis are:</strong></p>\r\n<ul>\r\n<li>Azaserine (inhibits the reaction catalysed by amidotransferase) <strong>(Option A)</strong></li>\r\n<li>Diazanorleucine (inhibits PRPP glutamine amidotransferase enzyme), 6-mercaptopurine (inhibits Adenyosuccinase and IMP dehydrogenase enzyme) <strong>(Option B)</strong></li>\r\n<li>Mycophenolic acid (inhibits IMP dehydrogenase enzyme)</li>\r\n</ul>\r\n<p><strong>Formyl transferase (Option C): </strong>This is anenzyme that add formyl groups during purine synthesis (e.g., transforming GAR to FGAR). This is not the target of mycophenolic acid.</p>", "options": ["Amidotransferase", "PRPP glutamyl amidotransferase", "Formyl transferase", "IMP dehydrogenase"], "html_options": ["Amidotransferase", "PRPP glutamyl amidotransferase", "Formyl transferase", "IMP dehydrogenase"], "corr_idx": 3}, {"id": "1182333", "html_qtxt": "Which amino acid is involved in the de novo synthesis of both purine and pyrimidine?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Aspartic acid provides N1 of the purine ring and C4, C5, C6 & N1 of the pyrimidine ring. So it is involved in the synthesis of both purine and pyrimidine.</li>\n</ul>\n<p><strong>Sources of the nitrogen and carbon atoms of the purine ring: </strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090405f9b42d-206a-4216-b20d-3373f24221e7.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycine</strong> (<strong>Option A) </strong>is involved only in purine nucleotide synthesis. It provides C4, C5, and N7 of purine rings.</p>\n<p><strong>Glutamic</strong> <strong>acid</strong> (<strong>Option B)</strong> is not involved in purine and pyrimidine biosynthesis, but <strong>glutamine</strong> is involved in both purine and pyrimidine biosynthesis.</p>\n<p><strong>Alanine</strong> (<strong>Option C) </strong>does not take part in the synthesis of purine and pyrimidine.</p>", "options": ["Glycine", "Glutamic acid", "Alanine", "Aspartic acid"], "html_options": ["Glycine", "Glutamic acid", "Alanine", "Aspartic acid"], "corr_idx": 3}, {"id": "1182335", "html_qtxt": "Which of the following vitamin deficiencies can lead to purine deficiency states in humans?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Purine deficiency states, while rare in humans, generally occur due to a deficiency of folic acid.</li>\n<li>C2 of the purine ring is contributed by N10 formyl tetrahydrofolate, whereas C8 of the purine ring is contributed by N5 N10 methenyl tetrahydrofolate. So derivatives of tetrahydrofolate, which are produced from folic acid, play an important role in the de novo biosynthesis of purine nucleotides.</li>\n</ul>\n<p><strong>Sources of the nitrogen and carbon atoms of the purine ring:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509045682c64a-5d4c-4943-90a7-23a94bf51f19.png\">\n<p>So, any compounds that inhibit the formation of tetrahydrofolate and therefore block purine synthesis have been used in cancer chemotherapy to inhibit DNA replication in rapidly dividing cells.</p>\n<p><strong>Explanation of other options: </strong></p>\n<p><strong>Ascorbic acid (Vitamin C)</strong> <strong>(Option A)</strong> deficiency can lead to scurvy. It is not involved in purine biosynthesis reactions.</p>\n<p><strong>Pyridoxine</strong> <strong>(Option C)</strong> has no role in purine biosynthesis.</p>\n<p><strong>Calcitriol (Vitamin D)</strong> <strong>(Option D) </strong>also has no role in purine biosynthesis. Vitamin D deficiency can lead to rickets.</p>", "options": ["Ascorbic acid", "Folic acid", "Pyridoxine", "Calcitriol"], "html_options": ["Ascorbic acid", "Folic acid", "Pyridoxine", "Calcitriol"], "corr_idx": 1}, {"id": "1182337", "html_qtxt": "All of the following are true regarding de novo purine biosynthesis, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Human brain tissue has a low level of PRPP glutamyl amidotransferase, an enzyme involved in de novo synthesis. <strong>So the brain depends on a salvage pathway to produce purine nucleotides.</strong></li>\r\n<li><strong>The overall determinant of the rate of de novo purine nucleotide biosynthesis is the concentration of PRPP. </strong>This, in turn, depends on the rate of PRPP synthesis, utilization, degradation, and regulation.</li>\r\n<li>The rate of PRPP synthesis depends on the availability of ribose 5-phosphate and on the activity of PRPP synthetase, an enzyme whose activity is feedback inhibited by AMP, ADP, GMP, and GDP.</li>\r\n<li>Elevated levels of these nucleoside phosphates thus signal a physiologically appropriate overall decrease in their biosynthesis. <strong>(Option A is true)</strong></li>\r\n<li><strong>Multifunctional Catalysts Participate in Purine Nucleotide Biosynthesis</strong>. The enzymes of eukaryotes are polypeptides that possess multiple catalytic activities whose adjacent catalytic sites facilitate channelling of intermediates between sites. Three distinct multifunctional enzymes catalyze reactions differently. <strong>(Option B is true)</strong></li>\r\n<li><strong>Purine nucleoside biosynthesis is energetically costly.</strong> In addition to ATP, glycine, glutamine, aspartate, and reduced tetrahydrofolate derivatives are all consumed. Thus, it is of survival advantage to closely regulate purine biosynthesis in response to varying physiological needs. <strong>(Option D is true)</strong></li>\r\n</ul>", "options": ["Concentration of PRPP determines the rate of purine biosynthesis", "Distinct multifunctional enzymes catalyse the reactions", "The brain depends on de novo synthesis to produce purine nucleotides", "Energetically very costly"], "html_options": ["Concentration of PRPP determines the rate of purine biosynthesis", "Distinct multifunctional enzymes catalyse the reactions", "The brain depends on de novo synthesis to produce purine nucleotides", "Energetically very costly"], "corr_idx": 2}, {"id": "1182341", "html_qtxt": "The first purine nucleotide synthesised by de novo biosynthesis is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Inosine monophosphate (IMP)</strong> is the initial purine nucleotide produced by the de novo pathway, serving as the central branching point for all subsequent purine nucleotide synthesis.</li>\n<li>IMP then serves as the branch point:\n<ul>\n<li><strong>IMP &rarr; AMP</strong> via adenylosuccinate synthase and lyase</li>\n<li><strong>IMP &rarr; XMP &rarr; GMP</strong> via IMP dehydrogenase and GMP synthetase</li>\n</ul>\n</li>\n<li>PRPP (Phosphoribosyl Pyrophosphate) provides the ribose-phosphate scaffold, upon which the purine ring is built stepwise to form IMP.</li>\n<li>Subsequent amination and phosphorylation steps yield the end-product nucleotides AMP and GMP.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090407baf98a-0a6c-4397-b1e3-7be9a840a0c2.png\">\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Adenosine monophosphate (AMP) (Option A)</strong> is formed by the amination of IMP via the adenylosuccinate synthase/lyase sequence, not as the primary de novo product.</p>\n<p><strong>Guanosine monophosphate (GMP) (Option B)</strong> is synthesised in two steps from IMP - first to XMP by IMP dehydrogenase, then to GMP by GMP synthetase.</p>\n<p><strong>Xanthosine monophosphate (XMP) (Option D)</strong> is an intermediate in the pathway from IMP to GMP and is not the initial purine nucleotide produced.</p>", "options": ["Adenosine monophosphate (AMP)", "Guanosine monophosphate (GMP)", "Inosine monophosphate (IMP)", "Xanthosine monophosphate (XMP)"], "html_options": ["Adenosine monophosphate (AMP)", "Guanosine monophosphate (GMP)", "Inosine monophosphate (IMP)", "Xanthosine monophosphate (XMP)"], "corr_idx": 2}, {"id": "1182346", "html_qtxt": "The first pyrimidine nucleotide synthesised by de novo biosynthesis is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>During de novo pyrimidine biosynthesis, the first nucleotide synthesised is Orotate monophosphate (OMP).</li>\n<li>Then OMP&rarr;UMP&rarr;UDP (uridine diphosphate)&rarr; UTP (uridine triphosphate)&rarr;CTP (cytidine triphosphate)</li>\n<li>Also UMP&rarr;UDP&rarr;dUDP&rarr;dUMP&rarr;TMP</li>\n<li>OMP <strong>(Option A)</strong> is produced first during de novo synthesis.</li>\n<li>UMP <strong>(Option B) </strong>is produced from OMP.</li>\n<li>dUMP <strong>(Option C)</strong> is produced from UMP.</li>\n<li>(Option D) TMP is also produced from UMP</li>\n<li>De novo biosynthesis of pyrimidine nucleotide reactions:<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090483e06574-8d08-4e29-b992-b6104a3b85e4.png\">\n</li>\n</ul>", "options": ["Orotate monophosphate (OMP)", "Uridine monophosphate (UMP)", "Deoxy uridine monophosphate (dUMP)", "Thymidine monophosphate (TMP)"], "html_options": ["Orotate monophosphate (OMP)", "Uridine monophosphate (UMP)", "Deoxy uridine monophosphate (dUMP)", "Thymidine monophosphate (TMP)"], "corr_idx": 0}, {"id": "1182359", "html_qtxt": "A 45-year-old male presented with pain and swelling in the great toe. On blood investigation, his uric acid level is found to be 9 mg/dl (normal 3.5 to 7 mg/dl). This clinical condition is associated with defects in which of the following metabolic processes?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>The given condition points to the diagnosis of gout, which is caused by a defect in purine metabolism.</p>\r\n<ul>\r\n<li>Gout is a metabolic disorder caused by hyperuricemia.</li>\r\n<li>Due to the low solubility of uric acid in water, it will get deposited in the synovial joint, leading to <strong>arthritis</strong>.</li>\r\n<li>Uric acid is an <strong>end product</strong> of <strong>purine nucleotide</strong> At physiological pH, uric acid is mostly ionised and present in plasma as sodium urate.</li>\r\n<li>Insoluble urate crystals precipitate in synovial fluid and other tissues, triggering intense inflammation.</li>\r\n<li><strong>Epidemiology:</strong> More common in middle-aged men; risk rises with age, obesity, and a high-purine diet.</li>\r\n<li><strong>Clinical features:</strong>\r\n<ul>\r\n<li>Acute onset of severe pain, erythema, and swelling - often of the first metatarsophalangeal joint (\"podagra\").</li>\r\n<li>Chronic tophaceous gout may develop tophi in soft tissues.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Risk factors:</strong>\r\n<ul>\r\n<li>High alcohol intake</li>\r\n<li>Red meat/seafood consumption</li>\r\n<li>Renal insufficiency</li>\r\n<li>Diuretic use</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Pyrimidine metabolism(Option B): </strong>The end product of pyrimidine catabolism is highly water-soluble, so overproduction of pyrimidine catabolites is rarely associated with clinical disease. Defects in pyrimidine nucleotide synthesis can lead to orotic aciduria.</p>\r\n<p><strong>Protein metabolism (Option C) </strong>The end product of protein catabolism is urea. Any defect in protein catabolism can lead to increased or decreased urea levels in the blood. Urea cycle defects can lead to hyperammonemia.</p>\r\n<p><strong>Phenylalanine metabolism (Option D): </strong>A defect in phenylalanine catabolism can lead to phenylketonuria.</p>", "options": ["Purine metabolism", "Pyrimidine metabolism", "Protein metabolism", "Phenylalanine metabolism"], "html_options": ["Purine metabolism", "Pyrimidine metabolism", "Protein metabolism", "Phenylalanine metabolism"], "corr_idx": 0}, {"id": "1182362", "html_qtxt": "Which of the following conditions can cause elevated blood uric acid levels while showing reduced or absent uric acid excretion in the urine?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In lactic acidosis, accumulated lactate competes with urate for renal tubular secretion, reducing uric acid excretion.</li>\r\n<li>This competition causes <strong>hyperuricemia</strong> despite <strong>low or absent uricosuria</strong>.</li>\r\n<li>Uric acid is an end product of purine nucleotide degradation. It is excreted by the kidneys. The daily excretion of uric acid is around 600 mg.</li>\r\n<li>Normal level of uric acid in blood is 3 to 7 mg/dl in males & 2-6 mg/dl in females (lower in females compared to males)</li>\r\n<li>Hyperuricemia is an increased level of uric acid in the blood (more than 7mg/dl). It may or may not be associated with increased excretion of uric acid in urine (uricosuria)</li>\r\n<li>Causes of Hyperuricemia & Gout-May be:\r\n<ul>\r\n<li><strong>Primary:</strong> Inborn error of metabolism which leads to overproduction of purines, which leads to increased purine catabolism, leading to overproduction of uric acid</li>\r\n<li><strong>Secondary:</strong> Secondary to other disorders, which lead to either overproduction of uric acid or reduced excretion of uric acid</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Defect in PRPP synthase enzyme (Option A): </strong>PRPP enzyme activity is abnormally increased. PRPP synthase is <strong>overactive</strong> and lacks feedback inhibition &rarr; &uarr; PRPP &rarr; &uarr; de novo purine synthesis &rarr; &uarr; uric acid production and &uarr; uricosuria.</p>\r\n<p><strong>Lesch&ndash;Nyhan syndrome (Option B) </strong>occurs due to a defect in the HGPRT (Hypoxanthine guanine phosphoribosyl transferase) enzyme of the purine salvage pathway. <strong>HGPRT loss</strong> &rarr; &darr; salvage, &uarr; PRPP &rarr; &uarr; purine synthesis and catabolism &rarr; hyperuricemia <strong>with</strong> &uarr; uricosuria.</p>\r\n<p><strong>Leukaemia (Option C) </strong>is a blood cancer, characterised by excessive cell turnover. <strong>High cell turnover</strong> &rarr; excessive nucleic acid degradation &rarr; &uarr; purine breakdown to uric acid &rarr; hyperuricemia <strong>with</strong> elevated urinary excretion.</p>", "options": ["Defect in PRPP synthase enzyme", "Lesch Nyhan syndrome", "Leukemia", "Lactic acidosis"], "html_options": ["Defect in PRPP synthase enzyme", "Lesch Nyhan syndrome", "Leukemia", "Lactic acidosis"], "corr_idx": 3}, {"id": "1182364", "html_qtxt": "Allantoin is a more water-soluble product of purine catabolism compared to uric acid. But in humans, uric acid is not further converted into allantoin due to a lack of the enzyme:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Uricase</strong> (urate oxidase) catalyses the oxidation of uric acid to <strong>allantoin</strong>, which is highly water-soluble.</li>\r\n<li>Humans <strong>lack</strong> uricase, so uric acid remains the end product of purine catabolism.</li>\r\n<li>Lack of uricase in humans contributes to susceptibility to <strong>gout</strong> and uric acid kidney stones.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Xanthine oxidase</strong> <strong>(Option A) </strong>enzyme converts Hypoxanthine into Xanthine and Xanthine into Uric acid. This enzyme is present in both mammals and humans, so both break down purines up to uric acid.</p>\r\n<p><strong>HGPRTase (Option B)</strong> is an enzyme involved in the salvage pathway. It converts Guanine & Hypoxanthine into GMP & IMP. Its deficiency can lead to Lesch-Nyhan syndrome.</p>\r\n<p><strong>Urease (Option C) </strong>catalyses the hydrolysis of Urea into ammonia and carbon dioxide. It is also not present in humans, so human urea is excreted in urine.</p>", "options": ["Xanthine oxidase", "HGPRTase", "Urease", "Uricase"], "html_options": ["Xanthine oxidase", "HGPRTase", "Urease", "Uricase"], "corr_idx": 3}, {"id": "1182366", "html_qtxt": "All of the following enzyme defects can lead to hyperuricemia and gout, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>ADA deficiency causes accumulation of adenosine and deoxyadenosine, leading to severe combined immunodeficiency (SCID) and hypouricemia, not hyperuricemia.</li>\r\n<li>Hyperuricemia arises from overproduction or underexcretion of uric acid, the end product of purine catabolism.</li>\r\n<li>Hypouricemia is clinically not significant.</li>\r\n<li><strong>Causes: </strong>\r\n<ul>\r\n<li>ADA deficiency</li>\r\n<li>XO deficiency</li>\r\n<li>Purine nucleoside phosphorylase deficiency</li>\r\n<li>PRPP Synthetase Deficiency</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options: </strong></p>\r\n<p>Deficiency of <strong>Glucose 6 Phosphatase</strong> <strong>(Option A)</strong> (Von Gierke's disease) leads to accumulation of glucose 6 phosphate (precursor of PRPP), which is diverted to the HMP shunt and increased ribose 5 phosphate, which increases de novo synthesis. Such overproduction of purine is further metabolised and produces more uric acid and hyperuricemia.<strong> </strong></p>\r\n<p><strong>HGPRT</strong> (<strong>Hypoxanthine guanine phosphoribosyl transferase)</strong> <strong>(Option B) </strong>is an enzyme involved in the salvage pathway. Its deficiency can lead to reduced purine salvage and increased purine nucleotide synthesis, which further catabolizes and produces more uric acid and hyperuricemia. HGPRTase deficiency can lead to <strong>Lesch-Nyhan syndrome.</strong></p>\r\n<p><strong>Phosphoribosyl amido transferase (PRAT) (Option D):</strong> This enzyme is involved in the de novo synthesis of purine nucleotides. It is abnormally active, not subject to feedback inhibition by excess nucleotides. So, increased purine synthesis, which is further catabolized and produced in more uric acid and hyperuricemia.</p>", "options": ["Glucose 6 phosphatase", "Hypoxanthine guanine phosphoribosyl transferase", "Adenosine deaminase", "Phosphoribosyl amido transferase"], "html_options": ["Glucose 6 phosphatase", "Hypoxanthine guanine phosphoribosyl transferase", "Adenosine deaminase", "Phosphoribosyl amido transferase"], "corr_idx": 2}, {"id": "1182367", "html_qtxt": "All of the following is an end product of pyrimidine catabolism, except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The catabolism of the pyrimidines forms highly water-soluble products- CO2, NH3, &beta;-alanine, and &beta;-aminoisobutyrate, but not glycine.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509041027021f-4a67-40db-a7e8-8f64c6d93c1a.png\">\n<p><strong>Explanation of other options: </strong></p>\n<p><strong>Ammonia</strong> <strong>(Option A)</strong> is released during the deamination of the pyrimidine ring.</p>\n<p><strong>Carbon dioxide</strong> <strong>(Option B) </strong>is generated during the oxidative ring opening and decarboxylation steps.</p>\n<p><strong>Alanine</strong> <strong>(Option D), </strong>specifically <strong>&beta;-alanine</strong>,is  produced from uracil catabolism (not the standard &alpha;-alanine of protein metabolism).</p>", "options": ["Ammonia", "Carbon dioxide", "Glycine", "Alanine"], "html_options": ["Ammonia", "Carbon dioxide", "Glycine", "Alanine"], "corr_idx": 2}, {"id": "1182368", "html_qtxt": "&beta;-hydroxybutyric aciduria occurs due to:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Disorders of &beta;-alanine and &beta;-aminoisobutyrate metabolism arise from defects in enzymes of pyrimidine catabolism.</p>\r\n<ul>\r\n<li><strong>&beta;-Hydroxybutyric aciduria</strong> arises from total or partial deficiency of <strong>dihydropyrimidine dehydrogenase</strong>.</li>\r\n<li>It is a disorder of <strong>pyrimidine catabolism</strong>, also termed <strong>combined uraciluria-thyminuria</strong>, reflecting accumulation of upstream bases.</li>\r\n<li>This defect impairs the formation of the <strong>&beta;-amino acids</strong>-&beta;-alanine and &beta;-aminoisobutyrate-linking it to &beta;-amino acid metabolism.</li>\r\n<li><strong>Genetic</strong> cases present with serious <strong>neurologic complications</strong> due to toxic metabolite buildup.</li>\r\n<li>A <strong>nongenetic</strong> form can be induced by <strong>5-fluorouracil</strong> therapy in patients with inherently low dihydropyrimidine dehydrogenase activity.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Vitamin B12</strong> <strong>(Option A)</strong> deficiency leads to methylmalonic aciduria.</p>\r\n<p><strong>ADA</strong> (Adenosine deaminase) (<strong>Option B)</strong> enzyme deficiency can lead to SCID (Severe Combined Immunodeficiency disease), an immunological disease.</p>\r\n<p><strong>Orotate phosphoribosyl transferase enzyme</strong> <strong>deficiency</strong> <strong>(Option C) </strong>can lead to Orotic aciduria.</p>", "options": ["Vitamin B12 deficiency", "ADA enzyme deficiency", "Orotate phosphoribosyl transferase enzyme deficiency", "Dihydro pyrimidine dehydrogenase enzyme deficiency"], "html_options": ["Vitamin B12 deficiency", "ADA enzyme deficiency", "Orotate phosphoribosyl transferase enzyme deficiency", "Dihydro pyrimidine dehydrogenase enzyme deficiency"], "corr_idx": 3}, {"id": "1182371", "html_qtxt": "Type II Orotic aciduria occurs due to a deficiency of the enzyme:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Type II orotic aciduria is defined by an isolated deficiency of OMP (orotidylate) decarboxylase, the second activity of UMP synthase.</li>\n<li>This block prevents conversion of OMP to UMP, causing accumulation and urinary excretion of orotic acid.</li>\n</ul>\n<p><strong>Orotic Aciduria: </strong></p>\n<ul>\n<li>Increased excretion of Orotic acid in urine</li>\n<li>Disorder of pyrimidine nucleotide synthesis</li>\n</ul>\n<p><strong>Causes:</strong></p>\n<ul>\n<li><strong>Primary orotic aciduria:</strong>\n<ul>\n<li>Inherited deficiency of enzymes involved in pyrimidine biosynthesis: UMP synthase</li>\n<li>UMP synthase is a multi-enzyme complex containing both orotate phosphoribosyl transferase and/ or orotidylate (OMP) decarboxylase activity</li>\n<li>Two types based on severity:\n<ul>\n<li><strong>Type I Orotic aciduria: </strong>Severe deficiency of both enzymes</li>\n<li><strong>Type II Orotic aciduria: </strong>Deficiency of only orotidylate (OMP) decarboxylase</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Secondary Orotic aciduria:</strong>\n<ul>\n<li><strong>Drug-induced orotic aciduria:</strong> Allopurinol & 6-Azauridin: Metabolites of these drugs inhibit OMP decarboxylase</li>\n<li><strong>Ornithine transcarbamoylase deficiency</strong>: A urea cycle disorder, resulting in the accumulation of Carbamoyl Phosphate (CP) in mitochondria, which is then diverted to cytosolic overproduction of orotic acid</li>\n<li><strong>Reye's syndrome</strong>: Severely damaged mitochondria, not able to utilise carbamoyl phosphate in the formation of urea, which then diverts to cytosolic overproduction of orotic acid</li>\n</ul>\n</li>\n</ul>\n<p><strong>Clinical features:</strong></p>\n<ul>\n<li>Accumulation of orotic acid in the blood, orotic acid crystals in the urine may lead to urinary tract obstruction</li>\n<li>A defect in pyrimidine nucleotide synthesis results in inhibition of DNA and RNA synthesis, which causes megaloblastic anaemia & growth retardation</li>\n</ul>\n<p><strong>Treatment: </strong></p>\n<p>Administration of Uridine: because Uridine bypasses defective enzyme steps.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509047f4c0cc6-0a6b-4e4e-8c9d-49031b8c9550.png\">\n<p><strong>Explanation of other options: </strong></p>\n<p>Type I orotic aciduria reflects a deficiency of both <strong>orotate phosphoribosyl transferase</strong> and orotidylate decarboxylase. <strong>(Option A)</strong></p>\n<p><strong>Dihydropyrimidine dehydrogenase (Option B) </strong>is an enzyme involved in pyrimidine catabolism. Its deficiency results in &beta;-hydroxybutyric aciduria.</p>\n<p><strong>Glucose 6-phosphatase (Option D) </strong>deficiency leads to Von Gierke's disease, a disease associated with glycogen metabolism.</p>", "options": ["Orotate phosphoribosyl transferase", "Dihydropyrimidine dehydrogenase", "Orotidylate decarboxylase", "Glucose 6 phosphatase"], "html_options": ["Orotate phosphoribosyl transferase", "Dihydropyrimidine dehydrogenase", "Orotidylate decarboxylase", "Glucose 6 phosphatase"], "corr_idx": 2}]}, {"moduleId": 1008730, "name": "Nucleic Acid Structure (DNA & RNA), Function", "questions": [{"id": "1182376", "html_qtxt": "All of the following deoxynucleotides are present in DNA except", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<ul>\n<li>DNA's four monomeric <strong>deoxynucleotides </strong>are<strong> deoxyadenylate, deoxyguanylate, deoxycytidylate, </strong>and</li>\n<li><strong>Deoxyuridylate</strong> is not incorporated into DNA; uracil is found only in RNA.</li>\n<li>These DNA nucleotides are linked by 3'&rarr;5' phosphodiester bonds to form each strand.</li>\n<li>Thymidylate is deoxythymidine monophosphate carrying thymine's methylated base, which is critical for DNA stability and repair. <strong>(Option B)</strong></li>\n<li>Deoxyguanylate is deoxyguanosine monophosphate, containing guanine, which participates in canonical G-C base pairing and can form secondary structures like G-quadruplexes.<strong> (Option C)</strong></li>\n<li>Deoxycytidylate is deoxycytidine monophosphate carrying cytosine, whose deamination to uracil in DNA is recognised and corrected by base-excision repair. <strong>(Option D)</strong></li>\n</ul>", "options": ["Deoxyuridylate", "Thymidylate", "Deoxyguanylate", "Deoxycytidylate"], "html_options": ["Deoxyuridylate", "Thymidylate", "Deoxyguanylate", "Deoxycytidylate"], "corr_idx": 0}, {"id": "1182413", "html_qtxt": "Which of the following bonds do not involve the N base in the formation of bonds?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<ul>\n<li>Phosphodiester bonds do not involve N bases in bond formation.</li>\n<li>The phosphodiester bond joins the 3' hydroxyl group of deoxyribose of one nucleotide to the 5' hydroxyl group of another nucleotide through a phosphate group.</li>\n<li>All deoxyribonucleotides are linked together by a 3' - 5' phosphodiester bond in the DNA strand.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509048b18c0ac-efe3-489a-a379-9e8851d71ab3.png\">\n </li>\n<li>The two strands of this double-stranded helix are held together by hydrogen bonds between the purine and pyrimidine bases of the respective linear molecules.</li>\n<li>The pairings between the purine and pyrimidine nucleotides on the opposite strands are very specific and are dependent on hydrogen bonding of A with T and G with C (often referred to as Watson-Crick base pairs).</li>\n</ul>\n<p>Three hydrogen bonds hold the deoxyguanosine nucleotide to the deoxycytidine nucleotide, whereas the other pair, the A-T pair, is held together by two hydrogen bonds.<strong> (Option A ruled out) </strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509049f05c9ea-48c0-4279-9a6f-fe3fec0a5bc3.png\">\n<p>The two strands of this double-stranded helix are also held together by Van Der Waals and hydrophobic interactions between the stacked adjacent base pairs. <strong>(Option B ruled out) </strong></p>\n<p>N Base (purine or pyrimidine) attached to pentose sugar (ribose or deoxyribose) by beta-N glycosidic bond. C1 of sugar is linked to N1 of pyrimidine or N9 of purine. <strong>(Option C ruled out)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509040d0bb44f-2191-429a-b889-88ddc770a96a.png\">", "options": ["Hydrogen bond", "Hydrophobic interactions", "Beta N glycosidic bond", "Phosphodiester bond"], "html_options": ["Hydrogen bond", "Hydrophobic interactions", "Beta N glycosidic bond", "Phosphodiester bond"], "corr_idx": 3}, {"id": "1182421", "html_qtxt": "Which one of the following sentences is true about circular DNA?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In some organisms, such as bacteria, bacteriophages, many DNA-containing animal viruses, as well as organelles such as mitochondria, the ends of the DNA molecules are joined to create a closed circle with no covalently free ends, <strong>eliminating all free 3'- and 5'-termini</strong>.</li>\n<li>This energy-requiring process puts the molecule under torsional stress, and the greater the number of supercoils, the greater the stress or torsion (test this by twisting a rubber band).</li>\n<li>Circular DNA can adopt <strong>relaxed</strong> or <strong>supercoiled</strong> conformations, regulated by topoisomerases. <strong>(Option A ruled out)</strong></li>\n<li>Supercoiling aids in compaction and regulates replication and transcription.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Destroy the polarity of DNA: (Option B)</strong> Formation of circular DNA will not destroy the polarity of DNA molecules.</p>\n<p><strong>Nuclear DNA is in circular for</strong>m <strong>(Option D):</strong> Nuclear DNA is linear DNA, not in circular form. But mitochondrial DNA is circular.</p>", "options": ["Always exist in supercoiled form", "Destroy polarity of DNA", "Eliminate all 3' and 5' hydroxyl and phosphoryl groups", "Nuclear DNA is in circular form"], "html_options": ["Always exist in supercoiled form", "Destroy polarity of DNA", "Eliminate all 3' and 5' hydroxyl and phosphoryl groups", "Nuclear DNA is in circular form"], "corr_idx": 2}, {"id": "1182423", "html_qtxt": "The chemical nature of RNA is different from DNA in all of the following except,", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>RNA and DNA both contain the same purine bases (adenine and guanine); this feature does not differ.</li>\n<li>The chemical nature of RNA is different from that of DNA:\n<ul>\n<li>RNA is a polymer of purine and pyrimidine ribonucleotides linked together by 3' 5'-phosphodiester bonds analogous to those in DNA.</li>\n<li>Although sharing many features with DNA, RNA possesses several specific differences in sugar, pyrimidine N base, alkali hydrolysis, etc</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090438cde4d6-4e85-4201-94d2-c05e29639548.png\">", "options": ["Purine N base", "Sugar", "Pyrimidine N base", "Alkali hydrolysis"], "html_options": ["Purine N base", "Sugar", "Pyrimidine N base", "Alkali hydrolysis"], "corr_idx": 0}, {"id": "1182425", "html_qtxt": "The retroviruses (eg, HIV) are transcribed by reverse transcriptase enzymes to produce a double-stranded DNA copy of their RNA genome. This viral reverse transcriptase enzyme is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Retroviral reverse transcriptase uses the RNA genome as a template to synthesise a complementary DNA strand; hence, it is an RNA-dependent DNA polymerase.</li>\n<li>The resulting double-stranded DNA integrates into the host genome as a proviral DNA, serving as a template for viral mRNA and genome synthesis.</li>\n<li>Genomic insertion of such integrating \"proviral\" DNA molecules can, depending on the site involved, be mutagenic, inactivating a gene or dysregulating its expression.</li>\n<li>The genetic material for some animal and plant viruses is RNA rather than DNA.</li>\n<li>Many animal RNA viruses, specifically, the retroviruses (eg, the human immunodeficiency virus, or HIV), are transcribed by viral RNA-dependent DNA polymerase, the so-called <strong>reverse transcriptase</strong>, to produce a double-stranded DNA copy of their RNA genome.</li>\n</ul>", "options": ["RNA-dependent DNA polymerase", "DNA-dependent DNA polymerase", "RNA-dependent RNA polymerase", "DNA-dependent RNA polymerase"], "html_options": ["RNA-dependent DNA polymerase", "DNA-dependent DNA polymerase", "RNA-dependent RNA polymerase", "DNA-dependent RNA polymerase"], "corr_idx": 0}, {"id": "1182433", "html_qtxt": "Almost all eukaryotic mRNA molecules, at the 3'-hydroxyl terminus, have an attached, non genetically encoded polymer of adenylate residues, which is known as the poly(A) tail. Such poly (A) chains are present in all mRNA that code for different proteins, except mRNA that codes for:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Eukaryotic mRNAs have unique chemical characteristics.</p>\n<ul>\n<li>The 5' terminus of mRNA is \"capped\" by a 7-methylguanosine triphosphate.</li>\n<li>The cap is involved in the recognition of mRNA by the translation machinery, and also helps stabilise the mRNA by preventing the nucleolytic attack by 5'-exoribonucleases.</li>\n<li>The protein-synthesising machinery begins translating the mRNA into proteins, beginning downstream of the 5' or capped terminus.</li>\n<li>At the other end of almost all eukaryotic mRNA molecules, the 3'-hydroxyl terminus has an attached, non genetically encoded polymer of adenylate residues 20 to 250 nucleotides in length.</li>\n<li>The <strong>poly(A) \"tail\"</strong> at the 3'-end of mRNAs <strong>maintains the intracellular stability </strong>of the <strong>specific mRNA</strong> by preventing the attack of 3'-exoribonucleases and also facilitates translation.</li>\n<li>A few mRNAs, including those for some <strong>histones</strong>, <strong>do not contain a poly (A) tail.</strong></li>\n<li>Both the mRNA \"cap\" and \"poly(A) tail\" are added <strong>posttranscriptionally</strong> by nontemplate-directed enzymes to mRNA precursor molecules (pre-mRNA).</li>\n</ul>\n<p><strong>Reverse transcriptase (Option A): </strong>This is a viral enzyme whose mRNA comes from retroviruses, and it <strong>has a poly(A) tail</strong>. Viral mRNAs mimic host mRNAs and are <strong>polyadenylated</strong> to ensure translation in eukaryotic cells.</p>\n<p><strong>RNA polymerase (Option B): </strong>The mRNA for RNA polymerase subunits is processed like typical eukaryotic mRNA and <strong>has a poly(A) tail</strong>. It is <strong>transcribed by RNA polymerase II</strong> and polyadenylated during post-transcriptional modification.</p>\n<p><strong>DNA polymerase (Option C): </strong>The mRNA coding for DNA polymerase is a standard protein-coding mRNA and includes a <strong>poly(A) tail</strong>. It undergoes <strong>normal mRNA processing</strong>, including 5'capping, splicing, and 3'polyadenylation.</p>", "options": ["Reverse transcriptase", "RNA polymerase", "DNA polymerase", "Histone"], "html_options": ["Reverse transcriptase", "RNA polymerase", "DNA polymerase", "Histone"], "corr_idx": 3}, {"id": "1182435", "html_qtxt": "Which of the following is true regarding messenger RNA?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Messenger RNA is the most heterogeneous in abundance, size, and stability. Specific transcriptional and post-transcriptional mechanisms contribute to this large dynamic range in mRNA content.</li>\n</ul>\n<p><strong>Function:</strong></p>\n<ul>\n<li>All members of the mRNA class act as <strong>messengers</strong>, conveying genetic information from DNA to the <strong>protein-synthesizing machinery</strong> (ribosomes).</li>\n</ul>\n<p><strong>Role in Translation:</strong></p>\n<ul>\n<li>Each mRNA serves as a <strong>template</strong> for assembling a specific sequence of amino acids to produce a <strong>specific protein</strong>, the final gene product.</li>\n</ul>\n<p><strong>Posttranscriptional Modifications:</strong></p>\n<ul>\n<li>The <strong>5' \"cap\"</strong> by 7-methylguanosine triphosphate and <strong>3' \"poly(A) tail\"</strong> are <strong>not coded</strong> by DNA but are added <strong>posttranscriptionally</strong>. <strong>(Option A & B)</strong></li>\n<li>These modifications are made by <strong>nontemplate-directed enzymes</strong> to the <strong>pre-mRNA</strong> (precursor mRNA).</li>\n</ul>\n<p><strong>Proportion of Cellular RNA:<br /> </strong> mRNA makes up only <strong>2-5%</strong> of the total RNA in eukaryotic cells.</p>\n<p><strong>Pre-mRNA Processing in Mammals:</strong></p>\n<ul>\n<li>In mammalian cells (including human cells), the <strong>cytoplasmic mRNA</strong> is <strong>not</strong> the direct product of transcription.</li>\n<li>Instead, it is derived from <strong>pre-mRNA</strong>, which undergoes <strong>extensive processing</strong> before exiting the nucleus.</li>\n</ul>\n<p><strong>Size and Complexity of Pre-mRNA:</strong></p>\n<ul>\n<li><strong>Primary transcripts (pre-mRNA)</strong> in the nucleus are often <strong>10&ndash;50 times longer</strong> than the final mature mRNA. <strong>(Option D)</strong></li>\n<li>They are <strong>highly heterogeneous</strong> in size and structure before processing.</li>\n</ul>\n<p><strong>Maturation Process:</strong></p>\n<p>Pre-mRNA undergoes:</p>\n<ul>\n<li><strong>5' capping</strong></li>\n<li><strong>Splicing</strong> (removal of introns)</li>\n<li><strong>3' polyadenylation<br /> </strong>to become mature, functional mRNA that enters the <strong>cytoplasm</strong> for translation.</li>\n</ul>", "options": ["5' terminal end has poly A tail", "3' terminal end is capped by 7 methyl guanosine triphosphate", "Most heterogeneous RNA", "Pre mRNA is shorter than mature mRNA molecule"], "html_options": ["5' terminal end has poly A tail", "3' terminal end is capped by 7 methyl guanosine triphosphate", "Most heterogeneous RNA", "Pre mRNA is shorter than mature mRNA molecule"], "corr_idx": 2}, {"id": "1182439", "html_qtxt": "The tRNA molecules serve as adapters for the translation of the information in the sequence of nucleotides of the mRNA into specific amino acids. All of the following features are found commonly in all the tRNA molecules, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The CCA sequence at the 3&prime; end of every tRNA is added post-transcriptionally by a <strong>specific nucleotidyl transferase enzyme</strong>, not by a non-enzymatic process.</li>\n<li>The acceptor arm terminates in the nucleotides CpCpAOH. These three nucleotides are added post-transcriptionally by a specific nucleotidyl transferase enzyme. The tRNA-appropriate amino acid is attached, or 'charged', onto the 3'-OH group of the A moiety of the acceptor arm through the action of specific aminoacyl tRNA synthetases.</li>\n</ul>\n<p><strong>Transfer RNA:</strong></p>\n<ul>\n<li><strong>Length:</strong> Typically <strong>74-95 nucleotides</strong></li>\n<li><strong>Processing:</strong> Synthesized as a <strong>precursor</strong>, then processed in the <strong>nucleus</strong> like other RNAs.</li>\n<li><strong>Function: </strong>Acts as an <strong>adapter</strong> that translates <strong>mRNA codons</strong> into <strong>amino acids</strong> during protein synthesis.</li>\n<li><strong>Variety:</strong> At least <strong>20 tRNA species</strong> per cell - one or more for each of the <strong>20 amino acids</strong>. <strong>(Option A)</strong></li>\n<li><strong>Structure:</strong>\n<ul>\n<li><strong>Primary structure:</strong> Linear nucleotide sequence.</li>\n<li><strong>Secondary structure:</strong> <strong>Cloverleaf</strong> form due to intrastrand base pairing.</li>\n<li>Contains <strong>four arms/stems</strong>: <strong>(Option B)</strong>\n<ul>\n<li>Acceptor arm (ends in CpCpAOH added post-transcriptionally)</li>\n<li>D arm</li>\n<li>T&psi;C arm</li>\n<li>Variable (extra) arm</li>\n</ul>\n</li>\n<li>Charging: The <strong>correct amino acid</strong> is attached to the <strong>3'-OH of the terminal A</strong> by specific <strong>aminoacyl-tRNA synthetases</strong>.</li>\n<li><strong>Abundance: </strong>Makes up about <strong>20% of total cellular RNA</strong>.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090487f3bb11-f4b7-429c-b325-e800384f42d6.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>(Option D) </strong>There is intrastrand complementarity in all tRNA molecules, which generates an extensively folded secondary structure that appears in two dimensions like a cloverleaf.</p>", "options": ["There may be one or more tRNA for specific amino acid", "All tRNA contain four main arms", "At the acceptor arm, CCA sequence is added post-transcriptionally by a non enzymatic process.", "Have complementary N bases within strand"], "html_options": ["There may be one or more tRNA for specific amino acid", "All tRNA contain four main arms", "At the acceptor arm, CCA sequence is added post-transcriptionally by a non enzymatic process.", "Have complementary N bases within strand"], "corr_idx": 2}, {"id": "1182441", "html_qtxt": "The smaller subunit of the mammalian ribosome contains which of the following rRNAs?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<ul>\n<li>The eukaryotic ribosome splits into a 40S small subunit and a 60S large subunit.</li>\n<li>The smaller <strong>40S subunit</strong> contains a single <strong>18S rRNA</strong></li>\n<li><strong>5S, 5.8S, and 28S rRNAs</strong> reside in the <strong>60S large subunit</strong>.</li>\n</ul>\n<p><strong>Ribosomal RNA</strong></p>\n<ul>\n<li>A ribosome is a cytoplasmic nucleoprotein structure that acts as the machinery for the synthesis of proteins from the mRNA templates. On the ribosomes, the mRNA and tRNA molecules interact to translate the information transcribed from the gene during mRNA synthesis into a specific protein. During periods of active protein synthesis, many ribosomes can be associated with any mRNA molecule to form an assembly called the polysome.</li>\n<li>The 60S subunit contains a 5S rRNA, a 5.8S rRNA, and a 28S rRNA; there are also more than 50 specific polypeptides. <strong>(Option A, B, & D)</strong></li>\n<li>The 40S subunit is smaller and contains a single 18S rRNA and approximately 30 distinct polypeptide chains.</li>\n<li>Except for 5S rRNA, all other rRNA molecules are processed from a single 45S precursor RNA molecule in the nucleolus.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904fedeeb78-b401-4d34-bc61-0d83aeca6d9a.png\">", "options": ["5S rRNA", "5.8S rRNA", "18S rRNA", "28S rRNA"], "html_options": ["5S rRNA", "5.8S rRNA", "18S rRNA", "28S rRNA"], "corr_idx": 2}, {"id": "1182448", "html_qtxt": "Which of the following snRNAs is involved in the production of the correct 3' ends of histone mRNA, which lacks a poly(A) tail?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<p>The U7 snRNA is involved in the production of the correct 3' ends of histone mRNA-which lacks a poly(A) tail.</p>\n<p><strong>Small Nuclear RNAs</strong></p>\n<ul>\n<li>snRNAs, a subset of the small nuclear RNAs, are significantly involved in rRNA and mRNA processing and gene regulation.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904fc3b849a-be75-4b39-8df5-9fbabf335a8c.png\"></li>\n<li>Of the several snRNAs, U1, U2, U4, U5, and U6 are involved in intron removal and the processing of mRNA precursors into mRNA within the nucleus. (<strong>Option A, B, and C)</strong></li>\n<li>The U7 snRNA is involved in the production of the correct 3' ends of histone mRNA-which lacks a poly(A) tail.</li>\n<li>7SK RNA associates with several proteins to form a ribonucleoprotein complex, termed P-TEFb, that modulates mRNA gene transcription elongation by RNA polymerase II.</li>\n</ul>", "options": ["U4", "U5", "U6", "U7"], "html_options": ["U4", "U5", "U6", "U7"], "corr_idx": 3}, {"id": "1182453", "html_qtxt": "Which of the following RNAs is specifically used to decrease specific protein levels?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<ul>\n<li>The small non-coding RNAs (ncRNAs) termed miRNAs (Micro-RNAs) and siRNAs (silencing RNAs) typically inhibit gene expression at the level of specific protein production by targeting mRNAs through one of several distinct mechanisms.</li>\n<li><strong>siRNAs</strong> are frequently used to <strong>decrease</strong> or \"<strong>knockdown</strong>\" <strong>specific protein levels</strong> (via siRNA homology-directed mRNA degradation) in experimental contexts in the laboratory.</li>\n</ul>\n<p><strong>circRNAs</strong> <strong>(Option B)</strong>: There are two classes of larger noncoding RNAs: the circular RNAs (circRNAs) and the long noncoding RNAs, or lncRNAs. While the functions of circRNAs are still being elucidated, they seem to be particularly abundant in cells of the nervous system. Similar to lncRNAs, these molecules likely play important roles in cellular biology by regulating gene expression at multiple levels.</p>\n<p><strong>Small Nuclear RNAs (snRNAs) (Option C)</strong>, a subset of the small nuclear RNAs, are significantly involved in rRNA and mRNA processing and gene regulation.</p>\n<p><strong>Ribosomal RNA (Option D):</strong> On the ribosomes, the mRNA and tRNA molecules interact to translate the information transcribed from the gene during mRNA synthesis into a specific protein.</p>", "options": ["siRNA", "circRNA", "snRNA", "rRNA"], "html_options": ["siRNA", "circRNA", "snRNA", "rRNA"], "corr_idx": 0}, {"id": "1182456", "html_qtxt": "RNAs are far less stable than DNA due to presence of:", "html_expl": "<p><strong>Explanation for answer:</strong></p>\n<p>RNAs are far less stable than DNA since the 2'-hydroxyl group of RNA (absent in DNA) functions as a nucleophile during hydrolysis of the 3',5'-phosphodiester bond.</p>\n<ul>\n<li>DNA and RNA are both polynucleotides made of nucleotides linked by <strong>3',5'-phosphodiester bonds</strong>, forming the sugar-phosphate backbone.</li>\n<li>Although <strong>hydrolysis</strong> of these phosphodiester bonds is <strong>thermodynamically favoured</strong>, in DNA it occurs very slowly without enzymatic action, allowing DNA to <strong>persist for long periods</strong>, even in <strong>fossils</strong>.</li>\n<li>In contrast, <strong>RNA is much less stable</strong> than DNA. This is because <strong>RNA contains a 2'-hydroxyl (-OH) group</strong> on the ribose sugar (which DNA lacks).</li>\n<li>This 2'-OH group acts as a <strong>nucleophile</strong> and facilitates the <strong>hydrolysis</strong> of the 3',5'-phosphodiester bond. Thus, the presence of the <strong>2'-hydroxyl group in ribose</strong> makes RNA inherently more prone to breakdown.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509043b58ab38-fa34-4b50-a654-38834af304be.png\">", "options": ["Uracil", "Unusual nucleotides", "snRNA", "2' hydroxyl group in ribose"], "html_options": ["Uracil", "Unusual nucleotides", "snRNA", "2' hydroxyl group in ribose"], "corr_idx": 3}, {"id": "1182458", "html_qtxt": "Which of the following is true about denaturation of DNA?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Denaturation can be <strong>used to analyse the structure of DNA.</strong></p>\n<ul>\n<li>The double-stranded structure of DNA can be separated into two component strands in solution by <strong>increasing the temperature</strong> or <strong>decreasing the salt concentration</strong>.</li>\n<li>Not only do the two stacks of bases pull apart, but the bases themselves unstack while still connected in the polymer by the phosphodiester backbone.</li>\n<li>The strands of a given molecule of DNA separate over a temperature range.</li>\n<li>The midpoint is called the melting temperature, or Tm.</li>\n<li>The Tm is influenced by the base composition of the DNA and by the salt concentration of the solution.</li>\n<li>A 10-fold increase in monovalent cation concentration increases the&nbsp;<em>T</em>m by 16.6&deg;C by neutralising the intrinsic interchain repulsion between the highly negatively charged phosphates of the phosphodiester backbone.</li>\n</ul>\n<p><strong>Decrease optical absorbance</strong> <strong>(Option A): </strong>Concomitant with this denaturation of the DNA molecule is an increase in the optical absorbance of the purine and pyrimidine bases, a phenomenon referred to as hyperchromicity of denaturation.</p>\n<p><strong>Increase its viscosity (Option B):</strong> Because of the stacking of the bases and the hydrogen bonding between the stacks, the double-stranded DNA molecule exhibits properties of a rigid rod and, in solution, is a viscous material that reduces or loses its viscosity upon denaturation.</p>\n<p><strong>DNA rich in G-C pairs melts at a lower temperature than DNA rich in A-T pairs (Option D):</strong> DNA rich in G-C pairs, which have three hydrogen bonds, melts at a higher temperature than DNA rich in A-T pairs, which have two hydrogen bonds.</p>", "options": ["Decrease optical absorbance", "Increase its viscosity", "Used to analyse structure of DNA", "DNA rich in G-C pairs melts at lower temperature than DNA rich in A-T pairs"], "html_options": ["Decrease optical absorbance", "Increase its viscosity", "Used to analyse structure of DNA", "DNA rich in G-C pairs melts at lower temperature than DNA rich in A-T pairs"], "corr_idx": 2}]}, {"moduleId": 1008731, "name": "DNA Organization, Replication, Damage And Repair", "questions": [{"id": "1182306", "html_qtxt": "Chromatin contains which of the following components?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Chromatin is the chromosomal material in the nuclei of cells of eukaryotic organisms.</p>\r\n<ul>\r\n<li>Chromatin consists of,\r\n<ul>\r\n<li><strong>Very long double-stranded DNA</strong> (dsDNA) molecules: The dsDNA helix in each chromosome has a length that is thousands of times the diameter of the cell nucleus. <strong>(Option A ruled out)</strong></li>\r\n<li>Small <strong>basic</strong> proteins termed <strong>histones</strong>: The histones help to condense the DNA, and also integrally participate in gene regulation. <strong>(Option B ruled out)</strong></li>\r\n<li>Smaller amount of <strong>nonhistone proteins</strong> (most of which are <strong>acidic</strong> and larger than histones): The nonhistone proteins include enzymes involved in DNA replication and repair, and the proteins involved in RNA synthesis, processing, and transport to the cytoplasm. <strong>(Option C ruled out)</strong></li>\r\n<li>Small quantity of <strong> (Option D)</strong></li>\r\n<li>Electron microscopic studies of chromatin have demonstrated dense spherical particles called <strong>nucleosomes</strong>, which are approximately 10 nm in diameter and connected by DNA filaments. Nucleosomes are composed of DNA wound around an octameric complex of histone molecules.</li>\r\n</ul>\r\n</li>\r\n</ul>", "options": ["Single-stranded DNA", "Acidic histone proteins", "Basic Non-histone proteins", "RNA"], "html_options": ["Single-stranded DNA", "Acidic histone proteins", "Basic Non-histone proteins", "RNA"], "corr_idx": 3}, {"id": "1182311", "html_qtxt": "Compared to nuclear DNA, mitochondrial DNA has,", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Mitochondrial DNA has very few untranslated sequences compared to nuclear DNA.</p>\r\n<p><strong>Mitochondrial DNA </strong></p>\r\n<p><strong>General Characteristics</strong></p>\r\n<ul>\r\n<li>Structure: Small, circular, <strong>double-stranded</strong> DNA <strong>(Option D)</strong></li>\r\n<li>Copies per cell: Each mitochondrion contains 2 to 10 copies</li>\r\n<li>Size: Contains 16,569 base pairs (~16 kb)</li>\r\n<li>Proportion: Makes up about 1% of total cellular DNA</li>\r\n<li>Strands: Composed of a heavy (H) and light (L) strand</li>\r\n</ul>\r\n<p><strong>Genetic Content</strong></p>\r\n<ul>\r\n<li>Encodes 13 polypeptides of the respiratory chain, including:\r\n<ul>\r\n<li>7 subunits of NADH dehydrogenase (Complex I)</li>\r\n<li>Cytochrome b (Complex III)</li>\r\n<li>3 subunits of cytochrome oxidase (Complex IV)</li>\r\n<li>2 subunits of ATP synthase</li>\r\n</ul>\r\n</li>\r\n<li>Also encodes:\r\n<ul>\r\n<li>2 rRNAs: 12S (small) and 16S (large)</li>\r\n<li>22 tRNAs</li>\r\n</ul>\r\n</li>\r\n<li>Note: The majority of mitochondrial proteins (~54 of 67) are encoded by nuclear genes</li>\r\n</ul>\r\n<p><strong>Unique Genetic Code</strong></p>\r\n<ul>\r\n<li>Genetic code differs slightly from nuclear DNA: <strong>(Option C)</strong>\r\n<ul>\r\n<li>UGA &rarr; Tryptophan (Trp), not a stop codon in mitochondrial DNA</li>\r\n<li>AGA and AGG &rarr; Stop codons, not Arginine</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Special Features</strong></p>\r\n<ul>\r\n<li>Contains very few untranslated (non-coding) sequences</li>\r\n<li>High mutation rate: 5 to 10 times higher than nuclear DNA</li>\r\n<li>mtDNA sequence comparisons are used in evolutionary studies</li>\r\n</ul>\r\n<p><strong>Inheritance Pattern</strong></p>\r\n<ul>\r\n<li>Inherited maternally (non-Mendelian inheritance)</li>\r\n<li>All mitochondria are contributed by the ovum</li>\r\n<li>Affected mothers can pass mtDNA mutations to all children</li>\r\n<li>Only daughters can transmit the trait</li>\r\n<li>Some mtDNA deletions may occur during oogenesis and are not inherited</li>\r\n</ul>\r\n<p><strong>Associated Diseases</strong></p>\r\n<ul>\r\n<li>Mutations in mtDNA are linked to:\r\n<ul>\r\n<li>Myopathies</li>\r\n<li>Neurologic disorders</li>\r\n<li>Some forms of diabetes mellitus</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>General Characteristics</strong></p>\r\n<ul>\r\n<li>Structure: Small, circular, double-stranded DNA</li>\r\n<li>Copies per cell: Each mitochondrion contains 2 to 10 copies</li>\r\n<li>Size: Contains 16,569 base pairs (~16 kb)</li>\r\n<li>Proportion: Makes up about 1% of total cellular DNA</li>\r\n<li>Strands: Composed of a heavy (H) and light (L) strand</li>\r\n</ul>\r\n<p><strong>Genetic Content</strong></p>\r\n<ul>\r\n<li>Encodes 13 polypeptides of the respiratory chain, including:\r\n<ul>\r\n<li>7 subunits of NADH dehydrogenase (Complex I)</li>\r\n<li>Cytochrome b (Complex III)</li>\r\n<li>3 subunits of cytochrome oxidase (Complex IV)</li>\r\n<li>2 subunits of ATP synthase</li>\r\n</ul>\r\n</li>\r\n<li>Also encodes:\r\n<ul>\r\n<li>2 rRNAs: 12S (small) and 16S (large)</li>\r\n<li>22 tRNAs</li>\r\n</ul>\r\n</li>\r\n<li>Note: The majority of mitochondrial proteins (~54 of 67) are encoded by nuclear genes</li>\r\n</ul>\r\n<p><strong>Unique Genetic Code</strong></p>\r\n<ul>\r\n<li>Genetic code differs from nuclear DNA:\r\n<ul>\r\n<li>UGA &rarr; Tryptophan (Trp), not a stop codon</li>\r\n<li>AGA and AGG &rarr; Stop codons, not Arginine</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Special Features</strong></p>\r\n<ul>\r\n<li>Contains very few untranslated (non-coding) sequences</li>\r\n<li>High mutation rate: 5 to 10 times higher than nuclear DNA <strong>(Option B)</strong></li>\r\n<li>mtDNA sequence comparisons are used in evolutionary studies</li>\r\n</ul>\r\n<p><strong>Inheritance Pattern</strong></p>\r\n<ul>\r\n<li>Inherited maternally (non-Mendelian inheritance)</li>\r\n<li>All mitochondria are contributed by the ovum</li>\r\n<li>Affected mothers can pass mtDNA mutations to all children</li>\r\n<li>Only daughters can transmit the trait</li>\r\n<li>Some mtDNA deletions may occur during oogenesis and are not inherited</li>\r\n</ul>\r\n<p><strong>Associated Diseases</strong></p>\r\n<ul>\r\n<li>Mutations in mtDNA are linked to:\r\n<ul>\r\n<li>Myopathies</li>\r\n<li>Neurologic disorders</li>\r\n<li>Some forms of diabetes mellitus</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>(Option B) High mutation rate compare to nuclear DNA (5-10 times that of nuclear DNA)</p>\r\n<p>(Option C) Genetic code of mitochondrial DNA slightly differs from the standard code</p>\r\n<p>UGA (standard stop codon) is read as Trp (Tryptophan)</p>\r\n<p>AGA and AGG (standard codons for Arg - Arginine) are read as stop codons</p>\r\n<p>(Option D) Mitochondrial DNA is circular, double stranded DNA (nuclear DNA is linear and double stranded)</p>", "options": ["Fewer untranslated sequences", "Low mutation rate", "Completely different genetic codes", "Circular single-stranded DNA"], "html_options": ["Fewer untranslated sequences", "Low mutation rate", "Completely different genetic codes", "Circular single-stranded DNA"], "corr_idx": 0}, {"id": "1182313", "html_qtxt": "Which of the following types of histone covalent modification is associated with DNA repair?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The four core histones are subject to at least <strong>six types of covalent modification</strong> or posttranslational modifications (PTMs): <strong>Acetylation, methylation, phosphorylation, ADP-ribosylation, monoubiquitylation, and sumoylation. </strong></li>\n<li>These histone modifications play important roles in chromatin structure and function, as given in the following table:</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509048f11fec0-5b45-4a7d-ad8d-b43418dbd67a.png\"><p><strong>Methylation</strong> <strong>(Option A) </strong>of histones is correlated with activation and repression of gene transcription.</p>\n<p><strong>Sumoylation</strong> <strong>(Option C)</strong> of histones is associated with transcription repression</p>\n<p><strong>Acetylation</strong> <strong>(Option D) </strong>is associated with chromosomal assembly during DNA replication</p>", "options": ["Methylation", "ADP ribosylation", "Sumoylation", "Acetylation"], "html_options": ["Methylation", "ADP ribosylation", "Sumoylation", "Acetylation"], "corr_idx": 1}, {"id": "1182317", "html_qtxt": "Which of the following is a true sentence about linker DNA?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>In chromatin, core nucleosome particles are connected by DNA, termed \"linker DNA\".</p>\r\n<ul>\r\n<li>It is a short DNA consisting of roughly 30-bp regions. <strong>(Option A)</strong></li>\r\n<li>It links two nucleosomes and is not present inside the nucleosome core. <strong>(Option B)</strong></li>\r\n<li>Contains the histone H1, whereas the H2A & H2B histones are present in the nucleosome core. <strong>(Option C)</strong></li>\r\n<li>Two strands of DNA are linked by hydrogen bonds, not linker DNA. <strong>(Option D)</strong></li>\r\n</ul>", "options": ["Short DNA consisting of roughly only 30 bp", "Present in the nucleosome core", "Contain histone 2A & 2B", "Links two strands of DNA"], "html_options": ["Short DNA consisting of roughly only 30 bp", "Present in the nucleosome core", "Contain histone 2A & 2B", "Links two strands of DNA"], "corr_idx": 0}, {"id": "1182320", "html_qtxt": "Which of the following is true regarding chromatin containing active genes?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Some regions of chromatin are active & others are inactive.</p>\r\n<ul>\r\n<li>Generally, every cell of an individual metazoan organism contains the same genetic information. Thus, the differences between cell types within an organism must be explained by differential expression of the common genetic information.</li>\r\n<li>Chromatin containing active genes (ie, transcriptionally or potentially transcriptionally active chromatin) has been shown to differ in several ways from that of inactive regions:\r\n<ul>\r\n<li>The <strong>nucleosome structure of</strong> active chromatin appears to be <strong>altered</strong>, sometimes quite extensively, in highly active regions. <strong>(Option A)</strong></li>\r\n<li>DNA in active chromatin contains large regions (about 100,000 bases long) that are relatively <strong>more sensitive to digestion</strong> by a nuclease such as DNase I.</li>\r\n<li>Transcriptionally <strong>inactive</strong> chromatin is <strong>densely packed</strong> during <strong>interphase,</strong> as observed by electron microscopic studies and is referred to as <strong>heterochromatin (Option D). </strong>In contrast, transcriptionally active chromatin stains less densely and is referred to as <strong>euchromatin</strong>. <strong>(Option C)</strong></li>\r\n</ul>\r\n</li>\r\n<li>Generally, euchromatin is replicated earlier than heterochromatin in the mammalian cell cycle.</li>\r\n<li>The chromatin in these regions of inactivity is often high in meC content, and histones therein contain relatively lower levels of certain activating covalent modifications and higher levels of repressing histone post-translational modifications.</li>\r\n</ul>", "options": ["Nucleosome structure of active chromatin remain the same", "More sensitive to digestion by a nuclease", "Densely packed during interphase", "Also referred to as heterochromatin"], "html_options": ["Nucleosome structure of active chromatin remain the same", "More sensitive to digestion by a nuclease", "Densely packed during interphase", "Also referred to as heterochromatin"], "corr_idx": 1}, {"id": "1182322", "html_qtxt": "Which of the following is characteristic of facultative heterochromatin?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\r\n<ul>\r\n<li>There are two types of heterochromatin:\r\n<ul>\r\n<li><strong>Constitutive</strong>:\r\n<ul>\r\n<li>It is always condensed and thus essentially inactive. <strong>(Option A & B)</strong></li>\r\n<li>It is found in the regions near the chromosomal centromere and at chromosomal ends (telomeres). <strong>(Option C)</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Facultative:</strong>\r\n<ul>\r\n<li>Facultative heterochromatin is at times condensed, but at other times it is actively transcribed and, thus, uncondensed and appears as euchromatin.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Of the two members of the X chromosome pair in mammalian females, one X chromosome is almost completely inactive transcriptionally and is heterochromatic.</li>\r\n<li>However, the heterochromatic X chromosome condenses during gametogenesis and becomes transcriptionally active during early embryogenesis - thus, it is facultative heterochromatin.</li>\r\n</ul>", "options": ["Always stain densely", "Essentially always inactive", "Found in the regions near the chromosomal centromere and telomeres", "When it is actively transcribed, then it is uncondensed and appears as euchromatin"], "html_options": ["Always stain densely", "Essentially always inactive", "Found in the regions near the chromosomal centromere and telomeres", "When it is actively transcribed, then it is uncondensed and appears as euchromatin"], "corr_idx": 3}, {"id": "1182326", "html_qtxt": "Chromosomal DNA is packaged and organised at several levels. The highest packing ratio is found in which of the following structures?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Higher-order structures provide for the compaction of chromatin.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904e7ba4508-df38-4abe-83a8-b0a7a3e2a83a.png\">\n<br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904b8d5800a-dd39-47dc-a054-b0db619478f4.png\">", "options": ["Naked double helical DNA", "Nucleosomes", "30 nm chromatin fibre", "Metaphase chromosome loops"], "html_options": ["Naked double helical DNA", "Nucleosomes", "30 nm chromatin fibre", "Metaphase chromosome loops"], "corr_idx": 3}, {"id": "1182329", "html_qtxt": "What is true about telomeres?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Telomeres consist of short TG-rich repeats.</p>\n<ul>\n<li>Human telomeres have a variable number of repeats of the sequence 5'-TTAGGG-3', which can extend for several kilobases.</li>\n<li>The ends of each chromosome contain structures called telomeres.</li>\n<li>The <strong>centromere</strong> connects two sister chromatids. <strong>(Option B)</strong></li>\n<li><strong>Telomerase</strong>, a multisubunit RNA template-containing complex related to viral RNA-dependent DNA polymerases (reverse transcriptases), is the enzyme responsible for <strong>telomere synthesis</strong> and thus for maintaining the length of the telomere. <strong>(Option C)</strong></li>\n<li><strong>Telomere shortening</strong> has been associated with both <strong>malignant transformation</strong> and <strong>ageing (Option D)</strong>, so telomeres and telomerase enzymes have become an attractive target for cancer chemotherapy and drug development.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509048b525775-5d05-4d12-a569-dd0c02733f83.png\">", "options": ["Consists of short TG-rich repeats", "Connect two sister chromatids", "Breakdown by enzyme telomerase", "Lengthen with ageing"], "html_options": ["Consists of short TG-rich repeats", "Connect two sister chromatids", "Breakdown by enzyme telomerase", "Lengthen with ageing"], "corr_idx": 0}, {"id": "1182332", "html_qtxt": "Which of the following statements is true regarding coding and noncoding regions in DNA?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>In eukaryotic DNA, coding regions, which ultimately appear in the cytoplasm as single mRNA molecules, are often interrupted by large non-protein-coding sequences.</p>\r\n<ul>\r\n<li>These <strong>intervening sequences</strong>, or <strong>introns</strong>, are present in the primary mRNA transcript (originally called hnRNA).</li>\r\n<li>Before the mRNA becomes mature, these introns must be precisely removed, and the <strong>coding segments</strong>, called <strong>exons</strong>, are spliced together. <strong>(Option B)</strong></li>\r\n<li>Most genes have at least one intron and can have as many as 50.</li>\r\n<li>In many cases, the introns are longer than the exons. <strong>(Option C)</strong></li>\r\n<li>Although the exact role of introns isn't completely clear, they allow for alternative splicing, which increases the variety of proteins produced from a single gene.</li>\r\n<li>They may also allow for more rapid recombination and genetic rearrangement by separating functional domains of coding information. <strong>(Option D)</strong></li>\r\n<li>Occasionally, other RNA molecules may also be located within intronic DNA.</li>\r\n</ul>", "options": ["Coding regions are often interrupted by intervening sequences", "Coding regions are termed as introns, and noncoding regions are termed as exons", "Coding regions are much longer than non-coding regions", "Coding regions may help in genetic rearrangement by recombination"], "html_options": ["Coding regions are often interrupted by intervening sequences", "Coding regions are termed as introns, and noncoding regions are termed as exons", "Coding regions are much longer than non-coding regions", "Coding regions may help in genetic rearrangement by recombination"], "corr_idx": 0}, {"id": "1182336", "html_qtxt": "The Alu family in the human genome is present in:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>At least 30% of the human genome consists of repetitive DNA sequences.</li>\r\n<li>One type of <strong>repetitive DNA</strong> is the <strong>SINEs</strong> (Short Interspersed Nuclear Elements).</li>\r\n<li>The <strong>Alu family</strong> belongs to the SINEs and is highly abundant in the human genome.</li>\r\n<li>The Alu sequences are present in about 500,000 copies per haploid genome and make up approximately 10% of the human genome.</li>\r\n<li>Another category of repetitive sequences includes <strong>microsatellite repeats,</strong> consisting of 2 to 6 base pair units repeated in tandem (e.g., AC, CG, AT, CA), commonly found 50,000 to 100,000 times in the genome. <strong>(Option C)</strong></li>\r\n<li>Some <strong>trinucleotide repeats</strong> (like CGG, CAG, CTG) can expand and cause genetic diseases such as fragile X syndrome and Huntington's disease. <strong>(Option D)</strong></li>\r\n<li><strong>LINE-1</strong> (Long Interspersed Nuclear Element-1) is a type of autonomous retrotransposon that inserts copies of itself into the genome using an RNA intermediate. Its activity is usually strongly suppressed in somatic cells to maintain genome stability and prevent DNA damage. <strong>(Option A)</strong></li>\r\n</ul>", "options": ["Long interspersed nuclear elements (LINEs)", "Short interspersed nuclear elements (SINEs)", "Microsatellite Repeat Sequences", "Trinucleotide sequences"], "html_options": ["Long interspersed nuclear elements (LINEs)", "Short interspersed nuclear elements (SINEs)", "Microsatellite Repeat Sequences", "Trinucleotide sequences"], "corr_idx": 1}, {"id": "1182339", "html_qtxt": "Which of the following is characteristic of DNA replication?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Salient Features of DNA Replication</strong></p>\r\n<ul>\r\n<li>DNA replication is the process of copying DNA to pass genetic information from the parent cell to daughter cells.</li>\r\n<li>It occurs during the <strong>S phase</strong> of the cell cycle, also known as the <strong>Synthetic phase</strong>. <strong>(Option D)</strong></li>\r\n<li><strong>Two new complementary strands</strong> are synthesised from a <strong>double-stranded DNA (dsDNA)</strong></li>\r\n<li><strong>One strand goes to each daughter nucleus</strong>; hence, in each daughter cell, one strand is from the parent, and one is newly synthesised.</li>\r\n<li>This mechanism is called <strong>semiconservative synthesis</strong>, as the <strong>parental DNA strand is conserved</strong> in the daughter cells. <strong>(Option A)</strong></li>\r\n<li>Replication <strong>requires a single-stranded DNA (ssDNA)</strong> template, which is generated after <strong>unwinding dsDNA</strong>.</li>\r\n<li>On one DNA strand, synthesis is <strong>continuous</strong>; on the other strand, it is <strong>discontinuous</strong>. <strong>(Option C)</strong></li>\r\n<li>After replication, the <strong>parental and newly synthesised strands re-form a dsDNA</strong>.</li>\r\n<li>Replication begins at specific <strong>sites of initiation</strong>, where a replication complex assembles.</li>\r\n<li>The process ensures <strong>genetic stability</strong> by being complete and involving <strong>proofreading mechanisms</strong> for <strong>high fidelity</strong>.</li>\r\n<li>Synthesis of new DNA requires <strong>four dNTPs, enzymes, and magnesium</strong>.</li>\r\n</ul>", "options": ["Conservative", "Can occur from ssDNA only", "Continuous", "Occurs during the M phase of the cell cycle"], "html_options": ["Conservative", "Can occur from ssDNA only", "Continuous", "Occurs during the M phase of the cell cycle"], "corr_idx": 1}, {"id": "1182343", "html_qtxt": "Which of the following enzymes leads to the unwinding of DNA during DNA replication?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Helicases lead to the unwinding of DNA during replication.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904d66bfbba-d2b8-4751-a538-3e0f4ae2505c.png\">\n<p><strong>DNA polymerase</strong> <strong>(Option A) </strong>leads to deoxynucleotide polymerisation.</p>\n<p><strong>Topoisomerase (Option B)</strong> relieves torsional strain that results from helicase-induced unwinding</p>\n<p><strong>DNA Primase (Option D)</strong> initiates synthesis of RNA primers.</p>", "options": ["DNA polymerase", "Topoisomerase", "Helicase", "DNA Primase"], "html_options": ["DNA polymerase", "Topoisomerase", "Helicase", "DNA Primase"], "corr_idx": 2}, {"id": "1182351", "html_qtxt": "A replication fork consists of all of the following components except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>A replication fork consists of four components that form in the following sequence:</p>\n<ol>\n<li>DNA helicase unwinds a short segment of the parental duplex DNA</li>\n<li>SSBs bind to ssDNA and prevent premature reannealing of ssDNA to dsDNA</li>\n<li>Primase initiates the synthesis of an RNA molecule that is essential for priming DNA synthesis</li>\n<li>DNA polymerase initiates the synthesis of the nascent daughter strand</li>\n</ol>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090425157f8e-42b7-4e34-bd07-23c2b2cbfb9a.png\">\n<p><strong>DNA ligase</strong> <strong>(Option D) </strong>is involved in sealing the single-strand nick between the nascent chain and Okazaki fragments on the lagging strand at termination of replication.</p>", "options": ["DNA polymerase", "SSB protein", "DNA Primase", "DNA ligase"], "html_options": ["DNA polymerase", "SSB protein", "DNA Primase", "DNA ligase"], "corr_idx": 3}, {"id": "1182353", "html_qtxt": "Okazaki fragments are found on:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>DNA polymerases only synthesise DNA in the 5' to 3' direction. Because the DNA strands are antiparallel, the polymerase functions asymmetrically.</li>\r\n<li>On the leading (forward) strand, the DNA is synthesised continuously.</li>\r\n<li>On the lagging (retrograde) strand, the DNA is synthesised in <strong>short</strong> (1-5 kb) <strong>fragments</strong>, the so-called <strong>Okazaki fragments,</strong> so named after the scientist who discovered them.</li>\r\n<li>Several Okazaki fragments (up to 1000) must be sequentially synthesised for each replication fork.</li>\r\n</ul>\r\n<p>On the <strong>leading (forward) strand</strong> <strong>(Option B)</strong>, the DNA is synthesised continuously and hence does not form Okazaki fragments.</p>\r\n<p><strong>Messenger RNA and Ribosomal RNA</strong> <strong>(Option C & D)</strong>: Any RNA does not contain Okazaki fragments.</p>", "options": ["Retrograde strand of DNA", "Forward strand of DNA", "Messenger RNA", "Ribosomal RNA"], "html_options": ["Retrograde strand of DNA", "Forward strand of DNA", "Messenger RNA", "Ribosomal RNA"], "corr_idx": 0}, {"id": "1182357", "html_qtxt": "Primosome is a mobile complex between:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>During DNA replication, several <strong>Okazaki fragments</strong> (up to 1000) must be synthesised on the <strong>lagging strand</strong> at each replication fork.</li>\r\n<li>To initiate this, <strong>helicase</strong> unwinds double-stranded DNA (dsDNA) in the <strong>5&prime; to 3&prime; direction</strong>.</li>\r\n<li><strong>Helicase associates with primase</strong> to give primase proper access to the DNA template.</li>\r\n<li>This interaction enables <strong>RNA primer synthesis</strong>, which is essential because <strong>DNA polymerases cannot initiate DNA synthesis de novo</strong>.</li>\r\n<li>The mobile complex formed between <strong>helicase and primase</strong> is called the <strong>primosome</strong>.</li>\r\n<li>Once an Okazaki fragment is completed and the polymerase is released, a <strong>new RNA primer</strong> is synthesised for the next fragment.</li>\r\n<li>The same <strong>DNA polymerase</strong> remains at the replication fork to synthesise the next Okazaki fragment.</li>\r\n</ul>", "options": ["SSB protein & Polymerase", "Helicase & Primase", "Polymerase & Primase", "SSB protein & Primase"], "html_options": ["SSB protein & Polymerase", "Helicase & Primase", "Polymerase & Primase", "SSB protein & Primase"], "corr_idx": 1}, {"id": "1182361", "html_qtxt": "A number of different DNA polymerase molecules engage in DNA replication. All of them share the following properties, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Multiple DNA polymerases</strong> are involved in DNA replication.</li>\n<li>These polymerases share three key properties:\n<ul>\n<li><strong>Chain elongation (Option A)</strong> - Refers to the rate of nucleotide addition (measured in nucleotides per second).</li>\n<li><strong>Processivity</strong> <strong>(Option B)</strong> - Refers to the number of nucleotides added before the polymerase dissociates from the template strand.</li>\n<li><strong>Proofreading (Option C)</strong> - Involves detecting and correcting errors in nucleotide incorporation.</li>\n</ul>\n</li>\n<li><strong>Chain termination (Option D)</strong> is <strong>not</strong> a shared property of DNA polymerases and is <strong>not</strong> part of the replication function. <strong>DNA ligase</strong>, not DNA polymerase, seals nicks between Okazaki fragments at the <strong>end of replication</strong> on the lagging strand.</li>\n<li>In <strong> coli</strong>:\n<ul>\n<li><strong>DNA polymerase III (pol III)</strong>:\n<ul>\n<li>Works at the replication fork.</li>\n<li>Has the <strong>highest rate of chain elongation</strong> and <strong>maximum processivity</strong>.</li>\n<li>Can polymerize <strong>up to 0.5 Mb</strong> in one cycle on the leading strand.</li>\n<li>Associates with <strong> &beta; subunits of the sliding clamp</strong>, enhancing its <strong>stability, processivity (100-50,000 nt)</strong>, and <strong>elongation rate (20-50 nt/s)</strong>.</li>\n</ul>\n</li>\n<li><strong>DNA polymerase I (pol I)</strong> and <strong>II (pol II)</strong>:\n<ul>\n<li>Primarily involved in <strong>proofreading and repair</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Eukaryotes</strong> have equivalents of these polymerases and many additional ones, mostly used in <strong>DNA repair</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509045ad5092c-3c8f-40ef-92eb-f385dc8fcff2.png\">", "options": ["Chain elongation", "Processivity", "Proofreading", "Chain termination"], "html_options": ["Chain elongation", "Processivity", "Proofreading", "Chain termination"], "corr_idx": 3}, {"id": "1182363", "html_qtxt": "Which of the following is true regarding reverse transcriptase enzymes?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Reverse transcriptase is an enzyme that functions as an <strong>RNA-dependent DNA polymerase</strong>. It synthesises DNA using RNA as a template.</li>\r\n<li>RNA polymerase lacks reverse transcriptase activity and performs only transcription. In contrast, telomerase enzymes do possess reverse transcriptase activity. <strong>(Option A ruled out)</strong></li>\r\n<li>It should not be confused with DNA-dependent RNA polymerase, which synthesises RNA from a DNA template. <strong>(Option B ruled out)</strong><br /> Reverse transcriptase is present in RNA viruses, specifically retroviruses.</li>\r\n<li>In <strong>retroviruses</strong>, this enzyme synthesises a single-stranded DNA (and then a double-stranded DNA) from the<strong> single-stranded RNA genome</strong>. This process begins with the formation of a DNA-RNA hybrid molecule. <strong>(Option D ruled out)</strong></li>\r\n</ul>", "options": ["RNA polymerase having reverse transcriptase activity", "DNA-dependent RNA polymerase", "RNA-dependent DNA polymerase", "Present in DNA virus"], "html_options": ["RNA polymerase having reverse transcriptase activity", "DNA-dependent RNA polymerase", "RNA-dependent DNA polymerase", "Present in DNA virus"], "corr_idx": 2}, {"id": "1182374", "html_qtxt": "Progress through the mammalian cell cycle is continuously monitored via multiple cell-cycle checkpoints. Which of the following cyclin-dependent kinases (CDKs) regulates the transition of the cell cycle from G2 to M phase?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>CDK1 is involved in the transition from G2 to M phase.</p>\n<p><strong>General Role of Cyclins and CDKs</strong></p>\n<ul>\n<li>Cyclins are proteins whose levels rise and fall throughout the cell cycle.</li>\n<li>They regulate cell cycle progression by activating cyclin-dependent kinases (CDKs).</li>\n<li>CDKs are serine/threonine protein kinases that phosphorylate key substrates at specific cell cycle stages.</li>\n</ul>\n<p><strong>G1 Phase and G1/S Transition</strong></p>\n<ul>\n<li>Cyclin D levels increase in the late G1 phase.</li>\n<li>Cyclin D activates <strong>CDK4 and CDK6</strong>, forming active cyclin D-CDK4/6 complexes. <strong>(Option C & D)</strong></li>\n<li>These complexes phosphorylate the retinoblastoma (Rb) protein.</li>\n<li>Unphosphorylated Rb binds and inactivates E2F, a transcription factor needed for S-phase gene expression.</li>\n<li>Phosphorylation of Rb releases E2F, leading to transcription of genes required for DNA synthesis.</li>\n<li>This transition past the restriction point commits the cell irreversibly to enter the S phase.</li>\n</ul>\n<p><strong>S Phase Initiation</strong></p>\n<ul>\n<li><strong>Cyclin E-CDK2</strong> complex forms in late G1 and helps initiate S phase. <strong>(Option B)</strong></li>\n<li>After cyclin E is degraded, CDK2 pairs with cyclin A to continue and support DNA replication.</li>\n</ul>\n<p><strong>G2/M Transition</strong></p>\n<ul>\n<li><strong>Cyclin B-CDK1</strong> complex is essential for the transition from the G2 phase into mitosis (M phase).</li>\n<li>This complex acts as the rate-limiting factor for initiating mitosis.</li>\n</ul>\n<p><strong>Cancer and Cell Cycle Dysregulation</strong></p>\n<ul>\n<li>Oncoviruses and oncogenes can bypass normal G1 to S phase controls.</li>\n<li>Overproduction of cyclins, loss of CDK inhibitors, or premature activation of CDK-cyclin complexes may lead to uncontrolled cell proliferation.</li>\n<li>Some viral oncoproteins inactivate Rb, releasing E2F inappropriately and triggering abnormal cell division.</li>\n<li>Inactivation or mutation of Rb, a tumor suppressor gene, is linked to cancer development.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509046f0c1eee-7c5b-44f3-8d87-bab8eff6de02.png\">", "options": ["CDK 1", "CDK 2", "CDK 4", "CDK 6"], "html_options": ["CDK 1", "CDK 2", "CDK 4", "CDK 6"], "corr_idx": 0}, {"id": "1182377", "html_qtxt": "A 6-month-old boy, born to consanguineous parents, presents with recurrent diarrhea, chest infections, fever, irritability, and weight loss. Labs show low hemoglobin and low WBC count. A probable diagnosis of SCID (Severe Combined Immunodeficiency) was made. Which DNA repair mechanism is defective in this condition?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Repair of damaged DNA is critical for maintaining genomic integrity and thereby preventing the propagation of mutations, either horizontally (somatic cells) or vertically (germ cells).</li>\n<li>DNA is subjected to a huge array of chemical, physical, and biological assaults daily; hence, efficient recognition and repair of DNA lesions are essential.</li>\n<li>Consequently, eukaryotic cells contain five major DNA repair pathways.</li>\n<li>The mechanisms of DNA repair include nucleotide excision repair (NER), mismatch repair (MMR), base excision repair (BER), homologous recombination (HR), and nonhomologous end-joining (NHEJ) repair pathways</li>\n</ul>\n<p>There are many diseases associated with defective DNA repair mechanisms:</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904f064eb49-8d7a-47a7-8fd2-880cc08686cc.png\">", "options": ["Nucleotide excision repair", "Base excision repair", "Homologous recombination", "Nonhomologous end-joining"], "html_options": ["Nucleotide excision repair", "Base excision repair", "Homologous recombination", "Nonhomologous end-joining"], "corr_idx": 3}, {"id": "1182380", "html_qtxt": "UV light might damage DNA by forming pyrimidine dimers. Formation of pyrimidine dimers will be repaired by which of the following DNA repair mechanisms?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>DNA is subjected to a huge array of chemical, physical, and biological assaults daily; hence, efficient recognition and repair of DNA lesions is essential.</p>\n<ul>\n<li>Consequently, eukaryotic cells contain five major DNA repair pathways.</li>\n<li>The mechanisms of DNA repair include\n<ul>\n<li>Nucleotide excision repair (NER)</li>\n<li>Mismatch repair (MMR)</li>\n<li>Base excision repair (BER)</li>\n<li>Homologous recombination (HR)</li>\n<li>Nonhomologous end-joining (NHEJ)</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904df7a635f-9891-4e81-9bcb-339065ac77d2.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904b6990375-6d7f-4935-938b-39e140b442a4.png\">", "options": ["Nucleotide excision repair", "Base excision repair", "Mismatch repair", "Homologous recombination"], "html_options": ["Nucleotide excision repair", "Base excision repair", "Mismatch repair", "Homologous recombination"], "corr_idx": 0}, {"id": "1182381", "html_qtxt": "Which of the following is true regarding the template strand of DNA?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Within a particular gene in the double-stranded DNA molecules, the genetic information resides in the sequence of nucleotides on one strand, the template strand. It is sometimes referred to as the noncoding strand.</li>\n<li>The opposite strand of the template strand is considered the coding strand because it matches the sequence of the RNA transcript (but containing uracil in place of thymine) that encodes the protein.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904dc822ecb-abbf-4f44-980b-76da69855e83.png\">\n<ul>\n<li>The relationship between the sequences of an RNA transcript and its gene, in which the coding and template strands are shown with their polarities in the above figure.</li>\n<li>The RNA transcript with a 5' to 3' polarity is complementary to the template strand with its 3' to 5' polarity.</li>\n<li>The sequence in the RNA transcript and its polarity are the same as that in the coding strand, except that the U of the transcript replaces the T of the gene; the initiating nucleotide of RNAs contains a terminal 5-triphosphate (pppA in the above image).</li>\n</ul>\n<p><strong>The sequences of nucleotides match the sequence of mRNA transcripts (Option A): </strong>The template strand is also known as a noncoding strand, so the sequences of nucleotides in the template strand are the same as the noncoding strand.</p>\n<p><strong>The sequences of nucleotides match the sequence of mRNA transcripts (Option B): </strong>The template strand sequences of nucleotides are complementary to the coding strands. The sequences of coding strand matches with the sequence of mRNA transcripts</p>\n<p><strong>It codes for proteins (Option C):</strong> The coding strand codes for proteins.</p>", "options": ["The sequences of nucleotides are opposite to the noncoding strand", "The sequences of nucleotides match the sequence of mRNA transcripts", "It codes for proteins", "It is copied or transcribed during RNA synthesis."], "html_options": ["The sequences of nucleotides are opposite to the noncoding strand", "The sequences of nucleotides match the sequence of mRNA transcripts", "It codes for proteins", "It is copied or transcribed during RNA synthesis."], "corr_idx": 3}, {"id": "1182382", "html_qtxt": "The topoisomerase enzyme is an important target for chemotherapy. This enzyme can relax or insert supercoils in DNA. Which of the following is true about the supercoiling of DNA?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\r\n<ul>\r\n<li>Supercoils are introduced when a closed circle is twisted around its own axis or when a linear piece of duplex DNA, whose ends are fixed, is twisted.</li>\r\n<li>This energy-requiring process puts the molecule under torsional stress, and the greater the number of supercoils, the greater the stress or torsion.</li>\r\n<li>Topoisomerase is an enzyme that catalyzes topological changes of DNA.</li>\r\n<li>Topoisomerase enzymes can relax or insert supercoils in DNA, using ATP as an energy source.</li>\r\n<li>Supercoiling is a prerequisite for DNA replication and transcription, so topoisomerase is an important target for chemotherapy.</li>\r\n</ul>\r\n<p><strong>Topoisomerases present in humans only (Option A):</strong> Homologs of this enzyme exist in all organisms, not only in humans.</p>\r\n<p><strong>Negative supercoils occur when B-DNA is twisted in the clockwise direction (Option B):</strong> Negative supercoils are formed when the molecule is twisted in the direction opposite from the clockwise turns of the right-handed double helix found in B-DNA. Such DNA is said to be underwound.</p>\r\n<p><strong>Circular DNA cannot form supercoiling (Option D):</strong> Closed circles exist in relaxed or supercoiled forms.</p>", "options": ["Topoisomerases present in humans only", "Negative supercoils occur when B-DNA is twisted in the clockwise direction", "Supercoiled DNA is a preferred form in biological systems", "Circular DNA cannot form supercoiling"], "html_options": ["Topoisomerases present in humans only", "Negative supercoils occur when B-DNA is twisted in the clockwise direction", "Supercoiled DNA is a preferred form in biological systems", "Circular DNA cannot form supercoiling"], "corr_idx": 2}]}, {"moduleId": 1008732, "name": "RNA Synthesis (Transcription), Processing And Modification", "questions": [{"id": "1182304", "html_qtxt": "All of the following are non-protein-coding RNA, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>All eukaryotic cells have two major classes of RNA:\r\n<ul>\r\n<li><strong>Protein-coding RNAs or mRNAs</strong></li>\r\n<li>Two forms of abundant <strong>non-protein-coding RNAs</strong>, delineated based on size:\r\n<ul>\r\n<li>The <strong>large ribosomal RNAs (rRNAs)</strong> and <strong>long noncoding RNAs</strong> (lncRNAs)</li>\r\n<li>Small noncoding <strong>transfer RNAs</strong> (tRNAs), the <strong>small nuclear RNAs</strong> (snRNAs) and the <strong>micro</strong> and <strong>silencing RNAs (</strong>miRNAs and siRNAs).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>mRNA carries genetic information from DNA to the cellular machinery responsible for protein synthesis, where it serves as a template for assembling amino acids into a specific protein-the final product of gene expression.</li>\r\n<li>The <strong>mRNAs, rRNAs, and tRNAs</strong> are directly involved in <strong>protein synthesis</strong>, while the other RNAs participate in either mRNA splicing (snRNAs) or modulation of gene expression by altering mRNA function (mi/siRNAs) and/or expression (lncRNAs).</li>\r\n<li>These RNAs differ in their diversity, stability, and abundance in cells.</li>\r\n</ul>\r\n<p><strong>Ribosomal RNA (rRNA) (Option A) </strong>helps in protein synthesis by providing a framework for protein synthesis.</p>\r\n<p><strong>Transfer RNA (tRNA) (Option B) </strong>helps in protein synthesis by transferring specific amino acids as per the code on mRNA during the synthesis of protein.</p>\r\n<p><strong>Small nuclear RNA (snRNA) (Option D) </strong>helps in protein splicing.</p>", "options": ["Ribosomal RNA", "Transfer RNA", "Messenger RNA", "Small nuclear RNA"], "html_options": ["Ribosomal RNA", "Transfer RNA", "Messenger RNA", "Small nuclear RNA"], "corr_idx": 2}, {"id": "1182309", "html_qtxt": "Which of the following RNAs is present in an abundant amount in a cell?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Ribosomal RNA is 80% of the total RNA in a cell, so it is the most abundant in a cell.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901b951ee6c-ee8a-4da5-a5b7-5f9f877da397.png\">\n<p><strong>Messenger RNA (Option A) </strong>is 2 to 5% of total RNA in the cell.</p>\n<p><strong>Transfer RNA (Option B) </strong>is around 15% of the total RNA in the cell.</p>\n<p><strong>Micro RNA (Option D) </strong>is <1% of total RNA in cells.</p>", "options": ["Messenger RNA", "Transfer RNA", "Ribosomal RNA", "Micro RNA"], "html_options": ["Messenger RNA", "Transfer RNA", "Ribosomal RNA", "Micro RNA"], "corr_idx": 2}, {"id": "1182314", "html_qtxt": "RNA synthesis is different from DNA synthesis in the following ways, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Both DNA and RNA synthesis occur in the <strong>5' to 3' direction</strong>; RNA synthesis does <strong>not</strong> occur in the 3' to 5' direction.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901d4c9079d-d4e2-40f8-87c4-37b6cf8be44a.png\">\n<p>In summary, Option B is the exception because a primer is indeed involved in RNA synthesis, similar to DNA synthesis.</p>", "options": ["No efficient proofreading function during RNA synthesis", "Primer is not involved in RNA synthesis", "DNA synthesis occurs with 5-3 polarity, whereas RNA synthesis occurs with 3-5 polarity", "U replaces T as the complementary base for A in RNA synthesis"], "html_options": ["No efficient proofreading function during RNA synthesis", "Primer is not involved in RNA synthesis", "DNA synthesis occurs with 5-3 polarity, whereas RNA synthesis occurs with 3-5 polarity", "U replaces T as the complementary base for A in RNA synthesis"], "corr_idx": 2}, {"id": "1182323", "html_qtxt": "Which of the following forms of mammalian RNA polymerase enzyme is highly sensitive to the action of &alpha;-amanitin?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>RNA Polymerase II is highly sensitive to the action of &alpha;-amanitin.</p>\n<p><strong>&alpha;-amanitin:</strong></p>\n<ul>\n<li>It is a peptide toxin derived from the mushroom &lsquo;Amanita phalloides,' which is a specific differential inhibitor of the eukaryotic nuclear DNA-dependent RNA polymerases and, as such, has proven to be a powerful research tool.</li>\n<li>&alpha;-amanitin blocks the translocation of RNA polymerase during phosphodiester bond formation.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901ebd2f934-a0ce-45fb-92b0-9b48307d434a.png\"></li>\n</ul>\n<p><strong>RNA Polymerase I (Option A) </strong>is insensitive to the action of &alpha;-amanitin.</p>\n<p><strong>RNA Polymerase III (Option C)  </strong>has intermediate sensitivity to the action of &alpha;-amanitin.</p>\n<p><strong>Reverse transcriptase (Option D): </strong>No action of &alpha;-amanitin on reverse transcriptase.</p>", "options": ["RNA Polymerase I", "RNA Polymerase II", "RNA Polymerase III", "Reverse transcriptase"], "html_options": ["RNA Polymerase I", "RNA Polymerase II", "RNA Polymerase III", "Reverse transcriptase"], "corr_idx": 1}, {"id": "1182325", "html_qtxt": "Spliceosomes consist of all of the following small nuclear RNA, except,", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>The <strong>spliceosome</strong> is a special multicomponent complex that converts the primary transcript into mature mRNA.</p>\r\n<p>It consists of:</p>\r\n<ul>\r\n<li>The primary transcript</li>\r\n<li>Five small nuclear RNAs (<strong>snRNAs</strong>): U1, U2, U4, U5, and U6 <strong>(Options A, B, & D ruled out)</strong></li>\r\n<li>Over 60 proteins, many containing <strong>RRM (RNA recognition motif)</strong> and <strong>SR (serine-arginine) protein motifs</strong></li>\r\n</ul>\r\n<p>The snRNAs and RRM/SR-containing proteins together form <strong>small nuclear ribonucleoprotein (snRNP) complexes</strong>.</p>\r\n<p><strong>Sequence of spliceosome assembly and action:</strong></p>\r\n<ul>\r\n<li><strong>U1 snRNP</strong> binds first by base pairing to the <strong>5' exon-intron boundary</strong>.</li>\r\n<li><strong>U2 snRNP</strong> binds to the <strong>branch site</strong>, exposing the nucleophilic adenine (A) residue.</li>\r\n<li>The <strong>U4/U5/U6 snRNP complex</strong> mediates ATP-dependent unwinding, disrupting the base pairing between U4 and U6 and releasing U4.</li>\r\n<li><strong>U6 snRNA</strong> then interacts with U2, then with U1, bringing together the 5'-splice site, branch point, and 3'-splice site.</li>\r\n<li><strong>U5</strong> enhances this alignment.</li>\r\n</ul>", "options": ["U1", "U2", "U3", "U4"], "html_options": ["U1", "U2", "U3", "U4"], "corr_idx": 2}, {"id": "1182331", "html_qtxt": "A 2-year-old child presented with pallor, jaundice, and abnormal enlargement of the liver and spleen. On investigation, he has low Hb and hypochromic microcytic anaemia. He was diagnosed with beta thalassemia major. Which of the following processes is most likely to be affected in this child?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>A defect in mRNA splicing can cause disease.</li>\r\n<li>One of the first examples of the critical importance of accurate splicing was the discovery that one form of &beta;-thalassemia, a disease in which the &beta;-globin gene of haemoglobin is severely underexpressed, results from a nucleotide change at an exon-intron junction.</li>\r\n<li>This mutation precludes the removal of the intron, altering the translational reading frame of &beta;-globin mRNA, thereby blocking the &beta;-chain protein production and hence haemoglobin.</li>\r\n</ul>\r\n<p><strong>mRNA capping (Option B): </strong>mRNA capping is a general process involved in stabilizing mRNA and initiating translation. Defects in capping are not specifically linked to beta thalassemia.</p>\r\n<p><strong>mRNA synthesis (Option C): </strong>mRNA synthesis (transcription) is a broad process. Beta thalassemia is more specifically related to the faulty processing of beta-globin mRNA rather than its synthesis.</p>\r\n<p><strong>U4 (Option D): </strong>U4 is one of the small nuclear RNAs involved in the spliceosome complex. While important in splicing, a defect in U4 alone is not the known cause of beta thalassemia. The disease relates to abnormal splicing of the beta-globin gene itself, not a universal spliceosome RNA defect.</p>", "options": ["mRNA splicing", "mRNA capping", "mRNA synthesis", "U4"], "html_options": ["mRNA splicing", "mRNA capping", "mRNA synthesis", "U4"], "corr_idx": 0}, {"id": "1182340", "html_qtxt": "Below is an image of transfer RNA, which helps in the transfer of amino acids from the cytoplasm to the ribosome during protein synthesis.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509011bb15192-88a3-4a39-860a-6af6b0c22c41.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Transfer RNA</strong></p>\n<ul>\n<li>About 15% of the total RNA in the cell.</li>\n<li>They are easily soluble, also k/a soluble RNA or sRNA.</li>\n<li>They are present in the cytoplasm</li>\n<li>General structure is similar to other RNA. Additionally have some typical structural characteristics.</li>\n</ul>\n<p><strong>Typical Structural Characteristics:</strong></p>\n<ul>\n<li>The smallest of the three major types of RNA molecule (73-93 nucleotides in length).</li>\n<li>Contain some unusual bases (eg Dihydrouracil, Pseudouridine & hypoxanthine).</li>\n<li>Have extensive internal base-pairing that produces a characteristic structure (Clover leaf-like structure).</li>\n<li>In their structure, they have 5 different parts (5 arms), which differ in structure & function.\n<ul>\n<li><strong>Acceptor Arm</strong>:\n<ul>\n<li>It carries the amino acid.</li>\n<li>At the 3' End, it has 7 base pairs.</li>\n<li>The end sequence is CCA-3'.</li>\n<li>Each tRNA serves as an \"adaptor\" molecule that carries its specific amino acid-covalently attached to its 3'-end, to the site of protein synthesis</li>\n</ul>\n</li>\n<li><strong>Anticodon Arm</strong>: <strong>(Option C)</strong>\n<ul>\n<li>Present at the opposite side of the acceptor arm.</li>\n<li>It recognizes the codon present in mRNA.</li>\n<li>It has base sequences complementary to mRNA codon. The specificity of tRNA is in anticodon sites.</li>\n</ul>\n</li>\n<li><strong>DHU Arm</strong> (<strong>D arm</strong>): <strong>(Option D)</strong>\n<ul>\n<li>Named due to presence of a dihydrouridine (DHU) in this area.</li>\n<li>It is a recognition site for the enzyme which adds amino acid to t RNA.</li>\n</ul>\n</li>\n<li><strong>Pseudouridine Arm</strong>: <strong>(Option B)</strong>\n<ul>\n<li>Opposite to the DHU arm, named as it contains pseudouridine.</li>\n<li>It is involved in binding tRNA to ribosomes</li>\n</ul>\n</li>\n<li>About 75% of tRNA molecules possess a <strong>short extra arm</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901b1f582f0-cf48-4294-a4e5-26822ba6317a.png\"></li>\n</ul>\n</li>\n</ul>\n<p><strong>Functions of tRNA:</strong></p>\n<ul>\n<li>Transfer amino acids from cytoplasm to ribosome for protein synthesis; so k/a transfer RNA.</li>\n<li>It recognizes the genetic code on mRNA, which specifies specific amino acids.</li>\n<li>At least 20 species of tRNA molecules in every cell, at least one (and often several) corresponding to each of the 20 amino acids required for protein synthesis.</li>\n<li>Specific tRNA carries its specific amino acid, which is then added in the growing polypeptide chain.</li>\n</ul>", "options": ["3' End", "Pseudouridine arm", "Anticodon arm", "D loop"], "html_options": ["3' End", "Pseudouridine arm", "Anticodon arm", "D loop"], "corr_idx": 0}, {"id": "1182348", "html_qtxt": "Dactinomycin (known to biochemists as actinomycin D) was the first antibiotic to find therapeutic application in tumour chemotherapy. Which of the following describes its mechanism of action during RNA transcription?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Dactinomycin (Actinomycin D) is an antibiotic derived from <em>Streptomyces</em> species that binds tightly to double-stranded DNA.</p>\r\n<ul>\r\n<li>By intercalating between base pairs, it prevents the progression or movement of RNA polymerase along the DNA template, thereby <strong>inhibiting the elongation phase of RNA transcription</strong>.</li>\r\n<li>This action blocks the synthesis of RNA chains, which is why it is effectively used as an anticancer drug.</li>\r\n</ul>\r\n<p>Other inhibitors of transcription differ in their mechanisms:</p>\r\n<ul>\r\n<li>Rifampicin binds to the beta subunit of prokaryotic RNA polymerase, blocking <strong>initiation</strong> of transcription.</li>\r\n<li>Alpha amanitin, a mushroom toxin, specifically inactivates <strong>RNA polymerase II</strong> in eukaryotes.</li>\r\n<li>Synthetic analogs like 3'-deoxyadenosine cause <strong>chain termination</strong> by incorrect nucleotide incorporation.</li>\r\n</ul>", "options": ["Bind to the beta subunit of RNA polymerase to block the initiation of transcription", "Binds to the DNA template and interferes with the movement of RNA polymerase along the DNA", "Inactivates RNA polymerase II", "Causes incorrect entry into chain causing chain termination"], "html_options": ["Bind to the beta subunit of RNA polymerase to block the initiation of transcription", "Binds to the DNA template and interferes with the movement of RNA polymerase along the DNA", "Inactivates RNA polymerase II", "Causes incorrect entry into chain causing chain termination"], "corr_idx": 1}, {"id": "1182349", "html_qtxt": "The base sequence of the strand of DNA used as the template for transcription is 5'-GTACTAG-3'. What is the base sequence of the RNA product?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The RNA product has a sequence that is complementary to the template strand and identical to the coding strand of DNA.</li>\n<li>The RNA transcript has the same polarity (5'-3') as the coding strand but contains U rather than T.</li>\n<li>Thus, the DNA template <strong>5'-GTACTAG-3'</strong> would produce the RNA product <strong>3'-CAUGAUC-5'</strong>or, written correctly in standard direction, <strong>5'-CUAGUAC-3'</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250901d0fb3850-eabf-48d0-b936-3c73b4b14ec9.png\"></li>\n</ul>", "options": ["3'-CUAGUAC-5'", "5'-CUAGUAC-3'", "5'-CTAGTAC-3'", "3'-CTAGTAC-5'"], "html_options": ["3'-CUAGUAC-5'", "5'-CUAGUAC-3'", "5'-CTAGTAC-3'", "3'-CTAGTAC-5'"], "corr_idx": 1}, {"id": "1182350", "html_qtxt": " A 3-year-old child presented with trouble walking to the paediatrician. He is diagnosed with DMD (Duchenne muscular dystrophy) by PCR. Genetic analysis shows that the patient's gene for the muscle protein dystrophin on the X chromosome contains a mutation in its promoter region. Which would be the most likely defective process in this child?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Mutations in the promoter typically prevent formation of the RNA polymerase II transcription complex, resulting in a decrease in the initiation of mRNA synthesis during transcription.</li>\r\n<li>Translation is the synthesis of protein from mRNA.</li>\r\n<li>A mutation in promoter regions does not lead to any problem during translation or post-translational modifications. <strong>(Option A & B)</strong></li>\r\n<li>A deficiency of dystrophin mRNA will result in a deficiency in the production of the dystrophin protein.</li>\r\n<li>Post-transcriptional modifications like capping, splicing, and tailing defects are not a consequence of promoter mutations. <strong>(Option D)</strong></li>\r\n</ul>", "options": ["Translation of dystrophin protein", "Post-translational modification in dystrophin protein", "Transcription of dystrophin mRNA", "Post-transcriptional modification in dystrophin mRNA"], "html_options": ["Translation of dystrophin protein", "Post-translational modification in dystrophin protein", "Transcription of dystrophin mRNA", "Post-transcriptional modification in dystrophin mRNA"], "corr_idx": 2}, {"id": "1182354", "html_qtxt": "A mutation in which of the following sequences in eukaryotic mRNA will affect post-translational modification of messenger RNA?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>AAUAA recognition sequence is for addition of poly A tail during post transcriptional modification of messenger RNA.</li>\r\n<li>Poly(A) tails are added to the 3' end of mRNA molecules in a posttranscriptional processing step.</li>\r\n<li>The mRNA is first cleaved about 20 nucleotides downstream from an AAUAA recognition sequence.</li>\r\n<li>Another enzyme, poly(A) polymerase, adds a poly(A) tail which is subsequently extended to as many as 200 A residues.</li>\r\n<li>The poly(A) tail both protects the 3' end of mRNA from 3' &rarr; 5' exonuclease attack and facilitates translation</li>\r\n</ul>\r\n<p><strong>CCA</strong> <strong>(Option A) </strong>is added to the 3'-end of transfer RNA by nucleotidyl transferase.</p>\r\n<p><strong>CAAT</strong> <strong>(Option B) </strong>and <strong>TATAAA (Option D)</strong> are sequences found in promoters for RNA polymerase II.</p>", "options": ["CCA", "CAAT", "AAUAA", "TATAAA"], "html_options": ["CCA", "CAAT", "AAUAA", "TATAAA"], "corr_idx": 2}, {"id": "1182358", "html_qtxt": "The major product of RNA Polymerase I in eukaryotes is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Ribosomal RNA is a product of RNA Polymerase I.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509019653b7fc-3ccb-4203-a39e-36ec375dd76f.png\">\n<p>(Option A) Transfer RNA is a product of RNA Polymerase III.</p>\n<p>(Option B) Messenger RNA is a product of RNA Polymerase II.</p>\n<p>(Option D) Micro RNA is a product of RNA Polymerase II.</p>", "options": ["Transfer RNA", "Messenger RNA", "Ribosomal RNA", "Micro RNA"], "html_options": ["Transfer RNA", "Messenger RNA", "Ribosomal RNA", "Micro RNA"], "corr_idx": 2}]}, {"moduleId": 1008733, "name": "Genetic Code & Protein Synthesis (Translation), Regulation Of Gene Expression ", "questions": [{"id": "1182389", "html_qtxt": "Degeneracy of the genetic code means:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Degeneracy in the genetic code is when multiple codons decode the same amino acid.</p>\n<ul>\n<li>Some amino acids are encoded by several codons; for example, six different codons, UCU, UCC, UCA, UCG, AGU, and AGC, all specify serine.</li>\n<li>Other amino acids, such as methionine and tryptophan, have a single codon.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090123d3f398-dd8e-4758-8f86-f5e1bf3ca1b6.png\">\n<p><strong>Features of genetic codons:</strong></p>\n<ul>\n<li>The genetic code is usually universal from lower and higher eukaryotes, including humans, except for those of mitochondrial codes.</li>\n<li>The reading of the genetic code during the process of protein synthesis does not involve any overlap of codons. Thus, the genetic code is non-overlapping.</li>\n<li>Once the reading is commenced at a specific start codon, there is no punctuation between codons, and the message is read in a continuing sequence of nucleotide triplets until a translation stop codon is reached.</li>\n<li>For any specific codon, only a single amino acid is specified; with rare exceptions, the genetic code is unambiguous, i.e., given a specific codon, only a single amino acid is indicated.</li>\n</ul>\n<p><strong>Single codon decode for two amino acids (Option B):</strong> For any specific codon, only a single amino acid is specified. A single codon never decodes for two amino acids during protein synthesis.</p>\n<p><strong>First nucleotide in a codon is responsible for degeneracy (Option C): </strong>In general, the third nucleotide in a codon is less important than the first two in determining the specific amino acid to be incorporated, and this accounts for most of the degeneracy of the code.</p>\n<p><strong>For a specific codon, only a single amino acid is indicated(Option D):</strong> For any specific codon, only a single amino acid is specified; with rare exceptions, the genetic code is unambiguous-that is, given a specific codon, only a single amino acid is indicated. However, it does not explain degeneracy.</p>", "options": ["Multiple codons decode the same amino acid", "Single codon decode for two amino acids", "First nucleotide in a codon is responsible for degeneracy", "For a specific codon, only a single amino acid is indicated"], "html_options": ["Multiple codons decode the same amino acid", "Single codon decode for two amino acids", "First nucleotide in a codon is responsible for degeneracy", "For a specific codon, only a single amino acid is indicated"], "corr_idx": 0}, {"id": "1182390", "html_qtxt": "True about nonsense codon is:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Each codon consists of a sequence of three nucleotides; that is, it is a triplet code.</li>\r\n<li>Three of the 64 possible codons do not code for specific amino acids; these have been termed <strong>nonsense codons</strong>.</li>\r\n<li>These nonsense codons are utilised in the cell as translation termination signals; they specify where the polymerisation of amino acids into a protein molecule is to stop.</li>\r\n<li>They are also commonly known as <strong>stop codons</strong> for their ability to \"stop\" translation.</li>\r\n<li>The remaining 61 codons code for the 20 amino acids added to proteins cotranslationally.</li>\r\n</ul>", "options": ["Code for multiple amino acids", "Code for the same amino acid", "Do not code for any amino acid", "None of the above"], "html_options": ["Code for multiple amino acids", "Code for the same amino acid", "Do not code for any amino acid", "None of the above"], "corr_idx": 2}, {"id": "1182393", "html_qtxt": "The enzyme aminoacyl-tRNA synthetase is involved in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Nucleic acids do not have intrinsic affinity for the functional groups of specific amino acids.</li>\n<li>Therefore, a protein is required to recognize both a specific amino acid and its corresponding tRNA.</li>\n<li>A total of at least 20 specific enzymes are responsible for this dual recognition and attachment process.</li>\n<li>These enzymes catalyze the attachment of the correct amino acid to its specific tRNA, a process known as <strong>tRNA charging</strong>.</li>\n<li>This process is energy-dependent and occurs in two steps.</li>\n<li>One specific enzyme catalyzes this reaction for each of the 20 standard amino acids.</li>\n<li>These enzymes are known as <strong>aminoacyl-tRNA synthetases</strong>.</li>\n<li>The amino acid is covalently linked to its tRNA via an ester bond.</li>\n<li>This charged tRNA remains stable until the amino acid is incorporated at its correct position during polypeptide synthesis on the ribosome.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509010d03ff9e-1969-41db-a598-c1f1e21d55a2.png\">\n<p><strong>Dissociation of tRNA from ribosomes (Option A) </strong>occurs during <strong>translocation or termination</strong>, but it is <strong>not mediated</strong> by aminoacyl-tRNA synthetase. This is a function of <strong>elongation or release factors</strong>, not tRNA charging enzymes.</p>\n<p><strong>Termination</strong> <strong>of protein synthesis (Option C)</strong> is triggered when a <strong>stop codon</strong> is encountered in the mRNA. This involves <strong>release factors</strong>, not aminoacyl-tRNA synthetase. These release factors promote the release of the newly formed polypeptide chain from the ribosome.</p>\n<p><strong>Initiation</strong> <strong>of protein synthesis (Option D) </strong>involves <strong>initiation factors</strong>, the <strong>ribosome</strong>, and <strong>initiator tRNA (usually tRNAi^Met in eukaryotes)</strong>, but <strong>not aminoacyl-tRNA synthetase</strong>. Although the initiator tRNA must be charged beforehand, the actual <strong>initiation step</strong> doesn't involve this enzyme directly.</p>", "options": ["Dissociation of tRNA from 80S ribosomes", "Charging of tRNA with amino acids", "Termination of protein synthesis", "Initiation of protein synthesis"], "html_options": ["Dissociation of tRNA from 80S ribosomes", "Charging of tRNA with amino acids", "Termination of protein synthesis", "Initiation of protein synthesis"], "corr_idx": 1}, {"id": "1182394", "html_qtxt": "Substitution of the base can result in:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Single-base changes (point mutations) may be transitions or transversions. In the former, a given pyrimidine is changed to the other pyrimidine or a given purine is changed to the other purine.</li>\r\n<li>Transversions are changes from a purine to either of the two pyrimidines or the change of a pyrimidine into either of the two purines.</li>\r\n<li>When the nucleotide sequence of a protein-coding gene containing the mutation is transcribed into an mRNA molecule, then the RNA molecule will, of course, possess the base change at the corresponding location.</li>\r\n<li>Single-base changes in the mRNA may have one of several effects when translated into protein:\r\n<ul>\r\n<li>There may be no detectable effect because of the degeneracy of the code; such mutations are often referred to as <strong>silent</strong>. This would be most likely if the changed base in the mRNA molecule were to be at the third nucleotide of a codon. <strong>(Option A)</strong></li>\r\n<li>A <strong>missense</strong>effect will occur when a different amino acid is incorporated at the corresponding site in the protein molecule. This mistaken amino acid-or missense, depending on its location in the specific protein-might be acceptable, partially acceptable, or unacceptable to the function of that protein molecule. <strong>(Option B)</strong></li>\r\n<li>A <strong>nonsense</strong>codon may appear, which would then result in the premature termination of translation and the production of only a fragment of the intended protein molecule. <strong>(Option C)</strong></li>\r\n</ul>\r\n</li>\r\n</ul>", "options": ["Silent mutation", "Missense mutation", "Nonsense mutation", "All of these"], "html_options": ["Silent mutation", "Missense mutation", "Nonsense mutation", "All of these"], "corr_idx": 3}, {"id": "1182395", "html_qtxt": "Frameshift mutation can occur due to all of the following except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Substitution (point mutation) replaces one nucleotide with another. It <strong>does not shift</strong> the reading frame and therefore <strong>does not cause a frameshift mutation</strong>. It may result in a silent, missense, or nonsense mutation instead.</p>\n<ul>\n<li>Inserting one nucleotide into a DNA sequence shifts the mRNA reading frame during translation. This leads to distorted codon grouping, often producing a garbled amino acid sequence or premature stop codons. <strong>(Option A)</strong></li>\n<li>Similar to a single nucleotide insertion, inserting two nucleotides alters the reading frame (since it&rsquo;s not a multiple of 3), causing a frameshift mutation and resulting in aberrant protein synthesis. <strong>(Option B)</strong></li>\n<li>Deletion of one nucleotide also causes a shift in the reading frame, leading to incorrect codon recognition, garbled protein sequences, and potential early stop codons. <strong>(Option C)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509014dd923dd-7611-4eb6-a436-ab53a43b0ad8.png\">", "options": ["Insertion of one nucleotide in DNA", "Insertion of two nucleotides in DNA", "Deletion of one nucleotide in DNA", "Substitution of base in DNA"], "html_options": ["Insertion of one nucleotide in DNA", "Insertion of two nucleotides in DNA", "Deletion of one nucleotide in DNA", "Substitution of base in DNA"], "corr_idx": 3}, {"id": "1182402", "html_qtxt": "All of the following are true sentences for P bodies, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Non-Translating mRNAs </strong>can form ribonucleoprotein particles that accumulate in cytoplasmic organelles termed P Bodies. P bodies are non-translating mRNA, never translated into protein.</p>\r\n<ul>\r\n<li>P bodies are sites of mRNA metabolism.<strong> (Option B) </strong></li>\r\n<li>Over 35 distinct proteins have been suggested to reside exclusively or extensively within P bodies.</li>\r\n<li>These proteins range from mRNA decapping enzymes, RNA helicases, and RNA exonucleases (5'-3' and 3'-5'), to components involved in miRNA function and mRNA quality control. However, incorporation of an mRNP is not an unequivocal mRNA \"death sentence\".</li>\r\n<li>Indeed, though the mechanisms are not yet fully understood, certain mRNAs appear to be temporarily stored in P bodies and then retrieved and utilized for protein translation.</li>\r\n<li>This suggests that an equilibrium exists where the cytoplasmic functions of mRNA (translation and degradation) are controlled by the dynamic interaction of mRNA with polysomes and P bodies.</li>\r\n<li>Specific mRNAs can associate with the protein constituents that form P bodies, small dense compartments that incorporate mRNAs as mRNPs.</li>\r\n<li>These cytoplasmic organelles are related to similar small mRNA-containing granules found in neurons and certain maternal cells. <strong>(Option C) </strong></li>\r\n<li>mRNAs, bound by specific packaging proteins are exported from the nucleus as <strong>ribonucleoprotein particles</strong> (mRNPs). <strong>(Option D)</strong></li>\r\n</ul>", "options": ["Translating mRNA", "Site for mRNA metabolism", "Accumulate in Cytoplasmic Organelles", "Can Form Ribonucleoprotein Particles"], "html_options": ["Translating mRNA", "Site for mRNA metabolism", "Accumulate in Cytoplasmic Organelles", "Can Form Ribonucleoprotein Particles"], "corr_idx": 0}, {"id": "1182404", "html_qtxt": "Which of the following pharmacological agents inhibits protein synthesis due to its structural similarity with tyrosyl-tRNA?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Puromycin is a structural analogue of tyrosyl-tRNA.</li>\r\n<li>Puromycin is incorporated via the A site on the ribosome into the carboxyl terminal position of a peptide but causes the premature release of the polypeptide.</li>\r\n<li>Puromycin, as a tyrosyl-tRNA analogue, effectively inhibits protein synthesis in both prokaryotes and eukaryotes.</li>\r\n</ul>\r\n<p><strong>Tetracycline (Option A)</strong> prevents the binding of aminoacyl-tRNAs to the bacterial ribosome A site.</p>\r\n<p><strong>Chloramphenicol (Option B)</strong> works by binding to 23S rRNA, which is interesting in view of the newly appreciated role of rRNA in peptide bond formation through its peptidyl transferase activity.</p>\r\n<p><strong>Cycloheximide (Option D)</strong> inhibits peptidyl transferase in the 60S ribosomal subunit in eukaryotes, presumably by binding to an rRNA component.</p>", "options": ["Tetracyclines", "Chloramphenicol", "Puromycin", "Cycloheximide"], "html_options": ["Tetracyclines", "Chloramphenicol", "Puromycin", "Cycloheximide"], "corr_idx": 2}, {"id": "1182406", "html_qtxt": "An operon, the unit of genetic expression, consists of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The operon model consists of <strong>related genes</strong> along with <strong>operator</strong> and <strong>promoter</strong> sequences.</p>\n<ul>\n<li>Jacob and Monod in 1961 described their operon model in a classic paper.</li>\n<li>Their hypothesis was to a large extent based on observations on the regulation of lactose metabolism by the intestinal bacterium E. coli.</li>\n<li>The molecular mechanisms responsible for the regulation of the genes involved in the metabolism of lactose are now among the best-understood in any organism.</li>\n<li> &beta;-Galactosidase hydrolyses the &beta;-galactoside lactose to galactose and glucose.</li>\n<li>The gene encoding &beta;-galactosidase (lacZ) is clustered with the genes encoding lactose permease (lacY) and thiogalactoside transacetylase (lacA).</li>\n<li>The genes encoding these three enzymes, along with the lac promoter and lac operator (a regulatory region), and the lacI gene encoding the LacI repressor, are physically linked and constitute the lac operon.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090142198e83-33ce-413f-88a8-3630989ea2b8.png\">", "options": ["Related genes and sequences", "Operator", "Promoter", "All of the above"], "html_options": ["Related genes and sequences", "Operator", "Promoter", "All of the above"], "corr_idx": 3}, {"id": "1182409", "html_qtxt": "Which of the following is not a characteristic of an enhancer during the regulation of the &beta;-interferon gene?", "html_expl": "<p><strong>Explanation for answer:</strong></p>\r\n<p>An enhancer during the regulation of the &beta;-interferon gene, work even when located at a further distance from the promoter.</p>\r\n<ul>\r\n<li>They can exert their positive influence on transcription even when separated by tens of thousands of base pairs from a promoter.</li>\r\n<li>Certain DNA elements facilitate or enhance initiation at the promoter and hence are termed enhancers. <strong>(Option A) </strong></li>\r\n<li>Enhancer elements, which typically contain multiple binding sites for transactivator proteins, differ from the promoter in notable ways.</li>\r\n<li>Work when oriented in either direction, work upstream (5') or downstream (3') from the promoter. <strong>(Option C) </strong></li>\r\n<li>Can work with homologous or heterologous promoters. <strong>(Option D)</strong></li>\r\n<li>Other features of enhancers are:\r\n<ul>\r\n<li>Work by binding one or more proteins</li>\r\n<li>Work by recruiting chromatin-modifying coregulatory complexes</li>\r\n<li>Work by facilitating the binding or function of the basal transcription complex at the cis-linked promoter</li>\r\n<li>One of the best-understood mammalian enhancer systems is that of the &beta;-interferon gene.\r\n<ul>\r\n<li>This gene is induced on viral infection of mammalian cells.</li>\r\n<li>One goal of the cell, once virally infected, is to attempt to mount an antiviral response to save the infected cell, then to help save the entire organism from viral infection.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>", "options": ["Facilitate initiation at the promoter", "Influence only when located near the promoter region", "Work when oriented in either direction, upstream (5') or downstream (3') from the promoter", "Can work with homologous or heterologous promoters"], "html_options": ["Facilitate initiation at the promoter", "Influence only when located near the promoter region", "Work when oriented in either direction, upstream (5') or downstream (3') from the promoter", "Can work with homologous or heterologous promoters"], "corr_idx": 1}, {"id": "1192073", "html_qtxt": "A defect in the cystic fibrosis transmembrane regulator protein (CFTR) is responsible for Cystic fibrosis. CFTR is a:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Cystic Fibrosis is due to Mutations in the Gene Encoding CFTR, a Chloride Transporter.</li>\r\n<li>Cystic fibrosis (CF) is a recessive genetic disorder prevalent among whites in North America and certain parts of northern Europe.</li>\r\n<li>CF is characterised by chronic bacterial infections of the airways and sinuses, fat malabsorption due to pancreatic exocrine insufficiency, infertility in males due to abnormal development of the vas deferens, and elevated levels of chloride in sweat (>60 mmol/L).</li>\r\n<li>It is now known that mutations in a gene encoding a protein named cystic fibrosis transmembrane regulator protein (CFTR) are responsible for CF.</li>\r\n<li><strong>CFTR is a cyclic AMP-regulated Cl&minus; transporter.</strong></li>\r\n</ul>", "options": ["Cyclic AMP-regulated Cl&oline;transporter", "Cyclic GMP-regulated Cl&oline;transporter", "Cyclic AMP-regulated Na+ transporter", "Cyclic GMP-regulated Na+ transporter"], "html_options": ["Cyclic AMP-regulated Cl&oline;transporter", "Cyclic GMP-regulated Cl&oline;transporter", "Cyclic AMP-regulated Na+ transporter", "Cyclic GMP-regulated Na+ transporter"], "corr_idx": 0}]}, {"moduleId": 1008734, "name": "Molecular Techniques", "questions": [{"id": "1182328", "html_qtxt": "EcoRI is a restriction endonuclease used to cut the human DNA before inserting it into a plasmid. Which of the following is the recognition sequence for this enzyme?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Certain endonuclease enzymes that cut DNA at specific DNA sequences within the molecule are a key tool in recombinant DNA research. These enzymes were termed restriction enzymes, or Res.</li>\n<li>Restriction enzymes cut the DNA of any source into unique, short pieces in a sequence-specific manner, in contrast to most other enzymatic, chemical, or physical methods, which break DNA randomly.</li>\n<li>Restriction enzymes are named after the bacterium from which they are isolated.</li>\n<li>For example, EcoRI is from Escherichia coli,</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090184a9d21b-e352-4d58-a14d-df20b3823f50.png\">", "options": ["GTTAAC", "GAATTC", "AAGTTC", "AAGCTT"], "html_options": ["GTTAAC", "GAATTC", "AAGTTC", "AAGCTT"], "corr_idx": 1}, {"id": "1182338", "html_qtxt": "CRISPR-Cas9 has revolutionised genomic DNA studies. Which of the following is true for CRISPR-Cas9?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>CRISPR-Cas9 (clustered regularly interspersed short palindromic repeats - associated gene 9)</strong></p>\n<ul>\n<li><strong>CRISPR</strong> is a gene editing and regulatory technique. <strong>(Option A)</strong></li>\n<li>Found in <strong>prokaryotes</strong> (bacteria and archaea), derived from <strong>bacteriophage DNA</strong>.</li>\n<li>Acts as an <strong>antiviral defense system</strong>, helping prokaryotes <strong>detect and destroy</strong> DNA from similar bacteriophages.</li>\n<li>Provides <strong>adaptive immunity</strong> to prevent reinfection by specific phages.</li>\n<li>Complements <strong>restriction endonucleases</strong> and <strong>methylases</strong>.</li>\n<li><strong>RNA-based targeting</strong> guides the <strong>Cas9 nuclease</strong> to complementary DNA for editing.</li>\n</ul>\n<p><strong>CAS9: CRISPR-associated protein 9</strong></p>\n<ul>\n<li>An endonuclease enzyme. <strong>(Option C)</strong></li>\n<li>It uses CRISPR sequences as a guide (as guide RNA). <strong>(Option B)</strong></li>\n<li>Then recognises specific DNA strands that are complementary to the CRISPR sequence & cleaves them.</li>\n</ul>\n<p><strong>CRISPR CAS9</strong></p>\n<ul>\n<li>Both together are used to edit genes within organisms.</li>\n<li>Within bacteria, this CRISPR-RNA-Cas9 complex then degrades and inactivates the targeted DNA.</li>\n</ul>\n<p><strong>Applications of CRISPR in Eukaryotes:</strong></p>\n<ul>\n<li>CRISPR has been <strong>adapted for use in eukaryotic cells</strong>, including <strong>humans</strong>, functioning as an <strong>RNA-guided site-specific nuclease</strong>.</li>\n<li>It has <strong>broad applications</strong> in:\n<ul>\n<li><strong>Medicine</strong> - used experimentally for genetic disorders (e.g., <strong>sickle cell disease</strong>) and <strong>viral infections</strong> like <strong>HIV</strong>.</li>\n<li><strong>Basic research</strong> - enables <strong>gene deletion</strong>, <strong>editing</strong>, <strong>visualization</strong>, and <strong>transcription modulation</strong>.</li>\n<li><strong>Agriculture & food industry</strong> - applied for genetic improvements.</li>\n</ul>\n</li>\n<li>CRISPR is a <strong>highly specific and efficient tool</strong> for <strong>DNA manipulation</strong> and <strong>genetic analysis</strong> in mammalian cells.</li>\n<li>A variant, <strong>C2c2</strong>, can <strong>site-specifically cleave RNA</strong>, offering the potential to <strong>alter mRNA levels</strong> in human cells.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509012dcd4827-0fb5-4649-8cab-cc643137bab3.png\">", "options": ["Gene amplifying technique", "Used DNA as a guide", "Having exonuclease activity", "Cas9 has enzymatic activity"], "html_options": ["Gene amplifying technique", "Used DNA as a guide", "Having exonuclease activity", "Cas9 has enzymatic activity"], "corr_idx": 3}, {"id": "1182345", "html_qtxt": "In addition to Taq polymerases, PCR requires all of the following, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Primase is not used in PCR.</p>\n<p><strong>The Polymerase Chain Reaction Method </strong></p>\n<ul>\n<li>PCR is a technique to amplify specific DNA sequences.</li>\n<li>It is highly <strong>sensitive</strong>, <strong>selective</strong>, and <strong>rapid</strong>.</li>\n<li>Specificity comes from <strong>two oligonucleotide primers</strong> that bind to complementary sequences flanking the target DNA.</li>\n</ul>\n<p><strong>Steps in PCR:</strong></p>\n<ol>\n<li><strong>Denaturation</strong>\n<ul>\n<li>DNA is heated (>90&deg;C) to separate strands.</li>\n</ul>\n</li>\n<li><strong>Annealing</strong>\n<ul>\n<li>Primers bind to complementary sequences (50-75&deg;C).</li>\n</ul>\n</li>\n<li><strong>Extension</strong>\n<ul>\n<li>DNA polymerase synthesizes new strands from the primers using dNTPs.</li>\n</ul>\n</li>\n</ol>\n<ul>\n<li>Each cycle doubles the amount of target DNA &rarr; <strong>exponential amplification</strong>.</li>\n<li><strong>Thermostable DNA polymerase</strong> (from thermophilic bacteria) is used to withstand high temperatures.</li>\n<li>Typical amplification:\n<ul>\n<li><strong>20 cycles</strong> &rarr; ~10<sup>6</sup>-fold</li>\n<li><strong>30 cycles</strong> &rarr; ~10<sup>6</sup>-fold</li>\n</ul>\n</li>\n<li>DNA fragments of <strong>50 bp to 10 kb</strong> can be amplified.</li>\n<li>Each cycle takes <strong>&le; 5-10 minutes</strong>.</li>\n<li>Conditions vary by target and require <strong>empirical optimization</strong>.</li>\n</ul>\n<p><strong>Applications of PCR:</strong></p>\n<ul>\n<li>DNA/RNA sequencing platforms</li>\n<li>Forensic analysis from single cells (e.g., sperm, hair follicle)</li>\n<li>Detection of infectious agents (e.g., latent viruses)</li>\n<li>Prenatal genetic diagnosis</li>\n<li>Detection of polymorphisms (SNPs, indels, gene amplifications)</li>\n<li>Tissue typing for organ transplants</li>\n<li>Evolutionary studies using ancient DNA</li>\n<li>Quantitative RNA analysis (via RT-PCR using reverse transcriptase)</li>\n<li>ChIP assays for studying protein-DNA interactions</li>\n</ul>\n<p><strong>Template DNA (Option A) </strong>is used as a target DNA to amplify specific sequences.</p>\n<p>All four <strong>Deoxyribonucleotide triphosphates</strong> <strong>(Option B) </strong>are used in PCR, which are polymerized by DNA polymerase.</p>\n<p><strong>Primers (Option C)</strong> that hybridize to complementary sequences on opposite strands of DNA and flank the target sequence.</p>", "options": ["Template DNA", "Deoxyribonucleotide triphosphate", "Primers", "Primase"], "html_options": ["Template DNA", "Deoxyribonucleotide triphosphate", "Primers", "Primase"], "corr_idx": 3}, {"id": "1182352", "html_qtxt": "Many genetic diseases and viral infections are diagnosed on the basis of PCR. Specificity of PCR is based on the use of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>PCR is a method of amplifying a target sequence of DNA.</li>\n<li>The development of PCR has revolutionized the ways in which both DNA and RNA can be studied.</li>\n<li>PCR provides a sensitive, selective, and extremely rapid means of amplifying any desired sequence of DNA.</li>\n<li>Specificity is based on the use of two oligonucleotide primers that hybridize to complementary sequences on opposite strands of DNA and flank the target sequence.</li>\n</ul>\n<p><strong>Taq DNA Polymerase enzyme (Option A): </strong>DNA synthesis is catalysed by a heat-stable DNA polymerase purified from one of a number of different thermophilic bacteria, organisms that grow at 70 to 80&deg;C. Specificity is based on the use of two oligonucleotide primers that hybridise to complementary sequences on opposite strands of DNA and flank the target sequence.</p>\n<p><strong>Deoxyribonucleotide (Option C): </strong>All four Deoxyribonucleotides are used in PCR, which are polymerised by DNA polymerase.</p>\n<p><strong>Temperature (Option D):</strong> The DNA sample is first heat-denatured (>90&deg;C) to separate the two strands of the template DNA containing the target sequence.</p>", "options": ["Taq DNA Polymerase enzyme", "Oligonucleotide primers", "Deoxyribonucleotide", "Temperature"], "html_options": ["Taq DNA Polymerase enzyme", "Oligonucleotide primers", "Deoxyribonucleotide", "Temperature"], "corr_idx": 1}, {"id": "1182365", "html_qtxt": "The overlay blot technique is used to detect:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Overlay blot examines <strong>protein-protein interactions</strong>.</p>\n<ul>\n<li>In this technique, proteins are separated by electrophoresis, blotted to a membrane, renatured, and analysed for an interaction with a protein by incubation with a specific labelled protein probe (overlay assay) using either a labelled protein or, alternatively, protein-protein interactions are detected using a specific antibody.</li>\n</ul>\n<p><strong>Blotting & Probing Techniques Allow Visualisation of Specific Target Molecules</strong></p>\n<ul>\n<li>Visualisation of a specific DNA or RNA fragment or protein among the many thousands of contaminating non-target molecules in a complex sample requires the convergence of a number of techniques, collectively termed <strong>blot transfer</strong>.</li>\n<li>The first technique is named for the person who devised the technique, <strong>Edward</strong> <strong>Southern</strong>; the other names began as laboratory jargon, but are now accepted terms.</li>\n<li>These procedures are useful in determining how many copies of a gene are in a given tissue or whether there are any alterations in a gene (deletions, insertions, or rearrangements) because the requisite, initial gel electrophoresis step separates the molecules on the basis of size.</li>\n<li>Occasionally, if a specific base is changed and a restriction site is altered, these procedures can detect a point mutation.</li>\n<li>The <strong>Northern</strong> and <strong>Western</strong> <strong>blot</strong> transfer techniques are used to size and quantify specific <strong>RNA</strong> and <strong>protein</strong> molecules, respectively. <strong>(Option C & D)</strong></li>\n<li>A fourth technique, the <strong>Southwestern</strong> or <strong>overlay</strong> <strong>blot</strong>, which examines <strong>protein-nucleic acid interactions or protein-protein interactions</strong>, respectively are variant of the Southern/Northern/Western blotting methods. <strong>(Option B)</strong></li>\n</ul>", "options": ["Protein-Protein interactions", "Protein-nucleic acid interactions", "Size and quantify specific RNA molecules", "Size and quantify specific protein molecules"], "html_options": ["Protein-Protein interactions", "Protein-nucleic acid interactions", "Size and quantify specific RNA molecules", "Size and quantify specific protein molecules"], "corr_idx": 0}, {"id": "1182372", "html_qtxt": "Which of the following is the most powerful technique used in transcription factor research that allows identifying genome-wide DNA binding sites for transcription factors?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Chromatin immunoprecipitation-sequencing (ChIP-seq) is used for the simultaneous identification of all of the genomic sites bound by a given transcription factor under a given set of physiologic conditions.</p>\n<p><strong>Systematic deletion mapping (Option A)</strong> is a genetic mapping technique that enables the determination of the location of specific genes on chromosomes.</p>\n<p><strong>DNase I sensitivity (Option B) </strong>assay is used for discovering regulatory domains. This method maps discrete sites in the genome where the conformation of chromatin renders its DNA hypersensitive to cleavage by the endonuclease DNase I.</p>\n<p><strong>Fluorescence in situ hybridisation (FISH) (Option D)</strong> is a molecular cytogenetic technique that uses fluorescent probes that bind to only particular parts of a nucleic acid sequence with a high degree of sequence complementarity.</p>", "options": ["Systematic deletion mapping", "DNase I sensitivity", "Chromatin immunoprecipitation-sequencing (ChIP-seq)", "Fluorescence in situ hybridisation (FISH)"], "html_options": ["Systematic deletion mapping", "DNase I sensitivity", "Chromatin immunoprecipitation-sequencing (ChIP-seq)", "Fluorescence in situ hybridisation (FISH)"], "corr_idx": 2}, {"id": "1182379", "html_qtxt": "Which of the following can lead to the Denaturation of DNA?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The organic solvent formamide, which is commonly used in recombinant DNA experiments, destabilizes hydrogen bonding between bases, thereby lowering the <em>T</em>m.</p>\n<ul>\n<li>Formamide addition allows the strands of DNA or DNA-RNA hybrids to be separated at much lower temperatures and minimizes the phosphodiester bond breakage and chemical damage to nucleotides that can occur upon extended incubation at higher temperatures.</li>\n<li>The double-stranded structure of DNA can be separated into two component strands in solution by increasing the temperature or decreasing the salt concentration. <strong>(Option B) </strong></li>\n<li>Not only do the two stacks of bases pull apart, but the bases themselves unstack while still connected in the polymer by the phosphodiester backbone.</li>\n<li>DNA can be denatured by increasing the temperature. <strong>(Option A) </strong></li>\n<li>The strands of a given molecule of DNA separate over a temperature range.</li>\n<li>The midpoint is called the <strong>melting temperature, or Tm</strong>.</li>\n<li>The Tm is influenced by the base composition of the DNA and by the salt concentration of the solution.</li>\n<li>DNA rich in G-C pairs, which has three hydrogen bonds, melts at a higher temperature than DNA rich in A-T pairs, which has two hydrogen bonds.</li>\n<li>A 10-fold increase in monovalent cation concentration increases the Tm by 16.6&deg;C by neutralising the intrinsic inter-chain repulsion between the highly negatively charged.</li>\n<li>DNA can be denatured at extreme pH (not at physiological pH around 7.4) <strong>(Option D)</strong></li>\n</ul>", "options": ["Decreasing temperature", "Increasing salt concentration", "Formamide", "Physiological pH"], "html_options": ["Decreasing temperature", "Increasing salt concentration", "Formamide", "Physiological pH"], "corr_idx": 2}]}, {"moduleId": 1008736, "name": "Fat Soluble Vitamins", "questions": [{"id": "1169884", "html_qtxt": "True regarding Common properties of lipid soluble vitamins is?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Due to their storage capability, toxicity can result from excessive intake of fat-soluble vitamins.</li>\n<li>For instance, hypervitaminosis A and D can result from overconsumption of supplements or fortified foods.</li>\n<li>The lipid-soluble vitamins are hydrophobic compounds that can be absorbed efficiently only when there is normal fat absorption. Like other lipids, they are transported in the blood in lipoproteins or attached to specific binding proteins. <strong>(Other options ruled out)</strong></li>\n<li>As well as dietary inadequacy, conditions affecting the digestion and absorption of the lipid-soluble vitamins, such as a very-low-fat diet, steatorrhea, and disorders of the biliary system, intestinal absorption disorders can all lead to deficiency syndromes, including:\n<ul>\n<li>Night blindness and xerophthalmia (vitamin A)</li>\n<li>Rickets in young children and osteomalacia in adults (vitamin D)</li>\n<li>Neurologic disorders and hemolytic anaemia of the newborn (vitamin E)</li>\n<li>Hemorrhagic disease of the newborn (vitamin K).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key takeaways:</strong></p>\n<p><strong>Vitamins can be divided into two categories:</strong></p>\n<ul>\n<li><strong>Fat-soluble:</strong>\n<ul>\n<li>Vitamin A</li>\n<li>Vitamin D</li>\n<li>Vitamin E</li>\n<li>Vitamin K</li>\n</ul>\n</li>\n<li><strong>Water soluble:</strong>\n<ul>\n<li>Vitamin B</li>\n<li>Vitamin C</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-1d93f5e8-7a2c-4c60-bd48-0a51c97e3f25.png\">", "options": ["They are hydrophilic", "They can be absorbed in conditions associated with fat malabsorption", "They are transported in blood freely", "Toxicity may occur as a result of excess intake"], "html_options": ["They are hydrophilic", "They can be absorbed in conditions associated with fat malabsorption", "They are transported in blood freely", "Toxicity may occur as a result of excess intake"], "corr_idx": 3}, {"id": "1169890", "html_qtxt": "Vitamin A functions as a prosthetic group in cones of the eye as.", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Vitamin A functions as retinaldehyde, the prosthetic group of the rods and cones, as Rhodopsin in the rods and Iodopsin in the cones in the retina.</p>\n<p><strong>Vitamin A:</strong></p>\n<ul>\n<li>Each cone cell in the retina is specialised to detect one of three primary colours: blue, green, or red. This specialisation allows for colour vision.</li>\n<li>Each cone cell contains a single type of opsin pigment that determines its sensitivity to a specific wavelength of light, corresponding to one of the primary colours.</li>\n<li>Vitamin A deficiency is the most important preventable cause of blindness.</li>\n<li>The earliest sign of deficiency is loss of sensitivity to green light<strong>,</strong>followed by impairment in adapting to dim light, night blindness and eventually inability to see in the dark.</li>\n<li>In vitamin A deficiency, both time and ability to adapt in the dark are poor. Vitamin A is essential for the synthesis of rhodopsin in rod cells, which are responsible for vision in low-light conditions.</li>\n<li>Prolonged deficiency leads to xerophthalmia, keratinisation of the cornea and eventually blindness.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Rhodopsin(Option A): </strong>Vitamin A functions as a prosthetic group of the rods as Rhodopsin.</p>\n<p><strong>Conopsin(Option B): </strong>It is a photopigment, a light-sensitive protein and when bound to retinal, becomes Iodopsin.</p>", "options": ["Rhodopsin", "Conopsin", "Colopsin", "Iodopsin"], "html_options": ["Rhodopsin", "Conopsin", "Colopsin", "Iodopsin"], "corr_idx": 3}, {"id": "1169898", "html_qtxt": "False about Vitamin A is?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In vitamin A deficiency, the time taken to adapt to darkness is increased, not decreased. This is due to impaired regeneration of rhodopsin in rod cells, leading to prolonged dark adaptation. So, the above D statement is wrong.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option A: </strong>Each cone cell in the retina is specialised to detect one of three primary colours: blue, green, or red. This specialisation allows for colour vision.</p>\n<p><strong>Option B</strong>: Each cone cell contains a single type of opsin pigment that determines its sensitivity to a specific wavelength of light, corresponding to one of the primary colours</p>\n<p><strong>Option C: </strong>In vitamin A deficiency, both time and ability to adapt in the dark are poor. Vitamin A is essential for the synthesis of rhodopsin in rod cells, which are responsible for vision in low-light conditions. A deficiency in vitamin A impairs rhodopsin regeneration, leading to delayed or impaired dark adaptation, commonly known as night blindness.</p>", "options": ["Any one cone has only one type of Color vision i.e. Blue, green or red", "Any one cone has only one type of opsin pigment", "Ability to adapt in darkness is decreased in Vitamin A deficiency is decreased", "Time taken to adapt in the dark is decreased in Vitamin A deficiency"], "html_options": ["Any one cone has only one type of Color vision i.e. Blue, green or red", "Any one cone has only one type of opsin pigment", "Ability to adapt in darkness is decreased in Vitamin A deficiency is decreased", "Time taken to adapt in the dark is decreased in Vitamin A deficiency"], "corr_idx": 3}, {"id": "1169902", "html_qtxt": "The deficiency of Vitamin A impairs the function of which of the following?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Vitamin A has a role in gene expression and tissue differentiation.</p>\n<p><strong>In this regard, Vitamin A forms two receptors:</strong></p>\n<ul>\n<li>Retinoic acid receptors(RARs): these bind all-trans retinoic acid and</li>\n<li>Retinoid X receptors(RXRs): these bind all-cis retinoic acid. These receptors also play an additional role in forming Dimers to help form receptors for Vitamin D and Thyroid hormones, causing the deficiency of Vitamin A to impair Vitamin D and thyroid hormone functions.</li>\n</ul>\n<p><strong>RXR:</strong></p>\n<ul>\n<li>RXR dimers are used for receptor formation, but deficiency causes the formation of inactive dimers.</li>\n<li>They, in turn, bind to occupied Vit. D and thyroid hormone to cause their repression, thus causing a negative role in their functions, having a more severe effect than simple deficiency.</li>\n</ul>\n<p><strong>Key takeaways:</strong></p>\n<ul>\n<li>Retinoic acid is the compound that is involved in gene expression and tissue differentiation.</li>\n<li>The retina is involved in the visual cycle. The absorption of light by rhodopsin causes isomerisation of 11-cis retinal to 11 trans retinal, which leads to the generation of a nerve impulse. Both cis retinal and trans retinal have no role in the regulation of gene expression and tissue differentiation.</li>\n<li>Retinol is vitamin A alcohol, with no role in the regulation of gene expression and tissue differentiation.</li>\n</ul>", "options": ["Vitamin C and thyroid hormone", "Vitamin D and Vitamin K", "Vitamin D and thyroid hormone", "Vitamin C and Vitamin K"], "html_options": ["Vitamin C and thyroid hormone", "Vitamin D and Vitamin K", "Vitamin D and thyroid hormone", "Vitamin C and Vitamin K"], "corr_idx": 2}, {"id": "1169904", "html_qtxt": "The Following is not a symptom of Vitamin. A toxicity?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Headache and Ataxia are caused by vitamin A toxicity due to increased cerebrospinal fluid and not decreased, so the D option is incorrect.</li>\n<li>There is only a limited capacity to metabolise vitamin A, and excessive intakes lead to accumulation beyond the capacity of intracellular binding proteins. Unbound vitamin A causes membrane lysis and tissue damage.</li>\n</ul>\n<p><strong>Vitamin A toxicity leads to:</strong></p>\n<ul>\n<li>Headache and increased intracranial pressure (pseudotumor cerebri).</li>\n<li>Nausea and vomiting</li>\n<li>Drowsiness, dizziness, irritability</li>\n<li>Blurred or double vision, visual disturbances.</li>\n<li>Hair changes (alopecia), eyebrow loss, and desquamation of skin. <strong>(Option C ruled out.)</strong></li>\n<li>Hepatomegaly and liver damage. <strong>(Option A ruled out.)</strong></li>\n<li>Bone pain, cortical hyperostosis, arthralgia, fractures.</li>\n<li>Hypercalcemia <strong>(Option B ruled out)</strong></li>\n<li>Bulging fontanelle, craniotabes.</li>\n<li>Poor weight gain or failure to thrive (children).</li>\n<li>Jaundice or yellowed skin</li>\n</ul>\n<p><strong>Key takeaways:</strong></p>\n<p><strong>Vitamin A teratogenicity:</strong></p>\n<ul>\n<li>A syndrome of severe congenital malformations may occur in infants of mothers who have consumed therapeutic doses (0.5-1.5 mg/kg) of oral 13-cis-retinoic acid, generally taken for the treatment of acne or cancer, during the 1st trimester of pregnancy</li>\n<li>These malformations result in a high incidence (>20%) of spontaneous abortions and birth defects, including characteristic craniofacial abnormalities.</li>\n<li>Excessive intake of carotenoids is not associated with toxicity but can cause yellow colouration of the skin (carotenodermia) and serum (carotenemia) that disappears when intake is reduced. ced</li>\n</ul>", "options": ["Hepatomegaly due to hyperactivation of Stella cells present in the space of Disse", "Hypercalcemia and altered calcium homeostasis", "Alopecia and desquamation of skin", "Headache and ataxia due to decreased cerebrospinal fluid"], "html_options": ["Hepatomegaly due to hyperactivation of Stella cells present in the space of Disse", "Hypercalcemia and altered calcium homeostasis", "Alopecia and desquamation of skin", "Headache and ataxia due to decreased cerebrospinal fluid"], "corr_idx": 3}, {"id": "1169906", "html_qtxt": "The Active form of Vitamin. D is?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The active form of Vitamin. D is 1, 25 (OH)2 Vit. D is also called Calcitriol.</li>\n<li>Cholecalciferol, either synthesised in the skin or from food, undergoes two hydroxylations to yield the active metabolite, 1,25-dihydroxy vitamin D or calcitriol.</li>\n<li>Ergocalciferol from fortified foods undergoes similar hydroxylation to yield calcitriol.</li>\n<li>In the liver, cholecalciferol is hydroxylated to form the 25-hydroxy derivative, calcidiol. This is released into the circulation bound to a vitamin D-binding globulin, which is the main storage form of the vitamin.</li>\n<li>In the kidney, calcidiol undergoes either 1-hydroxylation to yield the active metabolite 1,25-dihydroxy vitamin D (calcitriol) or 24-hydroxylation to yield a probably inactive metabolite, 24,25-dihydroxy vitamin D (24-hydroxy calcidiol).</li>\n</ul>\n<p><strong>Vitamin D functions and deficiency:</strong></p>\n<ul>\n <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-fac18754-2b61-45f0-83c9-89b0e7a34d91.png\">\n<li>Vitamin D is not strictly a vitamin since it can be synthesised in the skin, and in most conditions, this is the major source of the vitamin. Only when sunlight exposure is inadequate, a dietary source is required.</li>\n<li>Its main function is in the regulation of calcium absorption and homeostasis. Most of its actions are&nbsp;mediated by way of nuclear receptors that regulate gene expression. It also has a role in regulating cell proliferation and differentiation.</li>\n<li>There is evidence that intakes considerably higher than are required to maintain calcium homeostasis reduce the risk of insulin resistance, obesity, and the metabolic syndrome, as well as various cancers.</li>\n<li>Deficiency, leading to rickets in children and osteomalacia in adults, is a problem in northern latitudes, where sunlight exposure is inadequate.e</li>\n</ul>\n<p><strong>Vitamin D toxicity:</strong></p>\n<ul>\n<li>Excess Vit. D is the most toxic vitamin when taken in excess as it causes abnormal calcification of soft tissues, contraction of blood vessels and high blood pressure.</li>\n<li>Although excess dietary vitamin D is toxic, excessive exposure to sunlight does not lead to vitamin D poisoning, because there is a limited capacity to form the precursor, 7-dehydrocholesterol, and prolonged exposure of previtamin D to sunlight leads to formation of inactive compounds.</li>\n</ul>", "options": ["25 OH Vit. D", "1, 25 (OH)2 Vit. D", "Cholecalciferol", "Ergocalciferol"], "html_options": ["25 OH Vit. D", "1, 25 (OH)2 Vit. D", "Cholecalciferol", "Ergocalciferol"], "corr_idx": 1}, {"id": "1169908", "html_qtxt": "Vit. D is regulated by?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The primary role of vitamin D is to control calcium homeostasis in the body.</li>\n<li>Vitamin D metabolism is regulated by factors that respond to the plasma concentrations of calcium and phosphate.</li>\n<li>Calcitriol and Calcium are the two main regulators of Vitamin D.</li>\n</ul>\n<p><strong>Role of Calcitriol:</strong> Calcitriol (the active form of vitamin D) is a key player in this regulation.</p>\n<ul>\n<li>When there is an excess of calcitriol (active vitamin D) in the body, it acts to reduce its synthesis.</li>\n<li>Calcitriol induces the enzyme 24-hydroxylase, which breaks down active vitamin D.</li>\n<li>Calcitriol represses the enzyme 1-hydroxylase, which is responsible for the synthesis of active vitamin D in the kidney.</li>\n</ul>\n<p><strong>Calcium and Phosphate Affecting Vitamin D Activity:</strong></p>\n<ul>\n<li>When the concentration of calcium in the blood decreases, it triggers the activation of vitamin D to increase calcium absorption in the intestines.</li>\n<li>Reduced phosphate levels in the blood also contribute to the activation of vitamin D, aiding in calcium absorption.</li>\n<li>The primary and central function of vitamin D is to maintain the concentration of calcium in the bloodstream, ensuring calcium homeostasis.</li>\n</ul>\n<p><strong>Functions of Vitamin D:</strong></p>\n<p><strong>Maintaining the plasma calcium concentration:</strong></p>\n<ul>\n<li>It increases intestinal absorption of calcium</li>\n<li>It reduces excretion of calcium(by stimulating reabsorption in the distal renal tubules).</li>\n<li>And it mobilises bone mineral.</li>\n</ul>\n<p><strong>Other functions:</strong></p>\n<ul>\n<li>Calcitriol is involved in insulin secretion.</li>\n<li>Synthesis and secretion of parathyroid and thyroid hormones.</li>\n<li>Immune function: inhibition of production of interleukin by activated T-lymphocytes and of immunoglobulin by activated B-lymphocytes, differentiation of monocyte precursor cells, and modulation of cell proliferation.</li>\n</ul>\n<p><strong>Vitamin D Toxicity:</strong></p>\n<ul>\n<li>Excess Vit. D is the most toxic vitamin when taken in excess, as it causes abnormal calcification of soft tissues, which can lead to contraction of blood vessels and high blood pressure.</li>\n<li>Although excess dietary vitamin D is toxic, excessive exposure to sunlight does not lead to vitamin D poisoning, because there is a limited capacity to form the precursor, 7-dehydrocholesterol, and prolonged exposure of previtamin D to sunlight leads to the formation of inactive compounds.</li>\n</ul>", "options": ["Vit. A and phosphate", "Calcidiol and calcium", "Vit. A and calcium", "Calcitriol and calcium"], "html_options": ["Vit. A and phosphate", "Calcidiol and calcium", "Vit. A and calcium", "Calcitriol and calcium"], "corr_idx": 3}, {"id": "1169912", "html_qtxt": "Vit. E is the major antioxidant in which of the following?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>E is a chain-breaking, free radical-trapping antioxidant present in cell membranes and plasma lipoproteins that acts by reacting with the lipid peroxide radicals formed by peroxidation of polyunsaturated fatty acids. It traps the free radicals, forming inactive complexes, thus reducing the oxidative stress.</li>\n<li>C reduces the tocopheroxyl radical back to tocopherol, thus releasing Vitamin E. L-&alpha;-tocopherol is inactive. D-&alpha;-tocopherol is the most active. Synthetic D-&alpha;-tocopherol does not have the same biologic potency as the naturally occurring compound.</li>\n<li>The resultant stable monodehydroascorbate radical then undergoes enzymic or non-enzymic reaction to yield ascorbate and dehydroascorbate, neither of which is a radical.</li>\n<li>Vitamin C and beta carotene also act as antioxidants, but are less abundant in the plasma membrane.</li>\n<li>Premature infants are born with inadequate reserves of vitamin E. The erythrocyte membranes are abnormally fragile as a result of lipid peroxidation, leading to hemolytic anaemia.</li>\n<li>Thus, Vit E deficiency leads to hemolytic anaemia due to lipid peroxidation, leading to fragile RBC membranes.</li>\n<li>Vitamin E deficiency in humans, leading to nerve and muscle membrane damage, may lead to neurological dysfunction</li>\n</ul>\n<p><strong>Causes of Vitamin E deficiency:</strong></p>\n<ul>\n<li>Severe fat malabsorption</li>\n<li>Cystic fibrosis</li>\n<li>Chronic liver disease.</li>\n<li>Dietary deficiency of Vit. E in human beings is very rare and generally not associated with Vitamin. E deficiency.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-34b2d0ef-98c1-4825-9f7d-6e4a93c8a715.png\">\n<p><strong>Key takeaways:</strong></p>\n<ul>\n<li>Ascorbate, uric acid, and a variety of polyphenols derived from plant foods act as<strong>water-soluble</strong>radical-trapping antioxidants, forming relatively stable radicals that persist long enough to undergo reaction to nonradical products.</li>\n<li>Ubiquinone and carotenes similarly act as<strong> lipid-soluble</strong> radical-trapping antioxidants in membranes and plasma lipoproteins.</li>\n</ul>", "options": ["Plasma membrane and lipoproteins", "Cell membrane and lipoproteins", "Plasma membrane and cell organelles", "Cell membrane and cell organelles"], "html_options": ["Plasma membrane and lipoproteins", "Cell membrane and lipoproteins", "Plasma membrane and cell organelles", "Cell membrane and cell organelles"], "corr_idx": 1}, {"id": "1169915", "html_qtxt": "Compounds that have the biological activity of Vitamin K are all except?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Quinolone is an antibiotic and has no relation to vitamin K.</li>\n</ul>\n<p><strong>Three compounds have the biological activity of vitamin K:</strong></p>\n<ul>\n<li>Phylloquinone, the normal dietary source, is found in green vegetables. <strong>(Option nA ruled out)</strong></li>\n<li>Menaquinones, synthesised by intestinal bacteria with differing lengths of side chain, are absorbed to some extent, but it is not clear to what extent they are biologically active. <strong>(Option B ruled out.t)</strong></li>\n<li>Menadione and menadiol diacetate, synthetic compounds that can be metabolised to phylloquinone. <strong>(Option C ruled out.).</strong></li>\n</ul>\n<p><strong>Cofactor activity of vitamin K:</strong></p>\n<ul>\n<li>Vitamin K is the cofactor for the carboxylation of glutamate residues in the postsynthetic modification of proteins to form the unusual amino acid &gamma;-carboxygutamate (GLA).</li>\n<li>Initially, vitamin K hyroquinone is oxidised to the epoxide, which activates a glutamate residue in the protein substrate to form a carbanion, which reacts nonenzymatically with carbon dioxide to form &gamma;-carboxygutamate.</li>\n<li>Thus, Vitamin K works by a Carboxylation mechanism for the formation of important proteins to form clotting factors.</li>\n<li>Several proteins undergo the same vitamin K-dependent carboxylation of glutamate to &gamma;-carboxyglutamate, which include:\n<ul>\n<li>Osteocalcin</li>\n<li>Protein C and S</li>\n<li>Matrix Gla protein in bone</li>\n<li>Nephrocalcin in the kidney and</li>\n<li>Growth arrest-specific gene Gas6, which is involved in both the regulation of differentiation and development in the nervous system and the control of apoptosis in other tissues.</li>\n</ul>\n</li>\n<li>All of these y-carboxyglutamate-containing proteins bind calcium, which causes a conformational change so that they interact with membrane phospholipids.</li>\n</ul>", "options": ["Phylloquinone", "Menaquinone", "Menadione", "Quinolone"], "html_options": ["Phylloquinone", "Menaquinone", "Menadione", "Quinolone"], "corr_idx": 3}, {"id": "1169920", "html_qtxt": "High dose Vit. K is an antidote for poisoning by which drug?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Vit K is reduced to form the active compound by both warfarin-sensitive and warfarin-insensitive enzymes.</li>\n<li>In the presence of warfarin, Vit. K epoxied cannot be reduced as the warfarin-sensitive enzyme is blocked, and the Vit. K, which then accumulates, is excreted by the body.</li>\n<li>If enough Vitamin K is provided, it can be metabolised(reduction reaction) into its active form by the warfarin-insensitive enzyme, and thus, carboxylation can continue.</li>\n<li>Thus, high-dose Vitamin. K can be used as an antidote for warfarin overdose.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Heparin(Option B):</strong> The antidote for Heparin is Protamine sulfate.</p>\n<p><strong>Aspirin(Option C): </strong>There is no antidote for aspirin poisoning; it's only supportive management and may involve treatment of dehydration, hyperthermia, hypokalemia and convulsions.</p>\n<p><strong>Clopidogrel(Option D): </strong>Overdosing of clopidogrel can be treated by platelet transfusion.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-7a5e2c81-1d4b-4c0e-97f3-14a5c6e89d2f.png\">", "options": ["Warfarin", "Heparin", "Aspirin", "Clopidogrel"], "html_options": ["Warfarin", "Heparin", "Aspirin", "Clopidogrel"], "corr_idx": 0}, {"id": "1169926", "html_qtxt": "Newborns are prone to develop Vitamin K deficiency due to?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Newborns have sterile intestines and initially lack the bacteria that synthesise vitamin K.(Option A)</li>\n<li>Human milk provides only about one-fifth of the daily requirement for vitamin K to newborns. <strong>(Option B)</strong></li>\n<li>Newborns may have immature liver function, including reduced activity of enzymes necessary to activate Vitamin K-dependent clotting factors. <strong>(Option C)</strong></li>\n<li>This is the reason that newborns are prone to developing Vitamin K deficiency, which is one of the causes of hemorrhagic disease of the newborn.</li>\n<li>It is recommended that all newborns receive a single intramuscular dose of vitamin K as prophylaxis against hemorrhagic disease.</li>\n</ul>", "options": ["Due to intestine bacteria which metabolise vit. K", "Low levels of Vitamin K in the breast milk", "Under functioning of Vitamin K activating enzyme", "All of the above"], "html_options": ["Due to intestine bacteria which metabolise vit. K", "Low levels of Vitamin K in the breast milk", "Under functioning of Vitamin K activating enzyme", "All of the above"], "corr_idx": 3}, {"id": "1169979", "html_qtxt": ": Which of the following statements is wrong about vitamins?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Vitamins are a group of organic nutrients, required in small quantities for a variety of biochemical functions, and are not required in very large amounts.</li>\n<li>Deficiency of a single vitamin of the B complex is rare since poor diets are most often associated with multiple deficiency states. <strong>(Option A ruled out.)</strong></li>\n<li>Generally, Vitamins cannot be synthesised by the body and therefore must be supplied in the diet. <strong>(Option C ruled out.)</strong></li>\n<li>Vitamins are a diverse group of chemical molecules; all are chemically non-amino. But the term vitamin, however, is continued without the final letter 'e'. So, the term&nbsp;vitamine&nbsp;(vital amine) is considered a misnomer. <strong>(Option D ruled out.)</strong></li>\n</ul>", "options": ["Deficiency of a single vitamin of the B complex is rare", "Required in large quantities for a variety of biochemical functions", "Generally cannot be synthesized by the body and must be supplied in the diet", "Vitamin is a misnomer term, as all vitamins are not amine in nature"], "html_options": ["Deficiency of a single vitamin of the B complex is rare", "Required in large quantities for a variety of biochemical functions", "Generally cannot be synthesized by the body and must be supplied in the diet", "Vitamin is a misnomer term, as all vitamins are not amine in nature"], "corr_idx": 1}, {"id": "1170025", "html_qtxt": "During inflammatory response, circulating form of vitamin A is reduced because:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>The circulating form of Vitamin A is reduced during inflammation because the synthesis of retinol binding protein is decreased.</strong></p>\n<p><strong>During the inflammatory process:</strong></p>\n<ul>\n<li>Those plasma proteins whose levels are changed in plasma (> 25%) during inflammation (as a result of any infection, injury, malignancy, surgery, etc) are known as Acute Phase Proteins or Acute Phase Reactants.</li>\n<li>Plasma proteins whose levels increase in inflammation, known as Positive acute-phase proteins. Examples are &alpha;<sub>1</sub>-antitypsin, &alpha;<sub>2</sub>-macroglobulin, C-reactive protein, Complement proteins, Ceruloplasmin, Haptoglobin, Ferritin, Fibrinogen, Mannose binding proteins etc.,</li>\n<li>Plasma proteins whose levels decrease in inflammation, known as Negative Acute Phase Proteins. Examples are Albumin, Prealbumin (Transthyretin), Transferrin, and Retinol binding proteins. <strong>(Option C ruled out.)</strong></li>\n<li>Retinol binding protein is required to transport the vitamin in the bloodstream.</li>\n<li>The synthesis of retinol-binding protein is reduced in response to infection (as it is a negative acute phase protein), so decreasing the circulating concentration of the vitamin and further impairing immune responses. <strong>(Option B ruled out.)</strong></li>\n</ul>", "options": ["The synthesis of retinol binding protein is decreased", "The synthesis of retinol binding protein is increased", "Retinol binding protein is positive acute phase proteins", "Vitamin A is destroyed"], "html_options": ["The synthesis of retinol binding protein is decreased", "The synthesis of retinol binding protein is increased", "Retinol binding protein is positive acute phase proteins", "Vitamin A is destroyed"], "corr_idx": 0}, {"id": "1170037", "html_qtxt": "All of the following is true regarding vitamin D, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In temperate climates, the plasma concentration of vitamin D exhibits a clear seasonal variation, being highest at the end of summer and lowest at the end of winter. This pattern corresponds with the intensity of solar UVB radiation, which is strongest in summer and weakest in winter, affecting the skin's ability to synthesise vitamin D<strong>.</strong></li>\n<li>In temperate climates, the plasma concentration of vitamin D is not lowest at the end of summer and not highest at the end of winter.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option A & B:</strong></p>\n<ul>\n<li>Vitamin D metabolism is both regulated by and regulates calcium homeostasis</li>\n<li>The main function of vitamin D is in the control of calcium homeostasis. And turn, vitamin D metabolism is regulated by factors that respond to plasma concentrations of calcium and phosphate.</li>\n<li>Calcitriol acts to reduce its synthesis by inducing the 24-hydroxylase and repressing the 1-hydroxylase in the kidney.</li>\n<li>The principal function of vitamin D is to maintain the plasma calcium concentration. Calcitriol achieves this in three ways: it increases intestinal absorption of calcium; it reduces excretion of calcium (by stimulating reabsorption in the distal renal tubules); and it mobilises bone mineral.</li>\n</ul>\n<p><strong>Option C: </strong>In temperate climates, the plasma concentration of vitamin D is highest at the end of summer and lowest at the end of winter. Beyond latitudes about 40&deg; north or south, there is very little ultraviolet radiation of the appropriate wavelength in winter.</p>", "options": ["Vitamin D metabolism is regulated by calcium homeostasis", "Vitamin D regulates calcium homeostasis", "In temperate climates, the plasma concentration of vitamin D is highest at the end of summer and lowest at the end of winter.", "In temperate climates, the plasma concentration of vitamin D is lowest at the end of summer and highest at the end of winter."], "html_options": ["Vitamin D metabolism is regulated by calcium homeostasis", "Vitamin D regulates calcium homeostasis", "In temperate climates, the plasma concentration of vitamin D is highest at the end of summer and lowest at the end of winter.", "In temperate climates, the plasma concentration of vitamin D is lowest at the end of summer and highest at the end of winter."], "corr_idx": 3}, {"id": "1170047", "html_qtxt": "A 52 years old male have history of bone pain and repeated fracture. He is suffering from chronic renal failure. On examination, following abnormality is observed. A patient is likely to be suffering from deficiency of which of the following compound?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-b42a9d8e-7135-4e0b-84a1-33e8b09c41f6.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The above picture represents Bow legs, also known as Genu Varum. The patient with chronic renal failure, bone pain, and repeated fractures is likely suffering from a deficiency of calcitriol.</li>\n<li>Calcitriol is the active form of vitamin D, which is synthesised in the kidneys. In patients with chronic renal failure, the kidneys may not be able to convert vitamin D into its active form (calcitriol) effectively.</li>\n<li>Calcitriol plays a crucial role in calcium homeostasis, bone health, and the absorption of calcium from the gastrointestinal tract.</li>\n<li>A deficiency of calcitriol can lead to impaired calcium absorption and metabolism, resulting in bone pain and increased susceptibility to fractures.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Ascorbic acid(Option A): </strong>It can cause scurvy, characterised by symptoms such as bleeding gums and skin issues, but it is not typically associated with bone pain and fractures.</p>\n<p><strong>Retinoic acid(Option B)</strong>: It is a derivative of vitamin A and is not commonly associated with the symptoms described.</p>\n<p><strong>Folic acid(Option C): </strong>Its deficiency can lead to anaemia and other symptoms, but it is not typically associated with bone pain and fractures.</p>", "options": ["Ascorbic acid", "Retinoic acid", "Folic acid", "Calcitriol"], "html_options": ["Ascorbic acid", "Retinoic acid", "Folic acid", "Calcitriol"], "corr_idx": 3}, {"id": "1170055", "html_qtxt": "A 54-year-old male presented with abdominal pain & jaundice. Ultrasound abdomen shows a stone in the biliary tract. Which of the following vitamin injections should be given before doing any surgical procedure on this patient to avoid excess bleeding?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This is a case of obstructive jaundice due to a biliary tract stone. Due to the absence of bile, lipid and lipid-soluble vitamins are not absorbed properly. Hence, it leads to a deficiency of fat-soluble vitamins (Vitamin A, D, E, K).</li>\n<li>This patient is prone to Vitamin K deficiency.</li>\n<li>Vitamin K is required for the clotting of blood. Vitamin injection should be given before doing any surgical procedure on this patient to avoid excess bleeding.</li>\n</ul>\n<p><strong>Sweet clover disease:</strong></p>\n<ul>\n<li>Vitamin K was discovered as a result of investigations into the cause of a bleeding disorder, sweet clover (haemorrhagic) disease of cattle and chickens fed on a fat-free diet.</li>\n<li>The missing factor in the diet of the chickens was vitamin K, while the cattle feed contained dicumarol, an antagonist of vitamin K.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Vitamin D(Option A):</strong> Vitamin D is fat fat-soluble vitamin. Its deficiency may be seen in this patient, but no role in clotting.</p>\n<p><strong>Vitamin C(Option C):</strong> Vitamin C is a water-soluble vitamin. Its absorption is not impaired in fat malabsorption. Although vitamin C deficiency can lead to bleeding due to fragile vessels, due to improper formation of collagen.</p>\n<p><strong>Vitamin B12(Option D):</strong> Vitamin B12 is a water-soluble vitamin. Its absorption is not impaired in fat malabsorption.</p>", "options": ["Vitamin D", "Vitamin K", "Vitamin C", "Vitamin B12"], "html_options": ["Vitamin D", "Vitamin K", "Vitamin C", "Vitamin B12"], "corr_idx": 1}, {"id": "1170073", "html_qtxt": "All of the following compounds are structural analogue of Vitamin K and inhibits Vitamin K activity, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Menadione (Vitamin K3) is a synthetic compound that can be metabolised to phylloquinone, so it has vitamin K activity.</li>\n<li>Warfarin, Dicumarol, and Coumarin are structural analogues of Vitamin K and inhibit Vitamin K activity (act as Vitamin K Antagonists). These are commonly used to reduce blood clotting in patients with a high risk of thromboembolism. <strong>(Other options ruled out)</strong></li>\n<li>They competitively inhibit enzyme Epoxide reductase & Quinone reductase (Vit K reductase)</li>\n<li><strong>Indication of use:</strong>Prophylaxis & treatment of venous thromboembolism (deep vein thrombosis, pulmonary embolism), Prophylaxis and treatment of Atrial fibrillation, Valvular stenosis, Heart valve replacement, etc..,</li>\n<li>Use of Warfarin during pregnancy can lead to foetal bone abnormalities (foetal warfarin syndrome)</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-5e3a7d92-fd40-47f6-8b4a-21e7d8a39f7b.png\">", "options": ["Warfarin", "Dicumarol", "Coumarin", "Menadione"], "html_options": ["Warfarin", "Dicumarol", "Coumarin", "Menadione"], "corr_idx": 3}]}, {"moduleId": 1008737, "name": "Water Soluble Vitamins And Minerals", "questions": [{"id": "1169956", "html_qtxt": "All of the clinical features are seen in deficiency of thiamine, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>RBC transketolase activity is reduced; it is the earliest & reliable index, even before clinical features.</li>\r\n<li>The activation of apotransketolase (the enzyme protein) in erythrocyte lysate by thiamine diphosphate added in vitro has become the accepted index of thiamine nutritional status.</li>\r\n</ul>\r\n<p><strong>Deficiency of thiamine leads to the disease Beriberi:</strong></p>\r\n<p>C<strong>linical features:</strong></p>\r\n<ul>\r\n<li>Chronic peripheral neuritis <strong>(Option A ruled out),</strong></li>\r\n<li>Beriberi, which may or may not be associated with heart failure <strong>(Option B ruled out)</strong> and Oedema</li>\r\n<li>Acute pernicious (fulminating) beriberi (Shoshin beriberi), in which heart failure and metabolic abnormalities predominate, without peripheral neuritis;</li>\r\n<li>Wernicke encephalopathy with Korsakoff psychosis, which is associated especially with alcohol and narcotic abuse.</li>\r\n<li>Lactic acidosis: The role of thiamine diphosphate in pyruvate dehydrogenase means that in deficiency, there is an impaired conversion of pyruvate to acetyl-CoA.</li>\r\n<li>In subjects on a relatively high carbohydrate diet, this results in increased plasma concentrations of lactate and pyruvate, which may cause life-threatening lactic acidosis.<strong> (Option C ruled out)</strong></li>\r\n</ul>", "options": ["Peripheral following  neuritis", "Heart failure", "Lactic acidosis", "Increased activity of erythrocyte transketolase enzyme"], "html_options": ["Peripheral following  neuritis", "Heart failure", "Lactic acidosis", "Increased activity of erythrocyte transketolase enzyme"], "corr_idx": 3}, {"id": "1169963", "html_qtxt": "Thiamine is intimately related to metabolism of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Thiamine has a central role in energy-yielding metabolism, and especially the metabolism of carbohydrates.</li>\n<li>Thiamine is intimately connected with the energy releasing reactions in carbohydrate metabolism</li>\n<li>Thiamine diphosphate is the coenzyme for three multienzyme complexes that catalyzes the oxidative decarboxylation reactions:\n<ul>\n<li>Pyruvate dehydrogenase: Convert Pyruvate aacetyl Co A</li>\n<li>&alpha;ketoglutarate dehydrogenase: In TCA cycle, Convert &alpha; ketoglutarate a Succinyl CoA (TCA cycle)</li>\n<li>Branched chain &alpha; keto acid dehydrogenase (decarboxylase): Convert branched chain amino acids (Valine, Leucine, Isoleucine) a its respective keto acids</li>\n</ul>\n</li>\n<li>In these three reactions, thiamine diphosphate provides a reactive carbon on the thiazole moiety that forms a carbanion, which then adds to the carbonyl group, for example, pyruvate. The addition compound is then decarboxylated, eliminating CO2.</li>\n<li>It is also a coenzyme for Transketolase enzymes, involved in the HMP shunt pathway, two transketolase reactions\n<ul>\n<li>Xylulose 5 P + Ribose 5 P - Sedoheptulose P + Glyceraldehyde 3 P</li>\n<li>Xylulose 5 P + Erythrose 4 P - Fructose 6 P + Glyceraldehyde 3 P</li>\n</ul>\n</li>\n<li>Thiamine triphosphate also has a role in nerve conduction; it phosphorylates and so activates a chloride channel in the nerve membrane</li>\n</ul>", "options": ["Fat", "Protein", "Carbohydrate", "Minerals"], "html_options": ["Fat", "Protein", "Carbohydrate", "Minerals"], "corr_idx": 2}, {"id": "1169967", "html_qtxt": "Which one of the vitamins is yellow and widely used as a food additive?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The main dietary sources of riboflavin are milk and dairy products<strong>. Riboflavin is intensely yellow, widely used as a food additive</strong>.</li>\n<li>Riboavin provides the reactive moieties of the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD).</li>\n<li>FMN is formed by ATP-dependent phosphorylation of riboflavin; FAD is synthesised by further reaction with ATP in which the AMP moiety is transferred onto FMN. Flavin Coenzymes Are Electron Carriers in Oxidoreduction Reactions.</li>\n<li>Riboflavin Deficiency Is Widespread but Not Fatal. Deficiency is characterised by chemosis, desquamation and inflammation of the tongue, and seborrheic dermatitis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thiamnine(Option A)</strong>: Thiamine is colourless.</p>\n<p><strong>Niacin(Option C):</strong> Niacin is also a colourless compound.</p>\n<p><strong>Beta carotene(Option D):</strong> Beta carotene is also yellow, but not used as a food additive.</p>", "options": ["Thiamine", "Riboflavin", "Niacin", "Beta carotene"], "html_options": ["Thiamine", "Riboflavin", "Niacin", "Beta carotene"], "corr_idx": 1}, {"id": "1169969", "html_qtxt": "All of the following vitamins act as coenzyme in oxidation reduction reactions, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In a redox reaction, one substance undergoes oxidation(loss of electrons) and the other undergoes reduction(gain of electrons). These processes occur simultaneously, ensuring the conservation of the charge.</li>\n<li>Thiamine diphosphate is the coenzyme for three multienzyme complexes that catalyse oxidative decarboxylation reactions, but not oxidation-reduction reactions.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Nicotinic acid and nicotinamide(Option B and C):</strong> Two compounds, nicotinic acid and nicotinamide, have the biological activity of niacin; their metabolic function is as the nicotinamide ring of the coenzymes NAD and NADP in oxidation/reduction reactions.</p>\n<p><strong>Riboflavin(Option D)</strong>: Riboflavin provides the reactive moieties of the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Such flavin coenzymes are electron carriers in oxidoreduction reactions</p>", "options": ["Thiamine", "Nicotinic acid", "Nicotinamide", "Riboflavin"], "html_options": ["Thiamine", "Nicotinic acid", "Nicotinamide", "Riboflavin"], "corr_idx": 0}, {"id": "1169973", "html_qtxt": "Which one of the following is not strictly a vitamin?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Higher organisms have to obtain all vitamins from their diet, because during evolution, the ability to synthesise vitamins was lost.</li>\n</ul>\n<p><strong>There are two exceptions to this rule:</strong></p>\n<ul>\n<li>Vitamin D (calcitriol), which is formed in the skin from 7-dehydrocholesterol on exposure to sunlight, and the active form is then converted in the body for various metabolic functions.</li>\n<li>Niacin (sometimes termed as vitamin B3), which can be formed from the essential amino acid tryptophan, do not strictly comply with this definition.</li>\n<li>60 mg of tryptophan is equivalent to 1 mg of dietary niacin.</li>\n<li>Vitamin B5 & B7 can be synthesised by gut bacteria and absorbed successfully from there.</li>\n<li>Vitamin B12 and K can be synthesised by gut bacteria, but are not absorbed successfully or are poorly absorbed.</li>\n<li>All other vitamins have to be obtained from the diet, and strictly comply with the definition of a vitamin. <strong>(Other options ruled out)</strong></li>\n</ul>", "options": ["Thiamine", "Folic acid", "Niacin", "Biotin"], "html_options": ["Thiamine", "Folic acid", "Niacin", "Biotin"], "corr_idx": 2}, {"id": "1169980", "html_qtxt": "Riboflavin nutritional status is assessed by measurement of which of the following enzymes after the addition of FAD in vitro?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Riboflavin nutritional status is assessed by the measurement of the activation of erythrocyte glutathione reductase by FAD added in vitro.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Transketolase(Option A)</strong>: Thiamine diphosphate is also the coenzyme for transketolase in the pentose phosphate pathway. The activation of transketolase in erythrocyte lysate by thiamine diphosphate added in vitro has become the accepted index of thiamine nutritional status.</p>\n<p><strong>Transaminase(Option C):</strong> Vitamin B6 status is assessed by assaying erythrocyte transaminases. The most widely used method of assessing vitamin B6 status is by the activation of erythrocyte transaminases by pyridoxal phosphate added in vitro.</p>\n<p><strong>Transaldolase(Option D)</strong>: Transaldolase is an enzyme in the HMP shunt. It is not used to assess riboflavin status.</p>", "options": ["Transketolase", "Glutathione reductase", "Transaminase", "Transaldolase"], "html_options": ["Transketolase", "Glutathione reductase", "Transaminase", "Transaldolase"], "corr_idx": 1}, {"id": "1169985", "html_qtxt": "During DNA repair mechanism, Poly ADP-ribosylation of nucleoproteins is required. The source of ADP ribose during Poly ADP-ribosylation of nucleoproteins is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>NAD and NADP are coenzymes of niacin, which are used in oxidation-reduction reactions.</li>\n<li>In addition to its coenzyme role, NAD is the source of ADP-ribose for the ADP-ribosylation of proteins and poly ADP-ribosylation of nucleoproteins involved in the DNA repair mechanism.</li>\n<li>Cyclic ADP-ribose and nicotinic acid adenine dinucleotide, formed from NAD, act to increase intracellular calcium in response to neurotransmitters and hormones.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>FAD(Option B):</strong> FAD is a coenzyme form of riboflavin, used as an electron carrier in oxidoreduction reactions.</p>\n<p><strong>NADP(Option C):</strong> NADP is a coenzyme for niacin, used in oxidation-reduction reactions.</p>\n<p><strong>HMP shunt (Option D):</strong> HMP shunt is a source of ribose (used during formation of nucleotide) and NADPH (required for synthesis of fatty acid, phospholipid, cholesterol, etc).</p>", "options": ["NAD", "FAD", "NADP", "HMP shunt"], "html_options": ["NAD", "FAD", "NADP", "HMP shunt"], "corr_idx": 0}, {"id": "1169994", "html_qtxt": "All the following sentences are true about pellagra, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In most outbreaks of pellagra, women are affected more than men, probably the result of inhibition of tryptophan metabolism by estrogen metabolites.</li>\n<li>Although the nutritional aetiology of pellagra is well established, and either tryptophan or niacin prevents or cures the disease, additional factors, including deficiency of riboflavin or vitamin B6, both of which are required for the synthesis of nicotinamide from tryptophan, may be important.</li>\n<li>Pellagra is caused by the deficiency of both Tryptophan & Niacin. <strong>(Option B ruled out)</strong></li>\n<li>Pellagra is characterised by photosensitive dermatitis. As the condition progresses, there is depressive psychosis and possibly diarrhoea. Untreated pellagra is fatal. <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>Other associations:</strong></p>\n<ul>\n<li>A number of genetic diseases that result in defects of tryptophan metabolism are associated with the development of pellagra, despite an adequate intake of both tryptophan and niacin.</li>\n<li>Hartnup disease is a rare genetic condition in which there is a defect in the membrane transport mechanism for tryptophan, resulting in large losses as a result of intestinal malabsorption and failure of renal reabsorption.</li>\n<li>In carcinoid syndrome, there is metastasis of a primary liver tumour of enterochromaffin cells, which synthesise 5-hydroxytryptamine. Overproduction of 5-hydroxytryptamine may account for as much as 60% of the body's tryptophan metabolism, causing pellagra because of the diversion away from NAD synthesis.</li>\n</ul>\n<p><strong>Key takeaways:</strong></p>\n<ul>\n<li>Nicotinic acid has been used to treat hyperlipidemia when doses of the order of 1 to 6 g/d are required, causing dilatation of blood vessels and flushing, along with skin irritation. Intakes of both nicotinic acid and nicotinamide over 500 mg/d cause liver damage.</li>\n<li>Niacin is used in the treatment of hyperlipidemia (Hyperlipoproteinemia type IIb (increase LDL & VLDL) because\n<ul>\n<li>It reduces serum levels of LDL, VLDL, TG and cholesterol</li>\n<li>It inhibits lipolysis, so decrease circulation of free fatty acid, so acetyl CoA pool is reduced; Cholesterol & TG synthesis in liver is decreased</li>\n<li>It reduces Lipoprotein (a) levels</li>\n</ul>\n</li>\n</ul>", "options": ["It is a multifactorial disease", "Tryptophan deficiency can lead to pellagra", "Males are affected more than females", "It is characterized by photosensitive dermatitis"], "html_options": ["It is a multifactorial disease", "Tryptophan deficiency can lead to pellagra", "Males are affected more than females", "It is characterized by photosensitive dermatitis"], "corr_idx": 2}, {"id": "1170004", "html_qtxt": "The active coenzyme form of vitamin B6 is:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Six compounds have vitamin B6 activity: Pyridoxine, pyridoxal, pyridoxamine, and their 5&prime;-phosphates.</li>\r\n<li>The active coenzyme is pyridoxal 5&prime;-phosphate.</li>\r\n<li>Pyridoxal phosphate is a coenzyme for many enzymes involved in amino acid metabolism, especially transamination and decarboxylation. It is also the cofactor of glycogen phosphorylase, where the phosphate group is catalytically important. In addition, it is important in steroid hormone action.</li>\r\n<li>Pyridoxal phosphate removes the hormone-receptor complex from DNA binding, terminating the action of the hormones.</li>\r\n<li>In vitamin B6 deficiency, there is increased sensitivity to the actions of steroid hormones like estrogens, androgens, cortisol, and vitamin D.</li>\r\n<li>Increased sensitivity to steroid hormone action may be important in the development of hormone-dependent cancer of the breast, uterus, and prostate, and vitamin B6 status may affect the prognosis.</li>\r\n<li>The active form of vitamin D is calcitriol. Calcitriol is now a day also considered a hormone.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508269c8fe934-1af9-4178-bb2a-37af2b93d506.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Pyridoxamine(Option A)</strong>: Pyridoxamine is a vitamin B6 compound, not its coenzyme form.</p>\r\n<p><strong>Pyridoxine phosphate(Option B):</strong> Pyridoxine phosphate is a 5&prime;-phosphates derivative of pyridoxine, not act as a coenzyme.</p>\r\n<p><strong>Pyridoxamine phosphate(Option D):</strong> Pyridoxamine phosphate is a 5&prime;-phosphates derivative of Pyridoxamine, not act as a coenzyme.</p>\r\n<p><strong>Key takeaways:</strong></p>\r\n<ul>\r\n<li>Some 80% of the body&rsquo;s total vitamin B6 is pyridoxal phosphate in muscle, mostly associated with glycogen phosphorylase.</li>\r\n</ul>", "options": ["Pyridoxamine", "Pyridoxin phosphate", "Pyridoxal phosphate", "Pyridoxamine phosphate"], "html_options": ["Pyridoxamine", "Pyridoxin phosphate", "Pyridoxal phosphate", "Pyridoxamine phosphate"], "corr_idx": 2}, {"id": "1170024", "html_qtxt": "All of the following is true regarding dietary sources of vitamin B12, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The term \"Vitamin B12\" is used as a generic descriptor for the cobalamins.</li>\n<li>Cobalamins are those corrinoids (cobalt-containing compounds possessing the corrin ring) having the biological activity of vitamin B12.</li>\n<li>Some corrinoids that are growth factors for microorganisms not only have no vitamin B12 activity, but may also be antimetabolites of the vitamin.</li>\n<li>So not all corrinoids produced by microorganisms have vitamin B12 activity</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option A</strong>: Although it is synthesised exclusively by microorganisms, for practical purposes, vitamin B12 is found only in foods of animal origin.</p>\n<p><strong>Option B</strong>: There being no plant sources of this vitamin, Strict vegetarians (vegans) are at risk of developing B12 deficiency.</p>\n<p><strong>Option C: </strong>Preparations of vitamin B12 made by bacterial fermentation are available</p>", "options": ["Found only in food of animal origin", "No plant sources for vitamin B12", "Preparations of vitamin B12 made by bacterial fermentation are available", "All corrinoids produced by microorganisms have vitamin B12 activity"], "html_options": ["Found only in food of animal origin", "No plant sources for vitamin B12", "Preparations of vitamin B12 made by bacterial fermentation are available", "All corrinoids produced by microorganisms have vitamin B12 activity"], "corr_idx": 3}, {"id": "1170027", "html_qtxt": "Which form of vitamin B12 is required as a coenzyme for the following reaction?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826d335415e-a096-4377-913c-e7cf94caeb11.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Various forms of vitamin B12, named according to the presence of a specific R group, like,\r\n<ul>\r\n<li>Methyl in Methylcobalamin: Major form seen in blood circulation & cell cytoplasm, acts as a coenzyme for methionine synthase.</li>\r\n<li>Cyanide in Cyanocobalamin (12a): Predominant, no physiological function, oral preparation in this form <strong>(Option C ruled out)</strong></li>\r\n<li>Hydroxyl in Hydroxycobalamin (12b): Injectable preparations are in this form. <strong>(Option D ruled out.).</strong></li>\r\n<li>Nitrite in Nitrocobalamin (12c):</li>\r\n<li>Adenosyl in Adenosylcobalamin: Major storage form, seen in the liver. When taken up by cells, it converts into deoxyadenosyl cobalamin (Ado B12) and acts as a coenzyme for methylmalonyl CoA mutase <strong>(Option D ruled out).</strong></li>\r\n</ul>\r\n</li>\r\n<li>The Ado-B12 and methyl B12 are the functional coenzymes in the body, produced by the replacement of the cyanide group with deoxyadenosyl or methyl group.</li>\r\n<li>There are only two vitamin B12-dependent enzymes:\r\n<ul>\r\n<li>Methylmalonyl-CoA mutase</li>\r\n<li>Methionine synthase</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508266c924cbc-8469-42ab-a322-1889701ddd6c.png\">", "options": ["Methylcobalamin", "Adenosylcobalamin", "Cyanocobalamin", "Hydroxycobalamin"], "html_options": ["Methylcobalamin", "Adenosylcobalamin", "Cyanocobalamin", "Hydroxycobalamin"], "corr_idx": 0}, {"id": "1170030", "html_qtxt": "Methyl malonic aciduria occurs due to a deficiency of which of the following vitamins?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Methylmalonic aciduria is a metabolic disorder characterised by elevated levels of methylmalonic acid in the urine and blood.</li>\r\n<li>This condition is primarily caused by defects in the enzyme<strong> methylmalonyl-CoA mutase,</strong> which requires <strong>vitamin B12 (cobalamin)</strong> as a cofactor to function properly.</li>\r\n<li>When vitamin B12 is deficient or the enzyme is defective, the conversion of methylmalonyl-CoA to succinyl-CoA is impaired, leading to the accumulation of methylmalonic acid.</li>\r\n</ul>\r\n<p><strong>In the citric acid cycle:</strong></p>\r\n<ul>\r\n<li>Methylmalonyl-CoA is formed as an intermediate in the catabolism of valine and by the carboxylation of propionyl-CoA arising in the catabolism of isoleucine, cholesterol, and rare fatty acids with an odd number of carbon atoms, or directly from propionate, a major product of microbial fermentation in ruminants.</li>\r\n<li>It undergoes a vitamin B12-dependent rearrangement to succinyl-CoA, catalysed by methylmalonyl-CoA mutase. This enzyme requires vitamin B12 as a coenzyme.</li>\r\n<li>The activity of this enzyme is greatly reduced in vitamin B12 deficiency, leading to an accumulation of methylmalonyl-CoA and urinary excretion of methylmalonic acid (Methylmalonic aciduria), which provides a means of assessing vitamin B12 nutritional status.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082618868db7-087e-4559-9500-7e9425973089.png\">", "options": ["Vitamin B1", "Vitamin B6", "Folic acid", "Vitamin B12"], "html_options": ["Vitamin B1", "Vitamin B6", "Folic acid", "Vitamin B12"], "corr_idx": 3}, {"id": "1170048", "html_qtxt": "All of the following sentences are true regarding folate supplementation, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Although folate supplementation will prevent some cancers, but there is also some evidence that folate supplements increase the rate of transformation of preneoplastic colorectal polyps into cancers, so that people with such polyps may be at increased risk of developing colorectal cancer if they have a high folate intake.</li>\n<li>While folate supplementation has well-established benefits in reducing the risk of neural tube defects and lowering homocysteine levels, its role in reducing the risk of atherosclerosis is not supported by consistent evidence.</li>\n<li>Therefore, the statement that folate supplementation reduces the risk of atherosclerosis is incorrect.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It reduces the risk of neural tube defects(Option B)</strong>:</p>\n<ul>\n<li>Supplements of 400 &mu;g/d of folic acid begun before conception result in a significant reduction in the incidence of spina bifida and other neural tube defects.</li>\n<li>Because of this, there is a mandatory enrichment of flour with folic acid in many countries.</li>\n</ul>\n<p><strong>It reduces the risk of atherosclerosis(Option C):</strong></p>\n<ul>\n<li>Elevated blood homocysteine is a significant risk factor for atherosclerosis, thrombosis, and hypertension.</li>\n<li>The condition is the result of an impaired ability to form methyltetrahydrofolate by methylenetetrahydrofolate reductase, causing functional folate deficiency, resulting in failure to remethylate homocysteine to methionine.</li>\n<li>People with an abnormal variant of methylenetetrahydrofolate reductase that occurs in 5 to 10% of the population do not develop hyperhomocysteinemia if they have a relatively high intake of folate.</li>\n<li>Several placebo-controlled trials of supplements of folate (commonly together with vitamins B6 and B12) have shown the expected lowering of plasma homocysteine, but apart from reduced incidence of stroke, there has been no effect on death from cardiovascular disease.</li>\n</ul>\n<p><strong>It reduces homocysteine levels in the blood(Option D): </strong>True.</p>", "options": ["It reduces the risk of colorectal cancer among people with preneoplastic polyps", "It reduces risk of neural tube defect", "It reduces risk of atherosclerosis", "It reduces homocysteine level in blood"], "html_options": ["It reduces the risk of colorectal cancer among people with preneoplastic polyps", "It reduces risk of neural tube defect", "It reduces risk of atherosclerosis", "It reduces homocysteine level in blood"], "corr_idx": 0}, {"id": "1170050", "html_qtxt": "Which one of the following drugs acts as an inhibitor of folate metabolism and is commonly used in cancer chemotherapy?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Methotrexate, an analogue of 10-methyltetrahydrofolate, inhibits dihydrofolate reductase and is commonly used in cancer chemotherapy.</li>\n<li>The methylation of deoxyuridine monophosphate (dUMP) to thymidine monophosphate (TMP), catalysed by thymidylate synthase, is essential for the synthesis of DNA.</li>\n<li>The one-carbon fragment of methylene-tetrahydrofolate is reduced to a methyl group with release of dihydrofolate, which is then reduced back to tetrahydrofolate by dihydrofolate reductase.</li>\n<li>Thymidylate synthase and dihydrofolate reductase are especially active in tissues with a high rate of cell division.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sulphonamides(Option A):</strong></p>\n<ul>\n<li>Sulphonamides are antibacterial agents.</li>\n<li>Bacterial cells synthesise folic acid in the cell by combining para-aminobenzoic acid (PABA) with pteroyl glutamic acid (PGA) by Folate synthase enzymes.</li>\n<li>This folic acid is required for bacterial multiplication.</li>\n<li>Sulphonamide drugs are structural analogues of PABA, so it will inhibit folate synthase enzyme, which inhibits folic acid synthesis in bacteria, and so bacterial cell division is stopped, and they die.</li>\n</ul>\n<p><strong>Trimethoprim (Option C)</strong>: Trimethoprim inhibits dihydrofolate reductases of some bacteria, so commonly used as an antibacterial agent.</p>\n<p><strong>Pyrimethamine (Option D):</strong> Pyrimethamine inhibits dihydrofolate reductases of parasites, so commonly used as an antimalarial agent. The dihydrofolate reductases of bacteria and parasites differ from the human enzyme.</p>", "options": ["Sulphonamide", "Methotrexate", "Trimethoprim", "Pyrimethamine"], "html_options": ["Sulphonamide", "Methotrexate", "Trimethoprim", "Pyrimethamine"], "corr_idx": 1}, {"id": "1170053", "html_qtxt": "Which of the following sentences is true regarding folate metabolism?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The folates in foods may have up to seven additional glutamate residues linked by &gamma;-peptide bonds.</li>\r\n<li>The extent to which the different forms of folate can be absorbed varies, and so folate intakes are calculated as dietary folate equivalents-the sum of &mu;g food folates + 1.7 &times; &mu;g of folic acid (used in food enrichment).</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Option B:</strong></p>\r\n<ul>\r\n<li>Vitamin B12 Deficiency Causes Functional Folate Deficiency-the 'Folate Trap'</li>\r\n<li>When acting as a methyl donor, S-adenosyl methionine forms homocysteine, which may be remethylated by methyltetrahydrofolate, catalysed by methionine synthase, a vitamin B12-dependent enzyme.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082615c0e4b2-0ca0-4fd4-81fe-08cbaacbb936.png\">\r\n<ul>\r\n<li>As the reduction of methylenetetrahydrofolate to methyltetrahydrofolate is irreversible and the major source of tetrahydrofolate for tissues is methyltetrahydrofolate, the role of methionine synthase is vital, and provides a link between the functions of folate and vitamin B12.</li>\r\n<li>Impairment of methionine synthase in vitamin B12deficiency results in the accumulation of methyltetrahydrofolate that cannot be used-the 'folate trap'.</li>\r\n<li>There is therefore a functional deficiency of folate, secondary to the deficiency of vitamin B12.</li>\r\n<li><strong>Option C</strong>: Folate deficiency can lead to hyperhomocysteinemia and increase the risk of atherosclerosis, thrombosis and hypertension.</li>\r\n<li><strong>Option D</strong>: 5-Formyl-tetrahydrofolate is more stable than folate and is therefore used pharmaceutically (known as folinic acid).</li>\r\n</ul>", "options": ["Dietary folate may be in polyglutamate form", "Folic acid deficiency causes functional Vitamin B12 deficiency", "Folic acid deficiency can lead to hypohomocysteinemia.", "5-Methyl tetrahydrofolate is the most stable form of folate"], "html_options": ["Dietary folate may be in polyglutamate form", "Folic acid deficiency causes functional Vitamin B12 deficiency", "Folic acid deficiency can lead to hypohomocysteinemia.", "5-Methyl tetrahydrofolate is the most stable form of folate"], "corr_idx": 0}, {"id": "1170057", "html_qtxt": "As shown in the image below, megaloblasts in a bone marrow smear are seen in which of the following vitamin deficiencies?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826bdb2a6b5-f1dd-4007-a603-896545265716.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The picture in the above slide represents Megaloblastic anaemia.</li>\r\n<li>Vitamin B9 deficiency is characterised by megaloblastic anaemia caused by diminished synthesis of purines and TMP, which leads to an inability of cells (including red cell precursors) to make DNA, and, therefore, they cannot divide.</li>\r\n<li>Vitamin B12 deficiency also indirectly causes symptoms of megaloblastic anaemia.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Vitamin B1(Option A)</strong>: Vitamin B1 deficiency is characterised by dry beriberi (peripheral neuropathy) and wet beriberi (characterised by oedema due to dilated cardiomyopathy, palpitation and breathlessness)</p>\r\n<p><strong>Vitamin B2(Option B):</strong> Vitamin B2 deficiency is characterised by dermatitis, cheilosis and glossitis.</p>\r\n<p><strong>Vitamin B6(Option C):</strong> Vitamin B6 deficiency is characterised by neurological dysfunction and anaemia.</p>", "options": ["Vitamin B1", "Vitamin B2", "Vitamin B6", "Vitamin B9"], "html_options": ["Vitamin B1", "Vitamin B2", "Vitamin B6", "Vitamin B9"], "corr_idx": 3}, {"id": "1170058", "html_qtxt": "All of the following can commonly lead to biotin deficiency, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Biotin is synthesised by intestinal flora more than the requirements, so dietary deficiency is unknown. Biotin is widely distributed in many foods as biocytin (&epsilon;-amino-biotinyl lysine), which is released on proteolysis.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option B:</strong> Patients on total parenteral nutrition for months can commonly show biotin deficiency. Biotin deficiency has been documented in patients receiving prolonged total parenteral nutrition (TPN) without added biotin supplementation.</p>\n<p><strong>Option C:</strong> Those who eat abnormally large amounts of uncooked egg white, which contains avidin, a protein that binds biotin and renders it unavailable for absorption. So, Biotin deficiency can be seen in such persons.</p>\n<p><strong>Option D:</strong> Use of antibiotics for long term can reduce normal intestinal flora, which affects the synthesis of biotin by them, leading to deficiency.</p>\n<p><strong>Key takeaways:</strong></p>\n<ul>\n<li>Biotin (also known as vitamin B<sub>7</sub>) is one of the <a href=\"https://en.wikipedia.org/wiki/B_vitamins\">B vitamins</a>. It is involved in a wide range of metabolic processes, both in humans and other organisms, primarily related to the utilisation of fats, carbohydrates, and amino acids.</li>\n<li>Primary biotin deficiency, meaning deficiency due to too little biotin in the diet, is rare because biotin is contained in many foods. Subclinical deficiency can cause mild symptoms, such as hair thinning, brittle fingernails, or skin rash, typically on the face.</li>\n</ul>", "options": ["Dietary deficiency", "Patients on total parenteral nutrition for months", "Ingestion of large amount of uncooked egg white", "Patient on long term antibiotics"], "html_options": ["Dietary deficiency", "Patients on total parenteral nutrition for months", "Ingestion of large amount of uncooked egg white", "Patient on long term antibiotics"], "corr_idx": 0}, {"id": "1170062", "html_qtxt": "Which one of the following reactions is a biotin-independent carboxylation reaction and does not require biotin as a coenzyme?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Conversion of pyruvate to malate is done by malic enzyme, which does not require biotin as a coenzyme (Biotin-independent Carboxylation Reaction).</li>\n<li>Biotin functions to transfer carbon dioxide in a small number of reactions (carboxylation reaction).</li>\n<li>A holocarboxylase synthetase catalyses the transfer of biotin onto a lysine residue of the apoenzyme to form the biocytin residue of the holoenzyme.</li>\n<li>The reactive intermediate is 1-N-carboxybiocytin, formed from bicarbonate in an ATP-dependent reaction.</li>\n<li>The carboxyl group is then transferred to the substrate for carboxylation.</li>\n</ul>\n<p><strong>Biotin-dependent Carboxylation Reaction:</strong></p>\n<ul>\n<li>Conversion of Pyruvate to oxaloacetate is done by the enzyme Pyruvate Carboxylase, which requires biotin as a coenzyme <strong>(Option A ruled out)</strong></li>\n<li>Conversion of Acetyl CoA to Malonyl CoA, done by Acetyl CoA Carboxylase, which requires biotin as a coenzyme <strong>(Option C ruled out)</strong></li>\n<li>Conversion of Propionyl CoA into Methylmalonyl CoA, done by Propionyl CoA Carboxylase, which requires biotin as a coenzyme<strong> (Option D ruled out)</strong></li>\n</ul>\n<p><strong>Biotin Independent Carboxylation Reactions</strong> (do not require Biotin)</p>\n<ul>\n<li><strong>Carbamoyl phosphate synthetase</strong>, in the urea cycle and pyrimidine synthesis</li>\n<li>Addition of CO2 to form C6 in the purine ring in the de novo synthesis of purine nucleotide</li>\n<li><strong>Malic enzyme</strong> converts pyruvate to malate.</li>\n</ul>", "options": ["Conversion of Pyruvate to oxaloacetate", "Conversion of pyruvate to malate", "Conversion of Acetyl CoA to Malonyl CoA", "Conversion of Propionyl CoA into Methyl malonyl CoA"], "html_options": ["Conversion of Pyruvate to oxaloacetate", "Conversion of pyruvate to malate", "Conversion of Acetyl CoA to Malonyl CoA", "Conversion of Propionyl CoA into Methyl malonyl CoA"], "corr_idx": 1}, {"id": "1170105", "html_qtxt": "Vitamin C can prevent all of the following clinical conditions except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Osteogenesis Imperfecta is not prevented or cured by giving vitamin C.</li>\n<li>It is a genetic disorder, inherited as an autosomal dominant trait</li>\n<li>Most common mutations are, replacement of glycine residues (that present as every third amino acid in the &alpha; chain) by cysteine or other large amino acids.</li>\n<li>This produces structurally abnormal a-chains, preventing the formation of the triple-helical conformation. mation</li>\n<li>It is characterised by weak bones that easily bend and fracture</li>\n<li>It is also known as brittle bone syndrome.</li>\n<li>Vitamin C can be used therapeutically in many conditions like Scurvy, Methemoglobinemia, Wound healing, severe burns and trauma, common cold etc.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Common cold(Option A): </strong>There is very little good evidence that high doses of vitamin C prevent the common cold, although they may reduce the duration and severity of symptoms</p>\n<p><strong>Iron deficiency(</strong>Option B)<strong>:</strong></p>\n<ul>\n<li>Vitamin C helps in iron absorption.</li>\n<li>Due to its reducing property, it converts ferric form into ferrous, which can be easily absorbed from the intestine (Fe<sup>+3</sup>&rarr; Fe<sup>+2</sup>).</li>\n<li>It also helps in the formation of ferritin (storage form of iron) and the mobilisation of iron from ferritin when needed.</li>\n</ul>\n<p><strong>Bleeding gums(Option C): </strong>Bleeding gums can occur due to defective collagen formation to vitamin C deficiency. Vitamin C supplementation can prevent it.</p>\n<p><strong>Key takeaways:</strong></p>\n<p>Ascorbic acid is considered a vitamin for human beings and some other primates due to the absence of the enzyme gulonolactone oxidase.</p>", "options": ["Common cold", "Iron deficiency", "Bleeding gums", "Osteogenesis Imperfecta"], "html_options": ["Common cold", "Iron deficiency", "Bleeding gums", "Osteogenesis Imperfecta"], "corr_idx": 3}, {"id": "1170113", "html_qtxt": "Following oral manifestation seen in deficiency of which of the following vitamins?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250826ca723197-f7f2-4de4-9071-ddb2eeb70d37.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This oral manifestation shows swollen, bleeding gums (scurvy), which occurs due to vitamin C (ascorbic acid) deficiency. Such gums occur due to a defect in the synthesis of collagen.</li>\r\n<li>Proline and lysine hydroxylases are required hydroxylation of proline and lysine, which is required for the post-synthetic modification of procollagen to Both these enzymes require vitamin C.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Vitamin D(Option A):</strong> Vitamin D deficiency is characterised by Osteomalacia in adults, leading to weakened bone and repeated fractures. In children, it can lead to rickets.</p>\r\n<p><strong>Vitamin B12(Option C)</strong>: Vitamin B12 deficiency is characterised by megaloblastic anaemia and neurological manifestations.</p>\r\n<p><strong>Vitamin B9(Option D)</strong>: Vitamin B9 deficiency also leads to megaloblastic anaemia.</p>", "options": ["Vitamin D", "Vitamin C", "Vitamin B12", "Vitamin B9"], "html_options": ["Vitamin D", "Vitamin C", "Vitamin B12", "Vitamin B9"], "corr_idx": 1}, {"id": "1170115", "html_qtxt": "All of the following sentences are true regarding vitamin B6 deficiency, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Pyridoxal phosphate is important in steroid hormone action.</li>\n<li>Pyridoxal phosphate removes the hormone-receptor complex from DNA binding, terminating the action of the hormones.</li>\n<li>In vitamin B6 deficiency, there is increased sensitivity to the actions of steroid hormones like estrogens, androgens, cortisol, and vitamin D.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option A</strong>: Moderate deficiency results in conditions such as abnormalities of tryptophan and methionine metabolism.</p>\n<p><strong>Option B: </strong>The most widely used method of assessing vitamin B6 status is by the activation of erythrocyte transaminases by pyridoxal phosphate added in vitro.</p>\n<p><strong>Option D</strong>: Increased sensitivity to steroid hormone action may be important in the development of hormone-dependent cancer of the breast, uterus, and prostate, and vitamin B6 status may affect the prognosis.</p>\n<p><strong>Key takeaways</strong>:</p>\n<ul>\n<li>Pyridoxal phosphate is a coenzyme for many enzymes involved in amino acid metabolism, especially transamination and decarboxylation. It is also the cofactor for glycogen phosphorylase, where the phosphate group is catalytically important.</li>\n<li>It is important in steroid hormone action. Pyridoxal phosphate removes the hormone-receptor complex from DNA binding, terminating the action of the hormones.</li>\n<li>If taken in excess, Vit B6 can cause sensory neuropathy.</li>\n</ul>", "options": ["Deficiency can occur due to abnormalities of tryptophan & methionine metabolism", "Deficiency status can be assessed by assaying erythrocyte transaminases", "Leads to a decreased sensitivity of steroid hormone action", "Can lead to breast, uterus and prostate cancer"], "html_options": ["Deficiency can occur due to abnormalities of tryptophan & methionine metabolism", "Deficiency status can be assessed by assaying erythrocyte transaminases", "Leads to a decreased sensitivity of steroid hormone action", "Can lead to breast, uterus and prostate cancer"], "corr_idx": 2}, {"id": "1170125", "html_qtxt": "Which one of the following is a function of biotin?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Biotin is a water-soluble B vitamin that functions primarily as a coenzyme for carboxylation reactions, which are essential in various metabolic pathways.</li>\r\n<li>It is covalently attached to specific enzymes known as carboxylases, facilitating the transfer of a carbon dioxide (CO<sub>2<sub/>) group to substrates.</li>\r\n<li>These reactions are crucial for processes such as gluconeogenesis, fatty acid synthesis, and amino acid catabolism.</li>\r\n<li>In addition to its role in a few carboxylation reactions, biotin also has a role in the regulation of the cell cycle through its action on biotinylated key nuclear proteins.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<ul>\r\n<li>Some carboxylation reactions in biological systems are dependent on biotin, termed Biotin-Dependent Carboxylation Reactions.</li>\r\n<li>But there are a few carboxylation reactions that do not require biotin, termed Biotin-Independent Carboxylation Reactions.\r\n<ul>\r\n<li>Carbamoyl phosphate synthetase, in the urea cycle and pyrimidine synthesis <strong>(Option A)</strong></li>\r\n<li>Addition of CO2 to form C6 in the purine ring in the de novo synthesis of purine nucleotide<strong> (Option B)</strong></li>\r\n<li>Malic enzyme, converting pyruvate to malate<strong> (Option C)</strong></li>\r\n</ul>\r\n</li>\r\n</ul>", "options": ["Coenzyme for the carboxylation reaction involving the enzyme Carbamoyl phosphate synthetase (in urea and pyrimidine synthesis)", "CO2 Fixation involving the addition of CO2 to the purine ring in de novo synthesis", "Coenzyme for Malic enzyme, converting pyruvate to malate.", "Regulation of the cell cycle"], "html_options": ["Coenzyme for the carboxylation reaction involving the enzyme Carbamoyl phosphate synthetase (in urea and pyrimidine synthesis)", "CO2 Fixation involving the addition of CO2 to the purine ring in de novo synthesis", "Coenzyme for Malic enzyme, converting pyruvate to malate.", "Regulation of the cell cycle"], "corr_idx": 3}, {"id": "1170127", "html_qtxt": "All of the following are true about minerals, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Minerals are<strong> inorganic elements</strong> that are essential for various physiological functions in the body.</li>\r\n<li>They are not derived from living organisms and do not contain carbon-hydrogen bonds, distinguishing them from organic compounds like vitamins.</li>\r\n<li>They must be provided in the diet as they cannot be synthesised. Minerals are essential nutrients that the body cannot synthesise in adequate amounts, so they must be obtained through the diet.<strong>(Option B ruled out)</strong></li>\r\n<li>Excessive intakes may be toxic like fluorosis (fluoride excess), hemochromatosis or hemosiderosis (iron toxicity), selenosis (selenium toxicity), etc <strong>(Option C ruled out)</strong></li>\r\n<li>When the intake is insufficient, deficiency signs may arise, for example, anaemia (iron deficiency), cretinism and goitre (iodine deficiency), etc. <strong>(Option D ruled out)</strong></li>\r\n</ul>\r\n<p><strong>Key takeaways:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508260b9cfc9d-664c-47f4-89d1-a1d9c94eb659.png\">", "options": ["Organic elements", "Must be provided in diet", "Excessive intake may be toxic", "When intake is insufficient, deficiency signs may arise"], "html_options": ["Organic elements", "Must be provided in diet", "Excessive intake may be toxic", "When intake is insufficient, deficiency signs may arise"], "corr_idx": 0}, {"id": "1170134", "html_qtxt": "Which of the following sentences is true regarding secretion and action of hepcidin?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Expression of the ferroportin gene (and possibly also that for the divalent metal ion transporter) is downregulated by hepcidin, a peptide secreted by the liver when body iron reserves are adequate. <strong>(Option A ruled out.)</strong></li>\r\n<li>In response to hypoxia, anaemia, or haemorrhage, the synthesis of hepcidin is reduced, leading to increased synthesis of ferroportin and increased iron absorption. <strong>(Option B ruled out.)</strong></li>\r\n<li>Hepcidin downregulates the ferroportin gene, so there's a reduced synthesis of ferroportin and hence, decreased iron absorption. <strong>(Option C ruled out.)</strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508263d8892b5-e77c-46f7-8b70-27c950e59f2e.png\">", "options": ["Upregulate ferroportin gene", "Downregulate ferroportin gene", "Increased iron absorption", "Synthesis is enhanced during hypoxia"], "html_options": ["Upregulate ferroportin gene", "Downregulate ferroportin gene", "Increased iron absorption", "Synthesis is enhanced during hypoxia"], "corr_idx": 1}, {"id": "1170136", "html_qtxt": "All of the following factors enhance iron absorption, except:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Calcium is known to inhibit iron absorption. It competes with iron in the intestine for its absorption, hence decreasing its absorption significantly<strong>. </strong></li>\r\n<li>The absorption of both inorganic and heme iron is impaired by calcium; a glass of milk with a meal significantly reduces iron availability.</li>\r\n<li>Iron homeostasis is maintained by regulation at the level of absorption.</li>\r\n<li>When iron stores in the body are depleted, absorption is enhanced.</li>\r\n<li>When an adequate quantity of iron is stored, absorption is decreased. This is referred to as \"mucosal block\" of regulation of absorption of iron.</li>\r\n<li>So, excess intake of iron will never lead to iron overload (hemochromatosis).</li>\r\n<li>It can occur when repeated blood transfusions are given to patients or heredity.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508267e64e307-e876-467a-b5fd-b83038c08d12.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Ascorbic acid(Option A):</strong></p>\r\n<ul>\r\n<li>Ascorbic acid is vitamin C, which reduces Fe<sup>3+</sup>(Ferric) iron into Fe<sup>2+</sup>(ferrous) form.</li>\r\n<li>Inorganic iron is absorbed in the Fe<sup>2+</sup>(reduced) state, and hence, the presence of reducing agents enhances absorption.</li>\r\n<li>The most effective compound is vitamin C, and while intakes of 40 to 80 mg of vitamin C per day are more than adequate to meet requirements, an intake of<strong> 25 to 50 mg per meal</strong> enhances iron absorption, especially when iron salts are used to treat iron deficiency anaemia.</li>\r\n<li>Haeme iron from meat (which is in the form of Fe<sup>2+</sup>) is absorbed separately and is considerably more available than inorganic iron.</li>\r\n</ul>\r\n<p><strong>Alcohol and fructose(Option B and Option D)</strong>: Alcohol and fructose also enhance iron absorption<strong>.</strong>.</p>", "options": ["Ascorbic acid", "Alcohol", "Calcium", "Fructose"], "html_options": ["Ascorbic acid", "Alcohol", "Calcium", "Fructose"], "corr_idx": 2}, {"id": "1170145", "html_qtxt": "Calcium absorption is reduced by all of the following, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glucose does not affect calcium absorption . Glucose is a primary source of energy to the body since it is a carbohydrate and does not interfere with calcium absorption.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phytic acid(Option B):</strong></p>\n<ul>\n<li>Phytic acid (chemically inositol hexaphosphate), present in cereals, binds calcium in the intestinal lumen, preventing its absorption.</li>\n<li>Other minerals, including zinc, are also chelated by phytate.</li>\n<li>This is mainly a problem among people who consume large amounts of unleavened whole-wheat products; yeast contains an enzyme, phytase, that dephosphorylates phytate, rendering it inactive.</li>\n</ul>\n<p><strong>Oxalate(Option C)</strong>: High concentrations of fatty acids in the intestinal lumen, as a result of impaired fat absorption, can also reduce calcium absorption by forming insoluble calcium salts.</p>\n<p><strong>Fatty acid(Option D)</strong>: High intake of oxalate can also reduce calcium absorption as calcium oxalate is insoluble.</p>", "options": ["Glucose", "Phytic acid", "Oxalate", "Fatty acid"], "html_options": ["Glucose", "Phytic acid", "Oxalate", "Fatty acid"], "corr_idx": 0}, {"id": "1170146", "html_qtxt": "Keshan disease is a cardiomyopathy, first identified in China. It occurs due to eating food produced from soil deficient in which of the following minerals?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Selenium deficiency in combination with a viral infection, specifically a mutated strain of coxsackie virus, can lead to Keshan disease.</li>\n<li>It is prevalent in Keshan province in China, soil is deficient in selenium.</li>\n<li>Leads to cardiac problems like myocardial necrosis, cardiac arrhythmias, cardiac enlargement, cardiomyopathy, etc</li>\n<li>Isolated selenium deficiency in other parts of the world causes liver necrosis, cirrhosis, cardiomyopathy and muscular dystrophy.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Zinc(Option A):</strong></p>\n<ul>\n<li>Zinc deficiency can lead to Acrodermatitis enteropathica.</li>\n<li>Zinc Deficiency can also lead to stunted growth in children, loss of taste sensation, poor wound healing, skin lesions (hyperkeratosis, dermatitis), alopecia, and impaired spermatogenesis.</li>\n<li>It can also lead to depression, dementia and other psychiatric disorders.</li>\n</ul>\n<p><strong>Iodine(Option C):</strong></p>\n<ul>\n<li>Iodine deficiency can lead to goitre. Goitre is an enlargement of the thyroid gland.</li>\n<li>It occurs as a part of compensation for decreased synthesis of thyroid hormones (Associated with elevated TSH).</li>\n<li>It is also due to a failure in auto-regulation of T3 & T4 synthesis, caused by deficiency or excess of iodide</li>\n<li>It is more common in women & with increased age</li>\n</ul>\n<p><strong>Fluoride(</strong>Option D):</p>\n<ul>\n<li>Fluoride deficiency can lead to dental caries.</li>\n<li>Drinking water containing less than 0.5 ppm of fluoride is associated with the development of dental caries in children.</li>\n</ul>", "options": ["Zinc", "Selenium", "Iodine", "Fluoride"], "html_options": ["Zinc", "Selenium", "Iodine", "Fluoride"], "corr_idx": 1}, {"id": "1192294", "html_qtxt": "Which of the following reactions indicates the antioxidant role of vitamin C?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Although ascorbate is an antioxidant, reacting with superoxide and hydroxyl to yield monodehydroascorbate and hydrogen peroxide or water, it can also be a source of superoxide radicals by reaction with oxygen, and hydroxyl radicals by reaction with Cu2 + ions.</li>\n<li>However, these pro-oxidant actions require relatively high concentrations of ascorbate, which are unlikely to be reached in tissues, since once the plasma concentration of ascorbate reaches about 30 mmol/L, the renal threshold is reached, and at intakes above about 100 to 120 mg/d, the vitamin is excreted in the urine quantitatively with intake.</li>\n</ul>\n<p><strong>Antioxidant and Pro-Oxidant Roles of Vitamin:</strong></p>\n<p>Antioxidant roles:</p>\n<ul>\n<li>Ascorbate + 'O2&minus; &rarr; H2O2 + monodehydroascorbate;</li>\n<li>Catalase and peroxidases then catalyse the reaction: 2 H2O2 &rarr; 2 H2O + O2</li>\n<li>Ascorbate + 'OH &rarr; H2O + monodehydroascorbate .</li>\n</ul>\n<p><strong>Pro-oxidant roles:</strong></p>\n<ul>\n<li>Ascorbate + O2 &rarr; 'O2&minus; + monodehydroascorbate <strong>(Option B ruled out)</strong></li>\n<li>Ascorbate + Cu2 + &rarr; Cu+ + monodehydroascorbate <strong>(Option C ruled out)</strong></li>\n<li>Cu+ + H2O2 &rarr; Cu2 + + OH&minus; + 'OH <strong>(Option D ruled out)</strong></li>\n</ul>", "options": ["Ascorbate + 'OH &rarr; H2O + monodehydroascorbate", "Ascorbate + O2 &rarr; 'O2&macr; + monodehydroascorbate", "Ascorbate + Cu2+ &rarr; Cu+ + monodehydroascorbate", "Cu+ + H2O2 &rarr; Cu2+ + OH&macr; + 'OH"], "html_options": ["Ascorbate + 'OH &rarr; H2O + monodehydroascorbate", "Ascorbate + O2 &rarr; 'O2&macr; + monodehydroascorbate", "Ascorbate + Cu2+ &rarr; Cu+ + monodehydroascorbate", "Cu+ + H2O2 &rarr; Cu2+ + OH&macr; + 'OH"], "corr_idx": 0}]}, {"moduleId": 1008738, "name": "Bioenergetics", "questions": [{"id": "1192011", "html_qtxt": "All of the following are sources of phosphate taking part in energy capture, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Beta oxidation of fatty acids is not the source of phosphate in ATP production</p>\n<ul>\n<li>Produces <strong>NADH and FADH<sub>2</sub></strong>, which enter the <strong>ETC</strong> to generate ATP indirectly</li>\n<li>No direct <strong>Pi transfer to ADP</strong> occurs in this pathway</li>\n<li>ATP generation is <strong>oxidative and downstream</strong>, not direct</li>\n<li>ATP acts as the energy currency of the cell</li>\n<li>The high group transfer potential of ATP enables it to act as a donor of high-energy phosphate to form many compounds.</li>\n<li>Likewise, with the necessary enzymes, ADP can accept phosphate groups to form ATP from some compounds.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-8f3c9a12-7b45-4c0d-9c2f-3e7a1b94f6d1.png\">\n<ul>\n<li>In effect, an ATP/ADP cycle connects those processes that generate high-energy phosphate to those processes that utilize high-energy phosphate, continuously consuming and regenerating ATP.</li>\n<li>There are three major sources in which phosphate takes part in energy conservation or energy capture</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Oxidative phosphorylation(Option A):</strong> Oxidative phosphorylation is the greatest quantitative source of high-energy phosphate in aerobic organisms. ATP is generated in the mitochondrial matrix as O2 is reduced to H2O by electrons passing down the respiratory chain.</p>\n<p><strong>Glycolysis(Option B)</strong>: Glycolysis. A net formation of two high-energy phosphates results from the formation of lactate from one molecule of glucose, generated in two reactions catalyzed by phosphoglycerate kinase and pyruvate kinase, respectively.</p>\n<p><strong>TCA Cycle(Option C):</strong> The citric acid cycle. One high-energy phosphate is generated directly in the cycle at the succinate thiokinase step.</p>", "options": ["Oxidative phosphorylation", "Glycolysis", "TCA Cycle", "Beta oxidation of fatty acid"], "html_options": ["Oxidative phosphorylation", "Glycolysis", "TCA Cycle", "Beta oxidation of fatty acid"], "corr_idx": 3}, {"id": "1192012", "html_qtxt": "Which of the following is a high-energy compound?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>ACP</strong> is a central molecule in <strong>fatty acid synthesis</strong>.</li>\n<li>It carries <strong>acyl groups</strong> via a <strong>high-energy thioester bond</strong> (similar to CoA).</li>\n<li>This <strong>thioester linkage</strong> is a <strong>high-energy bond</strong>, making ACP a <strong>high-energy compound</strong> in metabolic terms.</li>\n<li>High-energy compounds are those that contain energy-rich bonds. They are present in all living cells, participating in the energy accumulation and conversion processes.</li>\n</ul>\n<p>They include,</p>\n<ol>\n<li>ATP (Adenosine triphosphate)</li>\n<li>Acyl carrier protein (Option B)</li>\n<li>S - adenosylmethionine (active methionine),</li>\n<li>Thiol esters involving coenzyme A (eg, acetyl-CoA),</li>\n<li>Amino acid esters involved in protein synthesis,</li>\n<li>Uridine diphosphate glucose (UDPGlc),</li>\n<li>5-phosphoribosyl-1-pyrophosphate (PRPP).</li>\n</ol>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Fatty acid(Option A):</strong> Fatty acids are not considered high-energy compounds as they do not contain energy-rich bonds. But they can produce energy through their breakdown (beta oxidation). One molecule of Palmitic acid (16C, saturated fatty acid), when completely broken down (by beta oxidation & electron transport chain), will produce a net of 106 ATPs. Similarly, one molecule of Stearic acid (18C, saturated fatty acid) will produce a net of 120 ATPs.</p>\n<p><strong>Glucose(Option C):</strong> Glucose is not considered a high-energy compound as it does not contain energy-rich bonds. Glucose can produce energy through its breakdown. One molecule of glucose (6C, aldohexose), when completely broken down into 6 CO2 (by glycolysis, TCA cycle & electron transport chain), will produce a net of 32 ATPs.</p>\n<p><strong>Glycerol(Option D): </strong>Glycerol is also not a high-energy compound.</p>", "options": ["Fatty acid", "Acyl carrier protein", "Glucose", "Glycerol"], "html_options": ["Fatty acid", "Acyl carrier protein", "Glucose", "Glycerol"], "corr_idx": 1}, {"id": "1192013", "html_qtxt": "A molecule carrying high-energy electrons generated during the pentose phosphate pathway is oxidized. How many molecules of ATP are synthesized per molecule of this electron carrier when it enters the mitochondrial electron transport chain?", "html_expl": "<p><strong>Explanation: </strong></p>\n<p><strong>Pentose Phosphate Pathway (PPP) </strong>produces <strong>NADPH. </strong>NADPH is never used to produce ATP in oxidative phosphorylation; instead, it is used for reductive biosynthesis of many compounds.</p>\n<ul>\n<li>NADPH <strong>does not feed into the mitochondrial ETC</strong>.</li>\n<li>It is used <strong>exclusively in cytosolic anabolic and protective reactions</strong>.</li>\n<li>So, <strong>no ATP is generated from NADPH via oxidative phosphorylation</strong>.</li>\n</ul>\n<p><strong>NADPH-Linked Pathways</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-21b7e3f5-64d9-4b1a-b2f1-2d947ae5a8c3.png\"><p><strong>Explanation of Other Options:</strong></p>\n<p><strong>1.5(Option B)</strong>: The oxidation of one molecule of FADH2 in oxidative phosphorylation produces 1.5 ATPs.</p>\n<p><strong>2.5(Option C)</strong>: The oxidation of one molecule of NADH in oxidative phosphorylation produces 2.5 ATPs.</p>\n<p><strong>3(Option D)</strong>: It was believed that the oxidation of one molecule of NADH in oxidative phosphorylation produces 3 ATPs earlier, but recently it has been corrected to 2.5.</p>", "options": ["Zero", "1.5", "2.5", "3"], "html_options": ["Zero", "1.5", "2.5", "3"], "corr_idx": 0}, {"id": "1192014", "html_qtxt": "Which of the following is acting as a phosphagen in vertebrate skeletal muscle?", "html_expl": "<p><strong>Explanation: </strong></p>\n<p>Creatine phosphate acts as a phosphagen in vertebrate skeletal muscle</p>\n<ul>\n<li><strong>Phosphagens</strong> are high-energy storage molecules that act as rapid ATP buffers in muscle and nerve tissues - they <strong>donate phosphate groups</strong> to ADP to regenerate ATP during short bursts of intense activity. Phosphagens act as storage forms of group transfer potential and include <strong>creatine phosphate, </strong>which occurs in vertebrate skeletal muscle, heart, spermatozoa, and brain, and arginine phosphate, which occurs in invertebrate muscle.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-d8f41b76-09ad-468e-9e84-7c51f0c6d2a2.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Arginine phosphate(Option B)</strong>: Arginine phosphate acts as a phosphagen in invertebrate muscle.</p>\n<p><strong>Glucose 6-phosphate and Fructose 6-phosphate (Option C & Option D)</strong>: Glucose 6-phosphate and fructose 6-phosphate do not act as Phosphagens.</p>", "options": ["Creatine phosphate", "Arginine phosphate", "Glucose 6 phosphate", "Fructose 6 phosphate"], "html_options": ["Creatine phosphate", "Arginine phosphate", "Glucose 6 phosphate", "Fructose 6 phosphate"], "corr_idx": 0}]}, {"moduleId": 1009768, "name": "Amino acid catabolism", "questions": [{"id": "1192226", "html_qtxt": "All of the following are important metabolic roles of glutathione except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glutathione is a <strong>conjugating agent,</strong> which is involved only in <strong>phase 2 of Detoxification,</strong> which comprises conjugation reactions.</p>\n<p>The process of detoxification mainly involves 2 phases: Phase 1 and Phase 2.</p>\n<p><strong>Phase 1:</strong></p>\n<ul>\n<li>In phase 1 reactions, xenobiotics are converted to more polar, hydroxylated derivatives.</li>\n<li>The main reaction involved is <strong>hydroxylation,</strong> which is catalysed by cytochrome P450 (a monooxygenase enzyme).</li>\n</ul>\n<p><strong>Phase 2:</strong></p>\n<ul>\n<li>In phase 2, hydroxylated derivatives from phase 1 are <strong>conjugated with molecules such as glutathione, glucuronic acid, or sulfate.</strong></li>\n<li>Conjugation renders them more water soluble, facilitating their eventual excretion in urine or bile.</li>\n</ul>\n<p><strong>Role of Glutathione in Phase 2 of Detoxification:</strong></p>\n<ul>\n<li><strong>Glutathione</strong> is a <strong>tripeptide</strong> derived from <strong>Glycine, Cysteine, and Glutamic acid</strong>. Thus also known as <strong>gamma-glutamyl cysteinyl glycine.</strong></li>\n<li>It plays an important role in the phase 2 metabolism of electrophilic compounds.\n<ul>\n<li>Acts as a <strong>conjugating agent</strong>, helping in the detoxification of electrophilic compounds by forming glutathione S-conjugates that are excreted in urine and bile. <strong>(Option D)</strong></li>\n<li>This reaction is catalyzed by <strong>glutathione S-transferases.</strong></li>\n</ul>\n</li>\n<li>Glutathione also provides the <strong>reducing agent for the reduction of hydrogen peroxide to water</strong> in the reaction catalysed by <strong>glutathione peroxidase.</strong></li>\n<li>Further, glutathione is an important intracellular reductant and antioxidant that helps to maintain essential SH groups of enzymes in their reduced state. <strong>(Option C)</strong></li>\n<li>A metabolic cycle involving glutathione as a carrier has been involved in the transport of certain amino acids across membranes in the kidney.\n<ul>\n<li>The first reaction of this cycle is catalysed by &gamma;-glutamyltransferase (GGT):\n<ul>\n<li>Amino acid + GSH &rarr; &gamma;-Glutamyl amino acid + Cysteinylglycine</li>\n</ul>\n</li>\n<li>This reaction helps in <strong>the transfer of amino acids across the plasma membrane as dipeptides. (Option B) </strong></li>\n</ul>\n</li>\n</ul>", "options": ["Help in the phase I detoxification reaction", "Transport of some amino acids across membranes in the kidney", "Important intracellular reductant and antioxidant", "Help in detoxification of electrophile compounds"], "html_options": ["Help in the phase I detoxification reaction", "Transport of some amino acids across membranes in the kidney", "Important intracellular reductant and antioxidant", "Help in detoxification of electrophile compounds"], "corr_idx": 0}, {"id": "1195583", "html_qtxt": "All are true regarding Glycine except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Glycine:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811105eae3f-05ed-4203-ae5f-e9a502e10725.png\">\n<ul>\n<li><strong>The simplest amino acid. (Option A)</strong></li>\n<li><strong>Non-essential amino acid</strong>.</li>\n<li>Only achiral amino acid - hence <strong>optically inactive. (Option A)</strong></li>\n<li><strong>Sarcosine</strong> (N-methyl glycine) is derived from glycine.</li>\n<li><strong>Glycine aminotransferases</strong> can catalyse the synthesis of glycine from glyoxylate and glutamate or alanine. <strong>(Option B)</strong></li>\n<li>Interconversion of Glycine to Serine is:\n<ul>\n<li>Catalysed by serine hydroxymethyltransferase</li>\n<li>Freely <strong>reversible reaction.</strong></li>\n<li>Coenzymes required are <strong>Folic acid (Vitamin B9), Pyridoxal Phosphate (Vitamin B6)</strong></li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081109712868-8c66-47b4-b8bc-6e73c8f25422.png\">\n<ul>\n<li>Glycine can be synthesised from <strong>choline and serine</strong>. <em>(Option D)</em></li>\n</ul>", "options": ["Glycine is the simplest amino acid and shows optical inactivity", "Glycine aminotransferases catalyse the synthesis of glycine from glyoxylate and glutamate or alanine.", "The interconversion of Glycine to Serine is not possible.", "Glycine can be synthesised from Choline and Serine."], "html_options": ["Glycine is the simplest amino acid and shows optical inactivity", "Glycine aminotransferases catalyse the synthesis of glycine from glyoxylate and glutamate or alanine.", "The interconversion of Glycine to Serine is not possible.", "Glycine can be synthesised from Choline and Serine."], "corr_idx": 2}, {"id": "1195586", "html_qtxt": "Glycine is not involved in the synthesis of which of the following:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Catecholamines are synthesised from tyrosine</strong> and not glycine.</p>\r\n<p><strong>Functions of glycine:</strong></p>\r\n<ul>\r\n<li><strong>Glutathione synthesis (Option C)</strong>\r\n<ul>\r\n<li>Glutathione is made up of three amino acids<strong>(tripeptide) - Glycine, Cysteine, and Glutamate. Also called gamma-glutamyl-glycine-cystine.</strong></li>\r\n<li>Glutathione is involved in <strong>free radical scavenging </strong></li>\r\n<li>Functions as an <strong>antioxidant</strong> and plays a role in <strong>detoxification.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Synthesis of purines - Adenine and guanine.</strong>\r\n<ul>\r\n<li>Contributes C4, C5 and N7 in the Purine ring.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Heme synthesis (Option B)</strong>\r\n<ul>\r\n<li>Glycine combines with succinylcholine to form &delta;-Aminolevulinic Acid, which is the rate-limiting step in heme biosynthesis.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Bile synthesis</strong>\r\n<ul>\r\n<li>Glycine conjugates with bile acids in the liver to form bile salts, which are more water-soluble and thus help in fat digestion and absorption.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Creatinine synthesis (Option A)</strong>\r\n<ul>\r\n<li>Glycine contributes to the synthesis of creatinine along with arginine and methionine, thus aiding energy metabolism.</li>\r\n</ul>\r\n</li>\r\n</ul>", "options": ["Creatinine", "Heme synthesis", "Glutathione", "Catecholamines"], "html_options": ["Creatinine", "Heme synthesis", "Glutathione", "Catecholamines"], "corr_idx": 3}, {"id": "1195589", "html_qtxt": "What is the primary metabolic defect in Primary Hyperoxaluria Type II?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Primary Hyperoxaluria Type II is associated with a deficiency of D-glycerate dehydrogenase (glyoxylate reductase enzyme complex)</p>\n<p>Also known as <strong>Glyceric Aciduria.</strong></p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycine Cleavage System (Option A): A defect</strong> in the glycine cleavage system results in <strong>nonketotic hyperglycinemia.</strong> It's a rare inborn error of glycine degradation, resulting in the accumulation of glycine in body tissues, including the CNS.</p>\n<p><strong>Alanine Glyoxylate Aminotransferase (Option B):</strong></p>\n<ul>\n<li>Deficiency of Alanine Glyoxylate Aminotransferase results in <strong>Primary Hyperoxaluria</strong> Type I - the most common form of Primary Hyperoxaluria.</li>\n<li>Alanine glyoxylate aminotransferase mediates the conversion of glyoxylate to glycine, a deficiency of which results in the accumulation of glyoxylate.</li>\n<li>Accumulated glyoxylate gets oxidised to Oxalate (Oxalic acid) and gets excreted in urine, resulting in <strong>Oxalic aciduria and renal stones</strong>.</li>\n<li>Alanine Glyoxylate Aminotransferase is a peroxisomal enzyme expressed only in the liver peroxisomes and requires pyridoxine (vitamin B6) as its cofactor.</li>\n<li>Primary Hyperoxaluria Type I is a <strong>Protein-targeting defect.</strong></li>\n</ul>\n<p><strong>Excess Vitamin C (Option D):</strong> Secondary hyperoxaluria results from non-genetic (acquired) causes, unlike Primary Hyperoxaluria, which is inherited. This can be due to:</p>\n<ul>\n<li>Pyridoxine deficiency (cofactor for alanine-glyoxylate aminotransferase)</li>\n<li>Ethylene glycol poisoning.</li>\n<li>High doses of vitamin C</li>\n<li>In patients with inflammatory bowel disease or extensive resection of the bowel (enteric hyperoxaluria).</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Primary Hyperoxaluria Type 1: Deficiency of Alanine Glyoxylate Aminotransferase</li>\n<li>Primary Hyperoxaluria Type 2: Deficiency of D-glycerate dehydrogenase</li>\n</ul>", "options": ["Glycine cleavage system", "Alanine Glyoxylate Aminotransferase", "D Glycerate Dehydrogenase", "Excess Vitamin C"], "html_options": ["Glycine cleavage system", "Alanine Glyoxylate Aminotransferase", "D Glycerate Dehydrogenase", "Excess Vitamin C"], "corr_idx": 2}, {"id": "1195590", "html_qtxt": "All are true about glutathione except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glutathione is a <strong>tripeptide</strong> and not a dipeptide.</p>\n<ul>\n<li>Glutathione is a tripeptide synthesised from the amino acids <strong>glycine, cysteine, and glutamate. (Option C)</strong></li>\n<li>Also known as <strong>gamma-glutamyl cysteinyl glycine.</strong></li>\n</ul>\n<p><strong>Functions of Glutathione:</strong></p>\n<ol>\n<li><strong>Free radical scavenging: (Option D)</strong>\n<ul>\n<li>Glutathione (GSH) plays an <strong>important role in protecting cells from oxidative stress</strong> by neutralising reactive oxygen species.</li>\n<li>Glutathione donates reducing equivalents (electrons) to detoxify free radicals, especially hydrogen peroxide (H2O2) and lipid peroxides. This reaction is catalysed by <strong>glutathione peroxidase</strong>.</li>\n<li>The oxidised form (GSSG) is then reduced back to GSH by <strong>glutathione reductase, using NADPH.</strong></li>\n</ul>\n</li>\n<li><strong> Methemoglobin reduction: (Option B)</strong>\n<ul>\n<li>Aids in converting methemoglobin (Fe3+) back to haemoglobin (Fe2+), preventing cyanosis, and ensuring efficient oxygen transport.</li>\n</ul>\n</li>\n<li><strong>Conjugation and Detoxification of Xenobiotics:</strong>\n<ul>\n<li>Glutathione plays an important role in the <strong>phase 2 metabolism of Xenobiotics.</strong></li>\n<li>Acts as a conjugating agent, helping in the detoxification of electrophilic compounds by forming glutathione S-conjugates that are excreted in urine and bile.</li>\n<li>This reaction is catalyzed by glutathione S-transferases.</li>\n</ul>\n</li>\n<li>Further, glutathione is an important <strong>intracellular reductant and antioxidant</strong> that helps to maintain essential SH groups of enzymes in their reduced state.</li>\n<li>Glutathione helps in the <strong>transfer of amino acids across the plasma membrane as dipeptides.</strong></li>\n</ol>", "options": ["It is a dipeptide involved in phase 2 of Detoxification", "Aids in converting methemoglobin back to haemoglobin", "It is composed of glycine, cysteine, and glutamate.", "Acts as an oxidant by neutralising reactive oxygen species."], "html_options": ["It is a dipeptide involved in phase 2 of Detoxification", "Aids in converting methemoglobin back to haemoglobin", "It is composed of glycine, cysteine, and glutamate.", "Acts as an oxidant by neutralising reactive oxygen species."], "corr_idx": 0}, {"id": "1195591", "html_qtxt": "Sulfur of cysteine are not used/utilized in the body for the following process/product:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Methionine</strong> is an <strong>essential amino acid</strong> and therefore cannot be synthesised from Cysteine.</li>\n<li>Instead, <strong>Cysteine,</strong> which is a <strong>non-essential amino acid,</strong> is synthesised from methionine via a <strong>transsulfuration reaction</strong>, in which the SH group from methionine is transferred to serine to form cysteine.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Helps in conversion of cyanide to thiocyanate (Option A):</strong> Cysteine is transaminated to form beta mercapto pyruvate, which can transfer sulfur to cyanide to form thiocyanate, thus helping in detoxifying cyanide.</p>\n<p><strong>Thiosulfate formation (Option B):</strong> The catabolism of sulfur-containing amino acids, methionine, and cysteine can lead to thiosulfate formation.</p>\n<p><strong>Disulfide bond formation between two adjacent peptides (Option D):</strong> Two cysteine residues form a disulfide bond (-S-S-), stabilising the tertiary and quaternary structure of proteins like insulin and immunoglobulin. They play a crucial role in protein folding and stability.</p>", "options": ["Help in the conversion of cyanide to thiocyanate", "Thiosulfate formation", "Introduction of sulfur in methionine", "Disulfide\tbond formation between\ttwo adjacent peptide"], "html_options": ["Help in the conversion of cyanide to thiocyanate", "Thiosulfate formation", "Introduction of sulfur in methionine", "Disulfide\tbond formation between\ttwo adjacent peptide"], "corr_idx": 2}, {"id": "1195592", "html_qtxt": "A 20-year-old male presents with recurrent episodes of renal colic. He has a family history of early-onset kidney stones. Urinalysis reveals hexagonal crystals and amino acid analysis shows increased excretion of lysine, arginine, and ornithine. Which of the following is true regarding the underlying condition?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The above scenario is suggestive of <strong>Cystinuria.</strong> Impaired reabsorption of dibasic amino acids (lysine, arginine, ornithine, and cystine) in the proximal renal tubule leads to hexagonal cystine crystals and recurrent stones in cystinuria.</p>\n<ul>\n<li>Cysteine is a non-essential and glucogenic amino acid</li>\n<li>Contains a thiol group, capable of forming a disulfide bond.</li>\n<li>It is found abundantly in the <strong>keratin of hair and nail</strong>. The more disulfide bonds, the harder the keratin is.</li>\n<li>Synthesised from methionine via <strong>transsulfuration reaction</strong> involving the transfer of sulfur from the SH group of methionine to serine.</li>\n</ul>\n<p><strong>Cystinuria:</strong></p>\n<ul>\n<li>An inborn error of metabolism is characterised by a defect in amino acid transporters <strong>SLC3A1</strong>(Cystinuria Type 1) and <strong>SLC7A9</strong> (Cystinuria Type 2).</li>\n<li>Symptoms - Flank pain, vomiting, formation of <strong>hexagonal crystals in urine</strong>.</li>\n<li>In Cystinuria, renal tubular and intestinal transport of <strong>dibasic amino acids Cysteine, ornithine, lysine, and arginine</strong> are affected.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811dd4e57da-e06a-4494-8c64-c5a5cb917f51.png\">\n<p><strong>Hexagonal crystals are seen in Cystinuria.</strong></p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Occurs due to a defect in the amino acid transporters SLC6A19 and SLC7A9 (Option B):</strong> A defect in the amino acid transporter SLC6A results in <strong>Hartnup disease</strong>. Hartnup disease is associated with defective intestinal and renal transport of tryptophan and other neutral amino acids.</p>\n<p><strong>Defective metabolism of aromatic amino acids (Option C):</strong> Defective metabolism of neutral amino acids also results in Hartnup disease.</p>\n<p><strong>Deficiency of cystathionine &beta;-synthase (Option D):</strong> Cystathionine &beta;-synthase deficiency results in <strong>homocystinuria</strong>, a metabolic disorder affecting <strong>methionine metabolism</strong>.</p>", "options": ["Impaired renal tubular reabsorption of dibasic amino acids", "Occurs due to a defect in the amino acid transporters SLC6A19 and SLC7A9.", "Defective metabolism of aromatic amino acids.", "Deficiency of cystathionine &beta;-synthase."], "html_options": ["Impaired renal tubular reabsorption of dibasic amino acids", "Occurs due to a defect in the amino acid transporters SLC6A19 and SLC7A9.", "Defective metabolism of aromatic amino acids.", "Deficiency of cystathionine &beta;-synthase."], "corr_idx": 0}, {"id": "1195593", "html_qtxt": "Which amino acid in glutathione is responsible for its reducing property?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Glutathione is a tripeptide (Glutamic acid + Cysteine + Glycine)</li>\n<li><strong>The -SH (sulfhydryl) group of cysteine</strong> is the active functional group that donates electrons to neutralise reactive oxygen species, making <strong>cysteine the key reducing component.</strong></li>\n<li>The active part of both Glutathione and N-acetyl cysteine is the Sulfhydryl group of Cysteine.</li>\n<li><strong>N-acetylcysteine</strong> is a precursor to cysteine that helps <strong>replenish glutathione levels.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycine (Option B):</strong> Non-reactive component; serves a structural role in glutathione. Glycine is the C-terminal amino acid in glutathione but does not participate in redox reactions.</p>\n<p><strong>Glutamate (Option C):</strong> Involved in peptide linkage via an unusual &gamma;-glutamyl bond, but not in reduction. It forms the backbone of the tripeptide, connecting to cysteine via its &gamma;-carboxyl group, contributing to stability.</p>\n<p><strong>Alanine (Option D):</strong> Not a component of glutathione. Alanine is not present in the glutathione tripeptide and plays no role in its reducing property.</p>", "options": ["Cysteine", "Glycine", "Glutamate", "Alanine"], "html_options": ["Cysteine", "Glycine", "Glutamate", "Alanine"], "corr_idx": 0}, {"id": "1195597", "html_qtxt": "What is Nitric Oxide synthesised from?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Nitric oxide (NO) is synthesised in endothelial cells from <strong>arginine</strong> via the enzyme <strong>NO synthase</strong>, which is activated by calcium. The reaction converts <strong>arginine</strong> into <strong>NO</strong> and <strong>citrulline</strong> using NADPH and cofactors such as FAD, FMN, heme, and tetrahydrobiopterin.</p>\n<ul>\n<li>NO diffuses into smooth muscle cells and activates soluble guanylyl cyclase.</li>\n<li>This leads to increased <strong>cGMP</strong> production, activation of <strong>cGMP-dependent protein kinases</strong>, and <strong>vasodilation</strong>.</li>\n<li>NO also inhibits <strong>platelet aggregation</strong>.</li>\n</ul>\n<p>Explanation of Other Options:</p>\n<p><strong>Citrulline (Option B):</strong> Product; not a precursor. Citrulline is formed along with NO during the oxidation of arginine by NO synthase.</p>\n<p><strong>Alanine (Option C):</strong> Not involved. Alanine is a non-polar amino acid not related to NO synthesis.</p>\n<p><strong>Cysteine (Option D):</strong> Not the substrate. Though cysteine contains a thiol group important in redox reactions, it is not used in NO biosynthesis.</p>", "options": ["Arginine", "Citrulline", "Alanine", "Cysteine"], "html_options": ["Arginine", "Citrulline", "Alanine", "Cysteine"], "corr_idx": 0}, {"id": "1195598", "html_qtxt": "A patient with suspected Folic acid deficiency was advised Histidine Load Test. Following the test, urine analysis showed elevated formiminoglutamic acid levels. Which among the following is the possible underlying defect?", "html_expl": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811b2daca0d-e5bf-41b0-9482-aaa6ce5213c8.png\">\n<p><strong>Metabolism of Histidine</strong></p>\n<ul>\n<li><strong>The FIGLU</strong> Test, also known as the <strong>Histidine load test,</strong> is used to detect <strong>folate deficiency.</strong></li>\n<li>In the metabolism of the amino acid histidine, there is a <strong>folic acid-dependent step</strong> where <strong>formimino-glutamic acid (FIGLU)</strong> is converted to <strong>glutamic acid</strong> with the help of the enzyme <strong>Formimino transferase</strong>.</li>\n<li>In folic acid-deficient patients, this reaction cannot be carried out; as a result, FIGLU accumulates in the blood and is excreted in urine.</li>\n<li><strong>FIGLU excretion in urine is an index of folic acid deficiency</strong>.</li>\n<li>When a \"loading dose\" of histidine is given, the excretion of FIGLU in urine is increased further (Histidine loading test).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Deficiency of histidase (Option A):</strong> Histidase catalyses non-oxidative deamination of histidine to Urocanic acid. Deficiency of histidase results in histidinemia.</p>\n<p><strong>Deficiency of histidine decarboxylase (Option B):</strong> Histidine decarboxylase is involved in the decarboxylation of histidine to histamine.</p>\n<p><strong>Deficiency of urocanase (Option C):</strong> Urocanase deficiency results in a defect in the conversion of urocanic acid to imidazolone propionic acid, resulting in urocanic aciduria.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Histidine Load Test (also called 'FIGLU test')</p>\n<ul>\n<li>To identify Folic Acid Deficiency.</li>\n<li>FIGLU excreted in urine is measured following a Histidine load.</li>\n</ul>", "options": ["Deficiency of histidase", "Deficiency of histidine decarboxylase", "Deficiency of Urocanase", "Deficiency of folic acid"], "html_options": ["Deficiency of histidase", "Deficiency of histidine decarboxylase", "Deficiency of Urocanase", "Deficiency of folic acid"], "corr_idx": 3}, {"id": "1195600", "html_qtxt": "All are true about Nitric Oxide except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Nitric Oxide</strong> acts through the <strong>second messenger cGMP</strong> and not cAMP.</p>\n<p><strong>Nitric Oxide</strong></p>\n<ul>\n<li>The uncharged molecule with an unpaired electron is a highly reactive, free radical.\n<ul>\n<li>Very short half-life (0.1 seconds)</li>\n<li>Formerly called <strong>Endothelium Derived Relaxing Factor</strong></li>\n<li>Gaseous molecules</li>\n<li>The second messenger is <strong>cGMP</strong></li>\n</ul>\n</li>\n<li><strong>Arginine</strong> is a substrate for Nitric Oxide synthase, which converts it to Nitric Oxide and Citrulline.</li>\n<li>Nitric Oxide Synthase is a cytosolic enzyme with three isoforms - iNOS, eNOS, and nNOS. The endothelial and neuronal forms of NO synthase are activated by Ca2+.</li>\n</ul>\n<p><strong>Functions of Nitric Oxide</strong></p>\n<ul>\n<li><strong>Potent Vasodilator.</strong></li>\n<li>Involved in Penile erection</li>\n<li>Neurotransmitters in the brain and the Peripheral Nervous System.</li>\n<li>A low level of NO is involved in Pylorospasm in Congenital Hypertrophic Pyloric Stenosis.</li>\n<li>Inhibit adhesion, activation and aggregation of Platelets.</li>\n<li><strong>Potent muscle relaxant</strong></li>\n</ul>", "options": ["Synthesised from arginine", "NO is a potent muscle relaxant", "Otherwise called Endothelium-derived Relaxing Factor", "Acts through cAMP"], "html_options": ["Synthesised from arginine", "NO is a potent muscle relaxant", "Otherwise called Endothelium-derived Relaxing Factor", "Acts through cAMP"], "corr_idx": 3}, {"id": "1195601", "html_qtxt": "Creatinine is formed from:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Biosynthesis of creatine and creatinine:</strong></p>\n<p>Creatine and creatinine are synthesised from three amino acids, namely:</p>\n<ol>\n<li><strong>Glycine</strong></li>\n<li><strong>Arginine</strong></li>\n<li><strong>Methionine</strong></li>\n</ol>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811e8a3c7e8-47cb-4b1f-8499-ec165d94d3d5.png\">\n<p><strong>Creatinine Synthesis:</strong></p>\n<ul>\n<li>In the first step, the amidino group of arginine is <strong>transferred</strong> to glycine to form guanidoacetic acid. This synthesis of <strong>guanidoacetic</strong> acid occurs in the kidney.</li>\n<li>Guanidoacetic acid then undergoes a methylation reaction in the liver with the help of SAM to form creatine.</li>\n<li>Creatine thus formed has two fates: either undergoes spontaneous conversion to creatinine or gets phosphorylated in the muscles to creatine phosphate.</li>\n<li><strong>Creatinine phosphate</strong> serves as an <strong>immediate source of energy in the muscle</strong>.</li>\n</ul>", "options": ["Arginine, Glycine", "Arginine, Lysine", "Methionine, Leucine", "Histamine only"], "html_options": ["Arginine, Glycine", "Arginine, Lysine", "Methionine, Leucine", "Histamine only"], "corr_idx": 0}, {"id": "1195603", "html_qtxt": "Match the following amino acids with their respective decarboxylation products:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811691a0aa4-dfe4-430b-b387-8b404b0dadb1.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811da54912c-0ce2-492d-af09-ca4b8629c515.png\">\n<p><strong>Decarboxylation Reactions:</strong></p>\n<p>Amino acids undergo an <strong>alpha decarboxylation</strong> reaction to form corresponding biological <strong>amines.</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508112f030f32-fa9a-4af2-9fa5-b9118f89489f.png\">", "options": ["1-a, 2-b, 3-c, 4-d", "1-b, 2-a, 3-c, 4-d", "1-a, 2-b, 3-d, 4-c", "1-b, 2-c, 3-a, 4-d"], "html_options": ["1-a, 2-b, 3-c, 4-d", "1-b, 2-a, 3-c, 4-d", "1-a, 2-b, 3-d, 4-c", "1-b, 2-c, 3-a, 4-d"], "corr_idx": 1}, {"id": "1195604", "html_qtxt": "Which of the following is not true regarding proline metabolism?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Type I hyperprolinemia</strong> is associated with a <strong>deficiency of Proline dehydrogenase.</strong></p>\n<p><strong>Proline:</strong></p>\n<ul>\n<li>The catabolism of proline takes place in mitochondria. <strong>(Option A)</strong></li>\n<li>There are two metabolic disorders of proline catabolism:\n<ol>\n<li><strong>Type I Hyperprolinemia:</strong> The Enzyme deficiency is <strong>proline dehydrogenase.</strong></li>\n<li><strong>Type II Hyperprolinemia:</strong> The Metabolic defect is the <strong>dehydrogenase</strong> that is involved in the conversion of glutamate-&gamma;-semialdehyde to glutamic acid.</li>\n</ol>\n</li>\n<li>Both are inherited as <strong>autosomal recessive traits. (Option C)</strong></li>\n<li>Since proline does not participate in transamination, its &alpha;-amino nitrogen is retained throughout a two-stage oxidation to glutamate.\n<ul>\n<li>Oxidation to &Delta;1-pyrroline-5-carboxylate is catalysed by proline dehydrogenase.</li>\n<li>Subsequent oxidation to glutamate is catalysed by &Delta;1-pyrroline-5-carboxylate dehydrogenase (also called glutamate-&gamma;-semialdehyde dehydrogenase).</li>\n</ul>\n</li>\n<li>Inherited as autosomal recessive traits, both are associated with mental retardation. <strong>(Option D)</strong></li>\n</ul>", "options": ["The catabolism of proline occurs in mitochondria", "Type II hyperprolinemia is associated with a deficiency of Proline dehydrogenase", "Type II hyperprolinemia is inherited as an autosomal recessive trait.", "Both Type I and II hyperprolinemia are associated with mental retardation."], "html_options": ["The catabolism of proline occurs in mitochondria", "Type II hyperprolinemia is associated with a deficiency of Proline dehydrogenase", "Type II hyperprolinemia is inherited as an autosomal recessive trait.", "Both Type I and II hyperprolinemia are associated with mental retardation."], "corr_idx": 1}, {"id": "1195607", "html_qtxt": "A newborn presents with poor feeding, lethargy, and a characteristic maple syrup odour to the urine. On examination, there is hypotonia and intermittent apnea. Urine analysis in this infant will show which aminoacid/s?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The above-described clinical scenario in this infant is suggestive of <strong>Maple syrup urine disease.</strong> The basic biochemical defect is a <strong>deficiency of Branched Chain Ketoacid Dehydrogenase,</strong> resulting in the accumulation of <strong>branched-chain keto acids - Leucine, Isoleucine and Valine,</strong> which are then excreted in Urine.</p>\n<p><strong>Maple Syrup Urine Disease:</strong></p>\n<p><strong>Biochemical defect</strong></p>\n<ul>\n<li>Deficiency of the enzyme Branched Chain Ketoacid Dehydrogenase.</li>\n<li>Results in <strong>deficient</strong> decarboxylation of branched-chain keto acids - Valine, Leucine, Isoleucine.</li>\n</ul>\n<p><strong>Clinical features</strong></p>\n<ul>\n<li>Mental Retardation</li>\n<li>Convulsion</li>\n<li>Acidosis, Coma</li>\n<li>Burnt Sugar [Maple Syrup] smell of urine (Due to excretion of branched-chain keto acid in urine)</li>\n</ul>\n<p><strong>Tests for MSUD</strong></p>\n<ul>\n<li>Di Nitro Phenyl Hydrazine Test (DNPH Test)</li>\n<li>Rothera's Test (Positive)</li>\n<li>Enzyme Analysis</li>\n</ul>\n<p><strong>Treatment</strong></p>\n<ul>\n<li>Restrict Branched Chain Amino Acid</li>\n<li>Give high doses of Thiamine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Leucine, Lysine (Option A):</strong> Lysine is not a branched-chain amino acid.</p>\n<p><strong>Leucine only (Option C):</strong> Although leucine is elevated, <strong>isoleucine</strong> and <strong>valine</strong> are also involved.</p>\n<p><strong>Lysine only (Option D):</strong> Lysine is unrelated to MSUD.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Maple Syrup Urine Disease</strong> is due to a deficiency in <strong>branched-chain ketoacid dehydrogenase</strong>, leading to the accumulation of <strong>leucine, isoleucine, and valine</strong> in blood and urine.</p>", "options": ["Leucine, Lysine", "Leucine, Isoleucine", "Leucine only", "Lysine only"], "html_options": ["Leucine, Lysine", "Leucine, Isoleucine", "Leucine only", "Lysine only"], "corr_idx": 1}, {"id": "1195609", "html_qtxt": "Which of the following is used as a specific treatment for Isovaleric Acidemia?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycine is used as a specific treatment for Isovaleric Acidemia to enhance the excretion of toxic metabolites.</p>\n<ul>\n<li><strong>Isovaleric acidemia:</strong></li>\n<li>Isovaleric acidemia is a metabolic disorder of branched-chain amino acid catabolism.</li>\n<li>In isovaleric acidemia, ingestion of protein-rich foods elevates isovalerate, the deviation product of isovaleryl-CoA.</li>\n<li>The impaired enzyme in isovaleric acidemia is <strong>isovaleryl-CoA dehydrogenase</strong>.</li>\n<li>Vomiting, acidosis and coma follow ingestion of excess protein.</li>\n<li>Accumulated isovaleryl-CoA is hydrolysed to isovalerate and excreted.</li>\n<li><strong>Treatment of Isovaleric Acidemia:</strong>\n<ul>\n<li>Hydration</li>\n<li>Reversal of the catabolic state (by providing adequate calories orally or intravenously).</li>\n<li>Correction of metabolic acidosis (by infusing sodium bicarbonate)</li>\n</ul>\n</li>\n<li><strong>Removal of the excess isovaleric acid by:</strong>\n<ol>\n<li>Administering Glycine: Because isovalerylglycine has a high urinary clearance, administration of glycine (250 mg/kg/24 hr) is recommended to enhance the formation of isovalerylglycine.</li>\n<li>Administering L-Carnitine: L-carnitine (100 mg/kg/24 hr orally) also increases the removal of isovaleric acid by forming isovalerylcarnitine, which is excreted in the urine</li>\n</ol>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Arginine (Option A):</strong> Basic amino acid; not involved in isovaleric acid detoxification. Used in other urea cycle disorders.</p>\n<p><strong>Lysine (Option B):</strong> Ketogenic amino acid; no role in isovaleric acidemia management.</p>\n<p><strong>Methionine (Option D):</strong> Sulfur-containing essential amino acid; not used in the treatment. May worsen metabolic load.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Glycine is administered in isovaleric acidemia to facilitate detoxification by forming isovalerylglycine.</p>", "options": ["Arginine", "Lysine", "Glycine", "Methionine"], "html_options": ["Arginine", "Lysine", "Glycine", "Methionine"], "corr_idx": 2}]}, {"moduleId": 1009769, "name": "Heme Synthesis and Porphyria", "questions": [{"id": "1195563", "html_qtxt": "The nitrogen atom of aspartate formed from asparagine using the enzyme asparaginase is from:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The nitrogen atom in asparagine is derived from <strong>glutamine</strong> via the action of <strong>asparagine synthetase</strong>, which is analogous to the reaction catalysed by <strong>glutamine synthetase</strong>, except that it uses glutamine instead of ammonium ions as the nitrogen donor.</p>\n<ul>\n<li>This explains why asparagine synthetase <strong>cannot fix ammonia</strong>, unlike glutamine synthetase.</li>\n<li>In contrast, <strong>bacterial asparagine synthetase</strong> can also use <strong>ammonium ions</strong> as a nitrogen source.</li>\n</ul>\n<p><strong>Asparagine synthetase</strong>: Transfers the amide nitrogen from <strong>glutamine</strong> to aspartate to form <strong>asparagine</strong>.</p>\n<ul>\n<li><strong>Reaction</strong>: Aspartate + Glutamine + ATP &rarr; Asparagine + Glutamate + AMP + PPi</li>\n<li>Glutamine serves as an <strong>amide group donor</strong>, not ammonium.</li>\n<li><strong>Asparaginase</strong> catalyses the reverse reaction, breaking down asparagine to <strong>aspartate</strong> and releasing <strong>ammonia</strong>.</li>\n<li><strong>Clinical relevance</strong>: Asparaginase is used in <strong>acute lymphoblastic leukaemia</strong> treatment, targeting leukemic cells dependent on exogenous asparagine.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811fb1089ca-6833-4882-8723-fb69ca77d9d1.png\">\n<p><strong>Explanation of Other Options</strong>:</p>\n<p><strong>Ammonium (Option A)</strong>: Nitrogen source for <strong>glutamine synthetase</strong>, not for human asparagine synthetase.</p>\n<p><strong>Glutamate (Option B)</strong>: Product of glutamine deamidation; not the direct nitrogen donor in this context.</p>\n<p><strong>Alpha-Ketoglutarate (Option D)</strong>: Involved in transamination reactions and glutamate synthesis, not directly linked to asparagine synthesis.</p>\n<p><strong>Key Takeaways</strong>:</p>\n<p>Glutamine is the nitrogen donor for asparagine synthesis in humans; ammonium is used only in bacteria.</p>", "options": ["Ammonium", "Glutamate", "Glutamine", "Alpha Ketoglutarate"], "html_options": ["Ammonium", "Glutamate", "Glutamine", "Alpha Ketoglutarate"], "corr_idx": 2}, {"id": "1195564", "html_qtxt": "Oxaloacetate is formed from:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Oxaloacetate is derived from <strong>Aspartate and Asparagine</strong>, both of which contribute all four carbon atoms to the TCA intermediate.</p>\n<ul>\n<li><strong>Asparagine</strong> is first converted to <strong>Aspartate</strong> by <strong>Asparaginase</strong> (hydrolytic deamidation).</li>\n<li><strong>Aspartate</strong> then undergoes <strong>transamination</strong> to form <strong>Oxaloacetate</strong>.</li>\n</ul>\n<p>Asparagine + H2O &rarr; Aspartate + NH4</p>\n<p>Aspartate + Pyruvate &rarr; Alanine + Oxaloacetate</p>\n<ul>\n<li>Asparagine &rarr; Aspartate: via <strong>Asparaginase</strong></li>\n<li>Aspartate &rarr; Oxaloacetate: via <strong>Transaminase</strong> (AST / Aspartate Transaminase)</li>\n<li>These steps are key components of <strong>glucogenic amino acid catabolism</strong>.</li>\n<li><strong>Glucogenic amino acids</strong> are converted into TCA cycle intermediates, such as <strong>oxaloacetate</strong>, and are involved in gluconeogenesis.</li>\n</ul>\n<p><strong>Explanation of Other Options</strong>:</p>\n<p><strong>Proline (Option A)</strong>: Yields <strong>glutamate</strong>, which is further catabolized to <strong>&alpha;-ketoglutarate</strong>, not oxaloacetate.</p>\n<p><strong>Histidine and Arginine (Option B)</strong>: Catabolized to <strong>glutamate</strong>, leading to <strong>&alpha;-ketoglutarate</strong> formation.</p>\n<p><strong>Glutamate and Glutamine (Option C)</strong>: Degraded to <strong>&alpha;-ketoglutarate</strong>, a TCA intermediate upstream of oxaloacetate.</p>\n<p><strong>Key Takeaways</strong>:</p>\n<p>Aspartate and asparagine are both glucogenic amino acids that contribute to oxaloacetate formation.</p>", "options": ["Proline", "Histidine and Arginine", "Glutamate and Glutamine", "Aspartate and Asparagine"], "html_options": ["Proline", "Histidine and Arginine", "Glutamate and Glutamine", "Aspartate and Asparagine"], "corr_idx": 3}, {"id": "1195565", "html_qtxt": "Which among the following is the essential cofactor required for the formation of hydroxyproline and hydroxylysine?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<p><strong>Ascorbic acid plays an important role in the formation of hydroxyproline and hydroxylysine, an integral part of collagen structure.</strong></p>\n<ul>\n<li>In collagen structure, each polypeptide chain is twisted into a left-handed helix of three residues (Glycine-X-Y) per turn.</li>\n<li>This repeating structure, represented as <strong>(Gly-X-Y)n</strong>, is an absolute requirement for the formation of the triple helix.</li>\n<li>While X and Y can be any other amino acids, the X positions are often proline, and the Y positions are often hydroxyproline.</li>\n<li>Proline and hydroxyproline confer rigidity on the collagen molecule.</li>\n<li>Hydroxyproline is formed by the <strong>post-translational hydroxylation</strong> of peptide-bond proline residues catalysed by the enzyme prolyl hydroxylase, whose cofactors are <strong>ascorbic acid (vitamin C) and &alpha;-ketoglutarate. </strong></li>\n<li>Lysines in the Y position may also be post-translational modified to hydroxylysine through the action of lysyl hydroxylase, an enzyme with similar cofactors to prolyl hydroxylase.</li>\n</ul>\n<p><strong>Explanation of Other Options</strong>:</p>\n<p><strong>Pyridoxal phosphate (Option A)</strong>: Coenzyme in transamination and decarboxylation; not involved in collagen hydroxylation.</p>\n<p><strong>Thiamine pyrophosphate (Option C)</strong>: Cofactor in oxidative decarboxylation reactions (e.g., pyruvate dehydrogenase); unrelated to proline/lysine hydroxylation.</p>\n<p><strong>Methylcobalamin (Option D)</strong>: Active form of vitamin B&#8321;&#8322;, a coenzyme in methylation reactions; not involved in collagen modification.</p>\n<p><strong>Key takeaways : </strong></p>\n<ul>\n<li>Hydroxylation of Proline and Lysine is catalysed by <strong>Prolyl Hydroxylase and Lysyl Hydroxylase,</strong> respectively, with cofactors that are <strong>Vitamin C and &alpha;-ketoglutarate.</strong></li>\n</ul>", "options": ["Pyridoxal phosphate", "Ascorbic acid", "Thiamine pyrophosphate", "Methylcobalamin"], "html_options": ["Pyridoxal phosphate", "Ascorbic acid", "Thiamine pyrophosphate", "Methylcobalamin"], "corr_idx": 1}, {"id": "1195566", "html_qtxt": "Stickler Syndrome is due to a deficiency of which type of collagen?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Stickler syndrome </strong>is characterised by<strong> abnormal forms of type II collagen</strong> due to a <strong>mutation in the COL2A1 gene.</strong></p>\n<ul>\n<li><strong>A defect in Type II collagen results in Chondrodysplasia.</strong></li>\n<li>Chondrodysplasias are a mixed group of hereditary disorders affecting the cartilage. They are manifested by short-limbed dwarfism and numerous skeletal deformities.</li>\n<li>A number of them are due to a variety of mutations in the <strong>COL2A1 gene</strong>, leading to abnormal forms of <strong>type II collagen. </strong></li>\n<li>One example is <strong>Stickler syndrome</strong> (may also be due to mutations in the COL11A1 and COL11A2 genes), manifested by degeneration of the joint cartilage and of the vitreous body of the eye.</li>\n</ul>\n<p><strong>Explanation of other options : </strong></p>\n<p><strong>Type I Collagen</strong> <strong>(Option A): </strong></p>\n<ul>\n<li>A defect in Type I collagen leads to <strong>osteogenesis imperfecta</strong>.</li>\n<li>Also known as Brittle Bone disease or Pseudo Battered Baby syndrome, it is characterised by :\n<ul>\n<li>Multiple fractures</li>\n<li>Blue sclera</li>\n<li>Hearing loss</li>\n</ul>\n</li>\n</ul>\n<p><strong>Type III Collagen</strong> <strong>(Option C): </strong></p>\n<ul>\n<li>If Type III Collagen is defective, it leads to Ehler-Danlos Syndrome.</li>\n<li>Also known as Rubber Man syndrome.</li>\n<li>However, all types of collagen can be defective in Ehlers-Danlos syndrome:\n<ul>\n<li>If Type I collagen is involved, it can result in a hypermobile joint.</li>\n<li>A defect in Type V collagen can cause hyperelastic skin.</li>\n</ul>\n</li>\n<li>In Ehler-Danlos Syndrome, there is an increased risk of :\n<ul>\n<li>MV prolapse</li>\n<li>Aortic dissection</li>\n</ul>\n</li>\n</ul>\n<p><strong>Type IV Collagen</strong> <strong>(Option D): </strong></p>\n<ul>\n<li>Type IV collagen defects lead to <strong>Alport syndrome.</strong></li>\n<li>In Alport syndrome, the Alpha 5 chain is defective.</li>\n<li>Clinical features :\n<ul>\n<li>Hematuria</li>\n<li>Sensorineural hearing loss</li>\n<li>Anterior Lenticonus</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508110fc301d7-448d-4800-9b2f-174f3ad55833.png\">", "options": ["Type I Collagen", "Type II Collagen", "Type III Collagen", "Type IV Collagen"], "html_options": ["Type I Collagen", "Type II Collagen", "Type III Collagen", "Type IV Collagen"], "corr_idx": 1}, {"id": "1195567", "html_qtxt": "All amino acids mentioned below yield succinyl CoA except :", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Lysine is a <strong>strictly ketogenic</strong> amino acid and does not contribute to succinyl-CoA formation.</p>\n<ul>\n<li><strong>Valine</strong>, <strong>isoleucine</strong>, and <strong>methionine</strong> are glucogenic or both glucogenic and ketogenic and are known to form <strong>succinyl-CoA</strong>, an intermediate of the TCA cycle. <strong>(Other options are ruled out)</strong></li>\n<li><strong>Propionyl-CoA</strong>, derived from these amino acids, is converted to methylmalonyl-CoA and then to succinyl-CoA via <strong>methylmalonyl-CoA mutase</strong>.</li>\n<li><strong>Lysine</strong>, on the other hand, is metabolised to <strong>acetyl-CoA</strong> or <strong>acetoacetyl-CoA</strong> but <strong>never</strong> forms TCA cycle intermediates like succinyl-CoA.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508110c8c3661-36c4-4d6c-870a-5cf0a04e3f40.png\">\n<ul>\n<li>Amino acids classified as glucogenic yield TCA cycle intermediates (e.g., oxaloacetate, &alpha;-ketoglutarate, succinyl-CoA).</li>\n<li><strong>Lysine and leucine </strong>are the only <strong>purely ketogenic</strong> amino acids.</li>\n<li>Succinyl-CoA plays a central role in both the <strong>TCA cycle</strong> and <strong>heme synthesis</strong>.</li>\n</ul>", "options": ["Isoleucine", "Methionine", "Valine", "Lysine"], "html_options": ["Isoleucine", "Methionine", "Valine", "Lysine"], "corr_idx": 3}, {"id": "1195568", "html_qtxt": "At isoelectric pH, protein:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>At the <strong>isoelectric point (pI)</strong>, a protein or amino acid exists in a <strong>zwitterionic</strong> form, carrying equal numbers of positive and negative charges- hence, its <strong>net charge becomes zero</strong>. This condition results in:</p>\n<ul>\n<li><strong>No migration</strong> during electrophoresis</li>\n<li><strong>Minimum solubility</strong></li>\n<li><strong>Maximum precipitation</strong></li>\n<li><strong>Reduced buffering capacity</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Migrates (Option B):</strong> Proteins do <strong>not migrate</strong> in an electric field at pI due to the net charge being zero.</p>\n<p><strong>Positively charged (Option C ):</strong> Occurs only at <strong>pH below pI</strong>, not at pI.</p>\n<p><strong>Negatively charged (Option D):</strong> Occurs <strong>above the pI</strong>, not at pI.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>At <strong>pI</strong>, proteins have <strong>no net charge</strong>, leading to <strong>no electrophoretic mobility</strong> and <strong>minimal solubility</strong>- a principle used in protein purification.</p>", "options": ["Have net charge '0'", "Migrate", "Are positively charged", "Are negatively charged"], "html_options": ["Have net charge '0'", "Migrate", "Are positively charged", "Are negatively charged"], "corr_idx": 0}, {"id": "1195569", "html_qtxt": "Proteins are linear polymers of amino acids. They fold into compact structures. Sometimes, these folded structures associate to form homo- or heterodimers. Which one of the following refers to this associated form?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Quaternary structure refers to the spatial arrangement and interactions of multiple polypeptide subunits within a functional protein. It typically involves:</p>\n<ul>\n<li>Association of homo- or hetero-polypeptides</li>\n<li>Stabilisation by noncovalent interactions (hydrophobic interactions, hydrogen bonds, ionic bonds, van der Waals forces)</li>\n<li>Sometimes, covalent disulfide bonds may be present</li>\n</ul>\n<p><strong>Primary Structure </strong></p>\n<p>It is the linear sequence of amino acids held together by peptide bonds in its peptide chains. The bond involved in primary structure is the Peptide Bond, a type of covalent bond.</p>\n<p><strong>Secondary Structure</strong></p>\n<ul>\n<li>Configurational relationship between residues that are about 3-4 amino Acids apart in a linear sequence.</li>\n<li>The folding of short (3 to 30-residue), contiguous segments of polypeptide into geometrically ordered units</li>\n<li>Bonds involved in the secondary structure are primarily <strong>noncovalen</strong>t bonds, like:\n<ul>\n<li>Hydrogen Bond (Most important Bond)</li>\n<li>Hydrophobic Bond</li>\n<li>Electrostatic Bond (Ionic Bond, Salt Bridges)</li>\n<li>van der Waals forces.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Tertiary structure: </strong>The entire three-dimensional conformation of a polypeptide is referred to as tertiary structure. </p>\n<p><strong>Quaternary structure: </strong>If more than one polypeptide aggregates to form one functional protein, the spatial relationship between the polypeptide subunits is referred to as quaternary structure.</p>\n<p>Bonds involved in Tertiary and Quaternary Structures are primarily noncovalent bonds.</p>\n<ul>\n<li>Hydrophobic Interaction</li>\n<li>Hydrogen Bond</li>\n<li>Electrostatic Bond</li>\n<li>Van der Waal's Forces</li>\n</ul>\n<p>Some covalent bonds may be present, like disulfide bonds (both intra- & inter-strand) and cross-links between side chains of strands.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Denatured state (Option A):</strong> Refers to unfolded or structurally disrupted proteins, not native functional assemblies.</p>\n<p><strong>Molecular aggregation (Option B):</strong> Often refers to nonspecific or pathological protein clumping, not an organised quaternary structure.</p>\n<p><strong>Precipitation (Option C):</strong> A physical phenomenon due to loss of solubility, not a structural organisation level.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Quaternary structure</strong> describes the organised assembly of two or more polypeptide chains into a functional multimeric protein.</p>", "options": ["Denatured state", "Molecular aggregation", "Precipitation", "Quaternary structure"], "html_options": ["Denatured state", "Molecular aggregation", "Precipitation", "Quaternary structure"], "corr_idx": 3}, {"id": "1195570", "html_qtxt": "Which among the following is the structure of myoglobin?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Myoglobin is a single-chain globular protein that functions as an oxygen storage molecule in muscle. It consists of only one polypeptide chain and one heme prosthetic group, classifying it as a <strong>monomer</strong>.</p>\r\n<ul>\r\n<li>It does <strong>not exhibit cooperative binding</strong>, unlike haemoglobin.</li>\r\n<li>The absence of quaternary structure accounts for its <strong>hyperbolic oxygen dissociation curve</strong>.</li>\r\n<li>This structural simplicity supports its rapid oxygen release in hypoxic muscle conditions.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Homodimer (Option A):</strong> A homodimer has two identical polypeptide chains, seen in some enzymes, but not in myoglobin.</p>\r\n<p><strong>Heterodimer (Option B):</strong> Refers to two different subunits; haemoglobin has heterodimeric &alpha; and &beta; chains, but myoglobin does not.</p>\r\n<p><strong>Tetramer (Option C):</strong> Haemoglobin is a tetramer (&alpha;<sub>2</sub>&beta;<sub>2</sub>); myoglobin lacks this multimeric structure.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Myoglobin is a monomeric protein with no quaternary structure and a hyperbolic oxygen-binding curve.</p>", "options": ["Monomer", "Homodimer", "Heterodimer", "Tetramer"], "html_options": ["Monomer", "Homodimer", "Heterodimer", "Tetramer"], "corr_idx": 0}, {"id": "1195572", "html_qtxt": "In forming a 3D structure following factors help except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Peptide bonds form the primary linear structure but do not directly contribute to tertiary folding.</p>\n<ul>\n<li>Tertiary and quaternary structures arise from side-chain interactions (hydrophobic, hydrogen, ionic, van der Waals forces) and sometimes disulfide bonds.</li>\n<li>The <strong>amino acid sequence</strong> (primary structure) determines the folding pattern, as side chains interact to form complex 3D conformations. (Option B ruled out)</li>\n<li><strong>Interactions between polypeptide chains</strong> are essential for quaternary structure formation. (Option C ruled out)</li>\n<li><strong>Chaperone proteins</strong> assist in proper folding and prevent aggregation of nascent polypeptides. (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Primary structure (peptide bonds) determines the sequence but is not directly responsible for the folding into tertiary or quaternary structures.</p>", "options": ["Peptide bond", "Amino acid sequence", "Interaction between polypeptides", "Chaperone"], "html_options": ["Peptide bond", "Amino acid sequence", "Interaction between polypeptides", "Chaperone"], "corr_idx": 0}, {"id": "1195573", "html_qtxt": "An alpha helix of a protein is most likely to be disrupted if a missense mutation introduces the following amino acid within the alpha-helical structure:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycine, due to its small side chain and high flexibility, disrupts the stability of the alpha helix by introducing bends or irregularities.</p>\n<ul>\n<li>The alpha helix is stabilised by hydrogen bonds between the carbonyl oxygen of one residue and the amide hydrogen of the fourth residue ahead.</li>\n<li>Glycine, being highly flexible with no side chain (just a hydrogen atom), fails to maintain the regular geometry of the helix.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Alanine (Option A):</strong> Small, nonpolar side chain; commonly found in alpha helices and stabilises them.</p>\n<p><strong>Aspartic acid (Option B):</strong> Polar and negatively charged, but does not inherently disrupt the helix unless involved in unfavourable electrostatics.</p>\n<p><strong>Tyrosine (Option C):</strong> Bulky aromatic side chain, but tolerated within helices if properly positioned.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Glycine disrupts the alpha helix due to its conformational flexibility and lack of side-chain bulk.</p>", "options": ["Alanine", "Aspartic acid", "Tyrosine", "Glycine"], "html_options": ["Alanine", "Aspartic acid", "Tyrosine", "Glycine"], "corr_idx": 3}, {"id": "1195574", "html_qtxt": "Precipitation of proteins occurs in all except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Proteins precipitate maximally at their isoelectric pH, not when moved away from it.</p>\n<ul>\n<li>Protein precipitation is facilitated when the net charge is neutralised-this occurs at the isoelectric point (pI).</li>\n<li><strong>At pI</strong>, proteins lose their shell of hydration due to a lack of net charge, promoting aggregation.</li>\n<li><strong>Organic solvents</strong> (like alcohol or acetone) remove water, reducing protein solubility and causing precipitation. (Option A ruled out)</li>\n<li><strong>Trichloroacetic acid</strong> and <strong>heavy metal salts</strong> cause precipitation by denaturing proteins or disrupting hydration shells. (Option C and D ruled out)</li>\n<li><strong>Moving away from pI</strong> increases the net charge on proteins, enhancing their solubility and reducing precipitation.</li>\n</ul>\n<p>Methods to precipitate protein by removing the shell of hydration:</p>\n<ul>\n<li>Precipitation by neutral salts\n<ul>\n<li>Concentrated Salt solution removes the shell of hydration.</li>\n<li>The reagents used are Ammonium sulfate. This is called salting out.</li>\n</ul>\n</li>\n<li>Precipitation by organic solvents\n<ul>\n<li>The reagents used are ether, alcohol, acetone, etc.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Precipitation of proteins is most efficient at their isoelectric pH due to loss of net charge and shell of hydration.<br /> </p>", "options": ["Adding alcohol and acetone", "pH changes are moved away from the isoelectric pH", "With Trichloroacetic acid", "With heavy metals"], "html_options": ["Adding alcohol and acetone", "pH changes are moved away from the isoelectric pH", "With Trichloroacetic acid", "With heavy metals"], "corr_idx": 1}, {"id": "1195575", "html_qtxt": "Following SDS-PAGE electrophoresis, a protein appears as a single band at 100 kDa. After treatment with β-mercaptoethanol, it shows two widely separated bands of 20 kDa and 30 kDa. Which of the following is the most appropriate explanation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>A 100 kDa protein that breaks into two subunits (20 kDa and 30 kDa) after &beta;-mercaptoethanol treatment indicates it was a tetramer of covalently linked subunits, specifically 2 of each type.</p>\n<ul>\n<li>SDS-PAGE separates proteins based on size under denaturing conditions. Without reducing agents, disulfide-linked subunits migrate together.</li>\n<li>Treatment with &beta;-mercaptoethanol reduces disulfide bonds, allowing subunits to separate and migrate based on individual molecular weights.</li>\n<li>A 100 kDa protein yielding 20 kDa and 30 kDa subunits suggests a <strong>tetrameric structure (2&times;20 + 2&times;30 kDa)</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Protein has undergone hydrolysis of S-S linkage (Option A):</strong> &beta;-mercaptoethanol reduces (does not hydrolyse) disulfide bonds.</p>\n<p><strong>It is a dimer of 2 subunits of 20 and 30 kDa (Option B):</strong> 20 + 30 = 50 kDa, not 100 kDa.</p>\n<p><strong>Protein breakdown due to non-covalent linkage (Option D):</strong> SDS denatures proteins and breaks non-covalent bonds. Disulfide bonds are covalent.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>SDS-PAGE with reducing agents like &beta;-mercaptoethanol reveals covalently linked multimeric subunits of a protein.<br /> </p>", "options": ["The Protein has undergone hydrolysis of the S-S linkage", "It is a dimer of 2 subunits of 20 and 30 KDa", "It is a tetramer of 2,20 KDa and 2,30 KDa", "Protein breakdown due to non-covalent linkage"], "html_options": ["The Protein has undergone hydrolysis of the S-S linkage", "It is a dimer of 2 subunits of 20 and 30 KDa", "It is a tetramer of 2,20 KDa and 2,30 KDa", "Protein breakdown due to non-covalent linkage"], "corr_idx": 2}, {"id": "1195576", "html_qtxt": "The methods used to study the structure of proteins include all except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The Edman reaction enables peptides & proteins to be sequenced.</p>\n<ul>\n<li>Edman's reaction is used to detect the sequence of amino acids in a polypeptide.</li>\n<li>Pehr Edman introduced phenylisothiocyanate (Edman reagent) to selectively label the amino-terminal residue of a peptide.</li>\n<li>In contrast to the Sanger reagent, the phenylisothiohydantoin (PTH) derivative can be removed under mild conditions to generate a new amino-terminal residue.</li>\n<li>Successive rounds of derivatisation with the Edman reagent can therefore be used to sequence many residues of a single sample of peptide.</li>\n<li>Even so, the determination of the complete sequence of a protein by chemical methods remains a time- and labour-intensive process.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>UV Spectroscopy (Option A):</strong> Used to study structural features by analysing the absorbance of aromatic side chains.</p>\n<p><strong>NMR Spectroscopy (Option B):</strong> An advanced method for determining tertiary and quaternary structures of proteins in solution.</p>\n<p><strong>X-ray Crystallography (Option C):</strong> Gold standard for detailed 3D structural elucidation of crystallised proteins.</p>", "options": ["UV Spectroscopy", "NMR Spectroscopy", "X-ray crystallography", "Edman's technique"], "html_options": ["UV Spectroscopy", "NMR Spectroscopy", "X-ray crystallography", "Edman's technique"], "corr_idx": 3}, {"id": "1195578", "html_qtxt": "In SDS-PAGE, proteins are separated based on:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>SDS binds uniformly to proteins and neutralises their native charges, allowing separation purely based on molecular mass.</p>\n<ul>\n<li>SDS (sodium dodecyl sulfate) is a strong anionic detergent that denatures proteins and imparts a uniform negative charge proportional to protein length.</li>\n<li>This masks the intrinsic charges of proteins, ensuring that migration in polyacrylamide gel is governed solely by molecular weight.</li>\n<li>Smaller proteins migrate faster through the gel matrix, while larger ones migrate more slowly.</li>\n<li>SDS-PAGE can also be paired with reducing agents like <strong>2-mercaptoethanol</strong> or <strong>dithiothreitol</strong> to break disulfide bonds in multimeric proteins.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Charge (Option B):</strong> Native PAGE separates proteins by charge and size, but SDS-PAGE masks intrinsic charge.</p>\n<p><strong>Density (Option C):</strong> Not relevant to SDS-PAGE; density is not a separation criterion.</p>\n<p><strong>Solubility (Option D):</strong> Solubility plays no role in SDS-PAGE migration.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>SDS-PAGE separates proteins based on molecular mass alone by equalising their charge-to-mass ratio.<br /> </p>", "options": ["Mass", "Charge", "Density", "Solubility"], "html_options": ["Mass", "Charge", "Density", "Solubility"], "corr_idx": 0}, {"id": "1195579", "html_qtxt": "Amino acid sequence is not found by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Amino acid sequence determination is not performed by Benedict's reagent, which is a test for reducing sugars.</p>\n<p>Methods of Protein Sequencing:</p>\n<p><strong>Sanger's Technique</strong></p>\n<ul>\n<li>Sanger's Reagent is 1, Fluoro 2, 4 Dinitrobenzene</li>\n<li>Sanger's Reagent derivatises the amino-terminal residues.</li>\n<li>The first Protein to be sequenced by the method is Insulin by Fredrick Sanger. He got the Nobel Prize in 1958.</li>\n<li>Only dipeptides or tripeptides can be sequenced.</li>\n</ul>\n<p><strong>Edman's Technique</strong></p>\n<ul>\n<li>By using Edman's Reagent (Phenyl Iso-Thio-cyanate).</li>\n<li>Phenyl Isothiocyanate derivatives are the amino terminal of a Polypeptide.</li>\n<li>Edman's Technique can sequence many residues (5-30 residues) of a single polypeptide sample, unlike Sanger's</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sanger's reagent (Option A):</strong> Labels the N-terminal amino acid to identify it during sequencing.</p>\n<p><strong>Trypsin (Option C):</strong> Cleaves polypeptides at specific sites to generate peptides for sequencing.</p>\n<p><strong>Cyanogen bromide (Option D):</strong> Specifically cleaves at methionine residues to aid sequence analysis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Benedict's reagent is a carbohydrate detection reagent and plays no role in protein or peptide sequencing.</p>", "options": ["Sanger's reagent", "Benedict's reagent", "Trypsin", "Cyanogen bromide"], "html_options": ["Sanger's reagent", "Benedict's reagent", "Trypsin", "Cyanogen bromide"], "corr_idx": 1}, {"id": "1195580", "html_qtxt": "Molecules up to size 4 kDa are identified by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Quadrupole mass spectrometry is best suited for detecting molecular species of 4000 Da or less.</p>\n<ul>\n<li>Quadrupole analysers use oscillating electric fields to filter ions by mass-to-charge (m/z) ratio.</li>\n<li>Particularly effective for low-mass molecules and is used in targeted proteomics and small peptide detection.</li>\n<li>These systems operate with high resolution and speed, ideal for molecules under 4 kDa.</li>\n<li>It is the standard for low-mass detection in contrast to TOF-MS.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Gene array chip (Option A):</strong> Identifies gene expression by nucleic acid hybridisation, and has no role in mass determination.</p>\n<p><strong>Electrospray ionisation (Option B):</strong> An ionisation method that converts large molecules into ions for MS but does not itself analyse mass or define detection limits.</p>\n<p><strong>Matrix-assisted laser desorption ionisation (Option D):</strong> Suitable for ionising large macromolecules for MS analysis, but not ideal for precise quantification of small molecules like those under 4 kDa.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Quadrupole mass spectrometry is the method of choice for detecting molecules up to 4 kDa.</p>", "options": ["Gene array chip", "Electrospray ionization", "Quadrupole mass spectrometry", "Matrix-assisted Laser Desorption ionisation"], "html_options": ["Gene array chip", "Electrospray ionization", "Quadrupole mass spectrometry", "Matrix-assisted Laser Desorption ionisation"], "corr_idx": 2}, {"id": "1195581", "html_qtxt": "Collagen of which type is found in hyaline cartilage?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Hyaline cartilage is predominantly composed of <strong>type II collagen</strong>, which provides resistance to intermittent pressure and tensile strength.</p>\n<ul>\n<li>Type II collagen forms fine fibrils that aggregate with proteoglycans, contributing to the load-bearing property of cartilage.</li>\n<li>It is found in articular surfaces, costal cartilage, nasal cartilage, and the embryonic skeleton.</li>\n<li>This type is crucial in endochondral ossification and cartilage repair mechanisms.</li>\n</ul>\n<p><strong>Types of Collagen:</strong></p>\n<ul>\n<li>Major Collagen present in Bone-Type I (90%)</li>\n<li>Major Collagen present in Dermis, ligaments and tendons-Type I (80%)</li>\n<li>Major Collagen present in Cartilage-Type II (40-50%)</li>\n<li>Major Collagen present in Hypertrophic Cartilage- Type X</li>\n<li>Major Collagen present in Aorta-Type I and Type III (20-40% each)</li>\n<li>Major Collagen present in Basement Membrane Type IV</li>\n<li>Most abundant Collagen-Type I</li>\n<li>Major Collagen in Keloid is Type 3 >> Type 1</li>\n</ul>\n<p>Collagen in Wound Healing: At first, a provisional matrix containing fibrin, plasma fibronectin, and type III collagen is formed, but this is replaced by a matrix composed primarily of type I collagen</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Type I (Option A):</strong> Found in skin, tendon, bone, and cornea; not the main collagen in cartilage.</p>\n<p><strong>Type III (Option C):</strong> Found in reticular fibres, blood vessels, fetal skin, and early wound healing.</p>\n<p><strong>Type IV (Option D):</strong> Forms mesh-like networks in the basement membrane, not in cartilage.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Type II collagen is the principal collagen type in hyaline cartilage, crucial for its resilience and structure.<br /> </p>", "options": ["Type I", "Type II", "Type III", "Type IV"], "html_options": ["Type I", "Type II", "Type III", "Type IV"], "corr_idx": 1}, {"id": "1195582", "html_qtxt": "Endoplasmic reticulum -signal transduction is through:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Signal peptides target proteins to the ER membrane, and the translocon forms the channel through which they are cotranslationally translocated.</p>\n<ul>\n<li>Signal recognition particle (SRP) binds to the signal peptide as it emerges from the ribosome.</li>\n<li>SRP guides the ribosome-nascent chain complex to the SRP receptor on the ER membrane.</li>\n<li>The complex then docks onto the <strong>Sec61 translocon</strong>, a multi-protein complex forming a gated pore.</li>\n<li>Translation resumes, and the polypeptide is translocated through the translocon into the ER lumen.</li>\n<li>The signal peptide is then cleaved by <strong>signal peptidase</strong>.</li>\n<li><strong>TRAM </strong>is <strong>Translocating Chain-Associated Membrane Protein</strong>. TRAM accelerates the translocation of certain proteins.</li>\n<li><strong>TRAP</strong>, <strong>Translocon-associated Protein Complex</strong>. The function of TRAP is not clear.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Chaperone (Option B):</strong> Involved post-translationally in protein folding and preventing aggregation, not signal-guided translocation into the ER.</p>\n<p><strong>Ubiquitin (Option C):</strong> Tags misfolded or damaged proteins for degradation via the proteasome, not part of the ER translocation.</p>\n<p><strong>Mannose 6 Phosphate (Option D):</strong> Targets proteins to lysosomes via the Golgi apparatus, not the ER membrane.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Translocon (Sec61 complex) is the ER membrane channel responsible for the cotranslational translocation of nascent peptides directed by signal sequences.</p>", "options": ["Translocon", "Chaperone", "Ubiquitin", "Mannose 6 Phosphate"], "html_options": ["Translocon", "Chaperone", "Ubiquitin", "Mannose 6 Phosphate"], "corr_idx": 0}]}, {"moduleId": 1010133, "name": "Amino acid classification and properties, protein structure and protein separation ", "questions": [{"id": "1211340", "html_qtxt": "All of the following are essential amino acids except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Alanine is a non-essential amino acid synthesised by the body via transamination of pyruvate.</p>\n<ul>\n<li>Essential amino acids cannot be synthesised by humans in sufficient amounts and must be obtained from the diet.</li>\n<li>Alanine is formed from pyruvate by transamination; thus, it does not need to be supplied exogenously.</li>\n<li>Methionine, lysine, and leucine are among the nine essential amino acids required in the human diet.</li>\n</ul>\n<p>Based on nutritional requirements, amino acids are classified into:</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508135ac778e7-5563-42d7-9991-50f4a7909f97.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Methionine (Option A):</strong> Essential sulfur-containing amino acid required for methylation reactions and synthesis of cysteine.</p>\n<p><strong>Lysine (Option B):</strong> Essential basic amino acid involved in collagen cross-linking and protein synthesis.</p>\n<p><strong>Leucine (Option D):</strong> Essential branched-chain amino acid important for muscle metabolism and repair.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Alanine is non-essential and synthesised endogenously, whereas methionine, lysine, and leucine must be acquired through diet.</p>", "options": ["Methionine", "Lysine", "Alanine", "Leucine"], "html_options": ["Methionine", "Lysine", "Alanine", "Leucine"], "corr_idx": 2}, {"id": "1211342", "html_qtxt": "Selenocysteine is coded by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>UGA normally functions as a stop codon, but in the presence of a selenocysteine insertion sequence (SECIS) in mRNA, it is redefined to encode selenocysteine.</p>\n<ul>\n<li>Selenocysteine is known as the 21st amino acid and is directly incorporated during translation.</li>\n<li>The codon UGA is recoded to specify selenocysteine when accompanied by a stem-loop structure called SECIS, typically found in the 3' untranslated region (UTR) of the mRNA.</li>\n<li>A unique elongation factor and a specialised tRNA (tRNA^Sec) are required for this incorporation.</li>\n</ul>\n<p><strong>Selenocysteine (21st Amino Acid):</strong></p>\n<ul>\n<li><strong>Occurrence in All Domains of Life:</strong>\n<ul>\n<li>Selenocysteine is found in proteins from every domain of life, indicating its significance in various organisms.</li>\n</ul>\n</li>\n<li><strong>Human Selenoproteins:</strong>\n<ul>\n<li>In humans, selenoproteins include certain peroxidases and reductases, selenoprotein P (which circulates in the plasma), and iodothyronine deiodinases (responsible for converting the prohormone T4 to the active thyroid hormone T3).</li>\n</ul>\n</li>\n<li><strong>Selenium Replaces Sulfur:</strong>\n<ul>\n<li>Selenocysteine gets its name from the fact that a selenium atom replaces the sulfur atom of its elemental analogue, cysteine.</li>\n</ul>\n</li>\n<li><strong>Direct Insertion in Polypeptide:</strong>\n<ul>\n<li>Selenocysteine is not the result of a posttranslational modification; instead, it is directly inserted into a growing polypeptide chain during translation.</li>\n</ul>\n</li>\n<li><strong>Termed the \"21st Amino Acid\":</strong>\n<ul>\n<li>Selenocysteine is often referred to as the \"21st amino acid\" due to its unique role in protein synthesis.</li>\n</ul>\n</li>\n<li><strong>Identification during Translation:</strong>\n<ul>\n<li>The protein synthesis machinery identifies a selenocysteine-specific UGA codon by the presence of an accompanying stem-loop structure known as the selenocysteine insertion element. This element is found in the untranslated region of the mRNA.</li>\n</ul>\n</li>\n<li><strong>UGA Codon Codes Selenocysteine:</strong>\n<ul>\n<li>The stop codon UGA is responsible for coding selenocysteine, not ending translation, as it does in the case of most other proteins.</li>\n</ul>\n</li>\n</ul>\n<p>This arrangement summarises the key points about selenocysteine and its unique role in protein synthesis.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>UAG (Option A):</strong> Typically a stop codon; codes for pyrrolysine in archaea, not selenocysteine.</p>\n<p><strong>UAA (Option C):</strong> A standard stop codon in most organisms.</p>\n<p><strong>GUA (Option D):</strong> Codes for valine; not involved in selenocysteine incorporation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>UGA, normally a stop codon, is reprogrammed to incorporate selenocysteine in the presence of a SECIS element.</p>", "options": ["UAG", "UGA", "UAA", "GUA"], "html_options": ["UAG", "UGA", "UAA", "GUA"], "corr_idx": 1}, {"id": "1211346", "html_qtxt": "Polar amino acids are:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Serine is a polar amino acid due to the presence of a hydroxyl group (-OH) in its side chain, enabling hydrogen bonding and water solubility.</p>\n<ul>\n<li>Amino acids are classified as polar or nonpolar based on the properties of their side chains.</li>\n<li>Serine, with its hydroxyl side group, falls under the polar uncharged category.</li>\n<li>Polar amino acids are typically found on the surfaces of proteins where they interact with aqueous environments.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508138334952c-8832-4058-876b-38d25956c827.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Tryptophan (Option B):</strong> Aromatic and relatively nonpolar due to its bulky indole side chain.</p>\n<p><strong>Tyrosine (Option C):</strong> Amphipathic but more hydrophobic than serine; often grouped as hydrophobic.</p>\n<p><strong>Valine (Option D):</strong> A branched-chain hydrophobic amino acid.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Serine is a polar, uncharged amino acid commonly involved in enzymatic activity and hydrogen bonding.</p>", "options": ["Serine", "Tryptophan", "Tyrosine", "Valine"], "html_options": ["Serine", "Tryptophan", "Tyrosine", "Valine"], "corr_idx": 0}, {"id": "1211354", "html_qtxt": "Basic amino acids are except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Leucine is a branched-chain aliphatic amino acid with a neutral side chain, not a basic amino acid.</p>\n<ul>\n<li>Basic amino acids contain side chains with a positive charge at physiological pH.</li>\n<li>Arginine, Lysine, and Histidine possess amino groups that accept protons, giving them basic properties.</li>\n<li>Leucine, on the other hand, is nonpolar and hydrophobic, with no ionizable group in its side chain.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081321201082-4a61-4118-b4f4-bda6a0e64819.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Arginine (Option B):</strong> Contains a guanidino group, the most basic of all amino acids (pKa &asymp; 12.5).</p>\n<p><strong>Lysine (Option C):</strong> Has an &epsilon;-amino group with a high pKa &asymp; of 10.8, making it strongly basic.</p>\n<p><strong>Histidine (Option D):</strong> Contains an imidazole ring; less basic (pKa &asymp; 6.0) but still classified as basic.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Arginine, lysine, and histidine are the three classical basic amino acids. Leucine is hydrophobic and neutral.</p>", "options": ["Leucine", "Arginine", "Lysine", "Histidine"], "html_options": ["Leucine", "Arginine", "Lysine", "Histidine"], "corr_idx": 0}, {"id": "1211356", "html_qtxt": "The Guanidinium group is associated with:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The side chain of arginine contains a guanidinium group, which is a strong base and contributes to its highly basic character.</p>\n<ul>\n<li>The <strong>guanidinium group</strong> has a <strong>delocalized positive charge</strong>, stabilised by resonance, making <strong>arginine the most basic of all amino acids</strong>.</li>\n<li>This group contributes to hydrogen bonding and ionic interactions in proteins.</li>\n<li>The side chain's high pKa (~12.5) allows arginine to remain positively charged across physiological pH ranges.</li>\n</ul>\n<p>The following is a list of special groups present in amino acids.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508139cca1818-30bd-4987-a100-43ab3601dcbc.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Tyrosine (Option A):</strong> Contains a phenolic hydroxyl group, not guanidinium.</p>\n<p><strong>Histidine (Option C):</strong> Has an imidazole ring, which is less basic and has a different structure.</p>\n<p><strong>Lysine (Option D):</strong> Contains a terminal &epsilon;-amino group, not guanidinium.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Arginine uniquely contains a guanidinium group, which imparts strong basicity and is critical for protein interactions.</p>", "options": ["Tyrosine", "Arginine", "Histidine", "Lysine"], "html_options": ["Tyrosine", "Arginine", "Histidine", "Lysine"], "corr_idx": 1}, {"id": "1211361", "html_qtxt": "Sulfur-containing amino acid is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Sulphur-containing amino acids are <strong>Cysteine and Methionine</strong>.</p>\n<ul>\n<li><strong>Cysteine</strong> is a sulfur-containing amino acid with a characteristic - SH group (sulfhydryl group).</li>\n<li>It is <strong>not essential nutritionally</strong> but is <strong>biosynthetically derived from methionine</strong>, making methionine the actual dietary source of sulfur.</li>\n<li>Methionine donates the sulfur atom for cysteine synthesis via homocysteine and serine.</li>\n<li>Both are crucial for protein structure and redox regulation through disulfide bonds and methylation.</li>\n<li>Special group in Cysteine is <strong>Sulfhydryl group Thioalcohol</strong>(-SH)</li>\n<li>Special group in Methionine is <strong>Thioalcohol</strong>(C-S-C)</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Leucine (Option B):</strong> Branched-chain hydrophobic amino acid; does not contain sulfur.</p>\n<p><strong>Arginine (Option C):</strong> Basic amino acid containing a guanidinium group; no sulfur atom.</p>\n<p><strong>Threonine (Option D):</strong> Polar uncharged amino acid; contains a hydroxyl group, not sulfur.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Cysteine and methionine are the only amino acids containing sulfur; cysteine is formed from methionine.</p>", "options": ["Cysteine", "Leucine", "Arginine", "Threonine"], "html_options": ["Cysteine", "Leucine", "Arginine", "Threonine"], "corr_idx": 0}, {"id": "1211363", "html_qtxt": "Amino acid produced by adding a hydroxyl group to the benzene ring chain of phenylalanine:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Tyrosine is formed from phenylalanine by the addition of a hydroxyl group to the para-position of its benzene ring.</p>\n<ul>\n<li>Phenylalanine contains a <strong>benzene</strong> ring as its side chain.</li>\n<li>Tyrosine has a <strong>phenol</strong> ring (benzene + hydroxyl group), formed via the action of <strong>phenylalanine hydroxylase</strong>.</li>\n<li>This reaction is irreversible and requires <strong>tetrahydrobiopterin</strong> as a cofactor.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250813fac3628b-808e-4480-9ebf-50ba6d04f8c0.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Threonine (Option A):</strong> Polar amino acid with a hydroxyl-containing aliphatic side chain; not derived from phenylalanine.</p>\n<p><strong>Histidine (Option B):</strong> Contains an imidazole ring; plays a role in acid-base catalysis, not a hydroxylation product.</p>\n<p><strong>Serine (Option D):</strong> Has a hydroxymethyl group; not related to phenylalanine metabolism.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Tyrosine is synthesised from phenylalanine by hydroxylation of its benzene ring to form a phenol group.</p>", "options": ["Threonine", "Histidine", "Tyrosine", "Serine"], "html_options": ["Threonine", "Histidine", "Tyrosine", "Serine"], "corr_idx": 2}, {"id": "1211369", "html_qtxt": "Which of the following is a nonaromatic amino acid with a hydroxyl R-group?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Threonine is a nonaromatic amino acid that contains a hydroxyl (-OH) group in its side chain.</p>\n<ul>\n<li>Nonaromatic amino acids with hydroxyl groups include <strong>serine</strong> and <strong>threonine</strong>.</li>\n<li>Threonine has a polar, uncharged side chain due to its hydroxyl group.</li>\n<li>It is involved in hydrogen bonding and is important in protein structure and function.</li>\n<li><strong>Aromatic</strong> amino acid with a hydroxyl group-<strong>Tyrosine</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phenylalanine (Option A):</strong> Aromatic amino acid with a benzyl side chain; no hydroxyl group.</p>\n<p><strong>Tyrosine (Option B):</strong> Aromatic amino acid with a phenol group (hydroxyl attached to an aromatic ring).</p>\n<p><strong>Methionine (Option D):</strong> Contains a sulfur (thioether) side chain; lacks a hydroxyl group.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Threonine is a polar, nonaromatic amino acid containing a hydroxyl group in its side chain.</p>", "options": ["Phenylalanine", "Tyrosine", "Threonine", "Methionine"], "html_options": ["Phenylalanine", "Tyrosine", "Threonine", "Methionine"], "corr_idx": 2}, {"id": "1211370", "html_qtxt": "Which of the following is not an aromatic amino acid?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Valine lacks an aromatic ring in its side chain and is classified as a branched-chain, aliphatic, hydrophobic amino acid.</p>\n<ul>\n<li>Valine has a branched aliphatic side chain without any aromatic structure.</li>\n<li><strong>Aromatic amino acids</strong> are those with ring structures that follow Huckel's rule and absorb UV light.</li>\n</ul>\n<p>Aromatic amino acids -</p>\n<ul>\n<li><strong>Histidine</strong>(with Imidazole ring)</li>\n<li><strong>Phenylalanine</strong>(Benzene ring)</li>\n<li><strong>Tyrosine</strong>(Phenol ring)</li>\n<li><strong>Tryptophan</strong>(Indole ring)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phenylalanine (Option A):</strong> Aromatic amino acid with a benzene ring in its side chain.</p>\n<p><strong>Tyrosine (Option B):</strong> An Aromatic amino acid with a phenol group.</p>\n<p><strong>Tryptophan (Option C):</strong> An Aromatic amino acid with an indole ring.</p>", "options": ["Phenylalanine", "Tyrosine", "Tryptophan", "Valine"], "html_options": ["Phenylalanine", "Tyrosine", "Tryptophan", "Valine"], "corr_idx": 3}, {"id": "1211372", "html_qtxt": "Which of the following group contains only nonessential amino acid?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Amino acids in the acidic group (Aspartate and Glutamate) are both nonessential.</strong></p>\n<ul>\n<li>Nutritionally, <strong>acidic amino acids</strong> (Aspartate, Glutamate) are synthesised endogenously and hence are nonessential.</li>\n<li>A group of amino acids that contains <strong>only essential</strong> amino acids is the <strong>branched-chain amino acids</strong> (Leucine, Isoleucine, Valine)</li>\n<li>A group of amino acids that contains <strong>only nonessential</strong> amino acids <strong>is acidic amino acids, amide group-containing&nbsp;amino acids, Imino acids, and simple amino acids.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Basic Amino Acid (Option B):</strong> Includes essential and semi-essential amino acids-hence not entirely nonessential.</p>\n<p><strong>Aromatic Amino Acid (Option C):</strong> Includes essential ones like Phenylalanine and Tryptophan.</p>\n<p><strong>Branched-chain amino acid (Option D):</strong> All three are essential amino acids.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Acidic amino acids form a group where all members are nutritionally nonessential.</p>", "options": ["Acidic Amino Acid", "Basic Amino Acid", "Aromatic Amino Acid", "Branched-chain amino Acid"], "html_options": ["Acidic Amino Acid", "Basic Amino Acid", "Aromatic Amino Acid", "Branched-chain amino Acid"], "corr_idx": 0}, {"id": "1211375", "html_qtxt": "An Amide group containing an amino acid is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glutamine is an amide derivative of glutamate, formed by amidation at the &gamma;-carboxyl group.</p>\n<ul>\n<li>Glutamate is converted to glutamine by the action of <strong>glutamine synthetase</strong>, utilising ATP and ammonium ions.</li>\n<li>This modification introduces an <strong>amide group (-CONH2)</strong> at the side chain.</li>\n<li>Glutamate and aspartate are <strong>acidic amino acids</strong> (contain -COOH in side chains), not amides.</li>\n<li>Asparagine is the amide counterpart of aspartate, while glutamine is the amide of glutamate.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glutamate (Option A):</strong> Acidic amino acid; precursor to glutamine, not an amide.</p>\n<p><strong>Glutamic acid (Option B):</strong> Same as glutamate; acidic, not amide-containing.</p>\n<p><strong>Aspartate (Option D):</strong> Acidic amino acid; amide counterpart is asparagine.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Glutamine and asparagine are the only naturally occurring <strong>amide group-containing amino acids</strong>.</p>", "options": ["Glutamate", "Glutamic acid", "Glutamine", "Aspartate"], "html_options": ["Glutamate", "Glutamic acid", "Glutamine", "Aspartate"], "corr_idx": 2}, {"id": "1211379", "html_qtxt": "Replacing alanine by which amino acid will increase the UV absorbance of proteins at 280 nm wavelength?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Tryptophan has the highest UV absorbance near 280 nm due to its indole ring structure.</p>\n<ul>\n<li>Tryptophan, tyrosine, and phenylalanine are aromatic amino acids that absorb ultraviolet (UV) light between 250-290 nm.</li>\n<li>Tryptophan contributes most to UV absorbance at 280 nm because its indole ring absorbs UV light ~10x more efficiently than either tyrosine or phenylalanine.</li>\n<li>This property is exploited in estimating protein concentration via UV spectrophotometry at 280 nm.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081388a77a12-0e9d-44cd-ad47-746dd5ccce46.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Leucine (Option A):</strong> Aliphatic, non-aromatic amino acid; does not absorb significantly in the UV range.</p>\n<p><strong>Proline (Option B):</strong> A cyclic imino acid without an aromatic ring; no UV absorbance at 280 nm.</p>\n<p><strong>Arginine (Option C):</strong> Basic amino acid with a guanidinium group; lacks a conjugated system needed for UV absorbance.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Tryptophan has the highest absorbance at 280 nm and contributes most to protein UV detection.</p>", "options": ["Leucine", "Proline", "Arginine", "Tryptophan"], "html_options": ["Leucine", "Proline", "Arginine", "Tryptophan"], "corr_idx": 3}, {"id": "1211385", "html_qtxt": "Carboxylation of clotting factors by vitamin K is required to be biologically active. Which of the following amino acid is carboxylated?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Vitamin K</strong> is the cofactor for the <strong>carboxylation of glutamate residues in the postsynthetic modification</strong> of proteins to form the unusual amino acid &gamma;-carboxyglutamate (Gla).</p>\n<ul>\n<li>Initially, vitamin K <strong>hydroquinone is oxidised to the epoxide</strong>, which <strong>activates a glutamate residue</strong>, which reacts <strong>nonenzymatically</strong> with carbon dioxide to form <strong>&gamma;-carboxyglutamate</strong>.</li>\n<li>Vitamin K <strong>epoxide is reduced to the quinone</strong> by a warfarin-sensitive reductase, and the <strong>quinone is reduced to the active hydroquinone</strong> by either the same warfarin-sensitive reductase or a warfarin-insensitive quinone reductase.</li>\n<li>The proteins that are gamma-carboxylated by vitamin K are:\n<ul>\n<li><strong>Clotting factors II, VII, IX, X</strong></li>\n<li><strong>Protein C, Protein S</strong></li>\n<li>Osteocalcin, Nephrocalcin</li>\n<li>Product of gene gas 6</li>\n</ul>\n</li>\n<li><strong>&gamma;-Carboxyglutamate chelates calcium ions</strong>, and so permits the binding of the blood-clotting proteins to membranes.\n<ul>\n<li>The vitamin that acts as a coenzyme for <strong>carboxylation</strong> is <strong>biotin</strong>.</li>\n<li>The vitamin that acts as a coenzyme for <strong>gamma carboxylation</strong> is <strong>vitamin K.</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Histidine (Option A):</strong> Has an imidazole side chain, not carboxylated in this process.</p>\n<p><strong>Histamine (Option B):</strong> This is not an amino acid but a decarboxylation product of histidine.</p>\n<p><strong>Aspartate (Option D):</strong> Acidic amino acid but not a substrate for &gamma;-carboxylation in vitamin K-dependent reactions.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Glutamate residues in specific proteins undergo vitamin K-dependent &gamma;-carboxylation to enable calcium binding for clotting function.</p>", "options": ["Histidine", "Histamine", "Glutamate", "Aspartate"], "html_options": ["Histidine", "Histamine", "Glutamate", "Aspartate"], "corr_idx": 2}, {"id": "1211387", "html_qtxt": "Which of the following is an optically inactive amino acid?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycine is optically inactive because it <strong>lacks a chiral (asymmetric) carbon atom</strong>.</p>\n<ul>\n<li>All standard amino acids except glycine possess a chiral &alpha;-carbon with four different substituents.</li>\n<li>Glycine has two hydrogen atoms attached to the &alpha;-carbon, making it achiral.</li>\n<li>Because of this, glycine does not rotate plane-polarised light, unlike the other amino acids, which are optically active.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Threonine (Option A):</strong> Has two chiral centres and is optically active.</p>\n<p><strong>Tyrosine (Option B):</strong> Contains an asymmetric carbon and thus is optically active.</p>\n<p><strong>Valine (Option C):</strong> Also has a chiral &alpha;-carbon, hence optically active.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Glycine is the only optically inactive standard amino acid due to its achiral &alpha;-carbon.</p>", "options": ["Threonine", "Tyrosine", "Valine", "Glycine"], "html_options": ["Threonine", "Tyrosine", "Valine", "Glycine"], "corr_idx": 3}, {"id": "1211389", "html_qtxt": "All biologically active amino acids are:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>L-forms of amino acids are biologically active and serve as the structural units of proteins.</p>\n<ul>\n<li>The <strong>L-amino acids</strong> occur in nature and are therefore called <strong>natural amino acids. L-&alpha;-Amino acids fulfil vital metabolic roles</strong> in addition to serving as the \"building blocks\" of proteins.</li>\n<li>L- amino acids are biologically active.</li>\n<li><strong>D-amino acids</strong> are seen in small amounts in <strong>micro-organisms</strong> and as constituents of certain <strong>antibiotics such as Gramicidin-S, Polymyxin, Actinomycin-D and Valinomycin</strong>, as well as bacterial cell wall peptidoglycans. D-amino acids have multiple functions in bacteria, like the synthesis of cross-links in the cell wall. <strong>(Other options ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>L-amino acids are the only biologically active forms used in human protein synthesis.</p>", "options": ["L-forms", "D-forms", "Mostly D-forms", "D- and L- forms"], "html_options": ["L-forms", "D-forms", "Mostly D-forms", "D- and L- forms"], "corr_idx": 0}, {"id": "1211390", "html_qtxt": "The flexibility of protein depends on:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glycine, due to its minimal side chain (-H), provides maximal conformational flexibility and is frequently found in bends and &beta;-turns.</p>\n<ul>\n<li><strong>Glycine</strong>, having the <strong>smallest R group,</strong> fits into small spaces and <strong>induces bends in the alpha helix</strong>.</li>\n<li>Glycine is <strong>usually present in beta turns</strong>.</li>\n<li>Roughly half of the residues in a \"typical\" globular protein reside in &alpha; helices or &beta; sheets, and half in loops, turns, bends, and other extended conformational features.</li>\n<li>Turns and bends refer to short segments of amino acids that join two units of the secondary structure, such as two adjacent strands of an antiparallel &beta; sheet.</li>\n<li>A <strong>&beta; turn</strong> involves four aminoacyl residues, in which the first residue is hydrogen-bonded to the fourth, <strong>resulting in a tight 180&deg; turn</strong>.</li>\n<li>Proline and glycine are often present in &beta; turns.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Tryptophan (Option A):</strong> Bulky aromatic side chain; stabilises protein core but is not involved in flexibility.</p>\n<p><strong>Phenylalanine (Option B):</strong> Large nonpolar aromatic residue; provides hydrophobic interactions, not flexibility.</p>\n<p><strong>Histidine (Option D):</strong> Polar and often found at active sites, but not a major contributor to protein flexibility.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Glycine's small side chain allows proteins to adopt flexible conformations, especially in &beta;-turns and tight bends.</p>", "options": ["Glycine", "Tryptophan", "Phenylalanine", "Histidine"], "html_options": ["Glycine", "Tryptophan", "Phenylalanine", "Histidine"], "corr_idx": 0}]}, {"moduleId": 1010134, "name": "Biosynthesis of amino acids, collagen ", "questions": [{"id": "1192015", "html_qtxt": "Which of the following oxidases is not a flavoprotein?", "html_expl": "<p><strong>Explanation:</strong></p><p>Cytochrome oxidase is not a flavoprotein; it is a <strong>hemoprotein</strong> containing heme groups and copper, not flavin cofactors.</p>\r\n<ul>\r\n<li>Flavoprotein enzymes contain <strong>flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD) as prosthetic groups.</strong></li>\r\n<li>FMN and FAD are formed in the body from the vitamin riboflavin.</li>\r\n<li>FMN and FAD are usually tightly, but not covalently, bound to their respective apoenzyme proteins. Metalloflavoproteins contain one or more metals as essential cofactors.</li>\r\n</ul>\r\n<p>Examples of flavoprotein oxidases include</p>\r\n<ol>\r\n<li><strong>Aldehyde dehydrogenase, </strong>an FAD-linked enzyme present in mammalian livers, which contains molybdenum and nonheme iron and acts on aldehydes and heterocyclic substrates <strong>(Option A ruled out).</strong></li>\r\n<li><strong>L-amino acid oxidase, </strong>an enzyme found in the kidney with general specificity for the oxidative deamination of the naturally occurring L-amino acids <strong>(Option C ruled out)</strong>.</li>\r\n<li><strong>Xanthine oxidase, </strong>which contains molybdenum and plays an important role in the conversion of purine bases to uric acid, is of particular significance in uricotelic animals <strong>(Option D ruled out)</strong>.</li>\r\n</ol>\r\n<p><strong>Cytochrome Oxidase </strong></p>\r\n<ul>\r\n<li>Cytochrome oxidase is a hemoprotein widely distributed in many tissues, having the typical heme prosthetic group present in myoglobin, haemoglobin, and other cytochromes.</li>\r\n<li>It is the terminal component of the chain of respiratory carriers found in mitochondria and transfers electrons resulting from the oxidation of substrate molecules by dehydrogenases to their final acceptor, oxygen.</li>\r\n<li>The action of the enzyme is blocked by carbon monoxide, cyanide, and hydrogen sulfide, and this causes poisoning by preventing cellular respiration.</li>\r\n<li>The cytochrome oxidase enzyme complex comprises heme a3 combined with another heme, heme a, in a single protein and so is also termed cytochrome aa3.</li>\r\n<li>It contains two molecules of heme, each having one Fe atom that oscillates between Fe3+ and Fe2+ during oxidation and reduction. Furthermore, two atoms of copper are present, one associated with each heme unit.</li>\r\n</ul>", "options": ["Aldehyde dehydrogenase", "Cytochrome oxidase", "L-amino acid oxidase", "Xanthine oxidase"], "html_options": ["Aldehyde dehydrogenase", "Cytochrome oxidase", "L-amino acid oxidase", "Xanthine oxidase"], "corr_idx": 1}, {"id": "1211320", "html_qtxt": "Which amino acid can protonate and deprotonate at neutral pH?", "html_expl": "<p><strong>Explanation:</strong></p><p>Histidine has an imidazole side chain with a <strong>pKa around 6.0-7.0</strong>, allowing it to <strong>exist in both protonated and deprotonated forms at physiological pH (~7.0)</strong>. This property enables histidine to act as an effective <strong>biological buffer</strong> and participate in enzymatic catalysis via acid-base reactions.</p>\r\n<ul>\r\n<li>Amino acids that can protonate and deprotonate are those that can act as a <strong>buffer</strong>.</li>\r\n<li>An amino acid whose <strong>pKa = pH</strong>of the medium has <strong>maximum buffering capacity</strong>.</li>\r\n<li>pKa of the imidazole group of histidine is 6.5-7.4.</li>\r\n<li>At pH = 7, the Imidazole group of <strong>histidine</strong>can act as a buffer.</li>\r\n<li>This is important in proteins where histidine side chains help stabilise local pH and are often found in active sites of enzymes.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Leucine (Option B):</strong> Aliphatic amino acid with non-ionizable side chain; <strong>no buffering near pH 7</strong>.</p>\r\n<p><strong>Glycine (Option C):</strong> No ionizable side chain; only &alpha;-amino and &alpha;-carboxyl groups present; <strong>no effective buffer at pH 7</strong>.</p>\r\n<p><strong>Arginine (Option D):</strong> Has a guanidino group with a <strong>high pKa (~12.5)</strong>; remains protonated at pH 7; <strong>not suitable for buffering at neutral pH</strong>.</p>", "options": ["Histidine", "Leucine", "Glycine", "Arginine"], "html_options": ["Histidine", "Leucine", "Glycine", "Arginine"], "corr_idx": 0}, {"id": "1211321", "html_qtxt": "Which of the following amino acids is purely ketogenic?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Leucine yields <strong>only acetyl-CoA</strong> on oxidation, which <strong>cannot be converted to glucose</strong>, making it <strong>purely ketogenic</strong>. It does not yield any intermediates that can enter the gluconeogenic pathway.</p>\n<ul>\n<li>Based on metabolism, amino acids can be classified into -\n<ol>\n<li><strong>Ketogenic</strong>- These amino acids yield <strong>only acetyl-CoA</strong> on oxidation, which cannot be used for gluconeogenesis. Ex: <strong>Lysine and leucine</strong></li>\n<li><strong>Ketogenic and glucogenic</strong>- Yield both acetyl-CoA and intermediates that can be used for gluconeogenesis. Ex: <strong>Phenylalanine, tyrosine, tryptophan, and isoleucine</strong></li>\n<li><strong>Glucogenic</strong>- These amino acids yield only pyruvate, or four- and five-carbon intermediates of the citric acid cycle, which can be used for gluconeogenesis. Ex: All the remaining amino acids</li>\n</ol>\n</li>\n<li><strong>Leucine and lysine</strong> are the <strong>only purely ketogenic amino acids</strong>.</li>\n<li>Acetyl-CoA cannot be used for gluconeogenesis due to the <strong>irreversible nature</strong> of the pyruvate dehydrogenase reaction and the <strong>loss of carbon as CO&#8322;</strong> during TCA cycle entry.</li>\n<li>Hence, substrates like fatty acids or amino acids that yield only acetyl-CoA cannot contribute to net glucose formation.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Valine (Option A): </strong>Glucogenic; yields succinyl-CoA, a TCA intermediate; <strong>can contribute to glucose synthesis</strong>.</p>\n<p><strong>Isoleucine (Option B):</strong> Both glucogenic and ketogenic; yields <strong>acetyl-CoA and succinyl-CoA</strong>.</p>\n<p><strong>Alanine</strong> (<strong>Option C):</strong> Glucogenic; converted to <strong>pyruvate</strong>, a key gluconeogenic substrate.</p>", "options": ["Valine", "Isoleucine", "Alanine", "Leucine"], "html_options": ["Valine", "Isoleucine", "Alanine", "Leucine"], "corr_idx": 3}, {"id": "1211326", "html_qtxt": "Increased alanine during prolonged fasting represents:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>During prolonged fasting, there is a <strong>mobilization of amino acids from skeletal muscle</strong>, especially alanine.</p>\n<ul>\n<li>This alanine is transported to the liver, where it enters the <strong>glucose-alanine cycle (Cahill cycle)</strong>.</li>\n<li>In this cycle, alanine is transaminated to pyruvate, which is used for <strong>gluconeogenesis</strong> to maintain blood glucose levels.</li>\n<li>The increase in plasma alanine is a physiological adaptation to <strong>support hepatic glucose output</strong>.</li>\n<li>This mechanism provides a <strong>non-carbohydrate source of glucose</strong> during fasting states.</li>\n<li>Alanine is a key gluconeogenic substrate formed in muscle and transported to the liver.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508118o3V1.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Impaired renal function (Option B):</strong> Affects urea excretion but is not the primary reason for elevated alanine in fasting.</p>\n<p><strong>Decreased utilization of amino acid from gluconeogenesis (Option C):</strong> In fasting, utilization increases, not decreases.</p>\n<p><strong>Leakage of amino acids from cells (Option D):</strong> Seen in trauma or cell injury, not a feature of normal fasting metabolism.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>An increase in Alanine in fasting reflects muscle protein breakdown for hepatic gluconeogenesis.</p>", "options": ["Increased breakdown of muscle proteins", "Impaired renal function", "Decreased utilization of amino acid from Gluconeogenesis", "Leakage of amino acids from cells due to plasma membrane damage"], "html_options": ["Increased breakdown of muscle proteins", "Impaired renal function", "Decreased utilization of amino acid from Gluconeogenesis", "Leakage of amino acids from cells due to plasma membrane damage"], "corr_idx": 0}, {"id": "1211328", "html_qtxt": "Transfer of an amino group from an amino acid to an alpha-keto acid is done by:", "html_expl": "<p><strong>Explanation:</strong></p><p>Transamination is the reversible process by which an amino group from an amino acid is transferred to an &alpha;-keto acid, forming a new amino acid and a new &alpha;-keto acid. This reaction is catalyzed by transaminases (aminotransferases).</p>\n<ul>\n<li>It is the first step in amino acid catabolism.</li>\n<li>It usually involves &alpha;-ketoglutarate as the amino group acceptor, forming glutamate.</li>\n<li>Requires<strong> pyridoxal phosphate</strong>(PLP), a derivative of vitamin B6, which is present at the catalytic site of all aminotransferases, and acts as a coenzyme.</li>\n<li>It is essential for routing nitrogen into amino acid metabolism and gluconeogenesis.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508111ZqIk.png\">\n<ul>\n<li>Transamination occurs via a <strong>ping-pong mechanism</strong>characterized by the alternate addition of a substrate and release of a product.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Aminases (Option B):</strong> Not involved in transamination; they catalyze the addition of ammonia to compounds.</p>\n<p><strong>Transketolases (Option C):</strong> Enzymes of the pentose phosphate pathway; transfer two-carbon fragments, not amino groups.</p>\n<p><strong>Deaminases (Option D):</strong> Remove amino groups as free ammonia, unlike transaminases, which transfer them to another molecule.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Transamination is catalyzed by transaminases and is essential for amino acid catabolism and nitrogen redistribution.</p>", "options": ["Transaminases", "Aminases", "Transketolases", "Deaminases"], "html_options": ["Transaminases", "Aminases", "Transketolases", "Deaminases"], "corr_idx": 0}, {"id": "1211330", "html_qtxt": "The amino acid that serves as a carrier of ammonia from skeletal muscle to the liver is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Alanine is synthesized in skeletal muscle by transamination of glucose-derived pyruvate and released into the blood, where it is taken up by the liver. In the liver, alanine is deaminated, and its carbon skeleton is used for gluconeogenesis, while the amino group enters the urea cycle. This is the basis of the glucose-alanine<em> cycle</em>.</p>\n<ul>\n<li>Skeletal muscle uses alanine to transport ammonia and pyruvate to the liver.</li>\n<li>The liver converts alanine into glucose (via gluconeogenesis) and disposes of nitrogen via the urea cycle.</li>\n<li>This process maintains nitrogen balance and glucose supply during fasting or exercise.</li>\n<li>The transport form of ammonia from most tissues, including the brain, is glutamine, but the transport form of ammonia from skeletal muscle is alanine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Methionine (Option B):</strong> Essential sulfur-containing amino acid; not involved in ammonia transport.</p>\n<p><strong>Arginine (Option C):</strong> Precursor in the urea cycle; involved in nitrogen disposal, not nitrogen transport from muscle.</p>\n<p><strong>Glutamine (Option D):</strong> Major ammonia transporter from most tissues (especially brain and gut), but not the primary form from skeletal muscle.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Alanine is the major amino acid that carries ammonia from skeletal muscle to the liver via the glucose-alanine cycle.</p>", "options": ["Alanine", "Methionine", "Arginine", "Glutamine"], "html_options": ["Alanine", "Methionine", "Arginine", "Glutamine"], "corr_idx": 0}, {"id": "1211332", "html_qtxt": "Glutamine in blood acts as:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glutamine serves as the major non-toxic carrier of ammonia in the blood. It is synthesized in tissues like muscle and brain and is taken up by the gut and kidney, where it contributes ammonia for excretion or metabolism.</p>\n<ul>\n<li>Glutamine acts as a safe storage and transport form of ammonia.</li>\n<li>It buffers toxic ammonia in tissues and carries it to sites of excretion (kidneys) or metabolism (liver).</li>\n<li>It also supports interorgan nitrogen exchange and contributes to acid-base balance.</li>\n<li>In addition to providing glutamine to serve as a <strong>carrier of nitrogen</strong>, carbon and energy between organs, glutamine synthase plays a major role in <strong>ammonia</strong><strong>detoxification and acid-base homeostasis.</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>An intermediate in the purine salvage pathway (Option B):</strong> Glutamine contributes nitrogen in purine biosynthesis, not the salvage pathway. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) handles salvage, not glutamine.</p>\n<p><strong>Major substrate for gluconeogenesis in the brain (Option C):</strong> The Brain primarily uses glucose and ketone bodies; glutamine is not a key gluconeogenic substrate in the brain.</p>\n<p><strong>Regulator of mitochondrial oxidative phosphorylation (Option D):</strong> Glutamine metabolism may influence cellular energy indirectly, but it is not a direct regulator of oxidative phosphorylation.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Glutamine is the principal transporter of ammonia from most tissues, maintaining nitrogen balance and preventing toxicity.</p>", "options": ["Carrier of neurotoxic nitrogenous waste", "An intermediate in the purine salvage pathway", "Major substrate for gluconeogenesis in the brain", "Regulator of mitochondrial oxidative phosphorylation"], "html_options": ["Carrier of neurotoxic nitrogenous waste", "An intermediate in the purine salvage pathway", "Major substrate for gluconeogenesis in the brain", "Regulator of mitochondrial oxidative phosphorylation"], "corr_idx": 0}, {"id": "1211334", "html_qtxt": "Amino acid absorption is by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Free amino acids are absorbed across the intestinal mucosa by&nbsp;<strong>sodium-dependent active transport</strong>.</p>\n<ul>\n<li>There are several different amino acid transporters, with specificity for the nature of the amino acid side-chain.</li>\n</ul>\n<p><strong>Meister's Cycle -</strong></p>\n<ul>\n<li>For <strong>absorption of neutral amino acids</strong>from the intestines, kidney tubules and brain.</li>\n<li>The main role is played by <strong>Glutathione</strong>. (GSH)</li>\n<li>For the transport of 1 amino acid and the regeneration of GSH, 3 ATPs are required.</li>\n</ul>\n<p>Disorders associated with Meister's Cycle are <strong>oxoprolinuria</strong> due to deficiency of 5-oxoprolinase.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Facilitated transport (Option A): </strong>This is a passive, carrier-mediated process <strong>without energy</strong> involvement. Amino acid absorption, however, requires <strong>active, energy-dependent</strong> transport.</p>\n<p><strong>Passive transport (Option B): </strong>Amino acid absorption does <strong>not</strong> occur through simple diffusion or passive mechanisms due to their polarity and size.</p>\n<p><strong>Pinocytosis (Option D): </strong>This bulk transport process is <strong>not the major route</strong> for amino acid absorption, although some large peptides might be taken up via this or similar mechanisms.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Amino acids are absorbed by sodium-dependent <strong>active transport</strong> systems in the small intestine, with carrier specificity based on amino acid properties.</p>", "options": ["Facilitated transport", "Passive transport", "Active transport", "Pinocytosis"], "html_options": ["Facilitated transport", "Passive transport", "Active transport", "Pinocytosis"], "corr_idx": 2}, {"id": "1211337", "html_qtxt": "Which of the following is the major end product of nitrogen metabolism in humans?", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Urea</strong> is the major end product of nitrogen catabolism in humans; humans are ureotelic.</p>\r\n<ul>\r\n<li><strong>Urea</strong> is the major nitrogenous waste product in humans, formed through a <strong>four-stage process</strong> involving:</li>\r\n</ul>\r\n<ol>\r\n<li><strong>Transamination</strong></li>\r\n<li><strong>Oxidative deamination of glutamate</strong></li>\r\n<li><strong>Ammonia transport</strong></li>\r\n<li><strong>Urea cycle reactions in the liver</strong></li>\r\n</ol>\r\n<ul>\r\n<li>Humans are <strong>ureotelic</strong> organisms, meaning they convert excess nitrogen (from amino acid catabolism) into <strong>urea</strong>, which is water-soluble and excreted through the urine.</li>\r\n<li>Expression of urea cycle enzymes increases during <strong>starvation</strong>, reflecting enhanced protein catabolism for energy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Uric acid (Option A): </strong>This is the major nitrogenous waste product in <strong>birds and reptiles</strong> (uricotelic animals). In humans, it is a minor product primarily from <strong>purine metabolism</strong>.</p>\r\n<p><strong>NH<sub>4</sub> (Ammonia) (Option C): </strong>Ammonia is highly <strong>toxic</strong> and is rapidly converted to urea in humans for safe excretion.</p>\r\n<p><strong>NH<sub>4</sub><sup>+</sup> (Ammonium ion) (Option D): </strong>Though ammonium ions are formed in tissues and transported (e.g., via glutamine), they are <strong>not the main excretory product</strong>.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<p><strong>Urea</strong> is the principal excretory form of nitrogen in humans, synthesized via the urea cycle in the liver.</p>", "options": ["Uric acid", "Urea", "NH3", "NH4+"], "html_options": ["Uric acid", "Urea", "NH3", "NH4+"], "corr_idx": 1}, {"id": "1211338", "html_qtxt": "Urea is the major end product of nitrogen metabolism. Synthesis of 1 mol of urea requires", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>All the listed components are essential for the synthesis of 1 mole of urea in humans. Urea formation involves:</p>\n<ul>\n<li><strong>4 ATP molecules</strong> (3 ATP hydrolyzed: 2 by CPS I and 1 by argininosuccinate synthetase, which breaks down to AMP + PPi)</li>\n<li><strong>1 mol of ammonium ion (NH<sub>4</sub><sup>+</sup>)</strong> and <strong>1 mol of aspartate</strong> as nitrogen donors</li>\n<li><strong>Five key enzymes</strong> of the urea cycle:\n<ol>\n<li>Carbamoyl phosphate synthetase I</li>\n<li>Ornithine transcarbamoylase</li>\n<li>Argininosuccinate synthetase</li>\n<li>Argininosuccinate lyase</li>\n<li>Arginase</li>\n</ol>\n</li>\n<li><strong>N-acetylglutamate</strong> is not a substrate but an <strong>essential activator</strong> of CPS I (carbamoyl phosphate synthetase I).</li>\n<li>The amino acids involved in the urea cycle mainly serve as <strong>nitrogen carriers</strong>.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811Lezxy.png\">\n<p><strong>Key Takeaways:</strong></p>\n<p>Synthesis of 1 mol of urea requires 4 ATP, 1 mol of NH&#8324;&#8314;, 1 mol of aspartate, and five key enzymes.</p>", "options": ["4 mol of ATP", "1 mol of ammonium ion", "Five enzymes", "All of the above"], "html_options": ["4 mol of ATP", "1 mol of ammonium ion", "Five enzymes", "All of the above"], "corr_idx": 3}, {"id": "1211339", "html_qtxt": "Which enzyme of the urea cycle is a hydrolase?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Arginase</strong> is a <strong>hydrolase enzyme</strong> in the urea cycle. It catalyses the <strong>hydrolytic cleavage of the guanidino group</strong> of <strong>arginine</strong> to form <strong>urea</strong> and <strong>ornithine</strong>, marking the final step in urea synthesis.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811VjQZG.png\">\n<ul>\n<li><strong>Arginase</strong> cleaves arginine with the addition of water (hydrolysis).</li>\n<li>Ornithine formed re-enters mitochondria to participate in additional cycles.</li>\n<li>Ornithine and lysine <strong>competitively inhibit</strong></li>\n<li>Arginase activity is crucial for disposing of excess nitrogen as urea.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Ornithine Transcarbamoylase (Option A): </strong><em>Transferase</em>; catalyzes the transfer of a carbamoyl group from carbamoyl phosphate to ornithine, forming citrulline.</p>\n<p><strong>Glutamate Synthase (Option C): </strong>Catalyzes the formation of glutamate from glutamine and &alpha;-ketoglutarate.</p>\n<p><strong>Argininosuccinase (Option D): </strong><em>Lyase</em>; catalyzes cleavage of argininosuccinate to arginine and fumarate, without hydrolysis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Arginase is the only <strong>hydrolase enzyme</strong> of the urea cycle, catalysing the final step that releases urea.</p>", "options": ["Ornithine Transcarbamoylase", "Arginase", "Glutamate Synthase", "Arginosuccinase."], "html_options": ["Ornithine Transcarbamoylase", "Arginase", "Glutamate Synthase", "Arginosuccinase."], "corr_idx": 1}, {"id": "1211341", "html_qtxt": "Carbamoyl phosphate synthase 1 is the pacemaker enzyme of the Urea Cycle. The activity of this enzyme is determined by", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Carbamoyl Phosphate Synthase I</strong>&nbsp;is the pacemaker (<strong>rate-limiting</strong>) enzyme of the urea cycle.</p>\n<ul>\n<li>The activity of carbamoyl phosphate synthase I is&nbsp;<strong>determined by N-acetyl glutamate</strong>, whose steady-state level is dictated by the balance between -\n<ul>\n<li>Its rate of synthesis from acetyl-CoA and glutamate (catalyzed by N-acetylglutamate synthase).</li>\n<li>Its rate of hydrolysis to acetate and glutamate (catalyzed by N-acetylglutamate deacylase (hydrolase)).</li>\n</ul>\n</li>\n</ul>\n<p>N-acetylglutamate enhances CPS I&rsquo;s affinity for ATP.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Glutamine (Option A): </strong>Not the direct activator of CPS I; used as a nitrogen donor in <strong>CPS II</strong>, which functions in pyrimidine synthesis.</p>\n<p><strong>Acetyl-CoA (Option C):</strong> It is a <strong>precursor</strong> in the synthesis of N-acetylglutamate but not the activator itself.</p>\n<p><strong>Acetate (Option D):</strong> It is a <strong>product</strong> of N-acetylglutamate hydrolysis, not a regulator or activator of CPS I.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>N-acetylglutamate</strong> is the allosteric activator of <strong>CPS I</strong>, the pacemaker enzyme of the urea cycle.</p>", "options": ["Glutamine", "N-acetyl glutamate", "Acetyl CoA", "Acetate"], "html_options": ["Glutamine", "N-acetyl glutamate", "Acetyl CoA", "Acetate"], "corr_idx": 1}, {"id": "1211343", "html_qtxt": "Following is the site for the urea cycle", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Urea synthesis takes place <strong>both in the mitochondria and the cytosol of hepatocytes</strong>.</p>\n<ul>\n<li>The <strong>first two steps</strong> of the urea cycle - catalyzed by <strong>carbamoyl phosphate synthetase I (CPS I)</strong> and <strong>ornithine transcarbamoylase (OTC)</strong> - occur in the <strong>mitochondrial matrix</strong>.</li>\n<li>The remaining steps - conversion of citrulline to argininosuccinate, cleavage to arginine and fumarate, and hydrolysis of arginine to urea and ornithine - occur in the <strong>cytosol</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>The <strong>urea cycle is compartmentalized</strong> between the <strong>liver mitochondria and cytosol</strong>, with specific steps in each.</p>", "options": ["Liver cytosol", "Liver mitochondria", "Liver cytosol and mitochondria", "None of above"], "html_options": ["Liver cytosol", "Liver mitochondria", "Liver cytosol and mitochondria", "None of above"], "corr_idx": 2}, {"id": "1211344", "html_qtxt": "A 4-day-old male neonate is brought in with poor feeding, lethargy, and vomiting. On examination, he has hypotonia and signs of encephalopathy. Arterial blood gas shows respiratory alkalosis. Serum ammonia levels are markedly elevated. Which of the following conditions is the most likely cause?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Ornithine transcarbamoylase (OTC) deficiency, the most common urea cycle disorder, leads to severe hyperammonemia due to the inability to incorporate ammonia into the urea cycle.</p>\n<ul>\n<li>Urea cycle disorders present with <strong>hyperammonemia</strong>, <strong>encephalopathy</strong>, and <strong>respiratory alkalosis</strong>, often in the <strong>first few days of life</strong>.</li>\n<li>OTC deficiency is <strong>X-linked</strong> and affects the <strong>second reaction</strong> of the urea cycle, converting carbamoyl phosphate and ornithine into citrulline.</li>\n<li>Accumulation of ammonia and glutamine occurs due to impaired urea formation.</li>\n<li>Ammonia intoxication is most severe when the metabolic block occurs at reactions 1 or 2, for if citrulline can be synthesised, some ammonia has already been removed by being covalently linked to an organic metabolite.</li>\n<li>Mothers heterozygous for OTC deficiency may also show mild hyperammonemia and aversion to high-protein diets.</li>\n<li><strong>The urea cycle</strong> converts toxic ammonia to urea in the <strong>liver</strong>.</li>\n<li>OTC catalyses the second step in the <strong>mitochondrial matrix</strong>, converting carbamoyl phosphate + ornithine &rarr; citrulline.</li>\n<li><strong>Deficiency of OTC</strong> causes ammonia to accumulate in the blood, leading to <strong>neurological toxicity</strong>.</li>\n<li>Enzyme defects in the first two steps (CPS I and OTC) cause the <strong>most severe </strong>hyperammonemia.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Galactosemia (Option B):</strong> Carbohydrate metabolism disorder; leads to hypoglycemia, hepatomegaly, and cataracts, not primarily hyperammonemia.</p>\n<p><strong>Histidinemia (Option C):</strong> A rare amino acid metabolism disorder with a benign course; does not cause hyperammonemia.</p>\n<p><strong>Phenylketonuria (Option D):</strong> Disorder of phenylalanine metabolism; causes intellectual disability and seizures, but not elevated ammonia.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Ornithine transcarbamoylase deficiency</strong> is the most common urea cycle disorder and presents with <strong>hyperammonemia and encephalopathy</strong> in neonates.</p>", "options": ["Ornithine transcarbamoylase deficiency", "Galactosemia", "Histidinemia", "Phenylketonuria"], "html_options": ["Ornithine transcarbamoylase deficiency", "Galactosemia", "Histidinemia", "Phenylketonuria"], "corr_idx": 0}, {"id": "1211345", "html_qtxt": "A 2-year-old female child presents with recurrent episodes of vomiting, irritability, and lethargy. She has signs of developmental delay and mental retardation. On examination, she is encephalopathic, and arterial blood gas reveals respiratory alkalosis. Laboratory investigations show elevated plasma ammonia levels. Empirical treatment with a urea cycle intermediate results in clinical improvement. Which of the following enzyme deficiencies is most likely responsible for her condition?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The clinical response to N-acetylglutamate administration strongly indicates <strong>N-acetylglutamate synthase (NAGS) deficiency</strong>, as N-acetylglutamate is a mandatory allosteric activator of <strong>carbamoyl phosphate synthetase I (CPS I)</strong>, the rate-limiting enzyme of the urea cycle.</p>\n<ul>\n<li>Clinical symptoms common to all urea cycle disorders include vomiting, intermittent ataxia, irritability, lethargy, and severe mental retardation.</li>\n<li>The most dramatic clinical presentation occurs in full-term infants who initially appear normal, then exhibit progressive lethargy, hypothermia, and apnea due to high plasma ammonia levels.</li>\n<li>The clinical features and treatment of all five disorders are similar. Significant improvement and minimisation of brain damage can accompany a <strong>low-protein</strong><strong>diet</strong>&nbsp;ingested as frequent small meals to avoid sudden increases in blood ammonia levels.</li>\n<li>The goal of dietary therapy is to provide sufficient protein, arginine, and energy to promote growth and development while simultaneously minimising the metabolic perturbations.</li>\n</ul>\n<p><strong>N-Acetylglutamate Synthase (NAGS) -</strong></p>\n<ul>\n<li>Catalyses the&nbsp;<strong>formation of N-acetylglutamate</strong>(essential for carbamoyl phosphate synthase I activity) from acetyl-CoA and glutamate.</li>\n<li>L-Glutamate + Acetyl-CoA &rarr; N-acetyl-L-glutamate + CoASH</li>\n<li>While the clinical and biochemical features of NAGS deficiency are indistinguishable from those arising from a defect in carbamoyl phosphate synthase I, a <strong>deficiency in NAGS may respond to the administration of N-acetyl glutamate.</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Ornithine transcarbamoylase deficiency (Option A): </strong>X-linked disorder; causes hyperammonemia but does not improve with N-acetylglutamate. Defect in reaction 2 of the urea cycle (ornithine + carbamoyl phosphate &rarr; citrulline).</p>\n<p><strong>Arginase deficiency (Option C): </strong>Manifests later in life with progressive spasticity and elevated arginine; ammonia levels, mildly elevated. Affects the final step of the urea cycle (arginine &rarr; ornithine + urea).</p>\n<p><strong>Argininosuccinate synthase deficiency (Option D): </strong>Results in citrullinemia with high citrulline levels and hyperammonemia; does not respond to N-acetylglutamate. Blocks the conversion of citrulline + aspartate &rarr; argininosuccinate.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>N-acetylglutamate synthase deficiency mimics carbamoyl phosphate synthetase I deficiency but is uniquely treatable with N-acetylglutamate administration.</p>", "options": ["Ornithine transcarbamoylase deficiency", "N Acetylglutamate synthase deficiency", "Arginase deficiency", "Argininosuccinate synthase deficiency"], "html_options": ["Ornithine transcarbamoylase deficiency", "N Acetylglutamate synthase deficiency", "Arginase deficiency", "Argininosuccinate synthase deficiency"], "corr_idx": 1}, {"id": "1211347", "html_qtxt": "Which of the following enzyme(s) is involved in the Urea Cycle?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Argininosuccinate synthetase is a cytosolic enzyme of the urea cycle that catalyses the condensation of citrulline and aspartate to form argininosuccinate, contributing the second nitrogen to urea.</p>\n<ul>\n<li>Glutamate Dehydrogenase - Oxidative deamination <strong>(Option A ruled out)</strong></li>\n<li>Argininosuccinate Synthetase - Urea Cycle</li>\n<li>Alpha Ketoglutarate Dehydrogenase and Isocitrate Dehydrogenase -TCA Cycle <strong>(Option C ruled out)</strong></li>\n<li>Fumarase -TCA Cycle<strong> (Option D ruled out)</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811b6wWo.png\">\n<p><strong>Reactions of the Urea Cycle -</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811oKX2H.png\">\n<p><strong>Key Takeaways:</strong></p>\n<p>Argininosuccinate synthetase is a central cytosolic enzyme in the urea cycle and catalyses a reaction that contributes to the second nitrogen atom in urea synthesis.</p>", "options": ["Glutamate Dehydrogenase", "Argininosuccinate Synthetase", "Alpha Ketoglutarate Dehydrogenase", "Isocitrate Dehydrogenase"], "html_options": ["Glutamate Dehydrogenase", "Argininosuccinate Synthetase", "Alpha Ketoglutarate Dehydrogenase", "Isocitrate Dehydrogenase"], "corr_idx": 1}, {"id": "1211349", "html_qtxt": "Glutamate dehydrogenase in mitochondria is activated by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Glutamate dehydrogenase (GDH) is a key mitochondrial enzyme involved in nitrogen metabolism and amino acid biosynthesis. It catalyses the oxidative deamination of glutamate to &alpha;-ketoglutarate and ammonia.</p>\n<ul>\n<li>GDH is <strong>allosterically activated by ADP</strong>, which signals low energy and promotes amino acid catabolism for energy production.</li>\n<li>It is <strong>inhibited by ATP, GTP, and NADH</strong>, reflecting high-energy states to reduce amino acid breakdown.</li>\n<li><strong>Glutamate Dehydrogenase (GDH):</strong>\n<ul>\n  <li>An enzyme that catalyses:<br /> <strong>L-Glutamate &rlhar; &alpha;-Ketoglutarate + NH&#8323;</strong></li>\n<li>Located in the mitochondria of the liver and other tissues.</li>\n  <li>Uses <strong>either NAD&#8314; or NADP&#8314;</strong> as a cofactor.</li>\n<li>Plays a central role in <strong>transdeamination</strong>: coordinated action of transaminases and GDH releases amino nitrogen as ammonia.</li>\n<li><strong>The reversible</strong> reaction also supports amino acid biosynthesis in anabolic conditions.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>ATP (Option A):</strong> Allosteric inhibitor of GDH; indicates high energy state, suppresses amino acid breakdown.</p>\n<p><strong>GTP (Option B):</strong> Strong inhibitor of GDH; similar regulatory role as ATP.</p>\n<p><strong>NADH (Option C):</strong> Product of the reaction and feedback inhibitor; high NADH levels signal a reduced need for NADH production.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Mitochondrial glutamate dehydrogenase is activated by ADP and inhibited by ATP, GTP, and NADH, thereby coupling nitrogen metabolism with cellular energy status.</p>", "options": ["ATP", "GTP", "NADH", "ADP"], "html_options": ["ATP", "GTP", "NADH", "ADP"], "corr_idx": 3}, {"id": "1211351", "html_qtxt": "Nitrogen atoms of urea are contributed by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The two nitrogen atoms in urea come from:</p>\n<ul>\n<li><strong>Ammonium ion</strong> (NH&#8324;&#8314;): contributed via the <strong>Carbamoyl Phosphate Synthetase I (CPS-I)</strong> reaction in the mitochondria.</li>\n<li><strong>Aspartate</strong>: provides the second nitrogen through the <strong>Argininosuccinate Synthetase</strong> step in the cytoplasm.</li>\n</ul>\n<p><strong>The urea cycle</strong> is the primary pathway for ammonia detoxification.</p>\n<ul>\n<li>It occurs partly in the <strong>mitochondria</strong> (CPS-I, OTC steps) and partly in the <strong>cytosol</strong> (rest of the steps).</li>\n<li><strong>The first nitrogen</strong> comes from the free ammonium ion converted to <strong>carbamoyl phosphate</strong> by <strong>CPS-I</strong>.</li>\n<li><strong>The second nitrogen</strong> is provided by <strong>aspartate</strong>, which combines with <strong>citrulline</strong> via <strong>argininosuccinate synthetase</strong>.</li>\n<li>The carbon in urea is derived from <strong>CO&#8322;</strong>.</li>\n<li>The cycle ultimately forms <strong>urea</strong> and <strong>regenerates ornithine</strong>.</li>\n<li>Overall reaction (simplified):</li>\n</ul>\n<p>NH&#8324;&#8314; + CO&#8322; + Aspartate + 3 ATP &rarr; Urea + Fumarate + 2 ADP + AMP + PPi + 2 Pi</p>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508117qQ8J.png\">\n<p><strong>Glutamate (Option B):</strong> An Amino acid is involved in transamination and glutamine synthesis; not a direct nitrogen donor in the urea molecule.</p>\n<p><strong>Glycine (Option C):</strong> Donates nitrogen in <strong>creatinine</strong> and <strong>purine synthesis</strong>, not in urea.</p>\n<p><strong>Asparagine (Option D):</strong> Related to aspartate metabolism but not a nitrogen donor in the urea cycle.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Ammonium and aspartate</strong> are the two direct nitrogen sources for urea synthesis.</li>\n<li><strong>CPS-I</strong> and <strong>argininosuccinate synthetase</strong> are the key enzymes incorporating these nitrogens.</li>\n</ul>", "options": ["Ammonium and Aspartate", "Ammonium and Glutamate", "Ammonium and Glycine", "Ammonium and Asparagine"], "html_options": ["Ammonium and Aspartate", "Ammonium and Glutamate", "Ammonium and Glycine", "Ammonium and Asparagine"], "corr_idx": 0}, {"id": "1211353", "html_qtxt": "A 6-month-old boy was admitted with failure to thrive with high glutamine and uracil in urine, hypoglycemia, and high blood ammonia levels. Treatment was given for 2 months. At 8 months of age, he was admitted again for failure to gain weight. Gastric tube feeding was not tolerated, and the child became comatose. Parenteral dextrose is given. The child recovered from a coma within 24 hours. What is the enzyme defect?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>In the given case, there is a deficiency of <strong>Ornithine transcarbamoylase (OTC)</strong> enzyme, and for that, the clue to diagnosis is:</p>\n<ul>\n<li><strong>High glutamine</strong>: Usually seen in hyperammonemia.</li>\n<li><strong>Increased uracil</strong>in urine can be seen in OTC defect because, as OTC is defective, carbamoyl phosphate in mitochondria spills into the cytoplasm. Then it enters into pyrimidine synthesis. Pyrimidine intermediates and pyrimidines can accumulate. Hence, uracil is present in urine.</li>\n</ul>\n<p><strong>Hyperammonemia Type II (OTC Deficiency)</strong></p>\n<ul>\n<li><strong>Most common</strong>urea cycle disorder.</li>\n<li>Disorder with <strong>X-linked, partially dominant</strong>inheritance (All other urea cycle disorders are Autosomal Recessive).</li>\n<li>Urea cycle disorder with <strong>orotic aciduria</strong></li>\n<li>Marked <strong>elevations</strong>of plasma concentrations of <strong>glutamine and alanine</strong> with<strong> low</strong> <strong>levels</strong> of <strong>citrulline and arginine</strong></li>\n<li>Orotate may precipitate in urine as <strong>pink-colored gravel or stones</strong>.</li>\n<li>Clinical presentation:\n<ul>\n<li>Poor feeding, vomiting, lethargy, seizures, coma.</li>\n<li>Recurrent decompensation during high protein intake or catabolic states.</li>\n<li>Rapid response to IV glucose infusion supports diagnosis by reducing catabolism and ammonia production.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>CPS1 (Option A):</strong> Causes <strong>Hyperammonemia Type I</strong>; no orotic aciduria/uraciluria seen because carbamoyl phosphate cannot be formed.</p>\n<p><strong>Arginase (Option C):</strong> Causes <strong>hyperargininemia</strong>, usually with spasticity, not coma or orotic aciduria.</p>\n<p><strong>Argininosuccinate synthetase (Option D):</strong> Causes <strong>citrullinemia</strong> with high <strong>citrulline</strong>, not uracil.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>OTC deficiency is the <strong>most common urea cycle disorder</strong>, presenting with <strong>hyperammonemia</strong> and <strong>uracil/orotic acid in urine</strong> due to diversion of excess mitochondrial carbamoyl phosphate into pyrimidine synthesis.</p>", "options": ["Carbamoyl phosphate synthetase I  (CPS1)", "Ornitine transcarbamoylase", "Arginase", "Argininosuccinate Synthetase"], "html_options": ["Carbamoyl phosphate synthetase I  (CPS1)", "Ornitine transcarbamoylase", "Arginase", "Argininosuccinate Synthetase"], "corr_idx": 1}, {"id": "1211357", "html_qtxt": "Which of the following is true in relation to the urea cycle?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Metabolic disorders have been identified for <strong>each of the five enzymes</strong> involved in the urea cycle, making <strong>every step clinically relevant</strong>. All of them can lead to hyperammonemia, with varying severity and clinical phenotypes depending on the step affected.</p>\n<p>The disorder is associated with all the steps of the urea cycle disorders.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811v7wUE.png\">\n<ul>\n<li><strong>The urea cycle</strong> involves 5 main enzymatic steps:\n<ul>\n<li>Carbamoyl phosphate synthetase I (CPS1) - mitochondria</li>\n<li>Ornithine transcarbamoylase (OTC) - mitochondria</li>\n<li>Argininosuccinate synthetase - cytoplasm</li>\n<li>Argininosuccinate lyase - cytoplasm</li>\n<li>Arginase - cytoplasm</li>\n</ul>\n</li>\n<li><strong>Inherited deficiencies</strong> are documented for <strong>each of these enzymes</strong>, including rare defects like <strong>N-acetylglutamate synthetase</strong> and <strong>ornithine transporter (HHH syndrome)</strong>.</li>\n<li>These disorders present with:\n<ul>\n<li><strong>Hyperammonemia</strong>, often life-threatening in neonates</li>\n<li><strong>Neurological symptoms</strong> like lethargy, vomiting, and coma</li>\n<li><strong>Response to low-protein diets and nitrogen-scavenging drugs</strong></li>\n</ul>\n</li>\n<li><strong>Newborn screening</strong> using tandem mass spectrometry helps early detection of such metabolic disorders.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>First 3 steps in cytoplasm (Option A):</strong> The <strong>first 2 steps occur in mitochondria</strong>, the remaining 3 in the cytosol.</p>\n<p><strong>Last 2 steps in mitochondria (Option B):</strong> <strong>Only the first two reactions</strong> are mitochondrial.</p>\n<p><strong>Urea is formed by NH&#8323;, glutamic acid and CO&#8322; (Option D):</strong> <strong>Glutamic acid is not a direct substrate</strong>. The <strong>nitrogens come from NH&#8323; and aspartate</strong>, and the carbon from CO&#8322;.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Each step</strong> in the urea cycle has a corresponding <strong>inherited enzyme deficiency</strong>, highlighting its clinical significance.</p>", "options": ["First 3 steps in the cytoplasm", "The Last 2 steps in mitochondria", "Defect of the enzyme of any step can cause a deficiency disease", "Urea is formed by NH3, glutamic acid, and CO2"], "html_options": ["First 3 steps in the cytoplasm", "The Last 2 steps in mitochondria", "Defect of the enzyme of any step can cause a deficiency disease", "Urea is formed by NH3, glutamic acid, and CO2"], "corr_idx": 2}, {"id": "1211358", "html_qtxt": "True about the urea cycle:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Increased dietary protein leads to enhanced amino acid catabolism, resulting in greater ammonia production, which stimulates increased urea cycle activity to detoxify ammonia.</p>\n<ul>\n<li>The <strong>urea cycle</strong> is the primary pathway for nitrogen excretion in humans and occurs mainly in the <strong>liver</strong>.</li>\n<li><strong>Nitrogen sources for urea</strong>: One nitrogen atom is from <strong>free ammonia</strong>, the other from <strong>aspartate</strong>.</li>\n<li><strong>Urea formation requires energy</strong>: Three ATP molecules are consumed per urea molecule - two by <strong>CPS-I</strong> and one by <strong>argininosuccinate synthetase</strong>.</li>\n<li>The <strong>five-step cycle</strong> occurs in both the <strong>mitochondria</strong> (steps 1 & 2) and the <strong>cytosol</strong> (steps 3&ndash;5).</li>\n<li><strong>High protein intake or fasting</strong> increases amino acid catabolism, enhancing urea cycle enzyme expression and urea output.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811t7V53.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Alanine and ammonia (Option A)</strong>: Nitrogen in urea comes from <strong>ammonia and aspartate</strong>, not alanine. Alanine transfers nitrogen via transamination to glutamate, which undergoes oxidative deamination to release ammonia.</p>\n<p><strong>ATP in argininosuccinate to arginine (Option B)</strong>: <strong>Argininosuccinate &rarr; arginine</strong> is catalysed by <strong>argininosuccinate lyase</strong> and <strong>does not require ATP</strong>. ATP is used earlier in the <strong>argininosuccinate synthetase</strong> step.</p>\n<p><strong>Only in cytoplasm (Option D)</strong>: The urea cycle occurs in both <strong>mitochondrial matrix</strong> (first 2 steps) and <strong>cytosol</strong> (last 3 steps). Hence, it is a <strong>bi-compartmental cycle</strong>.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>The urea cycle is upregulated in high-protein states.</li>\n<li>Two nitrogen atoms in urea come from ammonia and aspartate.</li>\n<li>It uses 3 ATP per cycle and occurs in both mitochondria and cytosol.</li>\n</ul>", "options": ["Nitrogen of the urea comes from alanine and ammonia", "Uses ATP during conversion of argininosuccinate to arginine", "On consumption of high amount of protein, excess urea is formed", "Occurs  only  in cytoplasm"], "html_options": ["Nitrogen of the urea comes from alanine and ammonia", "Uses ATP during conversion of argininosuccinate to arginine", "On consumption of high amount of protein, excess urea is formed", "Occurs  only  in cytoplasm"], "corr_idx": 2}]}, {"moduleId": 1010135, "name": "Aromatic amino acids and their metabolic products", "questions": [{"id": "1211348", "html_qtxt": "Which is elevated in pyridoxal phosphate deficiency?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Pyridoxal phosphate (PLP), the active form of vitamin B6, is a required coenzyme for <strong>kynureninase</strong>, an enzyme in the tryptophan degradation pathway. In PLP deficiency, the pathway is blocked, leading to accumulation and urinary excretion of <strong>xanthurenic acid</strong> after tryptophan load.</p>\n<p><strong>Tryptophan metabolism -</strong></p>\n<ul>\n<li>Tryptophan is degraded to amphibolic intermediates via the <strong>kynurenine-anthranilate pathway.</strong></li>\n<li>Tryptophan 2,3-dioxygenase opens the indole ring, incorporates molecular oxygen, and forms N-formylkynurenine.</li>\n<li>Hydrolytic removal of the formyl group of N-formylkynurenine, catalysed by kynurenine formylase, produces kynurenine.</li>\n<li>Since <strong>kynureninase requires pyridoxal phosphate</strong>, excretion of xanthurenate in response to a tryptophan load is diagnostic of vitamin B6 deficiency.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811df1ff7b0-432a-4a78-802f-61a0fe6adfc8.png\">\n<ul>\n<li>5-HIAA is elevated in carcinoid syndrome <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Xanthurenic acid is elevated in vitamin B6 deficiency, especially after a tryptophan load.</li>\n<li>PLP is essential for tryptophan metabolism via the kynurenine pathway.</li>\n</ul>", "options": ["FIGLU", "Xanthurenic acid", "Methylmalonic acid", "5-HIAA"], "html_options": ["FIGLU", "Xanthurenic acid", "Methylmalonic acid", "5-HIAA"], "corr_idx": 1}, {"id": "1211352", "html_qtxt": "Dopamine is synthesized from: ", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Dopamine is a catecholamine synthesised from <strong>tyrosine</strong>, a non-essential aromatic amino acid.</p>\n<ul>\n<li>The conversion involves two key enzymatic steps: hydroxylation of tyrosine to <strong>DOPA</strong> (by tyrosine hydroxylase) and decarboxylation of DOPA to <strong>dopamine</strong> by <strong>DOPA decarboxylase</strong>, which is a <strong>pyridoxal phosphate (PLP)</strong>-dependent enzyme.</li>\n<li>Tyrosine is responsible for the synthesis of -\n<ul>\n<li>Melanin</li>\n<li>Thyroxine hormones (T4 & T3)</li>\n<li>Catecholamines (Dopamine, Epinephrine, Norepinephrine)</li>\n</ul>\n</li>\n<li><strong>Dopamine synthesis pathway</strong>:\n<ol>\n<li><strong>Tyrosine &rarr; DOPA</strong> (via <strong>tyrosine hydroxylase</strong>)</li>\n<li><strong>DOPA &rarr; Dopamine</strong> (via <strong>DOPA decarboxylase</strong>, requires PLP)</li>\n</ol>\n</li>\n<li>This pathway occurs in <strong>neuronal and adrenal medullary cells</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811f75b49a9-8102-4512-9742-d3c125d48eef.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tryptophan (Option A): </strong>Precursor for <strong>serotonin</strong>, <strong>melatonin</strong>, and <strong>niacin</strong>, not dopamine.</p>\n<p><strong>Threonine (Option B):</strong> Degraded to <strong>propionyl-CoA</strong> or <strong>glycine</strong> - not involved in catecholamine synthesis.</p>\n<p><strong>Lysine (Option D): </strong>A ketogenic amino acid involved in <strong>carnitine</strong> biosynthesis, unrelated to dopamine.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Tyrosine is the precursor of dopamine</strong>, via DOPA as an intermediate.</li>\n<li><strong>DOPA decarboxylase</strong> requires <strong>vitamin B6 (PLP)</strong> for activity.</li>\n</ul>", "options": ["Tryptophan", "Threonine", "Tyrosine", "Lysine"], "html_options": ["Tryptophan", "Threonine", "Tyrosine", "Lysine"], "corr_idx": 2}, {"id": "1211355", "html_qtxt": "In Phenylketonuria the main aim of first line therapy is:", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>The primary therapeutic goal in <strong>Phenylketonuria (PKU)</strong> is to <strong>restrict phenylalanine intake</strong> through diet. This limits the accumulation of <strong>phenylalanine</strong>, the <strong>substrate</strong> for the deficient enzyme <strong>phenylalanine hydroxylase</strong>, and prevents neurotoxic effects such as <strong>mental retardation</strong>.</p>\r\n<p><strong>Phenylketonuria</strong>:-</p>\r\n<ul>\r\n<li><strong>Phenylketonuria (PKU)</strong> is an <strong>autosomal recessive disorder.</strong> Hyperphenylalaninemias arise from defects in -\r\n<ul>\r\n<li><strong>Phenylalanine hydroxylase</strong> (type I, classic phenylketonuria (PKU), frequency 1 in 10,000 births)</li>\r\n<li><strong>Dihydrobiopterin reductase</strong>(type II and III)</li>\r\n<li><strong>Dihydrobiopterin biosynthesis</strong>(type IV and V)</li>\r\n</ul>\r\n</li>\r\n<li>Alternative catabolites are excreted. A diet low in phenylalanine can prevent the mental retardation of PKU.</li>\r\n<li>DNA probes facilitate prenatal diagnosis of defects in phenylalanine hydroxylase or dihydrobiopterin reductase.</li>\r\n<li>Deficiency leads to <strong>hyperphenylalaninemia</strong> and <strong>accumulation of phenyl ketones</strong>, causing:\r\n<ul>\r\n<li>Mental retardation</li>\r\n<li>Seizures</li>\r\n<li>Hypopigmentation</li>\r\n</ul>\r\n</li>\r\n<li><strong>Treatment of Classical PKU:</strong></li>\r\n<li>A low-phenylalanine diet</li>\r\n<li>Administration of large neutral amino acids may help reduce Phe transport into the brain.</li>\r\n<li><strong>Tetrahydrobiopterin (BH4)</strong> supplementation in responsive cases</li>\r\n<li><strong>Screening:</strong></li>\r\n<li>Tandem mass spectrometry is the standard method</li>\r\n<li>Urine ferric chloride test (FeCl<sub>3</sub>) is an older screening tool (green colour with phenylpyruvate)</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Replacement of the defective enzyme (Option A): </strong>Enzyme replacement is not used in PKU. The issue is addressed through dietary management.</p>\r\n<p><strong>Replacement of the deficient product (Option B): </strong>Tyrosine (the product of PAH) may be supplemented, but this is <strong>not the primary goal</strong> of therapy.</p>\r\n<p><strong>Giving the missing amino acid by diet (Option D): </strong>Tyrosine may become conditionally essential in PKU, but the main strategy is to <strong>restrict phenylalanine</strong>.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Dietary phenylalanine restriction</strong> is the cornerstone of PKU management to prevent cognitive deficits.</li>\r\n<li><strong>Phenylalanine hydroxylase deficiency</strong> diverts phenylalanine to toxic metabolites.<br /> </li>\r\n</ul>", "options": ["Replacement of the defective enzyme", "Replacement of the deficient product", "Limiting the substrate for deficient enzyme", "Giving the missing amino acid by diet"], "html_options": ["Replacement of the defective enzyme", "Replacement of the deficient product", "Limiting the substrate for deficient enzyme", "Giving the missing amino acid by diet"], "corr_idx": 2}, {"id": "1211362", "html_qtxt": ": A 40-year-old woman presents with progressive palmoplantar pigmentation. X-ray spine shows calcification of IV disk. On adding Benedict's reagent to urine, it gives a greenish brown precipitate and a blue-black supernatant fluid. What is the diagnosis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The classic triad of <strong>darkening urine on standing</strong>, <strong>ochronosis (bluish-black pigmentation of connective tissues)</strong>, and <strong>calcification of intervertebral discs</strong> with <strong>positive Benedict's test</strong> suggests <strong>alkaptonuria</strong>, caused by <strong>homogentisate oxidase deficiency</strong>.</p>\n<p><strong>Alkaptonuria:</strong></p>\n<ul>\n<li>It is an <strong>autosomal recessive</strong>inborn error of metabolism.</li>\n<li><strong>Biochemical defect - Homogentisate Oxidase deficiency</strong>leads to accumulation of Homogentisic Acid (Homogentisate), which polymerises to form Alkapton bodies.</li>\n<li><strong>Clinical presentation -</strong>\n<ul>\n<li>Normal Life till the 3rd or 4th decade.</li>\n<li><strong>Urine darkens on exposure to air</strong>is the only manifestation in children.</li>\n<li>In adults, <strong>Ochronosis</strong>: Alkapton bodies in intervertebral disk, cartilage of nose, pinna, etc.</li>\n<li>No mental retardation</li>\n</ul>\n</li>\n<li><strong>Laboratory Diagnosis -</strong>\n<ul>\n<li>Alkalization increases the darkening of urine.</li>\n<li>Benedicts test positive in urine because homogentisic acid is a reducing agent.</li>\n<li>Ferric Chloride test positive.</li>\n<li>Silver Nitrate Test positive.</li>\n</ul>\n</li>\n<li><strong>Treatment</strong>-\n<ul>\n<li>Mainly <strong>symptomatic</strong></li>\n<li>Avoid a high-protein diet (rich in phenylalanine & tyrosine)</li>\n<li>Vitamin C may slow ochronosis progression</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081194a58c46-92dc-4bb4-b9f8-733b96aa4ef7.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Phenylketonuria (Option A): </strong>PAH deficiency; presents with mental retardation, fair complexion, and musty odour- not ochronosis or positive Benedict's. Tyrosine becomes essential; diagnosis via tandem MS in newborn screening.</p>\n<p><strong>Tyrosinemia type 2 (Option C): </strong>Tyrosine aminotransferase deficiency; presents with eye lesions (keratitis), skin lesions (painful palmoplantar hyperkeratosis), and intellectual disability- not intervertebral calcification.</p>\n<p><strong>Argininosuccinic aciduria (Option D): </strong>Urea cycle disorder; presents with hyperammonemia, vomiting, and lethargy in infancy- no dark urine or connective tissue pigmentation.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Alkaptonuria</strong> presents with ochronosis, darkening urine, and intervertebral disc calcification.</li>\n<li>It is due to <strong>homogentisate oxidase deficiency</strong>, leading to homogentisic acid accumulation.</li>\n</ul>", "options": ["Phenylketonuria", "Alkaptonuria", "Tyrosinemia type 2", "Argininosuccinic aciduria"], "html_options": ["Phenylketonuria", "Alkaptonuria", "Tyrosinemia type 2", "Argininosuccinic aciduria"], "corr_idx": 1}, {"id": "1211365", "html_qtxt": "Screening test for phenylketonuria from urine used for newborn infants is", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The FeCl&#8323; test is a classic urine screening test used to detect phenylpyruvate in the urine of infants suspected of having <strong>phenylketonuria (PKU)</strong>. A green colour indicates the presence of phenylpyruvate, a byproduct of excess phenylalanine metabolism.</p>\n<ul>\n<li><strong>Phenylketonuria (PKU)</strong> is caused by <strong>phenylalanine hydroxylase (PAH)</strong></li>\n<li>Leads to the accumulation of <strong>phenylalanine</strong> and its transaminated product <strong>phenylpyruvate</strong>.</li>\n<li><strong>FeCl3 (Ferric chloride) test</strong>:\n<ul>\n<li>Detects phenylpyruvate in urine.</li>\n<li>Produces a <strong>green</strong></li>\n<li>Less reliable and is now largely replaced by <strong>tandem mass spectrometry</strong> in many countries.</li>\n</ul>\n</li>\n<li><strong>Timing</strong>:\n<ul>\n<li>Phenylalanine elevation in blood may not be detectable until <strong>3-4 days postpartum</strong>.</li>\n<li>False positives can occur in <strong>premature infants</strong> due to immature liver enzyme systems.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Benedict test (Option A):</strong> Detects reducing sugars, not specific for phenylalanine or phenylpyruvate. Used in conditions like galactosemia or alkaptonuria.</p>\n<p><strong>FIGLU test (Option C): </strong>Used for diagnosing <strong>folic acid deficiency</strong> by measuring <strong>formiminoglutamic acid</strong> in urine after a histidine load.</p>\n<p><strong>Turbidometry (Option D): </strong>A nonspecific technique used in various clinical assays; not the traditional test for PKU.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>The FeCl&#8323;test</strong> is the classical screening method for detecting <strong>phenylpyruvate in urine</strong> in suspected <strong>PKU</strong></li>\n<li>Modern screening programs prefer <strong>tandem mass spectrometry</strong> for accuracy.</li>\n</ul>", "options": ["Benedict test", "FeCl3 Test", "FIGLU test", "Turbidometry"], "html_options": ["Benedict test", "FeCl3 Test", "FIGLU test", "Turbidometry"], "corr_idx": 1}, {"id": "1211371", "html_qtxt": "Which of the following metabolic defects is seen in Type I Tyrosinemia?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Type I tyrosinemia (also called <strong>tyrosinosis</strong>) is caused by a <strong>deficiency of fumarylacetoacetate hydrolase</strong>, which leads to the accumulation of toxic metabolites resulting in liver failure, renal dysfunction, and a risk of hepatocellular carcinoma.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508115f94325a-0c03-4faa-bc02-dce312e7d505.png\">\n<ul>\n<li><strong>Tyrosine degradation pathway</strong>:<br /> Tyrosine &rarr; p-Hydroxyphenylpyruvate &rarr; Homogentisate &rarr; Maleylacetoacetate &rarr; Fumarylacetoacetate &rarr; Fumarate + Acetoacetate</li>\n<li><strong>Type I Tyrosinemia</strong>:\n<ul>\n<li>Enzyme defect: <strong>Fumarylacetoacetate hydrolase (FAH)</strong></li>\n<li>Accumulation of <strong>fumarylacetoacetate</strong> and <strong>succinylacetone</strong> (toxic)</li>\n<li>Clinical features: Liver failure, renal tubular dysfunction, cabbage-like odour</li>\n<li>Treatment: <strong>Diet low in tyrosine and phenylalanine</strong>, NTBC (nitisinone)</li>\n</ul>\n</li>\n<li>Untreated acute and chronic tyrosinosis leads to death from  <strong>liver failure</strong>. Therapy employs a diet low in tyrosine and phenylalanine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tyrosine Transaminase (Option A): </strong>Alternate name for Tyrosine aminotransferase, which is defective in <strong>Type II tyrosinemia</strong>. Converts tyrosine to p-hydroxyphenylpyruvate.</p>\n<p><strong>4-Hydroxyphenylpyruvate Hydroxylase (Option C): </strong>Defective in <strong>neonatal tyrosinemia</strong>. Converts p-hydroxyphenylpyruvate to homogentisate.</p>\n<p><strong>Tyrosine Aminotransferase (Option D): </strong>Another name for <strong>Tyrosine transaminase</strong>; defective in <strong>Type II tyrosinemia</strong>. First step in tyrosine degradation.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Type I tyrosinemia is due to <strong>fumarylacetoacetate hydrolase deficiency</strong> and can lead to <strong>fatal liver failure</strong> without early intervention.<br /> </li>\n</ul>", "options": ["Tyrosine Transaminase", "Fumaryl Acetoacetate Hydrolase", "4-Hydroxy Phenylpyruvate Hydroxylase", "Tyrosine aminotransferase"], "html_options": ["Tyrosine Transaminase", "Fumaryl Acetoacetate Hydrolase", "4-Hydroxy Phenylpyruvate Hydroxylase", "Tyrosine aminotransferase"], "corr_idx": 1}, {"id": "1211373", "html_qtxt": "The terminal products of Phenylalanine metabolism are all except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Phenylalanine metabolism leads to the formation of fumarate, acetate, and acetyl-CoA. <strong>Oxaloacetate is not derived from phenylalanine</strong>; hence, it is the correct answer.</p>\n<ul>\n<li>Phenylalanine is first converted to tyrosine.</li>\n<li>Tyrosine undergoes multiple enzymatic steps to form homogentisate, which is further broken down into maleylacetoacetate and fumarylacetoacetate.</li>\n<li>Fumarylacetoacetate splits into:\n<ul>\n<li><strong>Fumarate</strong> &rarr; Glucogenic <strong>(Option A ruled out)</strong></li>\n<li><strong>Acetoacetate</strong> &rarr; Ketogenic</li>\n</ul>\n</li>\n<li>Acetoacetate gives rise to:\n<ul>\n<li><strong>Acetyl-CoA (Option B ruled out)</strong></li>\n<li><strong>Acetate (Option D ruled out)</strong></li>\n</ul>\n</li>\n</ul>", "options": ["Fumarate", "Acetyl-CoA", "Oxaloacetate", "Acetate"], "html_options": ["Fumarate", "Acetyl-CoA", "Oxaloacetate", "Acetate"], "corr_idx": 2}, {"id": "1211374", "html_qtxt": "Enzyme deficiency in albinism is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Tyrosinase is the key enzyme required for melanin biosynthesis; its deficiency leads to albinism.</p>\n<ul>\n<li>Albinism is an autosomal recessive disorder characterised by defective melanin production.</li>\n<li>Tyrosinase catalyses the initial steps in melanin synthesis, including the conversion of tyrosine to DOPA and subsequently to dopaquinone.</li>\n<li>In albinism, tyrosinase activity is either absent or significantly reduced, impairing melanin formation.</li>\n<li>Clinical manifestations include:\n<ul>\n<li>Hypopigmented skin, hair, and eyes.</li>\n<li>Increased sensitivity to UV radiation predisposes to melanomas.</li>\n<li>Ocular findings: photophobia, nystagmus, hypopigmented fundus, decreased visual acuity.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Tyrosine hydroxylase (Option B):</strong> Enzyme involved in catecholamine synthesis; not related to melanin production.</p>\n<p><strong>Phenylalanine hydroxylase (Option C):</strong> Converts phenylalanine to tyrosine; its deficiency causes phenylketonuria, not albinism.</p>\n<p><strong>Homogentisate oxidase (Option D):</strong> Deficiency causes alkaptonuria, which presents with dark urine and ochronosis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Tyrosinase is the essential enzyme for melanin production; its deficiency causes albinism.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081160a718de-f9b5-40ac-8e34-cbd29205180d.png\">", "options": ["Tyrosinase", "Tyrosine hydroxylase", "Phenylalanine hydroxylase", "Homogentisate oxidase"], "html_options": ["Tyrosinase", "Tyrosine hydroxylase", "Phenylalanine hydroxylase", "Homogentisate oxidase"], "corr_idx": 0}, {"id": "1211376", "html_qtxt": "Mousy body odour in PKU is due to:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The characteristic \"mousy\" or \"musty\" body odour in phenylketonuria (PKU) is due to the accumulation and excretion of phenylacetate, a byproduct of phenylalanine metabolism.</p>\n<ul>\n<li>Phenylketonuria is caused by a deficiency of <strong>phenylalanine hydroxylase</strong>, leading to the accumulation of phenylalanine.</li>\n<li>In the absence of this enzyme, <strong>phenylalanine</strong> is transaminated to <strong>phenylpyruvate</strong>.</li>\n<li>Phenylpyruvate is then metabolised into <strong>phenylacetate</strong> and <strong>phenyllactate</strong>.</li>\n<li><strong>Phenylacetate</strong> is responsible for the <strong>mousy/musty body odour</strong> observed in PKU patients.</li>\n<li>Excess phenylalanine and its derivatives are neurotoxic and cause irreversible cognitive impairment if untreated.</li>\n<li>Clinical Manifestations of Phenylketonuria (PKU) -\n<ul>\n<li>The affected infant is normal, at Profound<strong>mental retardation</strong>develops gradually if the infant remains untreated. Cognitive delay may not be evident for the 1st few months.</li>\n<li>Some may have a <strong>seborrheic or eczematoid rash</strong>, which is usually mild and disappears as the child grows older.</li>\n<li>These children have an <strong>unpleasant odour of phenylacetic</strong><strong>acid</strong>, which has been described as <strong>musty or mousey</strong>.</li>\n</ul>\n</li>\n<li>Early diagnosis and dietary restriction of phenylalanine can prevent neurological damage.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081191746a23-9075-47b5-aa6c-5f02fcf60ef0.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options: </strong></p>\n<p><strong>Phenylalanine (Option A):</strong> Aromatic essential amino acid; substrate that accumulates in PKU but does not directly cause the mousy odour. Elevated phenylalanine is neurotoxic, but odour arises from its metabolic products.</p>\n<p><strong>Phenylbutazone (Option C):</strong> NSAID used for inflammatory conditions; not a metabolite of phenylalanine. Structurally unrelated to phenylalanine metabolism and not associated with PKU.</p>\n<p><strong>Phenylacetylglutamine (Option D):</strong> Conjugate excreted in urea cycle disorders and some hyperammonemic states; not characteristic of PKU. Typically seen in alternative nitrogen excretion pathways, not in phenylalanine metabolism.</p>", "options": ["Phenylalanine", "Phenylacetate", "Phenylbutazone", "Phenylacetylglutamine"], "html_options": ["Phenylalanine", "Phenylacetate", "Phenylbutazone", "Phenylacetylglutamine"], "corr_idx": 1}, {"id": "1211377", "html_qtxt": "Which of the following amino acid can be converted into a vitamin?\t", "html_expl": "<p><strong>Explanation:</strong></p>\r\n<p>Tryptophan serves as a precursor for the synthesis of niacin (vitamin B<sub>3</sub>) in the human body through the kynurenine pathway.</p>\r\n<ul>\r\n<li>Approximately 60 mg of tryptophan yields 1 mg of niacin.</li>\r\n<li>This conversion is important in preventing pellagra in conditions of low dietary niacin.</li>\r\n<li>The pathway involves several enzymes and cofactors such as PLP (pyridoxal phosphate), iron, and FAD.</li>\r\n<li>Impairment in this conversion can occur due to deficiency of vitamin B<sub>6</sub>, iron, or riboflavin, or due to genetic disorders like Hartnup disease or carcinoid syndrome.</li>\r\n<li>Niacin and tryptophan are interdependent in maintaining adequate NAD<sup>+</sup> synthesis for energy metabolism.</li>\r\n<li>The tryptophan-to-niacin pathway also explains the occurrence of pellagra-like symptoms in vitamin B<sub>6</sub> deficiency.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811FZOKi.png\">", "options": ["Glycine", "Tryptophan", "Phenyalalanine", "Lysine"], "html_options": ["Glycine", "Tryptophan", "Phenyalalanine", "Lysine"], "corr_idx": 1}, {"id": "1211386", "html_qtxt": ": Which of the following would not act as a source of glycine by transamination?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Aspartate does not serve as a substrate in transamination reactions to form glycine. Glycine is formed by transamination reactions involving <strong>glyoxylate</strong>, <strong>glutamate</strong>, or <strong>alanine</strong>, not aspartate.</p>\n<ul>\n<li>Glycine can be synthesised by transamination of glyoxylate using either glutamate or alanine as the amino group donor.</li>\n<li>Other important sources of glycine include <strong>serine</strong> (via serine hydroxymethyltransferase) and <strong>choline</strong> (through several oxidation and demethylation steps).</li>\n</ul>\n<p><strong>Pathways of Glycine Synthesis:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508119472adba-e940-4096-aa32-d62a7aedcac1.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Alanine (Option A):</strong> The Amino group from alanine can be transferred to glyoxylate to form glycine via alanine-glyoxylate aminotransferase.</p>\n<p><strong>Glutamate (Option C):</strong> Major amino group donor in transamination; donates amino group to glyoxylate, forming glycine.</p>\n<p><strong>Glyoxylate (Option D):</strong> Key keto acid that accepts amino groups to generate glycine; highly active in hepatic metabolism.</p>", "options": ["Alanine\t", "Aspartate", "Glutamate", "Glyoxylate"], "html_options": ["Alanine\t", "Aspartate", "Glutamate", "Glyoxylate"], "corr_idx": 1}]}, {"moduleId": 1009770, "name": "Enzymes and its properties", "questions": [{"id": "1192017", "html_qtxt": "All of the following is true about peroxidase enzyme, except:", "html_expl": "<p><strong>Explanation:</strong></p><p>Peroxidases <strong>reduce peroxides</strong>, such as hydrogen peroxide (H2O2). They utilize an electron donor (also called a substrate) that gets oxidized in the process. The general reaction is: H2O2+AH2&rarr;2H2O+A, where AH2 is the electron donor that gets oxidized.</p>\n<ul>\n<li><strong>Presence in Milk (Option A):</strong> Peroxidases are indeed found in milk, often in high quantities.</li>\n<li><strong>Tissue Distribution and Metabolism (Option B):</strong> Peroxidases are active in various tissues, including leukocytes, platelets, and other tissues involved in <strong>eicosanoid metabolism</strong>. This indicates their role in processes involving lipid mediators.</li>\n<li><strong>Prosthetic Group (Option C):</strong> The prosthetic group present in peroxidase enzymes is <strong>protoheme</strong>. This heme group is critical for their catalytic activity, especially in their interaction with peroxides.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Peroxidases function by reducing peroxides (e.g., H2O2) while oxidizing various electron acceptors.</p>", "options": ["Found in milk", "Active in tissues involved in eicosanoid metabolism", "Their prosthetic group is protoheme", "Oxidises peroxides"], "html_options": ["Found in milk", "Active in tissues involved in eicosanoid metabolism", "Their prosthetic group is protoheme", "Oxidises peroxides"], "corr_idx": 3}, {"id": "1192018", "html_qtxt": "Which of the following molecules is present in glutathione peroxidase as a prosthetic group?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The molecule present in glutathione peroxidase as a prosthetic group is <strong>Selenium</strong>. This enzyme, found in erythrocytes and other tissues, plays a crucial role in protecting membrane lipids and hemoglobin from oxidative damage by catalyzing the destruction of hydrogen peroxide (H2O2) and lipid hydroperoxides. It achieves this by converting reduced glutathione to its oxidized form.</p>\n<p>Selenium is incorporated into various enzymes as selenocysteine, which is considered the 21st amino acid. Enzymes that contain selenocysteine include:</p>\n<ul>\n<li>Glutathione Peroxidase (types 1-8)</li>\n<li>Iodothyronine Deiodinase (types 1-3)</li>\n<li>Thioredoxin reductase (types 1-3)</li>\n<li>Glucose-6-phosphate dehydrogenase</li>\n<li>Exportin-1</li>\n<li>LRP-2, LRP-8</li>\n<li>eIF-4A3</li>\n<li>eEFsec</li>\n<li>Selenoprotein H, I, K, M, N, O, P, R (types 1, 2, 3), S, T, U, V, W</li>\n<li>Selenocysteine Lyase & Synthase</li>\n<li>Selenophosphate synthetase 1 & 2</li>\n<li>Tocopherol alpha transfer proteins</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Iron (Option A):</strong> Iron is a component of many enzymes, but it is not the prosthetic group for glutathione peroxidase. For example, iron is a key component of hemoglobin, myoglobin, and cytochrome enzymes.</p>\n<p><strong>Heme (Option B):</strong> Heme is an iron-containing porphyrin complex that serves as a prosthetic group in various hemoproteins, such as hemoglobin, cytochromes, and certain peroxidases (like catalase or myeloperoxidase), but not glutathione peroxidase.</p>\n<p><strong>Zinc (Option D):</strong> Zinc is a cofactor for many enzymes (e.g., carbonic anhydrase, alcohol dehydrogenase, superoxide dismutase), but it is not the prosthetic group for glutathione peroxidase.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Selenium is a unique and essential trace element that serves as the prosthetic group in glutathione peroxidase, an enzyme critical for antioxidant defense by reducing harmful peroxides.</p>", "options": ["Iron", "Heme", "Selenium", "Zinc"], "html_options": ["Iron", "Heme", "Selenium", "Zinc"], "corr_idx": 2}, {"id": "1192020", "html_qtxt": "Which of the following sentences is true regarding oxygenase enzymes?", "html_expl": "<p><strong>Explanation: </strong></p>\n<p>The true statement regarding oxygenase enzymes is that <strong>Hydroxyanthranilate dioxygenase contains iron</strong>. Oxygenases are enzymes that catalyze the direct transfer and incorporation of oxygen into a substrate molecule. They are divided into two subgroups: dioxygenases and monooxygenases. Hydroxyanthranilate dioxygenase is an example of a dioxygenase, and it contains iron.</p>\n<ul>\n<li><strong>Oxygenase:</strong> Enzymes that catalyze the direct transfer and incorporation of oxygen from molecular oxygen (O2) into a substrate molecule.</li>\n<li><strong>Subgroups:</strong> Oxygenases are divided into two main subgroups: <strong>dioxygenases</strong> and <strong>monooxygenases</strong>.</li>\n<li><strong>Dioxygenases:</strong>\n<ul>\n<li>Incorporate <strong>both atoms</strong> of molecular oxygen into the substrate (A+O2&rarr;AO2).</li>\n<li>Examples include homogentisate dioxygenase (oxidase) and <strong>3-hydroxyanthranilate dioxygenase (oxidase)</strong>. These enzymes contain <strong>iron</strong> <strong>(Option D is correct)</strong>..</li>\n</ul>\n</li>\n<li><strong>Monooxygenases (Mixed-Function Oxidases, Hydroxylases):</strong>\n<ul>\n<li>Incorporate <strong>only one atom</strong> of molecular oxygen into the substrate (A-H+O2+ZH2&rarr;A-OH+H2O+Z). The other oxygen atom is reduced to water, requiring an additional electron donor or co-substrate (Z).</li>\n<li>They are also known as <strong>mixed-function oxidases</strong> or hydroxylases <strong>(Option B is false).</strong></li>\n<li><strong>Cytochromes P450</strong> are important examples of monooxygenases, involved in steroid metabolism and detoxification of many drugs <strong>(Option A is false)</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Oxygenases are enzymes incorporating oxygen into substrates. Dioxygenases (e.g., homogentisate oxidase, hydroxyanthranilate dioxygenase) incorporate both oxygen atoms and often contain iron, while monooxygenases (mixed-function oxidases, e.g., Cytochromes P450) incorporate only one oxygen atom.</p>", "options": ["Cytochromes P450 is an example of dioxygenases", "Dioxygenases is also termed as Mixed function oxidases", "Homogentisate oxidase is an example of monooxygenase", "Hydroxy anthranilate dioxygenase contain iron"], "html_options": ["Cytochromes P450 is an example of dioxygenases", "Dioxygenases is also termed as Mixed function oxidases", "Homogentisate oxidase is an example of monooxygenase", "Hydroxy anthranilate dioxygenase contain iron"], "corr_idx": 3}, {"id": "1192026", "html_qtxt": "All of the following is true regarding superoxide, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The statement <strong>\"Superoxide dismutase protects anaerobic organisms against oxygen toxicity\" is not true about superoxide.</strong> Superoxide dismutase (SOD) is an enzyme that plays a crucial role in protecting <strong>aerobic organisms</strong> against the potential deleterious effects of superoxide and oxygen toxicity. Obligate anaerobes typically lack SOD because they cannot tolerate oxygen and thrive in oxygen-free environments.</p>\n<ul>\n<li><strong>Superoxide Formation:</strong> Superoxide (O2&minus;) is a potentially damaging free radical formed by the transfer of a single electron to molecular oxygen (O2). It can be formed in tissues.</li>\n<li><strong>Superoxide Dismutase function:</strong> SOD is responsible for the removal of superoxide. It catalyzes the dismutation of superoxide into oxygen (O2) and hydrogen peroxide (H2O2).</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Xanthine oxidase reaction can form superoxide (Option A):</strong> This statement is true. Superoxide is generated during the reoxidation of reduced flavins, a process that occurs in reactions like the xanthine oxidase reaction.</li>\n<li><strong>Superoxide dismutase enzyme present in both mitochondria and cytoplasm (Option B):</strong> Superoxide dismutase has isoforms found in different cellular compartments, including both mitochondria and the cytosol of aerobic tissues.</li>\n<li><strong>Superoxide acts as both oxidant and reductant (Option D):</strong> Superoxide is a reactive oxygen species that can participate in redox reactions by both gaining (acting as an oxidant) or losing (acting as a reductant) electrons, as exemplified by its ability to reduce cytochrome c.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Superoxide dismutase (SOD) is a crucial antioxidant enzyme protecting <em>aerobic organisms</em> from oxygen toxicity by converting superoxide radicals, and it is present in both mitochondrial and cytosolic compartments.</p>", "options": ["Xanthine oxidase reaction can form superoxide", "Superoxide dismutase enzyme present in both mitochondria and cytoplasm", "Superoxide dismutase protects anaerobic organisms against oxygen toxicity", "Superoxide acts as both oxidant and reductant"], "html_options": ["Xanthine oxidase reaction can form superoxide", "Superoxide dismutase enzyme present in both mitochondria and cytoplasm", "Superoxide dismutase protects anaerobic organisms against oxygen toxicity", "Superoxide acts as both oxidant and reductant"], "corr_idx": 2}, {"id": "1192273", "html_qtxt": "Which of the following enzyme estimation in serum is used specifically to diagnose hepatocellular injury during acute hepatitis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Alanine aminotransferase (ALT) </strong>estimation in serum is specifically used to diagnose <strong>hepatocellular injury </strong>during<strong> acute hepatitis</strong>. While both alanine (ALT) and aspartate (AST) aminotransferases are significantly elevated in acute viral hepatitis, ALT is considered more specific for liver disease because AST can also be elevated in cases of cardiac or skeletal muscle injury, whereas ALT is not.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>AST (Option A):</strong> While elevated in acute hepatitis, AST is not as specific as ALT for liver injury because it can also rise with damage to other tissues like cardiac or skeletal muscle.</li>\n<li><strong>ALP (Option C):</strong> Serum ALP is typically elevated in cholestatic liver diseases (obstructive jaundice) or bone disorders, not primarily for hepatocellular injury.</li>\n<li><strong>Amylase (Option D):</strong> Amylase is a marker for pancreatic inflammation (acute pancreatitis) and salivary gland disorders, not liver injury.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>ALT is the most specific serum enzyme marker for hepatocellular injury, such as that occurring in acute hepatitis.</p>", "options": ["AST", "ALT", "ALP", "Amylase"], "html_options": ["AST", "ALT", "ALP", "Amylase"], "corr_idx": 1}, {"id": "1192278", "html_qtxt": "A 45-year-old chronic alcoholic male presented with acute pain in the upper abdomen that radiates to the back along with fever and severe vomiting. A treating physician suspected acute pancreatitis. Which of the following plasma enzyme levels will be specifically increased in acute pancreatitis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>In a patient presenting with symptoms suggestive of acute pancreatitis, <strong>serum lipase is the enzyme level that will be specifically increased</strong>. While amylase also rises in acute pancreatitis, lipase is considered more specific for pancreatic inflammation. This is because amylase can be elevated due to other conditions, such as salivary gland diseases, and its levels can normalize more quickly in some cases of pancreatitis due to renal clearance.</p>\n<ul>\n<li>Clinically, acute pancreatitis often presents with acute upper abdominal pain radiating to the back, accompanied by fever and severe vomiting, especially in a chronic alcoholic male.</li>\n<li><strong>Lipase (Option B):</strong>\n<ul>\n<li><strong>Specificity:</strong> Serum lipase is considered <strong>highly specific for acute pancreatitis</strong>. Its elevation strongly indicates pancreatic inflammation.</li>\n<li><strong>Duration:</strong> Lipase levels typically rise within 4-8 hours of symptom onset and can remain elevated for 8-14 days.</li>\n</ul>\n</li>\n<li><strong>Amylase (Option A):</strong>\n<ul>\n<li><strong>Elevation in Pancreatitis:</strong> Plasma activity of amylase is also increased in acute pancreatitis.</li>\n<li><strong>Lack of Specificity:</strong> Amylase is <strong>not specific for pancreatitis</strong> because it is also produced by salivary glands, and its levels can be increased in salivary gland diseases.</li>\n<li><strong>Clearance:</strong> Amylase is a smaller molecule and is filtered at the glomerulus and secreted in the urine, meaning its plasma levels can return to normal relatively quickly, even in ongoing mild cases.</li>\n</ul>\n</li>\n<li><strong>ALT (Option C):</strong> Alanine aminotransferase (ALT) is a specific marker for <strong>hepatocellular injury</strong>, such as that seen in acute viral hepatitis or other liver diseases. It is not specifically elevated in acute pancreatitis.</li>\n<li><strong>ALP (Option D):</strong> Serum alkaline phosphatase (ALP) activity is primarily elevated in <strong>obstructive jaundice</strong>(cholestatic liver disease) or <strong>bone disease</strong>. It is not a specific marker for acute pancreatitis.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Serum lipase is the most specific and reliable enzyme marker for diagnosing acute pancreatitis.</p>", "options": ["Amylase", "Lipase", "ALT", "ALP"], "html_options": ["Amylase", "Lipase", "ALT", "ALP"], "corr_idx": 1}, {"id": "1195615", "html_qtxt": "A 68-year-old male presents to the emergency department with a sudden onset of severe abdominal pain and melena after self-medicating for chronic back pain with over-the-counter medication for several weeks. His medical history includes hypertension. Laboratory results show a normocytic anemia. The most likely pharmacological mechanism contributing to his current presentation involves the inhibition of an enzyme primarily responsible for:", "html_expl": "<p><strong>Explanation:</strong></p><p>The patient's presentation with severe abdominal pain and melena, following prolonged use of over-the-counter medication for back pain, strongly suggests a gastrointestinal bleed, a known side effect of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). NSAIDs, such as ibuprofen (common over-the-counter pain relievers), exert their therapeutic and adverse effects by inhibiting the <strong>cyclooxygenase (COX)</strong> enzyme. Cyclooxygenase is the enzyme primarily responsible for <strong>converting membrane lipids (specifically arachidonic acid) into potent inflammatory mediators (like prostaglandins that cause pain, fever, inflammation) and cytoprotective agents (like prostaglandins that protect the gastric mucosa)</strong>.</p>\n<ul>\n<li><strong>NSAID Mechanism:</strong> NSAIDs inhibit the <strong>Cyclooxygenase (COX) </strong>enzyme.</li>\n<li><strong>COX Function:</strong> COX catalyzes the conversion of arachidonic acid (a membrane lipid) into various eicosanoids, including prostaglandins, thromboxanes, and prostacyclins. These molecules have diverse physiological roles.</li>\n<li><strong>Dual Role of COX Products:</strong>\n<ul>\n<li><strong>Pro-inflammatory mediators:</strong> Some prostaglandins contribute to pain, fever, and inflammation (e.g., PGE2).</li>\n<li><strong>Cytoprotective agents:</strong> Other prostaglandins (e.g., PGE2, PGI2) play vital roles, such as maintaining renal blood flow and protecting the gastric mucosa by increasing mucus and bicarbonate secretion and improving mucosal blood flow.</li>\n</ul>\n</li>\n<li><strong>Adverse Effects:</strong> Inhibition of COX-1 (constitutive COX) by non-selective NSAIDs (like aspirin, ibuprofen) reduces the production of protective prostaglandins, leading to adverse effects such as gastric ulceration and bleeding. </li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Breaking down dietary fats in the intestine (Option A):</strong> This function is primarily carried out by <strong>pancreatic lipase</strong> and other lipases in the digestive system, which are not targets of NSAIDs.</p>\n<p><strong>Releasing arachidonic acid from cellular membranes, initiating the inflammatory cascade (Option C):</strong> This crucial step is catalyzed by <strong>Phospholipase A2</strong>. While this enzyme is upstream in the eicosanoid pathway, it is inhibited by corticosteroids, not NSAIDs.</p>\n<p><strong>Regulating blood pressure by converting angiotensin I to angiotensin II (Option D):</strong> This describes the function of <strong>Angiotensin-Converting Enzyme (ACE)</strong>. ACE inhibitors are a class of drugs that target this enzyme for hypertension treatment, unrelated to NSAID mechanisms.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>NSAIDs cause gastrointestinal side effects like bleeding by inhibiting Cyclooxygenase (COX), which reduces the production of prostaglandins vital for gastric mucosal protection<strong>.</strong></p>", "options": ["Breaking down dietary fats in the intestine.", "Converting membrane lipids into potent inflammatory mediators and cytoprotective agents.", "Releasing arachidonic acid from cellular membranes, initiating the inflammatory cascade.", "Regulating blood pressure by converting angiotensin I to angiotensin II."], "html_options": ["Breaking down dietary fats in the intestine.", "Converting membrane lipids into potent inflammatory mediators and cytoprotective agents.", "Releasing arachidonic acid from cellular membranes, initiating the inflammatory cascade.", "Regulating blood pressure by converting angiotensin I to angiotensin II."], "corr_idx": 0}, {"id": "1195616", "html_qtxt": "Suicidal Enzyme is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The enzyme referred to as a \"Suicidal Enzyme\" due to its self-catalyzed destruction is <strong>Cyclooxygenase (COX)</strong>. This unique property of COX contributes to the \"switching off\" or regulation of prostaglandin activity. During its catalytic cycle, COX produces reactive intermediates that can lead to the inactivation and degradation of the enzyme itself, hence the term \"suicidal.\"</p>\n<p><strong>Cyclooxygenase (COX):</strong></p>\n<ul>\n<li>Also known as <strong>prostaglandin H synthase</strong>.</li>\n<li>It is called a \"suicide enzyme\" because it undergoes <strong>self-catalyzed destruction</strong> during its normal catalytic cycle. This means that the enzyme's activity leads to its own inactivation and degradation.</li>\n<li>This property helps in the <strong>regulation and termination of prostaglandin synthesis</strong>, thus controlling inflammatory responses.</li>\n<li>COX is the target of NSAIDs, which inhibit its activity.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Lipoxygenase (Option A):</strong> This enzyme catalyzes the conversion of arachidonic acid into leukotrienes, a separate pathway from prostaglandins. It does not exhibit the characteristic self-catalyzed destruction seen in cyclooxygenase.</li>\n<li><strong>Thromboxane Synthase (Option C):</strong> This enzyme acts upon the product of cyclooxygenase (PGH2) to form thromboxanes. Its activity does not lead to its own destruction, differentiating it from a \"suicidal enzyme.\"</li>\n<li><strong>5' Nucleotidase (Option D):</strong> This enzyme is involved in the catabolism of nucleotides and has no known association with the \"suicidal enzyme\" characteristic or the eicosanoid pathway.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li><strong>Cyclooxygenase (COX) is known as a \"suicidal enzyme\" because it undergoes self-catalyzed inactivation as part of its regulatory mechanism for prostaglandin synthesis.</strong></li>\n</ul>", "options": ["Lipoxygenase", "Cyclooxygenase", "Thromboxane Synthase", "5' Nucleotidase"], "html_options": ["Lipoxygenase", "Cyclooxygenase", "Thromboxane Synthase", "5' Nucleotidase"], "corr_idx": 1}, {"id": "1195618", "html_qtxt": "Which of the following is a Lyase?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Among the given options, <strong>Aldolase B</strong> is an example of a <strong>Lyase</strong> enzyme. Lyases are a class of enzymes that catalyze the breaking of various chemical bonds( eg. C-C, C-O, C-N) by means other than hydrolysis or oxidation, often forming a new double bond or a new ring structure. Aldolase, specifically, catalyzes the cleavage of fructose-1,6-bisphosphate (in glycolysis) or fructose-1-phosphate (in fructose metabolism) into dihydroxyacetone phosphate and glyceraldehyde-3-phosphate or glyceraldehyde, respectively.</p>\n<p>A brief overview of each of the six classes:</p>\n<ol>\n<li><strong>Oxidoreductases (Class 1):</strong>\n<ul>\n<li><strong>Function:</strong> Catalyze oxidation-reduction reactions (transfer of electrons or hydrogen atoms).</li>\n<li><strong>Examples:</strong> Dehydrogenases, Oxidases, Reductases, Peroxidases, Oxygenases.</li>\n<li><strong>Mnemonic:</strong> \"Redox\" reactions.</li>\n</ul>\n</li>\n<li><strong>Transferases (Class 2):</strong>\n<ul>\n<li><strong>Function:</strong> Catalyze the transfer of a functional group (e.g., methyl, amino, phosphate) from one molecule (donor) to another (acceptor).</li>\n<li><strong>Examples:</strong> Kinases, Transaminases, Phosphorylases.</li>\n</ul>\n</li>\n<li><strong>Hydrolases (Class 3):</strong>\n<ul>\n<li><strong>Function:</strong> Catalyze the hydrolysis of various bonds (C-C, C-N, C-O, etc.) by the addition of water. They break bonds.</li>\n<li><strong>Examples:</strong> Proteases (peptidases), Lipases, Esterases, Phosphatases, Amylase.</li>\n</ul>\n</li>\n<li><strong>Lyases (Class 4):</strong>\n<ul>\n<li><strong>Function:</strong> Catalyze the cleavage of C-C, C-O, C-N, and other bonds by elimination, leaving behind double bonds or forming rings. They do <em>not</em> involve hydrolysis or oxidation.</li>\n<li><strong>Examples:</strong> Aldolase, Fumarase, Decarboxylases, Synthases (those that don't use ATP, unlike ligases).</li>\n</ul>\n</li>\n<li><strong>Isomerases (Class 5):</strong>\n<ul>\n<li><strong>Function:</strong> Catalyze the rearrangement of atoms within a single molecule, converting it into an isomer.</li>\n<li><strong>Examples:</strong> Mutases, Racemases, Epimerases, Phosphoglucoisomerase.</li>\n</ul>\n</li>\n<li><strong>Ligases (Class 6):</strong>\n<ul>\n<li><strong>Function:</strong> Catalyze the joining of two molecules to form a larger molecule, typically coupled with the hydrolysis of ATP or a similar high-energy phosphate compound. They \"ligate\" or \"tie\" molecules together.</li>\n<li><strong>Examples:</strong> Synthetases (e.g., DNA ligase, Acetyl-CoA synthetase, Aminoacyl-tRNA synthetase).</li>\n</ul>\n</li>\n</ol>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Acetyl Co A Synthetase (Option B):</strong> This enzyme belongs to the ligase class, as it catalyzes the joining of two molecules (acetate and coenzyme A) with the concomitant hydrolysis of ATP.</li>\n<li><strong>Fatty Acyl CoA Dehydrogenase (Option C):</strong> This enzyme is an oxidoreductase, specifically a dehydrogenase, involved in redox reactions where hydrogen atoms are removed from a substrate.</li>\n<li><strong>Acetyl CoA Carboxylase (Option D):</strong> This enzyme is also a ligase, as it catalyzes the formation of a new bond (carbon-carbon bond via carboxylation) coupled with ATP hydrolysis.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Lyases are enzymes that break chemical bonds non-hydrolytically and non-oxidatively, often forming double bonds; Aldolase B is a prime example of a lyase.</p>", "options": ["Aldolase B", "Acetyl Co A Synthetase", "Fatty Acyl CoA Dehydrogenase", "Acetyl CoA Carboxylase"], "html_options": ["Aldolase B", "Acetyl Co A Synthetase", "Fatty Acyl CoA Dehydrogenase", "Acetyl CoA Carboxylase"], "corr_idx": 0}, {"id": "1195625", "html_qtxt": "All of the following biochemical processes primarily involve enzymes classified as oxidoreductases, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The question asks to identify the biochemical process that <strong>does NOT</strong> primarily involve an enzyme classified as an <strong>oxidoreductase</strong>. Oxidoreductases are enzymes (Class I) that catalyze oxidation-reduction reactions (electron transfer). <strong>The breakdown of sucrose into glucose and fructose in the small intestine, </strong>this process is catalyzed by <strong>sucrase</strong>. Sucrase breaks down sucrose by <strong>hydrolysis</strong> (adding water to break the glycosidic bond). Enzymes that perform hydrolysis are classified as <strong>Hydrolases (Class III)</strong>. Hydrolases are <strong>not</strong> Oxidoreductases, as their mechanism does not involve electron transfer or changes in oxidation states. Therefore, this is the correct answer.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>The conversion of pyruvate to acetyl-CoA prior to the citric acid cycle (Option A):</strong> This reaction is an oxidative decarboxylation catalyzed by the Pyruvate Dehydrogenase Complex, an oxidoreductase.</p>\n<p><strong>The hydroxylation of drugs for detoxification in the liver (Option B):</strong> This is an oxidation reaction catalyzed by Cytochrome P450, a monooxygenase and thus an oxidoreductase.</p>\n<p><strong>The removal of toxic hydrogen peroxide in red blood cells (Option D):</strong> This detoxification process is a redox reaction catalyzed by enzymes like Catalase or Glutathione Peroxidase, both belonging to the oxidoreductase class.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Oxidoreductases facilitate electron transfer reactions (redox), while Hydrolases break bonds using water without involving redox processes.</strong></p>", "options": ["The conversion of pyruvate to acetyl-CoA prior to the citric acid cycle.", "The hydroxylation of drugs for detoxification in the liver.", "The breakdown of sucrose into glucose and fructose in the small intestine.", "The removal of toxic hydrogen peroxide in red blood cells."], "html_options": ["The conversion of pyruvate to acetyl-CoA prior to the citric acid cycle.", "The hydroxylation of drugs for detoxification in the liver.", "The breakdown of sucrose into glucose and fructose in the small intestine.", "The removal of toxic hydrogen peroxide in red blood cells."], "corr_idx": 2}, {"id": "1195628", "html_qtxt": "Which of the following is a class of transferase enzymes?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Among the given options, <strong>Kinases</strong> are a class of <strong>transferase</strong> <strong>enzymes</strong>. Transferases are enzymes that catalyze the transfer of a functional group (other than hydrogen) from one molecule (donor) to another (acceptor). Kinases specifically transfer a phosphate group, typically from ATP, to another molecule.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Aldolase (Option A):</strong> This enzyme is a <strong>Lyase</strong>, catalyzing the non-hydrolytic cleavage of fructose-1,6-bisphosphate in glycolysis.</li>\n<li><strong>Argininosuccinase (Option B):</strong> Also known as argininosuccinate lyase, this enzyme is a <strong>Lyase</strong> involved in the urea cycle, cleaving argininosuccinate.</li>\n<li>Fu<strong>marase (Option D):</strong> This enzyme is a <strong>Lyase</strong> (or hydratase, a subclass of lyases), involved in the citric acid cycle by adding water across a double bond.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Kinases are a prominent example of transferase enzymes, specifically catalyzing the transfer of phosphate groups, crucial for many metabolic and signaling pathways.</p>", "options": ["Aldolase", "Argininosuccinase", "Kinases", "Fumarase"], "html_options": ["Aldolase", "Argininosuccinase", "Kinases", "Fumarase"], "corr_idx": 2}, {"id": "1195634", "html_qtxt": "Which of the following is/are examples of hydrolases enzymes?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>All of the listed enzymes, Arginase, Pepsin, and Esterases, are indeed examples of hydrolases. Hydrolases (Class III of enzymes) are characterized by their ability to catalyze the hydrolytic cleavage of various chemical bonds. This means they break bonds by adding water across them, affecting bonds such as C-C, C-O, C-N, and other covalent bonds.</p>\n<ul>\n<li><strong>Hydrolases (Class 3):</strong> Enzymes that break chemical bonds by adding water (hydrolysis).</li>\n<li><strong>Primary Function:</strong> To break down complex molecules into simpler ones.</li>\n<li><strong>Common Substrates:</strong> Esters, peptide bonds, glycosidic bonds, etc.</li>\n<li><strong>Arginase:</strong> Hydrolyzes arginine in the urea cycle.</li>\n<li><strong>Pepsin:</strong> A protease that hydrolyzes peptide bonds in proteins.</li>\n<li><strong>Esterases:</strong> Hydrolyze ester bonds.</li>\n<li><strong>Other Examples:</strong> Lipases, Phosphatases, Amylase.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Hydrolases are a broad class of enzymes that break down molecules by adding water; common examples like arginase, pepsin, and esterases all exemplify this hydrolytic action.</p>", "options": ["Arginase", "Pepsin", "Esterases", "All of the above"], "html_options": ["Arginase", "Pepsin", "Esterases", "All of the above"], "corr_idx": 3}, {"id": "1195637", "html_qtxt": "During the metabolic breakdown of glucose, a key enzyme facilitates the conversion between dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P), ensuring the efficient progression of the pathway. The enzyme responsible for this type of reaction is primarily characterized by its ability to:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The question describes the interconversion of dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P) in glycolysis, a reaction catalyzed by <strong>Triose Phosphate Isomerase</strong>. This enzyme facilitates an internal rearrangement of atoms within a single molecule, changing its structure without adding or removing atoms, thus converting it into an isomer. Enzymes that catalyze such internal rearrangements, leading to geometric or structural changes within a molecule, are classified as <strong>Isomerases</strong>. The correct option directly describes this function.</p>\n<p><strong>Isomerases (Class 5):</strong> Catalyze intramolecular rearrangements, leading to geometric or structural changes within a single molecule.</p>\n<ul>\n<li><strong>Triose Phosphate Isomerase</strong>: A classic example, interconverting DHAP and G3P in glycolysis.</li>\n<li><strong>Other Isomerase examples</strong>: Mutases, Racemases, Epimerases, Phosphoglucoisomerase.</li>\n<li><strong>Distinguishing Feature</strong>: No net gain or loss of atoms, just rearrangement.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509143d5fc936-0a7b-48f4-b32a-e851dcf1abea.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Break covalent bonds without hydrolysis or oxidation, often forming double bonds (Option A):</strong> This describes the function of <strong>Lyases</strong> (Class 4), which catalyze bond cleavages by elimination (e.g., Aldolase, Fumarase). This is not the primary action of the enzyme in question.</p>\n<p><strong>Catalyze the joining of two molecules, coupled with ATP hydrolysis (Option B):</strong> This describes the function of <strong>Ligases</strong> (Class 6), which form new bonds by joining two molecules, typically consuming ATP (e.g., DNA ligase, Synthetases). This is contrary to the internal rearrangement.</p>\n<p><strong>Transfer functional groups from one substrate to another (Option C):</strong> This describes the function of <strong>Transferases</strong> (Class 2), which move a chemical group from one molecule to another (e.g., Kinases, Transaminases). The reaction between DHAP and G3P involves only one molecule rearranging, not a group transfer between two.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Isomerases are enzymes specialized in catalyzing internal rearrangements within a molecule, leading to a change in its geometric or structural form, as exemplified by the interconversion of DHAP and G3P in glycolysis.</p>", "options": ["Break covalent bonds without hydrolysis or oxidation, often forming double bonds.", "Catalyze the joining of two molecules, coupled with ATP hydrolysis", "Transfer functional groups from one substrate to another", "Catalyze geometric or structural changes within a molecule"], "html_options": ["Break covalent bonds without hydrolysis or oxidation, often forming double bonds.", "Catalyze the joining of two molecules, coupled with ATP hydrolysis", "Transfer functional groups from one substrate to another", "Catalyze geometric or structural changes within a molecule"], "corr_idx": 1}, {"id": "1195639", "html_qtxt": "All of the following are multienzyme complex except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Among the choices, <strong>Ribonuclease</strong> is a <strong>monomeric enzyme</strong>, meaning it consists of only one polypeptide chain. In contrast, Fatty acid synthetase, Prostaglandin synthase, and Pyruvate Dehydrogenase are all well-known examples of multienzyme complexes.</p>\n<p>A multienzyme complex is defined as a macromolecule where many different enzymes catalyzing distinct reaction sites are located at different sites of the same macromolecule. The complex typically becomes inactive when fractionated into individual enzyme units.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Fatty acid synthetase (Option A):</strong> This is a classic example of a multienzyme complex. It is a large, multifunctional enzyme system responsible for the synthesis of fatty acids, with multiple catalytic activities residing on a single polypeptide chain or closely associated chains.</p>\n<p><strong>Prostaglandin synthase (Option B):</strong> Also known as Cyclooxygenase (COX), this enzyme is considered a multienzyme complex due to its multiple catalytic activities (cyclooxygenase and peroxidase activities) residing within the same enzyme structure, involved in the synthesis of prostaglandins.</p>\n<p><strong>Pyruvate Dehydrogenase (Option D):</strong> The Pyruvate Dehydrogenase Complex is a large and well-studied multienzyme complex composed of three distinct enzymes (pyruvate dehydrogenase, dihydrolipoyl transacetylase, and dihydrolipoyl dehydrogenase) that work sequentially.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Multienzyme complexes are large, integrated enzymatic systems where multiple enzymes of a pathway are physically associated, providing efficiency, while monomeric enzymes like ribonuclease consist of a single polypeptide chain.</p>", "options": ["Fatty acid synthetase", "Prostaglandin synthase", "Ribonuclease", "Pyruvate Dehydrogenase"], "html_options": ["Fatty acid synthetase", "Prostaglandin synthase", "Ribonuclease", "Pyruvate Dehydrogenase"], "corr_idx": 2}, {"id": "1195641", "html_qtxt": "Exceptions to the proteinaceous nature of enzymes are", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The vast majority of enzymes are protein in nature, characterized by their large molecular weight. However, there is a notable exception to this rule: <strong>Ribozymes</strong>. Ribozymes are a class of RNA molecules that possess enzymatic activity, meaning they can catalyze specific biochemical reactions, despite not being proteins.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Dehydrogenase(Option A):</strong> Dehydrogenases are a class of oxidoreductase enzymes that catalyze oxidation-reduction reactions involving the transfer of hydrogen. They are protein in nature.</p>\n<p><strong>Kinases(Option C):</strong> Kinases are a class of transferase enzymes that specifically catalyze the transfer of phosphate groups. They are protein in nature.</p>\n<p><strong>Transferases(Option D):</strong> Transferases are a broad class of enzymes that catalyze the transfer of functional groups from one molecule to another. All enzymes classified as transferases are proteins.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>While nearly all enzymes are proteins, <strong>ribozymes</strong> are a crucial exception, being RNA molecules with intrinsic catalytic capabilities.</p>", "options": ["Dehydrogenase", "Ribozymes", "Kinases", "Transferases"], "html_options": ["Dehydrogenase", "Ribozymes", "Kinases", "Transferases"], "corr_idx": 1}, {"id": "1195644", "html_qtxt": "In holoenzyme, non-protein part is/are", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>A <strong>holoenzyme</strong> is defined as the complete and catalytically active form of an enzyme, consisting of a protein part called the <strong>apoenzyme</strong> and a non-protein part. This non-protein part is essential for the enzyme's activity and can be a <strong>coenzyme</strong>, a <strong>cofactor</strong>, or a <strong>prosthetic group</strong>. Therefore, all the options listed represent components of the non-protein part of a holoenzyme.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The active <strong>holoenzyme</strong> consists of the protein <strong>apoenzyme</strong> bound to a non-protein component, which can be a <strong>coenzyme</strong>, a <strong>cofactor</strong> (a broader term that includes coenzymes and inorganic ions), or a <strong>prosthetic group</strong>.</p>", "options": ["Coenzyme", "Co factor", "Prosthetic group", "All of the above"], "html_options": ["Coenzyme", "Co factor", "Prosthetic group", "All of the above"], "corr_idx": 3}, {"id": "1195651", "html_qtxt": "Enzymes require Molybdenum for activation?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Xanthine oxidase</strong> is the enzyme that specifically requires Molybdenum for its activation. Molybdenum is an essential trace element that serves as a cofactor, primarily in the form of a molybdenum cofactor (Moco), for a small number of enzymes involved in diverse metabolic pathways, including purine metabolism where xanthine oxidase plays a crucial role.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811c79c83e8-de18-478b-9c66-1a383ce5947e.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hexokinase(Option B):</strong> Hexokinase is an enzyme involved in glycolysis that requires magnesium (Mg2+) as a cofactor for its activity, not Molybdenum.</p>\n<p><strong>Carbonic anhydrase(Option C):</strong> Carbonic anhydrase is a highly efficient enzyme crucial for acid-base balance and carbon dioxide transport. It is a zinc-containing enzyme, meaning it requires Zinc (Zn2+) for its catalytic activity, not Molybdenum.</p>\n<p><strong>Lipase(Option D):</strong> Lipases are enzymes that catalyze the hydrolysis of fats (lipids). While some lipases may require calcium (Ca2+), they do not require Molybdenum for activation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Xanthine oxidase</strong> is a distinct example of an enzyme that uniquely requires <strong>Molybdenum</strong> as a cofactor for its proper activation and function in purine metabolism.</p>", "options": ["Xanthine oxidase", "Hexokinase", "Carbonic anhydrase", "Lipase"], "html_options": ["Xanthine oxidase", "Hexokinase", "Carbonic anhydrase", "Lipase"], "corr_idx": 0}, {"id": "1195657", "html_qtxt": "Km is the substrate concentration at which:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The Michaelis-Menten equation mathematically describes the relationship between the initial reaction velocity (vi) and substrate concentration ([S]). The <strong>Michaelis constant (Km)</strong> is specifically defined as the substrate concentration at which the initial reaction velocity (vi) is exactly <strong>half the maximal velocity (Vmax/2)</strong> that can be achieved by the enzyme at a given concentration. This value is an inverse measure of the enzyme's affinity for its substrate; a lower Kmindicates a higher affinity.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Half the substrate concentration is required for Vmax (Option A):</strong> This statement is incorrect. Km relates to the velocity, not directly to the substrate concentration needed for the entire Vmax. Vmax is achieved at very high substrate concentrations, effectively saturating the enzyme.</p>\n<p><strong>Vmax is achieved (Option B):</strong> This is incorrect. Vmax is approached as substrate concentration becomes very high (saturating), not specifically at Km. At Km, the velocity is half Vmax.</p>\n<p><strong>Quarter the Vmax is achieved (Option =C):</strong> This is incorrect. The definition of Km explicitly states that it is the substrate concentration at which half the Vmax is achieved.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811d0e14823-25ab-43af-8962-365086ed6572.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p>The <strong>Michaelis constant (Km)</strong> is a fundamental parameter in enzyme kinetics, precisely defined as the substrate concentration at which the enzyme reaction rate is <strong>half its maximal velocity (Vmax/2)</strong>, and it inversely reflects the enzyme's affinity for its substrate.</p>", "options": ["Half the substrate concentration is required for Vmax", "Vmax is achieved", "Quarter the Vmax is achieved", "Half the Vmax is achieved"], "html_options": ["Half the substrate concentration is required for Vmax", "Vmax is achieved", "Quarter the Vmax is achieved", "Half the Vmax is achieved"], "corr_idx": 3}, {"id": "1195659", "html_qtxt": "Which of the following is called the signature of enzymes?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The <strong>Michaelis constant (Km)</strong> is often referred to as the \"signature\" of an enzyme for a particular substrate. This is because Km is a unique and characteristic constant for a specific enzyme-substrate pair under given conditions (like pH and temperature). Unlike initial velocity (Vi) or maximal velocity (Vmax), Km is independent of the enzyme concentration. Its value provides insight into the enzyme's affinity for its substrate; a lower Km indicates a higher affinity, suggesting it's a preferred or \"natural\" substrate for that enzyme.</p>\n<ul>\n<li><strong>Michaelis Constant (Km):</strong>\n<ul>\n<li>Represents the substrate concentration ([S]) at which the reaction velocity (vi) is equal to 1/2Vmax.</li>\n<li>It is a characteristic constant for a given enzyme-substrate pair under specific conditions (pH, temperature, ionic strength).</li>\n<li><strong>Inverse measure of affinity:</strong> A small Km indicates high affinity of the enzyme for its substrate, meaning the enzyme reaches half its maximal velocity at a low substrate concentration.</li>\n<li>A large Km indicates low affinity.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Vmax (Option B):</strong> While Vmax is a crucial kinetic parameter, it is dependent on the enzyme concentration. If you double the amount of enzyme, you double the Vmax. Therefore, it is not considered a unique \"signature\" of the enzyme's intrinsic catalytic efficiency independent of its quantity.</p>\n<p><strong>Vi (Option C):</strong> Vi (initial velocity) is the instantaneous reaction rate at the beginning of the reaction. It varies significantly with both substrate and enzyme concentrations and thus is not a constant unique to the enzyme itself.</p>\n<p><strong>S(Option D):</strong> S represents the substrate concentration, which is a variable input to the reaction, not a characteristic constant of the enzyme itself.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The <strong>Michaelis constant (Km)</strong> is considered the \"signature of enzymes\" because it is a unique, fixed value for a given enzyme-substrate pair, independent of enzyme concentration, and provides crucial information about the enzyme's affinity for its substrate.</p>", "options": ["Km", "Vmax", "Vi", "S"], "html_options": ["Km", "Vmax", "Vi", "S"], "corr_idx": 0}, {"id": "1195673", "html_qtxt": "Coenzyme in decarboxylation reaction:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Pyridoxine (Vitamin B6)</strong> is the precursor to <strong>Pyridoxal Phosphate (PLP)</strong>, which serves as a crucial coenzyme in many enzyme-catalyzed reactions, including various decarboxylation reactions, particularly those of amino acids.</p>\n<ul>\n<li><strong>Pyridoxine (B6):</strong> Precursor to Pyridoxal Phosphate (PLP).</li>\n<li><strong>Pyridoxal Phosphate (PLP):</strong> A versatile coenzyme involved in numerous reactions of amino acid metabolism.</li>\n<li><strong>Decarboxylation Reactions:</strong> PLP is a key coenzyme for many decarboxylases, especially those removing carboxyl groups from amino acids (e.g., in the synthesis of neurotransmitters like GABA, serotonin, dopamine).</li>\n<li><strong>Other PLP-dependent reactions:</strong> Transamination, deamination, racemization.</li>\n<li><strong>Thiamine (Vitamin B1):</strong> As Thiamine Pyrophosphate (TPP), it is the coenzyme for specific oxidative decarboxylation reactions of alpha-keto acids (e.g., pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase).</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Niacin (Option A):</strong> Niacin (Vitamin B3) is a precursor for NAD+ and NADP+, which are coenzymes primarily involved in oxidation-reduction (redox) reactions (electron and hydrogen transfer), not typically decarboxylation.</p>\n<p><strong>Biotin (Option B):</strong> Biotin (Vitamin B7) is the coenzyme for carboxylation reactions, where a carboxyl group is added to a substrate (e.g., pyruvate carboxylase, acetyl-CoA carboxylase), which is the opposite of decarboxylation.</p>\n<p><strong>Riboflavin (Option D):</strong> Riboflavin (Vitamin B2) is a precursor for FAD and FMN, which are coenzymes primarily involved in oxidation-reduction reactions (electron transfer) and are prosthetic groups for flavoproteins, not typically decarboxylation.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508119de8b401-c249-45a9-a599-40996b7dad7b.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Pyridoxine</strong> (as Pyridoxal Phosphate) is the primary coenzyme for a wide range of decarboxylation reactions, especially in amino acid metabolism, while <strong>Biotin</strong> is the coenzyme for carboxylation, and <strong>Thiamine</strong> is specific for oxidative decarboxylation of alpha-keto acids.</p>", "options": ["Niacin", "Biotin", "Pyridoxine", "Riboflavin"], "html_options": ["Niacin", "Biotin", "Pyridoxine", "Riboflavin"], "corr_idx": 2}, {"id": "1195678", "html_qtxt": "All the following coenzymes participate in the transfer of hydrogen and electron, except :", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Pyridoxal Phosphate (PLP)</strong>, the active form of Vitamin B6, is primarily involved in various reactions of amino acid metabolism, most notably the <strong>transfer of amino groups</strong> (as seen in transamination reactions), as well as decarboxylation and deamination reactions. It does not directly function in hydrogen or electron transfer.</p>\n<p>In contrast, FAD, NAD+, and NADP+ are all well-known coenzymes that serve as crucial carriers of hydrogen atoms (protons and electrons) in a wide array of oxidation-reduction (redox) reactions within metabolism.</p>\n<p><strong>Coenzymes in Hydrogen/Electron Transfer:</strong></p>\n<ul>\n<li><strong>FAD (Flavin Adenine Dinucleotide):</strong> Derived from Riboflavin (Vitamin B2). It is a prosthetic group for flavoproteins and accepts/donates two hydrogen atoms (two protons and two electrons) in redox reactions (e.g., succinate dehydrogenase).</li>\n<li><strong>NAD+ (Nicotinamide Adenine Dinucleotide):</strong> Derived from Niacin (Vitamin B3). It accepts/donates one hydride ion (H&minus;) which is equivalent to two electrons and one proton, primarily in catabolic (oxidative) reactions (e.g., glycolysis, TCA cycle).</li>\n<li><strong>NADP+ (Nicotinamide Adenine Dinucleotide Phosphate):</strong> Also derived from Niacin (Vitamin B3). Structurally similar to NAD+, it primarily accepts/donates one hydride ion (H&minus;), often used in anabolic (reductive) reactions, such as fatty acid synthesis and the pentose phosphate pathway.</li>\n</ul>\n<p><strong>FAD (Option A):</strong> FAD (Flavin Adenine Dinucleotide) is a flavin coenzyme directly involved in accepting and donating hydrogen atoms and electrons during various oxidation-reduction reactions, such as those catalyzed by succinate dehydrogenase in the citric acid cycle.</p>\n<p><strong>NAD+ (Option C):</strong> NAD+ (Nicotinamide Adenine Dinucleotide) is a vital coenzyme that accepts a hydride ion (equivalent to two electrons and one proton) during many oxidative metabolic pathways, thereby participating in hydrogen and electron transfer.</p>\n<p><strong>NADP+ (Option D):</strong> NADP+(Nicotinamide Adenin Dinucleotide Phosphate) is another crucial coenzyme similar to NAD+ that accepts a hydride ion. It is predominantly used in reductive biosynthetic pathways (e.g., fatty acid synthesis) and detoxification, actively transferring hydrogen and electrons.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>While FAD, NAD+, and NADP+ are central to metabolic redox reactions involving the transfer of hydrogen and electrons, <strong>Pyridoxal Phosphate (PLP)</strong> uniquely functions in the <strong>transfer of amino groups</strong> and other transformations in amino acid metabolism, not as a direct hydrogen/electron carrier.</p>", "options": ["FAD", "PLP", "NAD+", "NADP+"], "html_options": ["FAD", "PLP", "NAD+", "NADP+"], "corr_idx": 1}, {"id": "1195681", "html_qtxt": "All of the following statements regarding enzyme specificity are correct except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Enzymes exhibit high specificity, acting on specific substrates or catalyzing specific types of reactions. The statement \"Human enzymes act only on D-amino acids\" is incorrect because human enzymes predominantly act on <strong>L-amino acids</strong>. While D-amino acids exist in nature (e.g., in bacterial cell walls, some peptide antibiotics), the vast majority of proteins in humans are composed of L-amino acids, and human enzymes involved in protein synthesis and metabolism are stereospecific for the L-configuration. Conversely, human enzymes act almost exclusively on <strong>D-carbohydrates</strong>.</p>\n<ul>\n<li><strong>Enzyme Specificity:</strong> Enzymes are highly specific, determined by the precise fit between the active site and the substrate. This can be:\n<ul>\n<li>Enzyme acts on only one substrate (e.g., Urease acts only on urea).</li>\n<li>Enzyme acts on a group of chemically related substrates (e.g., Hexokinase phosphorylates several hexoses).</li>\n<li>Enzymes act on only one stereoisomeric form of a substrate.</li>\n<li>Enzymes catalyze only one type of reaction (e.g., decarboxylase only catalyzes decarboxylation).</li>\n</ul>\n</li>\n<li><strong>Stereospecificity in Humans:</strong>\n<ul>\n<li>Human enzymes typically act on <strong>L-amino acids</strong>.</li>\n<li>Human enzymes typically act on <strong>D-carbohydrates</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Glucokinase phosphorylates only glucose (Option A):</strong> Glucokinase is an enzyme primarily found in the liver and pancreas, and it exhibits a high degree of specificity, primarily phosphorylating only glucose to glucose 6-phosphate.</p>\n<p><strong>Hexokinase exhibits relative substrate specificity (Option B):</strong> Hexokinase, found in most tissues, can phosphorylate not only glucose but also other hexoses like fructose, mannose, and glucosamine. This demonstrates its relative (or group) substrate specificity, as opposed to absolute specificity.</p>\n<p><strong>Glucose 6-phosphate undergoes multiple reactions, each catalysed by a separate enzyme (Option C):</strong> Glucose 6-phosphate is a branching point in metabolism. It can be converted to glucose (by glucose 6-phosphatase), oxidized in the pentose phosphate pathway (by glucose 6-phosphate dehydrogenase), or isomerized to fructose 6-phosphate (by phosphoglucose isomerase). Each of these distinct transformations is catalyzed by a different, specific enzyme, illustrating reaction specificity.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Enzymes exhibit various levels of specificity, including stereospecificity. A crucial point in human biochemistry is that enzymes primarily recognize and act upon <strong>L-amino acids</strong> and <strong>D-carbohydrates</strong>, making the statement about D-amino acids incorrect.</p>", "options": ["Glucokinase phosphorylates only glucose", "Hexokinase exhibits relative substrate specificity", "Glucose 6-phosphate undergoes multiple reactions, each catalysed by a separate enzyme", "Human enzymes act only on D-amino acids."], "html_options": ["Glucokinase phosphorylates only glucose", "Hexokinase exhibits relative substrate specificity", "Glucose 6-phosphate undergoes multiple reactions, each catalysed by a separate enzyme", "Human enzymes act only on D-amino acids."], "corr_idx": 3}, {"id": "1195685", "html_qtxt": "Marker enzyme for Golgi apparatus:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Marker enzymes are specific enzymes found predominantly in a particular subcellular organelle, serving as biochemical indicators for that organelle. <strong>Galactosyltransferase</strong> is considered a classic and reliable marker enzyme for the <strong>Golgi apparatus</strong>. This enzyme plays a crucial role in the glycosylation of proteins and lipids, a primary function of the Golgi complex, where it catalyzes the transfer of galactose residues to various acceptor molecules. </p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811c28c19d0-3947-43a4-abd7-bd8bc01e7d78.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Glucose 6 Phosphatase (Option B):</strong> Glucose 6-phosphatase is a key enzyme primarily located in the <strong>endoplasmic reticulum</strong> (ER), especially in the liver and kidney. It catalyzes the hydrolysis of glucose 6-phosphate to glucose and inorganic phosphate, a crucial step in gluconeogenesis and glycogenolysis, but it is not a marker for the Golgi apparatus.</p>\n<p><strong>5' Nucleotidase (Option C):</strong> 5' Nucleotidase is an enzyme predominantly found on the <strong>plasma membrane</strong> (cell surface) and is often used as a marker for the plasma membrane. It hydrolyzes nucleoside monophosphates to nucleosides and inorganic phosphates.</p>\n<p><strong>Catalase (Option D):</strong> Catalase is an antioxidant enzyme specifically found in <strong>peroxisomes</strong>. Its primary function is to catalyze the decomposition of hydrogen peroxide into water and oxygen, protecting the cell from oxidative damage. It is a marker for peroxisomes, not the Golgi apparatus.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Galactosyltransferase</strong> is the definitive marker enzyme for the <strong>Golgi apparatus</strong>, reflecting its central role in protein and lipid glycosylation processes.</p>", "options": ["Galactosyltransferase", "Glucose 6 Phosphatase", "5' Nucleotidase", "Catalase"], "html_options": ["Galactosyltransferase", "Glucose 6 Phosphatase", "5' Nucleotidase", "Catalase"], "corr_idx": 0}]}, {"moduleId": 1009771, "name": "Enzyme inhibition, Regulation, Isoenzymes and Applications", "questions": [{"id": "1195620", "html_qtxt": "The type of enzyme inhibition in which Succinate dehydrogenase reaction is inhibited by malonate is an example of:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The inhibition of succinate dehydrogenase by malonate is a classic example of <strong>competitive inhibition</strong>.</p>\n<ul>\n<li><strong>Competitive Inhibition:</strong>\n<ul>\n<li>Inhibitor (I) binds reversibly to the <strong>active site</strong> of the enzyme.</li>\n<li>The inhibitor's structure often <strong>resembles the substrate</strong> (substrate analog).</li>\n<li><strong>Effect on Km:</strong> Apparent Km increases (enzyme appears to have lower affinity for substrate).</li>\n<li><strong>Effect on Vmax:</strong> Vmax remains unchanged (can be reached at very high substrate concentrations).</li>\n<li><strong>Reversal:</strong> Can be overcome by increasing substrate concentration.</li>\n<li><strong>Example:</strong> Inhibition of succinate dehydrogenase by malonate.</li>\n</ul>\n</li>\n<li><strong>Succinate Dehydrogenase:</strong> An enzyme in the Krebs cycle that catalyzes the oxidation of succinate to fumarate.</li>\n<li><strong>Malonate:</strong> A structural analog of succinate that acts as a competitive inhibitor. It has only one methylene carbon, unlike succinate's two, preventing its dehydrogenation.</li>\n</ul>\n<p><strong>Explanation of Other Options:<br /> Noncompetitive (Option A):</strong> Noncompetitive inhibition occurs when the inhibitor binds to a site on the enzyme <em>distinct</em> from the active site (allosteric site), causing a conformational change that reduces the enzyme's catalytic efficiency. It reduces Vmax but typically does not change Km. This type of inhibition cannot be fully overcome by increasing substrate concentration. Malonate's action is not consistent with this mechanism.</p>\n<p><strong>Uncompetitive (Option B):</strong> Uncompetitive inhibition occurs when the inhibitor binds <em>only</em> to the enzyme-substrate (ES) complex. It leads to a decrease in both Vmax and Km. This type of inhibition is rare and does not describe the interaction between malonate and succinate dehydrogenase.</p>\n<p><strong>Allosteric (Option D):</strong> Allosteric regulation involves molecules binding to sites other than the active site (allosteric sites) to modulate enzyme activity. While noncompetitive inhibition is a type of allosteric inhibition, competitive inhibition, as seen with malonate, involves binding to the active site directly, not a separate allosteric site. Therefore, \"allosteric\" is a broader term, but \"competitive\" more specifically describes this particular type of active site inhibition.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The inhibition of succinate dehydrogenase by malonate is a classic demonstration of competitive inhibition, where a substrate analog (malonate) competes with the natural substrate (succinate) for binding to the enzyme's active site.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811c6313303-ef64-41b1-96ff-c97794bd2df5.png\">\n<p><strong>Some competitive inhibitors which are not drugs are</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508118c10c751-adc3-431b-8cb2-a97428f1d395.png\">", "options": ["Noncompetitive", "Uncompetitive", "Competitive", "Allosteric"], "html_options": ["Noncompetitive", "Uncompetitive", "Competitive", "Allosteric"], "corr_idx": 2}, {"id": "1195630", "html_qtxt": "Lineweaver-Burk plot is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The Lineweaver-Burk plot is a widely used graphical representation in enzyme kinetics. It is derived by taking the reciprocal of the Michaelis-Menten equation, resulting in a linear equation.</p>\n<ul>\n<li>A plot of 1/Vi (inverse of initial velocity) vs. 1/[S] (inverse of substrate concentration).</li>\n<li>Also known as the <strong>Double Reciprocal Plot</strong>.<strong>(Option B)</strong></li>\n<li>Produces a <strong>straight line graph</strong>.<strong>(Option C)</strong></li>\n<li><strong>Kinetic Parameters from Plot:(Option A)</strong>\n<ul>\n<li>X-intercept: &minus;1/Km</li>\n<li>Y-intercept: 1/Vmax</li>\n<li>Slope: Km/Vmax</li>\n</ul>\n</li>\n<li><strong>Utility:</strong>\n<ul>\n<li>Easier determination of Km and Vmax compared to hyperbolic plots.</li>\n<li>Useful for graphically distinguishing between competitive and noncompetitive inhibition. For competitive inhibition, lines from inhibited reactions converge at the y-axis (same Vmax). For noncompetitive inhibition, lines intersect on the x-axis (same Km).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong><p>\n<p>The <strong>Lineweaver-Burk plot</strong> is a powerful tool in enzyme kinetics, recognized by its characteristic <strong>double reciprocal</strong>nature (plotting inverse velocity vs. inverse substrate concentration) and its ability to produce a <strong>straight line graph</strong> that simplifies kinetic analysis.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508116460cd63-bd24-4b36-8cdb-985853196747.png\">", "options": ["Inversely initial velocity versus inverse of the substrate concentration", "Double reciprocal plot", "Gives a straight line graph", "All of the above"], "html_options": ["Inversely initial velocity versus inverse of the substrate concentration", "Double reciprocal plot", "Gives a straight line graph", "All of the above"], "corr_idx": 3}, {"id": "1195648", "html_qtxt": "Statin is a lipid lowering drug. Statin drug act by which of the following inhibition mechanisms on HMG CoA reductase?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Statins are a class of highly effective lipid-lowering drugs that primarily target cholesterol synthesis. They exert their therapeutic effect by acting as <strong>competitive inhibitors</strong> of the enzyme <strong>HMG-CoA reductase</strong>.</p>\n<ul>\n<li><strong>Statins:</strong> A class of drugs (e.g., atorvastatin, simvastatin) used to lower cholesterol levels.</li>\n<li><strong>Target Enzyme:</strong> <strong>HMG-CoA reductase</strong>.</li>\n<li><strong>Mechanism of Action:</strong> Statins act as <strong>competitive inhibitors</strong> of HMG-CoA reductase.</li>\n<li><strong>Rational for Competitive Inhibition:</strong> Statins mimic the structure of the natural substrate, HMG-CoA, allowing them to bind to the enzyme's active site and block substrate access.</li>\n<li><strong>Clinical Significance:</strong> Inhibition of HMG-CoA reductase by statins reduces endogenous cholesterol synthesis, leading to a decrease in plasma LDL cholesterol levels.</li>\n</ul>\n<p><strong>Explanation of Other Options: </strong><p>\n<p><strong>Un competitive Inhibition (Option B):</strong> Uncompetitive inhibition occurs when the inhibitor binds only to the enzyme-substrate (ES) complex. This type of inhibition typically decreases both the apparent Vmax and apparent Km. This mechanism is not how statins inhibit HMG-CoA reductase.</p>\n<p><strong>Non Competitive Inhibition (Option C):</strong>Noncompetitive inhibition involves the inhibitor binding to a site on the enzyme <em>distinct</em> from the active site (an allosteric site), leading to a conformational change that reduces the enzyme's catalytic efficiency. This results in a decrease in Vmax but usually no change in Km. This is not the mechanism of statin action.</p>\n<p><strong>Suicidal Inhibition (Option D):</strong> Suicidal (or mechanism-based) inhibition is an irreversible type of inhibition where the inhibitor is initially a substrate for the enzyme, but during the catalytic process, it is converted into a highly reactive intermediate that permanently inactivates the enzyme's active site. While some drugs are suicide inhibitors, statins are reversible competitive inhibitors.</p>\n<p><strong>Key Takeaway:</strong><p>\n<p>Statins are potent lipid-lowering drugs that act via <strong>competitive inhibition</strong> of <strong>HMG-CoA reductase</strong>, the rate-limiting enzyme in cholesterol synthesis, by mimicking its natural substrate.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811cd774a32-0101-4f57-8d80-564191d450b7.png\">", "options": ["Competitive Inhibition", "Un competitive Inhibition", "Non  Competitive Inhibition", "Suicidal Inhibition"], "html_options": ["Competitive Inhibition", "Un competitive Inhibition", "Non  Competitive Inhibition", "Suicidal Inhibition"], "corr_idx": 0}, {"id": "1195649", "html_qtxt": "All statements regarding Isoenzymes are correct except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Isoenzymes are defined as physically distinct forms of an enzyme that catalyze the <strong>same reaction</strong>. They are typically encoded by different genes (gene duplication) or by alternative splicing, leading to variations in their amino acid sequences. Consequently, these distinct chemical structures result in different <strong>physical properties</strong>.</p>\n<ul>\n<li><strong>Isoenzymes (Isozymes):</strong> Multiple forms of an enzyme that catalyze the <strong>same chemical reaction</strong>.</li>\n<li><strong>Origin:</strong> Often arise from gene duplication or differential gene expression.</li>\n<li><strong>Differences:</strong>\n<ul>\n<li><strong>Chemically and Immunologically Different (Option A):</strong> Due to variations in amino acid sequence.</li>\n<li><strong>Different Physical Properties (Contradicts Option B):</strong> This is a key distinguishing feature (e.g., different electrophoretic mobilities, heat sensitivities, pH optima, substrate affinities).</li>\n<li><strong>May have different Quaternary Structures: </strong>Variations are common (e.g., LDH isoenzymes are tetramers with different combinations of H and M subunits). They are distinct forms, implying possible differences in quaternary structure.</li>\n</ul>\n</li>\n<li><strong>Functional Significance:</strong> Often adapted to specific tissues or physiological conditions, exhibiting subtle differences in regulatory properties or substrate affinity (e.g., Hexokinase vs. Glucokinase).</li>\n<li><strong>Clinical Significance:</strong> Used as diagnostic markers (e.g., Lactate Dehydrogenase (LDH) isoenzymes for myocardial infarction, Creatine Kinase (CK) isoenzymes for tissue damage).</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Isoenzymes are distinct forms of an enzyme that catalyze the same reaction, but they <strong>differ chemically, immunologically, and in their physical properties</strong> (including potentially their quaternary structure), allowing them to be separated and often exhibiting different kinetic or regulatory characteristics.</p>", "options": ["Chemically and immunologically different forms of an enzyme", "Same forms with similar physical properties", "Catalyse same reactions", "None of the above"], "html_options": ["Chemically and immunologically different forms of an enzyme", "Same forms with similar physical properties", "Catalyse same reactions", "None of the above"], "corr_idx": 1}, {"id": "1195655", "html_qtxt": "The enzyme cytochrome oxidase is inhibited by cyanide, and prevents electron transport, regardless of substrate concentration. This reaction is characterized by:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Cytochrome oxidase that is inhibited by cyanide, which binds to a site <em>other than the active site</em> and prevents the reaction (electron transport) regardless of substrate concentration.</li>\n<li>This mechanism is characteristic of <strong>noncompetitive inhibition</strong>. In noncompetitive inhibition, the inhibitor binds to an allosteric site, causing a conformational change that reduces the enzyme's catalytic efficiency.</li>\n<li>This leads to a <strong>decrease in the maximum reaction rate (Vmax)</strong> because the enzyme's ability to turn over substrates is impaired, even if the active site is saturated. However, since the inhibitor does not compete for the active site, the enzyme's <strong>affinity for the substrate (Km) remains unchanged</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Km increases whereas Vmax decreases (Option A):</strong> This kinetic profile is characteristic of <strong>mixed noncompetitive inhibition</strong>, where the inhibitor binds to both the free enzyme and the enzyme-substrate complex, but with different affinities. This is not the primary characteristic of the described inhibition.</p>\n<p><strong>Km increases whereas Vmax remain unchanged (Option B):</strong> This kinetic profile is the hallmark of <strong>competitive inhibition</strong>, where the inhibitor structurally resembles the substrate and competes for the active site, thus increasing the apparent Km.</p>\n<p><strong>Vmax increases while Km decreases (Option C):</strong> This combination of kinetic changes is not typically observed with any form of enzyme inhibition. Inhibition, by definition, leads to a reduction in activity, not an increase in Vmax.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The inhibition of cytochrome oxidase by cyanide, where cyanide binds to an allosteric site and reduces catalytic efficiency without affecting substrate binding, is a clear example of <strong>noncompetitive inhibition</strong>, characterized by a <strong>decreased Vmax and an unchanged Km</strong>.</p>", "options": ["Km increases whereas Vmax decreases", "Km increases whereas Vmax remain unchanged", "Vmax increases while Km decreases", "Vmax decreases while Km remains unchanged"], "html_options": ["Km increases whereas Vmax decreases", "Km increases whereas Vmax remain unchanged", "Vmax increases while Km decreases", "Vmax decreases while Km remains unchanged"], "corr_idx": 3}, {"id": "1195670", "html_qtxt": "Enzymes act by reducing the", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Enzymes as Catalysts. </strong>They accelerate reaction rates without being consumed in the process.</li>\n<li><strong>Mechanism of Action:</strong> Enzymes lower the <strong>activation energy barrier</strong> (&Delta;G&Dagger;).</li>\n<li><strong>Effect on Reaction Rate:</strong> Lowering activation energy increases the proportion of reactant molecules that can reach the transition state, thus increasing the reaction rate.</li>\n<li><strong>No Effect on Equilibrium:</strong> Enzymes do not change the overall free energy change (&Delta;G) of the reaction or the position of equilibrium. They only affect the <em>rate</em> at which equilibrium is reached.</li>\n<li><strong>Stabilization of Transition State:</strong> The enzyme's active site stabilizes the transition state intermediates, effectively binding to them more tightly than to either substrates or products.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Binding energy (Option B):</strong> While enzymes utilize binding energy (energy derived from non-covalent interactions between the enzyme and substrate) to achieve catalysis, they don't \"reduce\" binding energy in a way that directly explains their primary mode of action on the reaction. Instead, they <em>use</em> binding energy to lower the activation energy, particularly by stabilizing the transition state.</p>\n<p><strong>Heat energy (Option C):</strong> Enzymes do not directly act by reducing heat energy. They function optimally within specific temperature ranges, and excessive heat can denature them, but their catalytic mechanism is not about reducing ambient heat.</p>\n<p><strong>All of the above (Option D):</strong> Since only activation energy is correctly reduced by enzymes to accelerate reactions, this option is incorrect.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Enzymes function by exquisitely lowering the <strong>activation energy</strong> required for a biochemical reaction, thereby significantly increasing the reaction rate without altering the overall thermodynamics or equilibrium of the reaction.</p>", "options": ["Activation energy", "Binding energy", "Heat energy", "All of the above"], "html_options": ["Activation energy", "Binding energy", "Heat energy", "All of the above"], "corr_idx": 0}, {"id": "1195679", "html_qtxt": "All of the following sentences are true about protein acetylation except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Protein acetylation is a crucial post-translational modification, particularly on lysine residues. The statement \"Acetylation decreases the steric bulk of the lysine side chain\" is incorrect. In fact, acetylation <strong>increases</strong> the steric bulk of the lysine side chain by adding an acetyl group. This addition changes the chemical properties of the lysine residue, transforming its basic, positively charged primary amine into a neutral, nonionizable amide. This change in charge and steric bulk has significant implications for protein structure, function, and interactions, especially in histones, where it affects chromatin structure and gene expression.</p>\n<ul>\n<li><strong>Protein Acetylation:</strong> A common post-translational modification involving the addition of an acetyl group.</li>\n<li><strong>Target Residue:</strong> Primarily occurs on the &epsilon;-amino group of <strong>lysine</strong></li>\n<li><strong>Enzyme Catalysis:</strong>\n<ul>\n<li><strong>Lysine acetyltransferases (KATs) / Histone acetyltransferases (HATs):</strong> Catalyze the transfer of an acetyl group from <strong>acetyl-CoA</strong> to the lysine residue, forming N-&epsilon;-acetyllysine.<strong>(Option B)</strong></li>\n</ul>\n</li>\n<li><strong>Effect of Acetylation:</strong>\n<ul>\n<li><strong>Increases steric bulk:</strong> The addition of the acetyl group makes the lysine side chain bulkier.</li>\n<li><strong>Neutralizes Charge (Option D):</strong> Transforms the basic, positively charged primary amine of lysine into a neutral, nonionizable amide. This charge neutralization is critical for many functions, especially in DNA-protein interactions.</li>\n</ul>\n</li>\n<li><strong>Reversibility:</strong> Acetylation is a reversible modification.\n<ul>\n<li><strong>Protein deacetylases:</strong> Two classes exist:\n<ul>\n<li><strong>Histone deacetylases (HDACs):</strong> Catalyze the hydrolytic removal of acetyl groups.</li>\n</ul>\n</li>\n<li><strong>Biological Significance (Option A):</strong> Acetylation-deacetylation is widely recognized for its critical role in regulating <strong>histones</strong> (affecting chromatin structure and gene transcription) and many <strong>other nuclear and cytoplasmic proteins</strong> involved in metabolism, signaling, and cellular processes.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Protein acetylation, particularly on lysine residues, <strong>increases the steric bulk</strong> of the lysine side chain and neutralizes its positive charge, impacting protein structure and function, especially in histones and other regulatory proteins.</p>", "options": ["Acetylation-deacetylation has long been associated with histones and other nuclear proteins", "Lysine acetyltransferases catalyze the transfer of the acetyl group of acetyl-CoA to the the &epsilon;-amino groups of lysyl residues, forming N-acetyl lysine", "Acetylation decreases the steric bulk of the lysine side chain", "It transforms a basic and potentially positively charged primary amine into a neutral, nonionizable amide"], "html_options": ["Acetylation-deacetylation has long been associated with histones and other nuclear proteins", "Lysine acetyltransferases catalyze the transfer of the acetyl group of acetyl-CoA to the the &epsilon;-amino groups of lysyl residues, forming N-acetyl lysine", "Acetylation decreases the steric bulk of the lysine side chain", "It transforms a basic and potentially positively charged primary amine into a neutral, nonionizable amide"], "corr_idx": 2}, {"id": "1195683", "html_qtxt": "A researcher is studying the enzyme succinate dehydrogenase, which catalyzes the oxidation of succinate to fumarate in the tricarboxylic acid (TCA) cycle. In a set of experiments, the enzyme is exposed to increasing concentrations of mercury chloride (HgCl2). The addition of mercury leads to a progressive decline in enzymatic activity, which is not reversed by increasing the concentration of succinate. This type of enzyme inhibition is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The experiment describes the inhibition of succinate dehydrogenase by mercury chloride (HgCl2), a heavy metal. The critical observation is that the inhibition is <em>not reversed by increasing the substrate (succinate) concentration</em>. This is a hallmark of <strong>noncompetitive inhibition</strong>.</p>\n<p>Heavy metal ions like mercury typically act as noncompetitive inhibitors by binding to sites on the enzyme (often sulfhydryl groups) that are distinct from the active site.</p>\n<p>This binding induces conformational changes, impairing the enzyme's catalytic efficiency and leading to a <strong>decrease in the maximal reaction rate (Vmax)</strong>. Because the inhibitor does not compete with the substrate for the active site, the enzyme's <strong>affinity for the substrate (Km) remains unchanged</strong>.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Competitive inhibition (Choice A):</strong> In competitive inhibition, the inhibitor structurally resembles the substrate and competes for the active site. This increases the apparent Km but does not change Vmax. The described experiment explicitly states that increasing substrate concentration does <em>not</em> reverse the inhibition, ruling out competitive inhibition.</p>\n<p><strong>Allosteric inhibition (Choice C):</strong> Allosteric inhibition is a broader term where a molecule binds to a site other than the active site (an allosteric site) to change enzyme activity. Noncompetitive inhibition is a <em>type</em> of allosteric inhibition, but \"noncompetitive\" more precisely describes the kinetic outcome (Vmax down, Km unchanged) and the fact that the inhibition cannot be overcome by increased substrate.</p>\n<p><strong>Feedback inhibition (Choice D):</strong> Feedback inhibition is a specific regulatory mechanism where the end-product of a metabolic pathway inhibits an enzyme earlier in the same pathway. It's not a general mechanism of enzyme inhibition like that caused by heavy metals.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The experimental findings (inhibition not reversed by increased substrate) demonstrate <strong>noncompetitive inhibition</strong>, characterized by a <strong>decreased Vmax and an unchanged Km</strong>. This is the typical effect of heavy metals like mercury (HgCl2) on enzymes.</p>", "options": ["Competitive inhibition", "Non competitive inhibition", "Allosteric inhibition", "Feedback inhibition"], "html_options": ["Competitive inhibition", "Non competitive inhibition", "Allosteric inhibition", "Feedback inhibition"], "corr_idx": 1}, {"id": "1195687", "html_qtxt": "All of the following sentences are true about Suicidal inhibition except", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Suicidal inhibition</strong>, also knn as <strong>mechanism-based inactivation</strong> (Option A), is a unique type of irreversible enzyme inhibition.</li>\n<li>A key characteristic is that the inhibitor, initially resembling a substrate, is processed by the enzyme's catalytic mechanism to generate a highly reactive intermediate.</li>\n<li>This intermediate then forms a stable <strong>covalent bond with the enzyme, irreversibly inhibiting it</strong>(Option B).</li>\n<li>Because the enzyme's activity continuously decreases over the course of the assay as it self-inactivates, the fundamental assumption of constant enzyme activity required for standard kinetic analyses like the <strong>Lineweaver-Burk plot or the Dixon plot is violated</strong>.</li>\n<li>Therefore, these graphical methods are <strong>not applicable</strong> to analyze suicidal inhibition, making statement C incorrect. The inhibition of Ornithine Decarboxylase by Difluoromethylornithine (DFMO) in treating Trypanosomiasis is indeed a classic example of suicidal inhibition (Option D).</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Suicidal inhibition</strong> involves the enzyme's own catalytic activity converting a substrate-like molecule into a reactive species that <strong>irreversibly binds</strong> to and inactivates the enzyme. Because enzyme activity declines during the assay, standard steady-state kinetic plots like <strong>Lineweaver-Burk and Dixon are not applicable</strong>.</p>", "options": ["Otherwise called mechanism based inactivation", "Irreversibly bind to the enzyme and inhibit the enzyme", "Lineweaver-Burk or the Dixon approach is applicable to this inhibiton", ". Treatment of Trypanosomiasis by Difluoromethyl ornithine (DFMO) inhibit Ornithine Decarboxylase is example of suicidal inhibition"], "html_options": ["Otherwise called mechanism based inactivation", "Irreversibly bind to the enzyme and inhibit the enzyme", "Lineweaver-Burk or the Dixon approach is applicable to this inhibiton", ". Treatment of Trypanosomiasis by Difluoromethyl ornithine (DFMO) inhibit Ornithine Decarboxylase is example of suicidal inhibition"], "corr_idx": 2}, {"id": "1195691", "html_qtxt": "All of the following statements about allosteric regulations are true except", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Allosteric regulation involves a modifier (effector) binding to a site on the enzyme <strong>distinct from the active site</strong> (the allosteric site) to modulate catalytic activity. A key characteristic of allosteric regulation, distinguishing it from competitive inhibition, is that the <strong>modifier (effector) does NOT need to be a structural analogue of the substrate</strong>. Its binding alters the enzyme's conformation, affecting the active site's catalytic efficiency or substrate affinity.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Some allosteric enzymes act by cooperative binding (Option A):</strong> Cooperative binding is a common feature of multisubunit allosteric enzymes, where the binding of a ligand to one subunit influences the binding affinity of other subunits for the same or different ligands, leading to sigmoidal (S-shaped) kinetics.</p>\n<p><strong>Allosteric enzymes exist as two classes: K class and V class (Option B):</strong> Allosteric enzymes are indeed broadly categorized into K-class (affecting Km) and V-class (affecting Vmax), based on how their kinetic parameters are altered by allosteric effectors.</p>\n<p><strong>Allosteric enzymes are those for which catalysis at the active site may be modulated by the presence of effectors at the allosteric site (Option C):</strong> This statement provides the fundamental definition of an allosteric enzyme. The effector binds to a non-active site, causing conformational changes that transmit to the active site to alter catalysis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The defining characteristic of allosteric regulation, which differentiates it from competitive inhibition, is that the <strong>modifier (effector) binds to a site distinct from the active site and does NOT need to be a structural analogue of the substrate</strong>.</p>", "options": ["Some allosteric enzymes act by cooperative binding", "Allosteric enzymes exist as two classes: K class and V class", "Allosteric enzymes are those  for which catalysis at the active site may be  modulated by the presence of effectors at the allosteric site", "The modifier need  be a structural analogue of the substrate"], "html_options": ["Some allosteric enzymes act by cooperative binding", "Allosteric enzymes exist as two classes: K class and V class", "Allosteric enzymes are those  for which catalysis at the active site may be  modulated by the presence of effectors at the allosteric site", "The modifier need  be a structural analogue of the substrate"], "corr_idx": 3}, {"id": "1195692", "html_qtxt": "Which of the following molecules act as allosteric modulators for the enzyme phosphofructokinase", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Phosphofructokinase-1 (PFK-1) is a key regulatory enzyme in glycolysis, often referred to as the rate-limiting enzyme. Its activity is tightly regulated by various allosteric modulators that signal the energy status of the cell. Among the given options, <strong>ATP and Fructose 2,6-bisphosphate</strong> are well-established allosteric modulators for PFK-1.</p>\n<ul>\n<li><strong>ATP:</strong> High concentrations of ATP act as an <strong>allosteric inhibitor</strong> of PFK-1. This makes sense as ATP signals a high energy state, and therefore, further breakdown of glucose via glycolysis is not immediately needed.</li>\n<li><strong>Fructose 2,6-bisphosphate (F2,6BP):</strong> This molecule is the most potent <strong>allosteric activator</strong> of PFK-1 in the liver. Its concentration is regulated by the bifunctional enzyme PFK-2/FBPase-2, which itself is controlled by hormones like insulin and glucagon. F2,6BP signals an abundance of glucose (when insulin is high), promoting glycolysis.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Acyl CoA and citrate (Option A):</strong> While citrate is an allosteric inhibitor of PFK-1, Acyl CoA (Fatty acyl-CoA) does not directly regulate PFK-1; it primarily inhibits hexokinase and can activate pyruvate carboxylase.</p>\n<p><strong>CTP and ATP (Option B):</strong> ATP is an allosteric inhibitor of PFK-1. However, CTP (Cytidine triphosphate) is typically an allosteric inhibitor of enzymes involved in pyrimidine synthesis (e.g., aspartate transcarbamoylase), not directly PFK-1.</p>\n<p><strong>Acetyl CoA and NAD+ (Option C):</strong> Acetyl CoA and NAD+ are not direct allosteric modulators of PFK-1. Acetyl CoA is a key regulator of pyruvate dehydrogenase and pyruvate carboxylase, and NAD+ is a coenzyme for dehydrogenases involved in redox reactions.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>ATP (inhibitor)</strong> and <strong>Fructose 2,6-bisphosphate (activator)</strong> are critical and well-known allosteric modulators that regulate the activity of <strong>phosphofructokinase-1 (PFK-1)</strong>, the major control point of glycolysis.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811c38c081e-e5bf-4bab-b242-0cf41866e75d.png\">", "options": ["Acyl CoA and citrate", "CTP and ATP", "Acetyl CoA and NAD+", "ATP and Fructose 2,6 biphosphate"], "html_options": ["Acyl CoA and citrate", "CTP and ATP", "Acetyl CoA and NAD+", "ATP and Fructose 2,6 biphosphate"], "corr_idx": 3}, {"id": "1195694", "html_qtxt": "Which of the following mechanisms are associated with covalent modification", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Covalent modification is a crucial mechanism for regulating enzyme activity by adding or removing a chemical group through the formation or breakage of a covalent bond. This modification can either increase or decrease the enzyme's activity. All of them are well-established examples.</p>\n<ul>\n<li><strong>Types of Covalent Modification:</strong>\n<ul>\n<li><strong>Irreversible:</strong> Partial proteolysis (zymogen activation).</li>\n<li><strong>Reversible:</strong> Addition/removal of a chemical group.</li>\n</ul>\n</li>\n<li><strong>Common Methods of Reversible Covalent Modification:</strong>\n<ul>\n<li><strong>Phosphorylation/Dephosphorylation (Option A):</strong> The most common type. Involves the addition (by kinases) or removal (by phosphatases) of a phosphate group, typically to serine, threonine, or tyrosine residues.</li>\n<li><strong>Acetylation (Option B):</strong> The addition of an acetyl group, often to lysine residues. Important in histone modification and other cellular processes.</li>\n<li><strong>ADP-ribosylation (Option C):</strong> The addition of an ADP-ribose group, often by bacterial toxins.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Phosphorylation, acetylation, and ADP-ribosylation</strong> are all important mechanisms of <strong>covalent modification</strong>, where chemical groups are covalently attached to enzymes to regulate their activity.</p>", "options": ["Reversible phosphorylation", "Acetylation", "ADP-ribosylation", "All of above"], "html_options": ["Reversible phosphorylation", "Acetylation", "ADP-ribosylation", "All of above"], "corr_idx": 3}]}, {"moduleId": 1009772, "name": "Clinical application of Enzymes", "questions": [{"id": "1195705", "html_qtxt": "All of the covalent modifications regulate enzyme kinetics except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Glycosylation</strong>(the addition of carbohydrate chains) is a widespread covalent modification of proteins.</li>\n<li>Its primary role is generally <strong>not the direct, rapid regulation of enzyme <em>kinetics</em></strong> (i.e., increasing or decreasing catalytic activity, Vmax, or Km).</li>\n<li>Instead, it often influences the enzyme's proper localization, interaction with other molecules, or overall stability. In contrast, phosphorylation, acetylation, and ADP-ribosylation are well-established, rapid, and reversible covalent modifications that directly alter an enzyme's catalytic efficiency or substrate affinity, thereby regulating its kinetic behavior.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Phosphorylation (Option A):</strong> This is a primary and highly prevalent mechanism for regulating enzyme kinetics. The addition or removal of a phosphate group can drastically change an enzyme's conformation and catalytic activity.</p>\n<p><strong>Acetylation (Option B):</strong> This is a significant covalent modification that regulates the activity of numerous enzymes and proteins by altering their charge, hydrophobicity, and interactions, thereby affecting kinetics.</p>\n<p><strong>ADP Ribosylation (Option C):</strong> This is a known covalent modification that impacts enzyme activity and signaling pathways, demonstrating a direct role in kinetic regulation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>While all listed options are covalent modifications, <strong>glycosylation</strong> primarily impacts protein structure, localization, and recognition, whereas <strong>phosphorylation, acetylation, and ADP-ribosylation</strong> are prominent mechanisms that directly and rapidly regulate an enzyme's catalytic <strong>kinetics</strong>.</p>", "options": ["Phosphorylation", "Acetylation", "ADP Ribosylation", "Glycosylation"], "html_options": ["Phosphorylation", "Acetylation", "ADP Ribosylation", "Glycosylation"], "corr_idx": 3}, {"id": "1195706", "html_qtxt": "Which of the following does not directly affect the activity of an enzyme", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Induction</strong> regulates the <strong>quantity</strong> of an enzyme by controlling its synthesis, rather than directly affecting the activity of existing enzyme molecules.</p>\n<ul>\n<li>Enzyme regulation occurs at two main levels: <strong>regulation of enzyme activity</strong> (modulating intrinsic catalytic efficiency) and <strong>regulation of enzyme quantity</strong> (controlling enzyme protein amount).</li>\n<li><strong>Regulation of Enzyme Activity</strong> involves direct changes to the enzyme molecule, such as:\n<ul>\n<li>Allosteric Regulation.</li>\n<li><strong>Covalent Modification</strong>, which includes <strong>Phosphorylation/dephosphorylation</strong> (most common), <strong>Methylation</strong>, <strong>Acetylation</strong>, Adenylation, and ADP ribosylation.</li>\n</ul>\n</li>\n<li><strong>Regulation of Enzyme Quantity</strong> involves mechanisms like <strong>Control of Enzyme Synthesis</strong> (e.g., <strong>Induction</strong> and repression) and <strong>Control of Enzyme Degradation</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Methylation (Option A):</strong> Methylation is a type of <strong>reversible covalent modification</strong> that can directly alter an enzyme's catalytic efficiency.</li>\n<li><strong>Acetylation (Option B):</strong> Acetylation is a form of <strong>reversible covalent modification</strong> that can influence enzyme function by altering protein charge and structure.</li>\n<li><strong>Phosphorylation (Option D):</strong> Phosphorylation/dephosphorylation is the <strong>most common type of reversible covalent modification</strong> that directly regulates enzyme activity by inducing conformational changes.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Induction</strong> regulates the <strong>amount of enzyme synthesized</strong>, while <strong>covalent modifications (like methylation, acetylation, and phosphorylation) directly alter the activity</strong> of existing enzyme molecules.</p>", "options": ["Methylation", "Acetylation", "Induction", "Phosphorylation"], "html_options": ["Methylation", "Acetylation", "Induction", "Phosphorylation"], "corr_idx": 2}, {"id": "1195707", "html_qtxt": "Which of the following molecules are secreted as proproteins?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Proproteins</strong> are inactive precursor proteins that require selective proteolytic cleavage to become active. <strong>Pepsin</strong>, <strong>Trypsin</strong>, and <strong>Insulin</strong> are all examples of molecules synthesized and secreted as inactive proproteins (zymogens or prohormones) that are later activated by proteolytic processing.</p>\n<ul>\n<li>Certain proteins are synthesized as <strong>inactive precursor proteins known as proproteins</strong>.</li>\n<li>Selective proteolysis converts a proprotein into its mature, active form.</li>\n<li>The proprotein forms of enzymes are specifically called <strong>proenzymes or zymogens</strong>.</li>\n<li>Examples of proteins synthesized as proproteins include:\n<ul>\n<li>The hormone <strong>insulin</strong> (as proinsulin).</li>\n<li>The digestive enzymes <strong>pepsin</strong> (as pepsinogen), <strong>trypsin</strong> (as trypsinogen), and chymotrypsin (as chymotrypsinogen).</li>\n<li>Several factors of the blood clotting and complement cascades.</li>\n<li>The connective tissue protein collagen (as procollagen).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Many important biological molecules, including digestive enzymes like <strong>pepsin</strong> and <strong>trypsin</strong>, and hormones like <strong>insulin</strong>, are initially synthesized and secreted as <strong>inactive proproteins</strong> (or zymogens/prohormones) that require proteolytic processing to become functionally active.</p>", "options": ["Pepsin", "Trypsin", "Insulin", "All of the above"], "html_options": ["Pepsin", "Trypsin", "Insulin", "All of the above"], "corr_idx": 3}, {"id": "1195708", "html_qtxt": "A patient with chronic pancreatitis is found to have impaired digestion of dietary proteins. Biochemical analysis reveals reduced activation of certain precursor enzymes secreted by the pancreas. One such precursor, which is inactive until cleaved in the small intestine to form an active protease that cleaves peptide bonds within protein chains, is best classified as which of the following?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The clinical scenario describes an inactive pancreatic precursor enzyme that requires cleavage to become an active protease. Such inactive precursors of enzymes are precisely defined as <strong>zymogens</strong> or proenzymes. The impaired activation due to chronic pancreatitis further supports this, as pancreatic enzymes are typically secreted as zymogens to prevent autodigestion.</p>\n<ul>\n<li><strong>Zymogens</strong> are inactive precursor forms of enzymes that are activated by selective, or 'partial', proteolysis.</li>\n<li>This activation is an example of <strong>irreversible covalent modification</strong>.</li>\n<li>Examples of pancreatic zymogens include trypsinogen and chymotrypsinogen, which are precursors to the digestive enzymes trypsin and chymotrypsin, respectively. These are crucial for protein digestion and become active endopeptidases (cleaving within protein chains) upon activation in the small intestine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Carboxypeptidase (Option B):</strong> <strong>This is an incorrect classification.</strong> Carboxypeptidases are a type of <strong>exopeptidase</strong> - enzymes that cleave amino acids specifically from the <strong>carboxyl (C-) end</strong> of a polypeptide chain. The description states the active form cleaves \"peptide bonds <em>within</em> protein chains,\" indicating an endopeptidase, not an exopeptidase like carboxypeptidase.</p>\n<p><strong>Transaminase (Option C):</strong> <strong>This is an incorrect classification.</strong> Transaminases (or aminotransferases) are enzymes that catalyze the transfer of an amino group between an amino acid and a &alpha;-keto acid. This is a distinct class of enzyme involved in amino acid metabolism, not protein digestion via proteolysis.</p>\n<p><strong>Exopeptidase (Option D):</strong> Exopeptidases cleave amino acids from the <strong>ends</strong> of polypeptide chains (either the N-terminus or C-terminus). The question explicitly states the active enzyme cleaves \"peptide bonds <em>within</em> protein chains,\" which is the definition of an endopeptidase. Therefore, the precursor cannot be classified as an exopeptidase.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Inactive precursors of enzymes, especially those involved in digestion like the one described, are known as <strong>zymogens</strong>, which undergo proteolytic activation to perform their catalytic function.</p>", "options": ["Zymogen", "Carboxypeptidase", "Transaminase", "Exopeptidase"], "html_options": ["Zymogen", "Carboxypeptidase", "Transaminase", "Exopeptidase"], "corr_idx": 0}, {"id": "1195720", "html_qtxt": "Markers of plasma membrane is/are:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>5'nucleotidase</strong> is a well-established and commonly used enzymatic marker for the <strong>plasma membrane</strong>. Different membranes within a cell have unique protein compositions, including specific enzymes that serve as markers to identify them.</p>\n<ul>\n<li>Every type of membrane possesses a <strong>different complement of proteins</strong>, including enzymes, which serve as <strong>markers of specific organelles and membranes</strong>.</li>\n<li>The <strong>plasma membrane</strong> contains various enzymes, pumps, transporters, channels, and receptors.</li>\n<li><strong>5'nucleotidase</strong> is an enzyme found on the outer surface of the plasma membrane, involved in the hydrolysis of nucleoside monophosphates. Its presence and activity are widely used to identify plasma membrane fractions in biochemical studies.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Galactosyltransferase (Option A):.</strong>Galactosyltransferase is primarily an enzyme of the <strong>Golgi apparatus</strong>, specifically involved in glycosylation processes within the Golgi lumen.</p>\n<p><strong>Tyrosinase (Option C):</strong>Tyrosinase is a key enzyme involved in melanin synthesis and is primarily located in the <strong>melanosomes</strong> (specialized organelles) of melanocytes. It is not a marker for the plasma membrane.</p>\n<p><strong>ATP synthetase (Option D):</strong> ATP synthetase (also known as ATP synthase) is a crucial enzyme involved in ATP production. In eukaryotes, it is primarily located in the <strong>inner mitochondrial membrane</strong> (oxidative phosphorylation). It is not a marker for the plasma membrane. </p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811d5780181-3aec-4485-9d47-75e526100d9a.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>5'nucleotidase</strong> is a commonly used and specific enzymatic marker for the <strong>plasma membrane</strong>, reflecting its unique protein composition.</p>", "options": ["Galactosyltransferase", "5'nucleotidase", "Tyrosinase", "ATP synthetase"], "html_options": ["Galactosyltransferase", "5'nucleotidase", "Tyrosinase", "ATP synthetase"], "corr_idx": 1}, {"id": "1195726", "html_qtxt": "Non-functional enzymes are all except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Lipoprotein lipase</strong> is classified as a <strong>functional enzyme</strong>. Functional enzymes are those that have specific, active roles in the plasma. In contrast, non-functional enzymes have no specific function in the serum and are typically present at very low levels, only rising significantly during tissue injury.</p>\n<ul>\n<li><strong>Functional enzymes</strong> are enzymes that have <strong>specific functions in the plasma</strong>.\n<ul>\n<li>Examples include <strong>Lipoprotein Lipase</strong>, Activated Coagulation Factors, Anti-coagulation proteins (Protein C & S), Activated Complement Factors, Pseudocholinesterase, and Butyrylcholinesterase.</li>\n</ul>\n</li>\n<li><strong>Non-functional enzymes</strong> are enzymes that have <strong>no specific function in the serum</strong>.\n<ul>\n<li>They are released from tissues due to normal wear and tear, or significantly increase in level during tissue injury, thus serving as <strong>diagnostic markers for tissue damage</strong>.</li>\n<li>Examples include LDH, Creatine Kinase, <strong>Alkaline Phosphatase</strong>, and <strong>Gamma glutamyl transpeptidase</strong>. Acid phosphatase is also generally considered a non-functional enzyme in serum, increasing in conditions like prostate cancer.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Alkaline phosphatase (Option A):</strong> Alkaline phosphatase is released into the serum from various tissues (e.g., bone, liver, intestine) and its elevated levels are used as a diagnostic marker for conditions affecting these organs, rather than having a specific physiological function in the plasma.</p>\n<p><strong>Acid phosphatase (Option B):</strong> Acid phosphatase (particularly prostatic acid phosphatase, PAP) is released into the serum from the prostate and is a marker for prostate conditions; it does not have a defined plasma function.</p>\n<p><strong>Gamma glutamyl transpeptidase (Option D):</strong> Gamma glutamyl transpeptidase (GGT) is primarily found in the liver, kidney, and pancreas. Its elevation in serum is a sensitive indicator of liver and biliary tract disease, thus functioning as a diagnostic marker rather than having a specific plasma role.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Lipoprotein lipase</strong> is a <strong>functional enzyme</strong> with a specific role in lipid metabolism in the plasma, unlike Alkaline phosphatase, Acid phosphatase, and Gamma glutamyl transpeptidase, which are <strong>non-functional enzymes</strong> whose elevated serum levels primarily indicate tissue injury or disease.</p>", "options": ["Alkaline phosphatase", "Acid phosphatase", "Lipoprotein lipase", "Gamma glutamyl transpeptidase"], "html_options": ["Alkaline phosphatase", "Acid phosphatase", "Lipoprotein lipase", "Gamma glutamyl transpeptidase"], "corr_idx": 2}, {"id": "1195728", "html_qtxt": "Peroxidase enzyme is used in estimating:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Peroxidase</strong>, in conjunction with glucose oxidase, is specifically used in diagnostic techniques to <strong>estimate glucose</strong> levels in biological fluids. Enzymes are employed in diagnostic methods to ensure specificity in analyte estimations, often by producing a measurable color reaction.</p>\n<ul>\n<li>Enzymes make methods for blood analyte estimations <strong>specific</strong>.</li>\n<li>For example, <strong>glucose oxidase</strong> and <strong>peroxidase</strong> are specifically used together to <strong>estimate glucose</strong>.</li>\n<li>Peroxidase is also used in techniques like ELISA (Enzyme-Linked Immunosorbent Assay), where an antibody tagged with peroxidase is used to identify the presence of another antibody in circulation by producing a color reaction.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hemoglobin (Option A):</strong> Hemoglobin estimation typically involves methods like cyanmethemoglobin or direct spectrophotometry, which do not directly use peroxidase enzyme for quantitation.</p>\n<p><strong>Ammonia (Option B):</strong>Ammonia estimation often involves enzymatic methods using enzymes like glutamate dehydrogenase, but not peroxidase for its direct quantitation.</p>\n<p><strong>Creatinine (Option C):</strong> Creatinine estimation commonly uses methods like the Jaffe reaction or enzymatic assays involving creatininase, creatinase, and sarcosine oxidase, but not peroxidase for its direct quantitation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Peroxidase enzyme</strong>, often in conjunction with glucose oxidase, is specifically utilized in diagnostic assays for the <strong>estimation of glucose</strong> in biological samples.</p>", "options": ["Hemoglobin", "Ammonia", "Creatinine", "Glucose"], "html_options": ["Hemoglobin", "Ammonia", "Creatinine", "Glucose"], "corr_idx": 3}, {"id": "1195733", "html_qtxt": "Which of the following estimates blood creatinine level most accurately:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The <strong>Enzyme assay (Enzymatic method)</strong> is considered the most accurate method because it is highly specific for creatinine, eliminating interference from other substances like ketones, bilirubin, or glucose that can affect chemical methods.</p>\n<ul>\n<li>Blood creatinine levels can be estimated by two main methods: <strong>Chemical Method (based on Jaffe's Test)</strong> and <strong>Enzymatic method</strong>.</li>\n<li>The <strong>Enzymatic method</strong> employs enzymes such as creatininase or creatinine deaminase.</li>\n<li>It is <strong>more specific</strong> and shows <strong>no interference by ketones, bilirubin, or glucose</strong>.</li>\n<li>This lack of interference allows it to <strong>measure creatinine accurately</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Jaffe method (Option A):</strong> The Jaffe method is a chemical method based on the reaction of creatinine with picrate in an alkaline medium to form a red-colored complex. However, it is prone to <strong>interference</strong> from non-creatinine chromogens like ketones, bilirubin, and glucose, leading to overestimation of creatinine.</p>\n<p><strong>Kinetic Jaffe method (Option B):</strong> The Kinetic Jaffe method is an improvement over the traditional Jaffe method, as it measures the rate of color formation rather than just the final color intensity, which helps minimize some interference. However, it still suffers from some non-specific reactions that the enzymatic method avoids.</p>\n<p><strong>Technicon method (Option C):</strong> While Technicon auto-analyzers can perform creatinine estimations, they typically use chemical methods (often automated Jaffe or kinetic Jaffe). Therefore, its accuracy is limited by the underlying chemical principle, making it less accurate than a dedicated enzymatic assay in terms of specificity.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The <strong>Enzyme assay</strong> is the <strong>most accurate method</strong> for estimating blood creatinine levels due to its high specificity and lack of interference from non-creatinine substances that plague chemical methods like the Jaffe reaction.</p>", "options": ["Jaffe method", "Kinetic Jaffe method", "Technicon method", "Enzyme assay"], "html_options": ["Jaffe method", "Kinetic Jaffe method", "Technicon method", "Enzyme assay"], "corr_idx": 3}, {"id": "1195736", "html_qtxt": "Which of the following is not raised in liver disorder is:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Lipase</strong> is an enzyme primarily associated with the <strong>pancreas</strong> and is elevated in conditions affecting the pancreas, such as pancreatitis. In contrast, ALP, AST, and SGOT are commonly elevated in various liver disorders.</p>\n<li><strong>Non-functional enzymes</strong> are useful diagnostic markers because their levels in blood plasma rise significantly during tissue injury, helping to identify the site of injury.</li>\n<li>Enzymes are valuable in <strong>clinical diagnosis</strong>, with their quantitative analysis providing information on diagnosis, prognosis, and treatment response for various disease processes.</li>\n<li>While enzymes are not absolutely specific for a single disease, general patterns of elevation indicate organ involvement.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>ALP (Alkaline Phosphatase) (Option B):</strong> <strong>This enzyme is commonly raised in liver disorders.</strong> Elevated ALP levels are particularly indicative of <strong>cholestatic liver diseases</strong> (e.g., bile duct obstruction, cholestasis), infiltrative liver diseases, and also bone disorders.</p>\n<p><strong>AST (Aspartate Aminotransferase) (Option C):</strong> <strong>This enzyme is commonly raised in liver disorders.</strong> AST (also known as SGOT) is found in various tissues, including the liver, heart, and skeletal muscle. Elevated AST levels are a key indicator of <strong>hepatocellular injury</strong> (e.g., hepatitis, cirrhosis), although they are not entirely liver-specific.</p>\n<p><strong>SGOT (Serum Glutamic Oxaloacetic Transaminase) (Option D):</strong> <strong>This enzyme is commonly raised in liver disorders.</strong> SGOT is an older name for <strong>AST (Aspartate Aminotransferase)</strong>. Therefore, like AST, elevated SGOT levels are a common indicator of <strong>liver cell damage</strong>.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Lipase</strong> is primarily a marker for <strong>pancreatic disorders</strong>, while <strong>ALP, AST (SGOT)</strong> are well-known enzymes whose elevated levels are commonly observed in various <strong>liver disorders</strong>, indicative of cholestasis or hepatocellular injury.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081145a8913b-ef8e-4fc9-a787-12fae57e76a1.png\">", "options": ["Lipase", "ALP", "AST", "SGOT"], "html_options": ["Lipase", "ALP", "AST", "SGOT"], "corr_idx": 0}, {"id": "1195738", "html_qtxt": "LDH-5 level elevated in which cell injury:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>Lactate Dehydrogenase (LDH) has five isoenzymes, and <strong>isozyme LDH-5 predominates in the liver</strong>. Therefore, an elevation of LDH-5 levels in the serum is indicative of liver cell injury.</p>\n<ul>\n<li>Lactate Dehydrogenase (LDH) is a tetrameric enzyme composed of H (heart) and M (muscle) monomer types, forming five isoenzymes: LDH-1 (HHHH), LDH-2 (HHHM), LDH-3 (HHMM), LDH-4 (HMMM), and LDH-5 (MMMM).</li>\n<li>The relative proportions of H and M subunits, and thus the distribution of each LDH isoenzyme, are tissue-specific.</li>\n<li><strong>Isozyme LDH-5 predominates in the liver</strong>.</li>\n<li>Tissue injury leads to the release of a characteristic pattern of LDH isoenzymes, which can be identified by electrophoresis.</li>\n<li><strong>LDH-1 has the fastest electrophoretic mobility</strong>, and <strong>LDH-5 has the least electrophoretic mobility</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Heart (Option B):</strong> <strong>Isozyme LDH-1 predominates in heart tissue</strong>. Therefore, LDH-1, not LDH-5, would be primarily elevated in heart cell injury (e.g., myocardial infarction).</p>\n<p><strong>Muscle (Option C):</strong> While LDH-5 (MMMM) is rich in M subunits, which are prevalent in muscle, <strong>LDH-5 is primarily associated with the liver</strong>. Muscle (skeletal muscle) also contains LDH-5, but liver is the predominant source. However, Creatine Kinase (CK) is a more specific and sensitive marker for muscle injury.</p>\n<p><strong>RBC (Red Blood Cells) (Option D):</strong> Red blood cells contain significant amounts of <strong>LDH-1 and LDH-2</strong>. Hemolysis (RBC injury) would typically lead to an elevation of these isoenzymes, not predominantly LDH-5. </p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508119742fb7d-351a-4b13-a769-ca4c0d3c0f11.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>LDH-5</strong> is the isoenzyme of lactate dehydrogenase that primarily <strong>predominates in the liver</strong>, making its elevation a marker for <strong>liver cell injury</strong>.</p>", "options": ["Liver", "Heart", "Muscle", "RBC"], "html_options": ["Liver", "Heart", "Muscle", "RBC"], "corr_idx": 0}, {"id": "1195749", "html_qtxt": "An isoenzyme variant of the following enzymes appear during pregnancy:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Alkaline Phosphatase (ALP)</strong>has a specific isoenzyme, <strong>placental ALP (PL-ALP)</strong>, which is synthesized by the placenta and significantly increases in maternal serum during pregnancy. This makes ALP the correct answer.</p>\n<ul>\n<li><strong>Isoenzymes</strong> are physically distinct forms of the same enzyme that catalyze the same reaction but are synthesized from the same or various tissues.</li>\n<li>During pregnancy, the <strong>placenta synthesizes a specific isoenzyme of Alkaline Phosphatase (ALP)</strong>, known as placental ALP (PL-ALP).</li>\n<li>The level of PL-ALP in maternal serum significantly <strong>increases throughout pregnancy</strong>, particularly in the third trimester.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>LDH (Lactate Dehydrogenase) (Option A):</strong> While LDH has various isoenzymes (LDH-1 to LDH-5) distributed in different tissues (e.g., heart, liver, muscle, RBCs), there isn't a specific LDH isoenzyme variant that characteristically appears or significantly increases due to pregnancy itself, distinct from tissue injury.</p>\n<p><strong>CK (Creatine Kinase) (Option B):</strong> CK has three main isoenzymes (CK-MM, CK-MB, CK-BB) associated primarily with skeletal muscle, heart, and brain/smooth muscle, respectively. While CK levels might show some variation during pregnancy (e.g., related to labor), there isn't a specific CK isoenzyme variant that characteristically appears <em>during</em> pregnancy as a physiological marker.</p>\n<p><strong>ADH (Alcohol Dehydrogenase) (Option D):</strong> ADH is primarily involved in alcohol metabolism and is found mainly in the liver and stomach. There is no specific isoenzyme variant of ADH known to appear or significantly increase during pregnancy.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Alkaline Phosphatase (ALP)</strong> has a specific isoenzyme, <strong>placental ALP (PL-ALP)</strong>, which is a physiological marker that appears and increases significantly in maternal serum during pregnancy.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508113e521600-4477-449f-b835-da9666878278.png\">", "options": ["LDH", "CK", "ALP", "ADH"], "html_options": ["LDH", "CK", "ALP", "ADH"], "corr_idx": 2}, {"id": "1195751", "html_qtxt": "Which of the following mechanisms elevate the levels of intracellular enzymes in plasma?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>All listed options tissue damage resulting in cell membrane disruption, increase in cell turnover, and neoplasia-can lead to increased plasma levels of intracellular enzymes. <strong>Tissue damage resulting in cell membrane disruption</strong> directly releases enzymes from the cytoplasm into the plasma. <strong>Increased cell turnover</strong> and <strong>neoplasia</strong> involve increased cell death (apoptosis/necrosis) or altered membrane permeability in rapidly dividing or abnormal cells, leading to enzyme leakage into the bloodstream.</p>\n<ul>\n<li>Enzymes are often released into plasma following <strong>cell death or injury</strong>.</li>\n<li>These released enzymes, though performing no physiological function in plasma, serve as <strong>biomarkers</strong> for diagnosing and prognosticating diseases affecting specific tissues.</li>\n<li>Following injury, the plasma concentration of a released enzyme may rise. Proteins resident to the cytoplasm tend to appear more rapidly.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tissue damage resulting in cell membrane disruption (Option A):</strong> When cells are damaged, their <strong>cell membranes are disrupted</strong>, leading to the direct leakage of intracellular enzymes from the cytoplasm into the bloodstream. This is a primary cause of elevated enzyme levels, as seen in myocardial infarction or hepatitis.</p>\n<p><strong>Increase in cell turnover (Option B):</strong> An <strong>increase in cell turnover</strong>, meaning a higher rate of cell death and regeneration, can lead to a continuous release of intracellular enzymes into the plasma. Even physiological turnover involves some release, but an accelerated rate (e.g., in certain proliferative or destructive conditions) will elevate levels.</p>\n<p><strong>Neoplasia (Option C):</strong> <strong>Neoplasia (cancer)</strong> involves uncontrolled cell proliferation and often increased cell death (necrosis or apoptosis) within the tumor, as well as altered membrane integrity of neoplastic cells. This leads to the leakage of intracellular enzymes into the plasma, and some enzymes can even be aberrantly produced by tumor cells, serving as tumor markers.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Elevated levels of intracellular enzymes in plasma serve as biomarkers, indicating cellular pathology. This elevation can result from various mechanisms including direct <strong>tissue damage causing cell membrane disruption</strong>, a general <strong>increase in cell turnover</strong>, or specific pathological processes like <strong>neoplasia</strong>, all leading to the release of these enzymes from within cells into the bloodstream.</p>", "options": ["Tissue damage resulting in cell membrane disruption", "Increase in cell turnover", "Neoplasia", "All of above"], "html_options": ["Tissue damage resulting in cell membrane disruption", "Increase in cell turnover", "Neoplasia", "All of above"], "corr_idx": 3}, {"id": "1195753", "html_qtxt": "All of the following statements are true about biomarkers of myocardial infarction except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>ALT (Alanine Aminotransferase)</strong> was one of the early enzymes used to diagnose MI, it is known to <strong>appear in plasma relatively slowly</strong> and is <strong>not specific to heart muscle</strong>. Liver is the primary source of ALT. Therefore, stating that ALT levels peak at 36-48 hours and are a key MI marker is incorrect in the context of specific and timely MI diagnosis. Modern guidelines emphasize cardiac-specific markers that appear much earlier.</p>\n<ul>\n<li><strong>Cardiac Biomarkers</strong> for MI include Creatine Kinase (CK-MB), Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT), and Myoglobin.</li>\n<li>Enzymes that appear in plasma <strong>12 hours or more following injury are of limited utility</strong> for early MI diagnosis.</li>\n<li>AST and ALT were among the first enzymes used, but they proved less than ideal due to <strong>slow appearance in plasma and lack of specificity to heart muscle</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Elevation in myoglobin levels is considered to be the earliest marker (Option A):</strong> Myoglobin is a small protein released very rapidly from damaged muscle cells, typically within 1-4 hours after MI onset. This makes it one of the <strong>earliest detectable markers</strong> of myocardial injury.</p>\n<p><strong>Troponin I and T, though not enzymes, serve as markers in the diagnosis of MI (Option B):</strong> Cardiac troponins (cTnI and cTnT) are regulatory proteins unique to cardiac muscle. They are <strong>highly specific and sensitive biomarkers</strong> for myocardial necrosis and are the <strong>gold standard</strong> for MI diagnosis, despite not being enzymes themselves.</p>\n<p><strong>CK-MB elevated in 3-6 h following MI (Option C):</strong> Creatine Kinase-MB (CK-MB) is an isoenzyme primarily found in cardiac muscle. Its levels typically <strong>rise within 3-6 hours</strong> following the onset of myocardial infarction, making it a useful early to intermediate marker for MI.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>While <strong>ALT</strong> was historically considered in MI, its <strong>slow appearance and lack of cardiac specificity</strong> make it an unreliable marker for acute MI diagnosis. <strong>Myoglobin</strong> is the earliest detectable marker, and <strong>cardiac troponins (cTnI/cTnT)</strong> are the most specific and sensitive biomarkers, with <strong>CK-MB</strong> also being an early to intermediate marker.</p>", "options": ["Elevation in myoglobin levels is considered to be the earliest marker", "Troponin I and T , though not enzymes, serve as markers in the diagnosis of MI.", "CK-MB elevated in 3-6 h following MI.", "ALT level elevated to the peak at 36-48 h following MI."], "html_options": ["Elevation in myoglobin levels is considered to be the earliest marker", "Troponin I and T , though not enzymes, serve as markers in the diagnosis of MI.", "CK-MB elevated in 3-6 h following MI.", "ALT level elevated to the peak at 36-48 h following MI."], "corr_idx": 3}]}, {"moduleId": 1010640, "name": "Ph, Buffers and Acid Base disorder", "questions": [{"id": "1192067", "html_qtxt": "In the chemical equilibrium HA &#8652; H &#8314; + A&#8315;, which of the following correctly represents the conjugate acid-base pair?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>A <strong>conjugate base</strong> forms when an <strong>acid loses</strong> a <strong>proton</strong></li>\n<li>A <strong>conjugate acid</strong> forms when a <strong>base</strong> <strong>gains</strong> a <strong>proton</strong></li>\n<li>The pair <strong>always differs</strong> by exactly <strong>one hydrogen ion</strong></li>\n  <li>In the equation: HA &#8652; H&#8314; + A&#8315;,\n<ul>\n<li>HA <strong>donates a proton (H&#8314;)</strong> and is thus the <strong>acid</strong></li>\n<li><strong>A&#8315;</strong>, which results from HA after <strong>losing a proton</strong>, is the <strong>conjugate base.</strong></li>\n<li>Hence, HA and A&#8315; form the conjugate acid-base pair.</li>\n</ul>\n</li>\n</ul>", "options": ["HA and H+", "HA and A<sup>-</sup>", "H+ and A<sup>-</sup>", "A<sup>-</sup>and H+"], "html_options": ["HA and H+", "HA and A<sup>-</sup>", "H+ and A<sup>-</sup>", "A<sup>-</sup>and H+"], "corr_idx": 1}, {"id": "1192071", "html_qtxt": "Which of the following is the major inorganic anion present in intracellular fluid (ICF)?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Phosphate</strong> is the <strong>predominant inorganic anion</strong> within the <strong>intracellular fluid (ICF),</strong> playing essential roles in buffering and cellular function.</li>\n<li>Phosphate plays critical roles in cellular function, including ATP buffering, enzyme regulation, and intracellular pH maintenance.</li>\n<li><strong>The intracellular fluid (ICF)</strong> differs significantly from the <strong>extracellular fluid (ECF)</strong> in its ionic composition:</li>\n  <li>The ICF is<strong> rich in potassium (K&#8314;) and magnesium (Mg&#178;&#8314;)</strong></li>\n<li>ECF, in contrast, is dominated by Na&#8314; and ClA&#8315;.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Chloride (Option A):</strong> It is the major anion in extracellular fluid.</p>\n<p><strong>Bicarbonate (Option B)</strong>: While bicarbonate is found in both compartments, its concentration is higher in ECF than in ICF.</p>\n<p><strong>Sulphate (Option D)</strong>: It is present in ICF but not in concentrations as high as phosphate, which dominates intracellular buffering.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816c8c18b3f-38aa-47e4-819e-2bf503067e2a.png\">", "options": ["Chloride", "Bicarbonate", "Phosphate", "Sulphate"], "html_options": ["Chloride", "Bicarbonate", "Phosphate", "Sulphate"], "corr_idx": 2}, {"id": "1192075", "html_qtxt": "A 30-year-old male was admitted to the hospital with the following investigation reports: Blood pH: 7.21, Bicarbonate: 19 mmol/l, plasma sodium: 140 mmol/l, plasma chloride: 113 mmol/l. From which of the following is the most probable underlying disease?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p>The patient has <strong>normal anion gap metabolic acidosis (NAGMA),</strong> most commonly caused by <strong>bicarbonate loss in diarrhoea.</strong></p>\n<ul>\n<li>pH 7.21: Indicates <strong>acidemia</strong></li>\n<li>Low bicarbonate (19 mmol/L): Points toward <strong>metabolic acidosis</strong></li>\n<li><strong>Anion gap </strong>= 140 - (113 + 19) = 8 mmol/L</li>\n<li>This is a <strong>normal anion gap metabolic acidosis(NAGMA).</strong></li>\n<li><strong>Acute diarrhoeal disease </strong>leads to<strong> bicarbonate-rich stool loss - NAGMA.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Acute renal failure (Option B)</strong>: Leads to <strong>retention of acids</strong> (sulfate, phosphate) &rarr; <strong>high anion gap.</strong></p>\n<p><strong>Type B lactic acidosis (Option C):</strong> Elevated lactic acid &rarr; increased unmeasured anions &rarr; <strong>high anion gap acidosis.</strong></p>\n<p><strong>Adrenal hyperplasia (Option D): </strong>Due to hyperaldosteronism, causes<strong> H<sup>+</sup> loss</strong> and <strong>alkalosis</strong>, not acidosis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Causes of NAGMA include:</p>\n<ul>\n<li><strong>Diarrhoea</strong> (bicarbonate loss from the gut)</li>\n<li><strong>Renal tubular acidosis</strong></li>\n<li><strong>Ureteral diversions</strong></li>\n</ul>", "options": ["Acute diarrhoeal disease", "Acute renal failure", "Type B lactic acidosis", "Adrenal hyperplasia"], "html_options": ["Acute diarrhoeal disease", "Acute renal failure", "Type B lactic acidosis", "Adrenal hyperplasia"], "corr_idx": 0}, {"id": "1192080", "html_qtxt": "Which of the following is the most important and major physiological buffer system in the human body?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>bicarbonate buffer system</strong> is the most <strong>important and predominant</strong> buffer in extracellular fluid, providing a first-line defence against pH changes.</li>\n</ul>\n<p><strong>Body Buffer Systems</strong></p>\n<ul>\n<li>The human body uses <strong>multiple buffer systems</strong> to maintain <strong>acid-base balance.</strong></li>\n<li>Among these, the <strong>bicarbonate buffer system is the most important</strong> and <strong>predominant</strong> in the <strong>extracellular fluid (ECF).</strong></li>\n<li>It plays a <strong>first-line defence</strong> role against changes in blood pH, especially in response to <strong>acid load</strong>.</li>\n</ul>\n<p><strong>Components of the Bicarbonate Buffer System:</strong></p>\n<ul>\n  <li><strong>HCO&#8323;&#8315; (bicarbonate ion)</strong> &rarr; base component, regulated by the <strong>kidneys</strong></li>\n<li><strong>H&#8322;CO&#8322; (carbonic acid)</strong> &rarr; acid component, regulated by the <strong>lungs</strong> through <strong>CO&#8322; exhalation</strong></li>\n<li>The buffering action is explained by the <strong>Henderson-Hasselbalch equation</strong>:</li>\n<li>pH = pKa + log ([HCO&#8323;&#8315;]/[H&#8322;CO&#8323;])</li>\n<li>Due to its <strong>efficient interaction</strong> between the <strong>respiratory</strong> (lungs) and <strong>metabolic</strong> (renal) components, it is considered the <strong>most effective physiological buffer</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phosphate buffer (Option A): </strong> It primarily buffers the <strong>intracellular compartment</strong> and <strong>urine</strong>.</p>\n<p><strong>Haemoglobin buffer (Option C):</strong> Significant in <strong>red blood cells</strong>, especially buffering <strong>CO&#8322;</strong>, but not the primary systemic buffer.</p>\n<p><strong>Albumin buffer (Option D):</strong> Albumin contributes to plasma buffering, but is <strong>less significant</strong> than the bicarbonate system.</p>", "options": ["Phosphate buffer", "Bicarbonate buffer", "Haemoglobin buffer", "Albumin buffer"], "html_options": ["Phosphate buffer", "Bicarbonate buffer", "Haemoglobin buffer", "Albumin buffer"], "corr_idx": 1}, {"id": "1192084", "html_qtxt": "Which of the following is not a renal mechanism for regulating pH in the body?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n  <li>The kidneys <strong>do not excrete bicarbonate; instead, they reabsorb filtered HCO&#8323;&#8315;</strong> to maintain acid-base balance, making its excretion an incorrect option.</li>\n</ul>\n<p><strong>Renal Mechanisms for pH Regulation:</strong></p>\n<ul>\n<li>The kidneys play a <strong>crucial role</strong> in regulating the <strong>body's pH</strong>, primarily through the <strong>excretion</strong> and <strong>reabsorption</strong> of different ions. The mechanisms involved include:\n<ol>\n<li><strong>Reabsorption of filtered HCO&#8323;&#8315;</strong> Rather than<strong> excreting bicarbonate,</strong> the kidneys <strong>reabsorb filtered bicarbonate ions</strong> to help <strong>maintain the body's pH balance.</strong></li>\n<li><strong>Excretion of H&#8314; ions (Option A):</strong> The kidneys <strong>excrete excess hydrogen ions</strong> to help <strong>acidify the urine</strong>, thereby reducing the body's acid load.</li>\n<li><strong>Excretion of H&#8314; ions as titratable acidity</strong> <strong>(Option C):</strong> The kidneys also excrete hydrogen ions in a form that can be titrated (e.g., <strong>bound to phosphate</strong>), which helps buffer the blood pH.</li>\n<li><strong>Excretion of NH&#8324;&#8314; ions</strong> <strong>(Option D):</strong> Ammonium ions (NH&#8324;&#8314;) are excreted in the urine as part of the body's mechanism to eliminate excess acid.</li>\n</ol>\n</li>\n<li>Therefore, the excretion of HCO&#8323;&#8315; <strong>does not</strong> contribute to pH regulation, but rather its reabsorption does.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>The kidneys regulate pH by <strong>excreting</strong> H&#8314; ions, <strong>reabsorbing</strong> bicarbonate, and <strong>excreting</strong> NH&#8324;&#8314; ions.</li>\n<li>The normal urinary pH is typically around <strong>0</strong>, which is <strong>lower</strong> than the <strong>blood pH</strong> (7.4).</li>\n<li><strong><strong>Acidification of urine</strong> helps the body to eliminate acids and <strong>prevent acidosis</strong></strong></li>\n</ul>", "options": ["Excretion of H+ ions", "Excretion of HCO3-", "Excretion of H+ ion as titrable acidity", "Excretion of NH4+ ions"], "html_options": ["Excretion of H+ ions", "Excretion of HCO3-", "Excretion of H+ ion as titrable acidity", "Excretion of NH4+ ions"], "corr_idx": 1}, {"id": "1192085", "html_qtxt": "A patient with congestive cardiac failure is started on acetazolamide as a diuretic. Prolonged administration of this drug is most likely to result in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Acetazolamide</strong> causes <strong>urinary alkalinization</strong> by inhibiting carbonic anhydrase, which impairs H<sup>+</sup> secretion and bicarbonate reabsorption.</li>\n</ul>\n<p><strong>Mechanism of Acetazolamide</strong>:</p>\n<ul>\n<li><strong>Acetazolamide</strong> is a <strong>carbonic anhydrase inhibitor</strong> that acts in the <strong>proximal tubules</strong> of the nephron.</li>\n<li>It inhibits carbonic anhydrase, <strong>reducing H<sup>+</sup> secretion</strong> into the tubular lumen.</li>\n<li><strong>Impairs bicarbonate reabsorption</strong>, leading to increased bicarbonate excretion in urine. <strong>(Option D ruled out)</strong></li>\n<li>The net effect is <strong>reduced acid secretion </strong>and<strong> retention of base,</strong> &rarr; <strong>alkaline urine. (Options A and B ruled out)</strong></li>\n<li>It is often used to manage <strong>metabolic alkalosis, glaucoma</strong>, and <strong>altitude sickness.</strong></li>\n</ul>", "options": ["Acidic urine", "Increase in titerable acidity of urine", "Alkaline urine", "Decreased bicarbonate excretion"], "html_options": ["Acidic urine", "Increase in titerable acidity of urine", "Alkaline urine", "Decreased bicarbonate excretion"], "corr_idx": 2}, {"id": "1192098", "html_qtxt": "Which of the following best describes the primary chemical change seen in respiratory acidosis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Respiratory acidosis</strong> is a form of acid-base imbalance resulting from <strong>hypoventilation</strong>, where there is <strong>accumulation of CO&#8322;</strong> in the blood.</li>\n<li>CO&#8322; combines with water to form <strong>carbonic acid (H&#8322;CO&#8323;):\n  CO&#8322; + H&#8652;H&#8322;CO&#8323;\n H&#8314; + HCO&#8323;&#8315;</strong></li>\n<li>Therefore, <strong>increased CO&#8322; leads to increased H&#8322;CO&#8323;, lowering the blood pH.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Decrease in H&#8322;CO&#8323; concentration (Option A): </strong>A decrease occurs in <strong>respiratory alkalosis</strong>, not acidosis.</p>\n<p><strong>Decrease in bicarbonate (HCO&#8323;&#8315;) (Option B):</strong> Seen in <strong>metabolic acidosis</strong>, not respiratory forms</p>\n<p><strong>Increase in bicarbonate (HCO&#8323;&#8315;) (Option (D):</strong> not seen initially, occurs later as <strong>renal compensation </strong>in<strong> chronic cases.</strong></p>", "options": ["Decrease in H2CO3 concentration", "Decrease in bicarbonate (HCO3&oline;) concentration", "Increase in H2CO3 concentration", "Increase in bicarbonate (HCO3&oline;) concentration"], "html_options": ["Decrease in H2CO3 concentration", "Decrease in bicarbonate (HCO3&oline;) concentration", "Increase in H2CO3 concentration", "Increase in bicarbonate (HCO3&oline;) concentration"], "corr_idx": 2}, {"id": "1192100", "html_qtxt": "Non-anion gap metabolic acidosis is typically seen in which of the following conditions?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Renal tubular acidosis (RTA)</strong> is a primary cause of <strong>normal anion gap metabolic acidosis (NAGMA),</strong> resulting from impaired acid excretion or defective bicarbonate reabsorption.</li>\n  <li>The anion gap (AG) is calculated as: AG = Na&#8314;- (Cl&#8315; + HCO&#8323;&#8315;)</li>\n<li>Normal range: 8-12 mmol/L</li>\n<li>A <strong>normal anion gap metabolic acidosis (NAGMA)</strong>, also called <strong>hyperchloremic acidosis</strong>, is due to loss of bicarbonate or failure to excrete H&#8314;, compensated by increased chloride.</li>\n<li><strong>Renal tubular acidosis</strong> occurs when <strong>tubular reabsorption </strong>of<strong> bicarbonate</strong> is <strong>defective</strong> or when <strong>acid excretion</strong> is <strong>impaired</strong>, without retention of unmeasured anions. This leads to normal AG metabolic acidosis.</li>\n</ul>\n<p><strong>Other causes</strong> of <strong>NAGMA</strong> :</p>\n<ul>\n<li><strong>Gastrointestinal causes like diarrhoea</strong></li>\n<li><strong>intestinal fistula</strong></li>\n<li><strong>Administration of acetazolamide</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lactic acidosis (Option A): High anion gap</strong> due to <strong>lactate accumulation</strong></p>\n<p><strong>Ketoacidosis (Option B): </strong>Elevated <strong>ketone</strong> bodies cause <strong>high AG metabolic acidosis</strong></p>\n<p><strong>Methanol poisoning (Option D):</strong> Generates formic acid, an unmeasured anion &rarr; <strong>high AG</strong></p>", "options": ["Lactic acidosis", "Ketoacidosis", "Renal tubular acidosis", "Methanol poisoning"], "html_options": ["Lactic acidosis", "Ketoacidosis", "Renal tubular acidosis", "Methanol poisoning"], "corr_idx": 2}, {"id": "1192102", "html_qtxt": "Which of the following biochemical changes is observed in the uncompensated phase of metabolic alkalosis?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In the <strong>uncompensated</strong> phase of <strong>metabolic alkalosis</strong>, there is an <strong>increase in plasma bicarbonate concentration</strong>, leading to an <strong>elevation in total CO&#8322; content</strong>.</li>\n<li>This condition can arise due to:</li>\n<li><strong>Vomiting</strong> or <strong>gastric suction (loss of HCl)</strong></li>\n<li><strong>Diuretic</strong> use</li>\n<li>Excess <strong>alkali intake</strong></li>\n</ul>\n<p>In the <strong>uncompensated</strong> phase, the following occurs:</p>\n<ul>\n  <li><strong>[HCO&#8323;]</strong> <strong>increases</strong> disproportionately <strong>(Option A ruled out)</strong></li>\n<li><strong>[H&#8322;CO&#8323;]</strong> remains <strong>unchanged</strong> or normal <strong>(Option D ruled out)</strong></li>\n<li>Total CO&#8322; content increases (since total CO&#8322; = HCO&#8323;&#8315; + dissolved CO&#8322; + carbonic acid). Hence, there is a rise in total CO&#8322; content.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816d850373d-3193-43a6-a79b-472635b4649d.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Decrease in ratio of [HCO&#8323;&#8315;]/[H&#8322;CO&#8323;] (Option C): </strong>The ratio increases due to a <strong>rise</strong> in HCO&#8323;&#8315;</p>", "options": ["Disproportionate decrease in [HCO3-]", "Increase in total CO2 content", "Decrease in ratio of [HCO3-] / [H2CO3]", "Decrease in [H2CO3]"], "html_options": ["Disproportionate decrease in [HCO3-]", "Increase in total CO2 content", "Decrease in ratio of [HCO3-] / [H2CO3]", "Decrease in [H2CO3]"], "corr_idx": 1}, {"id": "1192245", "html_qtxt": "All of the following anticoagulants will chelate calcium and so inhibit coagulation, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Heparin does not chelate calcium</strong>; instead, it acts by <strong>enhancing antithrombin III</strong> activity, unlike EDTA, citrate, and oxalate, which inhibit coagulation via calcium chelation.</li>\n</ul>\n<p><strong>Mechanisms of Anticoagulation</strong>:</p>\n<ul>\n<li>Most <strong>anticoagulants</strong> used in laboratory practice act by <strong>chelating calcium ions</strong> (Ca&sup2;<sup>+</sup>), which are <strong>essential cofactors </strong>in the<strong> coagulation cascade</strong>. Without calcium, <strong>fibrin clot formation</strong> is blocked.</li>\n<li><strong>EDTA, citrate, </strong>and<strong> oxalate</strong> act as calcium chelators, thereby inhibiting clot formation.</li>\n<li>These are commonly used in tubes for <strong>blood collection</strong>, especially when plasma is required for <strong>biochemical analysis</strong>.</li>\n</ul>\n<p><strong>Heparin</strong>, however, acts differently. It <strong>does not chelate calcium</strong>.</p>\n<p>Instead, it works by <strong>activating</strong> <strong>antithrombin III</strong>, which then <strong>inhibits thrombin</strong> and <strong>factor Xa</strong>, <strong>directly blocking coagulation pathways.</strong></p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Calcium</strong> is essential for the <strong>coagulation cascade.</strong></li>\n</ul>", "options": ["EDTA", "Heparin", "Citrate", "Oxalate"], "html_options": ["EDTA", "Heparin", "Citrate", "Oxalate"], "corr_idx": 1}, {"id": "1192248", "html_qtxt": "Which of the following methods is most commonly used to measure electrolytes such as sodium and potassium in clinical laboratories?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Electrolytes</strong> such as <strong>sodium (Na&#8314;), potassium (K&#8314;), chloride (Cl&#8315;)</strong> and others are most commonly measured using <strong>ion-selective electrodes</strong> (ISEs).</li>\n<li>This method is based on <strong>potentiometry</strong>, which measures the <strong>electric potential difference</strong> generated across a selective membrane.</li>\n<li>This technique is widely used in <strong>blood gas analysers</strong> and <strong>automated clinical chemistry platforms.</strong></li>\n<li>It provides <strong>rapid, accurate, </strong>and<strong> direct measurement</strong> of ion concentrations in serum or plasma.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>High-pressure liquid chromatography (HPLC) (Option A): </strong>Used for separating and <strong>analysing</strong> <strong>complex mixtures</strong> (e.g., drugs, amino acids, metabolites), not used for routine electrolyte measurement.</p>\n<p><strong>Absorption spectrophotometry (Option B):</strong> Used for <strong>enzyme activity assays</strong>, bilirubin, creatinine, etc., but not suitable for ions like Na&#8314; or K&#8314;.</p>\n<p><strong><strong>Fluorescence spectrophotometry (Option D): </strong>Used for <strong>detecting</strong> <strong>substances</strong> that <strong>fluoresce</strong>, such as certain hormones, drugs, or vitamins, not routine for electrolytes.</strong></p>", "options": ["High-pressure liquid chromatography", "Absorption spectrophotometry", "Potentiometry", "Fluorescence spectrophotometry"], "html_options": ["High-pressure liquid chromatography", "Absorption spectrophotometry", "Potentiometry", "Fluorescence spectrophotometry"], "corr_idx": 2}, {"id": "1192255", "html_qtxt": "Which of the following is true about the estimation of serum creatinine?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Serum creatinine</strong> levels remain <strong>within normal limits</strong> until there's a <strong>significant reduction (~50%) in glomerular filtration rate (GFR). </strong></li>\n<li>Therefore, early renal damage may not be detected, making this test <strong>less sensitive for early renal dysfunction.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Increased only in case of renal diseases (Option B):</strong> Apart from renal diseases, the Creatinine level is also increased in <strong>muscular diseases </strong>when muscle is damaged in large amounts due to their increased production, like <strong>myositis, myasthenia gravis, crush injury, etc</strong></p>\n<p><strong>End product of protein catabolism (Option C): </strong>Creatinine is a <strong>waste product</strong> formed in <strong>muscle from Creatine phosphate</strong> present in muscle. (Creatine Phosphate &rarr; Creatine &rarr; Creatinine). Then it is excreted in urine by the kidneys. <strong>Urea </strong>is an<strong> end product </strong>of<strong> protein </strong>and<strong> amino acid catabolism</strong>. Urea is produced by detoxification of NH3 in the liver (NH3 &rarr; Urea), then excreted by the kidneys in urine.</p>\n<p><strong>Serum Urea is a better marker than serum creatinine for estimation of renal function (Option D): Creatinine</strong> is a <strong>better</strong> marker than <strong>urea</strong>, as urea is influenced by <strong>diet, liver function, hydration status, </strong>and has<strong> greater variability.</strong></p>", "options": ["Test with poor sensitivity", "Increased only in case of renal diseases", "End product of protein catabolism", "Serum Urea is a better marker than serum creatinine for estimation of renal function"], "html_options": ["Test with poor sensitivity", "Increased only in case of renal diseases", "End product of protein catabolism", "Serum Urea is a better marker than serum creatinine for estimation of renal function"], "corr_idx": 0}, {"id": "1192269", "html_qtxt": "A compound ideal for the accurate measurement of renal clearance (GFR) should have which of the following characteristics?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>An ideal compound for determining <strong>glomerular filtration rate</strong> (GFR) should fulfil the following criteria:\n<ul>\n<li>Be <strong>freely filtered</strong> <strong>by the glomerulus</strong></li>\n<li>Be neither <strong>reabsorbed</strong> nor <strong>secreted</strong> by renal tubules<strong> (Option A and B ruled out )</strong></li>\n<li>Be <strong>excreted solely by the kidneys</strong> (no extra-renal excretion) <strong>(Option D ruled out)</strong></li>\n<li>Have a <strong>stable plasma concentration.</strong></li>\n</ul>\n</li>\n<li><strong>Inulin</strong> is considered the <strong>gold standard</strong> as it is freely filtered and not handled by renal tubules. However, due to the need for IV infusion, it is used mostly in research.</li>\n<li><strong>Creatinine</strong>, although commonly used in practice, <strong>slightly overestimates GFR</strong> because tubules secrete a small amount.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Inulin</strong> is <strong>ideal</strong>, <strong>creatinine</strong> is <strong>practical,</strong> but overestimates GFR.</li>\n</ul>", "options": ["Reabsorbed by tubules", "Secreted by tubules", "Freely filtered by the glomerulus", "Excreted by the extrarenal route"], "html_options": ["Reabsorbed by tubules", "Secreted by tubules", "Freely filtered by the glomerulus", "Excreted by the extrarenal route"], "corr_idx": 2}]}, {"moduleId": 1010642, "name": "Biological Membrane, Cytoskeleton & ECM", "questions": [{"id": "1192105", "html_qtxt": "Which of the following enzymes serves as a marker for the membrane of the endoplasmic reticulum (ER)?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Glucose-6-phosphatase</strong> is found in the membrane of the <strong>endoplasmic reticulum (ER), specifically the smooth ER</strong>, where it plays a critical role in <strong>gluconeogenesis</strong> and <strong>glycogenolysis</strong>, converting glucose-6-phosphate to free glucose.</li>\n<li><strong>ER</strong> functions in <strong>gluconeogenesis, lipid synthesis, and protein folding.</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816CGxqO.png\">", "options": ["5'-Nucleotidase", "Adenyl cyclase", "ATP synthase", "Glucose 6 phosphatase"], "html_options": ["5'-Nucleotidase", "Adenyl cyclase", "ATP synthase", "Glucose 6 phosphatase"], "corr_idx": 3}, {"id": "1192107", "html_qtxt": "Which of the following membrane proteins do not require detergents for their solubilisation and release from the membrane?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Ankyrin</strong> is a <strong>peripheral membrane protein</strong> that is not embedded in the lipid bilayer and can be released by salt solutions-<strong>no detergents required</strong>.</li>\n<li><strong>Integral membrane proteins</strong> (e.g., <strong>ion channels, GPCRs, Glycophorin A</strong>) are embedded within the lipid bilayer and interact with the <strong>hydrophobic</strong> core of the membrane.</li>\n<li>These <strong>require detergents</strong> to <strong>disrupt lipid-protein interactions</strong> and allow <strong>solubilization</strong>. <strong>(Options A, B and D ruled out)</strong></li>\n<li><strong>Peripheral membrane proteins</strong> (e.g., <strong>Ankyrin</strong>, Spectrin) are bound to the polar head groups of lipids or to other integral membrane proteins.</li>\n<li>These can be released by <strong>salt solutions </strong>of<strong> high ionic strength-no detergents needed.</strong></li>\n</ul>", "options": ["Ion channels", "G proteins", "Ankyrin", "Glycophorin A"], "html_options": ["Ion channels", "G proteins", "Ankyrin", "Glycophorin A"], "corr_idx": 2}, {"id": "1192110", "html_qtxt": "In which of the following membranes is the mass ratio of protein to lipid the highest?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The <strong>inner mitochondrial membrane</strong> has the highest <strong>protein-to-lipid ratio</strong>, owing to its dense packing of protein complexes <strong>involved in oxidative phosphorylation</strong>.</li>\n<li><strong>Membrane protein content</strong> is highly variable. The amount of <strong>proteins equals</strong> or <strong>exceeds</strong> the quantity of lipids in nearly all membranes. The outstanding exception is myelin, an electrical insulator found on many nerve fibres.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508167nW9A.png\">", "options": ["Outer mitochondrial membrane", "Inner mitochondrial membrane", "Myelin sheath", "RBC membrane"], "html_options": ["Outer mitochondrial membrane", "Inner mitochondrial membrane", "Myelin sheath", "RBC membrane"], "corr_idx": 1}, {"id": "1192113", "html_qtxt": "Which of the following lipids is present in the highest amount by mass in the membranes of human cells?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The major lipids in mammalian membranes are <strong>phospholipids</strong>, <strong>glycosphingolipids</strong> & <strong>cholesterol</strong>.</li>\n<li>Among these, <strong>phospholipids</strong> are the <strong>dominant lipid</strong> class, and within phospholipids, <strong>phosphatidylcholine (PC)</strong> is the most abundant <strong>phosphoglyceride by mass</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sphingomyelin (Option A):</strong> Important structural lipid, <strong>especially in neural tissue</strong>, but not the most abundant overall</p>\n<p><strong>Glycosphingolipid (Option B):</strong> Present in smaller amounts, mostly at the <strong>outer plasma membrane </strong>for<strong> signalling/recognition.</strong></p>\n<p><strong>Cholesterol (Option D): Most abundant sterol</strong>, modulates <strong>membrane fluidity</strong>, but less by mass than <strong>phosphatidylcholine.</strong></p>", "options": ["Sphingomyelin", "Glycosphingolipid", "Phosphatidylcholine", "Cholesterol"], "html_options": ["Sphingomyelin", "Glycosphingolipid", "Phosphatidylcholine", "Cholesterol"], "corr_idx": 2}, {"id": "1192115", "html_qtxt": "All of the following sentences are true regarding the plasma membrane, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>plasma membrane</strong> is composed primarily of a <strong>phospholipid bilayer</strong> with <strong>embedded proteins </strong>and<strong> cholesterol</strong>. Its structure creates a hydrophobic core, making it a <strong>selective barrier.</strong></li>\n<li>Phospholipids are <strong>amphipathic</strong>, possessing both <strong>hydrophilic</strong> (polar) and <strong>hydrophobic</strong> (non-polar) regions. They spontaneously form bilayers in aqueous environments.</li>\n<li>The <strong>hydrophobic interior </strong>of<strong> the membrane</strong> <strong>prevents free diffusion</strong> of most<strong> water-soluble (polar) substances </strong>such as<strong> ions, sugars, and amino acids</strong>. These substances require <strong>channel proteins</strong> or <strong>transporters</strong> to cross the membrane.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Detergents are used for protein solubilization (Option A): </strong>Commonly used to <strong>extract</strong> and <strong>stabilise</strong> membrane proteins during biochemical analysis.</p>\n<p><strong>Membrane lipids form bilayers (Option B):</strong> Lipid bilayers are the foundational structure of biological membranes.</p>\n<p><strong>Membrane lipids are amphipathic (Option C): </strong>Amphipathic nature is crucial for bilayer formation and membrane dynamics.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816BjQU6.png\">", "options": ["Detergents are widely used to solubilise and purify membrane proteins", "Membrane Lipids Form Bilayers", "Membrane Lipids Are Amphipathic", "Membrane is permeable to most water-soluble molecules"], "html_options": ["Detergents are widely used to solubilise and purify membrane proteins", "Membrane Lipids Form Bilayers", "Membrane Lipids Are Amphipathic", "Membrane is permeable to most water-soluble molecules"], "corr_idx": 3}, {"id": "1192119", "html_qtxt": "Which of the following molecules has the lowest permeability coefficient?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Sodium</strong>, being a <strong>charged ion,</strong> has the <strong>lowest permeability coefficient</strong> across lipid membranes due to the <strong>hydrophobic core</strong> acting as a <strong>strong barrier to polar and charged species. </strong></li>\n<li>The <strong>permeability coefficient</strong> is a measure of the ability of a molecule to <strong>diffuse</strong> <strong>across</strong> a <strong>permeability barrier</strong>.</li>\n<li>Molecules that move rapidly through a given membrane are said to have a high permeability coefficient.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816hJ1e6.png\">\n<p>So <strong>Sodium </strong>has the <strong>lowest permeability coefficient</strong> than Glucose <strong>(Option B),</strong> Tryptophan <strong>(Option C)</strong> & Glycerol <strong>(Option D)</strong>.</p>", "options": ["Sodium", "Glucose", "Tryptophan", "Glycerol"], "html_options": ["Sodium", "Glucose", "Tryptophan", "Glycerol"], "corr_idx": 0}, {"id": "1192125", "html_qtxt": "Membranes are an asymmetric structure. Which of the following components is present in higher amounts in the inner leaflet of the membrane?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Phospholipid asymmetry</strong> is a hallmark of biological membranes.</p>\n<ul>\n<li>The <strong>inner (cytosolic) leaflet</strong> is enriched with: <strong>Phosphatidylethanolamine,</strong> also called <strong>cephalin,</strong> and</li>\n<li>The <strong>outer leaflet</strong> contains: <strong>Phosphatidylcholine</strong> <strong>(lecithin)</strong>and <strong> (Options A and C ruled out)</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sugar (Option D) </strong>(glycoconjugates): <strong>Carbohydrates</strong> are usually attached to proteins/lipids on the <strong>outer surface</strong> of the plasma membrane</p>", "options": ["Lecithin", "Cephalin", "Sphingomyelin", "Sugar"], "html_options": ["Lecithin", "Cephalin", "Sphingomyelin", "Sugar"], "corr_idx": 1}, {"id": "1192131", "html_qtxt": "The temperature at which the membrane structure undergoes the transition from ordered to disordered (melting) is called the transition temperature (Tm). The fluidity of membranes is dependent on the lipid composition of the membrane, especially fatty acids. Which of the following types of fatty acids will increase the Tm value?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Long-chain fatty acids increase the Tm</strong> because longer hydrocarbon chains result in <strong>stronger van der Waals interactions</strong> between fatty acid tails, making the <strong>membrane more rigid and requiring more heat (higher temperature) to disrupt</strong>.</li>\n<li>The <strong>Tm (transition temperature)</strong> of membranes reflects how easily <strong>fatty acid chains</strong> within the bilayer shift from a <strong>rigid</strong> (gel-like) to a <strong>fluid</strong> It is affected by <strong>chain length </strong>and<strong> saturation</strong>:</li>\n</ul>\n<p><strong>Explanation of Other options:</strong></p>\n<p><strong>Short chain fatty acids (Option A): </strong>Decrease Tm due to reduced chain interactions</p>\n<p><strong>Unsaturated fatty acids (Option C): </strong>Introduce kinks, disrupt alignment &rarr; <strong>lower</strong> <strong>Tm</strong></p>\n<p><strong>Cis fatty acids (Option D): Increase</strong> <strong>membrane fluidity</strong> &rarr; <strong>lower &trade;</strong></p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Long saturated chains = high Tm (less fluid)</li>\n<li>Short or unsaturated chains = low Tm (more fluid)</li>\n<li>Membrane fluidity is essential for function and responsiveness</li>\n</ul>", "options": ["Short-chain fatty acids", "Long-chain fatty acids", "Unsaturated fatty acid", "Cis fatty acids"], "html_options": ["Short-chain fatty acids", "Long-chain fatty acids", "Unsaturated fatty acid", "Cis fatty acids"], "corr_idx": 1}, {"id": "1192137", "html_qtxt": "All of the following are features of caveola, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Caveolae</strong> are <strong>flask-shaped</strong> <strong>invaginations</strong> of the <strong>plasma membrane</strong>, enriched in cholesterol, sphingolipids, and the protein <strong>caveolin</strong>. <strong>(Option A)</strong></li>\n<li>They are considered <strong>specialised lipid raft (Option D)</strong> domains involved in:\n<ul>\n<li><strong>Endocytosis</strong></li>\n<li><strong>Signal transduction</strong></li>\n<li><strong>Mechanical stress sensing</strong></li>\n</ul>\n</li>\n<li><strong>Caveolin</strong>, the structural protein essential for caveola formation, is <strong>anchored</strong> to the <strong>inner leaflet </strong>of the<strong> plasma membrane</strong> via <strong>palmitoyl anchors</strong> (fatty acyl modifications). <strong>(Option B)</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816UpTHa.png\">", "options": ["It is an invagination in the plasma membrane.", "A protein, caveolin, plays an important role in the formation of caveolae", "Each caveolin monomer is anchored to the outer leaflet of the plasma membrane", "Caveolae may derive from lipid rafts."], "html_options": ["It is an invagination in the plasma membrane.", "A protein, caveolin, plays an important role in the formation of caveolae", "Each caveolin monomer is anchored to the outer leaflet of the plasma membrane", "Caveolae may derive from lipid rafts."], "corr_idx": 2}, {"id": "1192143", "html_qtxt": "Which of the following mechanisms is responsible for the cross-membrane movement of large molecules?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Cross-membrane movement</strong> of <strong>large molecules</strong> occurs by <strong>Endocytosis</strong> and <strong>Exocytosis</strong></li>\n<li><strong>Exocytosis</strong> involves <strong>fusion</strong> of <strong>intracellular vesicles </strong>with the<strong> plasma membrane</strong>, allowing bulk release of substances like <strong>hormones</strong> and <strong>neurotransmitters</strong>.</li>\n<li><strong>Cross membrane movement</strong> of <strong>small molecules</strong> occurs by <strong>Passive</strong> or <strong>Simple diffusion</strong> <strong>(Option A)</strong>, <strong>Facilitated diffusion</strong> <strong>(Option B)</strong> and <strong>Active transport</strong> <strong>(Option C)</strong>.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816CwSYt.png\">", "options": ["Simple diffusion", "Facilitated diffusion", "Active transport", "Exocytosis"], "html_options": ["Simple diffusion", "Facilitated diffusion", "Active transport", "Exocytosis"], "corr_idx": 3}, {"id": "1192150", "html_qtxt": "Which of the following filaments are termed microfilaments?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>cytoskeleton</strong> is a dynamic network of filamentous proteins critical for <strong>cell</strong> <strong>shape, motility, division, and intracellular transport</strong>. It is composed of:\n<ul>\n<li><strong>Microfilaments</strong> (Actin filaments)</li>\n<li><strong>Intermediate filaments (Option A ruled out) </strong></li>\n<li><strong>Microtubules (Option C ruled out) </strong></li>\n</ul>\n</li>\n<li>Actin filaments are the <strong>thinnest cytoskeletal fibres</strong> (diameter ~7 nm)</li>\n<li>Composed of <strong>G-actin monomers</strong> that polymerise to form <strong>F-actin</strong> (filamentous)</li>\n<li>Involved in:</li>\n<li><strong>Cell motility</strong></li>\n<li><strong>Endocytosis and exocytosis</strong></li>\n<li><strong>Cytokinesis</strong></li>\n<li><strong>Membrane integrity</strong></li>\n</ul>\n<p>Found in <strong>stress fibres, microvilli, </strong>and<strong> cortical actin networks.</strong></p>\n<p><strong>Explanation of other options: </strong></p>\n<p><strong>Myosin filaments (Option D): </strong>Motor proteins, not structural filaments of the cytoskeleton.</p>", "options": ["Intermediate filaments", "Actin filaments", "Microtubules", "Myosin filaments"], "html_options": ["Intermediate filaments", "Actin filaments", "Microtubules", "Myosin filaments"], "corr_idx": 1}, {"id": "1192153", "html_qtxt": "A 40-year-old male has a problem of infertility and chronic respiratory infection. He was probably diagnosed with Kartagener syndrome after many biochemical investigations. A mutation in the genes affecting the synthesis of which of the following proteins, which are involved in the movement of cilia and flagella, has been detected in this patient?", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Kartagener syndrome</strong> is a form of <strong>primary ciliary dyskinesia</strong> (PCD).</li>\n<li>It is caused by a genetic defect in <strong>dynein</strong> arms, leading to <strong>immotile cilia</strong> and <strong>flagella</strong>.</li>\n<li>This results in:\n<ul>\n<li>Male infertility (due to immotile sperm)</li>\n<li>Recurrent respiratory infections (due to impaired mucociliary clearance)</li>\n<li>Situs inversus (in ~50% of cases)</li>\n</ul>\n</li>\n<li><strong>Dynein</strong>, a <strong>microtubule-associated motor protein</strong>, provides <strong>ATP-powered movement</strong> along the minus end of <strong>microtubules</strong>. In <strong>axonemal cilia </strong>and<strong> flagella</strong>, dynein arms generate sliding forces required for <strong>motility</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Kinesin (Option (A):</strong> Moves cargo toward the plus end of microtubules (<strong>anterograde axonal transport</strong>), not involved in cilia movement.</p>\n<p><strong>Dynamin (Option B)</strong>: GTPase involved in <strong>endocytosis</strong>, not in ciliary or flagellar movement</p>\n<p><strong>Myosin (Option D)</strong>: <strong>Motor protein </strong>for<strong> actin filaments</strong>, relevant to muscle contraction, not microtubule-based cilia</p>", "options": ["Kinesin", "Dynamin", "Dynein", "Myosin"], "html_options": ["Kinesin", "Dynamin", "Dynein", "Myosin"], "corr_idx": 2}, {"id": "1192158", "html_qtxt": "A 60-year-old male presents with gout and is prescribed a drug that targets microtubule polymerisation to alleviate symptoms by inhibiting leukocyte chemotaxis. While reviewing his medication history, you note he is also receiving antifungal therapy and has previously undergone chemotherapy for Hodgkin lymphoma.<br> Which of the following medications in his list does not act by binding to microtubules?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Ciprofloxacin does not affect microtubules but inhibits bacterial DNA topoisomerase and gyrase.</strong></li>\n<li>Ciprofloxacin is a <strong>fluoroquinolone antibiotic</strong> that functions by <strong>inhibiting DNA replication</strong> in bacteria.</li>\n<li>It targets <strong>bacterial DNA topoisomerase II (gyrase)</strong> and <strong>topoisomerase IV</strong>, thus preventing DNA unwinding during replication. It does <strong>not interfere with microtubule function</strong> and is unrelated to the cytoskeletal system.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Colchicine (Option B):</strong> Binds to tubulin and <strong>prevents microtubule polymerisation</strong>, used in the treatment of <strong>acute gout</strong> to block <strong>leukocyte chemotaxis</strong>.</p>\n<p><strong>Vinblastine (Option C):</strong> A <strong>vinca alkaloid</strong> that binds to tubulin and inhibits <strong>mitotic spindle formation</strong>, commonly used in chemotherapy.</p>\n<p><strong>Griseofulvin (Option D:</strong> An <strong>antifungal agent</strong> that binds to fungal microtubules and disrupts <strong>mitosis</strong> by interfering with the mitotic spindle.</p>", "options": ["Ciprofloxacin", "Colchicine", "Vinblastine", "Griseofulvin"], "html_options": ["Ciprofloxacin", "Colchicine", "Vinblastine", "Griseofulvin"], "corr_idx": 0}, {"id": "1192161", "html_qtxt": "A 12-year-old male presents with signs of premature ageing, including alopecia, wrinkled skin, and skeletal abnormalities. Genetic analysis reveals a mutation in the LMNA gene, which encodes lamin A, a nuclear structural protein. Lamins belong to which of the following classes of cytoskeletal filaments?", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li><strong>Lamins</strong> are a subtype of <strong>intermediate filaments</strong>, specifically located in the <strong>nuclear lamina</strong>.</li>\n<li>They provide <strong>mechanical</strong> <strong>support</strong> to the <strong>nuclear envelope</strong> and are crucial for <strong>nuclear shape, integrity, </strong>and<strong> chromatin organisation.</strong></li>\n<li><strong>Lamin A mutations</strong> cause <strong>Hutchinson-Gilford Progeria Syndrome (HGPS),</strong> a rare disorder marked by <strong>accelerated ageing</strong> due to <strong>defective nuclear scaffolding.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Microfilaments (Option B):</strong> Composed of actin; involved in motility and shape, not nuclear structure.</p>\n<p><strong>Microtubules (Option C): </strong>Composed of tubulin; function in transport, mitotic spindle, and organelle positioning.</p>\n<p><strong>Muscle filaments (Option D):</strong> Composed of actin and myosin in muscle tissue; not related to lamins.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816PBguj.png\">", "options": ["Intermediate filaments", "Microfilaments", "Microtubules", "Muscle filaments"], "html_options": ["Intermediate filaments", "Microfilaments", "Microtubules", "Muscle filaments"], "corr_idx": 0}, {"id": "1192165", "html_qtxt": "All of the following are true about Osteopetrosis, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Osteopetrosis</strong> (also known as <strong>marble bone</strong> disease) is a rare genetic disorder characterised by <strong>abnormally increased bone density</strong> due to <strong>defective bone resorption</strong> by <em>osteoclasts</em>.</li>\n<li><strong>Osteopetrosis</strong> occurs due to <strong>mutations in the gene (located on chromosome 8q22) encoding carbonic anhydrase II (CA II)</strong>, one of four isozymes of carbonic anhydrase present in human tissues. <strong>(Option A)</strong></li>\n<li>Deficiency of CA II in <strong>osteoclasts prevents normal bone resorption</strong>, and osteopetrosis results <strong>(Option C)</strong>.</li>\n<li>One form osteopetrosis is <strong>associated with renal tubular acidosis</strong> and <strong>cerebral calcification. (Option D)</strong></li>\n</ul>", "options": ["Occurs due to a defect in the carbonic anhydrase II enzyme", "Associated with reduced bone density", "Characterised by inability of resorb bone", "Associated with renal tubular acidosis"], "html_options": ["Occurs due to a defect in the carbonic anhydrase II enzyme", "Associated with reduced bone density", "Characterised by inability of resorb bone", "Associated with renal tubular acidosis"], "corr_idx": 1}, {"id": "1192170", "html_qtxt": "A 5-year-old child was observed to have many skeletal abnormalities and short-limbed dwarfism. It is an inherited disorder leading to chondrodysplasia and mainly affecting cartilage. Which type of collagen will be abnormal in this child?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Chondrodysplasias</strong> are a mixed group of hereditary disorders affecting <strong>cartilage</strong>. They are manifested by <strong>short-limbed dwarfism</strong> and numerous <strong>skeletal deformities.</strong></li>\n<li>A few are due to a variety of mutations in the <strong>COL2A1 gene</strong>, leading to <strong>abnormal forms of type II collagen.</strong></li>\n<li>Chondrodysplasias are caused by mutations in genes encoding <strong>type II collagen & fibroblast growth factor receptors.</strong></li>\n</ul>\n<p><strong>Key takeaways:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816b0WGo.png\">", "options": ["Type I", "Type II", "Type III", "Type IV"], "html_options": ["Type I", "Type II", "Type III", "Type IV"], "corr_idx": 1}, {"id": "1192173", "html_qtxt": "All of the following extracellular matrix (ECM) components are present in the glomerular membrane, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Fibronectin</strong>, though abundant in the interstitial ECM, is not a major component of the glomerular basement membrane. It is primarily involved in <strong>wound healing</strong>, <strong>cell adhesion</strong>, and <strong>migration</strong> in the <strong>interstitial matrix</strong>, not the <strong>basal lamina</strong>.</li>\n</ul>\n<p>The <strong>glomerular basement membrane</strong> (GBM) is a specialized <strong>ECM</strong> structure forming part of the <strong>renal filtration barrier</strong>. It consists primarily of:</p>\n<ul>\n<li><strong>Laminin:</strong> a large, cross-shaped glycoprotein that interacts with <strong>integrins</strong> and <strong>dystroglycans</strong> on epithelial cells. <strong>(Option A)</strong></li>\n<li><strong>Type IV collagen: </strong>provides structural integrity to the basement membrane. <strong>(Option C)</strong></li>\n<li><strong>Entactin (Nidogen): </strong>a sulfated glycoprotein that serves as a <strong>cross-linker</strong> between laminin and collagen IV. <strong>(Option B)</strong></li>\n<li><strong>Perlecan: </strong>a heparan sulfate proteoglycan that contributes to <strong>charge-selective</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816KgMHU.png\">", "options": ["Laminin", "Entactin", "Type IV collagen", "Fibronectin"], "html_options": ["Laminin", "Entactin", "Type IV collagen", "Fibronectin"], "corr_idx": 3}, {"id": "1192177", "html_qtxt": "All of the following attachment proteins indirectly interact with fibronectin receptor with actin microfilaments, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Elastin</strong> is a structural protein of the ECM responsible for <strong>tissue elasticity</strong> (e.g., <strong>skin, lungs, arteries</strong>). It plays no role in linking integrins to the actin cytoskeleton.</li>\n<li><strong>Fibronectin</strong> is a <strong>high-molecular-weight</strong> glycoprotein of the extracellular matrix (ECM) that binds to <strong>membrane-spanning integrins</strong> (fibronectin receptors) and links the ECM to the actin cytoskeleton via a complex of adaptor proteins.</li>\n<li>The intracellular linkage is mediated by several actin-binding proteins, including:</li>\n<li><strong>Talin</strong> binds directly to the &beta;-subunit of integrins and connects to actin. <strong>(Option A)</strong></li>\n<li><strong>Vinculin</strong> reinforces talin-actin linkage and stabilises focal adhesions. <strong>(Option B)</strong></li>\n<li><strong>Paxillin</strong> functions as a scaffold protein that integrates signals from integrins and growth factor receptors. <strong>(Option C)</strong></li>\n<li><strong>Alpha-actinin</strong> crosslinks actin filaments and anchors them to integrin complexes.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816syT1R.png\">", "options": ["Talin", "Vinculin", "Paxillin", "Elastin"], "html_options": ["Talin", "Vinculin", "Paxillin", "Elastin"], "corr_idx": 3}, {"id": "1192180", "html_qtxt": "A 15-year-old tall boy presents with long fingers (arachnodactyly), hyperextensible joints, and a history of frequent dislocations. On ophthalmologic examination, he is found to have ectopia lentis. Echocardiography shows dilatation of the ascending aorta.<br> Which of the following proteins is most likely defective in this patient?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The presence of <strong>tall stature, arachnodactyly, ectopia lentis, and aortic root dilatation</strong> strongly suggests <strong>Marfan syndrome due to a Fibrillin-1 defect.</strong></li>\n<li><strong>Marfan syndrome</strong> is a relatively prevalent inherited disease affecting connective tissue; it is inherited as an autosomal dominant trait.</li>\n<li>It affects the eyes (eg, causing dislocation of the lens, known as ectopia lentis), the skeletal system (most patients are tall and exhibit long digits [arachnodactyly] and hyperextensibility of the joints), and the cardiovascular system (eg, causing weakness of the aortic media, leading to dilation of the ascending aorta).</li>\n<li>Most cases are caused by mutations in the gene (on <strong>chromosome 15) </strong>for <strong>fibrillin-1.</strong></li>\n<li>This results in abnormal fibrillin and/or lower amounts being deposited in the ECM.</li>\n<li>Since the cytokine transforming growth factor &beta; (TGF-&beta;) normally binds to fibrillin-1, decreased binding in Marfan syndrome causes disturbances in TGF-&beta; signalling.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Collagen Type II (Option A): </strong>Major component of cartilage, not implicated in Marfan syndrome.</p>\n<p><strong>Elastin (Option B): </strong>Functionally affected in Marfan syndrome, but the primary defect is not in the elastin gene.</p>\n<p><strong>Collagen Type IV (Option D): </strong>Component of basement membranes; associated with Alport syndrome, not Marfan.</p>", "options": ["Collagen Type II", "Elastin", "Fibrillin I", "Collagen Type IV"], "html_options": ["Collagen Type II", "Elastin", "Fibrillin I", "Collagen Type IV"], "corr_idx": 2}, {"id": "1192183", "html_qtxt": "Which of the following molecules is least likely to be a component of the ECM involved in providing structural or adhesive support?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Cadherins are <strong>calcium-dependent adhesion molecules</strong> that mediate <strong>cell-to-cell interactions</strong>, not cell-to-matrix interactions. Therefore, they are <strong>not part of the ECM</strong>, which provides structural integrity and anchorage for cells via interactions between ECM components and integrins.</li>\n<li>Most <strong>mammalian cells</strong> are located in tissues where they are surrounded by a <strong>complex extracellular matrix (ECM),</strong> often referred to as <strong>connective tissue</strong>, which protects the organs and also provides elasticity where required (eg, in <strong>blood vessels, lungs, and skin).</strong></li>\n<li>The ECM contains three major classes of biomolecules:\n<ul>\n<li><strong>Structural proteins</strong>, for example, <strong>collagen, elastin, and fibrillin</strong>; <strong>(Option C)</strong></li>\n<li><strong>Specialised proteins</strong> such as <strong>fibronectin</strong> and <strong>laminin</strong> <strong>(Option D)</strong></li>\n<li><strong>Proteoglycans</strong> <strong>(Option A)</strong></li>\n</ul>\n</li>\n</ul>", "options": ["Proteoglycans", "Cadherins", "Fibrillin", "Fibronectin"], "html_options": ["Proteoglycans", "Cadherins", "Fibrillin", "Fibronectin"], "corr_idx": 1}, {"id": "1192185", "html_qtxt": "Which of the following is true about the structure of collagen?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hydroxylysine</strong> residues in collagen can be <strong>post-translationally</strong> modified by the addition of galactose or galactosyl-glucose through <strong>O-glycosidic </strong> These O-glycosylation sites are important for proper <strong>fibril</strong> <strong>formation</strong> and <strong>intermolecular</strong> interactions.</li>\n<li><strong>Collagen</strong> is a structural protein that forms a <strong>triple helical superstructure</strong>, not a double helix<strong> (Option A ruled out). </strong></li>\n<li>Each <strong>&alpha;-chain</strong> forms a <strong>left-handed helix</strong>, and <strong>three such &alpha;-chains</strong> wind together to form a right-handed triple helix<strong> (Option B ruled out)</strong></li>\n<li><strong>Proline</strong> and <strong>hydroxyproline</strong> play a vital role in stabilising the triple helix by causing kinks and limiting flexibility - they confer <strong>rigidity</strong>, not flexibility <strong>(Option C ruled out).</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816eoY93.png\">", "options": ["Double helical structure", "Alpha chain winds around in a left-handed helix", "Proline and hydroxyproline confer flexibility to collagen molecules", "A glycosylation site in collagen contain O - glycosidic linkage"], "html_options": ["Double helical structure", "Alpha chain winds around in a left-handed helix", "Proline and hydroxyproline confer flexibility to collagen molecules", "A glycosylation site in collagen contain O - glycosidic linkage"], "corr_idx": 3}, {"id": "1192188", "html_qtxt": "Which among the following diseases is not related to collagen?", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li><strong>Wilson's diseas</strong>e is unrelated to collagen. It is a disorder of copper metabolism, due to an <strong>ATP7B</strong> gene mutation, leading to <strong>hepatic</strong> and <strong>neurological manifestations.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Menkes</strong> <strong>disease (Option A) </strong>is linked to collagen defects. It arises due to a <strong>copper deficiency</strong> resulting in <strong>defective cross-linking </strong>of<strong> collagen</strong> and elastin, caused by reduced activity of <strong>lysyl oxidase</strong>, a copper-dependent enzyme.</p>\n<p><strong>Ehlers-Danlos syndrome (Option B)</strong> is a group of connective tissue disorders involving defects in <strong>collagen synthesis, typically affecting types I, III, </strong>and<strong> V.</strong></p>\n<p><strong>Alport syndrome (Option C)</strong> is associated with mutations affecting Type IV collagen, a major component of basement membranes, particularly in the glomerulus, cochlea, and eyes.</p>", "options": ["Menkes disease", "Ehlers Danlos syndrome", "Alport syndrome", "Wilson's disease"], "html_options": ["Menkes disease", "Ehlers Danlos syndrome", "Alport syndrome", "Wilson's disease"], "corr_idx": 3}, {"id": "1192189", "html_qtxt": "Which one of the following sentences is true about Elastin?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Elastin</strong> contains unique <strong>intramolecular desmosine cross-links,</strong> which provide <strong>elasticity</strong> and <strong>recoil</strong>. These cross-links are formed between <strong>lysine residues</strong> and are specific to elastin. Collagen contains intramolecular aldol cross-links.</li>\n<li><strong>Elastin</strong> is encoded by a <strong>single gene</strong>, unlike collagen, which has multiple genetic types (e.g., Type I, II, III, IV, etc.)<strong> (Option A ruled out)</strong></li>\n<li>Elastin does not contain <strong>hydroxylysine</strong>, a residue typically found in <strong>collagen</strong> where it plays a role in <strong>cross-linking </strong>and<strong> (Option C)</strong></li>\n<li><strong>Glycosylation</strong> is not a feature of elastin. This <strong>post-translational modification</strong> is more characteristic of <strong>collagen</strong>.<strong> (Option D)</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816M2D4l.png\">", "options": ["Elastin is encoded by multiple genetic variants", "Intramolecular desmosine cross-links are characteristic of elastin", "Elastin contains hydroxylysine residues", "Glycosylation is a unique post-translational feature of elastin"], "html_options": ["Elastin is encoded by multiple genetic variants", "Intramolecular desmosine cross-links are characteristic of elastin", "Elastin contains hydroxylysine residues", "Glycosylation is a unique post-translational feature of elastin"], "corr_idx": 1}, {"id": "1192280", "html_qtxt": "Which of the following laboratory measurements is most appropriate for estimating total body radical burden?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>total body radical burden</strong> is most accurately estimated by assessing the <strong>products of lipid peroxidation</strong>. These include <strong>lipid peroxides</strong> and <strong>dialdehydes</strong>, which are by-products of oxidative stress on membrane lipids.</li>\n<li>Lipid peroxides are commonly quantified using the <strong>ferrous oxidation</strong> in <strong>xylenol orange (FOX) assay</strong>.</li>\n<li>Under acidic conditions, Fe&sup2;<sup>+</sup> is oxidised to Fe&sup3;<sup>+</sup>, forming a chromophore with xylenol orange, allowing quantification.</li>\n<li><strong>Dialdehydes</strong>, such as malondialdehyde (MDA), are detected using the <strong>thiobarbituric acid reactive substances (TBARS) assay</strong>, which yields a red fluorescent product.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Products of lipid reduction (Option B):</strong> These are not associated with oxidative stress; reduction implies removal of radicals, not their burden.</p>\n<p><strong>Product of protein breakdown (Option C): </strong>Indicates proteolysis, which is <strong>not specific</strong> to oxidative radical damage.</p>\n<p><strong>Product of protein reduction</strong> <strong>(Option D):</strong> Refers to non-radical-related processes and is <strong>not indicative of oxidative injury</strong>.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Lipid peroxidation products, such as <strong>MDA</strong> and <strong>lipid hydroperoxides</strong>, serve as reliable <strong>biomarkers for assessing the body's oxidative stress level.</strong></li>\n</ul>", "options": ["Products of lipid peroxidation", "Products of lipid reduction", "Product of protein breakdown", "Product of protein reduction"], "html_options": ["Products of lipid peroxidation", "Products of lipid reduction", "Product of protein breakdown", "Product of protein reduction"], "corr_idx": 0}, {"id": "1231448", "html_qtxt": "Which one of the following is a negative acute-phase protein?", "html_expl": "<p><strong>Explanation: </strong></p>\r\n<ul>\r\n<li><strong>Transthyretin,</strong> also known as <strong>prealbumin</strong>, whose level is decreased during inflammation, so termed a <strong>negative acute phase protein</strong>.</li>\r\n<li><strong>Acute Phase Proteins</strong></li>\r\n<li>Those plasma proteins whose levels are <strong>changed</strong> in plasma (> 25%) during <strong>inflammations</strong>(as a result of any infection, injury, malignancy, surgery, etc) are known as Acute Phase Proteins or Acute Phase Reactants.</li>\r\n<li>Such an acute-phase response is a nonspecific response and is associated with a characteristic pattern of changes in such proteins.</li>\r\n<li>Some mediators like <strong>cytokines (IL-1, IL-6), tumour necrosis factors &alpha; and &beta;, Interferons, platelet activating factor,</strong> etc, cause changes in such protein levels.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250816UxgK8.png\">\r\n<p><strong>C-reactive protein (CRP)</strong></p>\r\n<ul>\r\n<li>Major acute-phase proteins</li>\r\n<li>Beta globulin</li>\r\n<li>It involves in promotion of the immune system through the <strong>activation of the complement cascade.</strong></li>\r\n<li>Produced in the liver and is present in circulation in minute concentration (<1 mg/dl)</li>\r\n<li>Estimation of CRP in serum is important for the evaluation of the acute phase response during inflammation. It increases when inflammation is aggressive & decreases when inflammation subsides.</li>\r\n<li><strong>Preferred over ESR</strong> as changes are reflected earlier.</li>\r\n<li><strong>High sensitivity C-reactive protein (hsCRP)</strong> level in blood has a positive correlation with predicting the risk of <strong>coronary artery diseases</strong>.</li>\r\n</ul>", "options": ["Ferritin", "Transthyretin", "Ceruloplasmin", "Haptoglobin"], "html_options": ["Ferritin", "Transthyretin", "Ceruloplasmin", "Haptoglobin"], "corr_idx": 1}]}, {"moduleId": 1010643, "name": "Hormones and their actions, cell cycle and Tumours", "questions": [{"id": "1192194", "html_qtxt": "Which of the following statements regarding Hormone Response Elements (HREs) are true?<br>1. HREs are specific DNA sequences that bind activated hormone-receptor complexes<br>2. HREs are located on messenger RNA and bind steroid hormone receptors<br>3. HREs serve as high-affinity binding sites that facilitate transcription activation<br>4. HREs are formed by liganded mRNA-protein complexes in the cytoplasm", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li><strong>Hormone Response Elements (HREs)</strong> are <strong>specific DNA sequences</strong> located in the promoter regions of target genes.</li>\n<li>Lipophilic <strong>Group I hormones</strong> (e.g., steroid hormones, thyroid hormones) diffuse across the plasma membrane and bind to <strong>intracellular receptors</strong> (cytoplasmic or nuclear).</li>\n<li>The <strong>activated hormone-receptor complex</strong> translocates to the nucleus and binds to HREs.</li>\n<li>This binding recruits <strong>coactivator proteins</strong>, enhancing <strong>gene transcription</strong> and altering protein synthesis.</li>\n</ul>\n<p>Explanation of Other Options:</p>\n<ul>\n<li><strong>Statement 1 (True):</strong>\n<ul>\n<li>HREs are indeed <strong>specific DNA sequences</strong> that bind activated hormone-receptor complexes.</li>\n</ul>\n</li>\n<li><strong>Statement 2 (False):</strong>\n<ul>\n<li>HREs are <strong>not located on mRNA</strong>. They are genomic DNA elements, not post-transcriptional regulators.</li>\n</ul>\n</li>\n<li><strong>Statement 3 (True):</strong>\n<ul>\n<li>HREs act as <strong>high-affinity binding sites</strong> that facilitate transcription activation by recruiting transcriptional machinery.</li>\n</ul>\n</li>\n<li><strong>Statement 4 (False):</strong>\n<ul>\n<li>HREs are <strong>not formed in the cytoplasm</strong>. They are part of the <strong>nuclear DNA</strong> and function at the transcriptional level.</li>\n</ul>\n</li>\n</ul>", "options": ["1 and 3 are true; 2 and 4 are false", "1 and 2 are true; 3 and 4 are false", "1, 3 and 4 are true; 2 is false", "Only 3 is true; all others are false"], "html_options": ["1 and 3 are true; 2 and 4 are false", "1 and 2 are true; 3 and 4 are false", "1, 3 and 4 are true; 2 is false", "Only 3 is true; all others are false"], "corr_idx": 0}, {"id": "1192195", "html_qtxt": "Which of the following statements are true regarding Group II hormone signal transduction?<br>1.Cyclic GMP acts as a second messenger for some Group II hormones<br>2.Group II hormones bind intracellular receptors to initiate transcription<br>3.Phosphatidylinositol and Ca<sup>2+</sup> serve as second messengers<br>4. Receptors for Group II hormones are present on the cell surface", "html_expl": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Cyclic GMP</strong> (cGMP), generated via guanylyl cyclase, functions as a second messenger for certain Group II hormones. <strong>(Statement 1 is true)</strong></li>\n<li><strong>Ca&#178;&#8314;</strong> and <strong>phosphatidylinositol</strong> are classical second messengers in Group II hormone signaling. <strong>(Statement 3 is true)</strong></li>\n<li>Group II hormones <strong>do not bind intracellular receptors</strong>. They act via <strong>surface receptors</strong> and use <strong>Intracellular second messengers</strong>. <strong>(Statement 2 is false and 4 is true)</strong></li>\n</ul>", "options": ["1, 3, and 4 are true; 2 is false", "1 and 2 are true; 3 and 4 are false", "Only 4 is true", "All statements are true"], "html_options": ["1, 3, and 4 are true; 2 is false", "1 and 2 are true; 3 and 4 are false", "Only 4 is true", "All statements are true"], "corr_idx": 0}, {"id": "1192197", "html_qtxt": "Which of the following is true about Group I hormones?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Group I hormones</strong> are <strong>lipophilic</strong> (fat-soluble) hormones like steroids, thyroid hormones, and calcitriol. <strong>(Option A ruled out)</strong></li>\n<li>They are bound to <strong>transport proteins</strong> in circulation. <strong>(Option C ruled out)</strong></li>\n<li>Due to their stability and binding with plasma proteins, they exhibit a <strong>long half-life</strong> (ranging from hours to days).</li>\n<li>They <strong>cross the cell membrane</strong> and bind to <strong>intracellular receptors</strong>, forming hormone-receptor complexes that regulate gene transcription <strong>(Option B ruled out)</strong>.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508205268f4bc-8a30-42dc-b4d1-d0ee10bbd714.png\">", "options": ["Hydrophilic in nature", "Cannot cross cell membrane", "Bind to cell surface receptor", "Having a long half life"], "html_options": ["Hydrophilic in nature", "Cannot cross cell membrane", "Bind to cell surface receptor", "Having a long half life"], "corr_idx": 3}, {"id": "1192199", "html_qtxt": "Which of the following hormones inhibit Adenylyl cyclase and reduce the production of cAMP?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Intracellular cAMP regulation</strong> is a central aspect of signal transduction for <strong>Group II hormones</strong>.</li>\n<li>These hormones interact with cell surface receptors, leading to either activation or inhibition of the enzyme <strong>adenylyl cyclase,</strong> which catalyses the conversion of ATP to <strong>cyclic AMP (cAMP)</strong>, a <strong>secondary messenger.</strong></li>\n<li>Somatostatin binds to its receptor and activates <strong>Gi protein</strong>, which in turn <strong>inhibits adenylyl cyclase</strong>, hence <strong>decreasing cAMP.</strong></li>\n<li><strong>Calcitonin</strong>, <strong>Glucagon</strong>, and <strong>ADH</strong> interact with <strong>Gs</strong> proteins, leading to <strong>activation of adenylyl cyclase</strong> ,thus <strong>Increases cAMP. (Options B, C and D ruled out)</strong></li>\n</ul>", "options": ["Somatostatin", "Calcitonin", "Glucagon", "ADH"], "html_options": ["Somatostatin", "Calcitonin", "Glucagon", "ADH"], "corr_idx": 0}, {"id": "1192203", "html_qtxt": "Match the following toxins with their actions on G-protein &alpha; subunits:<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082050898b8b-ecd6-4e10-a9b5-43d2d226564d.png\">", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>Heterotrimeric G-proteins</strong> composed of <strong>&alpha;, &beta;</strong>, and<strong> &gamma; </strong>subunits.</li>\n<li>Since the &alpha; subunit in Gs differs from that in Gi, the proteins, which are distinct gene products, are designated &alpha;s and &alpha;i. The<strong> &alpha; subunits</strong> bind <strong>guanine nucleotides</strong>. The <strong>&beta;</strong> and <strong>&gamma;</strong> subunits are likely always associated (&beta;&gamma;) and appear to function predominantly as a <strong>heterodimer</strong>.</li>\n<li>The &alpha;s subunit has intrinsic <strong>GTPase</strong> The active form, &alpha;s-GTP, is inactivated on hydrolysis of the GTP to GDP; the trimeric Gs complex (&alpha;&beta;&gamma;) is then reformed and is ready for another cycle of activation.</li>\n<li><strong>Cholera toxin </strong>catalyses<strong> ADP-ribosylation </strong>of<strong> G&alpha;s, </strong>inhibiting its<strong> GTPase activity, </strong>resulting in<strong> irreversible activation.</strong></li>\n<li><strong>Pertussis toxin </strong>modifies<strong> G&alpha;i-2, </strong>preventing its dissociation from<strong> &beta;&gamma;, </strong>hence preventing its action<strong>.</strong></li>\n<li><strong>GTP </strong>binding activates<strong> G&alpha;s reversibly.</strong></li>\n<li><strong>GDP </strong>binding causes<strong> G&alpha;s to </strong>reassociate with<strong> &beta;&gamma;, </strong>inactivating the<strong> G protein.</strong></li>\n</ul>", "options": ["A-1, B-2, C-3, D-4", "A-2, B-1, C-3, D-4", "A-1, B-3, C-4, D-2", "A-1, B-2, C-4, D-3"], "html_options": ["A-1, B-2, C-3, D-4", "A-2, B-1, C-3, D-4", "A-1, B-3, C-4, D-2", "A-1, B-2, C-4, D-3"], "corr_idx": 0}, {"id": "1192204", "html_qtxt": "Which of the following molecules activates protein kinase A?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In <strong>eukaryotic</strong> cells, <strong>cyclic AMP</strong> (cAMP) binds to <strong>protein kinase A</strong> (PKA), a <strong>heterotetramer</strong> composed of <strong>two regulatory</strong> (R) and <strong>two catalytic</strong> (C) <strong>subunits</strong> (R&#8322;C&#8322; complex).</li>\n<li>In the <strong>inactive state,</strong> the <strong>R subunits</strong> inhibit the activity of the <strong>C subunits</strong>.</li>\n<li>When four molecules of cAMP bind to the R subunits, it causes <strong>dissociation </strong>of the<strong> R-C complex,</strong> thereby releasing the active C subunits.</li>\n<li>The active C subunits phosphorylate serine or threonine residues on target proteins using ATP as a phosphate donor.</li>\n<li>This phosphorylation modulates multiple cellular processes depending on the tissue and target proteins involved.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Calcium (Option A):</strong> Activates protein kinase C, not protein kinase A.</p>\n<p><strong>cGMP (Option B): </strong>Activates protein kinase G, not PKA.</p>\n<p><strong>ATP (Option D):</strong> Serves as a phosphate donor in the kinase reaction but does not activate protein kinase A.</p>", "options": ["Calcium", "cGMP", "cAMP", "ATP"], "html_options": ["Calcium", "cGMP", "cAMP", "ATP"], "corr_idx": 2}, {"id": "1192207", "html_qtxt": "Which of the following enzymes is primarily responsible for terminating the cellular actions of hormones that increase intracellular cAMP concentration?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The cellular actions of hormones that increase cAMP (cyclic adenosine monophosphate) levels are terminated by the action of <strong>phosphodiesterases</strong> (PDEs).</li>\n<li>These enzymes <strong>hydrolyse</strong> <strong>cAMP</strong> to <strong>5'-AMP</strong>, thereby stopping the <strong>cAMP-dependent</strong> signalling cascade.</li>\n<li>This enzymatic degradation is essential for the rapid turnover of second messengers and for ensuring that cellular responses cease once the hormonal signal is withdrawn.</li>\n<li>There are at least <strong>11 families</strong> of phosphodiesterases with distinct tissue distributions and regulatory properties, and they are often regulated by the very second messengers they degrade, including cAMP.</li>\n</ul>\n<p><strong>Explanation of Other options:</strong></p>\n<p><strong>Protein kinase (Option A):</strong> Protein kinase A is activated by cAMP and is part of the signalling cascade, not responsible for its termination.</p>\n<p><strong>Phospholipase (Option C):</strong> Involved in other signalling pathways like the IP&#8323;&#8315;-DAG cascade, not in cAMP breakdown.</p>\n<p><strong>Phosphoprotein phosphatase (Option D):</strong> Removes phosphate groups from proteins but does not degrade cAMP.</p>", "options": ["Protein Kinase", "Phosphodiesterase", "Phospholipase", "Phosphoprotein phosphatase"], "html_options": ["Protein Kinase", "Phosphodiesterase", "Phospholipase", "Phosphoprotein phosphatase"], "corr_idx": 1}, {"id": "1192208", "html_qtxt": "Which of the following hormone receptors has intrinsic tyrosine kinase activity", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Insulin receptor</strong> is a <strong>transmembrane receptor</strong> that possesses <strong>intrinsic tyrosine kinase</strong> activity located in its <strong>cytoplasmic </strong>domain.</li>\n<li>Upon insulin binding, <strong>autophosphorylation</strong> of the receptor occurs, initiating <strong>downstream signalling</strong>.</li>\n<li>This class of receptors is shared by growth factor receptors such as <strong>EGF</strong> and <strong>IGF-1</strong>, all of which demonstrate intrinsic tyrosine kinase activity.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glucagon (Option B): </strong>Binds to a <strong>G-protein coupled receptor</strong> (GPCR) on the cell surface, which activates adenylate cyclase via G&alpha;s. It does not have tyrosine kinase activity.</p>\n<p><strong>Steroid hormones (Option C): </strong>These hormones bind to <strong>intracellular receptors</strong>, which function as <strong>ligand-activated transcription factors</strong>.</p>\n<p><strong>Thyroid hormones (Option D):</strong> Bind to nuclear receptors, affecting gene transcription. </p>", "options": ["Insulin", "Glucagon", "Steroid hormone", "Thyroid hormone"], "html_options": ["Insulin", "Glucagon", "Steroid hormone", "Thyroid hormone"], "corr_idx": 0}, {"id": "1192212", "html_qtxt": "Which of the following hormones mediate their effect via an increase in cGMP level?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Atrial natriuretic peptide</strong> mediates their effect via increase in <strong>cGMP</strong> level</li>\n<li>Cyclic GMP is made from GTP by the enzyme guanylyl cyclase, which exists in soluble and membrane-bound forms.</li>\n<li>The atriopeptin, a family of peptides produced in cardiac atrial tissues, causes <strong>natriuresis</strong>, <strong>diuresis</strong>, <strong>vasodilation</strong>, and <strong>inhibition of aldosterone</strong> These peptides (eg, atrial natriuretic factor) bind to and activate the membrane-bound form of guanylyl cyclase. This increases cGMP and mediates the above effects.</li>\n<li>A series of compounds, including <strong>nitroprusside, nitroglycerin, nitric oxide, sodium nitrite, </strong>and<strong> sodium azide, </strong>all cause smooth muscle relaxation and are potent vasodilators.</li>\n<li>These agents increase cGMP by activating the soluble form of <strong>guanylyl cyclase</strong>, and inhibitors of cGMP <strong>phosphodiesterase</strong> (eg, the drug sildenafil (Viagra) enhance and prolong these responses.</li>\n<li>The increased cGMP activates <strong>cGMP-dependent protein kinase (PKG),</strong> which in turn phosphorylates several smooth muscle proteins. This is involved in the relaxation of smooth muscle and vasodilation.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thyroid hormone (Option A)</strong> act via <strong>intracellular</strong> receptor.</p>\n<p><strong>Calcitonin (Option B) </strong>acts via a cell surface receptor with cAMP as an <strong>i</strong>ntracellular signal.</p>\n<p><strong>Gastrin (Option D)</strong> functions via a cell surface receptor with second messenger <strong>calcium</strong> or IP3.</p>", "options": ["Thyroid hormone", "Calcitonin", "Atrial natriuretic peptide", "Gastrin"], "html_options": ["Thyroid hormone", "Calcitonin", "Atrial natriuretic peptide", "Gastrin"], "corr_idx": 2}, {"id": "1192276", "html_qtxt": "A 40-year-old female presents with central obesity, thin extremities, and facial plethora. A  particular hormone level remains elevated despite overnight administration of dexamethasone. Which organ system and which hormone are primarily being evaluated by this diagnostic test?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>overnight dexamethasone suppression</strong> test is used to assess <strong>adrenal cortisol overproduction</strong>, and is used for clinical diagnosis of <strong>adrenal hyperfunction (Cushing syndrome) </strong>or<strong> hypofunction (Addison's disease).</strong></li>\n<li>The secretion of <strong>cortisol</strong> from the adrenal gland exhibits <strong>diurnal variation</strong>; serum cortisol levels are <strong>highest </strong>during the<strong> early morning</strong> hours and <strong>lowest</strong> around <strong>midnight</strong>.</li>\n<li><strong>Loss</strong> of this <strong>diurnal variation</strong> is one of the earliest signs of adrenal hyperfunction.</li>\n<li>Measurement of serum cortisol in blood samples drawn at midnight and 8 am is, therefore, useful as a test.</li>\n<li>A diagnosis of adrenal hyperfunction is confirmed by demonstration of <strong>failure of suppression</strong> of the early morning concentration of <strong>cortisol</strong> following the administration of <strong>1 mg dexamethasone</strong> (a potent synthetic glucocorticoid) at midnight; this is the dexamethasone suppression test.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Liver, GLP (Option A):</strong> Tests used for diagnosis of <strong>liver</strong> disorders are: <strong>serum bilirubin</strong>, serum alanine <strong>(ALT)</strong> and aspartate <strong>(AST)</strong> aminotransferases, Serum alkaline phosphatase <strong>(ALP)</strong>, serum GGT (Gamma glutamyl transferase), estimation of <strong>total proteins, albumin, prothrombin time</strong>, estimation of blood ammonia level, etc</p>\n<p><strong>Kidney, insulin-like growth factor (Option B): </strong>Excretory functions of the <strong>kidney</strong> are assessed by estimation of <strong>serum urea, creatinine </strong>and<strong> uric acids, clearance tests, proteinuria, </strong>etc</p>\n<p><strong>Thyroid, thyroxine (Option D): </strong>Tests used for disorders involving the <strong>thyroid</strong> gland are estimation of <strong>TSH, T3 & T4 levels, thyroid autoantibodies,</strong> etc</p>", "options": ["Liver, GLP", "Kidney, insulin-like growth factor", "Adrenal gland, cortisol", "Thyroid, thyroxine."], "html_options": ["Liver, GLP", "Kidney, insulin-like growth factor", "Adrenal gland, cortisol", "Thyroid, thyroxine."], "corr_idx": 2}, {"id": "1192303", "html_qtxt": "All of the following statements  are true about Amyloid, except:", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li><strong>Amyloids</strong> are<strong> abnormal, insoluble aggregates of misfolded proteins</strong> that accumulate in tissues and organs and are implicated in a variety of human diseases.</li>\n<li>Their insolubility contributes to their pathogenicity, persistence, and resistance to normal proteolytic degradation.</li>\n<li><strong>Amyloids</strong> are <strong>toxic aggregates</strong> that result from the <strong>misfolding</strong> and self-assembly of normally soluble proteins into <strong>&beta;-sheet-rich fibrils. (Option A) </strong></li>\n<li><strong>Amyloids</strong> are characteristic of several <strong>neurodegenerative diseases</strong> such as <strong>Alzheimer's, Parkinson's, Huntington's disease</strong>, and <strong>prion diseases </strong>(e.g., Creutzfeldt-Jakob disease).<strong> (Option C)</strong></li>\n<li><strong>Amyloid</strong> aggregates are <strong>refractory</strong> to <strong>protease degradation</strong>, making them persistent and difficult to clear, which leads to <strong>chronic cellular stress </strong>and<strong> tissue damage. (Option D)</strong></li>\n</ul>", "options": ["Toxic aggregates of proteins", "Soluble aggregated proteins", "Hallmark of many neurodegenerative diseases", "Refractory to degradation by proteases"], "html_options": ["Toxic aggregates of proteins", "Soluble aggregated proteins", "Hallmark of many neurodegenerative diseases", "Refractory to degradation by proteases"], "corr_idx": 1}, {"id": "1192307", "html_qtxt": "Which of the following is termed a molecular countdown clock for ageing?", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li><strong>Telomeres</strong> are repetitive <strong>nucleotide sequences</strong> (rich in GT repeats) found at the ends of linear eukaryotic chromosomes.</li>\n<li>They serve as protective caps that prevent chromosomal ends from being recognised as <strong>DNA damage</strong>.</li>\n<li>With each round of DNA replication, <strong>telomeres progressively shorten</strong> because DNA polymerase cannot fully replicate the 3' end of linear chromosomes (<strong>end-replication problem</strong>). This shortening acts as a <strong>molecular countdown clock, signalling cellular ageing</strong>.</li>\n<li>Once telomeres become critically short, cells undergo <strong>senescence</strong> or <strong>apoptosis</strong>, preventing further division, a hallmark of the molecular clock theory of ageing.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Reactive oxygen species</strong> (ROS<strong>) (Option B) </strong>are involved in the <strong>free radical</strong> theory of ageing, which is distinct from the molecular clock theory.</p>\n<p><strong>Mitochondria (Option C) </strong>are sources of ROS and are implicated in ageing due to <strong>oxidative stress</strong>, but they are not considered molecular clocks.</p>\n<p><strong>Telomerase (Option D) </strong>is an enzyme that counteracts telomere shortening, especially in germ cells, stem cells, and cancer cells. It <strong>delays the ageing</strong> process rather than marking it.</p>", "options": ["Telomeres", "Reactive Oxygen species", "Mitochondria", "Telomerase"], "html_options": ["Telomeres", "Reactive Oxygen species", "Mitochondria", "Telomerase"], "corr_idx": 0}, {"id": "1192311", "html_qtxt": "Which of the following statements most accurately describes an aspect of the metabolic theory of ageing?", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li>The metabolic theory of ageing proposes that <strong>ageing</strong> is <strong>linked</strong> to the <strong>metabolic rate</strong> and <strong>cumulative oxidative damage</strong>.</li>\n<li><strong>Calorically restricted diets</strong> are associated with <strong>lower metabolic rates</strong>, <strong>reduced ROS generation</strong>, and <strong>enhanced mitochondrial efficiency</strong>, all of which <strong>delay ageing</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Elevated level of plasma glucose promotes the formation of cross-linked protein aggregates (Option A): </strong>Describes the glycation theory of ageing, not the metabolic theory. This is related to AGEs (advanced glycation end products) formation from chronic hyperglycemia.</p>\n<p><strong>Damage from reactive oxygen species multiplied by the tendency of oxygen free radicals to multiply via chain reactions (Option B): </strong>Refers to the free radical theory of ageing, which focuses on damage from reactive oxygen species (ROS), not the metabolic rate or dietary restriction.</p>\n<p><strong>Damage to mitochondrial genome, leading to deleterious effect on the protein of electron transport chain and subsequent ATP generation (Option D): </strong>Describes the mitochondrial theory of ageing, where mitochondrial DNA damage leads to defective proteins and impaired ATP generation.</p>", "options": ["Elevated level of plasma glucose promotes the formation of cross-linked protein aggregates", "Damage from reactive oxygen species multiplied by tendency of oxygen free radical to multiply via chain reactions", "Calorically restricted diets promote lower and more efficient metabolic activity", "Damage to mitochondrial genome, leading to deleterious effect on protein of electron transport chain and subsequent ATP generation"], "html_options": ["Elevated level of plasma glucose promotes the formation of cross-linked protein aggregates", "Damage from reactive oxygen species multiplied by tendency of oxygen free radical to multiply via chain reactions", "Calorically restricted diets promote lower and more efficient metabolic activity", "Damage to mitochondrial genome, leading to deleterious effect on protein of electron transport chain and subsequent ATP generation"], "corr_idx": 2}, {"id": "1192314", "html_qtxt": "All of the following mechanisms can be used to intercept damage caused by Reactive Oxygen species (ROS) and slow ageing, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Caspases</strong> are a family of <strong>cysteine proteases</strong> involved in <strong>apoptosis</strong>.</li>\n<li>They <strong>do not</strong> play a role in scavenging ROS and are <strong>not part of</strong> antioxidant defence systems.</li>\n<li>In fact, their activation can promote <strong>programmed cell death</strong>, often triggered by ROS-induced damage.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glutathione (Option A) </strong>is a <strong>cysteine-containing tripeptide</strong> that functions as a potent <strong>antioxidant</strong>. It reacts directly with ROS to convert them into less reactive forms (e.g., water) and helps in <strong>detoxifying xenobiotic compounds</strong>, thus contributing to the reduction of oxidative stress and ageing.</p>\n<p><strong>Superoxide dismutase (SOD) (Option B) </strong>converts superoxide radicals to <strong>hydrogen peroxide</strong>, reducing the damage caused by free radicals. SOD activity has been shown to correlate with increased lifespan in experimental models like Drosophila.</p>\n<p><strong>Catalase (Option D)</strong> converts hydrogen peroxide into water and oxygen. By <strong>detoxifying hydrogen peroxide</strong>, a ROS intermediate, catalase helps <strong>prevent oxidative damage</strong> and thus may contribute to slower ageing.</p>", "options": ["Glutathione", "Superoxide dismutase", "Caspases", "Catalase"], "html_options": ["Glutathione", "Superoxide dismutase", "Caspases", "Catalase"], "corr_idx": 2}, {"id": "1192316", "html_qtxt": "All of the following are key properties of cancer cells, except:", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>Cancer cells</strong> are characteristically <strong>resistant</strong> to <strong>apoptosis</strong> (programmed cell death), a key survival mechanism that allows them to persist despite genetic damage or unfavourable conditions.</p>\n<p><strong>Explanation of other options:-</strong></p>\n<p><strong>Self-sufficiency in growth signals (Option A): </strong>Cancer cells can generate their growth signals or activate pathways that bypass normal growth controls, allowing them to proliferate without external cues.</p>\n<p><strong>Insensitivity to anti-growth signals (Option B): </strong>Cancer cells resist signals that would normally halt cell division, enabling unchecked growth.</p>\n<p><strong>Limitless replicative potential (Option D):</strong> Many cancer cells evade normal replicative senescence by activating telomerase, allowing continuous cell division.</p>\n<p><strong>Key takeaways:</strong></p>\n<p>Six major biologic features of cancer cells:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820795e7622-40a1-440b-990c-66f9a6d57901.png\">", "options": ["Self-sufficient in growth signals", "Insensitive to anti-growth signals", "Sensitive to apoptosis", "Limitless replicative growth potentials"], "html_options": ["Self-sufficient in growth signals", "Insensitive to anti-growth signals", "Sensitive to apoptosis", "Limitless replicative growth potentials"], "corr_idx": 2}, {"id": "1192319", "html_qtxt": "Which of the following biochemical changes can occur in human cancer cell?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Decreased cell adhesion:</strong> Cancer cells show reduced expression of <strong>cell adhesion molecules (CAMs) such as E-cadherin. </strong></li>\n<li>This biochemical change facilitates <strong>metastasis</strong> and <strong>tissue invasion</strong>, key hallmarks of malignancy.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Reduced telomerase activity (Option A): </strong>Cancer cells show increased telomerase activity to maintain telomere length, enabling unlimited replication and cell immortality.</p>\n<p><strong>Activation of tumour suppressor genes (Option B): </strong>Cancer cells typically show inactivation of tumour suppressor genes (e.g., p53, Rb), which normally act to restrain cell proliferation.</p>\n<p><strong>Inactivation of oncogenes (Option C): </strong>Oncogenes are often activated in cancer cells, contributing to transformation and proliferation.</p>\n<p><strong>Key takeaways:</strong></p>\n<p>Human Cancer cells shows many biochemical and genetic changes like,</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082025d1c34a-d12e-4c2f-a2d0-3f1e0fd0ff3d.png\">", "options": ["Reduced telomerase activity", "Activation of tumor suppressor genes", "Inactivation of oncogenes", "Decrease adhesion"], "html_options": ["Reduced telomerase activity", "Activation of tumor suppressor genes", "Inactivation of oncogenes", "Decrease adhesion"], "corr_idx": 3}, {"id": "1192324", "html_qtxt": "Radiant damage can lead to following types of DNA damages which leading to cancer, except:", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li>Formation of <strong>purine dimers</strong> is not a common or recognised lesion induced by radiation.</li>\n<li><strong>Purines</strong> are more prone to other forms of damage, such as <strong>depurination</strong>.</li>\n<li><strong>Ionizing radiation</strong> causes a wide range of <strong>DNA damage</strong>, contributing to mutagenesis and cancer. Key types include:\n<ul>\n<li><strong>Formation of pyrimidine dimers (Option A) (</strong>especially thymine dimers) occurs due to UV radiation. Adjacent thymine bases covalently bond, distorting DNA structure.</li>\n<li><strong>Elimination</strong> of <strong>bases (Option C) </strong>leads to apurinic/apyrimidinic (AP) sites, following hydrolysis of N-glycosidic bonds. This is a typical result of radiation-induced damage.</li>\n<li><strong>Cross-linking of DNA strands (Option D)</strong>, both intra- and inter-strand, as well as with proteins (e.g. histones), is a hallmark of radiation damage. These lesions block replication and transcription.</li>\n</ul>\n</li>\n</ul>", "options": ["Formation of pyrimidine dimer", "Formation of purine dimer", "Elimination of bases", "Cross linking of DNA strands"], "html_options": ["Formation of pyrimidine dimer", "Formation of purine dimer", "Elimination of bases", "Cross linking of DNA strands"], "corr_idx": 1}, {"id": "1192326", "html_qtxt": "Which of the following is a correct statement regarding procarcinogens?", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li><strong>Procarcinogens</strong> are not carcinogenic in their native form; they must undergo <strong>metabolic activation</strong>, often by <strong>cytochrome P450 enzymes</strong> in the <strong>endoplasmic reticulum</strong>, to form <strong>ultimate carcinogens</strong>.</li>\n<li>This <strong>bioactivation</strong> process is essential for them to become electrophilic species capable of interacting with DNA and initiating carcinogenesis.</li>\n<li>Procarcinogens include compounds found in tobacco smoke, aflatoxins, and certain dietary and industrial chemicals.</li>\n</ul>\n<p><strong>Explanation of other options</strong>:</p>\n<p><strong>Interact directly with DNA (Option A):</strong> Some chemicals, such as <strong>mechlorethamine</strong> and <strong>&beta;-propiolactone,</strong> <strong>interact directly</strong> with DNA and are classified as <strong>carcinogens</strong>. However, <strong>procarcinogens</strong> require <strong>enzymatic conversion</strong> and do not directly interact with DNA in their native form.</p>\n<p><strong>Their carcinogenic potential is detected by the Guthrie test (Option C).</strong> The <strong>Ames</strong> test is used to detect <strong>carcinogenic potential</strong> through bacterial mutation assays. The <strong>Guthrie</strong> test is used for detecting <strong>phenylketonuria</strong>, not carcinogenic potential.</p>\n<p><strong>Also termed as Oncogenes (Option D): Oncogenes</strong> are mutated or overexpressed forms of <strong>proto-oncogenes</strong> that promote cancer. They are genes, not chemicals like procarcinogens, and do not require enzymatic activation to exert their effect.</p>", "options": ["Interact directly with DNA", "Required Cytochrome P450 for their activation into ultimate carcinogens", "Their carcinogenic potential is detected by Guthrie test", "Also termed as Oncogenes"], "html_options": ["Interact directly with DNA", "Required Cytochrome P450 for their activation into ultimate carcinogens", "Their carcinogenic potential is detected by Guthrie test", "Also termed as Oncogenes"], "corr_idx": 1}, {"id": "1192329", "html_qtxt": "The Ames assay is primarily used to assess:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>Ames test</strong> is a biological assay designed to <strong>detect mutagenic activity</strong> in compounds by measuring the ability of a chemical to cause mutations in the <strong>histidine</strong> operon of <strong>Salmonella typhimurium.</strong></li>\n<li>If the chemical is <strong>mutagenic</strong>, it will revert the <strong>His⁻</strong> strain to <strong>His⁺</strong>, enabling growth on <strong>histidine-free</strong></li>\n<li>An additional refinement includes adding mammalian microsomal enzymes (ER) to simulate metabolic activation (helpful in detecting procarcinogens).</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820d3477542-d2ef-4fb5-8f58-db0cac7755a8.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Oncogenic properties of certain Viruses (Option A): </strong>The Ames test is <strong>not</strong> used to <strong>detect oncogenic properties of viruses</strong>. Its primary function is to evaluate the mutagenic potential of chemical compounds.</p>\n<p><strong>Carcinogenic compound that alters epigenetic factors and leads to cancer (Option C): </strong>Ames assay <strong>does not</strong> assess <strong>epigenetic modifications or regulation</strong>; it is a mutagenicity screening test.</p>\n<p><strong>Markers for detection of tumour (Option D): </strong>Tumour markers like <strong>AFP, CEA, PSA</strong>, etc., are used for the <strong>detection</strong> of tumours, not the <strong>Ames</strong> assay.</p>", "options": ["Oncogenic properties of certain Viruses", "Ability to induce mutation by chemical carcinogens", "Carcinogenic compound which alters epigenetic factors and leading to cancer", "Markers for detection of tumor"], "html_options": ["Oncogenic properties of certain Viruses", "Ability to induce mutation by chemical carcinogens", "Carcinogenic compound which alters epigenetic factors and leading to cancer", "Markers for detection of tumor"], "corr_idx": 1}, {"id": "1192342", "html_qtxt": "The presence of carcinoembryonic antigen (CEA) in serum is detected in:", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Carcinoembryonic antigen (CEA)</strong> in serum is detected in cancer of the <strong>colon</strong>, lung, breast, pancreas, and ovary.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820abfd7b42-ecc7-47f5-b3a2-96a22e0f6f95.png\">", "options": ["Medullary carcinoma of thyroid", "Colorectal cancer", "Hepatocellular carcinoma", "Germ cell cancer"], "html_options": ["Medullary carcinoma of thyroid", "Colorectal cancer", "Hepatocellular carcinoma", "Germ cell cancer"], "corr_idx": 1}, {"id": "1192344", "html_qtxt": "The mechanism for action of RAS oncogene involves the following signal transduction molecule:", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li>RAS is a <strong>proto-oncogene</strong> that encodes a <strong>monomeric G-protein</strong> (GTPase) involved in transmitting signals from receptor <strong>tyrosine kinases</strong> (like EGFR) to downstream MAP kinase signalling pathways.</li>\n<li>In its normal state, RAS cycles between an <strong>active GTP-bound</strong> form and an <strong>inactive GDP-bound</strong> This cycling is tightly regulated by intrinsic GTPase activity.</li>\n<li>Mutations in RAS impair its ability to hydrolyse GTP, leading to constitutive activation, which promotes <strong>uncontrolled cell proliferation</strong>.</li>\n<li>This chronic signalling through the MAPK cascade promotes <strong>tumorigenesis</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>cAMP (Option A):</strong> A <strong>second messenger in Gs-protein</strong> coupled receptor pathways (e.g., glucagon, epinephrine), not related to RAS.</p>\n<p><strong>ADP (Option B): </strong>Involved in cellular energy balance but has no direct signalling role in the RAS pathway.</p>\n<p><strong>Calcium (Option D): </strong>Acts as an <strong>intracellular second messenger</strong> in various pathways but is not involved in RAS-mediated signalling.</p>", "options": ["cAMP", "ADP", "G protein", "Calcium"], "html_options": ["cAMP", "ADP", "G protein", "Calcium"], "corr_idx": 2}, {"id": "1192345", "html_qtxt": "The Philadelphia chromosome seen in chronic myelocytic leukaemia (CML) results from which of the following molecular mechanisms?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Chromosomal translocation</strong> involves the exchange of genetic material between <strong>nonhomologous chromosomes</strong>. This event can result in the formation of <strong>fusion genes</strong> with <strong>oncogenic</strong>potential.</li>\n<li>In <strong>chronic myelocytic leukaemia</strong> (CML), the Philadelphia chromosome is the result of a <strong>reciprocal</strong> translocation between <strong>chromosomes 9 and 22</strong>, designated as <strong>t(9;22)(q34;q11)</strong>.</li>\n<li>This translocation results in the fusion of the <strong>BCR</strong> gene (located on chromosome <strong>22</strong>) with the <strong>ABL</strong> gene (located on chromosome <strong>9</strong>), forming a <strong>BCR-ABL</strong> fusion gene that encodes a constitutively active <strong>tyrosine kinase</strong>, thereby promoting uncontrolled cell proliferation.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Gene amplification (Option B):</strong> Involves increased copies of a gene, seen in <strong>tumors with drug resistance</strong>, but not the mechanism in CML.</p>\n<p><strong>Promoter insertion (Option C): </strong>Seen in <strong>retroviral oncogenesis</strong>, where a strong viral promoter activates a proto-oncogene.</p>\n<p><strong>Enhancer insertion (Option D):</strong> Also viral in origin, activates <strong>transcription</strong> from <strong>distant sites</strong>; not implicated in the Philadelphia chromosome.</p>", "options": ["Chromosomal translocation", "Gene amplification", "Promoter Insertion", "Enhancer Insertion"], "html_options": ["Chromosomal translocation", "Gene amplification", "Promoter Insertion", "Enhancer Insertion"], "corr_idx": 0}, {"id": "1192346", "html_qtxt": "Which of the following is a tumour suppressor gene?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Rb (Retinoblastoma protein)</strong> is a classic example of a tumour suppressor gene.</li>\n<li>It regulates the <strong>G1-S checkpoint</strong> of the cell cycle by binding to and inhibiting the <strong>transcription factor E2F.</strong></li>\n<li><strong>Mutation</strong> or <strong>inactivation</strong> of the Rb gene removes this inhibition, resulting in <strong>uncontrolled cell division</strong>, a hallmark of tumor formation.</li>\n<li><strong>Loss-of-function</strong> mutations in tumour suppressor genes are typically <strong>recessive</strong>, requiring both alleles to be inactivated for a phenotypic effect.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Ras (Option A):</strong> A proto-oncogene; when mutated, it becomes an oncogene involved in signal transduction (GTPase activity).</p>\n<p><strong>Abl (Option B): </strong>Encodes tyrosine kinase; forms the BCR-ABL fusion gene in CML, an example of oncogene activation.</p>\n<p><strong>Myc (Option C):</strong> A transcription factor oncogene associated with Burkitt lymphoma and other malignancies.</p>\n<p><strong>Key takeaways:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508202976d8a7-7822-41cb-855a-aaafe798d1cd.png\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820bf337888-9de4-42e2-98ab-65832f5737ed.png\">", "options": ["Ras", "Abl", "Myc", "Rb"], "html_options": ["Ras", "Abl", "Myc", "Rb"], "corr_idx": 3}, {"id": "1192347", "html_qtxt": "All of the following are characteristic features of oncogenes, except:", "html_expl": "<p><strong>Explanation: </strong></p>\n<ul>\n<li>Strong tissue preference -not a characteristic feature of oncogenes.</li>\n<li><strong>Oncogenes</strong> typically do not show <strong>tissue-specific</strong></li>\n<li>A single oncogene can be associated with tumours arising from various tissues, and its effect is largely <strong>context-dependent</strong>, rather than tissue-specific.</li>\n<li>In contrast, <strong>Tumour suppressor</strong> genes often demonstrate <strong>strong tissue preference</strong> with respect to the type of cancers in which they are found (eg, mutations in the RB gene result in retinoblastoma)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Mutation in one allele is sufficient (Option A): </strong>Oncogenes act <strong>dominantly</strong>, i.e., mutation in just one allele is enough to <strong>induce oncogenic transformation</strong>.</p>\n<p>In contrast, <strong>tumour suppressor</strong> genes require <strong>the mutation of both alleles</strong> for functional loss.</p>\n<p><strong>Oncogenic effect is due to gain of function (Option B): </strong>Mutations in proto-oncogenes typically result in <strong>gain-of-function</strong>, promoting uncontrolled cell division and proliferation.</p>\n<p><strong>Mutations are never inherited (Option D):</strong> Most oncogene mutations are <strong>somatic</strong>, meaning they are acquired, not inherited. In contrast, mutations in <strong>tumour suppressor genes</strong> (e.g., BRCA1, RB) can be <strong>germline/inherited</strong>.</p>", "options": ["A Mutation in one allele is sufficient", "The oncogenic effect is due to the gain of function of a protein that signals cell division", "Strong tissue preference", "Mutations are never inherited"], "html_options": ["A Mutation in one allele is sufficient", "The oncogenic effect is due to the gain of function of a protein that signals cell division", "Strong tissue preference", "Mutations are never inherited"], "corr_idx": 2}, {"id": "1192348", "html_qtxt": "Which of the following gene associated with colorectal carcinogenesis is involved in tyrosine kinase signalling?", "html_expl": "<p><strong>Explanation:</strong></p>\n<p><strong>K-RAS</strong> encodes a protein involved in <strong>tyrosine kinase</strong> signaling, especially within the <strong>MAP kinase pathway</strong>, which plays a central role in cell growth and proliferation.</p>\n<p>In colorectal cancer, <strong>mutations in K-RAS</strong> lead to constitutive activation of downstream signaling, promoting<strong> oncogenesis.</strong></p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Beta-catenin (Option A): </strong>Encodes a structural protein in <strong>adherens junctions</strong>, important for epithelial cell integrity. It is a part of the <strong>WNT signaling pathway</strong>, not tyrosine kinase signaling.</p>\n<p><strong>P53 (Option C):</strong> Acts as a <strong>tumour suppressor gene</strong>, induced in response to DNA damage, functioning as a transcription factor.</p>\n<p><strong>BAX (Option D):</strong> A <strong>pro-apoptotic gene</strong> that promotes programmed cell death. It does not participate in tyrosine kinase pathways.</p>", "options": ["Beta catenin", "K-RAS", "P53", "BAX"], "html_options": ["Beta catenin", "K-RAS", "P53", "BAX"], "corr_idx": 1}, {"id": "1192349", "html_qtxt": "Which one of the following is a growth inhibitory factor?", "html_expl": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Transforming Growth Factor Beta (TGF-&beta;)</strong> is a well-characterized growth inhibitory factor.</li>\n<li>It inhibits proliferation in a wide variety of cell types and plays a key role in maintaining tissue homeostasis.</li>\n<li>TGF-&beta; can exert both stimulatory and inhibitory effects, depending on the cell type and biological context.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Epidermal Growth Factor (EGF) (Option A): </strong>Primarily acts as a <strong>mitogenic stimulant,</strong> promoting the growth and proliferation of epidermal and epithelial cells.</p>\n<p><strong>Transforming Growth Factor Alpha (TGF-&alpha;) (Option B):</strong> Has similar action to EGF; it stimulates cell proliferation, not inhibition.</p>\n<p><strong>Fibroblast Growth Factors (FGFs) (Option C):</strong> A family of growth factors that promote proliferation and differentiation in various cell types, especially <strong>mesenchymal</strong> and <strong>epithelial</strong> cells.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820036b550e-12ea-4a44-a1a0-e0ce57be215f.png\">", "options": ["Epidermal growth factor", "Transforming growth factor alpha", "Fibroblast growth factors", "Transforming growth factor beta"], "html_options": ["Epidermal growth factor", "Transforming growth factor alpha", "Fibroblast growth factors", "Transforming growth factor beta"], "corr_idx": 3}]}]}}]}

    const navListEl = document.getElementById('nav-list');
    const questionsContainerEl = document.getElementById('questions-container');
    const totalQCountEl = document.getElementById('total-q-count');
    const themeToggleBtn = document.getElementById('theme-toggle');
    const progressBar = document.getElementById('progress-bar');
    const breadcrumbEl = document.getElementById('breadcrumb');

    let currentModuleData = null;
    let markedQuestions = new Set();
    let attemptedQuestions = new Set();

    // --- Theme Toggle ---
    themeToggleBtn.addEventListener('click', () => {
        document.body.classList.toggle('dark-mode');
        const isDarkMode = document.body.classList.contains('dark-mode');
        themeToggleBtn.innerHTML = isDarkMode ? '<i class="fas fa-sun"></i>' : '<i class="fas fa-moon"></i>';
        localStorage.setItem('darkMode', isDarkMode);
    });

    function updateProgress() {
        if (!currentModuleData || currentModuleData.id === 'marked') {
            progressBar.style.width = '0%';
            return;
        }
        const total = currentModuleData.questions.length;
        const attempted = attemptedQuestions.size;
        const percentage = total > 0 ? (attempted / total) * 100 : 0;
        progressBar.style.width = `${percentage}%`;
    }

    function updateBreadcrumb(items) {
        breadcrumbEl.innerHTML = '';
        items.forEach((item, index) => {
            const span = document.createElement('span');
            span.className = 'breadcrumb-item';
            span.textContent = item;
            breadcrumbEl.appendChild(span);
        });
    }

    function setupQuestionInteractivity() {
        document.querySelectorAll('.options-list').forEach(list => {
            const correctIndex = parseInt(list.dataset.correctIndex, 10);
            const options = list.querySelectorAll('li');
            const uniqueId = list.dataset.uniqueQId; 
            const card = list.closest('.card');
            const explanationContainer = card.querySelector('.explanation-container');
            const explanationEl = explanationContainer.querySelector('.explanation');
            const showBtn = explanationContainer.querySelector('.show-explanation-btn');
            const markBtn = card.querySelector('.mark-review-btn');

            options.forEach((li, index) => {
                li.addEventListener('click', () => {
                    if (li.classList.contains('locked')) return;
                    
                    options.forEach(opt => opt.classList.add('locked'));
                    attemptedQuestions.add(uniqueId);
                    updateProgress();
                    
                    if (index === correctIndex) {
                        li.classList.add('user-correct');
                    } else {
                        li.classList.add('user-incorrect');
                    }

                    options[correctIndex].classList.add('correct-reveal');
                    
                    if (showBtn) showBtn.style.display = 'inline-block';
                });
            });

            if (showBtn) {
                showBtn.addEventListener('click', () => {
                    const isVisible = explanationEl.style.display === 'block';
                    explanationEl.style.display = isVisible ? 'none' : 'block';
                    showBtn.textContent = isVisible ? 'Show Explanation' : 'Hide Explanation';
                    if (!isVisible) {
                        explanationEl.scrollIntoView({ behavior: 'smooth', block: 'center' });
                    }
                });
            }

            if (markBtn) {
                markBtn.addEventListener('click', () => {
                    if (markedQuestions.has(uniqueId)) {
                        markedQuestions.delete(uniqueId);
                        markBtn.classList.remove('marked');
                        markBtn.textContent = 'Mark for Review';
                    } else {
                        markedQuestions.add(uniqueId);
                        markBtn.classList.add('marked');
                        markBtn.textContent = 'Marked';
                    }
                    updateMarkedCount();
                });
            }
        });

        if (window.MathJax) {
            MathJax.Hub.Queue(["Typeset", MathJax.Hub, questionsContainerEl]);
        }
    }
    
    function updateMarkedCount() {
        const markedLink = document.getElementById('nav-link-marked');
        if (markedLink) {
            markedLink.querySelector('.nav-count').textContent = markedQuestions.size;
        }
    }

    function renderQuestions(questions, title, breadcrumbItems) {
        if (!questions || questions.length === 0) {
            questionsContainerEl.innerHTML = `<p>No questions found for this view.</p>`;
            updateProgress();
            return;
        }

        updateBreadcrumb(breadcrumbItems);

        let html = '';
        questions.forEach((q, i) => {
            const uniqueId = q.uniqueId;
            const isMarked = markedQuestions.has(uniqueId);
            const correctLabel = String.fromCharCode(65 + (q.corr_idx || 0));
            const optionsHtml = q.html_options.map((opt, idx) => `
                <li>
                    <span class="option-label">${String.fromCharCode(65 + idx)}</span>
                    <span>${opt}</span>
                </li>
            `).join('');

            html += `
                <div class="card">
                    <div class="question-header">
                        <div class="question-number">Question ${i + 1}</div>
                        <button class="mark-review-btn ${isMarked ? 'marked' : ''}" data-unique-q-id="${uniqueId}">${isMarked ? 'Marked' : 'Mark for Review'}</button>
                    </div>
                    <div class="question-text">${q.html_qtxt}</div>
                    <ul class="options-list" data-correct-index="${q.corr_idx}" data-unique-q-id="${uniqueId}">
                        ${optionsHtml}
                    </ul>
                    <div class="explanation-container">
                        <button class="show-explanation-btn" style="display: none;">Show Explanation</button>
                        <div class="explanation">
                            <p class="correct-answer-label">Correct Answer: ${correctLabel}</p>
                            ${q.html_expl}
                        </div>
                    </div>
                </div>
            `;
        });

        questionsContainerEl.innerHTML = html;
        setupQuestionInteractivity();
        updateProgress();
    }

    function renderModule(categoryId, subjectId, moduleId) {
        let questionsToRender = [];
        let moduleName = '';
        let breadcrumbItems = ['Home'];

        if (moduleId === 'marked') {
            moduleName = 'Marked for Review';
            breadcrumbItems.push('Marked for Review');
            
            COURSE_DATA.categories.forEach(cat => {
                cat.subjects.forEach(sub => {
                    sub.modules.forEach(mod => {
                        mod.questions.forEach((q, i) => {
                            const potentialUniqueId = `${cat.categoryId}-${sub.subjectId}-${mod.moduleId}-${q.id || i}`;
                            if (markedQuestions.has(potentialUniqueId)) {
                                questionsToRender.push({ 
                                    ...q, 
                                    uniqueId: potentialUniqueId,
                                    _categoryId: cat.categoryId,
                                    _subjectId: sub.subjectId,
                                    _moduleId: mod.moduleId,
                                    _originalIndex: i 
                                });
                            }
                        });
                    });
                });
            });
            currentModuleData = { id: 'marked', name: moduleName, questions: questionsToRender };
        } else {
            let module = null;
            let categoryName = '';
            let subjectName = '';
            
            for (const cat of COURSE_DATA.categories) {
                if (cat.categoryId === categoryId) {
                    categoryName = cat.name;
                    breadcrumbItems.push(cat.name);
                    
                    for (const sub of cat.subjects) {
                        if (sub.subjectId === subjectId) {
                            subjectName = sub.name;
                            breadcrumbItems.push(subjectName);
                            
                            module = sub.modules.find(m => m.moduleId === moduleId);
                            if (module) {
                                moduleName = module.name;
                                breadcrumbItems.push(moduleName);
                                break;
                            }
                        }
                    }
                    if (module) break;
                }
            }
            
            if (!module) {
                questionsContainerEl.innerHTML = '<p>Error: Module not found.</p>';
                currentModuleData = null;
                return;
            }
            
            questionsToRender = module.questions.map((q, i) => ({
                ...q,
                uniqueId: `${categoryId}-${subjectId}-${moduleId}-${q.id || i}`
            }));
            
            currentModuleData = {
                id: moduleId,
                name: moduleName,
                questions: questionsToRender
            };
        }
        
        // Update active state in sidebar
        document.querySelectorAll('.nav-link').forEach(link => link.classList.remove('active'));
        const activeLink = document.getElementById(`nav-link-${moduleId}`);
        if (activeLink) activeLink.classList.add('active');

        renderQuestions(questionsToRender, moduleName, breadcrumbItems);
    }

    function renderSubject(categoryId, subjectId) {
        let questionsToRender = [];
        let subjectName = '';
        let breadcrumbItems = ['Home'];
        
        for (const cat of COURSE_DATA.categories) {
            if (cat.categoryId === categoryId) {
                breadcrumbItems.push(cat.name);
                
                for (const sub of cat.subjects) {
                    if (sub.subjectId === subjectId) {
                        subjectName = sub.name;
                        breadcrumbItems.push(subjectName);
                        
                        sub.modules.forEach(mod => {
                            mod.questions.forEach((q, i) => {
                                questionsToRender.push({
                                    ...q,
                                    uniqueId: `${categoryId}-${subjectId}-${mod.moduleId}-${q.id || i}`,
                                    moduleName: mod.name
                                });
                            });
                        });
                        break;
                    }
                }
                break;
            }
        }
        
        // Update active state in sidebar
        document.querySelectorAll('.nav-link').forEach(link => link.classList.remove('active'));
        const activeLink = document.getElementById(`nav-link-subject-${subjectId}`);
        if (activeLink) activeLink.classList.add('active');
        
        currentModuleData = {
            id: `subject-${subjectId}`,
            name: subjectName,
            questions: questionsToRender
        };
        
        renderQuestions(questionsToRender, subjectName, breadcrumbItems);
    }


    function collapseSiblingItems(item) {
        if (!item || !item.parentElement) return;
        Array.from(item.parentElement.children).forEach((sibling) => {
            if (sibling !== item && sibling.classList.contains('nav-item')) {
                sibling.classList.remove('expanded');
            }
        });
    }

    function buildNavigation() {
        navListEl.innerHTML = '';
        
        // Add "Marked for Review" link
        const markedItem = document.createElement('li');
        markedItem.className = 'nav-item';
        markedItem.innerHTML = `
            <div class="nav-link" id="nav-link-marked">
                <i class="fas fa-star nav-icon"></i>
                <span class="nav-text">Marked for Review</span>
                <span class="nav-count">0</span>
            </div>
        `;
        markedItem.querySelector('.nav-link').addEventListener('click', () => renderModule(null, null, 'marked'));
        navListEl.appendChild(markedItem);
        
        COURSE_DATA.categories.forEach(category => {
            const categoryItem = document.createElement('li');
            categoryItem.className = 'nav-item category-item';
            
            const categoryLink = document.createElement('div');
            categoryLink.className = 'nav-link';
            categoryLink.innerHTML = `
                <i class="fas fa-folder nav-icon"></i>
                <span class="nav-text">${category.name}</span>
                <i class="fas fa-chevron-right expand-icon"></i>
            `;
            
            const subNav = document.createElement('div');
            subNav.className = 'sub-nav';
            
            category.subjects.forEach(subject => {
                const subjectItem = document.createElement('li');
                subjectItem.className = 'nav-item subject-item';
                
                const subjectLink = document.createElement('div');
                subjectLink.className = 'nav-link';
                subjectLink.id = `nav-link-subject-${subject.subjectId}`;
                subjectLink.innerHTML = `
                    <i class="fas fa-book nav-icon"></i>
                    <span class="nav-text">${subject.name}</span>
                    <i class="fas fa-chevron-right expand-icon"></i>
                `;
                
                const moduleNav = document.createElement('div');
                moduleNav.className = 'sub-nav';
                
                let subjectQuestionCount = 0;
                
                subject.modules.forEach(module => {
                    subjectQuestionCount += module.questions.length;
                    
                    const moduleItem = document.createElement('li');
                    moduleItem.className = 'nav-item module-item';
                    
                    const moduleLink = document.createElement('div');
                    moduleLink.className = 'nav-link';
                    moduleLink.id = `nav-link-${module.moduleId}`;
                    moduleLink.innerHTML = `
                        <i class="fas fa-file nav-icon"></i>
                        <span class="nav-text">${module.name}</span>
                        <span class="nav-count">${module.questions.length}</span>
                    `;
                    
                    moduleLink.addEventListener('click', (e) => {
                        e.stopPropagation();
                        renderModule(category.categoryId, subject.subjectId, module.moduleId);
                    });
                    
                    moduleItem.appendChild(moduleLink);
                    moduleNav.appendChild(moduleItem);
                });
                
                // Add question count to subject
                subjectLink.innerHTML = `
                    <i class="fas fa-book nav-icon"></i>
                    <span class="nav-text">${subject.name}</span>
                    <span class="nav-count">${subjectQuestionCount}</span>
                    <i class="fas fa-chevron-right expand-icon"></i>
                `;
                
                subjectLink.addEventListener('click', (e) => {
                    e.stopPropagation();
                    const shouldExpand = !subjectItem.classList.contains('expanded');
                    collapseSiblingItems(subjectItem);
                    subjectItem.classList.toggle('expanded', shouldExpand);
                });
                
                subjectItem.appendChild(subjectLink);
                subjectItem.appendChild(moduleNav);
                subNav.appendChild(subjectItem);
            });
            
            categoryLink.addEventListener('click', (e) => {
                e.stopPropagation();
                const shouldExpand = !categoryItem.classList.contains('expanded');
                collapseSiblingItems(categoryItem);
                categoryItem.classList.toggle('expanded', shouldExpand);
            });
            
            categoryItem.appendChild(categoryLink);
            categoryItem.appendChild(subNav);
            navListEl.appendChild(categoryItem);
        });
    }

    function init() {
        if (!COURSE_DATA || !COURSE_DATA.categories) {
            questionsContainerEl.innerHTML = '<p>Error: Could not load course data.</p>';
            return;
        }

        COURSE_DATA.categories = COURSE_DATA.categories.map((category) => ({
            ...category,
            subjects: Array.isArray(category.subjects) ? category.subjects : [category.subjects].filter(Boolean)
        }));

        const darkModePref = localStorage.getItem('darkMode');
        if (darkModePref === 'true') {
            document.body.classList.add('dark-mode');
            themeToggleBtn.innerHTML = '<i class="fas fa-sun"></i>';
        }

        totalQCountEl.textContent = COURSE_DATA.total_questions;
        
        buildNavigation();
    }

    document.addEventListener('DOMContentLoaded', init);
</script>

</body>
</html>
